Citrus Sinensis ID: 030256

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180
Protein Sequence
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEEccEEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEEcccccccccccccccccccccccHHHHHcccccccccccHHHHHHHHHHHHcccccccccHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccEEEcHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEccEcccccEEEccccccEEcccccEEEEEEccHHHccHHHHcccEEcHHHHHHHHHHHHHHHHHcccccccccHHHHHHHc
Coil and Loop (DISEMBL)
MLKKLNKHLKSCLDCELNflssvnhpniiRLFDAFQAENCIFLVVEFCaggnlssyirlhgrvPEQTARKFLQQLGAGleilnshhiihrdlkpenillsgldddvMLKIADFglsctlypgnyaekvcgsplymapevlqfqrydekvdmWSVGAILFELlngyppfsayrpcfasrlc
Flexible Loop (DISEMBL)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC
Low Complexity Region (SEG)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC
Disordered region (IsUnstruct)
*******HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL***************LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA****
Disordered Region (DISOPRED)
************LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC
Disordered Region (DISEMBL)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC
Disordered Region (DISPRO)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	180	2.2.26 [Sep-21-2011]
Q9QY01	1037	Serine/threonine-protein	yes	no	0.877	0.152	0.451	2e-39
Q8IYT8	1036	Serine/threonine-protein	yes	no	0.877	0.152	0.451	5e-39
Q5ZJH6	468	Serine/threonine-protein	no	no	0.927	0.356	0.464	1e-37
A7KAL2	960	Serine/threonine-protein	yes	no	0.938	0.176	0.377	1e-37
Q0CLX3	964	Serine/threonine-protein	N/A	no	0.938	0.175	0.382	2e-37
Q3U3Q1	472	Serine/threonine-protein	no	no	0.922	0.351	0.473	5e-37
Q2UGZ7	934	Serine/threonine-protein	yes	no	0.938	0.180	0.377	5e-37
D3ZHP7	472	Serine/threonine-protein	no	no	0.922	0.351	0.473	6e-37
Q86CS2	668	Serine/threonine-protein	yes	no	0.916	0.247	0.428	1e-36
A1CX69	950	Serine/threonine-protein	N/A	no	0.938	0.177	0.373	1e-36

>sp|Q9QY01|ULK2_MOUSE Serine/threonine-protein kinase ULK2 OS=Mus musculus GN=Ulk2 PE=1 SV=1

 Score =  161 bits (407), Expect = 2e-39,   Method: Composition-based stats.
 Identities = 74/164 (45%), Positives = 105/164 (64%), Gaps = 6/164 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y++  G + E T R FL Q+
Sbjct: 56  EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 129
            A + IL+S  IIHRDLKP+NILLS  +        + +KIADFG +  L+    A  +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIADFGFARYLHSNTMAATLC 175

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           GSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF A  P
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQANSP 219

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3

 Score =  160 bits (404), Expect = 5e-39,   Method: Composition-based stats.
 Identities = 74/164 (45%), Positives = 105/164 (64%), Gaps = 6/164 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y++  G + E T R FL Q+
Sbjct: 56  EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 129
            A + IL+S  IIHRDLKP+NILLS  +        + +KIADFG +  L+    A  +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAATLC 175

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           GSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF A  P
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQANSP 219

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1

 Score =  155 bits (393), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 78/168 (46%), Positives = 113/168 (67%), Gaps = 1/168 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           + LN+     L  E+  L ++ HP+I+ L D     + I+L++EFCAGG+LS +IR+   
Sbjct: 49  RSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLSRFIRMRRI 108

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE+ AR FLQQL   L+ L+ H+I H DLKP+NILLS   ++  LK+ADFG +  + P 
Sbjct: 109 LPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSPW 167

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +    + GSPLYMAPE++  Q+YD +VD+WSVG IL+E L G PPF++
Sbjct: 168 DEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFAS 215

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A7KAL2|ATG1_PENCW Serine/threonine-protein kinase ATG1 OS=Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) GN=atg1 PE=3 SV=1

 Score =  155 bits (392), Expect = 1e-37,   Method: Composition-based stats.
 Identities = 82/217 (37%), Positives = 121/217 (55%), Gaps = 48/217 (22%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L KLNK LK  L  E++ L  ++HP+I+ L D  ++ + I LV+E+CA G+LS +I+   
Sbjct: 55  LSKLNKKLKENLSSEIDILKGLHHPHIVALIDCHESTSHIHLVMEYCALGDLSLFIKRRD 114

Query: 61  --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
                               G + E   R FL+QL + L+ L   ++IHRD+KP+N+LL 
Sbjct: 115 TLGSHKYTRDMIAKYPNPPGGSLNEVVTRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLC 174

Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
                                     +GL+   MLKIADFG + +L   + AE +CGSPL
Sbjct: 175 PSPSSYRSGHAQVMPYKGSDDSYEPTTGLESLPMLKIADFGFARSLPATSLAETLCGSPL 234

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPE+L++++YD K D+WSVG +L+E++ G PPF A
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGRPPFRA 271

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) (taxid: 500485)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0CLX3|ATG1_ASPTN Serine/threonine-protein kinase atg1 OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=atg1 PE=3 SV=1

 Score =  154 bits (390), Expect = 2e-37,   Method: Composition-based stats.
 Identities = 83/217 (38%), Positives = 119/217 (54%), Gaps = 48/217 (22%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L +LNK LK  L  E++ L  + HP+I+ L D  +  + I LV+E+CA G+LS +IR   
Sbjct: 59  LSQLNKKLKENLFSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSQFIRHRN 118

Query: 61  --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
                               G + E   R FL+QL + L+ L   ++IHRD+KP+N+LL 
Sbjct: 119 TLGEHRYTRDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 178

Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
                                     +GLD   MLKIADFG + +L   + AE +CGSPL
Sbjct: 179 PSPTSYRAGVAQIVPFKGSEDSFSPATGLDSLPMLKIADFGFARSLPATSLAETLCGSPL 238

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPE+L++++YD K D+WSVG +L+E++ G PPF A
Sbjct: 239 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPFRA 275

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus GN=Ulk3 PE=2 SV=1

 Score =  153 bits (387), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 80/169 (47%), Positives = 114/169 (67%), Gaps = 3/169 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
           K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct: 49  KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            +PE+ AR F+QQL + L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            +    + GSPLYMAPE++  ++YD +VD+WSVG IL+E L G PPF++
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFAS 215

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2UGZ7|ATG1_ASPOR Serine/threonine-protein kinase atg1 OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) GN=atg1 PE=3 SV=1

 Score =  153 bits (387), Expect = 5e-37,   Method: Composition-based stats.
 Identities = 82/217 (37%), Positives = 119/217 (54%), Gaps = 48/217 (22%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L KLNK LK  L  E++ L  + HP+I+ L D  +  + I LV+E+CA G+LS +I+   
Sbjct: 55  LSKLNKKLKENLSSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSLFIKRRD 114

Query: 61  --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
                               G + E   R FL+QL + L+ L   ++IHRD+KP+N+LL 
Sbjct: 115 TLGDHRYTQDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 174

Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
                                     +GL+   MLKIADFG + +L   + AE +CGSPL
Sbjct: 175 PSPSSYRSGVAQVVPFKGCDESFSPATGLESLPMLKIADFGFARSLPSTSLAETLCGSPL 234

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPE+L++++YD K D+WSVG +L+E++ G PPF A
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPFRA 271

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Aspergillus oryzae (strain ATCC 42149 / RIB 40) (taxid: 510516)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1

 Score =  153 bits (386), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 80/169 (47%), Positives = 114/169 (67%), Gaps = 3/169 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
           K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct: 49  KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            +PE+ AR F+QQL + L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            +    + GSPLYMAPE++  ++YD +VD+WSVG IL+E L G PPF++
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFAS 215

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86CS2|ATG1_DICDI Serine/threonine-protein kinase atg1 OS=Dictyostelium discoideum GN=atg1 PE=3 SV=1

 Score =  152 bits (384), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 72/168 (42%), Positives = 107/168 (63%), Gaps = 3/168 (1%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGR 62
           N  L   L+ E+  L  ++H NI+RL+D    E     I++++E C GG+ S YIR H +
Sbjct: 47  NSKLTENLNYEIRILKELSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKK 106

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E+ A  F++QL  GL+ L    I+HRDLKP+N+LLS   +  +LKI DFG +  + P 
Sbjct: 107 LTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPF 166

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           + ++  CGSPLYMAPE+L  + Y  K D+WSVG IL+E+L G P +++
Sbjct: 167 SLSDTFCGSPLYMAPEILHRKNYTVKADLWSVGIILYEMLVGEPAYNS 214

Serine/threonine protein kinase involved in autophagy. Involved in the control of autophagic vacuolar cell death.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A1CX69|ATG1_NEOFI Serine/threonine-protein kinase atg1 OS=Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / FGSC A1164 / NRRL 181) GN=atg1 PE=3 SV=1

 Score =  152 bits (383), Expect = 1e-36,   Method: Composition-based stats.
 Identities = 81/217 (37%), Positives = 119/217 (54%), Gaps = 48/217 (22%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L KLNK LK  L  E++ L  + HP+I+ L D  +  + I LV+E+CA G+LS +I+   
Sbjct: 39  LSKLNKKLKDNLSSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSLFIKRRD 98

Query: 61  --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
                               G + E   R FL+QL + L+ L   ++IHRD+KP+N+LL 
Sbjct: 99  TLGDHRYTRDMIAKYPNPPGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 158

Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
                                     +GL+   +LKIADFG + +L   + AE +CGSPL
Sbjct: 159 PSPSSYRSGVTQVVPFKGSEDSFNPATGLESLPLLKIADFGFARSLPATSLAETLCGSPL 218

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPE+L++++YD K D+WSVG +L+E++ G PPF A
Sbjct: 219 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPFRA 255

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / FGSC A1164 / NRRL 181) (taxid: 331117)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	180
255581995	321	serine/threonine-protein kinase, putativ	0.927	0.520	0.820	9e-75
359476946	260	PREDICTED: serine/threonine-protein kina	0.927	0.642	0.766	1e-71
225431573	275	PREDICTED: serine/threonine-protein kina	0.927	0.607	0.766	1e-71
224116060	266	predicted protein [Populus trichocarpa]	0.938	0.635	0.730	2e-68
357464547	290	Serine/threonine protein kinase GE16371	0.938	0.582	0.710	2e-66
297852566	266	hypothetical protein ARALYDRAFT_314341 [	0.927	0.627	0.682	7e-63
7770326	392	F27J15.5 [Arabidopsis thaliana]	0.927	0.426	0.658	1e-61
334183174	376	protein kinase-like protein [Arabidopsis	0.927	0.444	0.658	1e-61
30694500	408	protein kinase-like protein [Arabidopsis	0.927	0.409	0.658	2e-61
110736434	295	similar to MAP/ERK kinase kinase 3 [Arab	0.938	0.572	0.650	4e-61

>gi|255581995|ref|XP_002531795.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223528561|gb|EEF30583.1| serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  284 bits (727), Expect = 9e-75,   Method: Compositional matrix adjust.
 Identities = 137/167 (82%), Positives = 148/167 (88%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLNKHLK+CLDCELNFLSSVNHPNIIRLF  FQAE+ IFLV+EFCAGG+LSSYIR HG
Sbjct: 53  LSKLNKHLKNCLDCELNFLSSVNHPNIIRLFHVFQAESSIFLVLEFCAGGSLSSYIRHHG 112

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E+ AR+ +QQLGAGLEIL+SHHIIHRDLKPENILLSG   DV+LKIADFGLS  + P
Sbjct: 113 RVQEEIARRLMQQLGAGLEILHSHHIIHRDLKPENILLSGQFADVVLKIADFGLSRRVQP 172

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G YAE VCGSPLYMAPEVLQFQ YD+K DMWSVG ILFELLNGYPPF
Sbjct: 173 GKYAETVCGSPLYMAPEVLQFQSYDDKADMWSVGVILFELLNGYPPF 219

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359476946|ref|XP_003631917.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 2 [Vitis vinifera]

 Score =  274 bits (701), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 128/167 (76%), Positives = 150/167 (89%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++LK+ LDCE+NFLSSV+HPNIIRL   FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43  LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPF 209

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431573|ref|XP_002282420.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 1 [Vitis vinifera] gi|296088603|emb|CBI37594.3| unnamed protein product [Vitis vinifera]

 Score =  274 bits (700), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 128/167 (76%), Positives = 150/167 (89%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++LK+ LDCE+NFLSSV+HPNIIRL   FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43  LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPF 209

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116060|ref|XP_002332038.1| predicted protein [Populus trichocarpa] gi|222875263|gb|EEF12394.1| predicted protein [Populus trichocarpa]

 Score =  263 bits (671), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 125/171 (73%), Positives = 145/171 (84%), Gaps = 2/171 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLNK+L++CLDCELNFLSSVNH NIIRL D F+ + C+FLV+EFC+GGNL+SY++ HG
Sbjct: 38  LSKLNKNLRNCLDCELNFLSSVNHTNIIRLLDVFEDDCCMFLVLEFCSGGNLASYLQQHG 97

Query: 62  RVPEQTARKFLQQLGAG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           RV E+ A++F QQ+G+G  L+IL SHHIIHRDLKPENILLSG + DV+LKIADFGLS  +
Sbjct: 98  RVQEKIAKRFTQQMGSGDGLKILQSHHIIHRDLKPENILLSGKESDVVLKIADFGLSRRV 157

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            P NY E VCGSP YMAPEVLQFQRYD KVDMWSVG ILFELLNGYPPF  
Sbjct: 158 LPDNYVETVCGSPFYMAPEVLQFQRYDYKVDMWSVGVILFELLNGYPPFRG 208

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357464547|ref|XP_003602555.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] gi|355491603|gb|AES72806.1| Serine/threonine protein kinase GE16371 [Medicago truncatula]

 Score =  256 bits (654), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 120/169 (71%), Positives = 140/169 (82%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN HL++ LDCE+NFLSSVNHPNI+ L   FQ   C++LV+EFCAGGNL+SYIR H 
Sbjct: 58  LSKLNSHLRASLDCEINFLSSVNHPNIVHLLHFFQGNGCVYLVLEFCAGGNLASYIRCHE 117

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV + TA+KF+QQLG+GL++L+SH IIHRDLKPENILLS    D +LKIADFGLS T+ P
Sbjct: 118 RVHQLTAKKFIQQLGSGLKVLHSHGIIHRDLKPENILLSSHGADAVLKIADFGLSRTVRP 177

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           G Y E VCG+P YMAPEVLQFQRYD K DMWSVGA+LFELLNGYPPF+ 
Sbjct: 178 GEYVETVCGTPSYMAPEVLQFQRYDHKADMWSVGAMLFELLNGYPPFNG 226

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297852566|ref|XP_002894164.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] gi|297340006|gb|EFH70423.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata]

 Score =  244 bits (624), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 114/167 (68%), Positives = 138/167 (82%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L++CL+ EL FLSSV+HPNIIRL   FQ E  + +V+E+C GG LSSYI+ HG
Sbjct: 39  LSKLNRNLRTCLNNELEFLSSVDHPNIIRLLHVFQDEEFLVMVMEYCDGGTLSSYIQRHG 98

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++FL+Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L P
Sbjct: 99  RVEEDIAKRFLKQIGAGLEIIHDNHIIHRDLKPENILIVGSGDDLVLKIADFSLARKLLP 158

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 159 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 205

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7770326|gb|AAF69696.1|AC016041_1 F27J15.5 [Arabidopsis thaliana]

 Score =  241 bits (614), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 110/167 (65%), Positives = 138/167 (82%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 38  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 97

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 98  RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 157

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 158 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 204

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334183174|ref|NP_001185178.1| protein kinase-like protein [Arabidopsis thaliana] gi|332194280|gb|AEE32401.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  240 bits (613), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 110/167 (65%), Positives = 138/167 (82%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30694500|ref|NP_175344.2| protein kinase-like protein [Arabidopsis thaliana] gi|332194279|gb|AEE32400.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  240 bits (613), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 110/167 (65%), Positives = 138/167 (82%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110736434|dbj|BAF00185.1| similar to MAP/ERK kinase kinase 3 [Arabidopsis thaliana]

 Score =  239 bits (609), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 110/169 (65%), Positives = 138/169 (81%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 68  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 127

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 128 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 187

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF  
Sbjct: 188 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRG 236

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	180
TAIR|locus:2028496	408	AT1G49180 [Arabidopsis thalian	0.927	0.409	0.658	3.2e-58
TAIR|locus:2084440	712	AT3G53930 [Arabidopsis thalian	0.933	0.235	0.559	1e-47
TAIR|locus:2065680	733	AT2G37840 [Arabidopsis thalian	0.933	0.229	0.547	2.1e-47
TAIR|locus:2079527	626	AT3G61960 [Arabidopsis thalian	0.922	0.265	0.512	7.1e-45
UNIPROTKB|Q5ZJH6	468	ULK3 "Serine/threonine-protein	0.922	0.354	0.473	9.2e-36
MGI|MGI:1352758	1037	Ulk2 "unc-51 like kinase 2" [M	0.955	0.165	0.445	9.4e-36
RGD|1310181	1037	Ulk2 "Unc-51 like kinase 2 (C.	0.955	0.165	0.445	1.2e-35
UNIPROTKB|Q8IYT8	1036	ULK2 "Serine/threonine-protein	0.955	0.166	0.445	1.5e-35
UNIPROTKB|E2RF62	1037	ULK2 "Uncharacterized protein"	0.955	0.165	0.445	2e-35
UNIPROTKB|F1NHE7	1040	ULK2 "Uncharacterized protein"	0.955	0.165	0.445	2e-35

TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)]

 Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
 Identities = 110/167 (65%), Positives = 138/167 (82%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct:    40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query:    62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
             RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct:   100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query:   122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct:   160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)]

 Score = 499 (180.7 bits), Expect = 1.0e-47, P = 1.0e-47
 Identities = 94/168 (55%), Positives = 122/168 (72%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             + +LNK L+  L  E+  L  +NHPNIIR  D  +A   I LV+E+C GG+LS YI  HG
Sbjct:    53 MARLNKKLQESLMSEIIILRKINHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHG 112

Query:    62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
              VPE TA+ F+ QL AGL++L  ++IIHRDLKP+N+LLS  D+D  LKIADFG + +L P
Sbjct:   113 SVPEATAKHFMLQLAAGLQVLRDNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQP 172

Query:   122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
                AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G  PF+
Sbjct:   173 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFT 220

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)]

 Score = 498 (180.4 bits), Expect = 2.1e-47, P = 2.1e-47
 Identities = 92/168 (54%), Positives = 125/168 (74%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             + +LNK L+  L  E+  L  +NHPNIIRL D  ++   + LV+E+C GG+LS Y++ HG
Sbjct:    45 MDRLNKKLQESLMSEIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHG 104

Query:    62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
              VPE TA+ F+QQL AGL++L  ++IIHRDLKP+N+LLS  ++D  LKIADFG + +L P
Sbjct:   105 IVPEATAKHFMQQLAAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQP 164

Query:   122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
                AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G  PF+
Sbjct:   165 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFT 212

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)]

 Score = 472 (171.2 bits), Expect = 7.1e-45, P = 7.1e-45
 Identities = 85/166 (51%), Positives = 122/166 (73%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             K L+  ++  L  E++ LS+++HPNIIR ++A +  + IFLV+E+C+GG+L+ YI  HG+
Sbjct:    44 KLLSPKVRDNLLKEISILSTIDHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGK 103

Query:    63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             VPE  A+ F++QL  GL++L   H IHRDLKP+N+LLS  +   +LKI DFG + +L P 
Sbjct:   104 VPEAVAKHFMRQLALGLQVLQEKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPE 163

Query:   123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             + AE  CGSPLYMAPE+++ Q+YD K D+WS GAILF+L+ G PPF
Sbjct:   164 SMAETFCGSPLYMAPEIIRNQKYDAKADLWSAGAILFQLVTGKPPF 209

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)]

 Score = 386 (140.9 bits), Expect = 9.2e-36, P = 9.2e-36
 Identities = 80/169 (47%), Positives = 116/169 (68%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
             + LN+     L  E+  L ++ HP+I+ L D FQ ++  I+L++EFCAGG+LS +IR+  
Sbjct:    49 RSLNRASVENLLTEIEILKTIRHPHIVELKD-FQWDSDHIYLIMEFCAGGDLSRFIRMRR 107

Query:    62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
              +PE+ AR FLQQL   L+ L+ H+I H DLKP+NILLS   ++  LK+ADFG +  + P
Sbjct:   108 ILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSP 166

Query:   122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              +    + GSPLYMAPE++  Q+YD +VD+WSVG IL+E L G PPF++
Sbjct:   167 WDEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFAS 215

GO:0005524 "ATP binding" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=ISS

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

MGI|MGI:1352758 Ulk2 "unc-51 like kinase 2" [Mus musculus (taxid:10090)]

 Score = 397 (144.8 bits), Expect = 9.4e-36, P = 9.4e-36
 Identities = 81/182 (44%), Positives = 115/182 (63%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF A 
Sbjct:   158 DFGFARYLHSNTMAATLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQAN 217

Query:   172 RP 173
              P
Sbjct:   218 SP 219

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007399 "nervous system development" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0010506 "regulation of autophagy" evidence=ISO;IMP

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0031410 "cytoplasmic vesicle" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=ISO;IDA

GO:0042594 "response to starvation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0048671 "negative regulation of collateral sprouting" evidence=IMP

GO:0048675 "axon extension" evidence=IMP

RGD|1310181 Ulk2 "Unc-51 like kinase 2 (C. elegans)" [Rattus norvegicus (taxid:10116)]

 Score = 396 (144.5 bits), Expect = 1.2e-35, P = 1.2e-35
 Identities = 81/182 (44%), Positives = 114/182 (62%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS           + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYASRRKSNVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF A 
Sbjct:   158 DFGFARYLHSNTMAATLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQAN 217

Query:   172 RP 173
              P
Sbjct:   218 SP 219

GO:0003674 "molecular_function" evidence=ND

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0008150 "biological_process" evidence=ND

GO:0010506 "regulation of autophagy" evidence=IEA;ISO

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA;ISO

GO:0042594 "response to starvation" evidence=IEA;ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA;ISO

GO:0048675 "axon extension" evidence=IEA;ISO

UNIPROTKB|Q8IYT8 ULK2 "Serine/threonine-protein kinase ULK2" [Homo sapiens (taxid:9606)]

 Score = 395 (144.1 bits), Expect = 1.5e-35, P = 1.5e-35
 Identities = 81/182 (44%), Positives = 115/182 (63%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF A 
Sbjct:   158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQAN 217

Query:   172 RP 173
              P
Sbjct:   218 SP 219

GO:0007165 "signal transduction" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0048675 "axon extension" evidence=IEA

GO:0030659 "cytoplasmic vesicle membrane" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0010506 "regulation of autophagy" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042594 "response to starvation" evidence=ISS

UNIPROTKB|E2RF62 ULK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 394 (143.8 bits), Expect = 2.0e-35, P = 2.0e-35
 Identities = 81/182 (44%), Positives = 115/182 (63%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF A 
Sbjct:   158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLWSIGTVVYQCLVGKPPFQAN 217

Query:   172 RP 173
              P
Sbjct:   218 SP 219

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1NHE7 ULK2 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 394 (143.8 bits), Expect = 2.0e-35, P = 2.0e-35
 Identities = 81/182 (44%), Positives = 115/182 (63%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  + +FLV+E+C GG+L+ Y+
Sbjct:    33 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQEMPSSVFLVMEYCNGGDLADYL 92

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FLQQ+ A + IL+S  IIHRDLKP+NILLS           + +KIA
Sbjct:    93 QAKGTLSEDTIRVFLQQIAAAMRILHSKGIIHRDLKPQNILLSYASRRKSSVSGIRIKIA 152

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF A 
Sbjct:   153 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQAN 212

Query:   172 RP 173
              P
Sbjct:   213 SP 214

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0010506 "regulation of autophagy" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA

GO:0042594 "response to starvation" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0048675 "axon extension" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00034887001 SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (275 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	180
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-71
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-60
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-55
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-55
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-51
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-51
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-49
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-46
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-46
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-43
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-42
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-42
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-42
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-40
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-40
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-39
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-38
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-38
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-38
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-38
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-38
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-38
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-38
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-37
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-36
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-36
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-36
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-36
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-35
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-34
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-34
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-33
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-33
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-33
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-32
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-32
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-32
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-31
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-31
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-31
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-31
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-31
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-31
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-31
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-30
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-30
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-30
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-30
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-30
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-30
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-30
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-30
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-29
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-29
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-29
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-29
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-29
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-29
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-29
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-29
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-28
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-28
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-28
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-28
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-28
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-27
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-27
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-27
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-27
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-27
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-27
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-27
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-27
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-27
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-27
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-27
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-27
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-27
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-26
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-26
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-26
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-26
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-26
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-26
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-25
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-25
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-25
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-25
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-25
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-25
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-24
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-24
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-24
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-24
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-24
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-24
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-24
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-24
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-24
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-24
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-24
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-24
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-24
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-24
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-24
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-24
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-23
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-23
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-23
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-23
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-23
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-23
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-23
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-23
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-23
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-23
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-22
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-22
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-22
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-22
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-22
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-22
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-22
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-22
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-22
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-22
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-22
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-21
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-21
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-21
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-21
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-21
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-21
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-21
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-21
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-21
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-20
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-20
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-20
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-20
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-19
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-19
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-19
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-19
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-19
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-18
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-17
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-17
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-17
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-17
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-13
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	9e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-09
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-09
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	1e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	8e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	8e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	5e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  216 bits (553), Expect = 1e-71
 Identities = 78/173 (45%), Positives = 110/173 (63%), Gaps = 7/173 (4%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K            E+  L  + HPNI+RL+D F+ E+ ++LV+E+C GG+L   +
Sbjct: 29  IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           +  GR+ E  AR +L+Q+ + LE L+S  I+HRDLKPENIL   LD+D  +K+ADFGL+ 
Sbjct: 89  KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENIL---LDEDGHVKLADFGLAR 145

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            L PG       G+P YMAPEVL  + Y + VD+WS+G IL+ELL G PPF  
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPG 198

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  187 bits (477), Expect = 3e-60
 Identities = 80/175 (45%), Positives = 110/175 (62%), Gaps = 10/175 (5%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           +K L K  +          E+  L  ++HPNI+RL DAF+ ++ ++LV+E+C GG+L  Y
Sbjct: 29  VKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY 88

Query: 57  IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +   G + E  A+K   Q+  GLE L+S+ IIHRDLKPENIL   LD++ ++KIADFGL+
Sbjct: 89  LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL---LDENGVVKIADFGLA 145

Query: 117 CTLY-PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
             L    +      G+P YMAPEVL     Y  KVD+WS+G IL+ELL G PPFS
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFS 200

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (441), Expect = 3e-55
 Identities = 73/167 (43%), Positives = 104/167 (62%), Gaps = 9/167 (5%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K   S L      E+  L  +NHPNI++L+  F+ EN ++LV+E+C GG+L   +
Sbjct: 23  IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82

Query: 58  -RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
               G++ E    + L Q+  GLE L+S+ IIHRDLKPENILL    D+  +K+ADFGLS
Sbjct: 83  KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD--SDNGKVKLADFGLS 140

Query: 117 CTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFEL 161
             L    +  + + G+P YMAPEVL  +  Y EK D+WS+G IL+EL
Sbjct: 141 KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  173 bits (442), Expect = 7e-55
 Identities = 72/156 (46%), Positives = 98/156 (62%), Gaps = 4/156 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E N LS +NHP I++L  AFQ E  ++LV+E+  GG L S++   GR  E+ AR +  ++
Sbjct: 43  ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLY 134
              LE L+S  II+RDLKPENIL   LD D  +K+ DFGL+  L          CG+P Y
Sbjct: 103 VLALEYLHSLGIIYRDLKPENIL---LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +APEVL  + Y + VD WS+G +L+E+L G PPF A
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  164 bits (418), Expect = 3e-51
 Identities = 63/171 (36%), Positives = 102/171 (59%), Gaps = 8/171 (4%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
             L+ E+  LSS+ HPNI+R + + + E  N + + +E+ +GG+LSS ++  G++PE   
Sbjct: 44  EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI 103

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYA 125
           RK+ +Q+  GL  L+S+ I+HRD+K  NIL+     D ++K+ADFG +  L     G   
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGT 160

Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
             V G+P +MAPEV++ + Y    D+WS+G  + E+  G PP+S      A
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  164 bits (418), Expect = 3e-51
 Identities = 57/160 (35%), Positives = 96/160 (60%), Gaps = 8/160 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARKF 71
           E+  L  +NHPNII+ +++F+ +  + +V+E+  GG+LS  I+   +     PE+    +
Sbjct: 49  EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCG 130
             QL   L+ L+S  I+HRD+KP+NI L     + ++K+ DFG+S  L    + A+ V G
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVG 165

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +P Y++PE+ Q + Y+ K D+WS+G +L+EL     PF  
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  161 bits (410), Expect = 6e-50
 Identities = 64/177 (36%), Positives = 102/177 (57%), Gaps = 12/177 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             + K+    +  E + LS    P +++L+ +FQ +  ++LV+E+  GG+L+S +   G 
Sbjct: 30  DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------ 116
           + E  AR ++ ++   LE L+S+ IIHRDLKP+NIL   +D +  LK+ DFGLS      
Sbjct: 90  LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL---IDSNGHLKLTDFGLSKVGLVR 146

Query: 117 --CTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
               L      + ++ G+P Y+APEV+  Q + + VD WS+G IL+E L G PPF  
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  158 bits (401), Expect = 9e-49
 Identities = 59/159 (37%), Positives = 92/159 (57%), Gaps = 4/159 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L    HPNI++ + ++  ++ +++V+EFC+GG+L   ++   +   E       ++
Sbjct: 47  EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           L  GLE L+S+ IIHRD+K  NILL+    D  +K+ DFGLS  L        + G+P +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKARNTMVGTPYW 163

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV+  + YD K D+WS+G    EL  G PP+S   P
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  152 bits (387), Expect = 3e-46
 Identities = 65/158 (41%), Positives = 100/158 (63%), Gaps = 5/158 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L S+ HP ++ L+ +FQ ++ ++LV+E+  GG L S++R  GR PE  AR +  Q+
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              LE L+S  I++RDLKPEN+L   LD D  +KI DFG +  +    Y   +CG+P Y+
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLL---LDSDGYIKITDFGFAKRVKGRTYT--LCGTPEYL 165

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           APE++  + Y + VD W++G +++E+L GYPPF    P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  151 bits (383), Expect = 6e-46
 Identities = 65/175 (37%), Positives = 99/175 (56%), Gaps = 9/175 (5%)

Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK + K        +  +  E   L   NHP I++L+  F+ +  I++++E+C GG L +
Sbjct: 23  LKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            +R  G   E TAR ++  +    E L++  II+RDLKPEN+L   LD +  +K+ DFG 
Sbjct: 83  ILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL---LDSNGYVKLVDFGF 139

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +  L  G      CG+P Y+APE++  + YD  VD WS+G +L+ELL G PPF  
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  143 bits (363), Expect = 7e-43
 Identities = 61/180 (33%), Positives = 96/180 (53%), Gaps = 15/180 (8%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI---- 57
            + +  K  L  E+N L  + HPNI+R +D    ++   +++V+E+C GG+L+  I    
Sbjct: 37  NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96

Query: 58  RLHGRVPEQTARKFLQQLGAGLE-----ILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           +    + E+   + L QL   L          + ++HRDLKP NI L   D +  +K+ D
Sbjct: 97  KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGD 153

Query: 113 FGLSCTLYPGNYAEKVC-GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
           FGL+  L   +   K   G+P YM+PE L    YDEK D+WS+G +++EL    PPF+A 
Sbjct: 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  143 bits (362), Expect = 1e-42
 Identities = 60/175 (34%), Positives = 90/175 (51%), Gaps = 26/175 (14%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L  L+   HP II+L+  FQ E  ++ V+E+   G L  YIR +G + E+  R +  ++ 
Sbjct: 55  LTRLN--GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112

Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----------------- 119
             LE L+S  IIHRDLKPENIL   LD D+ +KI DFG +  L                 
Sbjct: 113 LALEYLHSKGIIHRDLKPENIL---LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 120 --YPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                N        G+  Y++PE+L  +   +  D+W++G I++++L G PPF  
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  141 bits (357), Expect = 4e-42
 Identities = 56/153 (36%), Positives = 86/153 (56%), Gaps = 3/153 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L  +NHP ++ L+ +FQ E  ++LVV+   GG+L  ++    +  E+  + ++ ++
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              LE L+S  IIHRD+KP+NIL   LD+   + I DF ++  + P        G+P YM
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNIL---LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           APEVL  Q Y   VD WS+G   +E L G  P+
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 7e-42
 Identities = 59/166 (35%), Positives = 86/166 (51%), Gaps = 27/166 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E++ L  + HPNI++L D    E  ++LV E+C   +L  Y+      +     +  + Q
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  GL   +SH I+HRDLKP+NIL   ++ D +LK+ADFGL+          +  G PL 
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNIL---INRDGVLKLADFGLA----------RAFGIPLR 153

Query: 134 ----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
                     Y APE+L   + Y   VD+WSVG I  E++ G P F
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  136 bits (345), Expect = 2e-40
 Identities = 65/159 (40%), Positives = 90/159 (56%), Gaps = 8/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E+  L+SVNHPNII   +AF   N + +V+E+   G+LS  I         +PEQ   + 
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             QL  GL+ L+   I+HRDLK  NILL   D    +KI D G+S  +   N A+   G+
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGIS-KVLKKNMAKTQIGT 164

Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           P YMAPEV + + Y  K D+WS+G +L+E+    PPF A
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 2e-40
 Identities = 61/153 (39%), Positives = 95/153 (62%), Gaps = 5/153 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L  V+HP IIRLF     +  +++++E+  GG L SY+R  GR    T   +  ++
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              LE L+S  I++RDLKPENIL   LD +  +K+ DFG +  L    +   +CG+P Y+
Sbjct: 111 VCALEYLHSKEIVYRDLKPENIL---LDKEGHIKLTDFGFAKKLRDRTWT--LCGTPEYL 165

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           APEV+Q + +++ VD W++G +++E+L GYPPF
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 4e-39
 Identities = 62/185 (33%), Positives = 98/185 (52%), Gaps = 33/185 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L+  + P I++L+ +FQ E  ++LV+E+  GG+L + +      PE+TAR ++ +L
Sbjct: 51  ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-----------------CT 118
              L+ ++    IHRD+KP+NIL   +D D  +K+ADFGL                    
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNIL---IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 119 LYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165
           L+  N              A    G+P Y+APEVL+   Y  + D WS+G IL+E+L G+
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227

Query: 166 PPFSA 170
           PPF +
Sbjct: 228 PPFYS 232

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  131 bits (332), Expect = 2e-38
 Identities = 54/160 (33%), Positives = 90/160 (56%), Gaps = 5/160 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L   + P I++ + ++     +++V+E+C  G++S  +++  +   E+     L Q
Sbjct: 48  EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
              GLE L+S+  IHRD+K  NILL   +++   K+ADFG+S  L         V G+P 
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +MAPEV+Q   Y+ K D+WS+G    E+  G PP+S   P
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  132 bits (334), Expect = 2e-38
 Identities = 60/159 (37%), Positives = 90/159 (56%), Gaps = 10/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L +  HP +++L D F   +   LV+E+     LS  +R   R +PE   + +++ 
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM 107

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGS 131
           L  G+  ++++ I+HRDLKP N+L+S    D +LKIADFGL+          Y+ +V  +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163

Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
             Y APE+L   R YD  VD+W+VG I  ELLNG P F 
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 2e-38
 Identities = 59/148 (39%), Positives = 94/148 (63%), Gaps = 6/148 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L+ +FQ+++ ++LV+E+  GG+ +S I+  G +PE  A++++ ++  G+E L+  
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            IIHRD+KPEN+L   +D    LK+ DFGLS     G   +K  G+P Y+APE +     
Sbjct: 117 GIIHRDIKPENLL---IDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170

Query: 146 DEKVDMWSVGAILFELLNGYPPFSAYRP 173
           D+  D WS+G ++FE L GYPPF A  P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  131 bits (331), Expect = 3e-38
 Identities = 54/159 (33%), Positives = 92/159 (57%), Gaps = 9/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
           E   +  ++HPN+++L     + E  +++V+E+  GG+L SY+R +  ++       F  
Sbjct: 51  EARIMRKLDHPNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFAL 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SP 132
           Q+  G+E L S + IHRDL   N L   + +++++KI+DFGLS  LY  +Y  K  G  P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL---VGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
           + +MAPE L+  ++  K D+WS G +L+E+   G  P+ 
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  131 bits (332), Expect = 3e-38
 Identities = 63/167 (37%), Positives = 96/167 (57%), Gaps = 12/167 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFL 72
           E+  +S  NHPN+++ + +F   + ++LV+ + +GG+L   ++     G + E      L
Sbjct: 49  EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV--- 128
           +++  GLE L+S+  IHRD+K  NIL   L +D  +KIADFG+S +L   G+   KV   
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNIL---LGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 129 -CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             G+P +MAPEV+ Q   YD K D+WS G    EL  G  P+S Y P
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 5e-38
 Identities = 66/178 (37%), Positives = 101/178 (56%), Gaps = 11/178 (6%)

Query: 2   LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK++ K L   L+       E + L++     +++L  AFQ +  ++L +E+  GG+  +
Sbjct: 31  LKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT 90

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            +   G + E  AR ++ ++   ++ L+    IHRDLKPEN L+   D    +K+ DFGL
Sbjct: 91  LLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGL 147

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           S  +    YA  V GSP YMAPEVL+ + YD  VD WS+G +L+E L G+PPFS   P
Sbjct: 148 SKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 7e-38
 Identities = 53/175 (30%), Positives = 97/175 (55%), Gaps = 8/175 (4%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
            +  K + + L+CE+  L ++ H  I++ +   + +  + + +E+  GG++   ++ +G 
Sbjct: 42  PETKKEVNA-LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA 100

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
           + E   RK+ +Q+  G+E L+S+ I+HRD+K  NIL    D    +K+ DFG S  L   
Sbjct: 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTI 157

Query: 122 ---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
              G   + V G+P +M+PEV+  + Y  K D+WSVG  + E+L   PP++ +  
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  131 bits (332), Expect = 7e-38
 Identities = 61/162 (37%), Positives = 93/162 (57%), Gaps = 7/162 (4%)

Query: 12  CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           C   E   L+    HP + +L   FQ ++ +F V+E+  GG+L  +I+  GR  E  AR 
Sbjct: 41  CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF 100

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
           +  ++  GL+ L+   II+RDLK +N+L   LD +  +KIADFG+ C   +  G      
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVL---LDSEGHIKIADFGM-CKEGILGGVTTSTF 156

Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           CG+P Y+APE+L +Q Y   VD W++G +L+E+L G  PF  
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  133 bits (334), Expect = 1e-37
 Identities = 76/197 (38%), Positives = 106/197 (53%), Gaps = 22/197 (11%)

Query: 2   LKKLNKHLKSC------LDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           LK L K L+S          E+  L+S+NHP NI++L+D FQ E  ++LV+E+  GG+L 
Sbjct: 27  LKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE 86

Query: 55  SYIRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
             ++  GR   + E  A   L Q+ + LE L+S  IIHRD+KPENILL    D  ++K+ 
Sbjct: 87  DLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD--RDGRVVKLI 144

Query: 112 DFGLSCTLYPGNYAEKV-------CGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFEL 161
           DFGL+  L        +        G+P YMAPEVL            D+WS+G  L+EL
Sbjct: 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204

Query: 162 LNGYPPFSAYRPCFASR 178
           L G PPF   +   A+ 
Sbjct: 205 LTGLPPFEGEKNSSATS 221

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 7e-37
 Identities = 54/167 (32%), Positives = 93/167 (55%), Gaps = 5/167 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K   + LKS +  E++ L ++ HPNI++   + +  + +++++E+   G+L   I+  G 
Sbjct: 37  KIKEEALKSIMQ-EIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP 95

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
            PE     ++ Q+  GL  L+   +IHRD+K  NIL +    D ++K+ADFG++  L   
Sbjct: 96  FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDV 152

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                 V G+P +MAPEV++        D+WS+G  + ELL G PP+
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  127 bits (322), Expect = 8e-37
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 10/160 (6%)

Query: 16  ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E   +  ++HPNI++L     + E  + +V+E+  GG+L  Y+R +    +       F 
Sbjct: 51  EARIMRKLDHPNIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA 109

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-S 131
            Q+  G+E L S + IHRDL   N L+    +++++KI+DFGLS  LY  +Y +   G  
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
           P+ +MAPE L+  ++  K D+WS G +L+E+   G  P+ 
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  128 bits (323), Expect = 1e-36
 Identities = 56/152 (36%), Positives = 90/152 (59%), Gaps = 5/152 (3%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82
            HPNI+  +D++   + +++V+E+  GG+L+  I  +  R+ E       +++  GLE L
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLYMAPEVLQ 141
           +S ++IHRD+K +NILLS  D  V  K+ADFG +  L         V G+P +MAPEV++
Sbjct: 133 HSQNVIHRDIKSDNILLS-KDGSV--KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            + Y  KVD+WS+G +  E+  G PP+    P
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  126 bits (320), Expect = 1e-36
 Identities = 52/159 (32%), Positives = 89/159 (55%), Gaps = 8/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E + +  ++HPNI+RL         +++V E+  GG+L  ++R HG  +  +   +   Q
Sbjct: 51  EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+E L S + +HRDL   N L+    +++++KI+DFGLS  +Y  +Y  K  G  L 
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167

Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
             +MAPE L+  ++  K D+WS G +L+E+   G  P+ 
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206

Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  126 bits (318), Expect = 3e-36
 Identities = 56/167 (33%), Positives = 90/167 (53%), Gaps = 17/167 (10%)

Query: 16  ELNFLSSVNHPNIIRLF--DAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFL 72
           E+  L  + HPN+++ +  +  + +  IF+  E+C+GG L   +  HGR+  E   R + 
Sbjct: 49  EMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTLEELLE-HGRILDEHVIRVYT 105

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-----TLYPGNYAEK 127
            QL  GL  L+SH I+HRD+KP NI    LD + ++K+ DFG +      T   G   + 
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIF---LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162

Query: 128 VCGSPLYMAPEVLQFQRYDEK---VDMWSVGAILFELLNGYPPFSAY 171
           + G+P YMAPEV+   +        D+WS+G ++ E+  G  P+S  
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 4e-36
 Identities = 61/183 (33%), Positives = 92/183 (50%), Gaps = 30/183 (16%)

Query: 3   KKLNKHLKSCLDC----ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           KK+ K   S  +C    E+  L  +N HPNI++L + F+  + ++ V E+  G NL   +
Sbjct: 30  KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLM 88

Query: 58  RLHGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +     P  E   R  + Q+  GL  ++ H   HRDLKPEN+L+SG +   ++KIADFGL
Sbjct: 89  KDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGL 145

Query: 116 SCTLYPGNYAEKVCGSP---------LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGY 165
                    A ++   P          Y APE+ L+   Y   VD+W++G I+ EL    
Sbjct: 146 ---------AREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Query: 166 PPF 168
           P F
Sbjct: 197 PLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  124 bits (314), Expect = 9e-36
 Identities = 55/162 (33%), Positives = 96/162 (59%), Gaps = 4/162 (2%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L+ E+  LS + HPNI++     + E+ +++ +E   GG+L+  ++ +G  PE   R + 
Sbjct: 49  LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           +Q+  GLE L+  + +HRD+K  NIL   +D + ++K+ADFG++  +   ++A+   GSP
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANIL---VDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165

Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            +MAPEV+ Q   Y    D+WS+G  + E+  G PP+S    
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  126 bits (318), Expect = 1e-35
 Identities = 62/160 (38%), Positives = 97/160 (60%), Gaps = 19/160 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L  ++HP I+ +  +FQ EN ++ ++EF  GG L +++R  GR P   A+ +  +L
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------- 128
               E L+S  II+RDLKPEN+L   LD+   +K+ DFG         +A+KV       
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLL---LDNKGHVKVTDFG---------FAKKVPDRTFTL 175

Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           CG+P Y+APEV+Q + + + VD W++G +L+E + GYPPF
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 1e-34
 Identities = 64/157 (40%), Positives = 89/157 (56%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  +NHPNII+L D F+ +  ++LV EF    +L   I+   R +PE   + +L Q
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
           L  GL   +SH I+HRDLKPEN+L++       LK+ADFGL+ +       Y   V  + 
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRPYTHYVV-TR 162

Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
            Y APE+L   + Y   VD+WSVG I  ELL+  P F
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  121 bits (305), Expect = 7e-34
 Identities = 64/157 (40%), Positives = 95/157 (60%), Gaps = 6/157 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E N L +V HP I+ L  AFQ    ++L++E+ +GG L  ++   G   E TA  +L ++
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPL 133
              LE L+   II+RDLKPENIL   LD    +K+ DFGL C  +++ G      CG+  
Sbjct: 110 SLALEHLHQQGIIYRDLKPENIL---LDAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIE 165

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPE+L    + + VD WS+GA+++++L G PPF+A
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  120 bits (302), Expect = 2e-33
 Identities = 64/156 (41%), Positives = 96/156 (61%), Gaps = 8/156 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E + L+ VNHP I++L  AFQ E  ++L+++F  GG+L  + RL   V   E+  + +L 
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 105

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           +L   L+ L+S  II+RDLKPENILL   D++  +K+ DFGLS  ++     A   CG+ 
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            YMAPEV+  + + +  D WS G ++FE+L G  PF
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  118 bits (299), Expect = 2e-33
 Identities = 55/167 (32%), Positives = 84/167 (50%), Gaps = 16/167 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
           E   +  + HPN++RL      E  ++LV+E+  GG+L  Y+R             +  +
Sbjct: 46  EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
               F  Q+  G+E L S   +HRDL   N L+   +D V+ KI+DFGLS  +Y  +Y  
Sbjct: 106 DLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG--EDLVV-KISDFGLSRDVYDDDYYR 162

Query: 127 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
           K  G  L   +MAPE L+   +  K D+WS G +L+E+   G  P+ 
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  119 bits (299), Expect = 2e-33
 Identities = 59/172 (34%), Positives = 94/172 (54%), Gaps = 8/172 (4%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
               K +   L  E+  L  ++H NI++       E  + + +E+  GG++ S +R +GR
Sbjct: 45  DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR 104

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL---SCTL 119
             EQ  R F +Q+  GL  L+S  I+HRDLK +N+L   +D D + KI+DFG+   S  +
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL---VDADGICKISDFGISKKSDDI 161

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFS 169
           Y  +    + GS  +MAPEV+      Y  KVD+WS+G ++ E+  G  P+S
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  118 bits (297), Expect = 3e-33
 Identities = 54/173 (31%), Positives = 98/173 (56%), Gaps = 8/173 (4%)

Query: 2   LKKLNKHLKS-CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           L K+N+  +   +D E   L+ ++   IIR +++F  +  + +V+E+   G+L   +++ 
Sbjct: 35  LSKMNRREREEAID-EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ 93

Query: 61  G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
               +PE    +F  Q+  GL  L+S  I+HRD+K  N+ L   D+   +KI D G++  
Sbjct: 94  RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKL 150

Query: 119 LYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           L    N+A  + G+P Y++PE+ + + Y+EK D+W++G +L+E   G  PF A
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  119 bits (300), Expect = 4e-33
 Identities = 61/146 (41%), Positives = 89/146 (60%), Gaps = 4/146 (2%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84
           HP +  LF  FQ +  +F V+E+  GG+L  +I+  GR  E  AR +  ++  GL+ L+ 
Sbjct: 55  HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 85  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQ 143
             II+RDLK +N+L   LD D  +KIADFG+    +     A   CG+P Y+APE+L+ Q
Sbjct: 115 KGIIYRDLKLDNVL---LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 144 RYDEKVDMWSVGAILFELLNGYPPFS 169
           +Y+E VD WS G +L+E+L G  PF 
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  118 bits (297), Expect = 4e-33
 Identities = 59/171 (34%), Positives = 89/171 (52%), Gaps = 12/171 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L S   P +++ + AF  E  I +V+E+  GG+L+  ++  G++PE       +Q+
Sbjct: 49  ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI 108

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCG 130
             GL+ L    HIIHRD+KP N+L++    +V  KIADFG    L  TL   N      G
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLIN-SKGEV--KIADFGISKVLENTLDQCNTF---VG 162

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG-YPPFSAYRPCFASRLC 180
           +  YM+PE +Q + Y    D+WS+G  L E   G +P     +P F   + 
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  116 bits (293), Expect = 1e-32
 Identities = 54/157 (34%), Positives = 91/157 (57%), Gaps = 4/157 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  ++HPNII  ++ F  +  + +V+E+  GG L+ YI+      + E T   F  
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+   L  +++  I+HRDLK +NILL      +++KI DFG+S  L   + A  V G+P 
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y++PE+ + + Y++K D+W++G +L+EL +    F A
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  118 bits (297), Expect = 1e-32
 Identities = 57/162 (35%), Positives = 90/162 (55%), Gaps = 7/162 (4%)

Query: 12  CLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           C   E   L+ +  HP +  L   FQ ++ +F V+E+  GG+L   I+   +  E  +R 
Sbjct: 41  CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
           +  ++   L  L+ H +I+RDLK +NILL   D +   K+ADFG+ C   +  G      
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGM-CKEGILNGVTTTTF 156

Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           CG+P Y+APE+LQ   Y   VD W++G +++E++ G PPF A
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  117 bits (294), Expect = 4e-32
 Identities = 66/169 (39%), Positives = 98/169 (57%), Gaps = 11/169 (6%)

Query: 3   KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           KK  KH+ +    E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  +++   
Sbjct: 36  KKEQKHIMA----ERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER 91

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--L 119
             PE  AR +  ++ + L  L+S +II+RDLKPENILL   D    + + DFGL C   +
Sbjct: 92  SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGI 147

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                    CG+P Y+APEVL+ Q YD  VD W +GA+L+E+L G PPF
Sbjct: 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 2e-31
 Identities = 58/161 (36%), Positives = 91/161 (56%), Gaps = 9/161 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FLS    P I + + +F   + +++++E+C GG+    ++  G++ E      L+++
Sbjct: 49  EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREV 107

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
             GLE L+    IHRD+K  NILLS   ++  +K+ADFG+S  L   +   K     G+P
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQL--TSTMSKRNTFVGTP 162

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            +MAPEV++   YDEK D+WS+G    EL  G PP S   P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  115 bits (289), Expect = 2e-31
 Identities = 55/152 (36%), Positives = 95/152 (62%), Gaps = 6/152 (3%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F ++ NHP ++ L   FQ E+ +F V+EF +GG+L  +++   ++PE+ AR +  ++   
Sbjct: 49  FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+ C   + PG+     CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDAEGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIA 164

Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           PE+L+ + Y   VD W++G ++FE++ G  PF
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (286), Expect = 3e-31
 Identities = 67/169 (39%), Positives = 93/169 (55%), Gaps = 18/169 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ LS   HPNI+ L++A+  EN +++++EFC GG L S +    R   E   R   +Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-----VC 129
           +   L  L+SH +IHRDLK  NILL+ LD DV  K+ADFG+S      N +         
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLT-LDGDV--KLADFGVSAK----NKSTLQKRDTFI 164

Query: 130 GSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           G+P +MAPEV+     +   YD K D+WS+G  L EL    PP     P
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  114 bits (288), Expect = 3e-31
 Identities = 56/151 (37%), Positives = 86/151 (56%), Gaps = 7/151 (4%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
           +S  HP ++ LF  FQ E+ +  V+E+ AGG+L  +I       E  A  +   +  GL+
Sbjct: 57  NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQ 115

Query: 81  ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPE 138
            L+ + I++RDLK +N+LL   D +  +KIADFGL C   +  G+     CG+P ++APE
Sbjct: 116 YLHENKIVYRDLKLDNLLL---DTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPE 171

Query: 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
           VL    Y   VD W +G +++E+L G  PF 
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 3e-31
 Identities = 62/157 (39%), Positives = 86/157 (54%), Gaps = 13/157 (8%)

Query: 20  LSSVNHPNIIRLFDAF---QAENC--IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           L S  HPNI+RL D     + +    + LV E     +L++Y+    +  +P +T +  +
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           +QL  G++ L+SH I+HRDLKP+NIL++    D  +KIADFGL+  +Y    A       
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLA-RIYSFEMALTSVVVT 169

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           L Y APEVL    Y   VDMWSVG I  EL    P F
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  112 bits (283), Expect = 3e-31
 Identities = 52/152 (34%), Positives = 86/152 (56%), Gaps = 10/152 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQ 73
           E+  LS + HPNII  ++ F  +N + + +E+  GG L   I  +      E+    +L 
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVCG 130
           Q+ + +  ++   I+HRD+K  NI L+      ++K+ DFG+S  L   Y    AE V G
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSM--AETVVG 163

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           +P YM+PE+ Q  +Y+ K D+W++G +L+ELL
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 7e-31
 Identities = 60/169 (35%), Positives = 88/169 (52%), Gaps = 20/169 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPE-QTA---RK 70
           E++ L    HPNI+  F ++   + +++V+E+C GG+L   Y    G + E Q A   R+
Sbjct: 50  EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
            L+    GL  L+    IHRD+K  NILL+   +D  +K+ADFG+S  L       K   
Sbjct: 110 TLK----GLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQL--TATIAKRKS 160

Query: 128 VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             G+P +MAPEV   +R   YD K D+W++G    EL    PP     P
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  112 bits (281), Expect = 9e-31
 Identities = 60/159 (37%), Positives = 89/159 (55%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  V+   I+ L  AF+ ++ + LV+    GG+L  +I   G    PE  A  +  
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+  GLE L+   I++RDLKPEN+LL   DD   ++I+D GL+  L  G   +   G+P 
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           YMAPEVLQ + YD  VD +++G  L+E++ G  PF   +
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  113 bits (284), Expect = 1e-30
 Identities = 55/152 (36%), Positives = 93/152 (61%), Gaps = 6/152 (3%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 49  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+ C   L PG+     CG+P Y+A
Sbjct: 109 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIA 164

Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           PE+L+ + Y   VD W++G ++FE++ G  PF
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  112 bits (281), Expect = 1e-30
 Identities = 55/168 (32%), Positives = 92/168 (54%), Gaps = 22/168 (13%)

Query: 14  DC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGR-VPEQT 67
           DC  E++ L  ++HPN+I+   +F   N + +V+E    G+LS  I   +   R +PE+T
Sbjct: 48  DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--- 124
             K+  QL + LE ++S  I+HRD+KP N+ ++      ++K+ D GL      G +   
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGL------GRFFSS 158

Query: 125 ----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               A  + G+P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  113 bits (283), Expect = 1e-30
 Identities = 63/167 (37%), Positives = 96/167 (57%), Gaps = 7/167 (4%)

Query: 5   LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
           LN+  +  +  E N  L +V HP ++ L  +FQ    ++ V++F  GG L  +++     
Sbjct: 34  LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSF 93

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYP 121
           PE  AR +  ++ + L  L+S +I++RDLKPENILL      V+    DFGL C   +  
Sbjct: 94  PEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL---TDFGL-CKEGIAQ 149

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            +     CG+P Y+APEV++ Q YD  VD W +GA+L+E+L G PPF
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 1e-30
 Identities = 59/168 (35%), Positives = 87/168 (51%), Gaps = 28/168 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E++ L  +NHPNI+RL D   +EN ++LV EF    +L  Y+             + +L 
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           QL  G+   +SH ++HRDLKP+N+L   +D +  LK+ADFGL+          +  G P+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLL---IDREGALKLADFGLA----------RAFGVPV 153

Query: 134 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
                      Y APE+L   R Y   VD+WS+G I  E++N  P F 
Sbjct: 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  112 bits (282), Expect = 2e-30
 Identities = 61/189 (32%), Positives = 108/189 (57%), Gaps = 25/189 (13%)

Query: 2   LKKLNKH---LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +KK+NK    L++ +     E + L+   +P ++ +F +F+ +  + +V+E+  GG+ ++
Sbjct: 31  MKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT 90

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            ++  G +P   AR +  +    LE L+++ I+HRDLKP+N+L++ +     +K+ DFGL
Sbjct: 91  LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGL 147

Query: 116 S--------CTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159
           S          LY G+          ++VCG+P Y+APEV+  Q Y + VD W++G IL+
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207

Query: 160 ELLNGYPPF 168
           E L G  PF
Sbjct: 208 EFLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  111 bits (280), Expect = 3e-30
 Identities = 57/152 (37%), Positives = 89/152 (58%), Gaps = 6/152 (3%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
            L ++ HP ++ L  +FQ    ++ V+++  GG L  +++      E  AR +  ++ + 
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
           +  L+S +II+RDLKPENILL   D    + + DFGL C   + P       CG+P Y+A
Sbjct: 109 IGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLA 164

Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           PEVL+ + YD  VD W +GA+L+E+L G PPF
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  112 bits (281), Expect = 3e-30
 Identities = 54/145 (37%), Positives = 88/145 (60%), Gaps = 6/145 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A  +  ++  GL  L+S 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
            II+RDLK +N++L   D +  +KIADFG+ C   ++ G      CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DAEGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176

Query: 144 RYDEKVDMWSVGAILFELLNGYPPF 168
            Y + VD W+ G +L+E+L G PPF
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  111 bits (279), Expect = 5e-30
 Identities = 65/169 (38%), Positives = 96/169 (56%), Gaps = 11/169 (6%)

Query: 3   KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           KK  KH+ S    E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  +++   
Sbjct: 36  KKEEKHIMS----ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 91

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TL 119
              E  AR +  ++ + L  L+S +I++RDLKPENILL   D    + + DFGL C   +
Sbjct: 92  CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGL-CKENI 147

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                    CG+P Y+APEVL  Q YD  VD W +GA+L+E+L G PPF
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  110 bits (278), Expect = 1e-29
 Identities = 60/185 (32%), Positives = 90/185 (48%), Gaps = 27/185 (14%)

Query: 3   KKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGN 52
           KK++      +D      E+  L  + H NII L D  +       N +++V E     +
Sbjct: 31  KKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METD 89

Query: 53  LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           L   I+    + +   + FL Q+  GL+ L+S ++IHRDLKP NIL+   + +  LKI D
Sbjct: 90  LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICD 146

Query: 113 FGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLN 163
           FGL+  + P    ++     L        Y APE+ L   RY + +D+WSVG I  ELL 
Sbjct: 147 FGLARGVDP----DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202

Query: 164 GYPPF 168
             P F
Sbjct: 203 RKPLF 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  110 bits (275), Expect = 2e-29
 Identities = 54/152 (35%), Positives = 93/152 (61%), Gaps = 6/152 (3%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + ++P ++ L   FQ  + +FLV+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 49  FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA 108

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
           L  L+   II+RDLK +N+L   LD D  +K+ D+G+ C   L PG+     CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIA 164

Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           PE+L+ + Y   VD W++G ++FE++ G  PF
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  109 bits (275), Expect = 2e-29
 Identities = 58/149 (38%), Positives = 89/149 (59%), Gaps = 6/149 (4%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           NHP + +L+  FQ  + +F V+EF  GG+L  +I+   R  E  AR +  ++ + L  L+
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPEVLQ 141
              II+RDLK +N+L   LD +   K+ADFG+ C   ++ G      CG+P Y+APE+LQ
Sbjct: 114 DKGIIYRDLKLDNVL---LDHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              Y   VD W++G +L+E+L G+ PF A
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  108 bits (272), Expect = 2e-29
 Identities = 63/165 (38%), Positives = 93/165 (56%), Gaps = 10/165 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
           E++ L+S +HPNI++L DAF  EN +++++EFCAGG + +  + L   + E   R   +Q
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
               L  L+ + IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P 
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTPY 168

Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +MAPEV+  +      YD K D+WS+G  L E+    PP     P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  110 bits (275), Expect = 2e-29
 Identities = 57/158 (36%), Positives = 92/158 (58%), Gaps = 5/158 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L+ +NHP  + L+ +F+ E+ ++LV+EF  GG   +++R + R P      +  Q+
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L S +I++RDLKPEN+L   LD D  +K+ DFG +  +    Y   +CG+P Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLL---LDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYI 195

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           APE+L    + +  D W++G  ++E+L G PPF A  P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  107 bits (269), Expect = 4e-29
 Identities = 55/160 (34%), Positives = 91/160 (56%), Gaps = 7/160 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  ++ +NHP+IIR+  A   ++   L VE+ AGG++S  +  +G   E     + +QL
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-----GNYAEKVCG 130
             GL  L+ + IIHRD+K  N+L+        L+IADFG +  L       G +  ++ G
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLG 170

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +  +MAPEVL+ ++Y    D+WSVG ++ E+    PP++A
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  108 bits (271), Expect = 6e-29
 Identities = 59/147 (40%), Positives = 88/147 (59%), Gaps = 6/147 (4%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            +P +  L+  FQ +  +F V+EF  GG+L  +I+  GR     A  +  ++  GL+ L+
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQ 141
           S  II+RDLK +N++L   D D  +KIADFG+ C   ++  N A   CG+P Y+APE+LQ
Sbjct: 114 SKGIIYRDLKLDNVML---DRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPF 168
             +Y   VD WS G +L+E+L G  PF
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  108 bits (270), Expect = 7e-29
 Identities = 61/155 (39%), Positives = 89/155 (57%), Gaps = 6/155 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L+ VN P I+ L  +FQ+   ++LV+ F  GG L  +++  GR     AR +  +L
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
              LE L+  ++I+RDLKPENIL   LD    + + DFGL C L   +       CG+P 
Sbjct: 103 LCALENLHKFNVIYRDLKPENIL---LDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPE 158

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APE+L    Y + VD W++G +L+E+L G PPF
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 8e-29
 Identities = 58/161 (36%), Positives = 90/161 (55%), Gaps = 14/161 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
           E+  L  + HPNI+RL +    + +  I++V E+    +L+  +     +  E   + ++
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVC 129
           +QL  GL+ L+S+ I+HRD+K  NIL+   ++D +LK+ADFGL+         +Y  +V 
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 130 GSPL-YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 168
              L Y  PE+L    RY  +VDMWSVG IL EL  G P F
Sbjct: 164 --TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  107 bits (268), Expect = 1e-28
 Identities = 55/158 (34%), Positives = 84/158 (53%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E++ +  + H NI+RL D    EN + LV E+    +L  Y+  HG    +   T + F 
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  G+   + + ++HRDLKP+N+L++       LK+ADFGL+     P N       +
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVT 163

Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
             Y AP+VL   R Y   +D+WSVG I+ E++ G P F
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 1e-28
 Identities = 56/147 (38%), Positives = 88/147 (59%), Gaps = 5/147 (3%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P I+ L  +FQ ++ ++LV ++ +GG L  +++  GR  E  A+ ++ +L   LE L+ +
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
            I++RDLKPENIL   LD    + + DFGLS   L         CG+  Y+APEVL  ++
Sbjct: 116 DIVYRDLKPENIL---LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 145 -YDEKVDMWSVGAILFELLNGYPPFSA 170
            Y + VD WS+G ++FE+  G+ PF A
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYA 199

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  107 bits (269), Expect = 3e-28
 Identities = 64/166 (38%), Positives = 93/166 (56%), Gaps = 21/166 (12%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E+ FL  + +HPNI++L +  +AEN   I+LV E+    +L + IR    + +   R  +
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-ANILEDVHKRYIM 113

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            QL   L+ ++S ++IHRDLKP NILL   + D  +K+ADFGL+ +L           +P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENP---ENP 167

Query: 133 L---------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +         Y APE+L    RY + VDMWSVG IL E+L G P F
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  104 bits (261), Expect = 7e-28
 Identities = 54/167 (32%), Positives = 93/167 (55%), Gaps = 9/167 (5%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           S L+CE+  L ++ H  I++ +   +  AE  + + +E+  GG++   ++ +G + E   
Sbjct: 49  SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT 108

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
           RK+ +Q+  G+  L+S+ I+HRD+K  NIL    D    +K+ DFG S  L      G  
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTG 165

Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
              V G+P +M+PEV+  + Y  K D+WS+G  + E+L   PP++ Y
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  104 bits (260), Expect = 9e-28
 Identities = 55/156 (35%), Positives = 90/156 (57%), Gaps = 5/156 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV-PEQTARKFLQ 73
           E+  L+ + HPNI+  F +FQ    +F+V+E+C GG+L   I R  G +  E     +  
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 132
           Q+  GL+ ++   I+HRD+K +NI LS   + ++ K+ DFG++  L         C G+P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y++PE+ Q + Y+ K D+WS+G +L+EL     PF
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  104 bits (263), Expect = 9e-28
 Identities = 61/156 (39%), Positives = 83/156 (53%), Gaps = 11/156 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQ 73
           E+  L  + HPNII L D F  ++ I LV EF    +L   I+    +    A  + ++ 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIK-DKSIVLTPADIKSYML 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPG-NYAEKVCGS 131
               GLE L+S+ I+HRDLKP N+L   +  D +LK+ADFGL+ +   P      +V  +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLL---IASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165

Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
             Y APE+L   R Y   VDMWSVG I  ELL   P
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  105 bits (262), Expect = 2e-27
 Identities = 54/145 (37%), Positives = 87/145 (60%), Gaps = 6/145 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L   I+  GR  E  A  +  ++  GL  L+S 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
            II+RDLK +N++L   D +  +KIADFG+ C   ++ G   +  CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176

Query: 144 RYDEKVDMWSVGAILFELLNGYPPF 168
            Y + VD W+ G +L+E+L G  PF
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  103 bits (259), Expect = 2e-27
 Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 10/173 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K   + +   L  E+  L  + H NI++   +    + + + +E+  GG++++ +  +G 
Sbjct: 43  KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA 102

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
             E   R F++Q+  GL  L++  IIHRD+K  NIL   +D+   +KI+DFG+S  L   
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL---VDNKGGIKISDFGISKKLEAN 159

Query: 122 ------GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                       + GS  +MAPEV++   Y  K D+WS+G ++ E+L G  PF
Sbjct: 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 2e-27
 Identities = 55/158 (34%), Positives = 86/158 (54%), Gaps = 10/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  L  + H NI+ L +AF+ +  ++LV E+     L   +    G +P    R ++ Q
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQ 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGS 131
           L   +   +SH+IIHRD+KPENIL+S   +  +LK+ DFG +  L         + V  +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYV-AT 164

Query: 132 PLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
             Y APE+L     Y + VD+W++G I+ ELL+G P F
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  103 bits (257), Expect = 2e-27
 Identities = 56/158 (35%), Positives = 96/158 (60%), Gaps = 6/158 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV-PEQTARKFLQ 73
           E   L+ + HPNI+   ++F+A+  +++V+E+C GG+L   I+L  G++ PE T  ++  
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 132
           Q+  G++ ++   ++HRD+K +NI L+    +  +K+ DFG +  L  PG YA    G+P
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTP 164

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+ +   Y+ K D+WS+G IL+EL     PF A
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  107 bits (268), Expect = 2e-27
 Identities = 64/195 (32%), Positives = 100/195 (51%), Gaps = 29/195 (14%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI--- 57
           + L +  KS L  E+N +  + H NI+R  D F  +A   +++++EFC  G+LS  I   
Sbjct: 49  RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108

Query: 58  -RLHGRVPEQTARKFLQQLGAGLEIL-------NSHHIIHRDLKPENILLS--------- 100
            ++ G++ E       +QL   L          N   ++HRDLKP+NI LS         
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168

Query: 101 -----GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL--QFQRYDEKVDMWS 153
                 L+   + KI DFGLS  +   + A    G+P Y +PE+L  + + YD+K DMW+
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228

Query: 154 VGAILFELLNGYPPF 168
           +G I++EL +G  PF
Sbjct: 229 LGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  103 bits (259), Expect = 3e-27
 Identities = 51/148 (34%), Positives = 81/148 (54%), Gaps = 7/148 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P ++ L  AFQ +  + L++++  GG L +++       E   R ++ ++   L+ L+  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ 143
            II+RD+K ENIL   LD +  + + DFGLS          A   CG+  YMAPEV++  
Sbjct: 125 GIIYRDIKLENIL---LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181

Query: 144 R--YDEKVDMWSVGAILFELLNGYPPFS 169
              +D+ VD WS+G + FELL G  PF+
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFT 209

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  103 bits (258), Expect = 3e-27
 Identities = 64/179 (35%), Positives = 96/179 (53%), Gaps = 22/179 (12%)

Query: 3   KKLNKHLKSCLDCELNF-----LSSVN-HPNIIRL----FDAFQAENCIFLVVEFCAGGN 52
           K + KH KS L+   N      L  ++ HPNI+RL    FD  +    + LV E     N
Sbjct: 30  KCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFD--RKTGRLALVFEL-MDMN 85

Query: 53  LSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           L   I+   R +PE+  + ++ QL   L+ ++ + I HRD+KPENIL+     D +LK+A
Sbjct: 86  LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLA 141

Query: 112 DFGLSCTLYP-GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           DFG    +Y    Y E +  +  Y APE +L    Y  K+D+W+VG + FE+L+ +P F
Sbjct: 142 DFGSCRGIYSKPPYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF 199

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 4e-27
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 35/181 (19%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGA 77
           L++++HP +  L+ +FQ E  + LV+++C GG L   ++      + E+ AR +  ++  
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----------- 126
            LE L+   I++RDLKPENILL      +ML  +DF LS                     
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHE-SGHIML--SDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 127 ---------KVC----------GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
                                 G+  Y+APEV+    +   VD W++G +L+E+L G  P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Query: 168 F 168
           F
Sbjct: 232 F 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  102 bits (257), Expect = 4e-27
 Identities = 56/154 (36%), Positives = 81/154 (52%), Gaps = 7/154 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
           EL+ L   N P I+  + AF     I + +E+  GG+L   ++   GR+PE+   K    
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108

Query: 75  LGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           +  GL  L   H IIHRD+KP NIL++       +K+ DFG+S  L   + A+   G+  
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV-NSLAKTFVGTSS 164

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFEL-LNGYP 166
           YMAPE +Q   Y  K D+WS+G  L EL    +P
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 4e-27
 Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 49/209 (23%)

Query: 1   MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           ML+K    H+++    E + L+  ++P +++L+ +FQ EN ++L++E+  GG++ + +  
Sbjct: 39  MLEKEQVAHVRA----ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK 94

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT- 118
                E+  R ++ +    ++ ++    IHRD+KP+N+L   LD    +K++DFGL CT 
Sbjct: 95  KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL---LDAKGHIKLSDFGL-CTG 150

Query: 119 --------LY-------PGNYAEKVC------------------------GSPLYMAPEV 139
                    Y       P N+ + +                         G+P Y+APEV
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210

Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                Y+++ D WS+G I++E+L GYPPF
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (257), Expect = 4e-27
 Identities = 55/148 (37%), Positives = 88/148 (59%), Gaps = 11/148 (7%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFLQQLGAGLEI 81
           HPNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ LQ     LE 
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALEF 130

Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVL 140
           L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+P +MAPEV+
Sbjct: 131 LHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPF 168
             + Y  KVD+WS+G +  E++ G PP+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  104 bits (261), Expect = 5e-27
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 53/211 (25%)

Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           H+K+    E + L+  ++  +++L+ +FQ ++ ++ V+++  GG++ S +   G   E  
Sbjct: 47  HVKA----ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL 102

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY------- 120
           AR ++ +L   +E ++    IHRD+KP+NIL   +D D  +K+ DFGL CT +       
Sbjct: 103 ARFYIAELTCAIESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGFRWTHDSK 158

Query: 121 ---PGNY-----------------------------------AEKVCGSPLYMAPEVLQF 142
               G++                                   A  + G+P Y+APEVL  
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218

Query: 143 QRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             Y +  D WSVG IL+E+L G PPF A  P
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  103 bits (258), Expect = 5e-27
 Identities = 53/145 (36%), Positives = 86/145 (59%), Gaps = 6/145 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A  +  ++  GL  L+  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
            II+RDLK +N++L   D +  +KIADFG+ C   +  G      CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176

Query: 144 RYDEKVDMWSVGAILFELLNGYPPF 168
            Y + VD W+ G +L+E+L G PPF
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  102 bits (256), Expect = 5e-27
 Identities = 58/165 (35%), Positives = 92/165 (55%), Gaps = 10/165 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
           E+  L++ NHP I++L  AF  +  +++++EFC GG + +  + L   + E   +   +Q
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           +   L+ L+S  IIHRDLK  N+LL+ LD D+  K+ADFG+S   +      +   G+P 
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLT-LDGDI--KLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +MAPEV+  +      YD K D+WS+G  L E+    PP     P
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  102 bits (256), Expect = 6e-27
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 16/164 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           EL    S   P I++ + AF  ++ + I + +E+C GG+L S   ++ +V ++  R   +
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEK 105

Query: 74  QLG-------AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            LG        GL  L+S  IIHRD+KP NIL   L     +K+ DFG+S  L   + A 
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL---LTRKGQVKLCDFGVSGELV-NSLAG 161

Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              G+  YMAPE +Q + Y    D+WS+G  L E+     PF  
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  102 bits (254), Expect = 7e-27
 Identities = 54/166 (32%), Positives = 94/166 (56%), Gaps = 10/166 (6%)

Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+  D+F  +N + +V+E    G+LS  I+   +    +
Sbjct: 44  KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE+T  K+  QL + +E ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160

Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            A   + G+P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 8e-27
 Identities = 61/175 (34%), Positives = 89/175 (50%), Gaps = 20/175 (11%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENC------IFLVVEFCAGG---NLSSYIRLHG-RVP 64
           E N L    NHPNI   + AF  +N       ++LV+E C GG   +L   +R  G R+ 
Sbjct: 52  EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
           E+     L++   GL  L+ + +IHRD+K +NILL+    +  +K+ DFG+S  L     
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168

Query: 125 AEKVC-GSPLYMAPEVL----QFQR-YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
                 G+P +MAPEV+    Q    YD + D+WS+G    EL +G PP     P
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  105 bits (262), Expect = 8e-27
 Identities = 58/162 (35%), Positives = 96/162 (59%), Gaps = 14/162 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVP--EQTARKF 71
           EL+ L++ +H  I++ FD F++++ + L++E+ +GG+L+  I  RL   +P  E      
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLYPG---NYAE 126
             Q+   L+ ++S  ++HRDLK  NI L  +G+     +K+ DFG S         + A 
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-----IKLGDFGFSKQYSDSVSLDVAS 229

Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             CG+P Y+APE+ + +RY +K DMWS+G IL+ELL  + PF
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  103 bits (258), Expect = 1e-26
 Identities = 59/166 (35%), Positives = 93/166 (56%), Gaps = 20/166 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARKF 71
           E + ++  N   I++L  AFQ +  +++V+E+  GG+L    S+Y      +PE+ AR +
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFY 147

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKV 128
             ++   L+ ++S   IHRD+KP+N+L   LD    LK+ADFG +C     N     +  
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFG-TCMKMDANGMVRCDTA 203

Query: 129 CGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPFSA 170
            G+P Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF A
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  101 bits (252), Expect = 2e-26
 Identities = 54/166 (32%), Positives = 94/166 (56%), Gaps = 10/166 (6%)

Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +
Sbjct: 44  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE+T  K+  QL + LE ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160

Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            A   + G+P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  100 bits (252), Expect = 3e-26
 Identities = 54/160 (33%), Positives = 93/160 (58%), Gaps = 17/160 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E+  +    HPNI+ ++ ++   + +++V+EF  GG L+  I  H R+ E Q A   L  
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------ 128
           L A L  L++  +IHRD+K ++ILL+    D  +K++DFG  C       +++V      
Sbjct: 125 LKA-LSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGF-C----AQVSKEVPRRKSL 175

Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            G+P +MAPEV+    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  101 bits (253), Expect = 3e-26
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
            + L  L+S  +++RDLK EN++   LD D  +KI DFGL C   +  G   +  CG+P 
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLM---LDKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 3e-26
 Identities = 52/165 (31%), Positives = 92/165 (55%), Gaps = 9/165 (5%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           L+CE+  L ++ H  I++ +   +   E  + + VE+  GG++   ++ +G + E   R+
Sbjct: 51  LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLY-PGNYAE 126
           + +Q+  G+  L+S+ I+HRD+K  NIL    D    +K+ DFG S    T+   G   +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            V G+P +M+PEV+  + Y  K D+WSV   + E+L   PP++ Y
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  100 bits (251), Expect = 3e-26
 Identities = 54/156 (34%), Positives = 81/156 (51%), Gaps = 5/156 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +     P I+  + AF  EN I + +EF   G+L    +  G +P +   K    +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L N H I+HRD+KP NIL++       +K+ DFG+S  L   + A+   G+  Y
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELI-NSIADTFVGTSTY 168

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           M+PE +Q  +Y  K D+WS+G  + EL  G  PF+ 
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  100 bits (250), Expect = 7e-26
 Identities = 56/146 (38%), Positives = 85/146 (58%), Gaps = 4/146 (2%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HP +  L+  FQ +  +F V+E+  GG+L  +I+   +     A  +  ++  GL+ L+
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF 142
           S  I++RDLK +NILL   D D  +KIADFG+      G+      CG+P Y+APE+L  
Sbjct: 114 SKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q+Y+  VD WS G +L+E+L G  PF
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 99.8 bits (249), Expect = 7e-26
 Identities = 55/160 (34%), Positives = 84/160 (52%), Gaps = 17/160 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  L  + H NI+RL+D   ++  + LV E+C   +L  Y    +G +  +  + F+ Q
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ 107

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP- 132
           L  GL   +SH+++HRDLKP+N+L++   +   LK+ADFGL+       +   V C S  
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLA-----RAFGIPVRCYSAE 159

Query: 133 ----LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP 167
                Y  P+VL   + Y   +DMWS G I  EL N   P
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 99.5 bits (248), Expect = 8e-26
 Identities = 53/159 (33%), Positives = 86/159 (54%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E+ A  +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G       G+  
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           YMAPEV++ +RY    D W +G +++E++ G  PF   +
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 98.9 bits (246), Expect = 1e-25
 Identities = 51/151 (33%), Positives = 81/151 (53%), Gaps = 9/151 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E   LS ++HP I++   +F   +   ++ E+C G +L   +         + E    ++
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG 130
             QL  G+  ++   I+HRDLK +NI L     + +LKI DFG+S  L    + A    G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTG 167

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           +P YM+PE L+ Q YD K D+WS+G IL+E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 98.8 bits (246), Expect = 1e-25
 Identities = 51/168 (30%), Positives = 91/168 (54%), Gaps = 10/168 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S+ H NI++       +N I + +EF  GG++SS +   G +PE    K+ +Q+
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------LSCTLYPGNYAEKV 128
             G+  L+++ ++HRD+K  N++L     + ++K+ DFG       +       N  + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
            G+P +MAPEV+    Y  K D+WS+G  +FE+  G PP ++     A
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 99.1 bits (247), Expect = 1e-25
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 18/167 (10%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR-----VP 64
           E++ L  ++    I+RL D    E       ++LV E+    +L  ++  +GR     +P
Sbjct: 50  EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPG 122
            +T + F+ QL  G+   + H ++HRDLKP+N+L+       +LKIAD GL    ++   
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVK 166

Query: 123 NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
           +Y  ++  +  Y APEVL     Y   VD+WSVG I  E+    P F
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 98.2 bits (244), Expect = 2e-25
 Identities = 51/167 (30%), Positives = 93/167 (55%), Gaps = 9/167 (5%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           + L+CE+  L ++ H  I++ +   +   E  + + +E   GG++   ++ +G + E   
Sbjct: 49  NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT 108

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
           RK+ +Q+  G+  L+S+ I+HRD+K  NIL   + +   +K+ DFG S  L      G  
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTG 165

Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            + V G+P +M+PEV+  + Y  K D+WSVG  + E+L   PP++ +
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 97.6 bits (243), Expect = 4e-25
 Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 9/159 (5%)

Query: 16  ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARK 70
           E+  +   + HPNI+R +  F   + +++V++   G  L    +S      R  E+    
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 71  FLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
              Q+   L  L+    I+HRDL P NI+L G DD V   I DFGL+    P +    V 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVT--ITDFGLAKQKQPESKLTSVV 174

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G+ LY  PE+++ + Y EK D+W+ G IL+++    PPF
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 98.6 bits (246), Expect = 4e-25
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 32/166 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           EL  L    H NII + D  +        +++V++     +L   I     + E+  R F
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
           L QL  GL+ ++S ++IHRDLKP N+L++    D  L+I DFG+         A  +  S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGM---------ARGLSSS 160

Query: 132 PL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELL 162
           P               Y APE+L     Y   +DMWSVG I  E+L
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 98.0 bits (244), Expect = 6e-25
 Identities = 60/165 (36%), Positives = 87/165 (52%), Gaps = 27/165 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H        +K LQ++
Sbjct: 65  EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVH--------KKPLQEV 115

Query: 76  -------GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
                  GA  GL  L+SH  IHRD+K  NILL+   +   +K+ADFG +  + P N   
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPAN--- 169

Query: 127 KVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 168
              G+P +MAPEV+      +YD KVD+WS+G    EL    PP 
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 98.9 bits (246), Expect = 6e-25
 Identities = 57/161 (35%), Positives = 94/161 (58%), Gaps = 10/161 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ A+ +  ++
Sbjct: 93  ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 151

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
              L+ ++S  +IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208

Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y++PEVL+ Q     Y  + D WSVG  LFE+L G  PF A
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 7e-25
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 20/169 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTA 68
           E+  L  + H N++ L + F   A+  ++L+ ++ A  +L   I+ H +     +P    
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLS-------CTLY 120
           +  L Q+  G+  L+S+ ++HRDLKP NIL+ G   +  ++KI D GL+         L 
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 121 PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
             +    V  +  Y APE+L   R Y + +D+W++G I  ELL   P F
Sbjct: 171 DLD---PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 97.1 bits (241), Expect = 1e-24
 Identities = 56/162 (34%), Positives = 92/162 (56%), Gaps = 11/162 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +  + +PNI+   D+F   + +F+V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL 125

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
           Q     LE L+++ +IHRD+K +N+LL G+D  V  K+ DFG    + P       + G+
Sbjct: 126 Q----ALEFLHANQVIHRDIKSDNVLL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178

Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 96.7 bits (240), Expect = 1e-24
 Identities = 56/162 (34%), Positives = 92/162 (56%), Gaps = 11/162 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS 131
           Q     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+
Sbjct: 127 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 179

Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 96.7 bits (240), Expect = 1e-24
 Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P I R + ++     +++++E+  GG+    ++  G + E      L+++
Sbjct: 52  EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV++   YD K D+WS+G    EL  G PP S   P
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 97.4 bits (242), Expect = 2e-24
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 53/218 (24%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           LN++  + +  E + L+  ++  +++L+ +FQ ++ ++ V+++  GG++ S +      P
Sbjct: 40  LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP 99

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT------ 118
           E  AR ++ +L   +E ++    IHRD+KP+NIL   +D D  +K+ DFGL CT      
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL---IDLDGHIKLTDFGL-CTGFRWTH 155

Query: 119 ---------------LYPGNY----------------------------AEKVCGSPLYM 135
                          + P +                             A  + G+P Y+
Sbjct: 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI 215

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           APEVL  + Y +  D WSVG ILFE+L G PPF A  P
Sbjct: 216 APEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 96.6 bits (241), Expect = 2e-24
 Identities = 55/163 (33%), Positives = 89/163 (54%), Gaps = 20/163 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAF----QAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  ++H N+I L D F      E+   ++LV     G +L++ ++   ++ +   +
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVK-CQKLSDDHIQ 121

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             + Q+  GL+ ++S  IIHRDLKP NI    +++D  LKI DFGL+         +++ 
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARHT-----DDEMT 173

Query: 130 G---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 95.4 bits (237), Expect = 3e-24
 Identities = 54/159 (33%), Positives = 85/159 (53%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E+ A  +  
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+  + ++RDLKPENILL   DD   ++I+D GL+  +  G       G+  
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           YMAPEVL  QRY    D W +G +++E++ G  PF   +
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 95.3 bits (237), Expect = 3e-24
 Identities = 60/160 (37%), Positives = 90/160 (56%), Gaps = 8/160 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AFQ +  + LV+    GG+L  +I      +   PE  A  +
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 130
             Q+ +GLE L+   II+RDLKPEN+LL   D+D  ++I+D GL+  L  G    K   G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAG 159

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +P +MAPE+LQ + YD  VD +++G  L+E++    PF A
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 96.2 bits (239), Expect = 3e-24
 Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 6/155 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
            + LE L+S  +++RD+K EN++L   D D  +KI DFGL C   +  G   +  CG+P 
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 96.6 bits (240), Expect = 3e-24
 Identities = 57/161 (35%), Positives = 93/161 (57%), Gaps = 10/161 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  ++
Sbjct: 93  ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 151

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
              L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF A
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 95.5 bits (237), Expect = 3e-24
 Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 5/155 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E  A  +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G   +   G+  
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           YMAPEV++ +RY    D W++G +L+E++ G  PF
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 96.0 bits (239), Expect = 4e-24
 Identities = 58/155 (37%), Positives = 83/155 (53%), Gaps = 9/155 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           EL  L  + H NII L D F      I+ V E   G +L   +     + +Q  + FL Q
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTEL-LGTDLHRLLT-SRPLEKQFIQYFLYQ 116

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  GL+ ++S  ++HRDLKP NIL+   +++  LKI DFGL+    P         +  Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYY 171

Query: 135 MAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            APE+ L +Q+YD +VD+WS G I  E+L G P F
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 95.5 bits (238), Expect = 5e-24
 Identities = 61/161 (37%), Positives = 86/161 (53%), Gaps = 11/161 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E+  L ++ HPNI+ L +    +  + IFLV+E+C   +L+S +  +     E   +  +
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCG 130
            QL  GL+ L+ + IIHRDLK  N+LL+   D   LKIADFGL+ T  L       KV  
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVV- 170

Query: 131 SPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +  Y APE+L     Y   +DMW+VG IL ELL   P    
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 94.1 bits (234), Expect = 6e-24
 Identities = 47/160 (29%), Positives = 93/160 (58%), Gaps = 10/160 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E+  LS++ HPNI++  ++F+    +++V+++C GG+L  Y +++ +     PE     +
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL--YKKINAQRGVLFPEDQILDW 106

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-G 130
             Q+   L+ ++   I+HRD+K +NI L+    D  +K+ DFG++  L       + C G
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIG 163

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +P Y++PE+ + + Y+ K D+W++G +L+E+      F A
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 94.3 bits (234), Expect = 6e-24
 Identities = 53/159 (33%), Positives = 84/159 (52%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++     +++++E+  GG+    +R  G   E      L+++
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV+Q   YD K D+WS+G    EL  G PP S   P
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 96.2 bits (239), Expect = 6e-24
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 57/222 (25%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+    H+K+    E + L+  ++  ++RL+ +FQ ++ ++ V+++  GG++ S +   
Sbjct: 40  LLRNQVAHVKA----ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM 95

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           G  PE  AR ++ +L   +E ++    IHRD+KP+NIL   +D D  +K+ DFGL CT +
Sbjct: 96  GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGF 151

Query: 121 ----------------------------PGN---------------------YAEKVCGS 131
                                       P N                      A  + G+
Sbjct: 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211

Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           P Y+APEVL    Y +  D WSVG IL+E+L G PPF A  P
Sbjct: 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 94.7 bits (235), Expect = 7e-24
 Identities = 60/166 (36%), Positives = 89/166 (53%), Gaps = 7/166 (4%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           N+ +K     EL  L ++   NI+ L +AF+    ++LV E+     L     +   VP 
Sbjct: 40  NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP 99

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
           +  R ++ QL   +   + + I+HRD+KPEN+L+S  D   +LK+ DFG +  L  G   
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNA 156

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           NY E V  +  Y +PE+L    Y + VDMWSVG IL EL +G P F
Sbjct: 157 NYTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 95.1 bits (236), Expect = 7e-24
 Identities = 58/175 (33%), Positives = 100/175 (57%), Gaps = 13/175 (7%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + ++  I  L  AFQ EN ++LV+++  GG+L + + +   R+
Sbjct: 40  LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYP 121
           PE  AR +L ++   ++ ++  H +HRD+KP+NIL   +D +  +++ADFG SC   +  
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG-SCLKLMED 155

Query: 122 GNYAEKVC-GSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYPPFSA 170
           G     V  G+P Y++PE+LQ       +Y  + D WS+G  ++E+L G  PF A
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 93.9 bits (233), Expect = 8e-24
 Identities = 53/181 (29%), Positives = 101/181 (55%), Gaps = 16/181 (8%)

Query: 1   MLKKLN-----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLS 54
           ++KKLN     +  +   + E   LS + HPNI+   ++++ E+  +++V+ FC GG+L 
Sbjct: 29  VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL- 87

Query: 55  SYIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            Y +L  +    +PE    ++  Q+   L+ L+  HI+HRDLK +N+ L+  +   ++K+
Sbjct: 88  -YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKV 143

Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
            D G++  L      A  + G+P YM+PE+   + Y+ K D+W++G  ++E+      F+
Sbjct: 144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Query: 170 A 170
           A
Sbjct: 204 A 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 94.4 bits (234), Expect = 9e-24
 Identities = 55/162 (33%), Positives = 91/162 (56%), Gaps = 11/162 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
           Q     L+ L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+
Sbjct: 126 Q----ALDFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178

Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 93.7 bits (233), Expect = 1e-23
 Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 28/161 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+          +  G P+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 154

Query: 134 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELL 162
                      Y APE+L   + Y   VD+WS+G I  E++
Sbjct: 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 93.2 bits (232), Expect = 2e-23
 Identities = 64/191 (33%), Positives = 92/191 (48%), Gaps = 30/191 (15%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           MLK  +   K   D   E+  +  +  H NII L      E  +++VVE+ A GNL  ++
Sbjct: 49  MLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL 107

Query: 58  RLHGRVPEQTARK-----------------FLQQLGAGLEILNSHHIIHRDLKPENILLS 100
           R   R P + A                   F  Q+  G+E L S   IHRDL   N+L++
Sbjct: 108 RAR-RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166

Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAI 157
             +D VM KIADFGL+  ++  +Y  K     L   +MAPE L  + Y  + D+WS G +
Sbjct: 167 --EDHVM-KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223

Query: 158 LFEL--LNGYP 166
           L+E+  L G P
Sbjct: 224 LWEIFTLGGSP 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 94.4 bits (235), Expect = 2e-23
 Identities = 58/158 (36%), Positives = 80/158 (50%), Gaps = 18/158 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRL---HGRVPEQ 66
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   H R+   
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQMDLDHERM--- 120

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
                L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T        
Sbjct: 121 --SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMT 175

Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
               +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 93.1 bits (231), Expect = 2e-23
 Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     EQ A  +  
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           +L  GLE L    I++RDLKPENILL   DD   ++I+D GL+  +  G       G+  
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           YMAPEV+  ++Y    D W +G +++E++ G  PF   +
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 2e-23
 Identities = 45/159 (28%), Positives = 89/159 (55%), Gaps = 9/159 (5%)

Query: 16  ELNFLSSVNH---PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E+  LS +     PNI + + ++     +++++E+  GG++ + ++  G + E+     +
Sbjct: 49  EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVII 107

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGS 131
           +++   L+ ++   +IHRD+K  NIL++    +V L   DFG++  L   +       G+
Sbjct: 108 REVLVALKYIHKVGVIHRDIKAANILVT-NTGNVKL--CDFGVAALLNQNSSKRSTFVGT 164

Query: 132 PLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFS 169
           P +MAPEV+   + YD K D+WS+G  ++E+  G PP+S
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 92.6 bits (231), Expect = 3e-23
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 19/152 (12%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           ++PN I+L+ +        L++++   G+L   ++  G++ E   +K ++QL   L  L+
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-------YMA 136
            H+IIH D+K EN+L     D +   + D+GL           K+ G+P        Y +
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRI--YLCDYGLC----------KIIGTPSCYDGTLDYFS 174

Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           PE ++   YD   D W+VG + +ELL G  PF
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 92.9 bits (231), Expect = 3e-23
 Identities = 52/168 (30%), Positives = 85/168 (50%), Gaps = 29/168 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFL 72
           E++ L  + HPNI+ L D    E+ ++L+ EF +  +L  Y   +     +  +  + +L
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYL 107

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+  G+   +S  ++HRDLKP+N+L   +D+  ++K+ADFGL+          +  G P
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLL---IDNKGVIKLADFGLA----------RAFGIP 154

Query: 133 L-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +           Y APEVL    RY   VD+WS+G I  E+    P F
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 93.5 bits (232), Expect = 4e-23
 Identities = 60/179 (33%), Positives = 99/179 (55%), Gaps = 16/179 (8%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
           MLK+      +C   E N L + +   I  L  AFQ EN ++LV+++  GG+L + + + 
Sbjct: 39  MLKRAET---ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF 95

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-- 117
             R+PE  AR ++ ++   +  ++  H +HRD+KP+N+L   LD +  +++ADFG SC  
Sbjct: 96  EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL---LDMNGHIRLADFG-SCLK 151

Query: 118 TLYPGNYAEKVC-GSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
               G     V  G+P Y++PE+LQ       +Y  + D WS+G  ++E+L G  PF A
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 91.6 bits (227), Expect = 5e-23
 Identities = 56/167 (33%), Positives = 90/167 (53%), Gaps = 8/167 (4%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQT 67
           LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G R+  + 
Sbjct: 36  LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
             + ++   AG+E L S H IHRDL   N L++   +  +LKI+DFG+S     G YA  
Sbjct: 96  LIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAST 152

Query: 128 --VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
             +   P+ + APE L + RY  + D+WS G +L+E  + G  P++ 
Sbjct: 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 92.4 bits (229), Expect = 5e-23
 Identities = 60/160 (37%), Positives = 84/160 (52%), Gaps = 13/160 (8%)

Query: 17  LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 55  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIK 113

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A    
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA-RIYSFQMALTSV 169

Query: 130 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
              L Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 93.0 bits (231), Expect = 6e-23
 Identities = 55/164 (33%), Positives = 88/164 (53%), Gaps = 12/164 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E + LS  N P I +L  AFQ ++ ++LV+E+  GG+L S + R   +  E  A+ +L +
Sbjct: 51  ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
           L   +  ++    +HRD+KPEN+L   +D    +K+ADFG +  L       ++   G+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVL---IDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 133 LYMAPEVLQFQR------YDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+APEVL          Y  + D WS+G I +E++ G  PF  
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 92.1 bits (229), Expect = 6e-23
 Identities = 58/165 (35%), Positives = 90/165 (54%), Gaps = 5/165 (3%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +K +K     E+  L  + H N++ L + F+ +  ++LV EF     L    +    + E
Sbjct: 40  DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDE 99

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNY 124
              RK+L Q+  G+E  +SH+IIHRD+KPENIL+S      ++K+ DFG + TL  PG  
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 156

Query: 125 AEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                 +  Y APE+L    +Y   VD+W+VG ++ E+L G P F
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 91.7 bits (227), Expect = 6e-23
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV++   YD K D+WS+G    EL  G PP S   P
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 92.5 bits (230), Expect = 8e-23
 Identities = 55/164 (33%), Positives = 81/164 (49%), Gaps = 15/164 (9%)

Query: 16  ELNFLSSV-NHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           EL  L     H NI  L+D         N ++L  E     +L   IR    + +   + 
Sbjct: 51  ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYA 125
           F+ Q+  GL+ ++S +++HRDLKP N+L++    D  LKI DFGL+            + 
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFM 166

Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            +   +  Y APE+ L FQ Y + +D+WSVG IL ELL   P F
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.1 bits (228), Expect = 9e-23
 Identities = 59/158 (37%), Positives = 85/158 (53%), Gaps = 13/158 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 75  EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 132

Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILL+   +   +K+ADFG +    P N      G+P 
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPAN---SFVGTPY 186

Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 168
           +MAPEV+      +YD KVD+WS+G    EL    PP 
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 91.6 bits (227), Expect = 9e-23
 Identities = 57/177 (32%), Positives = 93/177 (52%), Gaps = 19/177 (10%)

Query: 13  LDCELNFLSSV-NHPNIIRLFDAF-QAENCI----FLVVEFCAGGNLSSYI----RLHGR 62
           ++ E N L S+ NHPN+++ +  F +A+  +    +LV+E C GG+++  +        R
Sbjct: 65  IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E      L     GL+ L+++ IIHRD+K  NILL+    +  +K+ DFG+S  L   
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 181

Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
                   G+P +MAPEV+  ++     YD + D+WS+G    EL +G PP     P
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 9e-23
 Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 16/167 (9%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK  +   ++ L  E + ++++ HPN+++L       N +++V E+ A G+L  Y+R  
Sbjct: 36  CLKDDSTAAQAFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR 94

Query: 61  GR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--- 115
           GR  +       F   +  G+E L   + +HRDL   N+L+S   +D++ K++DFGL   
Sbjct: 95  GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151

Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            S     G    K      + APE L+ +++  K D+WS G +L+E+
Sbjct: 152 ASQGQDSGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 91.6 bits (227), Expect = 1e-22
 Identities = 59/158 (37%), Positives = 85/158 (53%), Gaps = 13/158 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 71  EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 128

Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILL+   +   +K+ADFG +    P N      G+P 
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPAN---SFVGTPY 182

Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 168
           +MAPEV+      +YD KVD+WS+G    EL    PP 
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 91.3 bits (226), Expect = 2e-22
 Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 6/155 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ ++ +  V+E+  GG L  ++       E   R +  ++
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
            + L+ L+S  I++RDLK EN++L   D D  +KI DFGL C   +      +  CG+P 
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGL-CKEGITDAATMKTFCGTPE 160

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 2e-22
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 56/219 (25%)

Query: 1   MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           M KK    H+K+    E + L+  + P ++ L+ +FQ    ++L++EF  GG+L + +  
Sbjct: 39  MFKKDQLAHVKA----ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK 94

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           +    E   R ++ +    +E ++    IHRD+KP+NIL   +D    +K++DFGLS   
Sbjct: 95  YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL---IDRGGHIKLSDFGLSTGF 151

Query: 120 YP---GNYAEKV---------------------------------------------CGS 131
           +      Y +K+                                              G+
Sbjct: 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211

Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           P Y+APE+   Q Y ++ D WS+GAI+FE L G+PPF +
Sbjct: 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCS 250

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 90.5 bits (224), Expect = 3e-22
 Identities = 59/158 (37%), Positives = 87/158 (55%), Gaps = 13/158 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 122

Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 176

Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 168
           +MAPEV+      +YD KVD+WS+G    EL    PP 
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 3e-22
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++ ++HP I+RL    + E  + LV+E    G L  Y++    +P    ++   Q+
Sbjct: 46  EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS-P 132
             G+  L S H +HRDL   N+LL    +    KI+DFG+S  L  G+  Y     G  P
Sbjct: 105 AMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           L + APE + + ++  K D+WS G  L+E  + G  P+
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 89.7 bits (222), Expect = 4e-22
 Identities = 52/157 (33%), Positives = 90/157 (57%), Gaps = 5/157 (3%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E+  R +  ++ 
Sbjct: 48  LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107

Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163

Query: 137 PEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           PEVLQ    YD   D +S+G +LF+LL G+ PF  ++
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 90.6 bits (225), Expect = 4e-22
 Identities = 54/169 (31%), Positives = 80/169 (47%), Gaps = 20/169 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  ++ + H NI+ L D +   + I LV++  A  +L   +    R+ E   +  L Q+
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS----CTLYPGNYAEKVCGS 131
             GL +L+  + +HRDL P NI +   +   + KIADFGL+       Y    ++     
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 132 P-----------LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
                        Y APE+L   ++Y   VDMWSVG I  ELL G P F
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234

Length = 335

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 90.6 bits (225), Expect = 4e-22
 Identities = 50/174 (28%), Positives = 93/174 (53%), Gaps = 25/174 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++++                   N +++V E     +L++ +   G
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLE-QG 109

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDP 167

Query: 122 -----GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
                G  +E +  +  Y +P  +L    Y + +DMW+ G I  E+L G P F+
Sbjct: 168 HYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 89.8 bits (223), Expect = 5e-22
 Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PE    K    +
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 164

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
           M+PE LQ   Y  + D+WS+G  L E+  G YP
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 89.5 bits (222), Expect = 5e-22
 Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 41/174 (23%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFC---------AGGNLSSYIRLHGRVPEQ 66
           E++ L  + H NI+RL D   +E  ++LV E+          +  + +   RL       
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL------- 103

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + +L Q+  G+   +SH ++HRDLKP+N+L+    +   LK+ADFGL+          
Sbjct: 104 -IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA---------- 150

Query: 127 KVCGSPL-----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
           +  G P+           Y APE+L   R Y   VD+WSVG I  E++N  P F
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 89.3 bits (221), Expect = 6e-22
 Identities = 50/148 (33%), Positives = 84/148 (56%), Gaps = 7/148 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P ++ L  AFQ +  + L++++  GG L +++    R  EQ  + +  ++   LE L+  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ 143
            II+RD+K ENIL   LD +  + + DFGLS   +      A   CG+  YMAP++++  
Sbjct: 125 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181

Query: 144 R--YDEKVDMWSVGAILFELLNGYPPFS 169
              +D+ VD WS+G +++ELL G  PF+
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFT 209

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 88.9 bits (220), Expect = 8e-22
 Identities = 52/159 (32%), Positives = 87/159 (54%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   L  VN P I+ L  AF+++  + LV+    GG+L  +I   G    +  R   +  
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+  G+  L+S  I++RD+KPEN+LL   DD    +++D GL+  L  G    +  G+  
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           YMAPE+L+ + Y   VD +++G  ++E++ G  PF  ++
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 88.8 bits (220), Expect = 8e-22
 Identities = 52/157 (33%), Positives = 89/157 (56%), Gaps = 5/157 (3%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107

Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163

Query: 137 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           PEVLQ    YD   D +S+G +LF+LL G+ PF  ++
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 91.4 bits (227), Expect = 9e-22
 Identities = 55/170 (32%), Positives = 82/170 (48%), Gaps = 13/170 (7%)

Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVP-E 65
           H ++    E    + + HPNI+ L D+ +A    +F V E+  G  L   +   G +P  
Sbjct: 20  HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
           +T R  LQ L A L   ++  I+HRDLKP+NI++S        K+ DFG+  TL PG   
Sbjct: 80  ETGRLMLQVLDA-LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRD 137

Query: 123 ------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
                     +V G+P Y APE L+ +      D+++ G I  E L G  
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 89.5 bits (222), Expect = 9e-22
 Identities = 55/152 (36%), Positives = 89/152 (58%), Gaps = 13/152 (8%)

Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHH 86
           I  L  AFQ EN ++LV+++  GG+L + + +   R+PE  AR +L ++   ++ ++   
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 87  IIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVC-GSPLYMAPEVLQFQ 143
            +HRD+KP+N+L   LD +  +++ADFG SC   L  G     V  G+P Y++PE+LQ  
Sbjct: 123 YVHRDIKPDNVL---LDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178

Query: 144 -----RYDEKVDMWSVGAILFELLNGYPPFSA 170
                RY  + D WS+G  ++E+L G  PF A
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 88.7 bits (220), Expect = 1e-21
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 23/176 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK----- 70
           E   +S + HPNI+ L      E    ++ E+ A G+L  ++  +    +  A       
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 71  --------FLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
                   FL    Q+ AG+E L+SHH +HRDL   N L+    + + +KI+DFGLS  +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLSRDI 174

Query: 120 YPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
           Y  +Y      S L   +M PE + + ++  + D+WS G +L+E+ + G  P+  +
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 88.5 bits (219), Expect = 1e-21
 Identities = 52/177 (29%), Positives = 94/177 (53%), Gaps = 19/177 (10%)

Query: 13  LDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSS----YIRLHGR 62
           ++ E N L ++ +HPN+++ +  +  ++      ++LV+E C GG+++     +++   R
Sbjct: 61  IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E      L +   GL+ L+ +  IHRD+K  NILL+    +  +K+ DFG+S  L   
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSAQLTST 177

Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
                   G+P +MAPEV+  ++     YD + D+WS+G    EL +G PP +   P
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 89.7 bits (222), Expect = 1e-21
 Identities = 59/155 (38%), Positives = 78/155 (50%), Gaps = 12/155 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVI--HMELDHERMS 126

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTACTNFMMTPYV 183

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ EL+ G
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 89.3 bits (221), Expect = 1e-21
 Identities = 53/156 (33%), Positives = 86/156 (55%), Gaps = 7/156 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  ++
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 76  GAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSP 132
            + L+ L+S  ++++RDLK EN++L   D D  +KI DFGL C   +  G   +  CG+P
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 160

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 88.4 bits (220), Expect = 1e-21
 Identities = 59/170 (34%), Positives = 85/170 (50%), Gaps = 33/170 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL- 72
           E+N L  + HPNI+ + +     N   I++V+E+    +L S +    +   Q+  K L 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
            QL +G+  L+ + I+HRDLK  N+LL+  G+     LKI DFGL+          +  G
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-----LKICDFGLA----------REYG 157

Query: 131 SPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
           SPL           Y APE+L   + Y   +DMWSVG I  ELL   P F
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 86.8 bits (215), Expect = 2e-21
 Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 7/160 (4%)

Query: 7   KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           K L+   +     L+ + H  PN++ L     +E+ +FLV++   GG L S+I     +P
Sbjct: 24  KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
           E+  +++  ++   L+ L+   I+ RDL P NIL   LDD   +++  F     +     
Sbjct: 84  EECVKRWAAEMVVALDALHREGIVCRDLNPNNIL---LDDRGHIQLTYFSRWSEVEDSCD 140

Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            E V    +Y APEV       E  D WS+GAILFELL G
Sbjct: 141 GEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 87.8 bits (218), Expect = 3e-21
 Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 27/170 (15%)

Query: 16  ELNFLSSVNHPNIIRLFD-----AFQAENC---IFLVVEFC----AGGNLSSYIRLHGRV 63
           E+  L  + H N++ L +     A          +LV EFC    AG  L S   +   +
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTL 118

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--- 120
            E   +K ++ L  GL  ++ + I+HRD+K  NIL++    D +LK+ADFGL+       
Sbjct: 119 SE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSK 173

Query: 121 ---PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
              P  Y  +V  +  Y  PE+L  +R Y   +DMW  G I+ E+    P
Sbjct: 174 NSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 87.4 bits (216), Expect = 3e-21
 Identities = 54/165 (32%), Positives = 95/165 (57%), Gaps = 7/165 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +   +H N++ +++++   + +++V+EF  GG L+  I  H R+  EQ A   L  
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 133
           L A L  L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P 
Sbjct: 128 LRA-LSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASR 178
           +MAPEV+    Y  +VD+WS+G ++ E+++G PP+    P  A R
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 87.0 bits (216), Expect = 4e-21
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 7/154 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + HPN++ L + F+ +  + LV E+C    L+   +    VPE   +K + Q 
Sbjct: 50  EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPL 133
              +   + H+ IHRD+KPENIL++       +K+ DFG +  L     +Y + V  +  
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165

Query: 134 YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166
           Y APE+L    +Y   VD+W++G +  ELL G P
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 4e-21
 Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 17/164 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII + D  +       N +++V E     +L   I+    +     + 
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQY 110

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYA 125
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL         + G   
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167

Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           E V  +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 86.6 bits (214), Expect = 5e-21
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 7/162 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H NI+  F ++   + +++ +EFC GG+L     + G + E       ++ 
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
             GL  L+S   +HRD+K  NILL+   D+  +K+ADFG+S  +       K   G+P +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172

Query: 135 MAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV   +R   Y++  D+W+VG    EL    PP     P
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 5e-21
 Identities = 52/162 (32%), Positives = 84/162 (51%), Gaps = 11/162 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   L   +HPNI++L      +  I++V+E   GG+L +++R    R+  +   +    
Sbjct: 42  EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSP 132
             AG+E L S + IHRDL   N L+    ++ +LKI+DFG+S     G Y   + +   P
Sbjct: 102 AAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNG----YPPFS 169
           + + APE L + RY  + D+WS G +L+E  +     YP  S
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 87.0 bits (215), Expect = 5e-21
 Identities = 47/165 (28%), Positives = 93/165 (56%), Gaps = 5/165 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ +++++   + +++V+EF  GG L+  I  H R+ E+        +
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRL 179
           MAPE++    Y  +VD+WS+G ++ E+++G PP+    P  A ++
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 87.0 bits (215), Expect = 8e-21
 Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 5/153 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
           M+PE LQ   Y  + D+WS+G  L E+  G  P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 1e-20
 Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  + LV E+    +L  Y+   G  +     R FL Q
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGN-YAEKVCGSP 132
           L  GL   +   ++HRDLKP+N+L+S   +   LK+ADFGL+     P   Y+ +V  + 
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVV-TL 167

Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
            Y  P+VL     Y   +DMW VG I +E+  G P F
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 85.7 bits (212), Expect = 1e-20
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 17/165 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           EL+ L     P I+  + AF  E  +++ +E+   G+L            +PE   R+  
Sbjct: 49  ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108

Query: 73  QQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             +  GL+ L   H+IIHRD+KP N+L++G   +  +K+ DFG+S  L   + A+   G 
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV-ASLAKTNIGC 164

Query: 132 PLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNG---YPP 167
             YMAPE +      Q   Y  + D+WS+G  + E+  G   YPP
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 85.3 bits (211), Expect = 1e-20
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 9/161 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E   +  ++H  +++L+     +  I++V E+ + G L +Y+R HG+  +     +  + 
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L S   IHRDL   N L   +DD   +K++DFGLS  +    Y   V GS   
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCL---VDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFP 164

Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEVL + ++  K D+W+ G +++E+ + G  P+  +
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 86.5 bits (214), Expect = 1e-20
 Identities = 61/182 (33%), Positives = 95/182 (52%), Gaps = 25/182 (13%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +      +  +LV+ F  G
Sbjct: 45  IKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF-MG 103

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   ++ H ++ E   +  + Q+  GL+ +++  IIHRDLKP N+    +++D  LKI
Sbjct: 104 TDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKI 159

Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
            DFGL+          ++ G   +  Y APEV L +  Y + VD+WSVG I+ E+L G P
Sbjct: 160 LDFGLA-----RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Query: 167 PF 168
            F
Sbjct: 215 LF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.1 bits (211), Expect = 2e-20
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 20/162 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +V+E  A G+L SY+R   R PE          
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR--SRRPEAENNPGLGPP 116

Query: 67  TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           T +KF+Q   ++  G+  L +   +HRDL   N +++   +D+ +KI DFG++  +Y  +
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETD 173

Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           Y  K     L   +MAPE L+   +  K D+WS G +L+E+ 
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 86.5 bits (214), Expect = 2e-20
 Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 14/156 (8%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E   L +VNHP++IR+ D     A  C+ L        +L +Y+ +    +P   A    
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS---DLYTYLTKRSRPLPIDQALIIE 163

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLY-PGNYAEKVCG 130
           +Q+  GL  L++  IIHRD+K ENI +   +D   + I D G +   +  P      + G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
           +    APEVL   +Y+ K D+WS G +LFE+L  YP
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML-AYP 253

Length = 357

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 85.9 bits (212), Expect = 2e-20
 Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++   R+PE+   K    +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
           M+PE LQ   Y  + D+WS+G  L EL  G YP
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.9 bits (210), Expect = 2e-20
 Identities = 53/153 (34%), Positives = 78/153 (50%), Gaps = 8/153 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   + P II  + AF  EN I +  EF  GG+L  Y     ++PE    +    +
Sbjct: 49  ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAV 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
             GL  L S  I+HRD+KP N+L++       +K+ DFG+S  L   + A+   G+  YM
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYM 160

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           APE +  ++Y    D+WS+G    EL  G  P+
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 85.8 bits (212), Expect = 3e-20
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 41/206 (19%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L K   + +  E + L   +   ++++F +FQ +  ++L++EF  GG++ + +     + 
Sbjct: 40  LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT------ 118
           E+  + ++ +    ++ ++    IHRD+KP+N+L   LD    +K++DFGL CT      
Sbjct: 100 EEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL---LDAKGHVKLSDFGL-CTGLKKAH 155

Query: 119 ---LY-------PGNY---------------------AEKVCGSPLYMAPEVLQFQRYDE 147
               Y       P ++                     A    G+P Y+APEV     Y++
Sbjct: 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215

Query: 148 KVDMWSVGAILFELLNGYPPFSAYRP 173
             D WS+G I++E+L GYPPF +  P
Sbjct: 216 LCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 84.6 bits (209), Expect = 4e-20
 Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 34/182 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------------ 63
           E N L  VNHP++I+L+ A   +  + L+VE+   G+L S++R   +V            
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 64  ------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                 P++ A        F  Q+  G++ L    ++HRDL   N+L++   +   +KI+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKIS 169

Query: 112 DFGLSCTLYPGN-YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NG 164
           DFGLS  +Y  + Y ++  G  P+ +MA E L    Y  + D+WS G +L+E++    N 
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 165 YP 166
           YP
Sbjct: 230 YP 231

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 84.2 bits (208), Expect = 6e-20
 Identities = 59/160 (36%), Positives = 84/160 (52%), Gaps = 13/160 (8%)

Query: 17  LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L + +HPNI+RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 53  LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK 111

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+  +Y    A   V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLA-RIYSCQMALTPV 167

Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             +  Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 83.6 bits (207), Expect = 6e-20
 Identities = 54/173 (31%), Positives = 76/173 (43%), Gaps = 20/173 (11%)

Query: 9   LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRV 63
           L   +D    E   + S++H N+IRL+        + +V E    G+L   +R    G  
Sbjct: 36  LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHF 94

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---- 119
              T   +  Q+  G+  L S   IHRDL   NILL+  DD V  KI DFGL   L    
Sbjct: 95  LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKV--KIGDFGLMRALPQNE 151

Query: 120 --YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             Y      KV   P  + APE L+ + +    D+W  G  L+E+   G  P+
Sbjct: 152 DHYVMEEHLKV---PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.5 bits (206), Expect = 7e-20
 Identities = 46/151 (30%), Positives = 82/151 (54%), Gaps = 7/151 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ E+ A G+L  +++    G+V       F  
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           + + APE + F  +  K D+WS G +L+E++
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 84.7 bits (209), Expect = 8e-20
 Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 39/182 (21%)

Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           ++++F +FQ +  ++L++EF  GG++ + +     + E+  + ++ +    ++ ++    
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--------------------- 126
           IHRD+KP+N+L   LD    +K++DFGL   L   +  E                     
Sbjct: 123 IHRDIKPDNLL---LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 127 ---------------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
                             G+P Y+APEV     Y++  D WS+G I++E+L GYPPF + 
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 172 RP 173
            P
Sbjct: 240 TP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 83.3 bits (206), Expect = 1e-19
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 22/164 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------- 61
           E   L++  H NI++ +      +   +V E+   G+L+ ++R HG              
Sbjct: 58  EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            +      +   Q+ +G+  L S H +HRDL   N L+     D+++KI DFG+S  +Y 
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMSRDVYT 174

Query: 122 GNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+
Sbjct: 175 TDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.5 bits (206), Expect = 1e-19
 Identities = 55/163 (33%), Positives = 87/163 (53%), Gaps = 24/163 (14%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
           H NII L  A   +  ++++VE+ + GNL  Y+R              RVP++  T +  
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 72  LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           +    Q+  G+E L S   IHRDL   N+L++  +++VM KIADFGL+  +   +Y +K 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARDVNNIDYYKKT 196

Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
               L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 82.5 bits (203), Expect = 2e-19
 Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 18/173 (10%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR--LHGRVPEQ 66
           E+N L   +H  NI   + AF  +N       ++LV+EFC  G+++  I+      + E+
Sbjct: 52  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
                 +++  GL  L+ H +IHRD+K +N+LL+   ++  +K+ DFG+S  L       
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168

Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
               G+P +MAPEV+         YD K D+WS+G    E+  G PP     P
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 82.2 bits (203), Expect = 2e-19
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 7/150 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  V          
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y A      P
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           + + APE L + ++  K D+W+ G +L+E+
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 82.2 bits (203), Expect = 2e-19
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 14/162 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+   S + H NI++   +        + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
           +Q+  GL+ L+ + I+HRD+K +N+L+   SG+     +KI+DFG S  L   N   E  
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAGINPCTETF 169

Query: 129 CGSPLYMAPEVL-QFQR-YDEKVDMWSVGAILFELLNGYPPF 168
            G+  YMAPEV+ +  R Y    D+WS+G  + E+  G PPF
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 82.7 bits (204), Expect = 2e-19
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  +  V E+    +L+ Y+  H G +     R F+ Q
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 132
           L  GL  ++  HI+HRDLKP+N+L+S L +   LK+ADFGL  + ++    Y+ +V  + 
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVV-TL 167

Query: 133 LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y  P+VL     Y   +D+W  G I  E+L G P F
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 82.8 bits (204), Expect = 2e-19
 Identities = 56/163 (34%), Positives = 88/163 (53%), Gaps = 24/163 (14%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
           H NII L  A   +  ++++VE+ + GNL  Y+R              +VPE+  + +  
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 72  LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           +    Q+  G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNVM-KIADFGLARDIHHIDYYKKT 199

Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
               L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 83.1 bits (205), Expect = 2e-19
 Identities = 55/164 (33%), Positives = 88/164 (53%), Gaps = 23/164 (14%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQ--TARKF 71
           H NII L  A   +  ++++VE+ + GNL  Y+R              ++PE+  T +  
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 72  LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           +    Q+  G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVM-KIADFGLARDVHNIDYYKKT 193

Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
               L   +MAPE L  + Y  + D+WS G +L+E+   G  P+
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 81.9 bits (202), Expect = 3e-19
 Identities = 50/157 (31%), Positives = 88/157 (56%), Gaps = 11/157 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   ++ ++H N++RL       N +++V+E  + GNL +++R  GR  V      +F  
Sbjct: 49  ETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
            +  G+E L S  ++HRDL   NIL+S   +D + K++DFGL+     G    K+   P+
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL---PV 161

Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            + APE L+ +++  K D+WS G +L+E+ + G  P+
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 82.4 bits (203), Expect = 3e-19
 Identities = 48/165 (29%), Positives = 93/165 (56%), Gaps = 7/165 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ ++ ++     +++++EF  GG L+  +    R+ E+      + +
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESV 126

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 133
              L  L+S  +IHRD+K ++ILL+ LD  V  K++DFG  C     +  ++  + G+P 
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLT-LDGRV--KLSDFGF-CAQISKDVPKRKSLVGTPY 182

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASR 178
           +MAPEV+    Y  +VD+WS+G ++ E+++G PP+ +  P  A +
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 82.7 bits (204), Expect = 3e-19
 Identities = 48/147 (32%), Positives = 81/147 (55%), Gaps = 6/147 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P ++ L  AFQ E  + L++++ +GG + +++       E   R +  ++   LE L+  
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQ 143
            I++RD+K ENIL   LD +  + + DFGLS              CG+  YMAPE+++ +
Sbjct: 125 GIVYRDIKLENIL---LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Query: 144 R-YDEKVDMWSVGAILFELLNGYPPFS 169
             + + VD WS+G ++FELL G  PF+
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFT 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 82.8 bits (204), Expect = 3e-19
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 12/155 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 186

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 82.8 bits (204), Expect = 3e-19
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 25/182 (13%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 47  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 105

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 106 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 161

Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
            DFGL+      +  +++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G  
Sbjct: 162 LDFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Query: 167 PF 168
            F
Sbjct: 217 LF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 83.8 bits (207), Expect = 4e-19
 Identities = 39/112 (34%), Positives = 72/112 (64%), Gaps = 3/112 (2%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           +NK++   +  E + L+    P I+ L+ + Q+ N ++LV+E+  GG++ S + ++G   
Sbjct: 43  INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD 102

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           E+ A K++ ++   L+ L+ H IIHRDLKP+N+L+S   ++  +K+ DFGLS
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 82.3 bits (203), Expect = 4e-19
 Identities = 58/163 (35%), Positives = 87/163 (53%), Gaps = 24/163 (14%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPE-QTARKFL 72
           H NII L      E  ++++VE+ A GNL  ++R              +VPE Q + K L
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 73  ----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
                Q+  G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVT--EDNVM-KIADFGLARGVHDIDYYKKT 193

Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
               L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 81.6 bits (201), Expect = 4e-19
 Identities = 48/171 (28%), Positives = 90/171 (52%), Gaps = 23/171 (13%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTARKFLQ 73
           S + HPNI+ L      E  + ++  +C+  +L  ++ +   H  V     ++T +  L+
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 74  ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
                    Q+ AG+E L+SHH++H+DL   N+L+    D + +KI+D GL   +Y  +Y
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADY 179

Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
            + +  S L   +M+PE + + ++    D+WS G +L+E+ + G  P+  Y
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.8 bits (200), Expect = 7e-19
 Identities = 43/156 (27%), Positives = 83/156 (53%), Gaps = 13/156 (8%)

Query: 17  LNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTAR 69
           L+FL+        +HPNIIRL         + ++ E+   G+L  ++R + G+       
Sbjct: 50  LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP--GNYAEK 127
             L+ + +G++ L+  + +HRDL   NIL++    +++ K++DFGLS  L      Y  K
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTK 166

Query: 128 VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
               P+ + APE + ++++    D+WS G +++E++
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 81.7 bits (202), Expect = 8e-19
 Identities = 60/187 (32%), Positives = 87/187 (46%), Gaps = 21/187 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           LKK+    ++ + C     EL  L    H N++   D  Q  +      I++V E     
Sbjct: 30  LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS- 88

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L   I     +     + FL Q+  GL+ L+S  I+HRD+KP N+L   ++ + +LKI 
Sbjct: 89  DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL---VNSNCVLKIC 145

Query: 112 DFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYP 166
           DFGL+    P        E V  +  Y APE+L   + Y   VD+WSVG I  ELL    
Sbjct: 146 DFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203

Query: 167 PFSAYRP 173
            F A  P
Sbjct: 204 LFQAQSP 210

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 80.8 bits (199), Expect = 9e-19
 Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L ++ H NI+ L D    E C+ LV E+    +L  Y+   G +      + F+ Q
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 132
           L  GL   +   I+HRDLKP+N+L   +++   LK+ADFGL  + ++    Y+ +V  + 
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLL---INEKGELKLADFGLARAKSVPTKTYSNEVV-TL 167

Query: 133 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y  P+V L    Y   +DMW VG IL+E+  G P F
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 80.4 bits (198), Expect = 1e-18
 Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 18/173 (10%)

Query: 16  ELNFLSSVNH-PNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQT 67
           E+N L   +H  NI   + AF        ++ ++LV+EFC  G+++  ++   G   ++ 
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121

Query: 68  ARKFL-QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
              ++ +++  GL  L++H +IHRD+K +N+LL+   ++  +K+ DFG+S  L       
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 178

Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
               G+P +MAPEV+         YD + D+WS+G    E+  G PP     P
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 81.2 bits (200), Expect = 1e-18
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 25/182 (13%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 45  VKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MG 103

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I
Sbjct: 104 ADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRI 159

Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
            DFGL+         +++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G  
Sbjct: 160 LDFGLA-----RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214

Query: 167 PF 168
            F
Sbjct: 215 LF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 1e-18
 Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 8/148 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P I++ +  F  ++ +F+ +E  +        R+ G +PE    K    +   L  L   
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133

Query: 86  H-IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL---- 140
           H +IHRD+KP NIL   LD    +K+ DFG+S  L       +  G   YMAPE +    
Sbjct: 134 HGVIHRDVKPSNIL---LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190

Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPF 168
              +YD + D+WS+G  L EL  G  P+
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPY 218

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 2e-18
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           ++SV+HP+++RL     +   + L+ +    G L  Y+R H   +  Q    +  Q+  G
Sbjct: 63  MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--PL-YM 135
           +  L    ++HRDL   N+L+        +KI DFGL+  L          G   P+ +M
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELL 162
           A E +  + Y  K D+WS G  ++EL+
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.8 bits (197), Expect = 2e-18
 Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 17/170 (10%)

Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           E +FL      S  NH NI+RL          F+++E  AGG+L S++R +   PE+ + 
Sbjct: 53  ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS 112

Query: 70  KFLQQL-------GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             ++ L         G + L  +H IHRD+   N LL+      + KIADFG++  +Y  
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172

Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           +Y  K   + L   +M PE      +  K D+WS G +L+E+ + GY P+
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.7 bits (196), Expect = 2e-18
 Identities = 43/164 (26%), Positives = 86/164 (52%), Gaps = 21/164 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------R 62
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG              
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + +       QQ+ AG+  L S H +HRDL   N L+    +++++KI DFG+S  +Y  
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYST 173

Query: 123 NYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           +Y  +V G  +    +M PE + ++++  + D+WS+G +L+E+ 
Sbjct: 174 DYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 80.5 bits (198), Expect = 2e-18
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMS 122

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 179

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.1 bits (195), Expect = 3e-18
 Identities = 49/161 (30%), Positives = 88/161 (54%), Gaps = 19/161 (11%)

Query: 24  NHPNIIRLFD-AFQAENC-----IFLVVEFCAGGNLSSYI---RLHG---RVPEQTARKF 71
           +HPN+++L    F+A +        +++ F   G+L S++   RL G   ++P QT  KF
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
           +  +  G+E L++ + IHRDL   N +   L +D+ + +ADFGLS  +Y G+Y  +   +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM---LREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +   ++A E L  + Y  K D+W+ G  ++E+   G  P+
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 3e-18
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 12/162 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HPN+++L+     +  IF+V E+ A G L +Y+R   G++  +        
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
           +   +E L S+  IHRDL   N L+    +D ++K++DFGL+  +    Y     G+  P
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSSQ-GTKFP 164

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNG----YPPFS 169
           + +  PEV  + R+  K D+WS G +++E+ +     Y  FS
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 79.9 bits (197), Expect = 4e-18
 Identities = 59/175 (33%), Positives = 88/175 (50%), Gaps = 20/175 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  VNHPN+++  D F     I +++EF  GG+L        +     AR+ L   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--- 178

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCGS 131
            +G+  L+  HI+HRD+KP N+L   ++    +KIADFG    L+ T+ P N +    G+
Sbjct: 179 -SGIAYLHRRHIVHRDIKPSNLL---INSAKNVKIADFGVSRILAQTMDPCNSS---VGT 231

Query: 132 PLYMAPEV----LQFQRYDEKV-DMWSVGAILFELLNGYPPFSAYRPC-FASRLC 180
             YM+PE     L    YD    D+WS+G  + E   G  PF   R   +AS +C
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC 286

Length = 353

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 79.3 bits (196), Expect = 4e-18
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 28/174 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLHG---RVPE 65
           E+  L  + HPN++ L D         + +     +V      +LS    L     ++ E
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGL--LENPSVKLTE 114

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
              + ++ QL  G+  L+ +HI+HRD+K  NIL   +D+  +LKIADFGL+         
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANIL---IDNQGILKIADFGLARPYDGPPPN 171

Query: 126 EKVCGSPL------------YMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYP 166
            K  G               Y  PE +L  +RY   VD+W +G +  E+    P
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.8 bits (194), Expect = 5e-18
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 9/159 (5%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           + S++H  I+RL       + + LV +    G+L  ++R H   +  Q    +  Q+  G
Sbjct: 63  MGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL-YM 135
           +  L  H ++HR+L   NILL     D +++IADFG++  LYP +  Y      +P+ +M
Sbjct: 122 MYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRP 173
           A E + F RY  + D+WS G  ++E+++ G  P++  RP
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 78.2 bits (192), Expect = 7e-18
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           S +  E+  +    H NI+  F ++ +   +++ +E+C GG+L     + G + E     
Sbjct: 51  SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VC 129
             ++   GL  L+S   +HRD+K  NILL+   D+  +K+ADFG++  +       K   
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFI 167

Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           G+P +MAPEV   ++   Y++  D+W+VG    EL    PP     P
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.7 bits (191), Expect = 8e-18
 Identities = 52/159 (32%), Positives = 80/159 (50%), Gaps = 6/159 (3%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRV 63
           L + LK     E   L   +HPNI++L         I++V+E   GG+  S++R     +
Sbjct: 31  LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDEL 90

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
             +   KF     AG+  L S + IHRDL   N L+    ++ +LKI+DFG+S     G 
Sbjct: 91  KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGI 147

Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE 160
           Y+       P+ + APE L + RY  + D+WS G +L+E
Sbjct: 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.8 bits (192), Expect = 9e-18
 Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)

Query: 16  ELNFLSSVNHPNIIRL--FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
           E+  L +++H NI++            + L++E+   G+L  Y++ H  ++  +    F 
Sbjct: 56  EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVC 129
            Q+  G++ L S   IHRDL   NIL   ++ + ++KI+DFGL+  L       Y ++  
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 130 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            SP+ + APE L+  ++    D+WS G  L+EL 
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.7 bits (191), Expect = 1e-17
 Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 24/177 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV-----PEQT 67
           E + ++ ++HPNI+ L      E  + ++ E+   G+L  ++ +   H  V      + T
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 68  ARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            +  L          Q+ AG+E L+SH  +H+DL   NIL+    + + +KI+D GLS  
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSRE 173

Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
           +Y  +Y      S L   +M PE + + ++    D+WS G +L+E+ + G  P+  +
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.4 bits (190), Expect = 2e-17
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 30/174 (17%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
           EL  L  + +HPNII L  A +    +++ +E+   GNL  ++R              HG
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 62  RVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                T+++ LQ    +  G++ L+    IHRDL   N+L+    +++  KIADFGLS  
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS-- 166

Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
              G   Y +K  G  P+ +MA E L +  Y  K D+WS G +L+E+  L G P
Sbjct: 167 --RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 77.4 bits (190), Expect = 2e-17
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 7/160 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  + LV E+    +L  Y+  H G +  +  + FL Q
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 133
           L  GL  ++  +I+HRDLKP+N+L+S   D   LK+ADFGL+     P +       +  
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTLW 168

Query: 134 YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           Y  P+V L    Y   +DMW VG I  E++ G   F   +
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 78.0 bits (192), Expect = 2e-17
 Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 11/152 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E++ L +++H  II L  A++ ++  C+ +    C   +L +Y+   G +P + A    +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           +L   L  L+   IIHRD+K ENI L   ++ V+    DFG +C L       +  G   
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVL---GDFGAACKLDAHPDTPQCYGWSG 249

Query: 134 YM---APEVLQFQRYDEKVDMWSVGAILFELL 162
            +   +PE+L    Y  K D+WS G +LFE+ 
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 76.7 bits (189), Expect = 2e-17
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 6/163 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           LK  +   +     E+  L  + H ++I LF        ++++ E    G+L +++R   
Sbjct: 38  LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97

Query: 61  GRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           G+V P  +      Q+  G+  L   + IHRDL   NIL+    +D++ K+ADFGL+  +
Sbjct: 98  GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLI 154

Query: 120 YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
               Y       P  + APE      +  K D+WS G +L+E+
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 76.8 bits (189), Expect = 3e-17
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 35/182 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT-------- 67
           E   ++  +HPNI++L         + L+ E+ A G+L+ ++R   R P           
Sbjct: 58  EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTS 115

Query: 68  -ARKFLQ---------------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
            ARK                  Q+ AG+  L+    +HRDL   N L+     ++++KIA
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE---NMVVKIA 172

Query: 112 DFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
           DFGLS  +Y  +Y  K   +      +M PE + + RY  + D+W+ G +L+E+ + G  
Sbjct: 173 DFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231

Query: 167 PF 168
           P+
Sbjct: 232 PY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 78.0 bits (192), Expect = 3e-17
 Identities = 52/143 (36%), Positives = 80/143 (55%), Gaps = 26/143 (18%)

Query: 41  IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL---EIL------NSHHIIHRD 91
           I LV+++   G+L   I+   +    T R F +   AGL   ++L      +S H+IHRD
Sbjct: 114 IALVLDYANAGDLRQEIKSRAK----TNRTFREH-EAGLLFIQVLLAVHHVHSKHMIHRD 168

Query: 92  LKPENILL--SGLDDDVMLKIADFGLSCTLYPGNYAEKV----CGSPLYMAPEVLQFQRY 145
           +K  NILL  +GL     +K+ DFG S  +Y    ++ V    CG+P Y+APE+ + + Y
Sbjct: 169 IKSANILLCSNGL-----VKLGDFGFS-KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222

Query: 146 DEKVDMWSVGAILFELLNGYPPF 168
            +K DM+S+G +L+ELL    PF
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPF 245

Length = 496

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 76.6 bits (189), Expect = 4e-17
 Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 19/172 (11%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + + +     E+  LS ++ PNI RL      +  + +++E+   G+L+ +++ H     
Sbjct: 59  SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 66  QTARKFLQ-----------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
             A                Q+ +G+  L S + +HRDL   N L+        +KIADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFG 175

Query: 115 LSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           +S  LY  +Y  +V G       +MA E +   ++  K D+W+ G  L+E+L
Sbjct: 176 MSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.8 bits (186), Expect = 4e-17
 Identities = 50/168 (29%), Positives = 88/168 (52%), Gaps = 9/168 (5%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +  LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ +++ +  V E
Sbjct: 36  DPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTE 94

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-- 123
           +   + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      
Sbjct: 95  KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENY 151

Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           Y  K  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 76.2 bits (187), Expect = 5e-17
 Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G  +     + FL Q
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 132
           L  GL   +   ++HRDLKP+N+L   +++   LK+ADFGL  + ++    Y+ +V  + 
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLL---INERGELKLADFGLARAKSIPTKTYSNEVV-TL 168

Query: 133 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y  P++ L    Y  ++DMW VG I +E+  G P F
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 76.5 bits (188), Expect = 6e-17
 Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 23/160 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  + H N+I L D F +          +LV+ +    +L   +     + E   +
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQ 120

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KV 128
             + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI DFGL+       +A+ ++
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLA------RHADAEM 171

Query: 129 CG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 164
            G   +  Y APEV L +  Y++ VD+WSVG I+ E+L G
Sbjct: 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 75.7 bits (186), Expect = 6e-17
 Identities = 43/160 (26%), Positives = 84/160 (52%), Gaps = 9/160 (5%)

Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNII L         + +V E+   G+L +++R H G+         L+
Sbjct: 54  SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 130
            + +G++ L+    +HRDL   NIL+   + +++ K++DFGLS  L       Y  +   
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170

Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 75.4 bits (185), Expect = 6e-17
 Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+      + I LV EF   G LS Y+R   G+  ++T       
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L S ++IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSST-GTKFP 164

Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             + +PEV  F +Y  K D+WS G +++E+ + G  P+
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 75.7 bits (186), Expect = 6e-17
 Identities = 55/168 (32%), Positives = 84/168 (50%), Gaps = 13/168 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S+ NHPNI++L          ++++E   GG+L SY+R             L++L
Sbjct: 49  EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108

Query: 76  GA-------GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAE 126
                    G   L   H IHRDL   N L+S  G D D ++KI DFGL+  +Y  +Y  
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 127 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           K     L   +MAPE L   ++  + D+WS G +++E+L  G  P+ A
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.7 bits (186), Expect = 7e-17
 Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 10/153 (6%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+N L ++ H NI++     + Q    + L++E+   G+L  Y+  H     Q    F Q
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-FAQ 114

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---G 130
           Q+  G+  L+S H IHRDL   N+L   LD+D ++KI DFGL+  +  G+   +V     
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 131 SPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 162
           SP++  A E L+  ++    D+WS G  L+ELL
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 7e-17
 Identities = 45/164 (27%), Positives = 86/164 (52%), Gaps = 17/164 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ EF   G L S++R + G+         L+ 
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--------YPGNYAE 126
           + AG++ L+  + +HRDL   NIL   ++ +++ K++DFGLS  L        Y  +   
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 127 KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           K+   P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 172 KI---PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 75.8 bits (186), Expect = 7e-17
 Identities = 46/180 (25%), Positives = 89/180 (49%), Gaps = 23/180 (12%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R +        + +V E+   G+L+ ++R HG
Sbjct: 43  LKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 102

Query: 62  ---RVPEQ---------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
              ++            T  + L    Q+ +G+  L S H +HRDL   N L+      +
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159

Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 160 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 76.6 bits (188), Expect = 8e-17
 Identities = 57/167 (34%), Positives = 86/167 (51%), Gaps = 16/167 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFL--VVEFCAGGNLSSYIRLHGR----V 63
           EL  + ++NH NII L D +      + E  IFL  V+EF     +  Y++ + R    +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           P    + +  QL   L  ++S  I HRDLKP+N+L+    +   LK+ DFG +  L  G 
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQ 225

Query: 124 YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
            +     S  Y APE+ L    Y   +D+WS+G I+ E++ GYP FS
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272

Length = 440

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 75.9 bits (187), Expect = 8e-17
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 11/160 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L  ++H N+I + D       +A N +++V E     +L   IR    + +   + 
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQY 112

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVC 129
           FL QL  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+  T   G++  +  
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYV 169

Query: 130 GSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            +  Y APE+ L    Y   +D+WSVG I  ELL   P F
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 75.8 bits (186), Expect = 9e-17
 Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L  + H NI+ L D    +  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
           +  GL   +   ++HRDLKP+N+L++   +   LK+ADFGL+   ++    Y+ +V  + 
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVV-TL 168

Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y  P+VL     Y  ++DMW VG I FE+ +G P F
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 75.0 bits (185), Expect = 1e-16
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 9/151 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR-VPEQTARKFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++   G+ +          
Sbjct: 51  EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+  G+  L S + IHRDL   NIL+    ++++ KIADFGL+  +    Y  +  G+  
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDEYTARE-GAKF 166

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
              + APE   + R+  K D+WS G +L E+
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 75.0 bits (184), Expect = 1e-16
 Identities = 44/150 (29%), Positives = 82/150 (54%), Gaps = 10/150 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF 
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
             +   +E L +++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 162

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           + + APE L+ +++  K D+WS G +L+E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 74.5 bits (183), Expect = 1e-16
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 9/161 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  +++V EF   G L +Y+R   G++ +       Q 
Sbjct: 49  EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+E L  +  IHRDL   N L+S      ++K++DFG++  +    Y     G+   
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFP 164

Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEV  F +Y  K D+WS G +++E+   G  PF   
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 2e-16
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + HP +I+L+     E  I++V E    G+L  Y++       ++P+      
Sbjct: 51  EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DM 108

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+ +G+  L + + IHRDL   N+L+    ++ + K+ADFGL+  +    Y  +  G+
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEARE-GA 164

Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
                + APE   + R+  K D+WS G +L E++
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.9 bits (181), Expect = 2e-16
 Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F  
Sbjct: 51  EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    P
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           + + APE + F  +  K D+WS G +L E++  G  P+
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 73.7 bits (181), Expect = 3e-16
 Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 15/160 (9%)

Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK---FLQQL 75
           +   +HPN++ L      +E    +V+ +   G+L ++IR     P  T +    F  Q+
Sbjct: 50  MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQV 107

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL 133
             G+E L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L
Sbjct: 108 AKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
              +MA E LQ Q++  K D+WS G +L+EL+  G PP+ 
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 73.9 bits (181), Expect = 3e-16
 Identities = 44/167 (26%), Positives = 84/167 (50%), Gaps = 24/167 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--------VPEQT 67
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG          P Q 
Sbjct: 57  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116

Query: 68  ARKF--------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             +           Q+ +G+  L S H +HRDL   N L+     ++++KI DFG+S  +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDV 173

Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           Y  +Y  +V G  +    +M PE + ++++  + D+WS G IL+E+ 
Sbjct: 174 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.4 bits (180), Expect = 4e-16
 Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 21/171 (12%)

Query: 16  ELNFLSSVNHPNIIRLFD------AFQAENCIFLVVEFCAGGNLSSYIRLHGR------- 62
           E   +   +HPN+I+L        A        +++ F   G+L +++ L  R       
Sbjct: 51  EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFT 109

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +P QT  +F+  + +G+E L+S + IHRDL   N +   L++++ + +ADFGLS  +Y G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCM---LNENMTVCVADFGLSKKIYSG 166

Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
           +Y  + C S L   ++A E L    Y    D+W+ G  ++E++  G  P++
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 73.9 bits (182), Expect = 4e-16
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+     + HPNI+    +F  ++ +++V    A G+    ++ H     PE      L+
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSP 132
            +   L+ ++S   IHR +K  +ILLSG D  V+L  +    S ++   G     V   P
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVL--SGLRYSVSMIKHGKRQRVVHDFP 165

Query: 133 LY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 169
                    ++PEVLQ   Q Y+EK D++SVG    EL NG+ PF 
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 73.7 bits (181), Expect = 5e-16
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 32/186 (17%)

Query: 1   MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           MLK   +   +  L  EL  +S + NH NI+ L  A      I ++ E+C  G+L +++R
Sbjct: 72  MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131

Query: 59  LHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
                  +    FL          Q+  G+  L S + IHRDL   N+LL+      ++K
Sbjct: 132 -------RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVK 181

Query: 110 IADFGLSC-TLYPGNYAEKVCGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--- 161
           I DFGL+   +   NY  K  G+   P+ +MAPE +    Y  + D+WS G +L+E+   
Sbjct: 182 ICDFGLARDIMNDSNYVVK--GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239

Query: 162 -LNGYP 166
             N YP
Sbjct: 240 GSNPYP 245

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.2 bits (180), Expect = 5e-16
 Identities = 42/124 (33%), Positives = 58/124 (46%), Gaps = 7/124 (5%)

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
           Y  L   +PE+   K        L  L     IIHRD+KP NIL   LD +  +K+ DFG
Sbjct: 97  YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL---LDRNGNIKLCDFG 153

Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
           +S  L       +  G   YMAPE +       YD + D+WS+G  L+E+  G  P+  +
Sbjct: 154 ISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213

Query: 172 RPCF 175
              F
Sbjct: 214 NSVF 217

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.8 bits (179), Expect = 6e-16
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 19/180 (10%)

Query: 4   KLNKHLKSC-LDCEL----NFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGN 52
           K+   +K+C           FL         +HP+I++L      EN +++V+E    G 
Sbjct: 34  KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGE 92

Query: 53  LSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           L SY++++   +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ 
Sbjct: 93  LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLG 149

Query: 112 DFGLSCTL-YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           DFGLS  L     Y       P+ +MAPE + F+R+    D+W  G  ++E+L  G  PF
Sbjct: 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 72.7 bits (178), Expect = 6e-16
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E   +  +++P I+R+    +AE  + LV+E  +GG L+ +  L G+   +      + +
Sbjct: 45  EAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKF--LSGKKDEITVSNVVELM 101

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCG 130
            Q+  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L   +  Y  +  G
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYKARSAG 158

Query: 131 S-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             PL + APE + F+++  + D+WS G  ++E  + G  P+
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.4 bits (177), Expect = 1e-15
 Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 30/174 (17%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
           EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R              + 
Sbjct: 45  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104

Query: 62  RVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                +++    F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS  
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-- 159

Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
              G   Y +K  G  P+ +MA E L +  Y    D+WS G +L+E+  L G P
Sbjct: 160 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 1e-15
 Identities = 50/166 (30%), Positives = 89/166 (53%), Gaps = 21/166 (12%)

Query: 20  LSSVNHPNIIRLFDA-FQ-AENCIF----LVVEFCAGGNLSSYIRLHGRV-------PEQ 66
           +   +HPN++RL     Q  E+  +    +++ F   G+L S++ L+ R+       P Q
Sbjct: 54  MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQ 112

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
              KF+  + +G+E L+S   IHRDL   N +   L++++ + +ADFGLS  +Y G+Y  
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCM---LNENMNVCVADFGLSKKIYNGDYYR 169

Query: 127 --KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             ++   P+ ++A E L  + Y  K D+WS G  ++E+   G  P+
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 71.6 bits (175), Expect = 2e-15
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 18/170 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
           E+  L  + HPN+I L   F   A+  ++L+ ++ A  +L   I+ H          ++P
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
               +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
            P    + V  +  Y APE+L   R Y + +D+W++G I  ELL   P F
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 71.0 bits (174), Expect = 3e-15
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 8/151 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E N +  + HP ++RL+ A   +  I+++ E+   G+L  +++     ++          
Sbjct: 51  EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  NIL+S   + +  KIADFGL+  +    Y A +    P
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAREGAKFP 166

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           + + APE + +  +  K D+WS G +L E++
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 71.3 bits (174), Expect = 4e-15
 Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 18/170 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
           E+  L  + HPN+I L   F   ++  ++L+ ++ A  +L   I+ H          ++P
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
               +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
            P    + V  +  Y APE+L   R Y + +D+W++G I  ELL   P F
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 71.0 bits (174), Expect = 6e-15
 Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 23/168 (13%)

Query: 16  ELNFLSSVNHPNI-----IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L  + HP+I     I L  + +    I++V E     +L   I+ +  +  +  + 
Sbjct: 49  EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQF 107

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--------CTLYPG 122
           FL QL   L+ +++ ++ HRDLKP+NIL +    D  LKI DFGL+          ++  
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWT 164

Query: 123 NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
           +Y      +  Y APE+    F +Y   +D+WS+G I  E+L G P F
Sbjct: 165 DYV----ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.8 bits (171), Expect = 1e-14
 Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 19/185 (10%)

Query: 1   MLKKLNK----HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           ++K L K    +L+S    EL+    ++H N++RL    +     ++++E+   G+L  +
Sbjct: 39  LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98

Query: 57  IRLHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
           +R      E+     L          Q+  G++ L++   +HRDL   N L+S       
Sbjct: 99  LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QRE 155

Query: 108 LKIADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164
           +K++   LS  +Y   Y + +    PL ++APE +Q   +  K D+WS G +++E+   G
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215

Query: 165 YPPFS 169
             PF 
Sbjct: 216 ELPFY 220

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 70.0 bits (171), Expect = 1e-14
 Identities = 55/165 (33%), Positives = 78/165 (47%), Gaps = 31/165 (18%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------QT 67
           HPNII L  A +    ++L +E+   GNL  ++R   RV E                 Q 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQ 125

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YA 125
              F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS     G   Y 
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYV 178

Query: 126 EKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           +K  G  P+ +MA E L +  Y    D+WS G +L+E+  L G P
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 69.6 bits (170), Expect = 1e-14
 Identities = 49/180 (27%), Positives = 89/180 (49%), Gaps = 27/180 (15%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----- 60
           NK+ ++    E+  LS +  PNIIRL      E+ + ++ E+   G+L+ ++  H     
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118

Query: 61  -----------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
                        +P  +    L    Q+ +G++ L+S + +HRDL   N L+     ++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE---NL 175

Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +KIADFG+S  LY G+Y  ++ G  +    +MA E +   ++    D+W+ G  L+E+L
Sbjct: 176 TIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 69.6 bits (170), Expect = 1e-14
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 20/163 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
           E+  +S + +PNIIRL     +++ + ++ E+   G+L+ ++              +P  
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 67  TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +    L    Q+ +G++ L S + +HRDL   N L   + +   +KIADFG+S  LY G+
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL---VGNHYTIKIADFGMSRNLYSGD 183

Query: 124 YAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           Y  ++ G  +    +MA E +   ++    D+W+ G  L+E+ 
Sbjct: 184 YY-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 68.2 bits (166), Expect = 3e-14
 Identities = 42/152 (27%), Positives = 82/152 (53%), Gaps = 12/152 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 51  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 107

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 164

Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            P+ + APE   + R+  K D+WS G +L EL
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.0 bits (166), Expect = 4e-14
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 19/163 (11%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-----LGA 77
           +NHPN+++            LV+EFC  G+L +Y+R +  +  Q A+K + Q     + +
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLY 134
           GL  L+    IH DL   N  L+    D+ +KI D+GL+   YP +Y    +       +
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 135 MAPEVLQFQRYDEKV-------DMWSVGAILFELL-NGYPPFS 169
           +APE+++ +  D          ++WS+G  ++EL      P+ 
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 67.7 bits (165), Expect = 5e-14
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 9/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +H NIIRL           ++ E+   G L  Y+R H G          L+ 
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YP-GNYAEKVCGS 131
           + AG++ L+  + +HRDL   NIL+   + ++  K++DFGLS  L   P G Y       
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172

Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 67.4 bits (164), Expect = 5e-14
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 13/160 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  ++ L+ A  +E  I++V EF   G+L  +++     + ++P+      
Sbjct: 51  EAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DM 107

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+    D+++ KIADFGL+  +    Y A +   
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNEYTARQGAK 164

Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE   + R+  K D+WS G +L EL+  G  P+
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.1 bits (164), Expect = 1e-13
 Identities = 62/189 (32%), Positives = 87/189 (46%), Gaps = 34/189 (17%)

Query: 16  ELNFLSSVNHPNIIRL----------FDAFQAENCIFLVVEFCAG---GNLSSYIRLHGR 62
           E+  L  +NH NI+ L           D  + +   +LV E+      G L S     G 
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----GL 110

Query: 63  V--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           V   E   + F++QL  GL   +  + +HRD+K  NIL   L++   +K+ADFGL+  LY
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL---LNNKGQIKLADFGLA-RLY 166

Query: 121 PGN----YAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC- 174
                  Y  KV  +  Y  PE +L  +RY   +D+WS G IL EL    P F A +   
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225

Query: 175 ---FASRLC 180
                SRLC
Sbjct: 226 QLELISRLC 234

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 66.2 bits (161), Expect = 2e-13
 Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 13/160 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR---VPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++   GR   +P       
Sbjct: 51  EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DM 107

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ AG+  +   + IHRDL+  NIL+    D ++ KIADFGL+  +    Y A +   
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAK 164

Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE   + R+  K D+WS G +L EL+  G  P+
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 65.7 bits (160), Expect = 3e-13
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 21/174 (12%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           NK+ ++    E+  +S +  PNIIRL       + + ++ E+   G+L+ ++  H    E
Sbjct: 59  NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQE 117

Query: 66  Q------------TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
                        T      Q+ +G++ L+S + +HRDL   N L+     +  +KIADF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADF 174

Query: 114 GLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
           G+S  LY G+Y  ++ G  +    +M+ E +   ++    D+W+ G  L+E+L 
Sbjct: 175 GMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 65.8 bits (160), Expect = 4e-13
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 10/164 (6%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
           K  LD E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q  
Sbjct: 54  KEILD-EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 111

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             +  Q+  G+  L    ++HRDL   N+L+        +KI DFGL+  L         
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHA 168

Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            G  +   +MA E +  + Y  + D+WS G  ++EL+  G  P+
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.4 bits (159), Expect = 4e-13
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQT 67
           E + +      +++RL           +V+E  A G+L SY+R          GR P  T
Sbjct: 59  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPT 117

Query: 68  ARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
            ++ +Q   ++  G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDY 174

Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
             K     L   +MAPE L+   +    DMWS G +L+E+
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 64.6 bits (157), Expect = 9e-13
 Identities = 56/170 (32%), Positives = 81/170 (47%), Gaps = 19/170 (11%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70
           L  EL+     NHPNI+     F A+N +++V  F A G+    I  H    + E     
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
            LQ +   L+ ++    +HR +K  +IL+S +D  V L     GL   L   N+ ++   
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLS----GLRSNLSMINHGQRLRV 160

Query: 128 VCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
           V   P Y       ++PEVLQ   Q YD K D++SVG    EL NG+ PF
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.0 bits (156), Expect = 1e-12
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 16/156 (10%)

Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
           E+  L S+ H NI++     + A      + LV+E+   G+L  Y++ H  R+  +    
Sbjct: 55  EIEILKSLQHDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEK 127
           +  Q+  G+E L S   +HRDL   NIL   ++ +  +KI DFGL+  L P +   Y  +
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNIL---VESENRVKIGDFGLTKVL-PQDKEYYKVR 168

Query: 128 VCG-SPLY-MAPEVLQFQRYDEKVDMWSVGAILFEL 161
             G SP++  APE L   ++    D+WS G +L+EL
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.4 bits (154), Expect = 2e-12
 Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 6/154 (3%)

Query: 12  CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
               E   L   +H NI+RL       N + +V E+ + G L S++R H G++       
Sbjct: 52  GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG 111

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-LSCTLYPGNYAEKVC 129
            L  L +G++ L+    +H+ L    +L++    D++ KI+ F  L        Y     
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKSEAIYTTMSG 168

Query: 130 GSP-LYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            SP L+ APE +Q+  +    D+WS G +++E++
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 2e-12
 Identities = 40/101 (39%), Positives = 59/101 (58%), Gaps = 11/101 (10%)

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
           Q+  G+E L S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  K  G  
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK--GDA 235

Query: 132 --PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             PL +MAPE +  + Y  + D+WS G +L+E+ + G  P+
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 63.0 bits (153), Expect = 3e-12
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ----QLGAG 78
           + HPNI++            LV E+C  G+L SY+         +    LQ    ++ AG
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYM 135
           +  ++ H+ +H DL   N  L+    D+ +K+ D+G+  + Y  +Y E     C    ++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168

Query: 136 APE-VLQFQ------RYDEKVDMWSVGAILFELL-NGYPPFS 169
           APE V +F          +  ++W++G  L+EL  N   P+S
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 3e-12
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 18/160 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------T 67
           E + +   N  +++RL           +++E    G+L SY+R   R   +        +
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPS 117

Query: 68  ARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
            +K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY 174

Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
             K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.0 bits (153), Expect = 3e-12
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E+  L ++ H NI++       +  N I L++EF   G+L  Y+ R   ++  +   K+ 
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--PGNYAEK-VC 129
            Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+  +      Y  K   
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172

Query: 130 GSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 162
            SP++  APE L   ++    D+WS G  L+ELL
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 5e-12
 Identities = 42/101 (41%), Positives = 61/101 (60%), Gaps = 11/101 (10%)

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
           Q+  G+E L S   IHRDL   NILLS  +++V +KI DFGL+  +Y   +Y  K  GS 
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLS--ENNV-VKICDFGLARDIYKDPDYVRK--GSA 236

Query: 132 --PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             PL +MAPE +  + Y  + D+WS G +L+E+ + G  P+
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.1 bits (151), Expect = 6e-12
 Identities = 40/119 (33%), Positives = 60/119 (50%), Gaps = 8/119 (6%)

Query: 62  RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            +PE    K    +   LE L+S   +IHRD+KP N+L   ++ +  +K+ DFG+S  L 
Sbjct: 99  TIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLV 155

Query: 121 PGNYAEKVCGSPLYMAPE----VLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCF 175
                    G   YMAPE     L  + YD K D+WS+G  + EL  G  P+ +++  F
Sbjct: 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF 214

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 7e-12
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 28/159 (17%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
           E   L  ++HP ++ L D        C+ L        +L +Y+    R   + + TA  
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS---DLYTYLGARLRPLGLAQVTA-- 264

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
             +QL + ++ ++   IIHRD+K EN+L++G +D   + + DFG +C      +A     
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAAC------FARGSWS 315

Query: 131 SPLYM---------APEVLQFQRYDEKVDMWSVGAILFE 160
           +P +          APEVL    Y   VD+WS G ++FE
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 62.3 bits (151), Expect = 7e-12
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L ++NHP+II+L   F       L++      +L  Y+     +         + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAEKVCGS 131
              ++ L+ + IIHRD+K ENI ++   D   + + DFG +C  +P     N      G+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAAC--FPVDINANKYYGWAGT 246

Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165
               APE+L    Y   VD+WS G +LFE+   +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.7 bits (150), Expect = 8e-12
 Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 21/166 (12%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           + L  E   L  ++H NI+ +     +     F++  +   GNL  +++          +
Sbjct: 53  TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112

Query: 70  KFLQ--------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
                       Q+  G+  L+   +IH+D+   N ++   D+++ +KI D  LS  L+P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFP 169

Query: 122 GNYAEKVC-----GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            +Y    C       P+ +MA E L  + Y    D+WS G +L+EL
Sbjct: 170 MDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 61.2 bits (148), Expect = 1e-11
 Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 9/154 (5%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           ++S++HP+++RL     +   I LV +    G L  Y+  H   +  Q    +  Q+  G
Sbjct: 63  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YM 135
           +  L    ++HRDL   N+L+   +    +KI DFGL+  L          G  +   +M
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           A E + ++++  + D+WS G  ++EL+  G  P+
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 1e-11
 Identities = 39/99 (39%), Positives = 58/99 (58%), Gaps = 7/99 (7%)

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
           Q+  G+E L S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  K     
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           PL +MAPE +  + Y  + D+WS G +L+E+ + G  P+
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 60.6 bits (147), Expect = 3e-11
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 14/170 (8%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           ++K++N  + S    E+  +  + HPNI++L    ++E   +L+ E+  G NLS  +R  
Sbjct: 719 VVKEIND-VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775

Query: 61  GRVPEQTARKFLQQLGAGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
             +  +  RK    +   L  L+      ++  +L PE I++ G  D+  L+++  GL C
Sbjct: 776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLRLSLPGLLC 833

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
           T        K   S  Y+APE  + +   EK D++  G IL ELL G  P
Sbjct: 834 T------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.2 bits (135), Expect = 8e-10
 Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 12/103 (11%)

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
           F  Q+  G+E L S + +HRDL   N+LL+      ++KI DFGL+   ++  NY  K  
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSK-- 296

Query: 130 GSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GS      +MAPE +    Y    D+WS G +L+E+  L G P
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.5 bits (133), Expect = 2e-09
 Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 21/167 (12%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVV---EFCAGGNLSSYI-----RLH 60
               L+ E+  L  +NH NI+++ +  ++E   +++    +F    +L S++        
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWK 261

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
            R   +  R  ++QL   +E ++   +IHRD+K ENI L+    D  + + DFG +    
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPFE 318

Query: 120 ---YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
                 +Y     G+    +PE+L    Y E  D+WS G IL ++L+
Sbjct: 319 KEREAFDYG--WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 12/103 (11%)

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
           F  Q+  G+E L S + +HRDL   N+L+    +  ++KI DFGL+   +   NY  K  
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK-- 298

Query: 130 GS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GS   PL +MAPE +    Y    D+WS G +L+E+  L G P
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 42/144 (29%), Positives = 63/144 (43%), Gaps = 16/144 (11%)

Query: 35  FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLK 93
           FQ E     +V    G  L  +I  HG    +   + + Q G  L+  ++  H++H DLK
Sbjct: 200 FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259

Query: 94  PENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
           PENIL+   D             D   ++I D G  C       A  +  +  Y +PEV+
Sbjct: 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA--IVSTRHYRSPEVV 317

Query: 141 QFQRYDEKVDMWSVGAILFELLNG 164
               +    DMWS+G I++EL  G
Sbjct: 318 LGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.3 bits (130), Expect = 3e-09
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 10/167 (5%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
           K  LD E   ++ V  P + RL       + + LV +    G L  Y+R +  R+  Q  
Sbjct: 54  KEILD-EAYVMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             +  Q+  G+  L    ++HRDL   N+L+   +    +KI DFGL+  L         
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHA 168

Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
            G  +   +MA E +  +R+  + D+WS G  ++EL+  G  P+   
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.8 bits (132), Expect = 3e-09
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 26/113 (23%)

Query: 77  AGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFGLSCTLY 120
           A +E ++S  ++HRDLKP+NILL                  L+++ +L I D       Y
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI-DVDERNICY 182

Query: 121 -----PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                PG    K+ G+P YMAPE L      E  D++++G IL+++L    P+
Sbjct: 183 SSMTIPG----KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 53.4 bits (128), Expect = 7e-09
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 30/183 (16%)

Query: 9   LKSCLDCELNFLSS-------VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L++C +  L  L +         HPNI+  +  F   + ++++  F A G+ +S ++ + 
Sbjct: 35  LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY- 93

Query: 62  RVPEQTARKFLQQL--GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
             PE  +   +  +  GA  GL  L+ +  IHR++K  +IL+SG D  V L     GLS 
Sbjct: 94  -FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG-DGLVSLS----GLSH 147

Query: 117 --CTLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGY 165
               +  G  A+ V   P +       ++PE+L+     Y+ K D++SVG    EL  G 
Sbjct: 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Query: 166 PPF 168
            PF
Sbjct: 208 VPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 51.6 bits (124), Expect = 1e-08
 Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 16/118 (13%)

Query: 51  GNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
            +L+  + + GR + E+       Q    L  L      HR  K  NILL+    D +LK
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALREL------HRQAKSGNILLT---WDGLLK 51

Query: 110 IADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
           +   G S        +      P +MAPEV+Q Q Y EK D++S+G  L+E L+   P
Sbjct: 52  L--DG-SVAFKTPEQSR---PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.5 bits (123), Expect = 3e-08
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 21/167 (12%)

Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQQLG--- 76
           S+ H N+++            LV+EFC  G+L  Y+R   R  E        LQ++    
Sbjct: 51  SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEI 109

Query: 77  -AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
             GL  L+ ++ IH DL   N LL+    D+ +KI D+GLS   Y  +Y    +++    
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 133 LYMAPEV-------LQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
            ++APE+       L      ++ ++WS+G  ++EL   G  P+   
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 3e-08
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 14/106 (13%)

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV 128
           +F  Q+  G++ L S + IHRD+   N+LL+   D  + KI DFGL+  +    NY  K 
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVK- 271

Query: 129 CGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 166
            G+   P+ +MAPE +    Y  + D+WS G +L+E+     + YP
Sbjct: 272 -GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.4 bits (123), Expect = 4e-08
 Identities = 21/48 (43%), Positives = 31/48 (64%)

Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           E++ G+P Y+APE+L  + +   VD W++G  LFE L G PPF+   P
Sbjct: 538 ERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETP 585

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 1e-07
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 11/104 (10%)

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVC 129
           F  Q+  G+  L S + IHRDL   NILL+      + KI DFGL+  +    NY  K  
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYVVK-- 273

Query: 130 GS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           G+   P+ +MAPE +    Y  + D+WS G +L+E+ + G  P+
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.7 bits (105), Expect = 8e-06
 Identities = 37/135 (27%), Positives = 62/135 (45%), Gaps = 17/135 (12%)

Query: 51  GNLSSYIRLHGRVPEQTA---------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
           G L  ++    ++P+            +  ++Q+  GL  L+   I+HRD+KPEN+L++ 
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344

Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCG--SPLYMAPEVLQFQRYDEKVDMWSVGAIL- 158
              D  +KI DFG +  +  G     + G   P Y  PE L   +   +    ++ A+L 
Sbjct: 345 ---DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLS 401

Query: 159 -FELLNGYPP-FSAY 171
            F  L G P  F +Y
Sbjct: 402 PFAWLYGRPDLFDSY 416

Length = 507

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 8e-06
 Identities = 42/138 (30%), Positives = 64/138 (46%), Gaps = 10/138 (7%)

Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS- 100
           +V EF   G L   +R   GRVP        QQL + L  L   +++H ++  +NILL+ 
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152

Query: 101 -GLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGA 156
            GL +     +K++D G+S T    +  E+V   P ++APE +          D WS G 
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTAL--SREERVERIP-WIAPECVPGGNSLSTAADKWSFGT 209

Query: 157 ILFEL-LNGYPPFSAYRP 173
            L E+  +G  P     P
Sbjct: 210 TLLEICFDGEVPLKERTP 227

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.0 bits (104), Expect = 1e-05
 Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 14/163 (8%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQLGA 77
           +S ++H ++++L+     +  I +V E+   G L  ++            K    +QL +
Sbjct: 55  MSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNV-SLHWKLDVAKQLAS 112

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPL 133
            L  L    ++H ++  +NIL++    +      +K++D G+  T+   +  E+V   P 
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV--LSREERVERIP- 169

Query: 134 YMAPEVLQ--FQRYDEKVDMWSVGAILFELL-NGYPPFSAYRP 173
           ++APE ++          D WS G  L E+  NG  P S    
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 1e-05
 Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 4/72 (5%)

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEK 127
           +  ++Q+   L+ L+S  I+HRD+KP+NI+ S  +     KI D G +  L  G NY  K
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPK 315

Query: 128 -VCGSPLYMAPE 138
                P Y APE
Sbjct: 316 EFLLDPRYAAPE 327

Length = 566

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.7 bits (103), Expect = 2e-05
 Identities = 41/185 (22%), Positives = 84/185 (45%), Gaps = 16/185 (8%)

Query: 1   MLKKLNKHLKSCLDCEL---NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +LK L+K  ++  +      + +S ++H +++  +      +   +V E+   G+L +Y+
Sbjct: 31  LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL 90

Query: 58  RL-HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-----MLKIA 111
           +     +      +  +QL   L  L    + H ++  +N+LL   +D        +K++
Sbjct: 91  KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150

Query: 112 DFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNG-YPPF 168
           D G+S T+ P     E++   P ++ PE ++  Q      D WS G  L+E+ +G   P 
Sbjct: 151 DPGISITVLPKEILLERI---P-WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206

Query: 169 SAYRP 173
           SA   
Sbjct: 207 SALDS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.9 bits (93), Expect = 3e-04
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 20/163 (12%)

Query: 18  NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQL 75
           + +  V+H +I+ L+     +    +V EF   G L  ++         T  KF   +QL
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQL 114

Query: 76  GAGLEILNSHHIIHRDLKPENILLS--GLDDDV--MLKIADFGLSCTLYPGNYAEKVCGS 131
            + L  L    ++H ++  +NILL+  G+D +    +K++D G+  T+   +  E V   
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL--SRQECVERI 172

Query: 132 PLYMAPEVLQFQRYDEKV-----DMWSVGAILFEL-LNGYPPF 168
           P ++APE ++    D K      D WS G  L+E+  NG  P 
Sbjct: 173 P-WIAPECVE----DSKNLSIAADKWSFGTTLWEICYNGEIPL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 39.7 bits (93), Expect = 3e-04
 Identities = 41/178 (23%), Positives = 77/178 (43%), Gaps = 17/178 (9%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNL 53
            KK +K  K  +D    E+  L  ++  NI++++  F  +       + L++E+C  G L
Sbjct: 51  FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY-GFIIDIVDDLPRLSLILEYCTRGYL 109

Query: 54  SSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
              +     +  +T          GL  L    +  +++L   + L+    ++  LKI  
Sbjct: 110 REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIIC 166

Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
            GL   L    +  K     +Y + ++L   F  Y  K D++S+G +L+E+  G  PF
Sbjct: 167 HGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222

Length = 283

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.1 bits (92), Expect = 5e-04
 Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 13/94 (13%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
           VN P  +   D         +V+E+  G  L   I  +G    + +R+  + +G     L
Sbjct: 61  VNVP-AVYFVD----PENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVG----KL 111

Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +S  IIH DL   N++LSG    + L I DFGL+
Sbjct: 112 HSAGIIHGDLTTSNMILSG--GKIYL-I-DFGLA 141

Length = 211

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.0 bits (86), Expect = 0.002
 Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 15/108 (13%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L  L+    P + ++  + +++   +L++E+  G  L         V E+      +QL 
Sbjct: 45  LQLLARKGLP-VPKVLASGESDGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLA 96

Query: 77  AGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
             L  L+      + H DL P NIL   +DD  +L I D+       P
Sbjct: 97  ELLAKLHQLPLLVLCHGDLHPGNIL---VDDGKILGIIDWE-YAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	180
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.98
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.98
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.98
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.98
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.98
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.98
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.98
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.98
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.98
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.98
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.98
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.98
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.98
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.98
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.98
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.98
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.98
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.98
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.98
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.98
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
PTZ00283	496	serine/threonine protein kinase; Provisional	99.98
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.98
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.98
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.98
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.98
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.98
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.98
PHA03209	357	serine/threonine kinase US3; Provisional	99.98
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.98
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.98
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.98
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.98
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.98
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.89
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.85
PRK09188	365	serine/threonine protein kinase; Provisional	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.77
PRK10345	210	hypothetical protein; Provisional	99.77
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.76
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.7
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
smart00090	237	RIO RIO-like kinase.	99.62
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.51
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.49
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.47
KOG3087	229	consensus Serine/threonine protein kinase [General	99.46
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.43
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.31
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.3
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.25
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.24
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.23
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.08
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.01
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.92
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.9
PRK09902	216	hypothetical protein; Provisional	98.9
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.82
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.76
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.43
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.39
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.35
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.33
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.15
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.1
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.1
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.02
PLN02876	822	acyl-CoA dehydrogenase	97.9
PF01636	239	APH: Phosphotransferase enzyme family This family	97.88
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.63
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.58
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.25
PRK05231	319	homoserine kinase; Provisional	97.04
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.03
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.01
KOG2270	520	consensus Serine/threonine protein kinase involved	97.01
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.87
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.78
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.74
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.53
PTZ00384	383	choline kinase; Provisional	96.19
PRK10593	297	hypothetical protein; Provisional	96.05
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.05
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.77
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.43
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.37
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.31
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.28
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.16
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	94.98
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.69
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.68
PLN02236	344	choline kinase	94.38
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.97
KOG1234	363	consensus ABC (ATP binding cassette) 1 protein [Ge	93.93
PRK10271	188	thiK thiamine kinase; Provisional	93.89
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.55
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	93.47
KOG4720	391	consensus Ethanolamine kinase [Lipid transport and	93.21
PLN02756	418	S-methyl-5-thioribose kinase	92.91
COG2334	331	Putative homoserine kinase type II (protein kinase	92.76
PRK14559	645	putative protein serine/threonine phosphatase; Pro	92.58

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=270.50  Aligned_cols=172  Identities=54%  Similarity=0.959  Sum_probs=159.9

Q ss_pred             hhhHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         4 ~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      .+.+..++.+..|+.+|++++|||||.++++..+++.+++|||||.||+|.+++...+.+++.++..++.||+.|+++||
T Consensus        47 ~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~  126 (429)
T KOG0595|consen   47 KLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH  126 (429)
T ss_pred             ccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34667888899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCC---ceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDD---VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +++++||||||.|||++.....   ..+||.|||+++.+.+.....+..|++.|||||+.....|+.++|+||+|+++|+
T Consensus       127 ~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq  206 (429)
T KOG0595|consen  127 ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQ  206 (429)
T ss_pred             HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHH
Confidence            9999999999999999754233   5689999999999988887888899999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCccc
Q 030256          161 LLNGYPPFSAYRPCF  175 (180)
Q Consensus       161 ~l~g~~pf~~~~~~~  175 (180)
                      +++|+.||++.++.+
T Consensus       207 ~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  207 CLTGKPPFDAETPKE  221 (429)
T ss_pred             HHhCCCCccccCHHH
Confidence            999999999777653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-42  Score=263.69  Aligned_cols=165  Identities=36%  Similarity=0.677  Sum_probs=157.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ++.+++.+.+|+++.++|+|||||+++++|++.+.+|++.|+|..++|..++++..+++|.+++.++.||+.++.|||++
T Consensus        58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~  137 (592)
T KOG0575|consen   58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL  137 (592)
T ss_pred             CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            67789999999999999999999999999999999999999999999999999888999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +++|||||..|+++   +++..++|+|||+|..+..+ +...+..||+.|+|||++...+.+..+||||+||++|.+|.|
T Consensus       138 ~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G  214 (592)
T KOG0575|consen  138 GIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVG  214 (592)
T ss_pred             Cceecccchhheee---cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhC
Confidence            99999999999999   67889999999999998754 778889999999999999999999999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ++||...+-
T Consensus       215 ~PPFetk~v  223 (592)
T KOG0575|consen  215 RPPFETKTV  223 (592)
T ss_pred             CCCcccchH
Confidence            999998653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-43  Score=258.34  Aligned_cols=163  Identities=40%  Similarity=0.722  Sum_probs=150.2

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~d   91 (180)
                      .+++|+++|++|+|||||+++++|+..+..|+||||++||+|.+.+-.++.+.+..-..+++|++.|+.|||++|++|||
T Consensus       222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRD  301 (475)
T KOG0615|consen  222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRD  301 (475)
T ss_pred             hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCccccc
Confidence            46799999999999999999999999999999999999999999998888999999999999999999999999999999


Q ss_pred             CCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC---CcchhHHHHHHHHHHHHhCCCCC
Q 030256           92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY---DEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        92 l~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~---~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |||+|||+....++..++|+|||+++..+....+.+.+||+.|.|||++.+.+.   ..+.|+||+||++|-+++|.+||
T Consensus       302 iKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF  381 (475)
T KOG0615|consen  302 IKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF  381 (475)
T ss_pred             CCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence            999999997655667799999999999998888999999999999999987653   34779999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+....
T Consensus       382 S~~~~~  387 (475)
T KOG0615|consen  382 SEEYTD  387 (475)
T ss_pred             ccccCC
Confidence            876543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=250.19  Aligned_cols=162  Identities=34%  Similarity=0.590  Sum_probs=152.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCC-eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ++..+..+.+|++++++.+||+||.+++.|..++ .+.++||||++|+|++++...+.+++..+..++.+++++|.|||+
T Consensus       117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~  196 (364)
T KOG0581|consen  117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE  196 (364)
T ss_pred             CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            7788899999999999999999999999999888 599999999999999999988899999999999999999999996


Q ss_pred             -CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           85 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        85 -~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                       .+++||||||+|+|+   +.+++|||||||.+..+-+. ...+..||..|||||.+.+..|+.++||||||.+++|+.+
T Consensus       197 ~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~  272 (364)
T KOG0581|consen  197 ERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI  272 (364)
T ss_pred             ccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh
Confidence             899999999999999   68999999999999887655 4456779999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 030256          164 GYPPFSAY  171 (180)
Q Consensus       164 g~~pf~~~  171 (180)
                      |+-||...
T Consensus       273 GrfP~~~~  280 (364)
T KOG0581|consen  273 GRFPYPPP  280 (364)
T ss_pred             CCCCCCCc
Confidence            99999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=243.65  Aligned_cols=163  Identities=42%  Similarity=0.703  Sum_probs=151.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+..++|..+|++++||.||+++..|++.+.+|+|+||+.||.|...+++.+.|++..+.-++..|+.||.|||+.|++
T Consensus        68 e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIi  147 (357)
T KOG0598|consen   68 EVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGII  147 (357)
T ss_pred             hHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCee
Confidence            35567889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |||+||+|||+   +..+.++|+|||+++.... +....+..||+.|+|||++.+.+++.++|.||||+++|+|++|.+|
T Consensus       148 yRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pP  224 (357)
T KOG0598|consen  148 YRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPP  224 (357)
T ss_pred             eccCCHHHeee---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCC
Confidence            99999999999   7899999999999985544 4455567899999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.+..
T Consensus       225 F~~~~~~  231 (357)
T KOG0598|consen  225 FYAEDVK  231 (357)
T ss_pred             CcCccHH
Confidence            9987754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=231.94  Aligned_cols=165  Identities=38%  Similarity=0.729  Sum_probs=154.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +..+.+-..+|..+|+.+.||.++++.+.+.+.+.+++||||++||.|.+++++.++|++..++.++.+|+.|++|||++
T Consensus        84 klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~  163 (355)
T KOG0616|consen   84 KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL  163 (355)
T ss_pred             HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc
Confidence            45566778889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++++||+||+||++   +.++.++++|||++......  +.+.+||+.|+|||.+.+.++..++|.||||+++|||+.|.
T Consensus       164 ~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~  238 (355)
T KOG0616|consen  164 DIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY  238 (355)
T ss_pred             CeeeccCChHHeee---ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence            99999999999999   68999999999999887544  56788999999999999999999999999999999999999


Q ss_pred             CCCCCCCccc
Q 030256          166 PPFSAYRPCF  175 (180)
Q Consensus       166 ~pf~~~~~~~  175 (180)
                      +||.+.++..
T Consensus       239 pPF~~~~~~~  248 (355)
T KOG0616|consen  239 PPFYDDNPIQ  248 (355)
T ss_pred             CCCcCCChHH
Confidence            9999988753

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=245.09  Aligned_cols=161  Identities=38%  Similarity=0.627  Sum_probs=146.5

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCC-eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .+.+.+|+.+|++++|||||+++|++.+.. ..++||||+++|+|.+++..  ...++...++.++.+|+.++.|||+++
T Consensus        83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~  162 (362)
T KOG0192|consen   83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG  162 (362)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            678999999999999999999999999887 79999999999999999987  567999999999999999999999999


Q ss_pred             -CeeecCCCCCeeeecCCCCc-eEEEeecCCccccCCC-CcccccccCccccCccccc--cccCCcchhHHHHHHHHHHH
Q 030256           87 -IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        87 -~~h~dl~~~nil~~~~~~~~-~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~--~~~~~~~~Di~slg~~~~~~  161 (180)
                       ++|+||||+|+|+   +... .++|+|||+++..... .......||..|+|||++.  ...++.++|+||+|+++||+
T Consensus       163 ~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl  239 (362)
T KOG0192|consen  163 PIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL  239 (362)
T ss_pred             CeeecccChhhEEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence             9999999999999   4664 8999999999777554 3344467999999999999  56899999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      +||+.||.+..+
T Consensus       240 ~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  240 LTGEIPFEDLAP  251 (362)
T ss_pred             HHCCCCCCCCCH
Confidence            999999988765

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-40  Score=230.89  Aligned_cols=165  Identities=33%  Similarity=0.628  Sum_probs=147.1

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCccccccce-EEEeCC-eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHH
Q 030256            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFD-AFQAEN-CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAG   78 (180)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~-~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~   78 (180)
                      +++..++.+..|+.+|++|+|||||++++ .+..++ .++++||++.+|+|+..++..    ..+++..+++++.|++.|
T Consensus        57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A  136 (375)
T KOG0591|consen   57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA  136 (375)
T ss_pred             ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence            36778899999999999999999999998 555555 499999999999999988632    349999999999999999


Q ss_pred             HHHHHh--CC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHH
Q 030256           79 LEILNS--HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS  153 (180)
Q Consensus        79 l~~lh~--~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~s  153 (180)
                      |..+|.  ..  +.||||||.||++   +.++.++|+|||+++.+.+... .....||+.|++||.+.+.+|+.+||+||
T Consensus       137 L~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWs  213 (375)
T KOG0591|consen  137 LYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWS  213 (375)
T ss_pred             HHHHhccccccceeeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHH
Confidence            999999  44  9999999999999   5888999999999988876543 34577999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 030256          154 VGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~  172 (180)
                      +||++|||...++||.+.+
T Consensus       214 lGCllyEMcaL~~PF~g~n  232 (375)
T KOG0591|consen  214 LGCLLYEMCALQSPFYGDN  232 (375)
T ss_pred             HHHHHHHHHhcCCCccccc
Confidence            9999999999999998864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=238.07  Aligned_cols=161  Identities=37%  Similarity=0.664  Sum_probs=147.5

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+.+|-+.|.+| +||+|++++-.|.++..+|+|+||.++|+|-+++++-+.|++.-.+.++.+|+.|++|||++|++
T Consensus       117 vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GII  196 (604)
T KOG0592|consen  117 VKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGII  196 (604)
T ss_pred             cchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCce
Confidence            45677899999999 89999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--------------cccccCccccCccccccccCCcchhHHHH
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------------EKVCGSPLYMAPEVLQFQRYDEKVDMWSV  154 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--------------~~~~~~~~~~ape~~~~~~~~~~~Di~sl  154 (180)
                      ||||||+|||+   +++++++|+|||.++.+......              ....||-.|++||++.+...+.++|+|+|
T Consensus       197 HRDlKPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAl  273 (604)
T KOG0592|consen  197 HRDLKPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWAL  273 (604)
T ss_pred             eccCChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHH
Confidence            99999999999   78999999999998776432111              23568899999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCc
Q 030256          155 GAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~~  173 (180)
                      ||++|+|+.|.+||.+.++
T Consensus       274 GCilyQmlaG~PPFra~Ne  292 (604)
T KOG0592|consen  274 GCILYQMLAGQPPFRAANE  292 (604)
T ss_pred             HHHHHHHhcCCCCCccccH
Confidence            9999999999999998775

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=236.82  Aligned_cols=162  Identities=43%  Similarity=0.765  Sum_probs=149.0

Q ss_pred             HHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|+.++++++ ||||+++++++.....+++||||+.||+|.+++...+++.+..+..++.|++.|++|+|++|+
T Consensus        62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi  141 (370)
T KOG0583|consen   62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGI  141 (370)
T ss_pred             cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCE
Confidence            4556779999999998 999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCC-ceEEEeecCCcccc-CCCCcccccccCccccCcccccccc-CC-cchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDD-VMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~-~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~ape~~~~~~-~~-~~~Di~slg~~~~~~l~  163 (180)
                      +||||||+|++++   .+ ..++|+|||++... .......+..|++.|+|||++.+.. |+ .++|+||+|+++|.|++
T Consensus       142 ~HRDLK~ENilld---~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~  218 (370)
T KOG0583|consen  142 VHRDLKPENILLD---GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC  218 (370)
T ss_pred             eeCCCCHHHEEec---CCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh
Confidence            9999999999994   55 89999999999877 5666777888999999999999877 75 78999999999999999


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |+.||++.+.
T Consensus       219 G~~PF~d~~~  228 (370)
T KOG0583|consen  219 GRLPFDDSNV  228 (370)
T ss_pred             CCCCCCCccH
Confidence            9999998654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=238.12  Aligned_cols=164  Identities=29%  Similarity=0.553  Sum_probs=145.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|+++|++|+|++||++++++..++.++||||||+.|+|.++++.  ...+...+.+.++.||+++++||+++++
T Consensus       245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~  324 (468)
T KOG0197|consen  245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY  324 (468)
T ss_pred             hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc
Confidence            36677999999999999999999999998899999999999999999986  3458999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccccc--ccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~--~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +||||..+|||+   +++..+||+|||+++...++......  .....|.|||.+....+|.+|||||+|+++||++| |
T Consensus       325 IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G  401 (468)
T KOG0197|consen  325 IHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG  401 (468)
T ss_pred             cchhhhhhheee---ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence            999999999999   57889999999999965555443322  23456999999999999999999999999999999 9


Q ss_pred             CCCCCCCCcccc
Q 030256          165 YPPFSAYRPCFA  176 (180)
Q Consensus       165 ~~pf~~~~~~~~  176 (180)
                      +.||+..+..++
T Consensus       402 ~~py~~msn~ev  413 (468)
T KOG0197|consen  402 RVPYPGMSNEEV  413 (468)
T ss_pred             CCCCCCCCHHHH
Confidence            999998876543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-38  Score=225.01  Aligned_cols=166  Identities=31%  Similarity=0.571  Sum_probs=147.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ++..+.-..||+++|++++|+|+|.++++|.-....++|+||++..-|.+ +... ..++...+..++.|++.|+.++|+
T Consensus        41 d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk  119 (396)
T KOG0593|consen   41 DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHK  119 (396)
T ss_pred             cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhh
Confidence            46678888999999999999999999999999999999999997755555 5544 459999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++++||||+|+||++   ..++.++|||||+++.+. ++..-.....|.+|.|||.+.+ ..|+...||||+||++.||+
T Consensus       120 ~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~  196 (396)
T KOG0593|consen  120 NNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELL  196 (396)
T ss_pred             cCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHh
Confidence            999999999999999   578899999999999887 4444345668899999999887 67999999999999999999


Q ss_pred             hCCCCCCCCCccc
Q 030256          163 NGYPPFSAYRPCF  175 (180)
Q Consensus       163 ~g~~pf~~~~~~~  175 (180)
                      +|++.|++.++-+
T Consensus       197 ~G~pL~PG~SDiD  209 (396)
T KOG0593|consen  197 TGEPLWPGRSDID  209 (396)
T ss_pred             cCCcCCCCcchHH
Confidence            9999999987654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.1e-38  Score=239.13  Aligned_cols=155  Identities=39%  Similarity=0.762  Sum_probs=145.6

Q ss_pred             HHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL   92 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl   92 (180)
                      +++|++++++++||||+.++++|+....+++|.||+.| +|..++...+.++++.+..++.+++.|+.|||++++.|+|+
T Consensus        48 l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~  126 (808)
T KOG0597|consen   48 LRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDM  126 (808)
T ss_pred             HHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccC
Confidence            89999999999999999999999999999999999977 99999999999999999999999999999999999999999


Q ss_pred             CCCCeeeecCCCCceEEEeecCCccccCCCCcc-cccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256           93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus        93 ~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                      +|.||++   ..++.+++||||+++....+... ....|++-|+|||...++.++..+|+||+||++||+..|++||-+.
T Consensus       127 kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~  203 (808)
T KOG0597|consen  127 KPQNILL---EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR  203 (808)
T ss_pred             Ccceeee---cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence            9999999   68999999999999888765443 4456999999999999999999999999999999999999999653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=229.53  Aligned_cols=159  Identities=37%  Similarity=0.678  Sum_probs=139.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCC--eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .+.+.+|+.+|++++|||||++++......  .+++.|||+++|+|.+++...+ +++++.+..+.+|++++|+|||++|
T Consensus        58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g  137 (313)
T KOG0198|consen   58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG  137 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456899999999999999999999855444  6999999999999999999877 7999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCC-CceEEEeecCCccccCC----CCcccccccCccccCccccccc-cCCcchhHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYP----GNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE  160 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~-~~~~~l~d~~~~~~~~~----~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~  160 (180)
                      ++|+||||+||++.   . ++.++|.|||.+.....    ........|++.|+|||+..++ ....++|+||+||++.|
T Consensus       138 ~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE  214 (313)
T KOG0198|consen  138 IVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE  214 (313)
T ss_pred             EeccCcccceEEEe---CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence            99999999999994   4 68999999999877653    2223356689999999999853 33459999999999999


Q ss_pred             HHhCCCCCCCC
Q 030256          161 LLNGYPPFSAY  171 (180)
Q Consensus       161 ~l~g~~pf~~~  171 (180)
                      |+||..||...
T Consensus       215 M~Tg~~PW~~~  225 (313)
T KOG0198|consen  215 MLTGKPPWSEF  225 (313)
T ss_pred             ccCCCCcchhh
Confidence            99999999873

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-36  Score=228.83  Aligned_cols=164  Identities=30%  Similarity=0.614  Sum_probs=144.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+++|..++++++|++|+++++.+.+.+.++++|||++|++|.+++.+.+.+++..+..++.|++.||++||++|+
T Consensus        43 ~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi  122 (363)
T cd05628          43 EQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF  122 (363)
T ss_pred             hHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567888999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC------------------------------------cccccccC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGS  131 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------------------------------------~~~~~~~~  131 (180)
                      +||||+|+||++   +.++.++|+|||++.......                                    ......|+
T Consensus       123 vHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt  199 (363)
T cd05628         123 IHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGT  199 (363)
T ss_pred             EecCCCHHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCC
Confidence            999999999999   467789999999986542110                                    01123578


Q ss_pred             ccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       132 ~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      ..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.++.
T Consensus       200 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~  242 (363)
T cd05628         200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ  242 (363)
T ss_pred             ccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence            8999999999888999999999999999999999999876654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-37  Score=235.68  Aligned_cols=163  Identities=39%  Similarity=0.750  Sum_probs=151.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +.+-..+.+|+-+|+-+.|||++.+++++++...+|++.||++||.|.+++-..+++++.++.++++||+.++.|.|..+
T Consensus        53 ~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~  132 (786)
T KOG0588|consen   53 SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN  132 (786)
T ss_pred             cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc
Confidence            44567789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+|++|+|+++   +....++|.|||+|.--..+....+.+|++.|.+||+.+|..| +.++||||.|++++.+++|.
T Consensus       133 icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~  209 (786)
T KOG0588|consen  133 ICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGK  209 (786)
T ss_pred             ceeccCCchhhhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCC
Confidence            9999999999999   5666699999999988777777788889999999999999987 57899999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||++.+
T Consensus       210 LPFdDdN  216 (786)
T KOG0588|consen  210 LPFDDDN  216 (786)
T ss_pred             CCCCCcc
Confidence            9999754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-36  Score=226.95  Aligned_cols=162  Identities=35%  Similarity=0.661  Sum_probs=145.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus        73 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  152 (340)
T PTZ00426         73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI  152 (340)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34556788999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||++......  .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       153 vHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~P  227 (340)
T PTZ00426        153 VYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP  227 (340)
T ss_pred             EccCCCHHHEEE---CCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCC
Confidence            999999999999   56788999999998765432  2244578899999999988899999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       228 f~~~~~~  234 (340)
T PTZ00426        228 FYANEPL  234 (340)
T ss_pred             CCCCCHH
Confidence            9887653

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-36  Score=228.28  Aligned_cols=169  Identities=33%  Similarity=0.651  Sum_probs=150.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+-.-++.|-.+|...++|+||+++..|.+...+|+||||++||++..++.+.+.+++..++.++.+++.|+..+|+.|
T Consensus       182 ~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g  261 (550)
T KOG0605|consen  182 KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG  261 (550)
T ss_pred             hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC
Confidence            34455678899999999999999999999999999999999999999999998899999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCC----------------------CCcc-------------------
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------------GNYA-------------------  125 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~----------------------~~~~-------------------  125 (180)
                      ++|+||||+|+|+   +..+.++|+|||++..+..                      ....                   
T Consensus       262 yIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~  338 (550)
T KOG0605|consen  262 YIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWK  338 (550)
T ss_pred             cccccCChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHH
Confidence            9999999999999   7899999999998743311                      0000                   


Q ss_pred             -------cccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 030256          126 -------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASR  178 (180)
Q Consensus       126 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~~~~~  178 (180)
                             ....||+.|+|||++.+.+++...|.|||||++||||.|.+||.+.+|.++++
T Consensus       339 ~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~r  398 (550)
T KOG0605|consen  339 RNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYR  398 (550)
T ss_pred             hhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                   02358999999999999999999999999999999999999999999986554

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=221.71  Aligned_cols=162  Identities=38%  Similarity=0.707  Sum_probs=145.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++...+.+++..+..++.|++.++++||++|+
T Consensus        43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  122 (291)
T cd05612          43 KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI  122 (291)
T ss_pred             HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34566889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||++.......  ....++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       123 ~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~p  197 (291)
T cd05612         123 VYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT--WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP  197 (291)
T ss_pred             eecCCCHHHeEE---CCCCCEEEEecCcchhccCCc--ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999   567789999999987654322  234578899999999988899999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       198 f~~~~~~  204 (291)
T cd05612         198 FFDDNPF  204 (291)
T ss_pred             CCCCCHH
Confidence            9876543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=227.73  Aligned_cols=158  Identities=35%  Similarity=0.549  Sum_probs=143.7

Q ss_pred             HHHHHHHhcCC-CccccccceEEEeCC-eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           14 DCELNFLSSVN-HPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        14 ~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      .||+..|++|+ ||||+++.+++.+++ .+++||||| .+.|..+++... .|+++.+..|+.||+++|+++|++|+.||
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR  134 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR  134 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            47999999997 999999999998887 999999999 679999987554 59999999999999999999999999999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccc-ccccCCcchhHHHHHHHHHHHHhCCCCCC
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS  169 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~-~~~~~~~~~Di~slg~~~~~~l~g~~pf~  169 (180)
                      |+||+|||+.   ....++|+|||+++......+-..+..|.+|.|||++ +++-|+.+.|+||+||+++|+.+-++.|+
T Consensus       135 DlKPENiLi~---~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  135 DLKPENILIS---GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP  211 (538)
T ss_pred             cCChhheEec---ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence            9999999994   5778999999999998877766677789999999975 57779999999999999999999999999


Q ss_pred             CCCccc
Q 030256          170 AYRPCF  175 (180)
Q Consensus       170 ~~~~~~  175 (180)
                      +.++.+
T Consensus       212 G~sE~D  217 (538)
T KOG0661|consen  212 GASEID  217 (538)
T ss_pred             CCcHHH
Confidence            987764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3e-36  Score=224.87  Aligned_cols=162  Identities=32%  Similarity=0.533  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+.++++++||||+++.+++..++..+++|||+++++|.+++.....+++..+..++.|++.+|++||++|++
T Consensus        38 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv  117 (323)
T cd05571          38 EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV  117 (323)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            34557789999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       118 HrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P  194 (323)
T cd05571         118 YRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  194 (323)
T ss_pred             eCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCC
Confidence            99999999999   5677899999999865422 2223345588999999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.+.
T Consensus       195 f~~~~~  200 (323)
T cd05571         195 FYNQDH  200 (323)
T ss_pred             CCCCCH
Confidence            977554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-37  Score=229.41  Aligned_cols=166  Identities=35%  Similarity=0.643  Sum_probs=151.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCe-EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ....++....|+.+++++.|||||.+.+.+..++. .+|+|+|++||++.+.+....  .|+++.++.|+.|++.|+.||
T Consensus        43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl  122 (426)
T KOG0589|consen   43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL  122 (426)
T ss_pred             CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            34455678889999999999999999999998887 999999999999999987654  499999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |+++++|+||++.||++   ..+..|+|+|||+++.+++.. ......||+.|++||.+.+.+|..++|+|||||++|||
T Consensus       123 H~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm  199 (426)
T KOG0589|consen  123 HENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEM  199 (426)
T ss_pred             Hhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHH
Confidence            99999999999999999   467778999999999998877 66778899999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCcc
Q 030256          162 LNGYPPFSAYRPC  174 (180)
Q Consensus       162 l~g~~pf~~~~~~  174 (180)
                      .+-+.+|.+.+-.
T Consensus       200 ~~lk~aF~a~~m~  212 (426)
T KOG0589|consen  200 CTLKPAFKASNMS  212 (426)
T ss_pred             HhcccccCccchH
Confidence            9999999987643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.3e-36  Score=222.83  Aligned_cols=163  Identities=32%  Similarity=0.526  Sum_probs=143.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|++++++++||||+++.+++...+..++||||+++++|..++.....+++..+..++.|++.++++||++|++
T Consensus        38 ~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  117 (323)
T cd05595          38 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  117 (323)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34456789999999999999999999999999999999999999999988788899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       118 H~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~P  194 (323)
T cd05595         118 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  194 (323)
T ss_pred             ecCCCHHHEEE---cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCC
Confidence            99999999999   56778999999987653322 222334578899999999988899999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.+..
T Consensus       195 f~~~~~~  201 (323)
T cd05595         195 FYNQDHE  201 (323)
T ss_pred             CCCCCHH
Confidence            9876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=209.43  Aligned_cols=173  Identities=38%  Similarity=0.603  Sum_probs=157.1

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      +|++.++.-+++++|++|=+.|+||||+++.+.+...+..++|+|+++|++|-.-+-+..-+++..+-..+.||++++.|
T Consensus        46 ~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~y  125 (355)
T KOG0033|consen   46 TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAY  125 (355)
T ss_pred             hhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            35667778899999999999999999999999999999999999999999997766555668899999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      .|.+|++|+|++|.|+++.+.++...++|+|||++...+....-....|++.|+|||+++...++..+|+|+-|+++|-+
T Consensus       126 CH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiL  205 (355)
T KOG0033|consen  126 CHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL  205 (355)
T ss_pred             HHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHH
Confidence            99999999999999999988778888999999999988865555567799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCcc
Q 030256          162 LNGYPPFSAYRPC  174 (180)
Q Consensus       162 l~g~~pf~~~~~~  174 (180)
                      +.|.+||.+.+..
T Consensus       206 L~G~~PF~~~~~~  218 (355)
T KOG0033|consen  206 LVGYPPFWDEDQH  218 (355)
T ss_pred             HhCCCCCCCccHH
Confidence            9999999985543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.2e-36  Score=224.60  Aligned_cols=160  Identities=38%  Similarity=0.708  Sum_probs=144.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+++..+++|||+++++|.+.+...+.+++..+..++.|++.++++||++|++
T Consensus        61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  140 (329)
T PTZ00263         61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII  140 (329)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45668899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++   +.++.++|+|||++.......  ....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       141 H~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  215 (329)
T PTZ00263        141 YRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF  215 (329)
T ss_pred             ecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCC
Confidence            99999999999   567789999999987654332  2345788999999999888999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.++
T Consensus       216 ~~~~~  220 (329)
T PTZ00263        216 FDDTP  220 (329)
T ss_pred             CCCCH
Confidence            87654

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=227.41  Aligned_cols=160  Identities=31%  Similarity=0.445  Sum_probs=142.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCC-eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..++.+|++++.+++|||+|+++|||.+.+ ..++|+||+++|+|.+++....  ++++...++|+.++|.||+|||+..
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~  194 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC  194 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence            456999999999999999999999999988 5999999999999999987554  7899999999999999999999964


Q ss_pred             ---CeeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCccccc-ccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           87 ---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKV-CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        87 ---~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~-~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                         ++||||||+||++   +.+...+|+|||++..... ....... .|+.+|++||+...+..+.++||||+|+++.|+
T Consensus       195 ~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEl  271 (361)
T KOG1187|consen  195 PPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLEL  271 (361)
T ss_pred             CCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHH
Confidence               9999999999999   6889999999999955443 3322222 689999999999988999999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|+.+.+...
T Consensus       272 itgr~~~d~~~  282 (361)
T KOG1187|consen  272 ITGRKAVDQSR  282 (361)
T ss_pred             HhCCcccCCCC
Confidence            99999888655

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-36  Score=213.10  Aligned_cols=162  Identities=40%  Similarity=0.798  Sum_probs=151.2

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+.+++-.+|+.+|+++ .||+|+++.++|+.+...++|+|.|+.|.|.+++...-.+++....++++|++++++|||.+
T Consensus        63 ~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~  142 (411)
T KOG0599|consen   63 YEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR  142 (411)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh
Confidence            45677888999999999 89999999999999999999999999999999999888899999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc------cccCCcchhHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~------~~~~~~~~Di~slg~~~~  159 (180)
                      +++|+|+||+||++   +++.+++|+|||+++.+.++......+||++|+|||.+.      ..+|+...|+|+.|+++|
T Consensus       143 ~IVHRDLKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImy  219 (411)
T KOG0599|consen  143 NIVHRDLKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMY  219 (411)
T ss_pred             hhhhcccChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHH
Confidence            99999999999999   678889999999999999999888999999999999874      335889999999999999


Q ss_pred             HHHhCCCCCCCC
Q 030256          160 ELLNGYPPFSAY  171 (180)
Q Consensus       160 ~~l~g~~pf~~~  171 (180)
                      .++.|-+||...
T Consensus       220 TLLaGcpPFwHR  231 (411)
T KOG0599|consen  220 TLLAGCPPFWHR  231 (411)
T ss_pred             HHHcCCCchhHH
Confidence            999999999643

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-36  Score=221.36  Aligned_cols=163  Identities=36%  Similarity=0.591  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|+.++++++||||+++++++...+..+++|||+++++|.+++....++++..+..++.|++.++++||++|+
T Consensus        35 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  114 (312)
T cd05585          35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNV  114 (312)
T ss_pred             hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34456778999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       115 ~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~  191 (312)
T cd05585         115 IYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP  191 (312)
T ss_pred             EeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCC
Confidence            999999999999   56778999999998654322 22233457889999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       192 pf~~~~~  198 (312)
T cd05585         192 PFYDENV  198 (312)
T ss_pred             CcCCCCH
Confidence            9986543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=229.36  Aligned_cols=165  Identities=32%  Similarity=0.628  Sum_probs=148.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+..++-+.+|+.+|+..+|+|||++++.|...+.+++||||++||+|.+.+. ...+++.++..+..+++.||++||.+
T Consensus       310 ~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~  388 (550)
T KOG0578|consen  310 KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHAR  388 (550)
T ss_pred             cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhc
Confidence            34456778899999999999999999999998899999999999999999887 55699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      |++|+||+.+||++   ..++.++|+|||++..+.... ...+-.||+.|+|||+.....|+.+.||||||++++||+.|
T Consensus       389 gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG  465 (550)
T KOG0578|consen  389 GIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG  465 (550)
T ss_pred             ceeeeccccceeEe---ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence            99999999999999   577789999999998876554 33456799999999999999999999999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ++||-..+|-
T Consensus       466 EPPYlnE~Pl  475 (550)
T KOG0578|consen  466 EPPYLNENPL  475 (550)
T ss_pred             CCCccCCChH
Confidence            9999766654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-36  Score=220.51  Aligned_cols=166  Identities=37%  Similarity=0.710  Sum_probs=154.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +++.--.+++|++|++.|+||||+.++++|+..+.+++||||..+|.|.+++...+.+++.++..++.||..|+.|.|.+
T Consensus        93 deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn  172 (668)
T KOG0611|consen   93 DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN  172 (668)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc
Confidence            34445568999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g  164 (180)
                      +++|+||+.+||++   +.++.++|.|||++--+.......+.+|++.|.+||+..+..| ++..|-||||+++|.++-|
T Consensus       173 rVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG  249 (668)
T KOG0611|consen  173 RVVHRDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG  249 (668)
T ss_pred             cceecccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence            99999999999999   6788899999999877777778888899999999999998886 5789999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ..||++.+..
T Consensus       250 tMPFDG~Dhk  259 (668)
T KOG0611|consen  250 TMPFDGRDHK  259 (668)
T ss_pred             ccccCCchHH
Confidence            9999998764

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-36  Score=228.39  Aligned_cols=163  Identities=33%  Similarity=0.623  Sum_probs=142.7

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      +..+.+++|++++++++||||+++++++.+.+.+++||||++|++|.+++.....+++..+..++.|++.+|+|||+.|+
T Consensus        43 ~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi  122 (377)
T cd05629          43 DQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF  122 (377)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567888999999999999999999999999999999999999999999877889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC------------c-------------------------------
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------Y-------------------------------  124 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------------~-------------------------------  124 (180)
                      +|+||+|+||++   +.++.++|+|||++.......            .                               
T Consensus       123 vHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (377)
T cd05629         123 IHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK  199 (377)
T ss_pred             eccCCCHHHEEE---CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence            999999999999   467789999999885321100            0                               


Q ss_pred             -----ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          125 -----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       125 -----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                           .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.++
T Consensus       200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (377)
T cd05629         200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS  253 (377)
T ss_pred             cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCH
Confidence                 0013478889999999888899999999999999999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-35  Score=222.48  Aligned_cols=162  Identities=31%  Similarity=0.525  Sum_probs=143.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|++++++++||||+++.+++...+..++||||+++++|..++.....+++..+..++.|++.++++||++|++
T Consensus        38 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv  117 (328)
T cd05593          38 EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV  117 (328)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            44567789999999999999999999999999999999999999999988778899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       118 HrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~P  194 (328)
T cd05593         118 YRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  194 (328)
T ss_pred             ecccCHHHeEE---CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCC
Confidence            99999999999   56778999999998654322 222334588899999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...+.
T Consensus       195 f~~~~~  200 (328)
T cd05593         195 FYNQDH  200 (328)
T ss_pred             CCCCCH
Confidence            976554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=222.66  Aligned_cols=161  Identities=38%  Similarity=0.690  Sum_probs=145.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|++++++++||||+++++++.+.+..+++|||++|++|.+++.....+++..+..++.|++.++++||+.|++
T Consensus        44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv  123 (333)
T cd05600          44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI  123 (333)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34567889999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++   +..+.++|+|||++.....  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       124 H~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  198 (333)
T cd05600         124 HRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF  198 (333)
T ss_pred             ccCCCHHHEEE---CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCC
Confidence            99999999999   5677899999999866543  223445788999999999889999999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      ...++.
T Consensus       199 ~~~~~~  204 (333)
T cd05600         199 SGSTPN  204 (333)
T ss_pred             CCCCHH
Confidence            876553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-36  Score=224.50  Aligned_cols=162  Identities=35%  Similarity=0.540  Sum_probs=142.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      -....||+.+|++|+||||+++.+...+.  +.+|+|+|||+ .+|.-++...+ +|++.++.-+++||+.+|.|+|.+|
T Consensus       160 ~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g  238 (560)
T KOG0600|consen  160 PITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG  238 (560)
T ss_pred             hHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence            34567899999999999999999987665  78999999995 59998877533 6999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHh
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~  163 (180)
                      ++|||||.+|||+   +.++.++|.|||+++......  ......-|.+|.|||.+.+. .|+.+.|+||.||++.||++
T Consensus       239 vlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~  315 (560)
T KOG0600|consen  239 VLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL  315 (560)
T ss_pred             eeeccccccceEE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc
Confidence            9999999999999   789999999999998665433  34456678999999998765 59999999999999999999


Q ss_pred             CCCCCCCCCccc
Q 030256          164 GYPPFSAYRPCF  175 (180)
Q Consensus       164 g~~pf~~~~~~~  175 (180)
                      |++.|.+.++-+
T Consensus       316 gkPI~~G~tEve  327 (560)
T KOG0600|consen  316 GKPILQGRTEVE  327 (560)
T ss_pred             CCCCcCCccHHH
Confidence            999999987654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-35  Score=220.84  Aligned_cols=161  Identities=39%  Similarity=0.640  Sum_probs=142.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ...+.+|++++++++||||+++++.+..++..+++|||+++++|.+++...+.+++..+..++.|++.++++||++|++|
T Consensus        44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  123 (323)
T cd05584          44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIY  123 (323)
T ss_pred             HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            34567899999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus       124 ~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf  200 (323)
T cd05584         124 RDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF  200 (323)
T ss_pred             CCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC
Confidence            9999999999   56778999999998654322 2223345788999999998888899999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.++
T Consensus       201 ~~~~~  205 (323)
T cd05584         201 TAENR  205 (323)
T ss_pred             CCCCH
Confidence            87654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-35  Score=226.30  Aligned_cols=164  Identities=35%  Similarity=0.660  Sum_probs=143.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|++++++++|+||+++++.+.+.+..++||||+++++|.+++...+.+++..+..++.|++.++++||++|+
T Consensus        43 ~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~i  122 (382)
T cd05625          43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF  122 (382)
T ss_pred             HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567889999999999999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCC---------------------------------------------
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------------------------------------  122 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---------------------------------------------  122 (180)
                      +|+||+|+||++   +.++.++|+|||++......                                             
T Consensus       123 vHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (382)
T cd05625         123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ  199 (382)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence            999999999999   56788999999986432100                                             


Q ss_pred             ---CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          123 ---NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       123 ---~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                         .......++..|+|||.+.+..++.++|+||+||++|+|++|+.||.+.++.
T Consensus       200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~  254 (382)
T cd05625         200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL  254 (382)
T ss_pred             cccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHH
Confidence               0001234788899999999888999999999999999999999999876653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-36  Score=225.34  Aligned_cols=163  Identities=32%  Similarity=0.669  Sum_probs=143.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|+++++.++|+||+++++++.+++.++++|||+++++|.+++...+.+++..+..++.|++.+|++||++|+
T Consensus        43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i  122 (364)
T cd05599          43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY  122 (364)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34456788999999999999999999999999999999999999999999878889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---------------------------------------cccc
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------------------------AEKV  128 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---------------------------------------~~~~  128 (180)
                      +|+||+|+||++   +.++.++|+|||++........                                       ....
T Consensus       123 vH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (364)
T cd05599         123 IHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST  199 (364)
T ss_pred             EeccCCHHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence            999999999999   5678899999998765422110                                       0113


Q ss_pred             ccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       129 ~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      .|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.++
T Consensus       200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~  244 (364)
T cd05599         200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP  244 (364)
T ss_pred             ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCH
Confidence            478899999999888899999999999999999999999987654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-35  Score=225.69  Aligned_cols=164  Identities=35%  Similarity=0.641  Sum_probs=143.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|++++++++|+||+++++++.+.+.++++|||++|++|.+++.....+++..+..++.|++.+|++||+.|+
T Consensus        43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~gi  122 (381)
T cd05626          43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF  122 (381)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--------------------------------------------
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------------------------------------------  123 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------------------------------------------  123 (180)
                      +|+||+|+||++   +..+.++|+|||++.......                                            
T Consensus       123 vHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (381)
T cd05626         123 IHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ  199 (381)
T ss_pred             eecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence            999999999999   567789999999864321000                                            


Q ss_pred             ----cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          124 ----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       124 ----~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                          ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.++.
T Consensus       200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~  254 (381)
T cd05626         200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT  254 (381)
T ss_pred             ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHH
Confidence                011235788999999998888999999999999999999999999876654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.3e-35  Score=214.67  Aligned_cols=161  Identities=33%  Similarity=0.538  Sum_probs=142.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|+.++++++|++++++.+++.+++..++++||+++++|.+.+...  ..+++..+..++.|++.++++||+.|+
T Consensus        44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05631          44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI  123 (285)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            445778999999999999999999999999999999999999998877543  358999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       124 iH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p  200 (285)
T cd05631         124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP  200 (285)
T ss_pred             EeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence            999999999999   56778999999998765443333345578999999999988999999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...+.
T Consensus       201 f~~~~~  206 (285)
T cd05631         201 FRKRKE  206 (285)
T ss_pred             CCCCCc
Confidence            987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-35  Score=225.85  Aligned_cols=163  Identities=34%  Similarity=0.647  Sum_probs=142.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|++++++++|+||+++++.+.+++.++++|||+++++|.+++...+.+++..+..++.|++.++++||++|++
T Consensus        44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  123 (376)
T cd05598          44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI  123 (376)
T ss_pred             hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            35668889999999999999999999999999999999999999999998878899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC--------------------------------------------Cc
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------------------NY  124 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~--------------------------------------------~~  124 (180)
                      |+||+|+||++   +.++.++|+|||++......                                            ..
T Consensus       124 HrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (376)
T cd05598         124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL  200 (376)
T ss_pred             eCCCCHHHEEE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence            99999999999   56778999999986422100                                            00


Q ss_pred             ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       125 ~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      .....|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.++.
T Consensus       201 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  250 (376)
T cd05598         201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPA  250 (376)
T ss_pred             ccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHH
Confidence            01235788999999999888999999999999999999999999877654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-35  Score=224.81  Aligned_cols=165  Identities=30%  Similarity=0.632  Sum_probs=145.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ......+++|..++.+++|++|+++++.+.+.+.+++||||++|++|.+++.+...+++..+..++.|++.++++||+.|
T Consensus        42 ~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g  121 (360)
T cd05627          42 KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG  121 (360)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34456788899999999999999999999999999999999999999999988888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC------------------------------------ccccccc
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCG  130 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------------------------------------~~~~~~~  130 (180)
                      ++|+||+|+||++   +.++.++|+|||++.......                                    ......|
T Consensus       122 ivHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  198 (360)
T cd05627         122 FIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVG  198 (360)
T ss_pred             eEccCCCHHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCC
Confidence            9999999999999   567889999999876442110                                    0112357


Q ss_pred             CccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       131 ~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      +..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.++.
T Consensus       199 t~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~  242 (360)
T cd05627         199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ  242 (360)
T ss_pred             CccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHH
Confidence            88999999999989999999999999999999999999877654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-35  Score=233.65  Aligned_cols=167  Identities=28%  Similarity=0.591  Sum_probs=149.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFL   72 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~   72 (180)
                      .+.+++|+||++++..++|||||+++|++..++..++|+|||..|+|.++|....              +++..+.+.++
T Consensus       530 ~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA  609 (774)
T KOG1026|consen  530 NQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIA  609 (774)
T ss_pred             HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHH
Confidence            3478899999999999999999999999999999999999999999999997432              27889999999


Q ss_pred             HHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcch
Q 030256           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      .||+.++.||-++.+||+||-.+|+++   .++..|||.|||+++.....+.-   ...+-..+|||||.+..+++|.+|
T Consensus       610 ~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteS  686 (774)
T KOG1026|consen  610 TQIAAGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTES  686 (774)
T ss_pred             HHHHHHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchh
Confidence            999999999999999999999999999   58889999999999887665432   133456889999999999999999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 030256          150 DMWSVGAILFELLN-GYPPFSAYRPCFA  176 (180)
Q Consensus       150 Di~slg~~~~~~l~-g~~pf~~~~~~~~  176 (180)
                      ||||+|+++||+++ |..||.+.+..++
T Consensus       687 DVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  687 DVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             hhhhhhhhhhhhhccccCcccccchHHH
Confidence            99999999999999 9999998776643

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-36  Score=226.90  Aligned_cols=164  Identities=33%  Similarity=0.602  Sum_probs=150.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +..++.-..++.=|++|+|+||+.+.++|.....+|||||||..|.|...++...+++...+..|.++|+.++.|||.+.
T Consensus       153 KKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK  232 (904)
T KOG4721|consen  153 KKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK  232 (904)
T ss_pred             HHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh
Confidence            34555556678889999999999999999999999999999999999999998899999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+|||.-|||++   .+..|+|+|||-++.......+....||..|+|||++++...+.+.||||+|+++|||+||..
T Consensus       233 IIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~Ei  309 (904)
T KOG4721|consen  233 IIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEI  309 (904)
T ss_pred             HhhhccCCCceEee---ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCC
Confidence            99999999999994   677799999999988877766777889999999999999999999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+-+-
T Consensus       310 PYkdVds  316 (904)
T KOG4721|consen  310 PYKDVDS  316 (904)
T ss_pred             Cccccch
Confidence            9976543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=215.69  Aligned_cols=162  Identities=36%  Similarity=0.635  Sum_probs=144.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      -+.+++|+..++.++||||++++.+|..+..+++||.+|.+|++.+.++...+  +++..+..++++++.||.|||.+|.
T Consensus        68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~  147 (516)
T KOG0582|consen   68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH  147 (516)
T ss_pred             HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence            46799999999999999999999999999999999999999999999986543  9999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cc----cccccCccccCccccc--cccCCcchhHHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YA----EKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~----~~~~~~~~~~ape~~~--~~~~~~~~Di~slg~~~~~  160 (180)
                      +|||+|+.|||+   +.++.|+|.|||....+.... ..    .+..+++.|+|||+++  ..+|+.++||||+|+++.|
T Consensus       148 IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~E  224 (516)
T KOG0582|consen  148 IHRDVKAGNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACE  224 (516)
T ss_pred             eecccccccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHH
Confidence            999999999999   689999999999876664432 11    3457899999999954  4469999999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030256          161 LLNGYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~g~~pf~~~~~~  174 (180)
                      +.+|..||....|-
T Consensus       225 LA~G~aPf~k~pPm  238 (516)
T KOG0582|consen  225 LAHGHAPFSKYPPM  238 (516)
T ss_pred             HhcCCCCcccCChH
Confidence            99999999987653

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-35  Score=221.36  Aligned_cols=162  Identities=38%  Similarity=0.615  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|++++++++||||+++++++.+++..++||||+++++|.+++.+...+++..+..++.|++.+|+|||+.|++
T Consensus        41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  120 (318)
T cd05582          41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII  120 (318)
T ss_pred             hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            34556789999999999999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       121 H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p  197 (318)
T cd05582         121 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP  197 (318)
T ss_pred             cCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCC
Confidence            99999999999   56778999999998765433 222344578899999999888889999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       198 ~~~~~~  203 (318)
T cd05582         198 FQGKDR  203 (318)
T ss_pred             CCCCCH
Confidence            987654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.2e-35  Score=217.56  Aligned_cols=163  Identities=37%  Similarity=0.615  Sum_probs=143.2

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+..|..+++.+ +||||+++++++...+.+++||||+++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus        38 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~i  117 (320)
T cd05590          38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI  117 (320)
T ss_pred             HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345566788888877 7999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus       118 vH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  194 (320)
T cd05590         118 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHA  194 (320)
T ss_pred             EeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCC
Confidence            999999999999   5677899999998765422 222334558899999999998889999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.++.
T Consensus       195 Pf~~~~~~  202 (320)
T cd05590         195 PFEAENED  202 (320)
T ss_pred             CCCCCCHH
Confidence            99876654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=226.21  Aligned_cols=164  Identities=34%  Similarity=0.618  Sum_probs=143.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ......+++|+.+++.++||||+++++++..++..++||||++|++|.+++..    ..++++..+..++.|++.+|+++
T Consensus       106 ~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l  185 (478)
T PTZ00267        106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV  185 (478)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            34456778899999999999999999999999999999999999999987753    34689999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      |+.|++||||+|+||++   +..+.++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|
T Consensus       186 H~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~  262 (478)
T PTZ00267        186 HSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILY  262 (478)
T ss_pred             HhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHH
Confidence            99999999999999999   5677899999999876543321   23345888999999999888999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      +|++|+.||.+.+.
T Consensus       263 el~tg~~Pf~~~~~  276 (478)
T PTZ00267        263 ELLTLHRPFKGPSQ  276 (478)
T ss_pred             HHHhCCCCCCCCCH
Confidence            99999999986543

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.4e-35  Score=220.21  Aligned_cols=162  Identities=32%  Similarity=0.539  Sum_probs=143.2

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~   87 (180)
                      ....+.+|.++++.++||||+++.+++..++..++||||+++++|..++.....+++..+..++.|++.+++|||+ .|+
T Consensus        38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~i  117 (325)
T cd05594          38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV  117 (325)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence            3456678999999999999999999999999999999999999999998877889999999999999999999997 799


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       118 vHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~  194 (325)
T cd05594         118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL  194 (325)
T ss_pred             EecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCC
Confidence            999999999999   5677899999998865332 222234458899999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       195 Pf~~~~~  201 (325)
T cd05594         195 PFYNQDH  201 (325)
T ss_pred             CCCCCCH
Confidence            9977654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.3e-35  Score=217.94  Aligned_cols=159  Identities=34%  Similarity=0.687  Sum_probs=141.5

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|..+++++ +||||+++++++.+.+.++++|||+++++|.+++....++++..+..++.|++.++++||++|+
T Consensus        38 ~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i  117 (329)
T cd05588          38 DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGI  117 (329)
T ss_pred             HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345578899999999 7999999999999999999999999999999998878889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||++.... .........++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus       118 vH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  194 (329)
T cd05588         118 IYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS  194 (329)
T ss_pred             EecCCCHHHeEE---CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCC
Confidence            999999999999   567789999999886532 2223334568889999999998889999999999999999999999


Q ss_pred             CCCC
Q 030256          167 PFSA  170 (180)
Q Consensus       167 pf~~  170 (180)
                      ||+.
T Consensus       195 Pf~~  198 (329)
T cd05588         195 PFDI  198 (329)
T ss_pred             Cccc
Confidence            9963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.9e-35  Score=216.78  Aligned_cols=160  Identities=35%  Similarity=0.629  Sum_probs=138.6

Q ss_pred             HHHHHHH-HHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ..+.+|. .+++.++||||+++++++.+.+..+++|||+++++|...+.....+++..+..++.|++.+|++||+.|++|
T Consensus        40 ~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH  119 (321)
T cd05603          40 NHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY  119 (321)
T ss_pred             HHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3344454 467888999999999999999999999999999999998887778999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       120 ~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  196 (321)
T cd05603         120 RDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF  196 (321)
T ss_pred             ccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCC
Confidence            9999999999   5677899999998865322 22223345788999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       197 ~~~~~  201 (321)
T cd05603         197 YSRDV  201 (321)
T ss_pred             CCCCH
Confidence            87653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.9e-35  Score=216.97  Aligned_cols=158  Identities=39%  Similarity=0.695  Sum_probs=138.0

Q ss_pred             HHHHHH-HHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 030256           13 LDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (180)
Q Consensus        13 ~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~d   91 (180)
                      +..|.. +++.++||||+++++.+.+.+..+++|||+++++|..++.....+++..+..++.|++.++++||++|++|+|
T Consensus        42 ~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~d  121 (323)
T cd05575          42 IMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD  121 (323)
T ss_pred             HHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence            334443 5678899999999999999999999999999999999998888899999999999999999999999999999


Q ss_pred             CCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256           92 LKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus        92 l~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      |+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+
T Consensus       122 ikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         122 LKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             CCHHHeEE---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence            99999999   5677899999998865322 2223344578899999999988899999999999999999999999987


Q ss_pred             CCc
Q 030256          171 YRP  173 (180)
Q Consensus       171 ~~~  173 (180)
                      .+.
T Consensus       199 ~~~  201 (323)
T cd05575         199 RDT  201 (323)
T ss_pred             CCH
Confidence            654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.4e-34  Score=215.32  Aligned_cols=163  Identities=33%  Similarity=0.533  Sum_probs=144.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-   85 (180)
                      +...+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++.....+++..+..++.|++.+++|||+. 
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  123 (331)
T cd06649          44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH  123 (331)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            4456789999999999999999999999999999999999999999999998878899999999999999999999986 


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +++|+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       124 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~  199 (331)
T cd06649         124 QIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR  199 (331)
T ss_pred             CEEcCCCChhhEEE---cCCCcEEEccCcccccccccc-cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence            69999999999999   467789999999986654322 22345788999999999888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...+.
T Consensus       200 ~p~~~~~~  207 (331)
T cd06649         200 YPIPPPDA  207 (331)
T ss_pred             CCCCCCCH
Confidence            99976543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=228.64  Aligned_cols=167  Identities=37%  Similarity=0.636  Sum_probs=152.2

Q ss_pred             hhHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +.++.-+..+.|.+++... +||.+++++.+|...+++|+||||+.||++.. +.....|++..+.-+++.++.||.|||
T Consensus       407 l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH  485 (694)
T KOG0694|consen  407 LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLH  485 (694)
T ss_pred             eccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHH
Confidence            4566678899999999999 59999999999999999999999999999543 343578999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++||++||||.+||++   +..+.++|+|||+++... ....+.+..||+.|+|||++.+..|+.+.|.||||+++|||+
T Consensus       486 ~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML  562 (694)
T KOG0694|consen  486 ENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML  562 (694)
T ss_pred             hcCceeeecchhheEE---cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH
Confidence            9999999999999999   789999999999997765 566778889999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccc
Q 030256          163 NGYPPFSAYRPCF  175 (180)
Q Consensus       163 ~g~~pf~~~~~~~  175 (180)
                      .|+.||++.++++
T Consensus       563 ~Gq~PF~gddEee  575 (694)
T KOG0694|consen  563 VGESPFPGDDEEE  575 (694)
T ss_pred             cCCCCCCCCCHHH
Confidence            9999999887763

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9e-35  Score=216.76  Aligned_cols=163  Identities=34%  Similarity=0.589  Sum_probs=143.0

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+..|.++++.+ +||+|+++++++...+.+++||||+++++|...+.....+++..+..++.|++.++++||++|+
T Consensus        38 ~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  117 (321)
T cd05591          38 DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV  117 (321)
T ss_pred             HHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345567788888876 8999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus       118 vHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~  194 (321)
T cd05591         118 IYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP  194 (321)
T ss_pred             eccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCC
Confidence            999999999999   56778999999988654322 22233457889999999998889999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.++.
T Consensus       195 Pf~~~~~~  202 (321)
T cd05591         195 PFEADNED  202 (321)
T ss_pred             CCCCCCHH
Confidence            99876643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.6e-34  Score=216.01  Aligned_cols=160  Identities=33%  Similarity=0.659  Sum_probs=141.8

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|..++.++ +|++|+++++++...+.+++||||+++++|..++.....+++..+..++.|++.++++||++|
T Consensus        37 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~  116 (327)
T cd05617          37 EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG  116 (327)
T ss_pred             hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3445678899999998 699999999999999999999999999999999887788999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||++.... .........++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus       117 ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~  193 (327)
T cd05617         117 IIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR  193 (327)
T ss_pred             eeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCC
Confidence            9999999999999   467789999999886532 222333455888999999999889999999999999999999999


Q ss_pred             CCCCC
Q 030256          166 PPFSA  170 (180)
Q Consensus       166 ~pf~~  170 (180)
                      .||..
T Consensus       194 ~pf~~  198 (327)
T cd05617         194 SPFDI  198 (327)
T ss_pred             CCCCc
Confidence            99964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-34  Score=216.59  Aligned_cols=155  Identities=37%  Similarity=0.660  Sum_probs=136.8

Q ss_pred             HHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 030256           17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN   96 (180)
Q Consensus        17 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~n   96 (180)
                      ..+++.++|+||+++++++...+..+++|||+++++|.+++.....+++..+..++.|++.+|++||++|++|+||+|+|
T Consensus        47 ~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~N  126 (325)
T cd05602          47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN  126 (325)
T ss_pred             HHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence            34567889999999999999999999999999999999999877889999999999999999999999999999999999


Q ss_pred             eeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256           97 ILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus        97 il~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      |++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..
T Consensus       127 ili---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  202 (325)
T cd05602         127 ILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA  202 (325)
T ss_pred             eEE---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH
Confidence            999   5677899999999865432 22233455889999999999888999999999999999999999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.1e-35  Score=209.99  Aligned_cols=159  Identities=33%  Similarity=0.477  Sum_probs=141.3

Q ss_pred             HHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      -.||+.+|.+++|||||.+.++....  +.+|+||||++ .+|.+.+..-+ +|...++.-++.|++.+++|||.+.++|
T Consensus       122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilH  200 (419)
T KOG0663|consen  122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILH  200 (419)
T ss_pred             hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEe
Confidence            35799999999999999999998754  57999999995 59999998655 7999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |||||+|+++   +..+.++++|||+++.++.+.. .....-|.+|.|||.+.+. .|+.+.|+||+||++.|++++.+.
T Consensus       201 RDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl  277 (419)
T KOG0663|consen  201 RDLKTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL  277 (419)
T ss_pred             cccchhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence            9999999999   6889999999999999877643 3445678999999998766 489999999999999999999999


Q ss_pred             CCCCCccc
Q 030256          168 FSAYRPCF  175 (180)
Q Consensus       168 f~~~~~~~  175 (180)
                      |++..+-+
T Consensus       278 f~G~sE~d  285 (419)
T KOG0663|consen  278 FPGKSEID  285 (419)
T ss_pred             CCCCchHH
Confidence            99887654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.8e-35  Score=203.79  Aligned_cols=163  Identities=34%  Similarity=0.503  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ......||+..|++++|+||+.+++.|...+.+.+|+||+ ..+|...++... .++...+..++.+++.+++|+|++.+
T Consensus        44 i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~I  122 (318)
T KOG0659|consen   44 INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWI  122 (318)
T ss_pred             ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhh
Confidence            3456778999999999999999999999999999999999 569999887543 59999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc-ccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|||+||.|+++   +.++.+++.|||+++..++..... ....+.+|.|||.+.|. .|+...|+||.||++.|++.|.
T Consensus       123 lHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~  199 (318)
T KOG0659|consen  123 LHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV  199 (318)
T ss_pred             hcccCCccceEE---cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC
Confidence            999999999999   688999999999999887654432 33578899999988755 5899999999999999999999


Q ss_pred             CCCCCCCccc
Q 030256          166 PPFSAYRPCF  175 (180)
Q Consensus       166 ~pf~~~~~~~  175 (180)
                      +-|++.++-+
T Consensus       200 P~fpG~sDid  209 (318)
T KOG0659|consen  200 PFFPGDSDID  209 (318)
T ss_pred             CCCCCCchHH
Confidence            9999877654

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.4e-35  Score=221.29  Aligned_cols=161  Identities=35%  Similarity=0.626  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++. ...+++..+..++.|++.+|++||++|++
T Consensus        86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-~~~~~~~~~~~~~~qil~aL~~LH~~~Iv  164 (370)
T cd05621          86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS-NYDVPEKWAKFYTAEVVLALDAIHSMGLI  164 (370)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34567889999999999999999999999999999999999999999886 44689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCcccccccc----CCcchhHHHHHHHHHHHH
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELL  162 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~----~~~~~Di~slg~~~~~~l  162 (180)
                      ||||+|+||++   +..+.++|+|||++........  .....++..|+|||.+.+..    ++.++|+||+|+++|+|+
T Consensus       165 HrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell  241 (370)
T cd05621         165 HRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML  241 (370)
T ss_pred             ecCCCHHHEEE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence            99999999999   5678899999999876543221  22445889999999986543    678999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|..||.+.+.
T Consensus       242 ~G~~Pf~~~~~  252 (370)
T cd05621         242 VGDTPFYADSL  252 (370)
T ss_pred             hCCCCCCCCCH
Confidence            99999987653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=221.00  Aligned_cols=163  Identities=37%  Similarity=0.682  Sum_probs=146.0

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|.+++..++|+||+++++++.+++..++||||+++++|.+++.....+++..+..++.|++.+|++||+.|+
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  122 (350)
T cd05573          43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF  122 (350)
T ss_pred             cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            44567888999999999999999999999999999999999999999999877889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC------------------------------cccccccCccccCc
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------YAEKVCGSPLYMAP  137 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------------------------------~~~~~~~~~~~~ap  137 (180)
                      +|+||+|+||++   +.++.++|+|||++.......                              ......++..|+||
T Consensus       123 iH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (350)
T cd05573         123 IHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP  199 (350)
T ss_pred             eccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence            999999999999   567889999999987654332                              12234578899999


Q ss_pred             cccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       138 e~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      |.+.+..++.++|+||||+++|+|++|+.||.+.++
T Consensus       200 E~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             HHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            999998999999999999999999999999987664

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=217.18  Aligned_cols=165  Identities=38%  Similarity=0.697  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|+.+|+++. ||||+.+.+.|++.+.+++|||++.||.|.+.+... .+++..+..++.|++.+++|+|+.|+
T Consensus        78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gv  156 (382)
T KOG0032|consen   78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGV  156 (382)
T ss_pred             cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3468999999999997 999999999999999999999999999999998766 49999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCC-CceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+|++|+|+++...+. ...++++|||++.............|++.|+|||++....++...|+||+|+++|.|++|..
T Consensus       157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~  236 (382)
T KOG0032|consen  157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP  236 (382)
T ss_pred             eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence            99999999999975443 45899999999988887667778889999999999999999999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.+..
T Consensus       237 PF~~~~~~  244 (382)
T KOG0032|consen  237 PFWGETEF  244 (382)
T ss_pred             CCcCCChh
Confidence            99987754

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-34  Score=214.22  Aligned_cols=161  Identities=40%  Similarity=0.698  Sum_probs=140.1

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+....|..++... +||||+++++++...+..+++|||++|++|..++.....+++..+..++.|++.++++||+.|++
T Consensus        39 ~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv  118 (316)
T cd05592          39 VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII  118 (316)
T ss_pred             HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            34455666777655 89999999999999999999999999999999998788899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       119 H~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~P  195 (316)
T cd05592         119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             eCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCC
Confidence            99999999999   56778999999998654322 222344578999999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       196 f~~~~~  201 (316)
T cd05592         196 FHGEDE  201 (316)
T ss_pred             CCCCCH
Confidence            987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-34  Score=216.06  Aligned_cols=158  Identities=33%  Similarity=0.665  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|..++.++ +||||+++++++...+..+++|||+++++|..++.....+++..+..++.|++.++++||++|+
T Consensus        38 ~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i  117 (329)
T cd05618          38 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI  117 (329)
T ss_pred             HHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345577888888887 8999999999999999999999999999999998878889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       118 vH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  194 (329)
T cd05618         118 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS  194 (329)
T ss_pred             eeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCC
Confidence            999999999999   5677899999998865322 222334557889999999998889999999999999999999999


Q ss_pred             CCC
Q 030256          167 PFS  169 (180)
Q Consensus       167 pf~  169 (180)
                      ||.
T Consensus       195 Pf~  197 (329)
T cd05618         195 PFD  197 (329)
T ss_pred             CCc
Confidence            995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-34  Score=218.88  Aligned_cols=162  Identities=35%  Similarity=0.622  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|..+++.++||||+++++.+.+++..+++|||++|++|.+++. ...+++..+..++.|++.++++||++|+
T Consensus        85 ~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i  163 (371)
T cd05622          85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGF  163 (371)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            344557789999999999999999999999999999999999999999886 4568999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCcccccccc----CCcchhHHHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFEL  161 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~----~~~~~Di~slg~~~~~~  161 (180)
                      +|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..    ++.++|+||+|+++|+|
T Consensus       164 vHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyel  240 (371)
T cd05622         164 IHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM  240 (371)
T ss_pred             EeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHH
Confidence            999999999999   5678899999999876643321  22345889999999986543    78899999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|..||.+.+.
T Consensus       241 l~G~~Pf~~~~~  252 (371)
T cd05622         241 LVGDTPFYADSL  252 (371)
T ss_pred             HhCCCCCCCCCH
Confidence            999999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=208.13  Aligned_cols=169  Identities=36%  Similarity=0.655  Sum_probs=149.4

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcC-CCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQ   74 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~   74 (180)
                      ||.+..  .+..++|+++--.. .|+|||.++++|++    ...+.+|||.++||.|.+.+...+.  |++.++..|++|
T Consensus        92 LKvL~D--s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~q  169 (400)
T KOG0604|consen   92 LKVLLD--SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQ  169 (400)
T ss_pred             HHHHhc--CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHH
Confidence            444433  34567788887777 79999999999864    3578999999999999999987765  999999999999


Q ss_pred             HHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHH
Q 030256           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  154 (180)
Q Consensus        75 i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~sl  154 (180)
                      |..|+.|||+.++.|||+||+|+++.+...+..++|+|||+++....+....+...|+.|.|||++...+++...|+||+
T Consensus       170 I~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSl  249 (400)
T KOG0604|consen  170 IGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL  249 (400)
T ss_pred             HHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccch
Confidence            99999999999999999999999998777788899999999988877777777778999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 030256          155 GAILFELLNGYPPFSAYR  172 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~  172 (180)
                      |+++|-+++|.+||.+..
T Consensus       250 gVimYIlLCGyPPFYS~h  267 (400)
T KOG0604|consen  250 GVIMYILLCGYPPFYSNH  267 (400)
T ss_pred             hHHHHHhhcCCCcccccC
Confidence            999999999999998754

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-34  Score=216.35  Aligned_cols=160  Identities=38%  Similarity=0.680  Sum_probs=139.2

Q ss_pred             HHHHHHHH-HHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ..+..|.. +++.++||||+++++++...+..+++|||+++++|...+....++++..+..++.|++.++++||+.|++|
T Consensus        40 ~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH  119 (325)
T cd05604          40 KHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY  119 (325)
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            34444544 56778999999999999999999999999999999999888888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       120 ~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf  196 (325)
T cd05604         120 RDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF  196 (325)
T ss_pred             cCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCC
Confidence            9999999999   5677899999999865322 22233445788999999999888999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       197 ~~~~~  201 (325)
T cd05604         197 YCRDV  201 (325)
T ss_pred             CCCCH
Confidence            87654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.1e-36  Score=215.25  Aligned_cols=161  Identities=35%  Similarity=0.564  Sum_probs=142.0

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeC--C---eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--N---CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~--~---~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .-.+|+++|++++|||||+++-+|..+  +   ...+||||++ .+|...++.    +..++.-.+.-+.+||+++++||
T Consensus        63 ~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL  141 (364)
T KOG0658|consen   63 YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL  141 (364)
T ss_pred             cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH
Confidence            456899999999999999999988543  2   5678999995 599988873    46688889999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~  161 (180)
                      |+.|++||||||.|++++  ...+.++|||||.|+.+..+.+.....-+..|.|||.+.+. .|+.+.|+||.||++.||
T Consensus       142 h~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aEL  219 (364)
T KOG0658|consen  142 HSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAEL  219 (364)
T ss_pred             HhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHH
Confidence            999999999999999996  67789999999999999888887777788899999988765 599999999999999999


Q ss_pred             HhCCCCCCCCCccc
Q 030256          162 LNGYPPFSAYRPCF  175 (180)
Q Consensus       162 l~g~~pf~~~~~~~  175 (180)
                      +.|++.|++.+..+
T Consensus       220 l~g~plFpG~s~~d  233 (364)
T KOG0658|consen  220 LKGQPLFPGDSSVD  233 (364)
T ss_pred             hcCCcccCCCCHHH
Confidence            99999999976654

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.4e-34  Score=208.52  Aligned_cols=161  Identities=32%  Similarity=0.524  Sum_probs=140.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+..|++++++++||||+++.+++.++...+++|||++|++|.+.+....  .+++..+..++.|++.++++||+.|+
T Consensus        37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i  116 (277)
T cd05607          37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI  116 (277)
T ss_pred             hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            3445679999999999999999999999999999999999999998875443  48899999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus       117 vH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p  193 (277)
T cd05607         117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP  193 (277)
T ss_pred             EEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCC
Confidence            999999999999   46778999999998766544333345578899999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+...
T Consensus       194 ~~~~~~  199 (277)
T cd05607         194 FKDHKE  199 (277)
T ss_pred             CCCCcc
Confidence            976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.3e-34  Score=212.86  Aligned_cols=162  Identities=37%  Similarity=0.667  Sum_probs=142.5

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|..+++.+ +||||+++++++...+.++++|||++|++|...+.....+++..+..++.|++.++++||+.|+
T Consensus        38 ~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i  117 (318)
T cd05570          38 DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI  117 (318)
T ss_pred             HHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            455677888899888 7999999999999999999999999999999999877889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus       118 vH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~  194 (318)
T cd05570         118 IYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS  194 (318)
T ss_pred             EccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCC
Confidence            999999999999   5677899999998865322 222233457889999999998899999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       195 pf~~~~~  201 (318)
T cd05570         195 PFEGDDE  201 (318)
T ss_pred             CCCCCCH
Confidence            9986554

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.6e-34  Score=210.96  Aligned_cols=163  Identities=33%  Similarity=0.553  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|++++++++|+||+++++++..++..+++|||++++.+..+......+++..+..++.|++.++++||+.|+
T Consensus        42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i  121 (287)
T cd07848          42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI  121 (287)
T ss_pred             cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34566788999999999999999999999999999999999887777655545679999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++   +.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       122 ~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~  198 (287)
T cd07848         122 VHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ  198 (287)
T ss_pred             ecCCCCHHHEEE---cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCC
Confidence            999999999999   567789999999987654322  122345788899999998888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.+.
T Consensus       199 ~pf~~~~~  206 (287)
T cd07848         199 PLFPGESE  206 (287)
T ss_pred             CCCCCCCH
Confidence            99987543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.2e-34  Score=212.75  Aligned_cols=161  Identities=38%  Similarity=0.623  Sum_probs=140.9

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+....|..++... +||+|+++++++.+.+..++||||+.+++|..++.....+++..+..++.|++.++++||++|++
T Consensus        39 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  118 (316)
T cd05620          39 VECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII  118 (316)
T ss_pred             HHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45566788888765 89999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus       119 HrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~P  195 (316)
T cd05620         119 YRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             ecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence            99999999999   5677899999998764321 2222345578999999999988999999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       196 f~~~~~  201 (316)
T cd05620         196 FHGDDE  201 (316)
T ss_pred             CCCCCH
Confidence            987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.4e-34  Score=213.25  Aligned_cols=162  Identities=35%  Similarity=0.626  Sum_probs=141.5

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+....|..++..+ .|++|+++.+++...+..++||||+++++|.+.+.....+++..+..++.|++.++++||+.|++
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  123 (323)
T cd05616          44 VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII  123 (323)
T ss_pred             HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            34566678888877 58999999999999999999999999999999998788899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       124 HrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~P  200 (323)
T cd05616         124 YRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP  200 (323)
T ss_pred             ecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCC
Confidence            99999999999   5677899999998865432 2222344578899999999988999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       201 f~~~~~~  207 (323)
T cd05616         201 FEGEDED  207 (323)
T ss_pred             CCCCCHH
Confidence            9876543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.9e-34  Score=211.95  Aligned_cols=162  Identities=37%  Similarity=0.615  Sum_probs=140.9

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+....|..+++.. +||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.++++||+.|++
T Consensus        39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv  118 (316)
T cd05619          39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV  118 (316)
T ss_pred             HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            34456677788765 99999999999999999999999999999999998777899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus       119 Hrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~p  195 (316)
T cd05619         119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             eCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCC
Confidence            99999999999   56778999999988653222 222344578899999999988899999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       196 f~~~~~~  202 (316)
T cd05619         196 FHGHDEE  202 (316)
T ss_pred             CCCCCHH
Confidence            9876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-35  Score=209.82  Aligned_cols=164  Identities=37%  Similarity=0.577  Sum_probs=144.0

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEe-----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      -.-.+..||+.+|+.++|+||+.+.+.+..     -+.+|+|+|+| +.+|...++.+..+++..+..++.|++.+++|+
T Consensus        63 ~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyi  141 (359)
T KOG0660|consen   63 IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYI  141 (359)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchh
Confidence            334557789999999999999999998754     24789999999 789999999877899999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCC---CCcccccccCccccCccccc-cccCCcchhHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~ape~~~-~~~~~~~~Di~slg~~~  158 (180)
                      |+.+++|||+||+|+++   +.+..++++|||+++....   .........|.+|.|||... ..+|+.+.||||.||++
T Consensus       142 HSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~  218 (359)
T KOG0660|consen  142 HSANVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCIL  218 (359)
T ss_pred             hcccccccccchhheee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHH
Confidence            99999999999999999   6888899999999988753   33445566889999999764 56799999999999999


Q ss_pred             HHHHhCCCCCCCCCccc
Q 030256          159 FELLNGYPPFSAYRPCF  175 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~~~  175 (180)
                      +||++|++.|++.+.-.
T Consensus       219 AEmL~gkplFpG~d~v~  235 (359)
T KOG0660|consen  219 AEMLTGKPLFPGKDYVH  235 (359)
T ss_pred             HHHHcCCCCCCCCchHH
Confidence            99999999999987643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.7e-34  Score=206.50  Aligned_cols=160  Identities=36%  Similarity=0.601  Sum_probs=142.1

Q ss_pred             HHHHHHHHHHhcCCCcc-ccccceEEEeCC------eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSVNHPN-IIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l   79 (180)
                      ....+|+.++++++|+| |+.+.+++...+      ..++|+||+ .-+|..++...+    .++...+..++.||+.++
T Consensus        55 ~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl  133 (323)
T KOG0594|consen   55 STAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGL  133 (323)
T ss_pred             chhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHH
Confidence            34578999999999999 999999998776      899999999 569999998765    477789999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCccccccc-cCCcchhHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI  157 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~  157 (180)
                      +|+|+++++||||||.||++   ++.+.++|+|||+++... +.....+...|.+|.|||++.+. .|+...|+||+||+
T Consensus       134 ~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI  210 (323)
T KOG0594|consen  134 AFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI  210 (323)
T ss_pred             HHHHhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence            99999999999999999999   568899999999998766 33434567789999999998876 68999999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030256          158 LFELLNGYPPFSAYRPC  174 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~~  174 (180)
                      ++||++++..|++.++.
T Consensus       211 faEm~~~~~LFpG~se~  227 (323)
T KOG0594|consen  211 FAEMFTRRPLFPGDSEI  227 (323)
T ss_pred             HHHHHhCCCCCCCCcHH
Confidence            99999999999987764

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.2e-34  Score=212.16  Aligned_cols=163  Identities=34%  Similarity=0.637  Sum_probs=141.5

Q ss_pred             HHHHHHHHHHHHHhcCCC-ccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+..|.+++..++| ++|+++.+++...+..+++|||+++++|.+++.....+++..+..++.|++.+++|||++|
T Consensus        42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05587          42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG  121 (324)
T ss_pred             hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            344567789999999966 4688899999999999999999999999999988888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       122 ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~  198 (324)
T cd05587         122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  198 (324)
T ss_pred             eEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCC
Confidence            9999999999999   4677899999998764322 22223445789999999999888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.++
T Consensus       199 ~pf~~~~~  206 (324)
T cd05587         199 PPFDGEDE  206 (324)
T ss_pred             CCCCCCCH
Confidence            99987654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.1e-34  Score=207.88  Aligned_cols=159  Identities=37%  Similarity=0.551  Sum_probs=139.1

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +.+..|++++++++|++|+++.+++...+..+++|||+++++|...+..    +..+++..+..++.|++.++++||++|
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  117 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR  117 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567899999999999999999999999999999999999999887642    346899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       118 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  194 (280)
T cd05608         118 IIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR  194 (280)
T ss_pred             cccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            9999999999999   4677899999999866543322 22345788899999999889999999999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||...+
T Consensus       195 ~pf~~~~  201 (280)
T cd05608         195 GPFRARG  201 (280)
T ss_pred             CCCCCCC
Confidence            9998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.3e-34  Score=217.48  Aligned_cols=161  Identities=34%  Similarity=0.602  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+.+++.++||||+++++++.+.+..++||||++|++|.+++. ...+++..+..++.|++.||+|||+.|++
T Consensus        86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iv  164 (370)
T cd05596          86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS-NYDIPEKWARFYTAEVVLALDAIHSMGFI  164 (370)
T ss_pred             hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34457789999999999999999999999999999999999999999886 45688999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccc----cCCcchhHHHHHHHHHHHH
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~----~~~~~~Di~slg~~~~~~l  162 (180)
                      |+||+|+||++   +.++.++|+|||.+........  .....++..|+|||.+.+.    .++.++|+||||+++|+|+
T Consensus       165 HrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell  241 (370)
T cd05596         165 HRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML  241 (370)
T ss_pred             ccCCCHHHEEE---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH
Confidence            99999999999   5678899999999876543221  2234588899999988643    3788999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|..||.+.+.
T Consensus       242 tG~~Pf~~~~~  252 (370)
T cd05596         242 VGDTPFYADSL  252 (370)
T ss_pred             hCCCCcCCCCH
Confidence            99999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.1e-34  Score=208.56  Aligned_cols=160  Identities=21%  Similarity=0.318  Sum_probs=139.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-   84 (180)
                      .+.+.+|+.++++++||||+++++++.+    ....+++|||+++++|.+++.....++......++.+++.++++||+ 
T Consensus        62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~  141 (283)
T PHA02988         62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY  141 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence            4667899999999999999999999876    35789999999999999999887889999999999999999999998 


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc--ccCCcchhHHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~--~~~~~~~Di~slg~~~~~~l  162 (180)
                      .+++|+||+|+||++   +.++.++++|||++.......  ....++..|+|||.+.+  ..++.++|+||||+++|+++
T Consensus       142 ~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~  216 (283)
T PHA02988        142 TNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF  216 (283)
T ss_pred             CCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence            499999999999999   567889999999986553322  22346788999999876  67899999999999999999


Q ss_pred             hCCCCCCCCCcc
Q 030256          163 NGYPPFSAYRPC  174 (180)
Q Consensus       163 ~g~~pf~~~~~~  174 (180)
                      +|..||.+.++.
T Consensus       217 ~g~~Pf~~~~~~  228 (283)
T PHA02988        217 TGKIPFENLTTK  228 (283)
T ss_pred             HCCCCCCCCCHH
Confidence            999999876543

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.6e-34  Score=213.35  Aligned_cols=159  Identities=33%  Similarity=0.548  Sum_probs=139.7

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|..+++.+ +|++|+++.+++..++.++++|||+++++|.+++.....+++..+..++.|++.+|++||+.|++
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  127 (332)
T cd05614          48 VEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV  127 (332)
T ss_pred             HHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            45678899999999 59999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g~  165 (180)
                      |+||+|+||++   +.++.++|+|||++.......  ......++..|+|||.+.+.. ++.++|+||+|+++|++++|.
T Consensus       128 HrDlkp~Nili---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  204 (332)
T cd05614         128 YRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA  204 (332)
T ss_pred             ecCCCHHHeEE---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence            99999999999   467789999999987643322  222345788999999987654 788999999999999999999


Q ss_pred             CCCCCC
Q 030256          166 PPFSAY  171 (180)
Q Consensus       166 ~pf~~~  171 (180)
                      .||...
T Consensus       205 ~pf~~~  210 (332)
T cd05614         205 SPFTLE  210 (332)
T ss_pred             CCCCCC
Confidence            999754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-33  Score=211.62  Aligned_cols=162  Identities=33%  Similarity=0.551  Sum_probs=143.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-   85 (180)
                      ......+.+|++++++++|+||+++++++..++..+++|||+++++|.+++...+.+++..+..++.+++.+++|||+. 
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  123 (333)
T cd06650          44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH  123 (333)
T ss_pred             HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            3456778999999999999999999999999999999999999999999998878899999999999999999999985 


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +++|+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       124 ~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~  199 (333)
T cd06650         124 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR  199 (333)
T ss_pred             CEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhhc-cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            79999999999999   466779999999886553221 22334788899999999888999999999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||...+
T Consensus       200 ~p~~~~~  206 (333)
T cd06650         200 YPIPPPD  206 (333)
T ss_pred             CCCCCcc
Confidence            9997644

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.8e-34  Score=211.70  Aligned_cols=160  Identities=36%  Similarity=0.653  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHH---hcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           10 KSCLDCELNFL---SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        10 ~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .+.+.+|.+++   +.++||||+++++++...+..++||||+++++|...+. ...+++..+..++.|++.++++||+.|
T Consensus        43 ~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05589          43 VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENK  121 (324)
T ss_pred             HHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            44566676655   56689999999999999999999999999999988775 457999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       122 ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~  198 (324)
T cd05589         122 IVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE  198 (324)
T ss_pred             eEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence            9999999999999   5678899999998765322 22233455788999999999888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.++
T Consensus       199 ~pf~~~~~  206 (324)
T cd05589         199 SPFPGDDE  206 (324)
T ss_pred             CCCCCCCH
Confidence            99987654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=207.59  Aligned_cols=161  Identities=32%  Similarity=0.536  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|+.++++++|++|+++.+.+..++..+++|||+++++|.+.+...  ..+++..+..++.|++.++++||+.|+
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05605          44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI  123 (285)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345678999999999999999999999999999999999999999887643  358999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   ++++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       124 vH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p  200 (285)
T cd05605         124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP  200 (285)
T ss_pred             EecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC
Confidence            999999999999   56778999999998765433333334578899999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.+.
T Consensus       201 f~~~~~  206 (285)
T cd05605         201 FRQRKE  206 (285)
T ss_pred             CCCCch
Confidence            987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-33  Score=212.04  Aligned_cols=162  Identities=32%  Similarity=0.566  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeC-CeEEEEEeccCCCChHHHHHhc--------------------------
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--------------------------   60 (180)
                      ....+.+|+.+++++ +||||+++++++... +.++++|||+++|+|.+++...                          
T Consensus        53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  132 (338)
T cd05102          53 EHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR  132 (338)
T ss_pred             HHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhc
Confidence            345688899999999 899999999988754 4689999999999999998642                          


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCC
Q 030256           61 ------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD  104 (180)
Q Consensus        61 ------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~  104 (180)
                                                          .+++...+..++.|++.|++|||++|++|+||+|+||++   +.
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~  209 (338)
T cd05102         133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SE  209 (338)
T ss_pred             cccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cC
Confidence                                                236778899999999999999999999999999999999   46


Q ss_pred             CceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          105 DVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       105 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      ++.++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+.
T Consensus       210 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~  282 (338)
T cd05102         210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI  282 (338)
T ss_pred             CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence            77899999999876533211   112234567999999988889999999999999999997 9999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-34  Score=212.11  Aligned_cols=163  Identities=33%  Similarity=0.621  Sum_probs=140.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|..+++.++|++|+++++++.+++..++||||++|++|.+++.+ ...+++..+..++.|++.++++||++|
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  122 (331)
T cd05597          43 AETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG  122 (331)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3455688899999999999999999999999999999999999999999976 356999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCcccccc-----ccCCcchhHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILF  159 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~-----~~~~~~~Di~slg~~~~  159 (180)
                      ++|+||+|+||++   +.++.++|+|||++.........  ....++..|+|||.+..     ..++.++|+||+|+++|
T Consensus       123 ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~  199 (331)
T cd05597         123 YVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY  199 (331)
T ss_pred             eEECCCCHHHEEE---CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHH
Confidence            9999999999999   56778999999998665433221  22357889999999863     34678999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      +|++|+.||.+.+.
T Consensus       200 el~~g~~Pf~~~~~  213 (331)
T cd05597         200 EMLYGETPFYAESL  213 (331)
T ss_pred             HHhhCCCCCCCCCH
Confidence            99999999987543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-33  Score=206.29  Aligned_cols=164  Identities=32%  Similarity=0.531  Sum_probs=142.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      -.+++.|.+||+.++||.++.++..++.+...|++||||+||+|...+++++  .|++..++.++..++-||+|||..|+
T Consensus       121 l~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGi  200 (459)
T KOG0610|consen  121 LKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGI  200 (459)
T ss_pred             HHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhce
Confidence            3456779999999999999999999999999999999999999999887665  49999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCC---------------------------------C-C----------
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---------------------------------G-N----------  123 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~---------------------------------~-~----------  123 (180)
                      ++|||||+|||+   .+++.+.|.||.++.....                                 . .          
T Consensus       201 vYRDLKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~  277 (459)
T KOG0610|consen  201 VYRDLKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESAS  277 (459)
T ss_pred             eeccCCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccc
Confidence            999999999999   5889999999987532200                                 0 0          


Q ss_pred             -------------cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 030256          124 -------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA  176 (180)
Q Consensus       124 -------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~~~  176 (180)
                                   ......||-.|+|||+..+.+.+.+.|.|+||+++|||+-|..||-+.+..+.
T Consensus       278 ~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T  343 (459)
T KOG0610|consen  278 RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET  343 (459)
T ss_pred             ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh
Confidence                         00123467779999999999999999999999999999999999998877643

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-33  Score=210.82  Aligned_cols=162  Identities=33%  Similarity=0.633  Sum_probs=140.9

Q ss_pred             HHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+..|..+++.+. |++|+++.+++.+.+.+++||||++|++|.+++.....+++..+..++.|++.|+++||++|++
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv  123 (323)
T cd05615          44 VECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII  123 (323)
T ss_pred             HHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            345677888888885 5788899999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       124 HrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p  200 (323)
T cd05615         124 YRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP  200 (323)
T ss_pred             ccCCCHHHeEE---CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCC
Confidence            99999999999   567789999999886543222 22334578899999999888899999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       201 f~~~~~~  207 (323)
T cd05615         201 FDGEDED  207 (323)
T ss_pred             CCCCCHH
Confidence            9876543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-33  Score=214.90  Aligned_cols=158  Identities=26%  Similarity=0.399  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      +..+.+|++++++++||||+++++++...+..+++++++ +++|..++.....+++..++.++.|++.||+|||++|++|
T Consensus       127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvH  205 (391)
T PHA03212        127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIH  205 (391)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            445788999999999999999999999999999999999 5689888887778999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCC--CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||+|+||++   +..+.++|+|||++......  .......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus       206 rDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  282 (391)
T PHA03212        206 RDIKAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS  282 (391)
T ss_pred             CCCChHhEEE---cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999   56778999999998653221  122235688999999999888899999999999999999999988


Q ss_pred             CCCC
Q 030256          168 FSAY  171 (180)
Q Consensus       168 f~~~  171 (180)
                      |-..
T Consensus       283 ~~~~  286 (391)
T PHA03212        283 LFEK  286 (391)
T ss_pred             cCCc
Confidence            7543

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=221.46  Aligned_cols=164  Identities=33%  Similarity=0.586  Sum_probs=145.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGA   77 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~   77 (180)
                      ...+++.-+|++++++++|+|||++.++-++.      +...++||||.||+|...+++..   .+++..++.++.++..
T Consensus        52 ~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~  131 (732)
T KOG4250|consen   52 LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVS  131 (732)
T ss_pred             cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHH
Confidence            45678889999999999999999999986543      36799999999999999997543   4999999999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeec-CCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVG  155 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg  155 (180)
                      |+.+||++|++||||||.||++.. .+....-+|+|||.++.+..+.......||..|++||.... +.++...|.||+|
T Consensus       132 al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~G  211 (732)
T KOG4250|consen  132 ALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFG  211 (732)
T ss_pred             HHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhh
Confidence            999999999999999999998743 23444579999999999988888888889999999999884 7789999999999


Q ss_pred             HHHHHHHhCCCCCCC
Q 030256          156 AILFELLNGYPPFSA  170 (180)
Q Consensus       156 ~~~~~~l~g~~pf~~  170 (180)
                      +++|+..||..||-.
T Consensus       212 vtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  212 VTLYECATGELPFIP  226 (732)
T ss_pred             hHHHHHhccCCCCCc
Confidence            999999999999954

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=203.09  Aligned_cols=161  Identities=32%  Similarity=0.649  Sum_probs=142.0

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ...+.+|++++++++||||+++++++.+++..++++|++++++|.+.+...+.+++..+..++.|++.++++||+.|++|
T Consensus        48 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H  127 (263)
T cd06625          48 VNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH  127 (263)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            45688899999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +||+|+||++   +.++.++|+|||.+.........    ....++..|+|||...+..++.++|+||+|+++|++++|+
T Consensus       128 ~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  204 (263)
T cd06625         128 RDIKGANILR---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK  204 (263)
T ss_pred             CCCCHHHEEE---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCC
Confidence            9999999999   46778999999998655332111    1234667899999999888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.+.
T Consensus       205 ~p~~~~~~  212 (263)
T cd06625         205 PPWAEFEA  212 (263)
T ss_pred             CCccccch
Confidence            99976543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.6e-34  Score=209.53  Aligned_cols=160  Identities=33%  Similarity=0.564  Sum_probs=137.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+.+|++++++++||||+++++++...+..+++|||+++ +|.+++...+ .+++..+..++.|++.|+++||++|++
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  125 (288)
T cd07871          47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL  125 (288)
T ss_pred             chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            44677899999999999999999999999999999999965 9998886554 478999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      |+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.
T Consensus       126 H~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~  202 (288)
T cd07871         126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP  202 (288)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999   567789999999986543322 2223456788999998865 457899999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       203 pf~~~~~  209 (288)
T cd07871         203 MFPGSTV  209 (288)
T ss_pred             CCCCCCH
Confidence            9987654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.6e-34  Score=215.01  Aligned_cols=163  Identities=34%  Similarity=0.562  Sum_probs=142.3

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +....+++|+.+++.++|++|+++.+++.+.+..+++|||+++++|.+++... ..+++..+..++.|++.+|++||+.|
T Consensus        43 ~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~  122 (330)
T cd05601          43 ETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG  122 (330)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            35567889999999999999999999999999999999999999999999876 67999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccc------cccCCcchhHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~------~~~~~~~~Di~slg~~~  158 (180)
                      ++|+||+|+||++   +..+.++|+|||++.........  ....++..|+|||.+.      ...++.++|+||+|+++
T Consensus       123 i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il  199 (330)
T cd05601         123 YVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA  199 (330)
T ss_pred             eEcccCchHheEE---CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence            9999999999999   57788999999998766443221  2235788999999986      44577899999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030256          159 FELLNGYPPFSAYRP  173 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~  173 (180)
                      |+|++|..||.+.+.
T Consensus       200 ~el~~g~~Pf~~~~~  214 (330)
T cd05601         200 YEMIYGRSPFHEGTS  214 (330)
T ss_pred             eeeccCCCCCCCCCH
Confidence            999999999976543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-33  Score=211.48  Aligned_cols=159  Identities=30%  Similarity=0.533  Sum_probs=136.0

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+|++++++++||||+++++++...     ...+++|||+ +++|.+++.....+++..+..++.|++.||+|||+
T Consensus        43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  121 (338)
T cd07859          43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT  121 (338)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH
Confidence            34578899999999999999999987543     2589999999 56999999877889999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCcccccc--ccCCcchhHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~--~~~~~~~Di~slg~~~  158 (180)
                      +|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+  ..++.++|+||+|+++
T Consensus       122 ~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl  198 (338)
T cd07859         122 ANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF  198 (338)
T ss_pred             CCeecCCCCHHHeEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence            999999999999999   5778899999999865432211    123457888999999865  5688999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030256          159 FELLNGYPPFSAYR  172 (180)
Q Consensus       159 ~~~l~g~~pf~~~~  172 (180)
                      |++++|+.||.+.+
T Consensus       199 ~el~tg~~pf~~~~  212 (338)
T cd07859         199 AEVLTGKPLFPGKN  212 (338)
T ss_pred             HHHHcCCCCCCCCC
Confidence            99999999997754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-35  Score=200.26  Aligned_cols=166  Identities=35%  Similarity=0.624  Sum_probs=150.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +......+++|+++.+.|+||||++++++|.++..+|+++||..+|++...+.  ...++++.....+..|++.|+.|+|
T Consensus        62 ~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h  141 (281)
T KOG0580|consen   62 KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH  141 (281)
T ss_pred             HhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc
Confidence            44557789999999999999999999999999999999999999999999998  5567999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      ..+++||||+|+|+++   ...+.+++.|||++-... ...-.+.+|+..|.+||...+...+...|+|++|++.||++.
T Consensus       142 ~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv  217 (281)
T KOG0580|consen  142 LKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV  217 (281)
T ss_pred             cCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh
Confidence            9999999999999999   578889999999986554 333446679999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccc
Q 030256          164 GYPPFSAYRPCF  175 (180)
Q Consensus       164 g~~pf~~~~~~~  175 (180)
                      |.+||.+.+.++
T Consensus       218 g~ppFes~~~~e  229 (281)
T KOG0580|consen  218 GLPPFESQSHSE  229 (281)
T ss_pred             cCCchhhhhhHH
Confidence            999999877553

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.2e-34  Score=212.43  Aligned_cols=163  Identities=33%  Similarity=0.615  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+.+|..+++.++|++|+++.+++.+.+..+++|||++|++|.+++.. ...+++..+..++.|++.+|++||++|
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~  122 (331)
T cd05624          43 AETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH  122 (331)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3445578899999999999999999999999999999999999999999986 457899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCcccccc-----ccCCcchhHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILF  159 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~-----~~~~~~~Di~slg~~~~  159 (180)
                      ++|+||+|+||++   +.++.++|+|||++.........  ....++..|+|||.+.+     ..++.++|+||+|+++|
T Consensus       123 iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~  199 (331)
T cd05624         123 YVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY  199 (331)
T ss_pred             eeeccCchHHEEE---cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhh
Confidence            9999999999999   56778999999998765433221  22457889999998865     45788999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      +|++|+.||.+.+.
T Consensus       200 ell~g~~Pf~~~~~  213 (331)
T cd05624         200 EMLYGETPFYAESL  213 (331)
T ss_pred             hhhhCCCCccCCCH
Confidence            99999999986553

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-33  Score=211.68  Aligned_cols=163  Identities=33%  Similarity=0.622  Sum_probs=140.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+..|..++..++|++|+++.+.+.+.+.+++||||+++++|.+++.+. ..+++..+..++.|++.++++||+.|
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~  122 (332)
T cd05623          43 AETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH  122 (332)
T ss_pred             hHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            33455788999999999999999999999999999999999999999999763 56899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccc-----cccCCcchhHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~  159 (180)
                      ++|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.     ...++.++|+||+|+++|
T Consensus       123 iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~  199 (332)
T cd05623         123 YVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMY  199 (332)
T ss_pred             eEecCCCHHHEEE---CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHH
Confidence            9999999999999   5677899999998865533222  12345889999999875     345788999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|+.||.+.+.
T Consensus       200 ell~g~~Pf~~~~~  213 (332)
T cd05623         200 EMLYGETPFYAESL  213 (332)
T ss_pred             HHhcCCCCCCCCCH
Confidence            99999999987553

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.2e-33  Score=204.50  Aligned_cols=161  Identities=40%  Similarity=0.747  Sum_probs=144.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|++++++++||||+++++++.+++..+++|||+++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i  122 (290)
T cd05580          43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI  122 (290)
T ss_pred             hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            44567888999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||++......  .....++..|+|||...+...+.++|+||||++++++++|..|
T Consensus       123 ~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  197 (290)
T cd05580         123 VYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP  197 (290)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999   46778999999998766444  2234477889999999888889999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       198 ~~~~~~  203 (290)
T cd05580         198 FFDDNP  203 (290)
T ss_pred             CCCCCH
Confidence            987653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.8e-33  Score=207.16  Aligned_cols=158  Identities=32%  Similarity=0.544  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ..+.+|+.+++.++||||+++++++.+++..+++|||+. ++|.+++... ..+++..+..++.|++.|+++||+.|++|
T Consensus        48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH  126 (303)
T cd07869          48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH  126 (303)
T ss_pred             hhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            456789999999999999999999999999999999995 6887777654 46899999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++|++++|..|
T Consensus       127 ~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  203 (303)
T cd07869         127 RDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA  203 (303)
T ss_pred             CCCCHHHEEE---CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999   56778999999988654322 22223456788999998765 4578899999999999999999999


Q ss_pred             CCCCC
Q 030256          168 FSAYR  172 (180)
Q Consensus       168 f~~~~  172 (180)
                      |.+.+
T Consensus       204 f~~~~  208 (303)
T cd07869         204 FPGMK  208 (303)
T ss_pred             CCCCc
Confidence            98643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=213.12  Aligned_cols=158  Identities=33%  Similarity=0.611  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      +.+++|+.+|+++.|||||+++++..+  .+.+|+|+|||..|.+...-. ..+ +++.+++.++.++..+|+|||.+|+
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~Qgi  231 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGI  231 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCe
Confidence            678999999999999999999999875  468999999999888865322 334 8999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccC------CCCcccccccCccccCcccccccc----CCcchhHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY------PGNYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAI  157 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~------~~~~~~~~~~~~~~~ape~~~~~~----~~~~~Di~slg~~  157 (180)
                      +||||||+|+|+   ++.+.++|.|||.+....      .........||+.|+|||.+.++.    .+.+.|+||+|++
T Consensus       232 iHRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT  308 (576)
T KOG0585|consen  232 IHRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT  308 (576)
T ss_pred             eccccchhheEE---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence            999999999999   567999999999987652      223334577999999999987633    4678999999999


Q ss_pred             HHHHHhCCCCCCCCC
Q 030256          158 LFELLNGYPPFSAYR  172 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~  172 (180)
                      +|.++-|+.||-+..
T Consensus       309 LYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  309 LYCLLFGQLPFFDDF  323 (576)
T ss_pred             HHHhhhccCCcccch
Confidence            999999999997754

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.3e-33  Score=202.82  Aligned_cols=165  Identities=28%  Similarity=0.584  Sum_probs=141.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK   70 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~   70 (180)
                      .....++.+|++++++++||||+++++++...+..++++||+++++|.+++...                ..++...+..
T Consensus        49 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  128 (283)
T cd05048          49 PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH  128 (283)
T ss_pred             HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHH
Confidence            345667899999999999999999999999888999999999999999998754                3478889999


Q ss_pred             HHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCc
Q 030256           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~  147 (180)
                      ++.|++.++++||+.|++|+||+|+||++   +.+..++|+|||++........   .....++..|+|||.+.+..++.
T Consensus       129 ~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  205 (283)
T cd05048         129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT  205 (283)
T ss_pred             HHHHHHHHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCch
Confidence            99999999999999999999999999999   4677899999999865533221   12233567799999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          148 KVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      ++|+||||+++|++++ |..||.+.++.
T Consensus       206 ~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         206 ESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999998 99999876553

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.6e-33  Score=201.11  Aligned_cols=162  Identities=32%  Similarity=0.602  Sum_probs=142.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+++|+.++++++||||+++++++...+..++++||+++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i  127 (267)
T cd06628          48 SMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI  127 (267)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCc
Confidence            34567889999999999999999999999999999999999999999999887889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-------ccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +|+||+|+||++   +.+..++|+|||.+........       .....++..|+|||...+..++.++|+||+|+++|+
T Consensus       128 vH~di~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~  204 (267)
T cd06628         128 IHRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVE  204 (267)
T ss_pred             ccccCCHHHEEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHH
Confidence            999999999999   5677899999998876642211       112336778999999988888999999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030256          161 LLNGYPPFSAYR  172 (180)
Q Consensus       161 ~l~g~~pf~~~~  172 (180)
                      +++|+.||.+.+
T Consensus       205 l~~g~~p~~~~~  216 (267)
T cd06628         205 MLTGKHPFPDCT  216 (267)
T ss_pred             HhhCCCCCCCcc
Confidence            999999997643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=201.22  Aligned_cols=165  Identities=35%  Similarity=0.585  Sum_probs=143.6

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+.+.++-+|++++.+. .|+||++++++|+++..+|+|||-|.||+|...+.+...|++.++.++.++|+.+|.+||.+
T Consensus       116 gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k  195 (463)
T KOG0607|consen  116 GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK  195 (463)
T ss_pred             chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc
Confidence            45688999999999999 79999999999999999999999999999999999889999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--------cccccccCccccCccccc---c--ccCCcchhHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQ---F--QRYDEKVDMW  152 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~---~--~~~~~~~Di~  152 (180)
                      |+.|+|+||+||+-...+.-..++||||.+........        ...+..|+-.|||||+..   +  ..|+.+.|+|
T Consensus       196 gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlw  275 (463)
T KOG0607|consen  196 GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLW  275 (463)
T ss_pred             CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHH
Confidence            99999999999998766666779999998875542211        112345778899999863   2  2478999999


Q ss_pred             HHHHHHHHHHhCCCCCCCC
Q 030256          153 SVGAILFELLNGYPPFSAY  171 (180)
Q Consensus       153 slg~~~~~~l~g~~pf~~~  171 (180)
                      |||+++|-|+.|++||.+.
T Consensus       276 SLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  276 SLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             HHHHHHHHHHhCCCCccCc
Confidence            9999999999999999753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.7e-34  Score=218.31  Aligned_cols=165  Identities=36%  Similarity=0.522  Sum_probs=145.3

Q ss_pred             HHHHHHHHHHHHHhcCC-C-----ccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVN-H-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l   79 (180)
                      ..-+....|+.+|..|+ |     -|+|+++++|...++.|+|+|.+ +.+|.++++.+.  .++...++.++.||+++|
T Consensus       224 ~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L  302 (586)
T KOG0667|consen  224 RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTAL  302 (586)
T ss_pred             HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            33445666999999995 3     37999999999999999999998 779999998664  589999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      ..||+.|++|+||||+|||+.+ .....|||+|||.++.......  ....+..|.|||++.+..++.+.|||||||+++
T Consensus       303 ~~L~~l~IIHcDLKPENILL~~-~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlA  379 (586)
T KOG0667|consen  303 LFLHELGIIHCDLKPENILLKD-PKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILA  379 (586)
T ss_pred             HHHHhCCeeeccCChhheeecc-CCcCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHH
Confidence            9999999999999999999975 3445899999999988765544  566788999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCcccc
Q 030256          160 ELLNGYPPFSAYRPCFA  176 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~~~  176 (180)
                      ||++|.+.|++.++.++
T Consensus       380 EL~tG~PLfpG~ne~DQ  396 (586)
T KOG0667|consen  380 ELFTGEPLFPGDNEYDQ  396 (586)
T ss_pred             hHhcCccccCCCCHHHH
Confidence            99999999999887654

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.8e-33  Score=203.37  Aligned_cols=162  Identities=26%  Similarity=0.588  Sum_probs=140.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKFL   72 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~   72 (180)
                      ....+.+|++++++++|+||+++++++...+..+++|||+++++|.+++....                .+++..++.++
T Consensus        50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  129 (291)
T cd05094          50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA  129 (291)
T ss_pred             HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence            34678899999999999999999999999999999999999999999987543                37889999999


Q ss_pred             HHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcch
Q 030256           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      .|++.++++||++|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||...+..++.++
T Consensus       130 ~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  206 (291)
T cd05094         130 SQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  206 (291)
T ss_pred             HHHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence            999999999999999999999999999   5677899999999866543221   1223346779999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          150 DMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       150 Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+||+|+++|++++ |..||...++
T Consensus       207 Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         207 DVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999 9999976554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=218.77  Aligned_cols=169  Identities=30%  Similarity=0.513  Sum_probs=148.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH
Q 030256            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +.+....++.+|++++++++|||||+++|+......++++||+|.||+|.+++++++. ++..+...++.+.+.+++|||
T Consensus       200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh  279 (474)
T KOG0194|consen  200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH  279 (474)
T ss_pred             ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence            4577888999999999999999999999999999999999999999999999998875 999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc-ccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      +++++||||-.+|+|+   ..+..++|+|||++..-..-.... ...-..+|+|||.+....++.++||||+|+++||++
T Consensus       280 ~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif  356 (474)
T KOG0194|consen  280 SKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF  356 (474)
T ss_pred             HCCCcchhHhHHHhee---cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence            9999999999999999   456668999999976543211111 222457799999999999999999999999999999


Q ss_pred             h-CCCCCCCCCcccc
Q 030256          163 N-GYPPFSAYRPCFA  176 (180)
Q Consensus       163 ~-g~~pf~~~~~~~~  176 (180)
                      + |..||.+....++
T Consensus       357 ~~g~~Py~g~~~~~v  371 (474)
T KOG0194|consen  357 ENGAEPYPGMKNYEV  371 (474)
T ss_pred             ccCCCCCCCCCHHHH
Confidence            9 8889998776544

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-32  Score=199.07  Aligned_cols=165  Identities=30%  Similarity=0.583  Sum_probs=144.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      .......+.+|++++++++|||++++++++.+.+..++++||+++++|.+++...  ..++...+..++.+++.++.+||
T Consensus        39 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH  118 (256)
T cd08529          39 NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH  118 (256)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3456778889999999999999999999999999999999999999999998764  46899999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      +.|++|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++++++
T Consensus       119 ~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  195 (256)
T cd08529         119 SKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC  195 (256)
T ss_pred             HCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence            9999999999999999   4667899999998876544322 22334677899999999888999999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|+.||...++
T Consensus       196 ~g~~p~~~~~~  206 (256)
T cd08529         196 TGKHPFDANNQ  206 (256)
T ss_pred             hCCCCCCCCCH
Confidence            99999987653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-32  Score=202.76  Aligned_cols=164  Identities=26%  Similarity=0.612  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------RVPEQTARKFLQ   73 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~   73 (180)
                      ......+.+|++++++++||+++++++++...+..++++||+++++|.+++...+             .+++..+..++.
T Consensus        48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  127 (288)
T cd05093          48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ  127 (288)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHH
Confidence            3446678999999999999999999999999999999999999999999987543             389999999999


Q ss_pred             HHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchh
Q 030256           74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVD  150 (180)
Q Consensus        74 ~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~D  150 (180)
                      |++.++++||++|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++.++|
T Consensus       128 ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD  204 (288)
T cd05093         128 QIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD  204 (288)
T ss_pred             HHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhh
Confidence            99999999999999999999999999   5677899999999876533221   11222456799999998888999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          151 MWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       151 i~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +||||+++++|++ |..||.+.++
T Consensus       205 iwslG~il~~l~t~g~~p~~~~~~  228 (288)
T cd05093         205 VWSLGVVLWEIFTYGKQPWYQLSN  228 (288)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999998 9999976554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-32  Score=202.34  Aligned_cols=161  Identities=34%  Similarity=0.536  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|+++++.++|++++++.+.+..++..++++||+++++|.+++...  .++++..+..++.|++.++.+||+.|+
T Consensus        44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  123 (285)
T cd05632          44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT  123 (285)
T ss_pred             HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            345678999999999999999999999999999999999999999887643  359999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.+..++|+|||++.............++..|+|||...+..++.++|+||+|+++|++++|..|
T Consensus       124 iH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P  200 (285)
T cd05632         124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP  200 (285)
T ss_pred             eecCCCHHHEEE---CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence            999999999999   45678999999988665433333344578899999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       201 ~~~~~~  206 (285)
T cd05632         201 FRGRKE  206 (285)
T ss_pred             CCCCCH
Confidence            987554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.9e-33  Score=203.17  Aligned_cols=160  Identities=34%  Similarity=0.565  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|+.++++++|++++++.+.+...+..+++|||++|++|.+++...+  .+++..+..++.|++.++.+||+.|+
T Consensus        44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05630          44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI  123 (285)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            3456789999999999999999999999999999999999999999886443  58999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +..+.++|+|||++.............++..|+|||...+..++.++|+||+|+++|++++|+.|
T Consensus       124 iH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P  200 (285)
T cd05630         124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP  200 (285)
T ss_pred             EeCCCCHHHEEE---CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence            999999999999   46777999999988665433333334578899999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030256          168 FSAYR  172 (180)
Q Consensus       168 f~~~~  172 (180)
                      |....
T Consensus       201 f~~~~  205 (285)
T cd05630         201 FQQRK  205 (285)
T ss_pred             CCCCC
Confidence            98654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=228.85  Aligned_cols=168  Identities=29%  Similarity=0.519  Sum_probs=148.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc------C-CCCHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------G-RVPEQTARKFLQQLGAG   78 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~-~~~~~~~~~~~~~i~~~   78 (180)
                      +.+...+|.+|..++++++|||||+++|++.+....++++|||+||+|..++++.      . .++..+++.++.+++.+
T Consensus       735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G  814 (1025)
T KOG1095|consen  735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG  814 (1025)
T ss_pred             CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence            5667888999999999999999999999999999999999999999999999866      2 38899999999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--c-cccCccccCccccccccCCcchhHHHHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--K-VCGSPLYMAPEVLQFQRYDEKVDMWSVG  155 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~-~~~~~~~~ape~~~~~~~~~~~Di~slg  155 (180)
                      +.||++++++||||..+|+|+   +....+||.|||+++.+.....-.  . -.-..+|+|||.+..+.++.++||||||
T Consensus       815 ~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFG  891 (1025)
T KOG1095|consen  815 MNYLESKHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFG  891 (1025)
T ss_pred             hHHHHhCCCcCcchhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhH
Confidence            999999999999999999999   567889999999998665443211  1 1234679999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcccc
Q 030256          156 AILFELLN-GYPPFSAYRPCFA  176 (180)
Q Consensus       156 ~~~~~~l~-g~~pf~~~~~~~~  176 (180)
                      +++||+++ |..||++.+..++
T Consensus       892 VllWEifslG~~PY~~~~n~~v  913 (1025)
T KOG1095|consen  892 VLLWEIFSLGATPYPSRSNFEV  913 (1025)
T ss_pred             HHHHHHHhCCCCCCCCcchHHH
Confidence            99999999 9999999876543

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-32  Score=199.99  Aligned_cols=162  Identities=38%  Similarity=0.714  Sum_probs=145.3

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|+.++++++||||+++++.+.+++..++++||+++++|.+++.+...+++..+..++.|++.++++||++|+
T Consensus        35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~  114 (262)
T cd05572          35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI  114 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            45577899999999999999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus       115 ~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p  191 (262)
T cd05572         115 IYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP  191 (262)
T ss_pred             ccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence            999999999999   46778999999998776544333334567889999998888899999999999999999999999


Q ss_pred             CCCCC
Q 030256          168 FSAYR  172 (180)
Q Consensus       168 f~~~~  172 (180)
                      |...+
T Consensus       192 ~~~~~  196 (262)
T cd05572         192 FGEDD  196 (262)
T ss_pred             cCCCC
Confidence            98766

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-32  Score=200.55  Aligned_cols=163  Identities=24%  Similarity=0.456  Sum_probs=139.0

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+.+|+..+++++||||+++++++..++..+++|||+++++|.+++... ..+++..++.++.|++.++++||++|
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~  127 (266)
T cd05064          48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG  127 (266)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34567889999999999999999999999999999999999999999998764 46899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      ++|+||+|+||++   +.+..++++|||............  ...++..|+|||...+..++.++|+||+|+++|++++ 
T Consensus       128 iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~  204 (266)
T cd05064         128 YVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY  204 (266)
T ss_pred             EeeccccHhhEEE---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcC
Confidence            9999999999999   467789999999765543221111  1223467999999988889999999999999999775 


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||.+.++
T Consensus       205 g~~p~~~~~~  214 (266)
T cd05064         205 GERPYWDMSG  214 (266)
T ss_pred             CCCCcCcCCH
Confidence            9999986554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=199.14  Aligned_cols=162  Identities=33%  Similarity=0.593  Sum_probs=142.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|++++++++|||++++++++.+.+..+++|||+++++|.+++... .++++..+..++.|++.++++||+.|+
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i  122 (262)
T cd06613          43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK  122 (262)
T ss_pred             hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4567889999999999999999999999999999999999999999998766 689999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc---cCCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~---~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||...+.   .++.++|+||+|+++++|++
T Consensus       123 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t  199 (262)
T cd06613         123 IHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE  199 (262)
T ss_pred             eecCCChhhEEE---CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh
Confidence            999999999999   567789999999886654322 12233467789999998766   78899999999999999999


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||.+.++
T Consensus       200 g~~p~~~~~~  209 (262)
T cd06613         200 LQPPMFDLHP  209 (262)
T ss_pred             CCCCCCCCCH
Confidence            9999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-33  Score=211.45  Aligned_cols=158  Identities=28%  Similarity=0.454  Sum_probs=139.9

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~d   91 (180)
                      ...+|++++++++||||+++++++...+..+++|+++ +++|.+++.....+++..+..++.|++.+|++||++|++|+|
T Consensus       132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrD  210 (392)
T PHA03207        132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRD  210 (392)
T ss_pred             cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            4568999999999999999999999999999999999 568988887777899999999999999999999999999999


Q ss_pred             CCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        92 l~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+|+||++   +..+.++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus       211 lkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf  287 (392)
T PHA03207        211 VKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL  287 (392)
T ss_pred             CCHHHEEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            99999999   5677899999999876543322   22345889999999999888999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       288 ~~~~~  292 (392)
T PHA03207        288 FGKQV  292 (392)
T ss_pred             CCCCC
Confidence            76543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=209.77  Aligned_cols=169  Identities=35%  Similarity=0.656  Sum_probs=154.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      +......+..|++.++-++|||||+++++...+..+|+|+|.-++|+|.+++-++. .+.++.+.+++.||+.|+.|.|+
T Consensus        57 D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq  136 (864)
T KOG4717|consen   57 DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ  136 (864)
T ss_pred             chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh
Confidence            44556678889999999999999999999999999999999999999999987665 59999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCC-cchhHHHHHHHHHHHHh
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLN  163 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Di~slg~~~~~~l~  163 (180)
                      ..+||+||+|+|+++-  .+-+-++|.|||++-...+.....+.+|+..|.|||++.+..|. ++.||||||+++|.+++
T Consensus       137 LHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC  214 (864)
T KOG4717|consen  137 LHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC  214 (864)
T ss_pred             hhhhcccCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh
Confidence            9999999999999875  67788999999999888888888888899999999999998885 57899999999999999


Q ss_pred             CCCCCCCCCcccc
Q 030256          164 GYPPFSAYRPCFA  176 (180)
Q Consensus       164 g~~pf~~~~~~~~  176 (180)
                      |++||...+.++.
T Consensus       215 Gq~PFqeANDSET  227 (864)
T KOG4717|consen  215 GQPPFQEANDSET  227 (864)
T ss_pred             CCCccccccchhh
Confidence            9999998887764

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-32  Score=198.17  Aligned_cols=165  Identities=33%  Similarity=0.556  Sum_probs=144.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +......+.+|++++++++|+||+++++++.+.+..++++||+++++|.+++...  ..+++..+..++.|++.++++||
T Consensus        39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  118 (256)
T cd08221          39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH  118 (256)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3455667889999999999999999999999999999999999999999999765  45899999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      +.|++|+||+|+||++   +.++.++++|||.+....... ......++..|.|||...+..++.++|+||+|+++++++
T Consensus       119 ~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~  195 (256)
T cd08221         119 KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL  195 (256)
T ss_pred             hCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence            9999999999999999   466789999999886654333 223345788899999998888899999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|..||...++
T Consensus       196 ~g~~~~~~~~~  206 (256)
T cd08221         196 TLKRTFDATNP  206 (256)
T ss_pred             HCCCCCCCCCH
Confidence            99999977544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-32  Score=203.28  Aligned_cols=163  Identities=28%  Similarity=0.552  Sum_probs=137.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------RVPEQT   67 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~   67 (180)
                      ...+..+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++....                   .++...
T Consensus        60 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (304)
T cd05096          60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS  139 (304)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHH
Confidence            3445678899999999999999999999999999999999999999999886431                   356788


Q ss_pred             HHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcccccccc
Q 030256           68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR  144 (180)
Q Consensus        68 ~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~  144 (180)
                      +..++.|++.++++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||...+..
T Consensus       140 ~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  216 (304)
T cd05096         140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK  216 (304)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence            99999999999999999999999999999999   5677899999999876543321   12223466799999998888


Q ss_pred             CCcchhHHHHHHHHHHHHh--CCCCCCCCC
Q 030256          145 YDEKVDMWSVGAILFELLN--GYPPFSAYR  172 (180)
Q Consensus       145 ~~~~~Di~slg~~~~~~l~--g~~pf~~~~  172 (180)
                      ++.++|+||+|+++|++++  +..||...+
T Consensus       217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  246 (304)
T cd05096         217 FTTASDVWAFGVTLWEILMLCKEQPYGELT  246 (304)
T ss_pred             CCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence            9999999999999999986  567887644

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.3e-32  Score=202.77  Aligned_cols=162  Identities=33%  Similarity=0.560  Sum_probs=142.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~   85 (180)
                      ......+.+|++++++++||||+++++.+..++..++++||+++++|.+++.+..++++..+..++.|++.++.|||+ .
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  119 (308)
T cd06615          40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH  119 (308)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            345567888999999999999999999999999999999999999999999888889999999999999999999997 6


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +++|+||+|+||++   +.++.++|+|||.+....... .....++..|+|||...+..++.++|+||+|++++++++|+
T Consensus       120 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~  195 (308)
T cd06615         120 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR  195 (308)
T ss_pred             CEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence            99999999999999   456779999999886543322 22345678899999988888899999999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||...+
T Consensus       196 ~p~~~~~  202 (308)
T cd06615         196 YPIPPPD  202 (308)
T ss_pred             CCCCCcc
Confidence            9997544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7e-33  Score=205.08  Aligned_cols=164  Identities=30%  Similarity=0.511  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~   69 (180)
                      +.....+.+|++++.++ +|+||+++++++..++.+++++||+++++|.+++....                .+++..++
T Consensus        48 ~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  127 (303)
T cd05088          48 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  127 (303)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHH
Confidence            34556788899999999 89999999999999999999999999999999986442                47889999


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcch
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      .++.|++.++++||++|++|+||+|+||++   +.++.++|+|||++..............+..|+|||...+..++.++
T Consensus       128 ~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  204 (303)
T cd05088         128 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  204 (303)
T ss_pred             HHHHHHHHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccc
Confidence            999999999999999999999999999999   46778999999988543221111112235569999998888889999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          150 DMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       150 Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+||+|++++++++ |..||.+.+.
T Consensus       205 Di~slG~il~ellt~g~~p~~~~~~  229 (303)
T cd05088         205 DVWSYGVLLWEIVSLGGTPYCGMTC  229 (303)
T ss_pred             cchhhhhHHHHHHhcCCCCcccCCh
Confidence            99999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=210.12  Aligned_cols=158  Identities=37%  Similarity=0.617  Sum_probs=135.8

Q ss_pred             HHHHHHHHhcC---CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           13 LDCELNFLSSV---NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        13 ~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ...|..++...   +||+|+++.+.+...+..+++|||+++++|..++...+.+++..+..++.|++.+++|||++|++|
T Consensus        40 ~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivH  119 (330)
T cd05586          40 TIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY  119 (330)
T ss_pred             HHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            33455666655   699999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..|
T Consensus       120 rDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~P  196 (330)
T cd05586         120 RDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP  196 (330)
T ss_pred             ccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCC
Confidence            9999999999   56778999999998654332 222344588899999988754 478999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.+.
T Consensus       197 f~~~~~  202 (330)
T cd05586         197 FYAEDT  202 (330)
T ss_pred             CCCCCH
Confidence            987654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.1e-33  Score=210.12  Aligned_cols=163  Identities=29%  Similarity=0.512  Sum_probs=138.3

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--------------------------
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------------   60 (180)
                      ...+.+.+|+++++.+ +|+||+++++++...+..+++|||+++++|.+++...                          
T Consensus        83 ~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (374)
T cd05106          83 DEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITL  162 (374)
T ss_pred             HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccch
Confidence            3456788999999999 8999999999999999999999999999999988542                          


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 030256           61 --------------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN   96 (180)
Q Consensus        61 --------------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~n   96 (180)
                                                                  .++++..+..++.|++.+++|||++|++|+||+|+|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~N  242 (374)
T cd05106         163 EKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARN  242 (374)
T ss_pred             hcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchhe
Confidence                                                        136788899999999999999999999999999999


Q ss_pred             eeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030256           97 ILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR  172 (180)
Q Consensus        97 il~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~  172 (180)
                      |++   +.+..++|+|||++.........   ....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+..
T Consensus       243 il~---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         243 VLL---TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             EEE---eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            999   46778999999998765432211   11223456999999988889999999999999999997 999997754


Q ss_pred             c
Q 030256          173 P  173 (180)
Q Consensus       173 ~  173 (180)
                      .
T Consensus       320 ~  320 (374)
T cd05106         320 V  320 (374)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.6e-33  Score=200.24  Aligned_cols=163  Identities=34%  Similarity=0.590  Sum_probs=146.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|++++++++||||+++++.+.+++..++++||+.|++|.+++....++++..+..++.|+++++.+||+.|+
T Consensus        42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (258)
T cd05578          42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI  121 (258)
T ss_pred             hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            44567889999999999999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|+++|++++|..|
T Consensus       122 ~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  198 (258)
T cd05578         122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP  198 (258)
T ss_pred             eccCCCHHHeEE---cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence            999999999999   56778999999998776554333345577889999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...+.
T Consensus       199 ~~~~~~  204 (258)
T cd05578         199 YRGHSR  204 (258)
T ss_pred             CCCCCc
Confidence            987663

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.9e-32  Score=197.22  Aligned_cols=163  Identities=28%  Similarity=0.514  Sum_probs=139.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+.+|+.+++.++|+||+++++++.. +..++++||+++++|.+++.....+++..+..++.|++.++++||++|
T Consensus        37 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~  115 (257)
T cd05116          37 PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN  115 (257)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456778899999999999999999998764 457899999999999999987778999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|+||+|.||++   +.+..++|+|||.+.........    ....++..|+|||...+..++.++|+||||+++|+++
T Consensus       116 i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  192 (257)
T cd05116         116 FVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF  192 (257)
T ss_pred             EeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence            9999999999999   46778999999998766443221    1112346799999988888899999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030256          163 N-GYPPFSAYRP  173 (180)
Q Consensus       163 ~-g~~pf~~~~~  173 (180)
                      + |..||.+.++
T Consensus       193 t~g~~p~~~~~~  204 (257)
T cd05116         193 SYGQKPYKGMKG  204 (257)
T ss_pred             hCCCCCCCCCCH
Confidence            8 9999987654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-32  Score=198.98  Aligned_cols=163  Identities=34%  Similarity=0.600  Sum_probs=142.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      +..+.+.+|+.++++++|+|++++++++.+.+..++++||+++++|.+++....++++..+..++.|++.|+++||++|+
T Consensus        45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i  124 (268)
T cd06630          45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI  124 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            35678899999999999999999999999999999999999999999999877889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      +|+||+|.||++.  ..+..++|+|||.+........     .....++..|+|||...+..++.++|+||+|+++++++
T Consensus       125 ~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~  202 (268)
T cd06630         125 IHRDVKGANLLID--STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA  202 (268)
T ss_pred             ecCCCCHHHEEEc--CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH
Confidence            9999999999994  2344699999999866643321     12234677899999998888899999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|..||...+
T Consensus       203 ~g~~p~~~~~  212 (268)
T cd06630         203 TAKPPWNAEK  212 (268)
T ss_pred             hCCCCCCCCC
Confidence            9999997544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-32  Score=198.25  Aligned_cols=162  Identities=32%  Similarity=0.601  Sum_probs=142.3

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|++++++++|+||+++.+++.+.+..++++||+++++|.+++.+..++++..+..++.|++.++++||+.|+
T Consensus        44 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (265)
T cd06631          44 KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV  123 (265)
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            33456889999999999999999999999999999999999999999999877889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCC-------CcccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +|+||+|+||++   +.++.++|+|||.+......       .......++..|+|||...+..++.++|+||+|+++++
T Consensus       124 ~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~  200 (265)
T cd06631         124 VHRDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE  200 (265)
T ss_pred             ccCCcCHHhEEE---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHH
Confidence            999999999999   56778999999988654211       11122346778999999988889999999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030256          161 LLNGYPPFSAYR  172 (180)
Q Consensus       161 ~l~g~~pf~~~~  172 (180)
                      +++|..||...+
T Consensus       201 l~~g~~p~~~~~  212 (265)
T cd06631         201 MATGKPPLASMD  212 (265)
T ss_pred             HHhCCCccccCC
Confidence            999999997654

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.9e-32  Score=199.29  Aligned_cols=162  Identities=27%  Similarity=0.583  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFLQQ   74 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~   74 (180)
                      ..+.+.+|++++++++|+||+++++++..++..+++|||+++++|.+++...+              .+++..+..++.|
T Consensus        51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  130 (280)
T cd05049          51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ  130 (280)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence            56789999999999999999999999999999999999999999999987542              3788899999999


Q ss_pred             HHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhH
Q 030256           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM  151 (180)
Q Consensus        75 i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di  151 (180)
                      ++.++++||++|++|+||+|+||++   +.++.++|+|||.+........   ......+..|+|||.+.+..++.++|+
T Consensus       131 i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  207 (280)
T cd05049         131 IASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV  207 (280)
T ss_pred             HHHHHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence            9999999999999999999999999   5678899999998865433221   122234567999999998899999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCc
Q 030256          152 WSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       152 ~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      ||+|+++|++++ |..||.+.+.
T Consensus       208 ~slG~il~e~~~~g~~p~~~~~~  230 (280)
T cd05049         208 WSFGVVLWEIFTYGKQPWYGLSN  230 (280)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-32  Score=199.77  Aligned_cols=161  Identities=37%  Similarity=0.563  Sum_probs=141.6

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|++++++++||+++++.+++...+..++++||+++++|.+++....  .+++..+..++.|++.++.+||+.|+
T Consensus        37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  116 (277)
T cd05577          37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI  116 (277)
T ss_pred             hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4455779999999999999999999999999999999999999999987665  69999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|++++++++|+.|
T Consensus       117 ~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p  193 (277)
T cd05577         117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP  193 (277)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCC
Confidence            999999999999   56778999999988665443333344567789999998888889999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...+.
T Consensus       194 ~~~~~~  199 (277)
T cd05577         194 FRQRKE  199 (277)
T ss_pred             CCCCcc
Confidence            976544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.8e-32  Score=201.31  Aligned_cols=164  Identities=29%  Similarity=0.505  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~   70 (180)
                      ...+.+.+|++++.++ +||||+++++++...+..++++||+++++|.+++....                .+++..+..
T Consensus        44 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  123 (297)
T cd05089          44 NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ  123 (297)
T ss_pred             HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHH
Confidence            3456788899999999 79999999999999999999999999999999986532                378889999


Q ss_pred             HHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchh
Q 030256           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVD  150 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~D  150 (180)
                      ++.|++.++++||++|++|+||+|+||++   +.+..++|+|||++..............+..|+|||...+..++.++|
T Consensus       124 i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  200 (297)
T cd05089         124 FASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSD  200 (297)
T ss_pred             HHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhh
Confidence            99999999999999999999999999999   467789999999875432211111112245699999998888999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          151 MWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       151 i~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      +||||+++|+|++ |..||.+.++.
T Consensus       201 vwSlG~il~el~t~g~~pf~~~~~~  225 (297)
T cd05089         201 VWSFGVLLWEIVSLGGTPYCGMTCA  225 (297)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999997 99999776543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.3e-32  Score=197.29  Aligned_cols=161  Identities=34%  Similarity=0.633  Sum_probs=142.5

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|++++++++|+|++++.+++......++++|++++++|.+++.. ...+++..+..++.|++.++++||+.|++
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~  121 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI  121 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            67899999999999999999999999999999999999999999999875 34689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+|++|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus       122 H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p  198 (256)
T cd06612         122 HRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP  198 (256)
T ss_pred             cCCCCcceEEE---CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   467789999999987665433 22233467789999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       199 ~~~~~~  204 (256)
T cd06612         199 YSDIHP  204 (256)
T ss_pred             CCCcch
Confidence            976554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-32  Score=209.60  Aligned_cols=161  Identities=30%  Similarity=0.516  Sum_probs=137.0

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--------------------------
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------------------   61 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------   61 (180)
                      ..+.+.+|+++++.+ +||||+++++++...+..+++|||+++|+|.+++....                          
T Consensus        81 ~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (375)
T cd05104          81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM  160 (375)
T ss_pred             HHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence            445688899999999 89999999999999999999999999999999886421                          


Q ss_pred             -------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecC
Q 030256           62 -------------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDL   92 (180)
Q Consensus        62 -------------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl   92 (180)
                                                                       .+++..+..++.|++.++++||+.|++|+||
T Consensus       161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  240 (375)
T cd05104         161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDL  240 (375)
T ss_pred             cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence                                                             3678889999999999999999999999999


Q ss_pred             CCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CCCCC
Q 030256           93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF  168 (180)
Q Consensus        93 ~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~~pf  168 (180)
                      +|+||++.   .+..++|+|||++........   .....++..|+|||...+..++.++|+||||+++|++++ |..||
T Consensus       241 kp~Nill~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~  317 (375)
T cd05104         241 AARNILLT---HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY  317 (375)
T ss_pred             chhhEEEE---CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            99999994   567799999999876543221   112223456999999998889999999999999999998 89999


Q ss_pred             CCCC
Q 030256          169 SAYR  172 (180)
Q Consensus       169 ~~~~  172 (180)
                      ....
T Consensus       318 ~~~~  321 (375)
T cd05104         318 PGMP  321 (375)
T ss_pred             CCCC
Confidence            7654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-32  Score=206.88  Aligned_cols=160  Identities=37%  Similarity=0.527  Sum_probs=136.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.+|+.+++.++||||+++++++...+      ..+++|||+++ +|...+.  ..+++..+..++.|++.+|++
T Consensus        62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~  138 (359)
T cd07876          62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKH  138 (359)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHH
Confidence            44566778999999999999999999886443      57999999954 6766553  458889999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ||++|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus       139 LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el  215 (359)
T cd07876         139 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL  215 (359)
T ss_pred             HHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence            999999999999999999   56788999999998765444333445578889999999988999999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.+.
T Consensus       216 ~tg~~pf~~~~~  227 (359)
T cd07876         216 VKGSVIFQGTDH  227 (359)
T ss_pred             HhCCCCCCCCCH
Confidence            999999987653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-32  Score=196.63  Aligned_cols=162  Identities=34%  Similarity=0.657  Sum_probs=144.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      +..+.+.+|++++++++|+|++++.+++.+++..++++||+++++|.+++....++++..+..++.|++.++++||+.|+
T Consensus        44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  123 (258)
T cd06632          44 EAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT  123 (258)
T ss_pred             HHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            45567889999999999999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|++||...... ++.++|+||+|+++|++++|+.
T Consensus       124 ~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~  200 (258)
T cd06632         124 VHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP  200 (258)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence            999999999999   467789999999887665444334455778899999987666 8999999999999999999999


Q ss_pred             CCCCCC
Q 030256          167 PFSAYR  172 (180)
Q Consensus       167 pf~~~~  172 (180)
                      ||....
T Consensus       201 pf~~~~  206 (258)
T cd06632         201 PWSQLE  206 (258)
T ss_pred             CcccCc
Confidence            997654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-32  Score=198.34  Aligned_cols=164  Identities=30%  Similarity=0.511  Sum_probs=137.9

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~   69 (180)
                      ....+.+.+|+++++++ +||||+++++++...+..+++|||+++++|.+++....                .++...+.
T Consensus        36 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~  115 (270)
T cd05047          36 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  115 (270)
T ss_pred             HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHH
Confidence            34556788999999999 89999999999999999999999999999999986432                37889999


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcch
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      .++.|++.++++||+.|++|+||+|+||++   +.+..++++|||++..............+..|+|||...+..++.++
T Consensus       116 ~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~  192 (270)
T cd05047         116 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  192 (270)
T ss_pred             HHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchh
Confidence            999999999999999999999999999999   56788999999987533211111112234569999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          150 DMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       150 Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+||||++++++++ |..||.+.+.
T Consensus       193 Di~slG~il~el~~~g~~pf~~~~~  217 (270)
T cd05047         193 DVWSYGVLLWEIVSLGGTPYCGMTC  217 (270)
T ss_pred             hHHHHHHHHHHHHcCCCCCccccCH
Confidence            99999999999997 9999976543

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.5e-32  Score=195.75  Aligned_cols=165  Identities=33%  Similarity=0.611  Sum_probs=144.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ......+.+|++++++++|||++++++.+...+..++++|++++++|.+++...  ..+++..+..++.+++.++++||+
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~  119 (256)
T cd08220          40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT  119 (256)
T ss_pred             cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            345667889999999999999999999999999999999999999999999764  348999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|++|+||+|+||++.  +.+..++++|||.+.............++..|+|||...+..++.++|+||+|++++++++|
T Consensus       120 ~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~  197 (256)
T cd08220         120 KLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL  197 (256)
T ss_pred             CCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence            9999999999999995  34556899999998776554444445577889999999888889999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||...+.
T Consensus       198 ~~~~~~~~~  206 (256)
T cd08220         198 KRAFEAANL  206 (256)
T ss_pred             CCCcccCch
Confidence            999977553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=206.88  Aligned_cols=165  Identities=37%  Similarity=0.564  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      +..+.-...|-++|++++.+.||.+-..|+..+.+|+|++.|+||+|.-++...+  .|++..++.++.+|+-+|++||.
T Consensus       226 r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~  305 (591)
T KOG0986|consen  226 RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR  305 (591)
T ss_pred             hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh
Confidence            3445566779999999999999999999999999999999999999999887665  59999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      .++|+||++|+||++   ++.+.++|+|+|++..+..........||.+|+|||++.+..|+...|.|||||++|+|+.|
T Consensus       306 ~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G  382 (591)
T KOG0986|consen  306 RRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAG  382 (591)
T ss_pred             cceeeccCChhheee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcc
Confidence            999999999999999   78999999999999999888877777899999999999999999999999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      +.||......
T Consensus       383 ~sPFr~~KeK  392 (591)
T KOG0986|consen  383 HSPFRQRKEK  392 (591)
T ss_pred             cCchhhhhhh
Confidence            9999766544

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-33  Score=212.38  Aligned_cols=159  Identities=34%  Similarity=0.589  Sum_probs=144.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      +...+++..|+.+|+.|+||||+++++++.+.  ..+.+|.|.+.+|+|..|+++.+.++...+..|+.||+++|.|||+
T Consensus        82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs  161 (632)
T KOG0584|consen   82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS  161 (632)
T ss_pred             hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc
Confidence            34458899999999999999999999998765  4699999999999999999999999999999999999999999999


Q ss_pred             CC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           85 HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        85 ~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      +.  ++|||||.+||++.  ...+.|||+|+|+|.......... ..||+.|||||... ..|....||||||.+++||+
T Consensus       162 ~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv  237 (632)
T KOG0584|consen  162 QDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSHAKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV  237 (632)
T ss_pred             CCCCccccccccceEEEc--CCcCceeecchhHHHHhhccccce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHH
Confidence            86  99999999999997  578889999999998876554443 67999999999987 67999999999999999999


Q ss_pred             hCCCCCC
Q 030256          163 NGYPPFS  169 (180)
Q Consensus       163 ~g~~pf~  169 (180)
                      |+.-||.
T Consensus       238 T~eYPYs  244 (632)
T KOG0584|consen  238 TSEYPYS  244 (632)
T ss_pred             hccCChh
Confidence            9999996

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.2e-32  Score=201.00  Aligned_cols=159  Identities=36%  Similarity=0.570  Sum_probs=134.3

Q ss_pred             HHHHHHHHHHhcC---CCccccccceEEE-----eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus        11 ~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~   80 (180)
                      ....+|+.+++.+   +||||+++++++.     .....++++|++. ++|.+++...  ..+++..+..++.|++.+++
T Consensus        46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~  124 (290)
T cd07862          46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD  124 (290)
T ss_pred             HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence            3455677777666   6999999999875     2456899999995 6999888654  34899999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +||++|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+
T Consensus       125 ~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e  201 (290)
T cd07862         125 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE  201 (290)
T ss_pred             HHHHCCeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHH
Confidence            9999999999999999999   5677899999999876654443444557889999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030256          161 LLNGYPPFSAYRP  173 (180)
Q Consensus       161 ~l~g~~pf~~~~~  173 (180)
                      +++|..||.+.++
T Consensus       202 l~~g~~~f~~~~~  214 (290)
T cd07862         202 MFRRKPLFRGSSD  214 (290)
T ss_pred             HHcCCCCcCCCCH
Confidence            9999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4e-32  Score=220.62  Aligned_cols=162  Identities=25%  Similarity=0.404  Sum_probs=139.0

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTARKFLQQLG   76 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~   76 (180)
                      ..++++.+|++++++++||||+++++++.+++..+++|||++|++|.+++...           ...+...+..++.|++
T Consensus        44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa  123 (932)
T PRK13184         44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC  123 (932)
T ss_pred             HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence            45667889999999999999999999999999999999999999999988632           2345677889999999


Q ss_pred             HHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-------------------CcccccccCccccCc
Q 030256           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------------------NYAEKVCGSPLYMAP  137 (180)
Q Consensus        77 ~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-------------------~~~~~~~~~~~~~ap  137 (180)
                      .++++||+.|++||||+|+||++   +..+.++|+|||++......                   .......|+..|+||
T Consensus       124 ~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        124 ATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             HHHHHHHHCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence            99999999999999999999999   56778999999998655211                   011123578899999


Q ss_pred             cccccccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       138 e~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      |...+..++.++|+||+|+++++|++|..||...+
T Consensus       201 E~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        201 ERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             HHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            99998889999999999999999999999997644

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4e-32  Score=195.88  Aligned_cols=164  Identities=34%  Similarity=0.602  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+....+.+|++++++++||||+++++++...+..++++||+++++|.+++.... .+++..+..++.|++.++++||+.
T Consensus        34 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  113 (252)
T cd05084          34 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK  113 (252)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4556778999999999999999999999999999999999999999999987544 589999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc---ccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |++|+||+|+||++   +.++.++|+|||.+..........   .......|+|||.+.+..++.++|+||+|+++|+++
T Consensus       114 ~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~  190 (252)
T cd05084         114 HCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF  190 (252)
T ss_pred             CccccccchheEEE---cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence            99999999999999   466779999999986543321111   111234699999998888999999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030256          163 N-GYPPFSAYRP  173 (180)
Q Consensus       163 ~-g~~pf~~~~~  173 (180)
                      + |..||...++
T Consensus       191 ~~~~~p~~~~~~  202 (252)
T cd05084         191 SLGAVPYANLSN  202 (252)
T ss_pred             hCCCCCccccCH
Confidence            7 9999976543

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.9e-32  Score=211.93  Aligned_cols=159  Identities=33%  Similarity=0.544  Sum_probs=131.8

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeC--------CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+|+.++++++|+||+++.+++...        ..++++|||++ ++|.+++.    ....+++..+..++.|++.||
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL  183 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL  183 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence            356799999999999999999876432        25779999996 47766654    245689999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCcchhHHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL  158 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~  158 (180)
                      +|||+.|++||||+|+||++.  .....++|+|||++.............++..|+|||.+.+. .++.++|+||+|+++
T Consensus       184 ~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil  261 (440)
T PTZ00036        184 AYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII  261 (440)
T ss_pred             HHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence            999999999999999999995  34456999999999876544444445578889999987654 589999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030256          159 FELLNGYPPFSAYRP  173 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~  173 (180)
                      |+|++|.+||.+.++
T Consensus       262 ~elltG~~pf~~~~~  276 (440)
T PTZ00036        262 AEMILGYPIFSGQSS  276 (440)
T ss_pred             HHHHhCCCCCCCCCh
Confidence            999999999987654

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4e-32  Score=196.24  Aligned_cols=163  Identities=31%  Similarity=0.562  Sum_probs=143.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l   79 (180)
                      ..+.+.+|++.++.++|++++++++++...+..++++||+++++|.+++...         ..+++..+..++.|++.++
T Consensus        39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al  118 (262)
T cd00192          39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM  118 (262)
T ss_pred             HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence            3677889999999999999999999999999999999999999999999875         6799999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCcchhHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      ++||++|++|+||+|+||++   +.++.++|+|||.+.......   ......++..|+|||......++.++|+||+|+
T Consensus       119 ~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  195 (262)
T cd00192         119 EYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV  195 (262)
T ss_pred             HHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHH
Confidence            99999999999999999999   466889999999987765432   122334677899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCcc
Q 030256          157 ILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       157 ~~~~~l~-g~~pf~~~~~~  174 (180)
                      +++++++ |..||.+.++.
T Consensus       196 il~~l~~~g~~p~~~~~~~  214 (262)
T cd00192         196 LLWEIFTLGATPYPGLSNE  214 (262)
T ss_pred             HHHHHHhcCCCCCCCCCHH
Confidence            9999999 69999876543

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5e-32  Score=198.04  Aligned_cols=167  Identities=29%  Similarity=0.492  Sum_probs=140.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l   79 (180)
                      ......+.+|+.++++++|+||+++++++.+.+..++++||++|++|.+++....       .+++..++.++.|++.++
T Consensus        50 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l  129 (277)
T cd05036          50 EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC  129 (277)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHH
Confidence            3445668889999999999999999999988888999999999999999987543       488999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      ++||+++++|+||+|+||++........++|+|||++.........   .....+..|+|||...+..++.++|+||||+
T Consensus       130 ~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  209 (277)
T cd05036         130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV  209 (277)
T ss_pred             HHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence            9999999999999999999964334456899999998765322211   1112345799999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCc
Q 030256          157 ILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       157 ~~~~~l~-g~~pf~~~~~  173 (180)
                      ++|++++ |..||++.+.
T Consensus       210 il~el~~~g~~pf~~~~~  227 (277)
T cd05036         210 LLWEIFSLGYMPYPGRTN  227 (277)
T ss_pred             HHHHHHcCCCCCCCCCCH
Confidence            9999997 9999987543

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-32  Score=197.70  Aligned_cols=161  Identities=30%  Similarity=0.559  Sum_probs=140.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ...+.+|+.+++.++|||++++++++...+..++++||+++++|.+++...+.+++..+..++.|++.++++||+.|++|
T Consensus        50 ~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  129 (267)
T cd06645          50 FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH  129 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            34577899999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccc---cccCCcchhHHHHHHHHHHHHhCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +||+|+||++   +..+.++|+|||.+....... ......++..|+|||.+.   ...++.++|+||+|+++|++++|.
T Consensus       130 ~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~  206 (267)
T cd06645         130 RDIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             CCCCHHHEEE---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCC
Confidence            9999999999   467789999999986554322 122345788899999874   445788999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...++
T Consensus       207 ~p~~~~~~  214 (267)
T cd06645         207 PPMFDLHP  214 (267)
T ss_pred             CCcccccc
Confidence            99965443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.9e-32  Score=198.42  Aligned_cols=164  Identities=26%  Similarity=0.579  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------RVPEQTARKF   71 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~   71 (180)
                      ......+.+|++++++++|+||+++++++.+.+..++++||+++++|.+++....               .+++..+..+
T Consensus        48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  127 (280)
T cd05092          48 ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI  127 (280)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHH
Confidence            4456679999999999999999999999999999999999999999999987543               3788999999


Q ss_pred             HHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcc
Q 030256           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  148 (180)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~  148 (180)
                      +.|++.++++||+.|++|+||+|+||++   +.+..++|+|||++........   .....++..|+|||...+..++.+
T Consensus       128 ~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (280)
T cd05092         128 ASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE  204 (280)
T ss_pred             HHHHHHHHHHHHHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch
Confidence            9999999999999999999999999999   4677899999998865433221   112223567999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          149 VDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       149 ~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +|+||||+++|++++ |..||.+.++
T Consensus       205 ~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         205 SDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            999999999999998 9999966443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.2e-32  Score=206.78  Aligned_cols=162  Identities=33%  Similarity=0.510  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....+.+|+++++.++|+||+++++++...+     ..++++||+. ++|.+.+.....+++..+..++.|++.+|++||
T Consensus        42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  120 (372)
T cd07853          42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH  120 (372)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999998766     7899999995 689888877778999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccc-cCCcchhHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE  160 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~  160 (180)
                      +.|++|+||+|+||++   +.++.++|+|||++.......  ......++..|+|||.+.+. .++.++|+||+|+++|+
T Consensus       121 ~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e  197 (372)
T cd07853         121 SAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE  197 (372)
T ss_pred             hCCeeCCCCChHHEEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence            9999999999999999   567889999999986543322  12223467789999998764 47889999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030256          161 LLNGYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~g~~pf~~~~~~  174 (180)
                      |++|+.||.+.++.
T Consensus       198 l~~g~~pf~~~~~~  211 (372)
T cd07853         198 LLGRRILFQAQSPI  211 (372)
T ss_pred             HHcCCCCCCCCCHH
Confidence            99999999877654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.8e-32  Score=195.78  Aligned_cols=163  Identities=25%  Similarity=0.529  Sum_probs=136.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +...+.+.+|+.++++++|+||+++++++.. +..+++|||+++++|.+++.. ...+++..++.++.|++.++++||++
T Consensus        36 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  114 (257)
T cd05115          36 KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK  114 (257)
T ss_pred             hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            3445678899999999999999999998754 468999999999999999874 34689999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+||+|+||++   +.+..++|+|||.+.........    ....++..|+|||...+..++.++|+||||+++|++
T Consensus       115 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  191 (257)
T cd05115         115 NFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA  191 (257)
T ss_pred             CeeecccchheEEE---cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHH
Confidence            99999999999999   46778999999988655332211    111124579999998888889999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030256          162 LN-GYPPFSAYRP  173 (180)
Q Consensus       162 l~-g~~pf~~~~~  173 (180)
                      ++ |..||.+.++
T Consensus       192 ~~~g~~p~~~~~~  204 (257)
T cd05115         192 FSYGQKPYKKMKG  204 (257)
T ss_pred             hcCCCCCcCcCCH
Confidence            96 9999976554

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-32  Score=196.07  Aligned_cols=157  Identities=41%  Similarity=0.738  Sum_probs=141.5

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~d   91 (180)
                      ...+|+.++++++||||+++++++.+.+..+++|+++++++|.+++.....++...+..++.|++.++++||+.|++|+|
T Consensus        44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~d  123 (260)
T PF00069_consen   44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRD  123 (260)
T ss_dssp             HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred             hhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            34559999999999999999999999999999999999889999998788999999999999999999999999999999


Q ss_pred             CCCCCeeeecCCCCceEEEeecCCcccc-CCCCcccccccCccccCccccc-cccCCcchhHHHHHHHHHHHHhCCCCCC
Q 030256           92 LKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFS  169 (180)
Q Consensus        92 l~~~nil~~~~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~ape~~~-~~~~~~~~Di~slg~~~~~~l~g~~pf~  169 (180)
                      |+|+||++   +.++.++|+|||.+... ..........++..|.|||... +...+.++|+||+|+++++|++|..||.
T Consensus       124 ikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~  200 (260)
T PF00069_consen  124 IKPENILL---DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE  200 (260)
T ss_dssp             BSGGGEEE---STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred             cccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999   57888999999998753 2233344555788899999998 7889999999999999999999999999


Q ss_pred             CC
Q 030256          170 AY  171 (180)
Q Consensus       170 ~~  171 (180)
                      +.
T Consensus       201 ~~  202 (260)
T PF00069_consen  201 ES  202 (260)
T ss_dssp             TS
T ss_pred             cc
Confidence            76

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=211.47  Aligned_cols=168  Identities=34%  Similarity=0.638  Sum_probs=159.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +.++.+-+-.|-.+|.+.+.|.||+++..|.++...|++||-|-||.|...++..+.|++.+...+...+++|++|||.+
T Consensus       460 dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k  539 (732)
T KOG0614|consen  460 DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK  539 (732)
T ss_pred             chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc
Confidence            55667778889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      |+++|||||+|+++   +.++-++|.|||+++.+..+..+-+..||+.|.|||+..+.+.+.+.|.||||++++|+++|.
T Consensus       540 ~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~  616 (732)
T KOG0614|consen  540 GIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS  616 (732)
T ss_pred             CceeccCChhheee---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence            99999999999999   688899999999999999988888889999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccc
Q 030256          166 PPFSAYRPCFA  176 (180)
Q Consensus       166 ~pf~~~~~~~~  176 (180)
                      +||.+.+|-..
T Consensus       617 pPFs~~dpmkt  627 (732)
T KOG0614|consen  617 PPFSGVDPMKT  627 (732)
T ss_pred             CCCCCCchHHH
Confidence            99999887543

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3e-32  Score=201.11  Aligned_cols=161  Identities=32%  Similarity=0.614  Sum_probs=140.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++|+|++++++.+..++..++++||+++++|.+++. ...++...+..++.|++.++++||+.|++
T Consensus        60 ~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~  138 (296)
T cd06654          60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVI  138 (296)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34668889999999999999999999999999999999999999999886 45688999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       139 H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~p  215 (296)
T cd06654         139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP  215 (296)
T ss_pred             cCCCCHHHEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence            99999999999   4667899999998765533221 1233577889999999888889999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       216 f~~~~~  221 (296)
T cd06654         216 YLNENP  221 (296)
T ss_pred             CCCCCH
Confidence            987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.8e-32  Score=195.15  Aligned_cols=161  Identities=26%  Similarity=0.553  Sum_probs=139.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|++++++++||||+++++++...+..+++|||+++++|.+++... +.+++..+..++.|++.++++||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05114          43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI  122 (256)
T ss_pred             HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            456788999999999999999999999999999999999999999988643 4689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      |+||+|+||++   +.+..++++|||.+..........  ...++..|+|||...+..++.++|+||+|+++|++++ |+
T Consensus       123 H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~  199 (256)
T cd05114         123 HRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK  199 (256)
T ss_pred             ccccCcceEEE---cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence            99999999999   467789999999887654322221  1223457999999988889999999999999999999 99


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...+.
T Consensus       200 ~p~~~~~~  207 (256)
T cd05114         200 MPFEKKSN  207 (256)
T ss_pred             CCCCCCCH
Confidence            99977654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-32  Score=200.04  Aligned_cols=165  Identities=35%  Similarity=0.594  Sum_probs=139.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .+..+.+.+|++.+++++||||+++++++...+..++++||+++++|.+++...  ..++...+..++.|++.|++|||+
T Consensus        42 ~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  121 (259)
T PF07714_consen   42 EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS  121 (259)
T ss_dssp             HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            345778999999999999999999999999878899999999999999999876  579999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ++++|++|+++||++   +.++.++|+|||+.........   .........|+|||.+.+..++.++||||||+++||+
T Consensus       122 ~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei  198 (259)
T PF07714_consen  122 NNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEI  198 (259)
T ss_dssp             TTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999   4677999999999877632211   1223456779999999988899999999999999999


Q ss_pred             Hh-CCCCCCCCCcc
Q 030256          162 LN-GYPPFSAYRPC  174 (180)
Q Consensus       162 l~-g~~pf~~~~~~  174 (180)
                      ++ |+.||.+.+..
T Consensus       199 ~~~~~~p~~~~~~~  212 (259)
T PF07714_consen  199 LTLGKFPFSDYDNE  212 (259)
T ss_dssp             HTTSSGTTTTSCHH
T ss_pred             cccccccccccccc
Confidence            99 78999876543

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.4e-32  Score=206.10  Aligned_cols=160  Identities=35%  Similarity=0.511  Sum_probs=137.0

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.+|+.+++.++||||+++++++...      ...++||||++ ++|.+.+.  ..++...+..++.|++.||++
T Consensus        65 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~  141 (364)
T cd07875          65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKH  141 (364)
T ss_pred             hhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHH--hcCCHHHHHHHHHHHHHHHHH
Confidence            3455677899999999999999999987543      35799999995 57777664  358889999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ||++|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||||+++|+|
T Consensus       142 LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el  218 (364)
T cd07875         142 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM  218 (364)
T ss_pred             HhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence            999999999999999999   56778999999999776554444445678899999999998999999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.+.
T Consensus       219 l~g~~pf~~~~~  230 (364)
T cd07875         219 IKGGVLFPGTDH  230 (364)
T ss_pred             HhCCCCCCCCCH
Confidence            999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-32  Score=197.50  Aligned_cols=161  Identities=34%  Similarity=0.631  Sum_probs=142.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|++++++++|+|++++.+++.++...++++|++++++|.+++... ++++..+..++.|++.++.+||+.+++
T Consensus        42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~  120 (274)
T cd06609          42 EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKI  120 (274)
T ss_pred             HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            3456788999999999999999999999999999999999999999998754 889999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++++|||.+....... ......++..|+|||...+..++.++|+||+|+++|++++|..|
T Consensus       121 h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p  197 (274)
T cd06609         121 HRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP  197 (274)
T ss_pred             cCCCCHHHEEE---CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   567789999999987765432 22234467789999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       198 ~~~~~~  203 (274)
T cd06609         198 LSDLHP  203 (274)
T ss_pred             cccCch
Confidence            986554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.8e-32  Score=205.06  Aligned_cols=157  Identities=32%  Similarity=0.538  Sum_probs=133.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ......+.+|++++++++|+||+++++++...+.+++++||+++++|.+.    ...++..+..++.|++.+|+|||++|
T Consensus       113 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~  188 (353)
T PLN00034        113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH  188 (353)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44567789999999999999999999999999999999999999998653    34567888899999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccc-----ccCCcchhHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-----~~~~~~~Di~slg~~~~~  160 (180)
                      ++|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+..     ...+.++|+||||+++|+
T Consensus       189 ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~e  265 (353)
T PLN00034        189 IVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE  265 (353)
T ss_pred             EeecCCCHHHEEE---cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHH
Confidence            9999999999999   567889999999987654322 2233457889999998743     224568999999999999


Q ss_pred             HHhCCCCCCC
Q 030256          161 LLNGYPPFSA  170 (180)
Q Consensus       161 ~l~g~~pf~~  170 (180)
                      +++|+.||..
T Consensus       266 l~~g~~pf~~  275 (353)
T PLN00034        266 FYLGRFPFGV  275 (353)
T ss_pred             HHhCCCCCCC
Confidence            9999999974

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.6e-32  Score=196.10  Aligned_cols=160  Identities=31%  Similarity=0.603  Sum_probs=138.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|++++++++|+||+++++++.+.  ..+++++||+++++|.+++.....+++..+..++.|++.++++||+.+
T Consensus        47 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (265)
T cd06652          47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM  126 (265)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345788899999999999999999988753  578899999999999999987778899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC----cccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|+||+|+||++   +.++.++|+|||.+.......    ......++..|+|||...+..++.++|+||||+++|+++
T Consensus       127 i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  203 (265)
T cd06652         127 IVHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML  203 (265)
T ss_pred             EecCCCCHHHEEe---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence            9999999999999   467789999999886543211    112234677899999998888899999999999999999


Q ss_pred             hCCCCCCCC
Q 030256          163 NGYPPFSAY  171 (180)
Q Consensus       163 ~g~~pf~~~  171 (180)
                      +|+.||...
T Consensus       204 ~g~~p~~~~  212 (265)
T cd06652         204 TEKPPWAEF  212 (265)
T ss_pred             hCCCCCCcc
Confidence            999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.3e-32  Score=197.40  Aligned_cols=158  Identities=34%  Similarity=0.580  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+++.+|++++++++||||+++++++...+..++++||+++++|..+    ..+++..+..++.|++.++.+||+.|
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~  115 (279)
T cd06619          40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK  115 (279)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34556788999999999999999999999999999999999999999654    35788899999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       116 i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~  191 (279)
T cd06619         116 ILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF  191 (279)
T ss_pred             EeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc-ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence            9999999999999   567889999999987654332 223457888999999988889999999999999999999999


Q ss_pred             CCCCCC
Q 030256          167 PFSAYR  172 (180)
Q Consensus       167 pf~~~~  172 (180)
                      ||....
T Consensus       192 pf~~~~  197 (279)
T cd06619         192 PYPQIQ  197 (279)
T ss_pred             Cchhhc
Confidence            997543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.4e-32  Score=196.71  Aligned_cols=161  Identities=30%  Similarity=0.544  Sum_probs=139.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ...+++|+.++++++|||++++++++...+..++++||+++++|.+++....++++..+..++.|++.++.+||+.|++|
T Consensus        50 ~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  129 (267)
T cd06646          50 FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH  129 (267)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            44678899999999999999999999999999999999999999999887788999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccc---cccCCcchhHHHHHHHHHHHHhCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|++|+||++   +.++.++|+|||++........ .....++..|+|||.+.   ...++.++|+||+|++++++++|+
T Consensus       130 ~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~  206 (267)
T cd06646         130 RDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             cCCCHHHEEE---CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCC
Confidence            9999999999   4667799999999876543221 22334677899999874   344788999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...++
T Consensus       207 ~p~~~~~~  214 (267)
T cd06646         207 PPMFDLHP  214 (267)
T ss_pred             CCccccch
Confidence            99965543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.1e-32  Score=195.81  Aligned_cols=160  Identities=21%  Similarity=0.359  Sum_probs=136.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+.+|+.++++++||||+++++++.. +..++++||+++++|.+++.... .++...+..++.|++.++++||++|++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  123 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV  123 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            5678899999999999999999999887 77899999999999999998766 689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCC----CCceEEEeecCCccccCCCCcccccccCccccCccccccc--cCCcchhHHHHHHHHHHHH
Q 030256           89 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        89 h~dl~~~nil~~~~~----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~--~~~~~~Di~slg~~~~~~l  162 (180)
                      |+||+|+||++....    ....++++|||.+.....   .....+...|+|||.+.+.  .++.++|+||+|+++|+++
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~  200 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC  200 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence            999999999995321    112699999999876543   1123356679999998776  6899999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030256          163 N-GYPPFSAYRP  173 (180)
Q Consensus       163 ~-g~~pf~~~~~  173 (180)
                      + |..||...++
T Consensus       201 ~~~~~p~~~~~~  212 (259)
T cd05037         201 SNGEEPLSTLSS  212 (259)
T ss_pred             hCCCCCcccCCc
Confidence            9 6888877653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-32  Score=198.12  Aligned_cols=162  Identities=30%  Similarity=0.538  Sum_probs=140.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++|+|++++++++...+..++++||+++++|..+......+++..+..++.|++.++++||+.|++
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~  122 (286)
T cd07847          43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI  122 (286)
T ss_pred             ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            34567889999999999999999999999999999999999988888777666799999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      |+||+|+||++   +.++.++|+|||++....... ......++..|+|||...+ ..++.++|+||+|++++++++|..
T Consensus       123 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~  199 (286)
T cd07847         123 HRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP  199 (286)
T ss_pred             ecCCChhhEEE---cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence            99999999999   466789999999987664433 1223346678999998865 457889999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.++
T Consensus       200 p~~~~~~  206 (286)
T cd07847         200 LWPGKSD  206 (286)
T ss_pred             CCCCCCh
Confidence            9987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-31  Score=199.00  Aligned_cols=163  Identities=33%  Similarity=0.609  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+++++.++||||+++++.+..++..+++|||++|++|.+++...+.+++..+..++.|++.++++||+.|++
T Consensus        44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  123 (305)
T cd05609          44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIV  123 (305)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34567789999999999999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC----------------cccccccCccccCccccccccCCcchhHH
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMW  152 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~  152 (180)
                      |+||+|+||++   +..+.++++|||.+.......                ......++..|+|||.+.+..++.++|+|
T Consensus       124 H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  200 (305)
T cd05609         124 HRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW  200 (305)
T ss_pred             ccCCchHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHH
Confidence            99999999999   467789999999875311100                00112356679999999888899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCcc
Q 030256          153 SVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       153 slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      |+|+++|++++|..||.+.++.
T Consensus       201 slG~vl~el~~g~~pf~~~~~~  222 (305)
T cd05609         201 AMGIILYEFLVGCVPFFGDTPE  222 (305)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999876543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4e-32  Score=205.04  Aligned_cols=159  Identities=35%  Similarity=0.503  Sum_probs=136.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.+|+.+++.++||||+++++++...      ...+++|||+++ ++...+.  ..++...+..++.|++.||++
T Consensus        58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~  134 (355)
T cd07874          58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKH  134 (355)
T ss_pred             HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHH
Confidence            3456677899999999999999999987543      357999999954 7766664  358889999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ||+.|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus       135 LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el  211 (355)
T cd07874         135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM  211 (355)
T ss_pred             HHhCCcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence            999999999999999999   56778999999999776554444445678899999999988899999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|+.||.+.+
T Consensus       212 ~~g~~pf~~~~  222 (355)
T cd07874         212 VRHKILFPGRD  222 (355)
T ss_pred             HhCCCCCCCCC
Confidence            99999998765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-32  Score=194.96  Aligned_cols=162  Identities=26%  Similarity=0.489  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|++++++++|+|++++.+++...+..++++|++++++|.+++....  .++...+..++.|++.++.+||+.|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  124 (261)
T cd05068          45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY  124 (261)
T ss_pred             HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4568889999999999999999999999999999999999999999987554  68999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccc--cccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.++.++|+|||++...........  ......|+|||...+..++.++|+||||++++++++ |
T Consensus       125 ~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g  201 (261)
T cd05068         125 IHRDLAARNVLV---GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG  201 (261)
T ss_pred             eeccCCcceEEE---cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcC
Confidence            999999999999   4677899999999876653322111  112346999999988889999999999999999999 9


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      +.||.+.++.
T Consensus       202 ~~p~~~~~~~  211 (261)
T cd05068         202 RMPYPGMTNA  211 (261)
T ss_pred             CCCCCCCCHH
Confidence            9999876543

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=211.85  Aligned_cols=165  Identities=30%  Similarity=0.527  Sum_probs=142.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .++.-+.|+.|+..|++-+|.||+-+.|++...+. .||..||+|-+|..++.-.. +|+..+.+.|++|+++++.|||.
T Consensus       428 t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA  506 (678)
T KOG0193|consen  428 TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA  506 (678)
T ss_pred             CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh
Confidence            56678889999999999999999999999998887 99999999999999986443 58999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccC---CCCcccccccCccccCccccccc---cCCcchhHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAIL  158 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~~~~~ape~~~~~---~~~~~~Di~slg~~~  158 (180)
                      ++|+|+|||..||++   .++..|+|+|||++....   .........+...|+|||+.+.+   +++..+||||+|+|.
T Consensus       507 K~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~  583 (678)
T KOG0193|consen  507 KNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW  583 (678)
T ss_pred             hhhhhhhccccceEE---ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence            999999999999999   567899999999985432   22333344577789999998744   489999999999999


Q ss_pred             HHHHhCCCCCCCCCcc
Q 030256          159 FELLNGYPPFSAYRPC  174 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~~  174 (180)
                      |||++|..||...+++
T Consensus       584 YELltg~lPysi~~~d  599 (678)
T KOG0193|consen  584 YELLTGELPYSIQNRD  599 (678)
T ss_pred             HHHHhCcCCcCCCChh
Confidence            9999999999955544

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.6e-32  Score=200.88  Aligned_cols=163  Identities=29%  Similarity=0.529  Sum_probs=133.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG   78 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~   78 (180)
                      ...+.+|++++++++||||+++++++..  +...++++||+ +++|.+++...         ..+++..+..++.|++.|
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07868          42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence            3457789999999999999999998854  45789999998 55888876532         248899999999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecC-CCCceEEEeecCCccccCCCC----cccccccCccccCccccccc-cCCcchhHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW  152 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~-~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~-~~~~~~Di~  152 (180)
                      +++||+.|++|+||+|+||++... +..+.++|+|||++.......    ......++..|+|||.+.+. .++.++|+|
T Consensus       121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07868         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence            999999999999999999999532 345679999999987654322    12234578889999998764 578999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCc
Q 030256          153 SVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       153 slg~~~~~~l~g~~pf~~~~~  173 (180)
                      |+|++++++++|+.||.....
T Consensus       201 slG~il~el~~g~~~f~~~~~  221 (317)
T cd07868         201 AIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             HHHHHHHHHHhCCCCccCCcc
Confidence            999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.7e-32  Score=195.34  Aligned_cols=161  Identities=27%  Similarity=0.552  Sum_probs=139.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|+.++++++||||+++++++...+..+++|||+.+++|.+++.... .+++..+..++.|++.++++||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05113          43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI  122 (256)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4568889999999999999999999998889999999999999999987643 689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      |+||+|+||++   +.++.++|+|||.+..........  ...++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus       123 H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~  199 (256)
T cd05113         123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK  199 (256)
T ss_pred             ccccCcceEEE---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence            99999999999   467789999999886554332211  1224467999999988889999999999999999998 99


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...++
T Consensus       200 ~p~~~~~~  207 (256)
T cd05113         200 MPYERFNN  207 (256)
T ss_pred             CCcCcCCH
Confidence            99976554

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.1e-32  Score=198.44  Aligned_cols=162  Identities=32%  Similarity=0.597  Sum_probs=141.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|++++++++|+||+++++++..++..++++||+++++|.+++. ..++++..+..++.+++.++.+||+.|+
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i  122 (277)
T cd06642          44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERK  122 (277)
T ss_pred             HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            345678999999999999999999999999999999999999999999876 4578999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-cccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++.   .++.++++|||++......... ....++..|+|||...+..++.++|+||+|++++++++|+.
T Consensus       123 vH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~  199 (277)
T cd06642         123 IHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             eccCCChheEEEe---CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCC
Confidence            9999999999994   5678999999998665433221 22346778999999988889999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+..+
T Consensus       200 p~~~~~~  206 (277)
T cd06642         200 PNSDLHP  206 (277)
T ss_pred             CCcccch
Confidence            9976543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1e-31  Score=200.76  Aligned_cols=161  Identities=29%  Similarity=0.428  Sum_probs=135.3

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+++|+++++.++||||+++++++..++..++++||+++++|.+++...  ..+++..+..++.|++.+|+|||+.
T Consensus        41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  120 (327)
T cd08227          41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM  120 (327)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            44567888999999999999999999999999999999999999999998653  3589999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--------cccccccCccccCcccccc--ccCCcchhHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVG  155 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~--~~~~~~~Di~slg  155 (180)
                      |++|+||+|+||++   +.++.+++.||+.........        ......++..|+|||.+.+  ..++.++|+||+|
T Consensus       121 ~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG  197 (327)
T cd08227         121 GYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG  197 (327)
T ss_pred             CEecCCCChhhEEE---ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHH
Confidence            99999999999999   466778999987543332111        1112235567999999875  4588999999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 030256          156 AILFELLNGYPPFSAY  171 (180)
Q Consensus       156 ~~~~~~l~g~~pf~~~  171 (180)
                      +++|++++|..||...
T Consensus       198 ~il~el~~g~~pf~~~  213 (327)
T cd08227         198 ITACELANGHVPFKDM  213 (327)
T ss_pred             HHHHHHHHCCCCCCCc
Confidence            9999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-31  Score=196.72  Aligned_cols=160  Identities=30%  Similarity=0.472  Sum_probs=136.2

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+|++++++++||||+++.+++..  ....+++|||+++++|.+++.. ..+++..+..++.|++.++++||++|
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~  127 (283)
T cd05080          49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQH  127 (283)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678889999999999999999998765  3468999999999999998874 46999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|+||+|+||++   +.+..++|+|||++........    .....++..|+|||...+..++.++|+||||+++++++
T Consensus       128 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~  204 (283)
T cd05080         128 YIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL  204 (283)
T ss_pred             eeccccChheEEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence            9999999999999   4667899999999876543221    11122445689999998888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|..||....
T Consensus       205 tg~~p~~~~~  214 (283)
T cd05080         205 THCDSKQSPP  214 (283)
T ss_pred             hCCCCCCCCc
Confidence            9999987644

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-31  Score=194.28  Aligned_cols=161  Identities=29%  Similarity=0.517  Sum_probs=138.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|++++++++|+|++++++++.. +..++++||+++++|.+++.....+++..+..++.|++.++++||+.+++
T Consensus        39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~  117 (257)
T cd05060          39 GKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV  117 (257)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            45678889999999999999999998764 46899999999999999998777899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc----ccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      |+||+|+||++   +.++.++|+|||.+..........    ...++..|+|||...+..++.++|+||||+++|++++ 
T Consensus       118 H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~  194 (257)
T cd05060         118 HRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY  194 (257)
T ss_pred             ccCcccceEEE---cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcC
Confidence            99999999999   467789999999987654332211    1112356999999988889999999999999999998 


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||...++
T Consensus       195 g~~p~~~~~~  204 (257)
T cd05060         195 GAKPYGEMKG  204 (257)
T ss_pred             CCCCcccCCH
Confidence            9999977654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.2e-31  Score=194.98  Aligned_cols=162  Identities=32%  Similarity=0.633  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+|+.++++++||||+++.+++..  .+.+++++|++++++|.+++.....+++..+..++.|++.++++||+.+
T Consensus        47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~  126 (266)
T cd06651          47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM  126 (266)
T ss_pred             HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            44568889999999999999999998875  3678999999999999999987778999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC----cccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|+||+|+||++   +.+..++|+|||++.......    ......++..|+|||...+..++.++|+||+|+++|+++
T Consensus       127 i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~  203 (266)
T cd06651         127 IVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML  203 (266)
T ss_pred             eeeCCCCHHHEEE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence            9999999999999   567789999999886543211    112234677899999998888999999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|+.||.+.++
T Consensus       204 ~g~~pf~~~~~  214 (266)
T cd06651         204 TEKPPWAEYEA  214 (266)
T ss_pred             HCCCCccccch
Confidence            99999986543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-31  Score=195.48  Aligned_cols=162  Identities=31%  Similarity=0.599  Sum_probs=141.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|+.++++++|+|++++++++.+++..++++||+++++|.+++. ..++++..+..++.|++.+++++|+.++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i  122 (277)
T cd06640          44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK  122 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            345678889999999999999999999999999999999999999999887 4578999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|+++|++++|..
T Consensus       123 vH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~  199 (277)
T cd06640         123 IHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             cCcCCChhhEEE---cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence            999999999999   4677899999999866543322 122346778999999988889999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||...++
T Consensus       200 p~~~~~~  206 (277)
T cd06640         200 PNSDMHP  206 (277)
T ss_pred             CCCCcCh
Confidence            9986553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-31  Score=194.85  Aligned_cols=164  Identities=31%  Similarity=0.607  Sum_probs=141.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .....++.+|+.+++.++|+|++++++++..++..++++|++++++|.+++..    ...+++..+..++.+++.++++|
T Consensus        43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L  122 (267)
T cd08229          43 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM  122 (267)
T ss_pred             HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            34556788999999999999999999999999999999999999999998863    34589999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|++|+||+|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|+++|++
T Consensus       123 H~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l  199 (267)
T cd08229         123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM  199 (267)
T ss_pred             HHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence            99999999999999999   4667899999998766543322 1233477889999999888899999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|..||.+...
T Consensus       200 ~~g~~p~~~~~~  211 (267)
T cd08229         200 AALQSPFYGDKM  211 (267)
T ss_pred             HhCCCCcccccc
Confidence            999999975443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-32  Score=209.85  Aligned_cols=165  Identities=40%  Similarity=0.748  Sum_probs=152.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+-+|+++++.++|||||+++.+.+....+|+||||..+|.+.+++.+++...+..+...+.|+..+++|+|+++
T Consensus        96 ~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~  175 (596)
T KOG0586|consen   96 PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN  175 (596)
T ss_pred             hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc
Confidence            34455678999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||++.|+++   +.+..++|+|||++..+.......+..|++.|.|||++.+.++ ++..|+||+|+++|.++.|.
T Consensus       176 ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~Gs  252 (596)
T KOG0586|consen  176 IVHRDLKAENILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGS  252 (596)
T ss_pred             eeccccchhhccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecc
Confidence            9999999999999   5777799999999988887777888899999999999998875 67899999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      +||++.+=.
T Consensus       253 LPFDG~~lk  261 (596)
T KOG0586|consen  253 LPFDGQNLK  261 (596)
T ss_pred             cccCCcccc
Confidence            999976543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.8e-32  Score=219.94  Aligned_cols=167  Identities=36%  Similarity=0.650  Sum_probs=139.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l   79 (180)
                      .......+.+|+.++++++||||+++++++.+  ...+++||||+++++|.+++...    ..+++..++.++.||+.+|
T Consensus        52 ~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~AL  131 (1021)
T PTZ00266         52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL  131 (1021)
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence            34456778899999999999999999998854  45799999999999999988642    4699999999999999999


Q ss_pred             HHHHhC-------CCeeecCCCCCeeeecC--------------CCCceEEEeecCCccccCCCCcccccccCccccCcc
Q 030256           80 EILNSH-------HIIHRDLKPENILLSGL--------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE  138 (180)
Q Consensus        80 ~~lh~~-------~~~h~dl~~~nil~~~~--------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape  138 (180)
                      +|||+.       +++|+||+|+||++...              +....++|+|||++.............+++.|+|||
T Consensus       132 aYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPE  211 (1021)
T PTZ00266        132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPE  211 (1021)
T ss_pred             HHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHH
Confidence            999985       49999999999999531              123458999999987665444334456889999999


Q ss_pred             cccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          139 VLQF--QRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       139 ~~~~--~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      .+.+  ..++.++||||||+++|+|++|..||...+
T Consensus       212 vL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        212 LLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             HHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence            8854  347889999999999999999999997644

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-31  Score=195.90  Aligned_cols=162  Identities=23%  Similarity=0.453  Sum_probs=137.2

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGAG   78 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~   78 (180)
                      ...++.+|+.+++.++|+||+++++++...+..++++||+++++|.+++....          .++...+..++.|++.+
T Consensus        52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  131 (277)
T cd05062          52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG  131 (277)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence            45568889999999999999999999998899999999999999999986532          25678899999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  155 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg  155 (180)
                      +++||+.|++|+||+|+||++   +.+..++|+|||++.........   ....++..|+|||...+..++.++|+||||
T Consensus       132 l~~lH~~~~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  208 (277)
T cd05062         132 MAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG  208 (277)
T ss_pred             HHHHHHCCcccCCcchheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHH
Confidence            999999999999999999999   46778999999988655332211   112235679999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCc
Q 030256          156 AILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       156 ~~~~~~l~-g~~pf~~~~~  173 (180)
                      +++|++++ |..||...++
T Consensus       209 ~~l~el~~~~~~p~~~~~~  227 (277)
T cd05062         209 VVLWEIATLAEQPYQGMSN  227 (277)
T ss_pred             HHHHHHHcCCCCCCCCCCH
Confidence            99999999 7899976554

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-31  Score=196.19  Aligned_cols=162  Identities=27%  Similarity=0.586  Sum_probs=138.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------------GRVPEQTARKF   71 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~~   71 (180)
                      ....+.+|++++++++||||+++++++...+..+++|||+++++|.+++...                 ..+++..+..+
T Consensus        50 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  129 (283)
T cd05090          50 QWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI  129 (283)
T ss_pred             HHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHH
Confidence            3457889999999999999999999999999999999999999999988532                 23778889999


Q ss_pred             HHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcc
Q 030256           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  148 (180)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~  148 (180)
                      +.|++.++++||++|++|+||+|+||++   +.+..++|+|||++........   .....++..|+|||.+.+..++.+
T Consensus       130 ~~~i~~al~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05090         130 AIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD  206 (283)
T ss_pred             HHHHHHHHHHHHhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCch
Confidence            9999999999999999999999999999   4667799999999876543221   122234566999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          149 VDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       149 ~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +|+||||+++|++++ |..||.+.++
T Consensus       207 ~Dv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05090         207 SDIWSFGVVLWEIFSFGLQPYYGFSN  232 (283)
T ss_pred             hhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-31  Score=194.29  Aligned_cols=161  Identities=27%  Similarity=0.516  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|++++++++|+|++++++++..++.++++|||+++++|.+++....  .++...++.++.|++.++++||++|+
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i  125 (263)
T cd05052          46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF  125 (263)
T ss_pred             HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            3567889999999999999999999999999999999999999999987543  58899999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.++.++|+|||.+..........  ....+..|+|||...+..++.++|+||||+++|++++ |
T Consensus       126 ~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g  202 (263)
T cd05052         126 IHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG  202 (263)
T ss_pred             eecccCcceEEE---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence            999999999999   467789999999987654432211  1223457999999988889999999999999999998 9


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||++.+.
T Consensus       203 ~~p~~~~~~  211 (263)
T cd05052         203 MSPYPGIDL  211 (263)
T ss_pred             CCCCCCCCH
Confidence            999976544

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-31  Score=193.93  Aligned_cols=162  Identities=27%  Similarity=0.559  Sum_probs=138.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|++++++++|+||+++++++...+..++++|++++++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  122 (256)
T cd05059          43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            346778999999999999999999999999999999999999999998754 4689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      |+||+|+||++   +.++.++++|||.+..........  ....+..|+|||...+..++.++|+||+|+++|++++ |.
T Consensus       123 H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~  199 (256)
T cd05059         123 HRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK  199 (256)
T ss_pred             cccccHhhEEE---CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence            99999999999   467789999999886654322111  1113346999999988889999999999999999999 89


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||...++.
T Consensus       200 ~p~~~~~~~  208 (256)
T cd05059         200 MPYERFSNS  208 (256)
T ss_pred             CCCCCCCHH
Confidence            999765543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.4e-32  Score=194.70  Aligned_cols=164  Identities=38%  Similarity=0.670  Sum_probs=143.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|++++++++|+|++++.+.+...+..++++|++++++|.+++...+.+++..+..++.|++.++++||+.|+
T Consensus        35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i  114 (265)
T cd05579          35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI  114 (265)
T ss_pred             hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence            45667889999999999999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---------cccccccCccccCccccccccCCcchhHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~  158 (180)
                      +|+||+|+||++   +.++.++|+|||++.......         ......++..|++||...+...+.++|+||+|+++
T Consensus       115 ~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~  191 (265)
T cd05579         115 IHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL  191 (265)
T ss_pred             ecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence            999999999999   567789999999876543321         11223466789999999888889999999999999


Q ss_pred             HHHHhCCCCCCCCCcc
Q 030256          159 FELLNGYPPFSAYRPC  174 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~~  174 (180)
                      +++++|..||...++.
T Consensus       192 ~~l~~g~~p~~~~~~~  207 (265)
T cd05579         192 YEFLVGIPPFHGETPE  207 (265)
T ss_pred             HHHHhCCCCCCCCCHH
Confidence            9999999999866543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-31  Score=194.71  Aligned_cols=164  Identities=31%  Similarity=0.620  Sum_probs=140.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      +.+....+.+|+++++.++|||++++++++.+.+..++++||+++++|.+++..    ...+++..+..++.|++.++++
T Consensus        42 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  121 (267)
T cd08228          42 DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH  121 (267)
T ss_pred             CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            345566788899999999999999999999999999999999999999988753    2348899999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      ||++|++|+||+|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|+++|+
T Consensus       122 LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~e  198 (267)
T cd08228         122 MHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE  198 (267)
T ss_pred             HhhCCeeCCCCCHHHEEE---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHH
Confidence            999999999999999999   4567799999998766543221 122346778999999988889999999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030256          161 LLNGYPPFSAYR  172 (180)
Q Consensus       161 ~l~g~~pf~~~~  172 (180)
                      +++|+.||....
T Consensus       199 l~~g~~p~~~~~  210 (267)
T cd08228         199 MAALQSPFYGDK  210 (267)
T ss_pred             HhcCCCCCcccc
Confidence            999999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-31  Score=195.49  Aligned_cols=163  Identities=37%  Similarity=0.600  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|+++++.++|+|++++++++...+..++++||+++++|..++.. ..++++..+..++.|++.++++||+.|
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  123 (282)
T cd06643          44 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK  123 (282)
T ss_pred             HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3455678899999999999999999999999999999999999999887754 456999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccc-----cccCCcchhHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~~  160 (180)
                      ++|+||+|+||++   +.++.++++|||++....... ......++..|+|||.+.     +..++.++|+||+|+++|+
T Consensus       124 i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~e  200 (282)
T cd06643         124 IIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE  200 (282)
T ss_pred             eeecCCCcccEEE---ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHH
Confidence            9999999999999   467789999999886543321 122334778899999873     3457789999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030256          161 LLNGYPPFSAYRP  173 (180)
Q Consensus       161 ~l~g~~pf~~~~~  173 (180)
                      +++|+.||.+.++
T Consensus       201 l~~g~~p~~~~~~  213 (282)
T cd06643         201 MAQIEPPHHELNP  213 (282)
T ss_pred             HccCCCCccccCH
Confidence            9999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-31  Score=197.74  Aligned_cols=162  Identities=30%  Similarity=0.520  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+.+|+.+++++ +|+||+++++++...+..++++||+.+++|.+++....  .+++.++..++.+++.++++||+
T Consensus        80 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~  159 (302)
T cd05055          80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS  159 (302)
T ss_pred             HHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3456788999999999 79999999999999999999999999999999987543  38999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      .+++|+||+|+||++   +.+..++++|||.+........   .....++..|+|||.+.+..++.++|+||+|+++|++
T Consensus       160 ~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el  236 (302)
T cd05055         160 KNCIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI  236 (302)
T ss_pred             CCeehhhhccceEEE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHH
Confidence            999999999999999   4677899999999876543321   1122345679999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCC
Q 030256          162 LN-GYPPFSAYR  172 (180)
Q Consensus       162 l~-g~~pf~~~~  172 (180)
                      ++ |..||.+..
T Consensus       237 ~t~g~~p~~~~~  248 (302)
T cd05055         237 FSLGSNPYPGMP  248 (302)
T ss_pred             HhCCCCCcCCCC
Confidence            98 999997654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.7e-32  Score=194.15  Aligned_cols=163  Identities=32%  Similarity=0.605  Sum_probs=141.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+.+|..++++++|+|++++.+.+.+++..++++||+++++|.+++...  ..+++..+..++.|++.++++||++
T Consensus        40 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~  119 (255)
T cd08219          40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK  119 (255)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            34567888999999999999999999999999999999999999999988643  3589999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      |++|+||+|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|
T Consensus       120 ~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g  196 (255)
T cd08219         120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL  196 (255)
T ss_pred             CcccCCCCcceEEE---CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc
Confidence            99999999999999   4677899999998866543221 2234477789999999888899999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||.+.+.
T Consensus       197 ~~p~~~~~~  205 (255)
T cd08219         197 KHPFQANSW  205 (255)
T ss_pred             cCCCCCCCH
Confidence            999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-31  Score=198.10  Aligned_cols=161  Identities=32%  Similarity=0.634  Sum_probs=141.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.+++.++|+|++++++++...+..++++||+++++|..++. ...+++..+..++.+++.++++||+.|++
T Consensus        59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~i~  137 (296)
T cd06655          59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHANQVI  137 (296)
T ss_pred             hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35667889999999999999999999999999999999999999999886 44689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++........ .....++..|+|||...+..++.++|+||+|+++|++++|..|
T Consensus       138 H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~p  214 (296)
T cd06655         138 HRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP  214 (296)
T ss_pred             cCCCCHHHEEE---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   4677899999998766543322 2233467789999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       215 f~~~~~  220 (296)
T cd06655         215 YLNENP  220 (296)
T ss_pred             CCCCCH
Confidence            987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.2e-32  Score=198.74  Aligned_cols=163  Identities=28%  Similarity=0.598  Sum_probs=141.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+.+|+..+++++|+|++++++.+..++..++++||+++++|.+++. ...+++..+..++.|++.++++||+.|
T Consensus        60 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~  138 (292)
T cd06658          60 QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQG  138 (292)
T ss_pred             HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3445668899999999999999999999999999999999999999999875 457899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||++........ .....++..|+|||...+..++.++|+||+|++++++++|.
T Consensus       139 ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~  215 (292)
T cd06658         139 VIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE  215 (292)
T ss_pred             EeecCCCHHHEEE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999   4667899999998865433221 22345778899999998888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...++
T Consensus       216 ~p~~~~~~  223 (292)
T cd06658         216 PPYFNEPP  223 (292)
T ss_pred             CCCCCCCH
Confidence            99986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-31  Score=193.33  Aligned_cols=162  Identities=28%  Similarity=0.468  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+.+|++.+++++|+||+++++.+.+ ...++++|++++++|.+++....  .+++..+..++.|++.++++||+.
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  116 (257)
T cd05040          38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK  116 (257)
T ss_pred             HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence            456778899999999999999999999888 88999999999999999987654  589999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+||+|+||++   +.++.++|+|||.+........    .....++..|+|||...+..++.++|+||+|+++++|
T Consensus       117 ~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el  193 (257)
T cd05040         117 RFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM  193 (257)
T ss_pred             CccccccCcccEEE---ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHH
Confidence            99999999999999   4568899999999876644221    1123355679999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030256          162 LN-GYPPFSAYRP  173 (180)
Q Consensus       162 l~-g~~pf~~~~~  173 (180)
                      ++ |..||...+.
T Consensus       194 ~t~g~~p~~~~~~  206 (257)
T cd05040         194 FTYGEEPWAGLSG  206 (257)
T ss_pred             HhCCCCCCCCCCH
Confidence            99 9999975543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.98  E-value=1.5e-31  Score=194.68  Aligned_cols=164  Identities=26%  Similarity=0.510  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ......+..|+.++++++||||+++.+++..++..++++||+++++|.+++... +.++...+..++.|++.++++||+.
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~  125 (269)
T cd05065          46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM  125 (269)
T ss_pred             HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            445677899999999999999999999999999999999999999999998754 4589999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccccc---c---cCccccCccccccccCCcchhHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---C---GSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~---~---~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      |++|+||+|+||++   +.+..++++|||.+............   .   .+..|+|||...+..++.++|+||+|+++|
T Consensus       126 g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~  202 (269)
T cd05065         126 NYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW  202 (269)
T ss_pred             CEeecccChheEEE---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHH
Confidence            99999999999999   56778999999987655332211111   1   134699999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCc
Q 030256          160 ELLN-GYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~-g~~pf~~~~~  173 (180)
                      |+++ |..||.+.+.
T Consensus       203 e~l~~g~~p~~~~~~  217 (269)
T cd05065         203 EVMSYGERPYWDMSN  217 (269)
T ss_pred             HHhcCCCCCCCCCCH
Confidence            9887 9999976543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=2.4e-31  Score=194.29  Aligned_cols=163  Identities=26%  Similarity=0.404  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...++.+|+.++++++||||+++++++..++..++||||+++++|..++.. .+.+++..+..++.|++.+++|||+.|+
T Consensus        59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  138 (274)
T cd05076          59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNL  138 (274)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCc
Confidence            445677899999999999999999999999999999999999999998865 4568999999999999999999999999


Q ss_pred             eeecCCCCCeeeecC----CCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHH-
Q 030256           88 IHRDLKPENILLSGL----DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL-  161 (180)
Q Consensus        88 ~h~dl~~~nil~~~~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~-  161 (180)
                      +|+||+|+||++...    .....++++|||.+......   ....++..|+|||.+.+ ..++.++|+||||+++|++ 
T Consensus       139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~  215 (274)
T cd05076         139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC  215 (274)
T ss_pred             cCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999531    12234899999987543222   12235677999998865 5578999999999999998 


Q ss_pred             HhCCCCCCCCCcc
Q 030256          162 LNGYPPFSAYRPC  174 (180)
Q Consensus       162 l~g~~pf~~~~~~  174 (180)
                      ++|..||.+..+.
T Consensus       216 ~~g~~p~~~~~~~  228 (274)
T cd05076         216 FDGEVPLKERTPS  228 (274)
T ss_pred             hCCCCCccccChH
Confidence            4799999876554

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.98  E-value=1.4e-31  Score=194.73  Aligned_cols=163  Identities=26%  Similarity=0.500  Sum_probs=134.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .....+.+|+..++.++|+||+++++.+...+..+++|||+++++|.+++.....     .++..+..++.|++.++++|
T Consensus        37 ~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  116 (269)
T cd05042          37 DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL  116 (269)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH
Confidence            3455678899999999999999999999999999999999999999999875432     46778899999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcccccc-------ccCCcchhHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-------QRYDEKVDMW  152 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~-------~~~~~~~Di~  152 (180)
                      |++|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||....       ..++.++|+|
T Consensus       117 H~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw  193 (269)
T cd05042         117 HQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIW  193 (269)
T ss_pred             HhcCEecccccHhheEe---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHH
Confidence            99999999999999999   5677899999998865432211   112234566999998642       3467899999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCc
Q 030256          153 SVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       153 slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+|+++|++++ |..||...++
T Consensus       194 slG~~l~el~~~~~~p~~~~~~  215 (269)
T cd05042         194 SLGVTMWELFTAADQPYPDLSD  215 (269)
T ss_pred             HHHHHHHHHHhCCCCCCCcCCH
Confidence            99999999999 8889976543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.1e-31  Score=193.43  Aligned_cols=162  Identities=30%  Similarity=0.613  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +....+++|++++++++|+||+++++++.+.  +.+++++|++++++|.+++.....+++..+..++.|++.++.+||+.
T Consensus        46 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~  125 (264)
T cd06653          46 KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN  125 (264)
T ss_pred             HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456788999999999999999999998754  56889999999999999998777899999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC----CcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+||+|+||++   +.++.++|+|||.+......    .......++..|+|||...+..++.++|+||+|++++++
T Consensus       126 ~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  202 (264)
T cd06653         126 MIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM  202 (264)
T ss_pred             CEecCCCCHHHEEE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHH
Confidence            99999999999999   46678999999998765321    111223467889999999888889999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|+.||.+..
T Consensus       203 ~~g~~p~~~~~  213 (264)
T cd06653         203 LTEKPPWAEYE  213 (264)
T ss_pred             HhCCCCCCccC
Confidence            99999997643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.98  E-value=1.1e-31  Score=199.02  Aligned_cols=159  Identities=31%  Similarity=0.538  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ..+.+|++++++++|+||+++++++..++..+++|||+++ +|.+++...+ .++...+..++.|++.++++||++|++|
T Consensus        49 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH  127 (309)
T cd07872          49 CTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH  127 (309)
T ss_pred             hhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            4567899999999999999999999999999999999964 8888776544 4889999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||+|+||++   +..+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.|
T Consensus       128 ~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~p  204 (309)
T cd07872         128 RDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL  204 (309)
T ss_pred             CCCCHHHEEE---CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999   567789999999986543322 2223446788999998764 4578999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.+.
T Consensus       205 f~~~~~  210 (309)
T cd07872         205 FPGSTV  210 (309)
T ss_pred             CCCCCh
Confidence            987654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2e-33  Score=207.13  Aligned_cols=164  Identities=32%  Similarity=0.600  Sum_probs=148.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+++|+.+|.+++++||.++++.+..+..++++|||+.||++.+.++..+.+++..+..++.+++.++.|+|.++.
T Consensus        53 deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~k  132 (467)
T KOG0201|consen   53 DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKK  132 (467)
T ss_pred             hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcce
Confidence            34567889999999999999999999999999999999999999999999877777999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||++.||++.   ..+.++++|||++..+..... ..+..||+.|||||+.....|+.++||||||++++||.+|.+
T Consensus       133 iHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GeP  209 (467)
T KOG0201|consen  133 IHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEP  209 (467)
T ss_pred             ecccccccceeEe---ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCC
Confidence            9999999999995   558999999999977655432 256779999999999998899999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+..|-
T Consensus       210 P~s~~hPm  217 (467)
T KOG0201|consen  210 PHSKLHPM  217 (467)
T ss_pred             CCcccCcc
Confidence            99887763

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=1.6e-31  Score=193.98  Aligned_cols=163  Identities=21%  Similarity=0.349  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+..|+.++++++||||+++++++..+...++++||+++++|..++... .++++..+..++.|++.+++|||+.|
T Consensus        46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  125 (262)
T cd05077          46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD  125 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence            34456788899999999999999999999888999999999999999888654 46899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCC----CCceEEEeecCCccccCCCCcccccccCccccCccccc-cccCCcchhHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~-~~~~~~~~Di~slg~~~~~~  161 (180)
                      ++|+||+|+||++....    ....++++|||.+......   ....++..|+|||... +..++.++|+||+|+++|++
T Consensus       126 ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el  202 (262)
T cd05077         126 LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI  202 (262)
T ss_pred             eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHH
Confidence            99999999999995311    1123899999987554322   1233667899999876 45688999999999999999


Q ss_pred             H-hCCCCCCCCCc
Q 030256          162 L-NGYPPFSAYRP  173 (180)
Q Consensus       162 l-~g~~pf~~~~~  173 (180)
                      + +|..||.....
T Consensus       203 ~~~~~~p~~~~~~  215 (262)
T cd05077         203 CYNGEIPLKDKTL  215 (262)
T ss_pred             HhCCCCCCCCcch
Confidence            7 68999876554

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.98  E-value=3.1e-31  Score=195.16  Aligned_cols=164  Identities=34%  Similarity=0.568  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+.+|+.++++++|+|++++.+.+..++..+++|||+++++|..++.+ ...+++..+..++.|++.++++||+.
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~  129 (292)
T cd06644          50 EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM  129 (292)
T ss_pred             HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            34456688899999999999999999999999999999999999999887754 35689999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccc-----cccCCcchhHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~  159 (180)
                      |++|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||...     ...++.++|+||+|+++|
T Consensus       130 ~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~  206 (292)
T cd06644         130 KIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI  206 (292)
T ss_pred             CeeecCCCcceEEE---cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence            99999999999999   467789999999876543221 122344677899999874     334678999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|..||...++
T Consensus       207 el~~g~~p~~~~~~  220 (292)
T cd06644         207 EMAQIEPPHHELNP  220 (292)
T ss_pred             HHhcCCCCCccccH
Confidence            99999999976543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=195.34  Aligned_cols=164  Identities=38%  Similarity=0.615  Sum_probs=139.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+.+|++++++++|+|++++++++..++..+++|||+++++|.+++... ..+++..+..++.|++.++++||+.
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~  122 (280)
T cd06611          43 EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH  122 (280)
T ss_pred             HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            334456888999999999999999999999999999999999999999998764 4699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccc-----cccCCcchhHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~  159 (180)
                      |++|+|++|+||++   +.++.++|+|||.+....... ......++..|+|||...     ...++.++|+||+|+++|
T Consensus       123 ~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~  199 (280)
T cd06611         123 KVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI  199 (280)
T ss_pred             CcccCCCChhhEEE---CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence            99999999999999   567889999999876543322 112334677899999874     334678999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|..||.+.++
T Consensus       200 ~l~~g~~p~~~~~~  213 (280)
T cd06611         200 ELAQMEPPHHELNP  213 (280)
T ss_pred             HHHhCCCCcccCCH
Confidence            99999999987653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.98  E-value=3.5e-31  Score=190.65  Aligned_cols=164  Identities=32%  Similarity=0.565  Sum_probs=139.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +..+..+.+|++++++++||||+++++++...+..+++|||+++++|.+++... ..+++..+..++.+++.++.++|++
T Consensus        33 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  112 (250)
T cd05085          33 QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK  112 (250)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            344557888999999999999999999999999999999999999999988654 4588999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      |++|+||+|+||++   +.++.++|+|||++..........  .......|+|||...+..++.++|+||+|+++|++++
T Consensus       113 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~  189 (250)
T cd05085         113 NCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS  189 (250)
T ss_pred             CeeecccChheEEE---cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence            99999999999999   467789999999886543322111  1223456999999988889999999999999999998


Q ss_pred             -CCCCCCCCCc
Q 030256          164 -GYPPFSAYRP  173 (180)
Q Consensus       164 -g~~pf~~~~~  173 (180)
                       |..||.+.+.
T Consensus       190 ~g~~p~~~~~~  200 (250)
T cd05085         190 LGVCPYPGMTN  200 (250)
T ss_pred             CCCCCCCCCCH
Confidence             9999976544

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=1.7e-31  Score=195.86  Aligned_cols=163  Identities=33%  Similarity=0.552  Sum_probs=143.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~   85 (180)
                      ......+.+|+++++.++||||+++++++...+..++++||+++++|.+++...+.+++..+..++.+++.++.+||+ .
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  123 (284)
T cd06620          44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH  123 (284)
T ss_pred             chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            445677889999999999999999999999999999999999999999999877889999999999999999999997 6


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +++|+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|.
T Consensus       124 ~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~  199 (284)
T cd06620         124 RIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK  199 (284)
T ss_pred             CeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence            89999999999999   467789999999876543222 12345788899999988888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...++
T Consensus       200 ~p~~~~~~  207 (284)
T cd06620         200 FPFAFSNI  207 (284)
T ss_pred             CCCcccch
Confidence            99986554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.9e-31  Score=197.33  Aligned_cols=162  Identities=31%  Similarity=0.536  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+|+++++.++|++|+++++.+.+++..++++||+.+++|.+++...  ..+++..+..++.|++.++++||+.|
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  123 (316)
T cd05574          44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG  123 (316)
T ss_pred             HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4456888999999999999999999999999999999999999999998754  46899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc------------------------------ccccccCccccC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------------------------AEKVCGSPLYMA  136 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~------------------------------~~~~~~~~~~~a  136 (180)
                      ++|+||+|+||++.   .++.++|+|||++........                              .....++..|+|
T Consensus       124 i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a  200 (316)
T cd05574         124 IVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA  200 (316)
T ss_pred             eeccCCChHHeEEc---CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence            99999999999994   567899999998765422111                              011245677999


Q ss_pred             ccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       137 pe~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      ||...+..++.++|+||+|+++|++++|..||.+.+.
T Consensus       201 PE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         201 PEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             HHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            9999888889999999999999999999999976654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.98  E-value=3.3e-31  Score=191.41  Aligned_cols=163  Identities=28%  Similarity=0.606  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+.+|++++++++|+|++++.+.+.. ++..++++|++++++|.+++...  ..+++.++..++.+++.++++||+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~  120 (257)
T cd08223          41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE  120 (257)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            445678889999999999999999998764 45789999999999999988753  358999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      .|++|+||+|+||++   +....++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++++
T Consensus       121 ~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~  197 (257)
T cd08223         121 KHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT  197 (257)
T ss_pred             CCeeccCCCchhEEE---ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc
Confidence            999999999999999   467789999999886654322 2223346788999999998889999999999999999999


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |+.||...+.
T Consensus       198 g~~~~~~~~~  207 (257)
T cd08223         198 LKHAFNAKDM  207 (257)
T ss_pred             CCCCCCCCCH
Confidence            9999986553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.98  E-value=1.5e-31  Score=197.45  Aligned_cols=161  Identities=31%  Similarity=0.611  Sum_probs=141.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.+++.++|+|++++++++..++..++++||+++++|.+++. ...+++..+..++.|++.++.+||+.|++
T Consensus        59 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~i~  137 (297)
T cd06656          59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALDFLHSNQVI  137 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34667889999999999999999999999999999999999999999886 45688999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|+++|++++|..|
T Consensus       138 H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~p  214 (297)
T cd06656         138 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP  214 (297)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999   5677899999998866543322 1234467789999999888889999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       215 f~~~~~  220 (297)
T cd06656         215 YLNENP  220 (297)
T ss_pred             CCCCCc
Confidence            977554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.98  E-value=2.3e-31  Score=195.66  Aligned_cols=162  Identities=31%  Similarity=0.541  Sum_probs=138.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc------------------------CCCCH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GRVPE   65 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~   65 (180)
                      ...+.+|+.++++++||||+++++.+..++..++++||+.+++|.+++...                        .+++.
T Consensus        47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  126 (290)
T cd05045          47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM  126 (290)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCH
Confidence            456888999999999999999999999999999999999999999987642                        23778


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcccccc
Q 030256           66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        66 ~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~  142 (180)
                      ..++.++.|++.++++||+.+++|+||+|+||++   +.+..++|+|||++........   ......+..|+|||...+
T Consensus       127 ~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~  203 (290)
T cd05045         127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD  203 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence            8999999999999999999999999999999999   4667899999999865533221   112224567999999888


Q ss_pred             ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          143 QRYDEKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       143 ~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      ..++.++|+||||++++++++ |..||++..+.
T Consensus       204 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            889999999999999999998 99999876653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.98  E-value=3.9e-31  Score=192.67  Aligned_cols=160  Identities=36%  Similarity=0.597  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|+.++++++|+|++++++++...+..++++||+++++|.+++...+++++..+..++.|++.++.+||+.|++|
T Consensus        52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  131 (272)
T cd06629          52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILH  131 (272)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence            45688899999999999999999999999999999999999999999987788999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCcccccccc--CCcchhHHHHHHHHHHHHhC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~--~~~~~Di~slg~~~~~~l~g  164 (180)
                      +||+|+||++   +.++.++++|||.+.......   ......++..|+|||...+..  ++.++|+||+|++++++++|
T Consensus       132 ~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  208 (272)
T cd06629         132 RDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG  208 (272)
T ss_pred             cCCChhhEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence            9999999999   567889999999886543221   112234677899999987654  78999999999999999999


Q ss_pred             CCCCCCCC
Q 030256          165 YPPFSAYR  172 (180)
Q Consensus       165 ~~pf~~~~  172 (180)
                      ..||...+
T Consensus       209 ~~p~~~~~  216 (272)
T cd06629         209 RRPWSDEE  216 (272)
T ss_pred             CCCCcCcc
Confidence            99997544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.98  E-value=2.2e-31  Score=203.56  Aligned_cols=163  Identities=29%  Similarity=0.526  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-------------------------
Q 030256            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------------------   60 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------------------   60 (180)
                      ....+.+.+|++++++++ ||||+++++++.+.+..+++|||+++++|.+++..+                         
T Consensus        81 ~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (400)
T cd05105          81 SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPAD  160 (400)
T ss_pred             hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccc
Confidence            344567889999999995 999999999999999999999999999999887542                         


Q ss_pred             -----------------------------------------------------------------------CCCCHHHHH
Q 030256           61 -----------------------------------------------------------------------GRVPEQTAR   69 (180)
Q Consensus        61 -----------------------------------------------------------------------~~~~~~~~~   69 (180)
                                                                                             ..+++..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~  240 (400)
T cd05105         161 ESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLL  240 (400)
T ss_pred             ccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHH
Confidence                                                                                   136777889


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCC
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD  146 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~  146 (180)
                      .++.|++.++++||+.+++|+||+|+||++.   .+..++|+|||++........   .....++..|+|||.+.+..++
T Consensus       241 ~~~~qi~~aL~~LH~~~ivH~dikp~Nill~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  317 (400)
T cd05105         241 SFTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT  317 (400)
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence            9999999999999999999999999999994   567899999999876533221   1223355679999999888899


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030256          147 EKVDMWSVGAILFELLN-GYPPFSAYR  172 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~-g~~pf~~~~  172 (180)
                      .++|+||||+++|++++ |..||.+..
T Consensus       318 ~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         318 TLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            99999999999999997 999997653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.98  E-value=2e-31  Score=193.13  Aligned_cols=161  Identities=29%  Similarity=0.579  Sum_probs=139.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|+.+++.++|+||+++++.+...+..++++|++++++|.+++...  ..++...+..++.+++.++++||+.++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i  124 (261)
T cd05072          45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY  124 (261)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            467888999999999999999999999999999999999999999998653  458889999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|+++|++++ |
T Consensus       125 ~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g  201 (261)
T cd05072         125 IHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG  201 (261)
T ss_pred             eccccchhhEEe---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccC
Confidence            999999999999   46778999999998765432211  12224567999999988888999999999999999998 9


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||.+.++
T Consensus       202 ~~p~~~~~~  210 (261)
T cd05072         202 KIPYPGMSN  210 (261)
T ss_pred             CCCCCCCCH
Confidence            999976554

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.98  E-value=2.1e-31  Score=195.45  Aligned_cols=162  Identities=33%  Similarity=0.562  Sum_probs=141.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|++++++++|+||+++++++...+..++++||++++.+..+..+...+++..+..++.+++.++++||+.|+
T Consensus        42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  121 (288)
T cd07833          42 DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI  121 (288)
T ss_pred             cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34577899999999999999999999999999999999999887777766666679999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|+|++|+||++   +.++.++|+|||.+.......  ......++..|+|||...+. .++.++|+||+|+++|++++|
T Consensus       122 ~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g  198 (288)
T cd07833         122 IHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG  198 (288)
T ss_pred             ecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhC
Confidence            999999999999   567889999999987665433  22234467789999998877 789999999999999999999


Q ss_pred             CCCCCCCC
Q 030256          165 YPPFSAYR  172 (180)
Q Consensus       165 ~~pf~~~~  172 (180)
                      +.||.+.+
T Consensus       199 ~~~~~~~~  206 (288)
T cd07833         199 EPLFPGDS  206 (288)
T ss_pred             CCCCCCCC
Confidence            99997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.98  E-value=2e-31  Score=198.20  Aligned_cols=163  Identities=29%  Similarity=0.533  Sum_probs=132.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEE--eCCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG   78 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~   78 (180)
                      ...+.+|++++++++||||+++.+++.  .+...++++||++ ++|.+++...         ..+++..+..++.|++.|
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07867          42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence            345788999999999999999999885  3567899999985 5887776421         247889999999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecC-CCCceEEEeecCCccccCCCCc----ccccccCccccCccccccc-cCCcchhHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMW  152 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~-~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~-~~~~~~Di~  152 (180)
                      |++||+.|++|+||+|+||++... +..+.++|+|||++........    .....++..|+|||.+.+. .++.++|+|
T Consensus       121 L~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07867         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence            999999999999999999998432 3456799999999876543321    1234567889999988764 478999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCc
Q 030256          153 SVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       153 slg~~~~~~l~g~~pf~~~~~  173 (180)
                      |+|+++|++++|..||.....
T Consensus       201 SlG~il~el~tg~~~f~~~~~  221 (317)
T cd07867         201 AIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             hHHHHHHHHHhCCCCcccccc
Confidence            999999999999999976543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=3.1e-31  Score=192.12  Aligned_cols=162  Identities=35%  Similarity=0.574  Sum_probs=145.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~   86 (180)
                      .....+.+|+..+++++|+|++++.+++...+..++++||+++++|.+++....++++..+..++.|++.++++||+ .|
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~  120 (264)
T cd06623          41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH  120 (264)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence            45677899999999999999999999999999999999999999999999877889999999999999999999999 99


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-cccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||+++|++++|+
T Consensus       121 ~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~  197 (264)
T cd06623         121 IIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK  197 (264)
T ss_pred             CccCCCCHHHEEE---CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999   56788999999988766443322 2345678899999998888999999999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||.+.+
T Consensus       198 ~p~~~~~  204 (264)
T cd06623         198 FPFLPPG  204 (264)
T ss_pred             CCCcccc
Confidence            9998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=3.8e-31  Score=193.52  Aligned_cols=163  Identities=26%  Similarity=0.439  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....++.+|+.++++++|+|++++++++.. ...++++||+++++|.+++..+ ..+++..+..++.|++.++++||++|
T Consensus        51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  129 (279)
T cd05057          51 KANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR  129 (279)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345678889999999999999999999887 7889999999999999998764 46899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc---ccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      ++|+||+|+||++   +.++.++|+|||.+..........   ....+..|+|||...+..++.++|+||+|++++++++
T Consensus       130 i~H~di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~  206 (279)
T cd05057         130 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT  206 (279)
T ss_pred             EEecccCcceEEE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhc
Confidence            9999999999999   467789999999987654332111   1112456999999888889999999999999999998


Q ss_pred             -CCCCCCCCCcc
Q 030256          164 -GYPPFSAYRPC  174 (180)
Q Consensus       164 -g~~pf~~~~~~  174 (180)
                       |..||.+.++.
T Consensus       207 ~g~~p~~~~~~~  218 (279)
T cd05057         207 FGAKPYEGIPAV  218 (279)
T ss_pred             CCCCCCCCCCHH
Confidence             99999876643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.98  E-value=2.7e-31  Score=195.03  Aligned_cols=162  Identities=29%  Similarity=0.597  Sum_probs=141.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|+.+++.++|+|++++++++...+..++++||+++++|.+++.. .+++...+..++.|++.++++||++|+
T Consensus        58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i  136 (285)
T cd06648          58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGV  136 (285)
T ss_pred             hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3455678899999999999999999999999999999999999999998875 678999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|+.
T Consensus       137 ~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~  213 (285)
T cd06648         137 IHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP  213 (285)
T ss_pred             ecCCCChhhEEE---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence            999999999999   5677899999998765433221 122447788999999988888999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||...++
T Consensus       214 p~~~~~~  220 (285)
T cd06648         214 PYFNEPP  220 (285)
T ss_pred             CCcCCCH
Confidence            9976553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.98  E-value=2e-31  Score=198.36  Aligned_cols=163  Identities=26%  Similarity=0.431  Sum_probs=138.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+++.+|+.+++.++||||+++++++... ..+++++++++++|.+++.... .++...+..++.|++.+|+|||+.
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~  128 (316)
T cd05108          50 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER  128 (316)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc
Confidence            34566788999999999999999999988765 4678999999999999987644 588999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |++|+||+|+||++   +.+..++|+|||++.........   .....+..|++||...+..++.++|+||+|+++|+++
T Consensus       129 ~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~  205 (316)
T cd05108         129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM  205 (316)
T ss_pred             CeeccccchhheEe---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence            99999999999999   46678999999998765433221   1122345799999999888999999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030256          163 N-GYPPFSAYRP  173 (180)
Q Consensus       163 ~-g~~pf~~~~~  173 (180)
                      + |..||.+.+.
T Consensus       206 t~g~~p~~~~~~  217 (316)
T cd05108         206 TFGSKPYDGIPA  217 (316)
T ss_pred             cCCCCCCCCCCH
Confidence            8 9999987554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=2e-31  Score=194.56  Aligned_cols=164  Identities=26%  Similarity=0.467  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGA   77 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~   77 (180)
                      .....+.+|+.+++.++|+|++++++++...+..++++||+++++|.+++....          .+++..+..++.|++.
T Consensus        51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  130 (277)
T cd05032          51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD  130 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence            345578889999999999999999999999999999999999999999986432          3677899999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  154 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~sl  154 (180)
                      ++++||+.+++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||...+..++.++|+|||
T Consensus       131 ~l~~lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  207 (277)
T cd05032         131 GMAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF  207 (277)
T ss_pred             HHHHHHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence            9999999999999999999999   5677899999999876543321   112234567999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCcc
Q 030256          155 GAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       155 g~~~~~~l~-g~~pf~~~~~~  174 (180)
                      |+++|++++ |..||.+.++.
T Consensus       208 G~il~el~t~g~~p~~~~~~~  228 (277)
T cd05032         208 GVVLWEMATLAEQPYQGLSNE  228 (277)
T ss_pred             HHHHHHhhccCCCCCccCCHH
Confidence            999999998 99999776543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.98  E-value=2.2e-31  Score=197.37  Aligned_cols=163  Identities=31%  Similarity=0.531  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~   70 (180)
                      .....+.+|+.+++.+ +|+||+++++++..++..++++||+++++|.+++....                .++...++.
T Consensus        65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  144 (307)
T cd05098          65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS  144 (307)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence            3445688899999999 79999999999999999999999999999999997542                378889999


Q ss_pred             HHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCc
Q 030256           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDE  147 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~  147 (180)
                      ++.|++.++++||++|++|+||+|+||++   +.++.++|+|||.+.........   ....++..|+|||...+..++.
T Consensus       145 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  221 (307)
T cd05098         145 CAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH  221 (307)
T ss_pred             HHHHHHHHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence            99999999999999999999999999999   46678999999988655332111   1112345799999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          148 KVDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      ++|+||+|+++|+|++ |..||.+.+.
T Consensus       222 ~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         222 QSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999999999999998 8899976554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.98  E-value=4e-31  Score=191.60  Aligned_cols=162  Identities=31%  Similarity=0.623  Sum_probs=142.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|++++++++|+||+++++++...+..++++||+++++|.+++.....+++..+..++.+++.++++||+.|+
T Consensus        41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  120 (264)
T cd06626          41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI  120 (264)
T ss_pred             HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence            46678999999999999999999999999999999999999999999999877778999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-----cccccCccccCcccccccc---CCcchhHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILF  159 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~ape~~~~~~---~~~~~Di~slg~~~~  159 (180)
                      +|+||+|+||++   +..+.++|+|||.+.........     ....++..|+|||.+.+..   ++.++|+||+|++++
T Consensus       121 ~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~  197 (264)
T cd06626         121 VHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL  197 (264)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence            999999999999   45778999999998766443221     1234677899999987665   889999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030256          160 ELLNGYPPFSAYR  172 (180)
Q Consensus       160 ~~l~g~~pf~~~~  172 (180)
                      ++++|+.||...+
T Consensus       198 ~l~~g~~pf~~~~  210 (264)
T cd06626         198 EMATGKRPWSELD  210 (264)
T ss_pred             HHHhCCCCccCCc
Confidence            9999999997653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=3.9e-31  Score=192.33  Aligned_cols=163  Identities=26%  Similarity=0.508  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+.+|+.++++++||||+++.+++..++..+++|||+++++|.+++... ..++...+..++.|++.++++||+.|
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  126 (267)
T cd05066          47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG  126 (267)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34567889999999999999999999999999999999999999999998765 45899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc----ccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|+||+|+||++   +.+..++++|||.+..........    ....+..|++||...+..++.++|+||+|+++|+++
T Consensus       127 i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell  203 (267)
T cd05066         127 YVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  203 (267)
T ss_pred             EeehhhchhcEEE---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHh
Confidence            9999999999999   467789999999887654332111    111235699999998888999999999999999988


Q ss_pred             h-CCCCCCCCCc
Q 030256          163 N-GYPPFSAYRP  173 (180)
Q Consensus       163 ~-g~~pf~~~~~  173 (180)
                      + |..||.+.++
T Consensus       204 ~~g~~p~~~~~~  215 (267)
T cd05066         204 SYGERPYWEMSN  215 (267)
T ss_pred             cCCCCCcccCCH
Confidence            7 9999976554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.9e-31  Score=208.76  Aligned_cols=164  Identities=30%  Similarity=0.524  Sum_probs=139.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCC--------eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQ   74 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~   74 (180)
                      +.....+.+|+..+..++|++++++.+.+...+        .++++|||+++++|.+++...    ..+++..+..++.|
T Consensus        72 ~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~q  151 (496)
T PTZ00283         72 EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ  151 (496)
T ss_pred             HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHH
Confidence            455667889999999999999999988764322        478999999999999988642    35899999999999


Q ss_pred             HHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC---CcccccccCccccCccccccccCCcchhH
Q 030256           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDM  151 (180)
Q Consensus        75 i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Di  151 (180)
                      ++.+|+|+|+.|++|+||+|+||++   +.++.++|+|||++......   .......++..|+|||.+.+..++.++|+
T Consensus       152 ll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV  228 (496)
T PTZ00283        152 VLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM  228 (496)
T ss_pred             HHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHH
Confidence            9999999999999999999999999   46778999999998665332   22234458889999999998889999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCc
Q 030256          152 WSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       152 ~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      ||+|+++|++++|+.||.+.+.
T Consensus       229 wSlGvilyeLltG~~Pf~~~~~  250 (496)
T PTZ00283        229 FSLGVLLYELLTLKRPFDGENM  250 (496)
T ss_pred             HHHHHHHHHHHHCCCCCCCCCH
Confidence            9999999999999999987554

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.98  E-value=1.9e-31  Score=197.34  Aligned_cols=164  Identities=30%  Similarity=0.517  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~   70 (180)
                      ...+.+.+|+.+++.+ +||||+++++++...+..+++|||+++++|.+++....                .++...+..
T Consensus        62 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (304)
T cd05101          62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS  141 (304)
T ss_pred             HHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence            3456788999999999 89999999999999999999999999999999987532                367788999


Q ss_pred             HHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCc
Q 030256           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDE  147 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~  147 (180)
                      ++.|++.++++||++|++|+||+|+||++   +.++.++|+|||.+.........   ....++..|+|||...+..++.
T Consensus       142 ~~~qi~~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  218 (304)
T cd05101         142 CTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  218 (304)
T ss_pred             HHHHHHHHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence            99999999999999999999999999999   46678999999998766432211   1122345799999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          148 KVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      ++|+||||+++|++++ |..||.+.+..
T Consensus       219 ~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         219 QSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999998 88898765443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=1.2e-31  Score=197.93  Aligned_cols=161  Identities=28%  Similarity=0.583  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+.+++.++|||++++++++..++..++++||+++++|.+++. ...+++..+..++.|++.++++||+.|++
T Consensus        61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iv  139 (297)
T cd06659          61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVI  139 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45568889999999999999999999999999999999999999998775 45789999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus       140 H~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  216 (297)
T cd06659         140 HRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP  216 (297)
T ss_pred             cCCCCHHHeEE---ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   5678899999998765433221 2234577889999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       217 ~~~~~~  222 (297)
T cd06659         217 YFSDSP  222 (297)
T ss_pred             CCCCCH
Confidence            975543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.98  E-value=3.8e-31  Score=192.23  Aligned_cols=164  Identities=24%  Similarity=0.509  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+..+.+|+.++++++|+||+++.+++...+..++++|++++++|.+++... +.++...+..++.|++.++++||++
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~  125 (266)
T cd05033          46 DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM  125 (266)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345567888999999999999999999999999999999999999999998754 4689999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      +++|+||+|+||++   +.++.++++|||.+.........   .....+..|+|||...+..++.++|+||+|+++|+++
T Consensus       126 ~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~  202 (266)
T cd05033         126 NYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM  202 (266)
T ss_pred             CcccCCCCcceEEE---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHH
Confidence            99999999999999   46778999999998776422111   1122345799999998888999999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030256          163 N-GYPPFSAYRP  173 (180)
Q Consensus       163 ~-g~~pf~~~~~  173 (180)
                      + |..||.....
T Consensus       203 ~~g~~p~~~~~~  214 (266)
T cd05033         203 SYGERPYWDMSN  214 (266)
T ss_pred             ccCCCCCCCCCH
Confidence            8 9999976543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.98  E-value=3.1e-31  Score=195.33  Aligned_cols=163  Identities=27%  Similarity=0.507  Sum_probs=140.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQLG   76 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~   76 (180)
                      .....+.+|++++++++|||++++++++..++..++++|++++++|.+++....           .+++..++.++.|++
T Consensus        61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  140 (296)
T cd05051          61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA  140 (296)
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence            456778899999999999999999999999999999999999999999987655           689999999999999


Q ss_pred             HHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHH
Q 030256           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWS  153 (180)
Q Consensus        77 ~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~s  153 (180)
                      .++++||+.|++|+||+|+||++   +..+.++|+|||.+........   .....++..|+|||...+..++.++|+||
T Consensus       141 ~al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  217 (296)
T cd05051         141 SGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA  217 (296)
T ss_pred             HHHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence            99999999999999999999999   4668899999999866543321   12233456799999998888999999999


Q ss_pred             HHHHHHHHHh--CCCCCCCCCc
Q 030256          154 VGAILFELLN--GYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~--g~~pf~~~~~  173 (180)
                      +|+++|++++  +..||...+.
T Consensus       218 lG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         218 FGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             hHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999998  7788876443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.98  E-value=4.7e-31  Score=193.17  Aligned_cols=162  Identities=29%  Similarity=0.530  Sum_probs=136.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...++..|+..+++++||||+++++++.. ...++++|++++++|.+++... ..+++..+..++.|++.++++||+.|+
T Consensus        52 ~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  130 (279)
T cd05111          52 TFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM  130 (279)
T ss_pred             HHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            34567778889999999999999998764 4577899999999999999754 468999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      +|+||+|+||++   +.+..++|+|||.+........   .....++..|++||...+..++.++|+||+|+++||+++ 
T Consensus       131 iH~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~  207 (279)
T cd05111         131 VHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY  207 (279)
T ss_pred             eccccCcceEEE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence            999999999999   5677899999999876533221   112234567999999988889999999999999999998 


Q ss_pred             CCCCCCCCCcc
Q 030256          164 GYPPFSAYRPC  174 (180)
Q Consensus       164 g~~pf~~~~~~  174 (180)
                      |..||.+.++.
T Consensus       208 g~~p~~~~~~~  218 (279)
T cd05111         208 GAEPYAGMRPH  218 (279)
T ss_pred             CCCCCCCCCHH
Confidence            99999876543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.98  E-value=4e-31  Score=196.57  Aligned_cols=162  Identities=30%  Similarity=0.527  Sum_probs=137.2

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHH
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~   71 (180)
                      ....+.+|+.+++++ +||||+++++++.+.+..++++||+++++|.+++...                ..++...+..+
T Consensus        60 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  139 (314)
T cd05099          60 DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC  139 (314)
T ss_pred             HHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHH
Confidence            345678899999999 6999999999999989999999999999999998653                23788899999


Q ss_pred             HHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcc
Q 030256           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  148 (180)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~  148 (180)
                      +.|++.++++||++|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++.+
T Consensus       140 ~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  216 (314)
T cd05099         140 AYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ  216 (314)
T ss_pred             HHHHHHHHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc
Confidence            9999999999999999999999999999   4567899999999876543211   111123356999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          149 VDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       149 ~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +|+||+|+++|++++ |..||.+.++
T Consensus       217 ~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         217 SDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             chhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999 8999977554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.98  E-value=3.7e-31  Score=193.90  Aligned_cols=164  Identities=27%  Similarity=0.587  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~   71 (180)
                      ...+.+.+|..++++++||||+++++++...+..+++++|+.+++|.+++...                ..++...+..+
T Consensus        50 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  129 (283)
T cd05091          50 PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI  129 (283)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHH
Confidence            44677889999999999999999999999989999999999999999998532                24788889999


Q ss_pred             HHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcc
Q 030256           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  148 (180)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~  148 (180)
                      +.|++.+++++|+.|++|+||+|+||++   ..+..++|+|||++........   .....++..|+|||...+..++.+
T Consensus       130 ~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05091         130 VTQIAAGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID  206 (283)
T ss_pred             HHHHHHHHHHHHHcCccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc
Confidence            9999999999999999999999999999   4667799999998876543221   112234567999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          149 VDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       149 ~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      +|+||+|+++|++++ |..||.+.++.
T Consensus       207 ~Dv~slG~~l~el~~~g~~p~~~~~~~  233 (283)
T cd05091         207 SDIWSYGVVLWEVFSYGLQPYCGYSNQ  233 (283)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999998 88899775543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=4.4e-31  Score=190.81  Aligned_cols=161  Identities=27%  Similarity=0.537  Sum_probs=140.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+|+.++++++|+|++++++++.+.+..++++|++++++|.+++....  .+++..+..++.|++.++++||+.|
T Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~  122 (256)
T cd05039          43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN  122 (256)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35678889999999999999999999998899999999999999999997665  6899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||.+........  .......|+|||......++.++|+||+|++++++++ |.
T Consensus       123 i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~  197 (256)
T cd05039         123 FVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR  197 (256)
T ss_pred             ccchhcccceEEE---eCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCC
Confidence            9999999999999   4677899999999876633222  2224567999999988888999999999999999997 99


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||...+..
T Consensus       198 ~p~~~~~~~  206 (256)
T cd05039         198 VPYPRIPLK  206 (256)
T ss_pred             CCCCCCCHH
Confidence            999776543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.3e-31  Score=189.58  Aligned_cols=161  Identities=45%  Similarity=0.716  Sum_probs=144.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|++++++++|+|++++++.+..++..+++||++++++|.+++.....+++..+..++.|++.++.++|+.+++
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~  115 (250)
T cd05123          36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII  115 (250)
T ss_pred             HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            45678899999999999999999999999999999999999999999998777899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +..+.++|+|||.+...... .......++..|+|||...+..++.++|+||||+++|++++|..|
T Consensus       116 H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p  192 (250)
T cd05123         116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP  192 (250)
T ss_pred             ecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            99999999999   46678999999988766443 223344567789999999888889999999999999999999999


Q ss_pred             CCCCC
Q 030256          168 FSAYR  172 (180)
Q Consensus       168 f~~~~  172 (180)
                      |...+
T Consensus       193 ~~~~~  197 (250)
T cd05123         193 FYAED  197 (250)
T ss_pred             CCCCC
Confidence            97665

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.98  E-value=5e-31  Score=191.70  Aligned_cols=164  Identities=26%  Similarity=0.478  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+..|++++++++|+|++++.+++.+.+..+++||++++++|.+++... +.+++..+..++.|++.++++||+.
T Consensus        47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~  126 (268)
T cd05063          47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM  126 (268)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            334567889999999999999999999999999999999999999999998754 4689999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc----ccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+|++|+||++   +.+..++++|||++..........    ....+..|+|||...+..++.++|+||+|+++|++
T Consensus       127 ~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el  203 (268)
T cd05063         127 NYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV  203 (268)
T ss_pred             CeeccccchhhEEE---cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence            99999999999999   467789999999886554322111    11123469999999888889999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030256          162 LN-GYPPFSAYRP  173 (180)
Q Consensus       162 l~-g~~pf~~~~~  173 (180)
                      ++ |..||...++
T Consensus       204 l~~g~~p~~~~~~  216 (268)
T cd05063         204 MSFGERPYWDMSN  216 (268)
T ss_pred             HhCCCCCCCcCCH
Confidence            98 9999976554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=3e-31  Score=200.47  Aligned_cols=153  Identities=31%  Similarity=0.456  Sum_probs=132.0

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      ....|+.++++++|+||+++++++...+..+++++++ .++|.+++.. ..++++..+..++.|++.||++||++|++|+
T Consensus       103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  181 (357)
T PHA03209        103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR  181 (357)
T ss_pred             ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            3456999999999999999999999999999999999 4588887764 3569999999999999999999999999999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      ||+|+||++   +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|+++++..|+
T Consensus       182 Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        182 DVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CCCHHHEEE---CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            999999999   567789999999986544333333455788999999999888999999999999999999854444

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.98  E-value=2.7e-31  Score=192.79  Aligned_cols=160  Identities=24%  Similarity=0.475  Sum_probs=135.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|++++++++|+||+++++++.. +..+++|||+++++|.+++...  ..+++..+..++.|++.+++++|+.++
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i  123 (262)
T cd05071          45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY  123 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4568899999999999999999988754 5579999999999999998753  348899999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|+++|++++ |
T Consensus       124 ~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g  200 (262)
T cd05071         124 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG  200 (262)
T ss_pred             cccccCcccEEE---cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence            999999999999   46778999999998665433221  12234567999999988889999999999999999999 8


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||.+.++
T Consensus       201 ~~p~~~~~~  209 (262)
T cd05071         201 RVPYPGMVN  209 (262)
T ss_pred             CCCCCCCCh
Confidence            999976554

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.98  E-value=1.8e-31  Score=193.55  Aligned_cols=161  Identities=35%  Similarity=0.590  Sum_probs=142.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS-   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~-   84 (180)
                      ......+.+|++++++++||||+++.+.+..++..++++|++++++|.+++... .++++..+..++.|++.+++++|+ 
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  119 (265)
T cd06605          40 EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK  119 (265)
T ss_pred             hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC
Confidence            345667889999999999999999999999999999999999999999999866 679999999999999999999999 


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      .|++|+||+|+||++   +.++.++|+|||.+.......... ..++..|+|||...+..++.++|+||+|++++++++|
T Consensus       120 ~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g  195 (265)
T cd06605         120 HKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG  195 (265)
T ss_pred             CCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHhhc-ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999999999   457789999999876553322222 4567789999999888899999999999999999999


Q ss_pred             CCCCCCC
Q 030256          165 YPPFSAY  171 (180)
Q Consensus       165 ~~pf~~~  171 (180)
                      ..||...
T Consensus       196 ~~p~~~~  202 (265)
T cd06605         196 RFPYPPE  202 (265)
T ss_pred             CCCCCcc
Confidence            9999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.98  E-value=2.7e-31  Score=195.01  Aligned_cols=158  Identities=36%  Similarity=0.571  Sum_probs=132.7

Q ss_pred             HHHHHHHHHhcC---CCccccccceEEEe-----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus        12 ~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ...+|+++++.+   +||||+++++++..     ....++++|++. ++|.+++....  .+++..+..++.|++.|+++
T Consensus        45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  123 (288)
T cd07863          45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF  123 (288)
T ss_pred             HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence            455677777665   79999999998754     246899999996 58888886543  48999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ||+.|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++
T Consensus       124 lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l  200 (288)
T cd07863         124 LHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM  200 (288)
T ss_pred             HHhCCeecCCCCHHHEEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHH
Confidence            999999999999999999   56778999999998766544333344578889999999888899999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|..||.+.+.
T Consensus       201 ~~g~~~f~~~~~  212 (288)
T cd07863         201 FRRKPLFCGNSE  212 (288)
T ss_pred             HhCCcCcCCCCH
Confidence            999999976543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.8e-31  Score=199.56  Aligned_cols=156  Identities=33%  Similarity=0.586  Sum_probs=133.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ...+.+|++++++++|+||+++++++...      ...+++++++ +++|.+++. ...+++..+..++.|++.+++|||
T Consensus        58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH  135 (343)
T cd07878          58 ARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIH  135 (343)
T ss_pred             HHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45577899999999999999999887533      3579999988 789988765 567999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|++|+||+|+||++   +.++.++|+|||++.......  ....++..|+|||.+.+ ..++.++|+||+|+++|+|+
T Consensus       136 ~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  210 (343)
T cd07878         136 SAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  210 (343)
T ss_pred             HCCeecccCChhhEEE---CCCCCEEEcCCccceecCCCc--CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH
Confidence            9999999999999999   567789999999987654332  23457888999999876 46889999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|+.||.+.+
T Consensus       211 ~g~~pf~~~~  220 (343)
T cd07878         211 KGKALFPGND  220 (343)
T ss_pred             HCCCCCCCCC
Confidence            9999998654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.98  E-value=3.4e-31  Score=195.37  Aligned_cols=161  Identities=36%  Similarity=0.532  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+..|++++++++|+||+++++++.+.+..++||||+ +++|.+++.... .+++..+..++.|+++++++||++|+
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i  123 (298)
T cd07841          45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWI  123 (298)
T ss_pred             hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4456778999999999999999999999999999999999 889999998665 79999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|.
T Consensus       124 ~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~  200 (298)
T cd07841         124 LHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV  200 (298)
T ss_pred             eecCCChhhEEE---cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence            999999999999   467789999999987664432 2222345677999998754 45788999999999999999998


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      +||.+.++
T Consensus       201 ~~~~~~~~  208 (298)
T cd07841         201 PFLPGDSD  208 (298)
T ss_pred             ccccCCcc
Confidence            88876553

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=2.3e-31  Score=195.33  Aligned_cols=162  Identities=35%  Similarity=0.646  Sum_probs=142.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|++.+++++|+|++++++.+...+..++++||+++++|.+++.... .++...+..++.+++.++++||+.|+
T Consensus        58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi  137 (286)
T cd06614          58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV  137 (286)
T ss_pred             hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            35678889999999999999999999999999999999999999999998776 79999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+|++|+||++   +.++.++|+|||.+........ .....++..|++||...+..++.++|+||+|+++|++++|..
T Consensus       138 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~  214 (286)
T cd06614         138 IHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP  214 (286)
T ss_pred             eeCCCChhhEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence            999999999999   4677899999998765443221 122345678999999888888999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||...++
T Consensus       215 p~~~~~~  221 (286)
T cd06614         215 PYLREPP  221 (286)
T ss_pred             CCCCCCH
Confidence            9987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=3.3e-31  Score=192.92  Aligned_cols=143  Identities=29%  Similarity=0.560  Sum_probs=128.4

Q ss_pred             CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCC
Q 030256           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD  103 (180)
Q Consensus        24 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~  103 (180)
                      +|+|++++++.+...+..+++|||+++++|.+++..+.++++..+..++.|++.++++||+.|++|+||+|+||++.   
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---  143 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---  143 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---
Confidence            79999999999999999999999999999999998777899999999999999999999999999999999999995   


Q ss_pred             CCc-eEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          104 DDV-MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       104 ~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      ..+ .++++|||.+.......   ...++..|+|||.+.+..++.++|+||+|++++++++|..||....
T Consensus       144 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  210 (267)
T PHA03390        144 RAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE  210 (267)
T ss_pred             CCCCeEEEecCccceecCCCc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            344 89999999886654332   2346788999999988889999999999999999999999998544

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=4.8e-31  Score=190.68  Aligned_cols=159  Identities=26%  Similarity=0.509  Sum_probs=136.0

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEE-eCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .+.+.+|+.++++++|++++++++++. .++..++++||+++++|.+++....  .+++..+..++.|++.++++||++|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  122 (256)
T cd05082          43 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456888999999999999999999754 5567899999999999999987544  3789999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||.+........  ....+..|+|||...+..++.++|+||+|+++|++++ |+
T Consensus       123 i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~  197 (256)
T cd05082         123 FVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR  197 (256)
T ss_pred             EeccccchheEEE---cCCCcEEecCCccceeccccCC--CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCC
Confidence            9999999999999   5677899999998865533221  2224567999999988889999999999999999997 99


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...+.
T Consensus       198 ~p~~~~~~  205 (256)
T cd05082         198 VPYPRIPL  205 (256)
T ss_pred             CCCCCCCH
Confidence            99976544

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=3.7e-31  Score=192.43  Aligned_cols=165  Identities=30%  Similarity=0.529  Sum_probs=138.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~   80 (180)
                      .....+.+|+.++++++||||+++++++..++..++++|++++++|.+++...       ..++...+..++.|++.+++
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  120 (269)
T cd05044          41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV  120 (269)
T ss_pred             hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence            34567888999999999999999999999989999999999999999998642       23788999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCC--CCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  155 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~--~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg  155 (180)
                      +||+.+++|+||+|+||++...+  ....++++|||++........   ......+..|+|||.+.+..++.++|+||||
T Consensus       121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG  200 (269)
T cd05044         121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG  200 (269)
T ss_pred             HHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHH
Confidence            99999999999999999996322  223799999999866543221   1122345679999999988899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCC
Q 030256          156 AILFELLN-GYPPFSAYR  172 (180)
Q Consensus       156 ~~~~~~l~-g~~pf~~~~  172 (180)
                      +++|++++ |..||...+
T Consensus       201 ~il~ellt~g~~p~~~~~  218 (269)
T cd05044         201 VLMWEILTLGQQPYPALN  218 (269)
T ss_pred             HHHHHHHHcCCCCCcccC
Confidence            99999998 999997654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=5.2e-31  Score=197.76  Aligned_cols=161  Identities=32%  Similarity=0.566  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhc---------------------------
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH---------------------------   60 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---------------------------   60 (180)
                      ...+.+|+++++++ +|+||+++++++.. +..++++++|+++++|.+++...                           
T Consensus        54 ~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  133 (337)
T cd05054          54 YKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL  133 (337)
T ss_pred             HHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence            45577899999999 89999999998764 46789999999999999988532                           


Q ss_pred             ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCc
Q 030256           61 ----------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV  106 (180)
Q Consensus        61 ----------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~  106 (180)
                                                        .+++...+..++.|++.++++||++|++|+||+|.||++.   .++
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~  210 (337)
T cd05054         134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENN  210 (337)
T ss_pred             ccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCC
Confidence                                              2578889999999999999999999999999999999994   567


Q ss_pred             eEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          107 MLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       107 ~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      .++|+|||++........   .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+..+
T Consensus       211 ~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~  281 (337)
T cd05054         211 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI  281 (337)
T ss_pred             cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            799999999876533221   112234567999999999999999999999999999998 9999976443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=5.7e-31  Score=190.66  Aligned_cols=162  Identities=26%  Similarity=0.493  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|++++++++|+|++++++++.+.+..+++|||+++++|.+++...  ..++...+..++.|++.++++||+.|
T Consensus        45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  124 (261)
T cd05148          45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN  124 (261)
T ss_pred             hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567889999999999999999999999999999999999999999998753  35899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      ++|+||+|+||++   +.++.++|+|||.+......... ....++..|++||...+..++.++|+||||++++++++ |
T Consensus       125 i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g  201 (261)
T cd05148         125 SIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG  201 (261)
T ss_pred             eeccccCcceEEE---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence            9999999999999   56778999999988665432211 12224557999999988889999999999999999998 8


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||...++
T Consensus       202 ~~p~~~~~~  210 (261)
T cd05148         202 QVPYPGMNN  210 (261)
T ss_pred             CCCCCcCCH
Confidence            999976553

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=7.3e-31  Score=190.91  Aligned_cols=163  Identities=33%  Similarity=0.529  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+.+|+.++++++|+||+++++++..++..++++||+++++|.+++... .++  ++..+..++.|++.++++||+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  126 (268)
T cd06624          47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD  126 (268)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999999999999999999999998754 445  888899999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccccc--CCcchhHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~--~~~~~Di~slg~~~~~~  161 (180)
                      .|++|+||+|+||+++  .....++|+|||.+........ .....++..|+|||...+..  ++.++|+||+|+++|++
T Consensus       127 ~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l  204 (268)
T cd06624         127 NQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM  204 (268)
T ss_pred             CCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHH
Confidence            9999999999999995  3356799999998866533221 22334678899999886543  78899999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|+.||....
T Consensus       205 ~~g~~p~~~~~  215 (268)
T cd06624         205 ATGKPPFIELG  215 (268)
T ss_pred             HhCCCCCcccc
Confidence            99999997543

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=2.4e-31  Score=195.73  Aligned_cols=163  Identities=33%  Similarity=0.562  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK   70 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~   70 (180)
                      +....+.+|+++++++ +|+||+++++++..++..+++|||+++++|.+++...                ..+++..++.
T Consensus        57 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  136 (293)
T cd05053          57 KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS  136 (293)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence            3445688899999999 8999999999999999999999999999999998642                3488999999


Q ss_pred             HHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCc
Q 030256           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~  147 (180)
                      ++.|++.++++||+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||...+..++.
T Consensus       137 i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  213 (293)
T cd05053         137 FAYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH  213 (293)
T ss_pred             HHHHHHHHHHHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence            99999999999999999999999999999   4677899999999876543221   11122345699999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          148 KVDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      ++|+||+|+++|++++ |..||.+.+.
T Consensus       214 ~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         214 QSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             ccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            9999999999999997 9999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=7.4e-31  Score=190.50  Aligned_cols=163  Identities=31%  Similarity=0.598  Sum_probs=140.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ......+.+|++++++++|++++++++++..++..++++||+++++|.+++...    ..+++..+..++.+++.++++|
T Consensus        43 ~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  122 (267)
T cd08224          43 AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM  122 (267)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH
Confidence            345677889999999999999999999999999999999999999999988642    3489999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |+.|++|+||+|+||++   +.++.++++|||.+........ .....++..|.|||...+..++.++|+||+|+++|++
T Consensus       123 h~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l  199 (267)
T cd08224         123 HSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM  199 (267)
T ss_pred             HhCCEecCCcChhhEEE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHH
Confidence            99999999999999999   4677899999998765433221 2233467789999999888899999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|..||....
T Consensus       200 ~~g~~p~~~~~  210 (267)
T cd08224         200 AALQSPFYGDK  210 (267)
T ss_pred             HHCCCCcccCC
Confidence            99999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=7.9e-31  Score=188.34  Aligned_cols=161  Identities=37%  Similarity=0.669  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|++++++++|++++++.+++..++..++++||+++++|.+++... ..+++..+..++.|++.++++||+.|+
T Consensus        40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  119 (253)
T cd05122          40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI  119 (253)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence            5577889999999999999999999999999999999999999999998765 579999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|++++++++|+.|
T Consensus       120 ~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p  196 (253)
T cd05122         120 IHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP  196 (253)
T ss_pred             ecCCCCHHHEEE---ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999   46788999999988776554323345577889999999888889999999999999999999999


Q ss_pred             CCCCC
Q 030256          168 FSAYR  172 (180)
Q Consensus       168 f~~~~  172 (180)
                      |...+
T Consensus       197 ~~~~~  201 (253)
T cd05122         197 YSELP  201 (253)
T ss_pred             CCCCc
Confidence            98763

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.3e-31  Score=205.19  Aligned_cols=154  Identities=25%  Similarity=0.394  Sum_probs=133.2

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ....+|++++++++|+||+++++++..++..+++++++ .++|..++... ..+++..++.++.|++.+|+|||++|++|
T Consensus       205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH  283 (461)
T PHA03211        205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIH  283 (461)
T ss_pred             cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence            34678999999999999999999999999999999999 56888887654 46999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||||+||++   +....++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++||+++|..
T Consensus       284 rDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~  360 (461)
T PHA03211        284 RDIKTENVLV---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA  360 (461)
T ss_pred             CcCCHHHEEE---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence            9999999999   4667899999999866533211   123457899999999998889999999999999999999776


Q ss_pred             CC
Q 030256          167 PF  168 (180)
Q Consensus       167 pf  168 (180)
                      |+
T Consensus       361 ~l  362 (461)
T PHA03211        361 SL  362 (461)
T ss_pred             Cc
Confidence            54

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=6.1e-31  Score=194.02  Aligned_cols=163  Identities=27%  Similarity=0.533  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQLG   76 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~   76 (180)
                      .....+.+|+.++++++|+||+++++++..++..++++||+++++|.+++....           .++...+..++.|++
T Consensus        61 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  140 (296)
T cd05095          61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA  140 (296)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHH
Confidence            345678899999999999999999999999999999999999999999987542           266778999999999


Q ss_pred             HHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHH
Q 030256           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWS  153 (180)
Q Consensus        77 ~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~s  153 (180)
                      .++++||+.|++|+||+|+||++   +.++.++|+|||.+........   ......+..|++||...+..++.++|+||
T Consensus       141 ~al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS  217 (296)
T cd05095         141 SGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA  217 (296)
T ss_pred             HHHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence            99999999999999999999999   4677899999999876543221   11222346799999888788999999999


Q ss_pred             HHHHHHHHHh--CCCCCCCCCc
Q 030256          154 VGAILFELLN--GYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~--g~~pf~~~~~  173 (180)
                      +|+++|++++  |..||...++
T Consensus       218 lG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         218 FGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             HHHHHHHHHHhCCCCCccccCh
Confidence            9999999998  7788876543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=6.8e-31  Score=191.22  Aligned_cols=163  Identities=26%  Similarity=0.468  Sum_probs=134.2

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....+.+|+.++++++||||+++++++.+....+++|||+++++|.+++....     ..+...+..++.|++.++++||
T Consensus        38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  117 (269)
T cd05087          38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH  117 (269)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence            34468889999999999999999999998889999999999999999986432     3567788899999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccc-------cCCcchhHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWS  153 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~-------~~~~~~Di~s  153 (180)
                      +.|++|+||+|+||++   +....++|+|||.+........   .....++..|+|||...+.       .++.++|+||
T Consensus       118 ~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  194 (269)
T cd05087         118 KNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS  194 (269)
T ss_pred             HCCEeccccCcceEEE---cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence            9999999999999999   4567899999998865433221   1123356679999987532       3578999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCcc
Q 030256          154 VGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       154 lg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      +|+++|++++ |..||...++.
T Consensus       195 lG~~l~el~~~g~~p~~~~~~~  216 (269)
T cd05087         195 LGVTIWELFELGSQPYRHLSDE  216 (269)
T ss_pred             HHHHHHHHHhCCCCCCCCCChH
Confidence            9999999996 99999765543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=8.4e-31  Score=188.90  Aligned_cols=162  Identities=38%  Similarity=0.682  Sum_probs=145.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+.+|++++++++|+|++++++.+...  +..++++|++++++|.+++.....+++..+..++.+++.++++||+.
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  120 (260)
T cd06606          41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN  120 (260)
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567889999999999999999999999888  89999999999999999998777899999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |++|+|++|+||++.   .++.++|+|||.+........   .....++..|.|||...+...+.++|+||+|+++++++
T Consensus       121 ~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~  197 (260)
T cd06606         121 GIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA  197 (260)
T ss_pred             CccccCCCHHHEEEc---CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence            999999999999994   577899999999877655543   33455778899999998888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|..||...+
T Consensus       198 ~g~~p~~~~~  207 (260)
T cd06606         198 TGKPPWSELG  207 (260)
T ss_pred             hCCCCCCCCC
Confidence            9999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9e-31  Score=189.62  Aligned_cols=156  Identities=38%  Similarity=0.703  Sum_probs=134.3

Q ss_pred             HHHHHHH-HhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 030256           13 LDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (180)
Q Consensus        13 ~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~d   91 (180)
                      +..|..+ ....+|+|++++++++..++..++++||+++++|.+++....++++..+..++.|++.++.+||+.|++|+|
T Consensus        43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~d  122 (260)
T cd05611          43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD  122 (260)
T ss_pred             HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            3444444 445589999999999999999999999999999999998778899999999999999999999999999999


Q ss_pred             CCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256           92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus        92 l~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                      |+|+||++   +.+..++|+|||.+.....   .....++..|++||...+..++.++|+||+|+++|++++|..||...
T Consensus       123 l~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         123 IKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             CCHHHeEE---CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            99999999   4677899999998765433   12234677899999998878899999999999999999999999765


Q ss_pred             Ccc
Q 030256          172 RPC  174 (180)
Q Consensus       172 ~~~  174 (180)
                      ++.
T Consensus       197 ~~~  199 (260)
T cd05611         197 TPD  199 (260)
T ss_pred             CHH
Confidence            543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=8.4e-31  Score=191.67  Aligned_cols=164  Identities=25%  Similarity=0.420  Sum_probs=137.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ......++.+|..+++.++|+||+++++++... ..+++++++++++|.+++... ..+++..+..++.|++.++++||+
T Consensus        49 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~  127 (279)
T cd05109          49 SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE  127 (279)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            344567788999999999999999999988654 467899999999999998764 468999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      +|++|+||+|+||++.   ..+.++|+|||++.........   .....+..|+|||...+..++.++|+||||+++||+
T Consensus       128 ~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el  204 (279)
T cd05109         128 VRLVHRDLAARNVLVK---SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL  204 (279)
T ss_pred             CCeeccccccceEEEc---CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence            9999999999999994   5667999999998765433221   112235679999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030256          162 LN-GYPPFSAYRP  173 (180)
Q Consensus       162 l~-g~~pf~~~~~  173 (180)
                      ++ |..||....+
T Consensus       205 ~t~g~~p~~~~~~  217 (279)
T cd05109         205 MTFGAKPYDGIPA  217 (279)
T ss_pred             HcCCCCCCCCCCH
Confidence            98 9999976543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=7.9e-31  Score=193.35  Aligned_cols=163  Identities=27%  Similarity=0.527  Sum_probs=137.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------RVPEQTARKFLQQ   74 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~   74 (180)
                      ....+.+.+|++++++++|+|++++++++...+..+++|||+++++|.+++....            .++...++.++.|
T Consensus        58 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  137 (295)
T cd05097          58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ  137 (295)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence            3445678899999999999999999999999999999999999999999886432            3678899999999


Q ss_pred             HHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhH
Q 030256           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM  151 (180)
Q Consensus        75 i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di  151 (180)
                      ++.++++||+.|++|+||+|+||++   +.+..++|+|||++........   .....++..|+|||...+..++.++|+
T Consensus       138 i~~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  214 (295)
T cd05097         138 IASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV  214 (295)
T ss_pred             HHHHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhH
Confidence            9999999999999999999999999   4567799999998865533221   112234567999999988889999999


Q ss_pred             HHHHHHHHHHHh--CCCCCCCCC
Q 030256          152 WSVGAILFELLN--GYPPFSAYR  172 (180)
Q Consensus       152 ~slg~~~~~~l~--g~~pf~~~~  172 (180)
                      ||||++++++++  +..||...+
T Consensus       215 wSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         215 WAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccC
Confidence            999999999988  677887644

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=210.42  Aligned_cols=163  Identities=28%  Similarity=0.495  Sum_probs=138.0

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCccccccceE-EEe---C---CeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQA---E---NCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL   75 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~---~---~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i   75 (180)
                      ++..-+.+++|++++++| +|+|||.+++. ...   +   -.+.+.||||.|+.|-++++.  +..|++.++++|+.++
T Consensus        74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv  153 (738)
T KOG1989|consen   74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV  153 (738)
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence            677788899999999999 59999999993 321   2   257899999999999999983  4569999999999999


Q ss_pred             HHHHHHHHhCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-c---------cccccCccccCcccc---
Q 030256           76 GAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-A---------EKVCGSPLYMAPEVL---  140 (180)
Q Consensus        76 ~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~---------~~~~~~~~~~ape~~---  140 (180)
                      ++|+++||...  ++|||||-+|||+   ..++..+|||||.++....... .         -...-|+-|.|||.+   
T Consensus       154 ~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly  230 (738)
T KOG1989|consen  154 CEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY  230 (738)
T ss_pred             HHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh
Confidence            99999999998  9999999999999   5777899999999866543321 1         013357789999986   


Q ss_pred             ccccCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256          141 QFQRYDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus       141 ~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                      .+...+.++|||+|||++|-++-...||+..
T Consensus       231 sg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  231 SGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             cCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            4667899999999999999999999999876

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=1e-30  Score=188.33  Aligned_cols=162  Identities=32%  Similarity=0.561  Sum_probs=139.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|++++++++|+||+++++++...+..++++|++++++|.+++... ..++...+..++.+++.++++||++++
T Consensus        35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i  114 (251)
T cd05041          35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC  114 (251)
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            5567889999999999999999999999999999999999999999998653 458899999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      +|+||+|+||++   +.++.++|+|||.+.........   .....+..|+|||.+.+..++.++|+||||++++++++ 
T Consensus       115 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~  191 (251)
T cd05041         115 IHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL  191 (251)
T ss_pred             ehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhc
Confidence            999999999999   56778999999988655422111   11123456999999988889999999999999999998 


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||.+.++
T Consensus       192 ~~~p~~~~~~  201 (251)
T cd05041         192 GDTPYPGMSN  201 (251)
T ss_pred             cCCCCccCCH
Confidence            8999977654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=6.7e-31  Score=192.77  Aligned_cols=163  Identities=29%  Similarity=0.517  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ......+.+|++++++++|+||+++++.+..++..++++||+++++|..++...   ..+++..+..++.+++.++.+||
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH  119 (286)
T cd06622          40 ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK  119 (286)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344567888999999999999999999999999999999999999999988753   36899999999999999999999


Q ss_pred             h-CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccccc------CCcchhHHHHHH
Q 030256           84 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR------YDEKVDMWSVGA  156 (180)
Q Consensus        84 ~-~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~------~~~~~Di~slg~  156 (180)
                      + .|++|+||+|+||++.   .++.++|+|||.+........ ....++..|+|||.+.+..      ++.++|+||+|+
T Consensus       120 ~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~  195 (286)
T cd06622         120 EEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVASLA-KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL  195 (286)
T ss_pred             hcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCCcc-ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHH
Confidence            7 5999999999999994   577899999998866533322 2233667899999885443      478999999999


Q ss_pred             HHHHHHhCCCCCCCCCc
Q 030256          157 ILFELLNGYPPFSAYRP  173 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~  173 (180)
                      ++|++++|..||...+.
T Consensus       196 il~~l~~g~~pf~~~~~  212 (286)
T cd06622         196 SILEMALGRYPYPPETY  212 (286)
T ss_pred             HHHHHHhCCCCCCCcch
Confidence            99999999999976443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1e-30  Score=189.28  Aligned_cols=163  Identities=21%  Similarity=0.372  Sum_probs=135.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+..|..+++.++|||++++++++..++..+++|||+++++|.+++..+. .+++..+..++.|++.++++||+.|
T Consensus        41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (258)
T cd05078          41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG  120 (258)
T ss_pred             HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            334567889999999999999999999999888999999999999999997654 5899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCC-----CceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCcchhHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDD-----DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE  160 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~-----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~  160 (180)
                      ++|+||+|+||++...+.     ...++++|||.+.......   ...++..|+|||.+.+. .++.++|+||+|+++|+
T Consensus       121 iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~  197 (258)
T cd05078         121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWE  197 (258)
T ss_pred             eecCCCccceEEEecccccccCCCceEEecccccccccCCch---hccccCCccCchhccCCCCCCchhhHHHHHHHHHH
Confidence            999999999999963221     1237899999876554322   23467789999998764 57899999999999999


Q ss_pred             HHhC-CCCCCCCCc
Q 030256          161 LLNG-YPPFSAYRP  173 (180)
Q Consensus       161 ~l~g-~~pf~~~~~  173 (180)
                      +++| ..||...++
T Consensus       198 l~~g~~~~~~~~~~  211 (258)
T cd05078         198 IFSGGDKPLSALDS  211 (258)
T ss_pred             HHcCCCCChhhccH
Confidence            9998 567665444

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=6.4e-31  Score=189.90  Aligned_cols=163  Identities=28%  Similarity=0.589  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .....++.+|++++++++|+||+++.+++...+..++++||+.+++|.+.+....  .+++..+..++.|++.++++||+
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (256)
T cd08218          40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD  119 (256)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3445678899999999999999999999999999999999999999999887543  57899999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-cccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|++|+||+|+||++   +.+..++++|||.+......... ....++..|+|||...+..++.++|+||+|++++++++
T Consensus       120 ~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~  196 (256)
T cd08218         120 RKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT  196 (256)
T ss_pred             CCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc
Confidence            999999999999999   46678999999988765443221 22346778999999988889999999999999999999


Q ss_pred             CCCCCCCCC
Q 030256          164 GYPPFSAYR  172 (180)
Q Consensus       164 g~~pf~~~~  172 (180)
                      |..||...+
T Consensus       197 g~~~~~~~~  205 (256)
T cd08218         197 LKHAFEAGN  205 (256)
T ss_pred             CCCCccCCC
Confidence            999997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=4.2e-31  Score=193.78  Aligned_cols=159  Identities=27%  Similarity=0.473  Sum_probs=135.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ......+.+|++++++++|||++++.+++...  ...+++|||++|++|.+++.+.. .+++..+..++.|++.++++||
T Consensus        47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH  126 (284)
T cd05079          47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG  126 (284)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34456789999999999999999999988765  57899999999999999987554 5899999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      ++|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||...+..++.++|+||||+++|
T Consensus       127 ~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~  203 (284)
T cd05079         127 SRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY  203 (284)
T ss_pred             HCCeeecccchheEEE---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence            9999999999999999   4567799999999876643321    11233556799999998888999999999999999


Q ss_pred             HHHhCCCCC
Q 030256          160 ELLNGYPPF  168 (180)
Q Consensus       160 ~~l~g~~pf  168 (180)
                      +++++..|+
T Consensus       204 ellt~~~~~  212 (284)
T cd05079         204 ELLTYCDSE  212 (284)
T ss_pred             hhhcCCCCC
Confidence            999977664

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=1e-30  Score=188.67  Aligned_cols=162  Identities=31%  Similarity=0.589  Sum_probs=140.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+..|++.+++++|+|++++++++.+.+..+++||++++++|.+++.....  +++..+..++.|++.++++||+.|
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~  123 (258)
T smart00219       44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN  123 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            456788999999999999999999999999999999999999999999876554  999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      ++|+||+|+||++   +.++.++|+|||.+..........  ...++..|+|||...+..++.++|+||+|++++++++ 
T Consensus       124 ~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~  200 (258)
T smart00219      124 FIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL  200 (258)
T ss_pred             eeecccccceEEE---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence            9999999999999   567789999999987665432111  1225578999999988889999999999999999998 


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||.+.+.
T Consensus       201 g~~p~~~~~~  210 (258)
T smart00219      201 GESPYPGMSN  210 (258)
T ss_pred             CCCCCCCCCH
Confidence            8999976544

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=6.8e-31  Score=194.19  Aligned_cols=160  Identities=30%  Similarity=0.522  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+.+|+.++++++|+||+++++++...+..++++||++ ++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus        48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~  126 (301)
T cd07873          48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL  126 (301)
T ss_pred             hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3456789999999999999999999999999999999996 5898887654 4589999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.
T Consensus       127 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  203 (301)
T cd07873         127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP  203 (301)
T ss_pred             CCCCCHHHEEE---CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence            99999999999   567789999999886543322 12223457789999987654 47889999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       204 ~f~~~~~  210 (301)
T cd07873         204 LFPGSTV  210 (301)
T ss_pred             CCCCCCH
Confidence            9987553

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.1e-30  Score=193.93  Aligned_cols=163  Identities=28%  Similarity=0.448  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ......+.+|++++++++|+||+++++++.+++..++++||+++++|.+++...  ..+++..+..++.|++.++++||+
T Consensus        40 ~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~  119 (314)
T cd08216          40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS  119 (314)
T ss_pred             hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445567999999999999999999999999999999999999999999998754  358899999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--------cccccccCccccCcccccc--ccCCcchhHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSV  154 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~--~~~~~~~Di~sl  154 (180)
                      .+++|+||+|+||++.   .++.+++.||+.+.......        ......++..|+|||.+.+  ..++.++|+||+
T Consensus       120 ~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~  196 (314)
T cd08216         120 KGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV  196 (314)
T ss_pred             CCeecCCCCcceEEEe---cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence            9999999999999994   56789999999875543211        1122335667999999865  357889999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 030256          155 GAILFELLNGYPPFSAYR  172 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~  172 (180)
                      |++++++++|..||.+.+
T Consensus       197 G~il~el~~g~~pf~~~~  214 (314)
T cd08216         197 GITACELANGHVPFKDMP  214 (314)
T ss_pred             HHHHHHHHhCCCCCCCCC
Confidence            999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=6.4e-31  Score=192.65  Aligned_cols=159  Identities=32%  Similarity=0.533  Sum_probs=135.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+|+.++++++|||++++++++.+++..++++||++ ++|.+++...   ..+++..+..++.|++.+|++||+.|
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~  121 (285)
T cd07861          43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR  121 (285)
T ss_pred             hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4567889999999999999999999999999999999996 5888887543   45899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++|+||+|+||++   +.++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus       122 i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg  198 (285)
T cd07861         122 VLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK  198 (285)
T ss_pred             eeecCCCHHHEEE---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence            9999999999999   5677899999998865543221 1223457789999987654 468899999999999999999


Q ss_pred             CCCCCCCC
Q 030256          165 YPPFSAYR  172 (180)
Q Consensus       165 ~~pf~~~~  172 (180)
                      +.||.+.+
T Consensus       199 ~~~~~~~~  206 (285)
T cd07861         199 KPLFHGDS  206 (285)
T ss_pred             CCCCCCCC
Confidence            99998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=3.7e-31  Score=206.33  Aligned_cols=162  Identities=27%  Similarity=0.484  Sum_probs=132.9

Q ss_pred             HHHHHHHHHHHHhcCCCc------cccccceEEEeC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHP------NIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.|++++++++|.      +++++.+++... +.++++++++ |++|.+++.+.+.+++..+..++.|++.+|+|
T Consensus       168 ~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~y  246 (467)
T PTZ00284        168 YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDY  246 (467)
T ss_pred             hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence            344567788888887554      588888888754 5789999988 78999988878889999999999999999999


Q ss_pred             HHh-CCCeeecCCCCCeeeecCC-------------CCceEEEeecCCccccCCCCcccccccCccccCccccccccCCc
Q 030256           82 LNS-HHIIHRDLKPENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE  147 (180)
Q Consensus        82 lh~-~~~~h~dl~~~nil~~~~~-------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~  147 (180)
                      ||+ .|++|+||||+||++...+             ....++|+|||.+......  .....++..|+|||.+.+..++.
T Consensus       247 LH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~~~  324 (467)
T PTZ00284        247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGLGWMY  324 (467)
T ss_pred             HHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcCCCCc
Confidence            998 5999999999999995321             1125999999987543222  22345788999999999999999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          148 KVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      ++|+|||||++|||++|+.||++.++
T Consensus       325 ~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        325 STDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            99999999999999999999987654

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=1.5e-30  Score=190.58  Aligned_cols=147  Identities=34%  Similarity=0.613  Sum_probs=128.7

Q ss_pred             cCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeec
Q 030256           22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSG  101 (180)
Q Consensus        22 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~  101 (180)
                      ..+|++++.+.+++..++..+++|||+++++|.+++..+..+++..+..++.|++.++++||+.|++|+||+|+||++  
T Consensus        53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~--  130 (279)
T cd05633          53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL--  130 (279)
T ss_pred             hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE--
Confidence            347999999999999999999999999999999999888889999999999999999999999999999999999999  


Q ss_pred             CCCCceEEEeecCCccccCCCCcccccccCccccCccccc-cccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          102 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       102 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~-~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                       +.++.++++|||++........ ....++..|+|||... +..++.++|+||+|++++++++|..||....
T Consensus       131 -~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         131 -DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             -CCCCCEEEccCCcceeccccCc-cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence             5677899999998865543322 2334788999999886 4557899999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=9.2e-31  Score=189.53  Aligned_cols=164  Identities=37%  Similarity=0.682  Sum_probs=141.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l   79 (180)
                      .+...+.+..|++++++++|+|++++++++..  ....++++||+++++|.+++..    ..++++..+..++.+++.++
T Consensus        39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l  118 (265)
T cd08217          39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL  118 (265)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence            34456678889999999999999999997753  4578999999999999999865    35689999999999999999


Q ss_pred             HHHH-----hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHH
Q 030256           80 EILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS  153 (180)
Q Consensus        80 ~~lh-----~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~s  153 (180)
                      ++||     +.+++|+||+|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||
T Consensus       119 ~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s  195 (265)
T cd08217         119 YECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS  195 (265)
T ss_pred             HHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHH
Confidence            9999     8999999999999999   4678899999999877654432 23345788899999998888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 030256          154 VGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~  172 (180)
                      +|++++++++|..||...+
T Consensus       196 lG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         196 LGCLIYELCALSPPFTARN  214 (265)
T ss_pred             HHHHHHHHHHCCCcccCcC
Confidence            9999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=1.2e-30  Score=189.06  Aligned_cols=160  Identities=26%  Similarity=0.491  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|++++++++|++++++++++.. +..+++|||+.+++|.+++....  .+++..+..++.|++.++++||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05069          45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4568889999999999999999988754 56889999999999999987543  47899999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|+++|++++ |
T Consensus       124 ~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g  200 (260)
T cd05069         124 IHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG  200 (260)
T ss_pred             eecccCcceEEE---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCC
Confidence            999999999999   56778999999998665433221  12234567999999988889999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||.+.++
T Consensus       201 ~~p~~~~~~  209 (260)
T cd05069         201 RVPYPGMVN  209 (260)
T ss_pred             CCCCCCCCH
Confidence            999987544

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=7.4e-31  Score=189.50  Aligned_cols=159  Identities=28%  Similarity=0.547  Sum_probs=135.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|+.++++++|||++++.+++..+ ..++++||+++++|.+++....  .++...+..++.|++.++++||+.|
T Consensus        42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  120 (254)
T cd05083          42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK  120 (254)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345788899999999999999999988654 4799999999999999987544  4789999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      ++|+|++|+||++   +.++.++|+|||.+.......  ........|+|||...+..++.++|+||+|++++++++ |.
T Consensus       121 ~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~  195 (254)
T cd05083         121 LVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR  195 (254)
T ss_pred             eeccccCcceEEE---cCCCcEEECCCccceeccccC--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999   466789999999886543221  12223467999999988889999999999999999997 99


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.+.
T Consensus       196 ~p~~~~~~  203 (254)
T cd05083         196 APYPKMSL  203 (254)
T ss_pred             CCCccCCH
Confidence            99976654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=9e-31  Score=189.63  Aligned_cols=161  Identities=27%  Similarity=0.515  Sum_probs=139.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|+.++++++|+|++++++++......++++|++++++|.+++....  .++...+..++.+++.++++||++|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i  124 (261)
T cd05034          45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY  124 (261)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4568899999999999999999999998889999999999999999987543  58999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.++.++++|||.+.........  .....+..|+|||...+..++.++|+||+|++++++++ |
T Consensus       125 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g  201 (261)
T cd05034         125 IHRDLAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYG  201 (261)
T ss_pred             ccCCcchheEEE---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCC
Confidence            999999999999   46788999999988765432211  11223457999999988889999999999999999998 9


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||.+.++
T Consensus       202 ~~p~~~~~~  210 (261)
T cd05034         202 RVPYPGMTN  210 (261)
T ss_pred             CCCCCCCCH
Confidence            999976553

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=206.40  Aligned_cols=167  Identities=27%  Similarity=0.524  Sum_probs=146.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      .++.+.+|.+|+++|.+++||||+.++++|..++.+++|+||++.|+|.+++..+.  .+.-....++++||+.+++||.
T Consensus       575 ~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe  654 (807)
T KOG1094|consen  575 TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE  654 (807)
T ss_pred             chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH
Confidence            45567899999999999999999999999999999999999999999999998773  3456677789999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +.++||||+.++|+++   +.+..+||+|||+++.+.....-   ....-..+|+|+|.+..++++.++|+|++|+++||
T Consensus       655 s~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE  731 (807)
T KOG1094|consen  655 SLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE  731 (807)
T ss_pred             hhchhhccccccceee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence            9999999999999999   68899999999999887665432   23345688999999999999999999999999999


Q ss_pred             HHh--CCCCCCCCCccc
Q 030256          161 LLN--GYPPFSAYRPCF  175 (180)
Q Consensus       161 ~l~--g~~pf~~~~~~~  175 (180)
                      +++  .+.||.+-+.++
T Consensus       732 ~~~~C~e~Py~~lt~e~  748 (807)
T KOG1094|consen  732 VFMLCREQPYSQLTDEQ  748 (807)
T ss_pred             HHHHHhhCchhhhhHHH
Confidence            866  899998766553

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-30  Score=189.75  Aligned_cols=163  Identities=28%  Similarity=0.522  Sum_probs=136.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCC------eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL   75 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i   75 (180)
                      ...+.+.+|++.+++++|+|++++++++...+      ..++++||+++++|..++...      ..+++..+..++.|+
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i  122 (273)
T cd05035          43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI  122 (273)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHH
Confidence            34567889999999999999999999875544      379999999999999887432      258899999999999


Q ss_pred             HHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHH
Q 030256           76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMW  152 (180)
Q Consensus        76 ~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~  152 (180)
                      +.++++||+.+++|+||+|+||++   +++..++|+|||.+.........   .....+..|+|||...+..++.++|+|
T Consensus       123 ~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~  199 (273)
T cd05035         123 ALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW  199 (273)
T ss_pred             HHHHHHHHhCCeeccccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchH
Confidence            999999999999999999999999   56778999999998765433211   112234579999999888899999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCc
Q 030256          153 SVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       153 slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+|+++|++++ |..||.+.++
T Consensus       200 SlG~il~el~~~g~~p~~~~~~  221 (273)
T cd05035         200 AFGVTMWEIATRGQTPYPGVEN  221 (273)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999 9999977554

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.9e-30  Score=189.92  Aligned_cols=150  Identities=34%  Similarity=0.602  Sum_probs=130.8

Q ss_pred             HHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCe
Q 030256           18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENI   97 (180)
Q Consensus        18 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~ni   97 (180)
                      .+++...||+++++.+.+...+..++++||+.|++|..++...+.+++..+..++.|++.++++||+.+++|+||+|+||
T Consensus        49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni  128 (278)
T cd05606          49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI  128 (278)
T ss_pred             HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence            34445589999999999999999999999999999999998777899999999999999999999999999999999999


Q ss_pred             eeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256           98 LLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus        98 l~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                      ++   +.++.++|+|||.+........ ....++..|+|||...+. .++.++|+||+|++++++++|+.||.+.
T Consensus       129 li---~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         129 LL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             EE---CCCCCEEEccCcCccccCccCC-cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            99   4667899999998865533222 234578889999998754 5889999999999999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.6e-31  Score=200.23  Aligned_cols=164  Identities=27%  Similarity=0.506  Sum_probs=140.7

Q ss_pred             hhhHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHH
Q 030256            4 KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         4 ~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~   81 (180)
                      ..+.+.-+-+..|+.+|.+| +|.+|+++++|-..++.+|+|||+- ..+|..++++... .....+..+.+|++.++.+
T Consensus       397 ~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~  475 (677)
T KOG0596|consen  397 EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKT  475 (677)
T ss_pred             hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHH
Confidence            34566677889999999999 7999999999999999999999975 7899999986654 3335888899999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCcccccccc-----------CCc
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR-----------YDE  147 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~-----------~~~  147 (180)
                      +|++|+||.||||.|.++    ..+.++|+|||.+.......   ......||..|++||.+....           .+.
T Consensus       476 IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r  551 (677)
T KOG0596|consen  476 IHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISR  551 (677)
T ss_pred             HHHhceeecCCCcccEEE----EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecC
Confidence            999999999999999998    57899999999998776543   334677999999999975321           567


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          148 KVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      ++|||||||++|+|+-|+.||....
T Consensus       552 ~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  552 KSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             ccchhhhhhHHHHHHhcCCchHHHH
Confidence            8999999999999999999997654

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=1e-30  Score=190.69  Aligned_cols=162  Identities=24%  Similarity=0.496  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l   79 (180)
                      ..+.+.+|++++++++|+|++++++++.+.+..+++|||+++++|.+++....         .+++..+..++.|++.++
T Consensus        51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l  130 (275)
T cd05046          51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM  130 (275)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999999899999999999999999997655         689999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  157 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~  157 (180)
                      ++||+.|++|+||+|+||++   +..+.++++|||.+........  .....++..|+|||...+..++.++|+||+|++
T Consensus       131 ~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~  207 (275)
T cd05046         131 DHLSNARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL  207 (275)
T ss_pred             HHhhhcCcccCcCccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHH
Confidence            99999999999999999999   4567899999998765432211  112234566999999888888999999999999


Q ss_pred             HHHHHh-CCCCCCCCCc
Q 030256          158 LFELLN-GYPPFSAYRP  173 (180)
Q Consensus       158 ~~~~l~-g~~pf~~~~~  173 (180)
                      ++++++ |..||.+.++
T Consensus       208 l~~l~~~~~~p~~~~~~  224 (275)
T cd05046         208 MWEVFTQGELPFYGLSD  224 (275)
T ss_pred             HHHHHhCCCCCccccch
Confidence            999998 8889965433

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=1.2e-30  Score=189.98  Aligned_cols=164  Identities=28%  Similarity=0.517  Sum_probs=135.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEe------CCeEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRL------HGRVPEQTARKFLQQ   74 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~   74 (180)
                      +...+.+.+|.+++++++|+||+++++++..      ....+++++|+++++|.+++..      ...+++..+..++.|
T Consensus        41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  120 (272)
T cd05075          41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD  120 (272)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence            4445678889999999999999999987632      2357899999999999988742      124789999999999


Q ss_pred             HHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhH
Q 030256           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM  151 (180)
Q Consensus        75 i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di  151 (180)
                      ++.++++||+.|++|+||+|+||++   +.+..++|+|||.+........   ......+..|++||...+..++.++|+
T Consensus       121 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  197 (272)
T cd05075         121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV  197 (272)
T ss_pred             HHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH
Confidence            9999999999999999999999999   5677899999999876543321   112234567999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCc
Q 030256          152 WSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       152 ~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      ||+|+++|++++ |+.||.+.++
T Consensus       198 ~slG~il~el~~~g~~p~~~~~~  220 (272)
T cd05075         198 WSFGVTMWEIATRGQTPYPGVEN  220 (272)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999 8999976543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=9.4e-31  Score=192.87  Aligned_cols=162  Identities=32%  Similarity=0.616  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|+.++++++|||++++++++...+..++++||+++++|.+++. ...++...+..++.+++.++++||+.|+
T Consensus        58 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~gi  136 (293)
T cd06647          58 PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQV  136 (293)
T ss_pred             hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            345678889999999999999999999999999999999999999999886 3468889999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+|++|+||++   +.++.++|+|||.+........ .....++..|++||...+..++.++|+||+|+++|++++|+.
T Consensus       137 ~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~  213 (293)
T cd06647         137 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP  213 (293)
T ss_pred             eeccCCHHHEEE---cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999   4667899999998765443322 222346778999999988888999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||...++
T Consensus       214 pf~~~~~  220 (293)
T cd06647         214 PYLNENP  220 (293)
T ss_pred             CCCCCCh
Confidence            9987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=216.12  Aligned_cols=164  Identities=34%  Similarity=0.608  Sum_probs=146.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ++..-..|..|-++|.--+.+.|+.+...|.+++++|+||||++||+|-.++.+..++++..+..++..+..|+..+|+.
T Consensus       115 Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m  194 (1317)
T KOG0612|consen  115 KRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM  194 (1317)
T ss_pred             hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc
Confidence            34456778889999999999999999999999999999999999999999999888899999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCcccccc-----ccCCcchhHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~-----~~~~~~~Di~slg~~~  158 (180)
                      |+|||||||+||++   +..+.++|.|||..-++......  ....||+.|+|||++..     +.|+...|.||+|+++
T Consensus       195 gyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~  271 (1317)
T KOG0612|consen  195 GYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFM  271 (1317)
T ss_pred             cceeccCCcceeEe---cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHH
Confidence            99999999999999   78999999999988777644332  34569999999999852     4588999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030256          159 FELLNGYPPFSAYR  172 (180)
Q Consensus       159 ~~~l~g~~pf~~~~  172 (180)
                      |||+-|..||.+.+
T Consensus       272 YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  272 YEMLYGETPFYADS  285 (1317)
T ss_pred             HHHHcCCCcchHHH
Confidence            99999999998643

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=1.4e-30  Score=190.88  Aligned_cols=161  Identities=35%  Similarity=0.595  Sum_probs=138.7

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+.+|+.++++++|+|++++++++..++..++|+||+ +++|.+++... .++++..+..++.|++.++++||+.|
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  119 (286)
T cd07832          41 GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG  119 (286)
T ss_pred             hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34567889999999999999999999999999999999999 99999988643 56899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHh
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~  163 (180)
                      ++|+||+|+||++   +.++.++++|||.+........  .....++..|+|||...+.. ++.++|+||+|++++++++
T Consensus       120 i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t  196 (286)
T cd07832         120 IMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN  196 (286)
T ss_pred             eecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc
Confidence            9999999999999   4577899999998876644321  22344778899999886544 6889999999999999999


Q ss_pred             CCCCCCCCC
Q 030256          164 GYPPFSAYR  172 (180)
Q Consensus       164 g~~pf~~~~  172 (180)
                      |.+||.+.+
T Consensus       197 g~~~~~~~~  205 (286)
T cd07832         197 GSPLFPGEN  205 (286)
T ss_pred             CCcCcCCCC
Confidence            998887654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.4e-30  Score=204.25  Aligned_cols=158  Identities=27%  Similarity=0.413  Sum_probs=132.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....+.+|++++++++|+||+++++++...+..+++++++ +++|.+++....     ......+..++.|++.+|+|||
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH  284 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH  284 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            4556889999999999999999999999999999999998 557777764321     2346678889999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ++|++|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus       285 ~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  361 (501)
T PHA03210        285 DKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM  361 (501)
T ss_pred             hCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999   5677899999999876644322  2235688999999999988999999999999999999


Q ss_pred             HhCCC-CCCC
Q 030256          162 LNGYP-PFSA  170 (180)
Q Consensus       162 l~g~~-pf~~  170 (180)
                      ++|.. ||..
T Consensus       362 l~~~~~p~~~  371 (501)
T PHA03210        362 LSHDFCPIGD  371 (501)
T ss_pred             HHCCCCCccC
Confidence            99765 4543

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=2.2e-30  Score=188.57  Aligned_cols=163  Identities=22%  Similarity=0.442  Sum_probs=134.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ...+.+.+|+.+++.++||||+++++.+.+....+++|||+++++|.+++...    ...+...+..++.|++.|+++||
T Consensus        37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH  116 (268)
T cd05086          37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH  116 (268)
T ss_pred             HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence            34567888999999999999999999999999999999999999999998754    23667788899999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCcccccc-------ccCCcchhHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-------QRYDEKVDMWS  153 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~-------~~~~~~~Di~s  153 (180)
                      +.+++|+||+|+||++   +.++.++|+|||.+.......   ......++..|+|||....       ..++.++|+||
T Consensus       117 ~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  193 (268)
T cd05086         117 KHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA  193 (268)
T ss_pred             HCCeeccCCccceEEE---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence            9999999999999999   567789999999875432211   1122346678999998743       23577899999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCc
Q 030256          154 VGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +|+++|++++ +..||...++
T Consensus       194 lG~~l~el~~~~~~p~~~~~~  214 (268)
T cd05086         194 LGVTLWELFENAAQPYSHLSD  214 (268)
T ss_pred             HHHHHHHHHhCCCCCCCCCCH
Confidence            9999999997 6778876554

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-30  Score=186.34  Aligned_cols=162  Identities=31%  Similarity=0.642  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|++++++++|+|++++.+++.+++..+++++++++++|.+++....++++..+..++.|++.++.+||+.|+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i  120 (254)
T cd06627          41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV  120 (254)
T ss_pred             HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            45677899999999999999999999999999999999999999999999877889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++.   .++.++|+|||.+........ .....++..|+|||...+..++.++|+|++|++++++++|..
T Consensus       121 ~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~  197 (254)
T cd06627         121 IHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP  197 (254)
T ss_pred             ccCCCCHHHEEEC---CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence            9999999999994   567899999999877654432 123446778999999887778999999999999999999999


Q ss_pred             CCCCCC
Q 030256          167 PFSAYR  172 (180)
Q Consensus       167 pf~~~~  172 (180)
                      ||.+.+
T Consensus       198 p~~~~~  203 (254)
T cd06627         198 PYYDLN  203 (254)
T ss_pred             CCCCcc
Confidence            997654

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.4e-30  Score=191.96  Aligned_cols=161  Identities=27%  Similarity=0.585  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|+.++++++|+|++++++.+..++..++++||+++++|.+++. ...+++..+..++.|++.++++||+.|+
T Consensus        59 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~gi  137 (292)
T cd06657          59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGV  137 (292)
T ss_pred             hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            455678889999999999999999999999999999999999999998765 5578999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++++|||.+........ .....++..|++||...+..++.++|+||+|+++|++++|..
T Consensus       138 vH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~  214 (292)
T cd06657         138 IHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP  214 (292)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999   5667899999998765543221 223446778999999888888999999999999999999999


Q ss_pred             CCCCCC
Q 030256          167 PFSAYR  172 (180)
Q Consensus       167 pf~~~~  172 (180)
                      ||.+.+
T Consensus       215 p~~~~~  220 (292)
T cd06657         215 PYFNEP  220 (292)
T ss_pred             CCCCCC
Confidence            997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=1.4e-30  Score=187.96  Aligned_cols=163  Identities=39%  Similarity=0.606  Sum_probs=142.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      +....++.+|++++++++|+||+++.+++.+.+..++++|++++++|.+++..    ...+++..+..++.+++.++++|
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l  119 (256)
T cd08530          40 QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL  119 (256)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            34566778899999999999999999999999999999999999999998865    34689999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |+.|++|+||+|.||++.   ....++|+|||.+...... ......++..|++||...+..++.++|+||+|+++++++
T Consensus       120 h~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~  195 (256)
T cd08530         120 HEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA  195 (256)
T ss_pred             hhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH
Confidence            999999999999999995   5677999999988665443 222344678899999998888899999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|+.||...+.
T Consensus       196 ~g~~p~~~~~~  206 (256)
T cd08530         196 TFAPPFEARSM  206 (256)
T ss_pred             hCCCCCCCCCH
Confidence            99999987654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=1.7e-30  Score=189.16  Aligned_cols=163  Identities=28%  Similarity=0.520  Sum_probs=137.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+..+.+.+|+.++++++|+|++++++++.+ +..+++|||+++++|.+++.... .++...+..++.+++.++++||+.
T Consensus        48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  126 (270)
T cd05056          48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK  126 (270)
T ss_pred             HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4456788999999999999999999998875 45789999999999999997644 589999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      |++|+||+|+||++.   ..+.++++|||.+..........  .......|+|||...+..++.++|+||||++++++++
T Consensus       127 ~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  203 (270)
T cd05056         127 RFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  203 (270)
T ss_pred             CeeccccChheEEEe---cCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHH
Confidence            999999999999994   56789999999886654332111  1123456999999888889999999999999999986


Q ss_pred             -CCCCCCCCCc
Q 030256          164 -GYPPFSAYRP  173 (180)
Q Consensus       164 -g~~pf~~~~~  173 (180)
                       |..||.+.+.
T Consensus       204 ~g~~pf~~~~~  214 (270)
T cd05056         204 LGVKPFQGVKN  214 (270)
T ss_pred             cCCCCCCCCCH
Confidence             9999976553

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=3.4e-31  Score=194.08  Aligned_cols=156  Identities=34%  Similarity=0.592  Sum_probs=132.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+.+|++++++++|+|++++++++.+.+..++++||++ ++|.+++.. ...+++..+..++.|++.++++||+.|++
T Consensus        43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~  121 (284)
T cd07839          43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL  121 (284)
T ss_pred             ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            4567789999999999999999999999999999999995 588887754 45699999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..
T Consensus       122 H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~  198 (284)
T cd07839         122 HRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  198 (284)
T ss_pred             cCCCCHHHEEE---cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence            99999999999   467789999999887554322 122334677899999887644 6899999999999999999888


Q ss_pred             CCC
Q 030256          167 PFS  169 (180)
Q Consensus       167 pf~  169 (180)
                      ||.
T Consensus       199 p~~  201 (284)
T cd07839         199 PLF  201 (284)
T ss_pred             CCc
Confidence            853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=1.4e-30  Score=188.92  Aligned_cols=162  Identities=38%  Similarity=0.657  Sum_probs=141.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+|+++++.++|+|++++++.+...+..++++|++++++|.+++...   ..+++..+..++.|++.++++||+.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~  121 (267)
T cd06610          42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN  121 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567889999999999999999999999999999999999999999998754   3589999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-----cccccCccccCccccccc-cCCcchhHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF  159 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~  159 (180)
                      |++|+||+|+||++   +.++.++|+|||.+.........     ....++..|+|||.+... .++.++|+||+|++++
T Consensus       122 ~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~  198 (267)
T cd06610         122 GQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI  198 (267)
T ss_pred             CeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence            99999999999999   45678999999988666443221     233467789999998766 6889999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|+.||...++
T Consensus       199 ~l~~g~~p~~~~~~  212 (267)
T cd06610         199 ELATGAAPYSKYPP  212 (267)
T ss_pred             HHHhCCCCccccCh
Confidence            99999999986554

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=2.1e-30  Score=187.20  Aligned_cols=160  Identities=28%  Similarity=0.565  Sum_probs=138.0

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+.+|++++++++||+++++++++......++++||+++++|.+++... .++++..+..++.+++.++++||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~  122 (256)
T cd05112          43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            356888999999999999999999999989999999999999999988754 4589999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      |+||+|+||++   +.+..++|+|||.+.........  .....+..|+|||...+..++.++|+||+|+++|++++ |.
T Consensus       123 h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~  199 (256)
T cd05112         123 HRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK  199 (256)
T ss_pred             ccccccceEEE---cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence            99999999999   46778999999988655433211  11223467999999988889999999999999999998 99


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||....
T Consensus       200 ~p~~~~~  206 (256)
T cd05112         200 TPYENRS  206 (256)
T ss_pred             CCCCcCC
Confidence            9997654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=1.8e-30  Score=194.62  Aligned_cols=162  Identities=31%  Similarity=0.532  Sum_probs=137.4

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHH
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKF   71 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~   71 (180)
                      ..+.+.+|+++++++ +|+||+++++++...+..++++||+++++|.+++....                .++...+..+
T Consensus        60 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  139 (334)
T cd05100          60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC  139 (334)
T ss_pred             HHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence            456788899999999 89999999999999899999999999999999987532                3677889999


Q ss_pred             HHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcc
Q 030256           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEK  148 (180)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~  148 (180)
                      +.|++.++++||++|++|+||+|+||++   +.++.++|+|||.+.........   ....++..|+|||...+..++.+
T Consensus       140 ~~qi~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  216 (334)
T cd05100         140 AYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ  216 (334)
T ss_pred             HHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch
Confidence            9999999999999999999999999999   45678999999998665432211   11123356999999998889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          149 VDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       149 ~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +|+||+|+++|++++ |..||.+.+.
T Consensus       217 ~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         217 SDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             hhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999998 8999977553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=210.52  Aligned_cols=161  Identities=34%  Similarity=0.568  Sum_probs=142.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      +..+-+..|+.+-+.|+|.|||+++|++..++.+-+.||-++||+|+++++.. +++  .+.++..+.+||+++|.|||+
T Consensus       614 r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe  693 (1226)
T KOG4279|consen  614 REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE  693 (1226)
T ss_pred             hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh
Confidence            34455778999999999999999999999999999999999999999999754 566  789999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc--cCCcchhHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~--~~~~~~Di~slg~~~~~~  161 (180)
                      +.+||||||-+|+++.  .-.+.++|.|||-++++..-. .+.+..||.-|+|||+...+  +|+.++|||||||++.||
T Consensus       694 n~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEM  771 (1226)
T KOG4279|consen  694 NKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEM  771 (1226)
T ss_pred             cceeeccccCCcEEEe--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEee
Confidence            9999999999999996  567789999999998875533 34567799999999998754  488999999999999999


Q ss_pred             HhCCCCCCC
Q 030256          162 LNGYPPFSA  170 (180)
Q Consensus       162 l~g~~pf~~  170 (180)
                      .||++||-.
T Consensus       772 ATGrPPF~E  780 (1226)
T KOG4279|consen  772 ATGRPPFVE  780 (1226)
T ss_pred             ccCCCCeee
Confidence            999999953

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=8.9e-31  Score=191.98  Aligned_cols=161  Identities=34%  Similarity=0.588  Sum_probs=138.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+++++.++||||+++++++...+..++++||+++++|..+......+++..+..++.|++.++++||+.|++
T Consensus        43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  122 (286)
T cd07846          43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII  122 (286)
T ss_pred             hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34567889999999999999999999999999999999999999988776666799999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      |+|++|+||++   +.++.++|+|||++........ .....++..|+|||...+ ..++.++|+||+|++++++++|..
T Consensus       123 h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~  199 (286)
T cd07846         123 HRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP  199 (286)
T ss_pred             ccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence            99999999999   5677899999998866533322 223346778999998865 346789999999999999999999


Q ss_pred             CCCCCC
Q 030256          167 PFSAYR  172 (180)
Q Consensus       167 pf~~~~  172 (180)
                      ||.+.+
T Consensus       200 ~~~~~~  205 (286)
T cd07846         200 LFPGDS  205 (286)
T ss_pred             CCCCCc
Confidence            997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=2.4e-30  Score=190.10  Aligned_cols=160  Identities=35%  Similarity=0.581  Sum_probs=137.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.+|++++++++||||+++++++..  .+.++++|||+++++|.+++..    ...+++..+..++.|++.++++
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~  120 (287)
T cd06621          41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY  120 (287)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            456678899999999999999999998864  3478999999999999987653    3458899999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ||+.|++|+||+|+||++   +....++|+|||++........ ....++..|++||...+..++.++|+||+|+++|++
T Consensus       121 lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l  196 (287)
T cd06621         121 LHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV  196 (287)
T ss_pred             HHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence            999999999999999999   4567799999998765433222 133467789999999888899999999999999999


Q ss_pred             HhCCCCCCCC
Q 030256          162 LNGYPPFSAY  171 (180)
Q Consensus       162 l~g~~pf~~~  171 (180)
                      ++|..||...
T Consensus       197 ~~g~~p~~~~  206 (287)
T cd06621         197 AQNRFPFPPE  206 (287)
T ss_pred             HhCCCCCCcc
Confidence            9999999866

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=1.4e-30  Score=191.32  Aligned_cols=163  Identities=28%  Similarity=0.595  Sum_probs=137.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------------CCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------RVP   64 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~   64 (180)
                      ......+.+|+.++++++|||++++++++.+++..++++||+++++|.+++....                      .++
T Consensus        49 ~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  128 (288)
T cd05050          49 ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS  128 (288)
T ss_pred             HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccC
Confidence            3456778899999999999999999999999889999999999999999986432                      367


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccc
Q 030256           65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQ  141 (180)
Q Consensus        65 ~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~  141 (180)
                      +..++.++.|++.++++||+.|++|+||+|+||++   +.++.++|+|||.+........   ......+..|+|||...
T Consensus       129 ~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (288)
T cd05050         129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF  205 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence            88899999999999999999999999999999999   5677899999998865433221   11222355699999988


Q ss_pred             cccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030256          142 FQRYDEKVDMWSVGAILFELLN-GYPPFSAYR  172 (180)
Q Consensus       142 ~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~  172 (180)
                      +..++.++|+||+|+++|++++ |..||.+.+
T Consensus       206 ~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         206 YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            8889999999999999999997 888986544

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.6e-30  Score=190.64  Aligned_cols=162  Identities=28%  Similarity=0.448  Sum_probs=134.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....+.+.+|++++++++||||+++.+++..  ....++++||+++++|.+++... ..+++..+..++.|++.++++||
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH  125 (284)
T cd05081          46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG  125 (284)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH
Confidence            3445678899999999999999999997643  45789999999999999998754 45899999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      ++|++|+||+|+||++   +.++.++|+|||++.........    ........|+|||...+..++.++|+||+|++++
T Consensus       126 ~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~  202 (284)
T cd05081         126 SKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY  202 (284)
T ss_pred             HCCceeccCCHhhEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence            9999999999999999   56778999999998765432211    1111234589999998888999999999999999


Q ss_pred             HHHhCCCCCCCC
Q 030256          160 ELLNGYPPFSAY  171 (180)
Q Consensus       160 ~~l~g~~pf~~~  171 (180)
                      ++++|..|+.+.
T Consensus       203 el~~~~~~~~~~  214 (284)
T cd05081         203 ELFTYSDKSCSP  214 (284)
T ss_pred             HHhhcCCcCCCc
Confidence            999987776543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-30  Score=189.59  Aligned_cols=162  Identities=28%  Similarity=0.605  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHHhcCC---CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....++.+|+.++++++   |||++++++++...+..+++|||+++++|.+++.. .++++..+..++.|++.++++||+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~  119 (277)
T cd06917          41 DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK  119 (277)
T ss_pred             hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34556888999999996   99999999999999999999999999999998864 578999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l  162 (180)
                      .|++|+||+|+||+++   ..+.++++|||.+........ .....++..|+|||...+ ..++.++|+||+|+++|+++
T Consensus       120 ~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll  196 (277)
T cd06917         120 VGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA  196 (277)
T ss_pred             CCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence            9999999999999994   577899999998876654332 223347778999998765 44689999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|..||.+.++
T Consensus       197 ~g~~p~~~~~~  207 (277)
T cd06917         197 TGNPPYSDVDA  207 (277)
T ss_pred             hCCCCCCCCCh
Confidence            99999976544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=1.8e-30  Score=188.16  Aligned_cols=160  Identities=26%  Similarity=0.491  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|+.++++++|++++++++++.. +..+++|||+++++|.+++...  ..+++..+..++.+++.++++||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05070          45 PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4568899999999999999999998754 5578999999999999998753  358999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++.   .++.++|+|||.+..........  ...++..|+|||...+..++.++|+||||+++|++++ |
T Consensus       124 ~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g  200 (260)
T cd05070         124 IHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG  200 (260)
T ss_pred             ccCCCccceEEEe---CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcC
Confidence            9999999999994   67789999999987654332111  1223457999999888889999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||.+.+.
T Consensus       201 ~~p~~~~~~  209 (260)
T cd05070         201 RVPYPGMNN  209 (260)
T ss_pred             CCCCCCCCH
Confidence            999977554

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2.2e-30  Score=190.42  Aligned_cols=159  Identities=33%  Similarity=0.556  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|+++++++ +|++|+++.+.+..++..++++||+++++|.+++....++++..+..++.|++.++++||+.|+
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i  126 (290)
T cd05613          47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI  126 (290)
T ss_pred             HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            346678899999999 6999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccc--cCCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~--~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++   +.++.++|+|||++.......  ......++..|+|||...+.  .++.++|+||+|+++|++++
T Consensus       127 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~  203 (290)
T cd05613         127 IYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT  203 (290)
T ss_pred             eccCCCHHHeEE---CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc
Confidence            999999999999   467789999999886654322  11234467889999988653  46788999999999999999


Q ss_pred             CCCCCCC
Q 030256          164 GYPPFSA  170 (180)
Q Consensus       164 g~~pf~~  170 (180)
                      |..||..
T Consensus       204 g~~p~~~  210 (290)
T cd05613         204 GASPFTV  210 (290)
T ss_pred             CCCCCCc
Confidence            9999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=1.5e-30  Score=196.40  Aligned_cols=158  Identities=36%  Similarity=0.535  Sum_probs=135.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ....+.+|+.++++++|+||+++++++...      ...++++||+. ++|.+.+...  ++...+..++.|++.++++|
T Consensus        58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~L  134 (353)
T cd07850          58 HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHL  134 (353)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999987543      35799999995 5888877533  88999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |+.|++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++++++
T Consensus       135 H~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~  211 (353)
T cd07850         135 HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  211 (353)
T ss_pred             HhCCeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH
Confidence            99999999999999999   567789999999987765444333445678899999999888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|+.||.+.+
T Consensus       212 ~g~~pf~~~~  221 (353)
T cd07850         212 RGTVLFPGTD  221 (353)
T ss_pred             HCCCCCCCCC
Confidence            9999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=2.9e-30  Score=188.73  Aligned_cols=161  Identities=30%  Similarity=0.613  Sum_probs=140.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+.++++++|||++++++++..++..++++||+++++|.+++. ..+++...+..++.+++.++.+||+.|++
T Consensus        45 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~  123 (277)
T cd06641          45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKI  123 (277)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCee
Confidence            34578889999999999999999999999999999999999999999886 45789999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|..|
T Consensus       124 h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  200 (277)
T cd06641         124 HRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             cCCCCHHhEEE---CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            99999999999   4667899999998765543321 1223467789999999888889999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       201 ~~~~~~  206 (277)
T cd06641         201 HSELHP  206 (277)
T ss_pred             CCccch
Confidence            976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2.8e-30  Score=187.14  Aligned_cols=162  Identities=30%  Similarity=0.502  Sum_probs=133.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEE-eCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+.+|..+++.++|||++++++++. .++..+++++|+.+++|.+++.... ..+...+..++.|++.++++||+.
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  117 (262)
T cd05058          38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK  117 (262)
T ss_pred             HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34567788999999999999999999765 4567899999999999999987543 467788899999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-----cccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +++|+||+|+||++   +..+.++|+|||++.......     ......++..|+|||...+..++.++|+||||+++|+
T Consensus       118 ~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e  194 (262)
T cd05058         118 KFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE  194 (262)
T ss_pred             CccccccCcceEEE---cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHH
Confidence            99999999999999   466789999999886543221     1112234567999999988889999999999999999


Q ss_pred             HHh-CCCCCCCCC
Q 030256          161 LLN-GYPPFSAYR  172 (180)
Q Consensus       161 ~l~-g~~pf~~~~  172 (180)
                      +++ |.+||...+
T Consensus       195 l~~~~~~~~~~~~  207 (262)
T cd05058         195 LMTRGAPPYPDVD  207 (262)
T ss_pred             HHcCCCCCCCCCC
Confidence            999 567776543

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=2.7e-30  Score=186.33  Aligned_cols=164  Identities=35%  Similarity=0.648  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ++....+.+|++++++++|+|++++.+.+...+..++++|++++++|.+++...    ..+++..+..++.+++.++++|
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l  119 (258)
T cd08215          40 EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL  119 (258)
T ss_pred             hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH
Confidence            356677889999999999999999999999999999999999999999998764    5699999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |+.|++|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++
T Consensus       120 h~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l  196 (258)
T cd08215         120 HSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL  196 (258)
T ss_pred             HhCCEecccCChHHeEE---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHH
Confidence            99999999999999999   467789999999887654443 22234567789999998888899999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|..||...++
T Consensus       197 ~~g~~p~~~~~~  208 (258)
T cd08215         197 CTLKHPFEGENL  208 (258)
T ss_pred             HcCCCCCCCCcH
Confidence            999999977643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.9e-30  Score=187.32  Aligned_cols=164  Identities=33%  Similarity=0.645  Sum_probs=141.0

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+.+|++++++++|+|++++++.+..++..++++||+++++|.+++....  .+++..+..++.|++.++++||+.
T Consensus        41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  120 (257)
T cd08225          41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR  120 (257)
T ss_pred             hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345678899999999999999999999999999999999999999999987543  478999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +++|+|++|+||+++  +....++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|
T Consensus       121 ~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g  198 (257)
T cd08225         121 KILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL  198 (257)
T ss_pred             CcccccCCHHHEEEc--CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999999995  3334579999998876644322 1233477789999999888899999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||...+.
T Consensus       199 ~~p~~~~~~  207 (257)
T cd08225         199 KHPFEGNNL  207 (257)
T ss_pred             CCCCCCccH
Confidence            999976543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=2.5e-30  Score=189.25  Aligned_cols=164  Identities=26%  Similarity=0.465  Sum_probs=139.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQLGA   77 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~   77 (180)
                      ......+.+|+.++++++|+|++++++++.. +...+++++++++++|.+++...        ..+++..++.++.+++.
T Consensus        49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~  128 (280)
T cd05043          49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC  128 (280)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence            4456778889999999999999999998765 56789999999999999998653        34889999999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSV  154 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~sl  154 (180)
                      ++++||+.+++|+||+|+||++   .....++++|||+++........   ....++..|+|||...+..++.++|+||+
T Consensus       129 ~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  205 (280)
T cd05043         129 GMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF  205 (280)
T ss_pred             HHHHHHHCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence            9999999999999999999999   46688999999998765332211   12234567999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCc
Q 030256          155 GAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       155 g~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+++|++++ |+.||.+.++
T Consensus       206 G~~l~el~~~g~~p~~~~~~  225 (280)
T cd05043         206 GVLLWELMTLGQTPYVEIDP  225 (280)
T ss_pred             HHHHHHHhcCCCCCcCcCCH
Confidence            999999999 9999986554

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=2.4e-30  Score=188.41  Aligned_cols=160  Identities=33%  Similarity=0.614  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~   80 (180)
                      ...+.+|+.+++++ +|+|++++++++...      ..+++++||+.+++|.+++...  ..+++..+..++.|++.+++
T Consensus        46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~  125 (272)
T cd06637          46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS  125 (272)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence            45688899999999 799999999998653      4689999999999999998754  35899999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccc-----cccCCcchhHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSV  154 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~sl  154 (180)
                      +||+.+++|+|++|+||++   +.++.++|+|||++....... ......++..|+|||.+.     +..++.++|+||+
T Consensus       126 ~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  202 (272)
T cd06637         126 HLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL  202 (272)
T ss_pred             HHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHH
Confidence            9999999999999999999   467789999999986543321 222345778899999875     3357889999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 030256          155 GAILFELLNGYPPFSAYR  172 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~  172 (180)
                      |+++|++++|..||.+..
T Consensus       203 Gv~l~el~~g~~p~~~~~  220 (272)
T cd06637         203 GITAIEMAEGAPPLCDMH  220 (272)
T ss_pred             HHHHHHHHhCCCCccccC
Confidence            999999999999997644

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=2.8e-30  Score=187.17  Aligned_cols=161  Identities=27%  Similarity=0.545  Sum_probs=137.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|++++++++|+|++++.+++.. ...++++||+++++|.+++.+.  ..++...+..++.|++.++++||+.|
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~  122 (260)
T cd05073          44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN  122 (260)
T ss_pred             HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35678889999999999999999999887 7789999999999999998753  34788899999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      ++|+||+|+||++   +....++|+|||.+.........  ....++..|+|||...+..++.++|+||+|++++++++ 
T Consensus       123 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~  199 (260)
T cd05073         123 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY  199 (260)
T ss_pred             ccccccCcceEEE---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence            9999999999999   56778999999988665432221  11224466999999988888999999999999999998 


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||.+.+.
T Consensus       200 g~~p~~~~~~  209 (260)
T cd05073         200 GRIPYPGMSN  209 (260)
T ss_pred             CCCCCCCCCH
Confidence            9999987544

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=8.9e-31  Score=187.51  Aligned_cols=154  Identities=31%  Similarity=0.462  Sum_probs=132.3

Q ss_pred             HHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL   92 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl   92 (180)
                      ..+|...+....|||++++++++...+..+++|||++|++|.+++....++++..+..++.|++.+++++|+.|++|+||
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl  111 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL  111 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence            34455566666899999999999999999999999999999999987778999999999999999999999999999999


Q ss_pred             CCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256           93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus        93 ~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                      +|+||++   +.++.+++.|||.+.......  ....++..|+|||...+..++.++|+||+|+++|++++|..|+...
T Consensus       112 kp~Nil~---~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~  185 (237)
T cd05576         112 NPNNILL---DDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH  185 (237)
T ss_pred             CHHHEEE---cCCCCEEEecccchhcccccc--ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence            9999999   467779999999775554322  1223456799999988888899999999999999999999887643

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-30  Score=190.45  Aligned_cols=158  Identities=32%  Similarity=0.525  Sum_probs=133.9

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ..+.+|++++++++|+||+++++++.+++..++|+||+.+ +|.+++... ..+++..+..++.|++.|+++||+.|++|
T Consensus        48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H  126 (291)
T cd07844          48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH  126 (291)
T ss_pred             hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            3456799999999999999999999999999999999964 999888654 35899999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||+|+||++   +.++.++|+|||.+........ .....++..|+|||...+ ..++.++|+||+|+++|++++|+.|
T Consensus       127 ~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~  203 (291)
T cd07844         127 RDLKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL  203 (291)
T ss_pred             ccCCHHHEEE---cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999   5677899999998865432211 112235677999998865 4578899999999999999999999


Q ss_pred             CCCCC
Q 030256          168 FSAYR  172 (180)
Q Consensus       168 f~~~~  172 (180)
                      |.+.+
T Consensus       204 ~~~~~  208 (291)
T cd07844         204 FPGST  208 (291)
T ss_pred             CCCCc
Confidence            97654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=2.8e-30  Score=189.95  Aligned_cols=158  Identities=32%  Similarity=0.525  Sum_probs=132.6

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ..+.+|+.++++++|+||+++.+++...+..++++||+. +++.+++... ..+++..+..++.|++.+|++||+.|++|
T Consensus        48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H  126 (291)
T cd07870          48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH  126 (291)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            356789999999999999999999999999999999995 6777666543 45788899999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||+|+||++   +.++.++|+|||.+....... ......++..|+|||...+. .++.++|+||+|+++|++++|..|
T Consensus       127 ~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  203 (291)
T cd07870         127 RDLKPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA  203 (291)
T ss_pred             CCCChHHEEE---cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999   467789999999886543221 12223467789999988654 478899999999999999999999


Q ss_pred             CCCCC
Q 030256          168 FSAYR  172 (180)
Q Consensus       168 f~~~~  172 (180)
                      |.+.+
T Consensus       204 f~~~~  208 (291)
T cd07870         204 FPGVS  208 (291)
T ss_pred             CCCch
Confidence            97654

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=2.3e-30  Score=190.57  Aligned_cols=158  Identities=32%  Similarity=0.501  Sum_probs=135.0

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+|++++++++||||+++.+++...  +..++++||+. ++|.+++.... .+++..+..++.|++.++++||+.|++
T Consensus        50 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~  128 (293)
T cd07843          50 TSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWIL  128 (293)
T ss_pred             hHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            456799999999999999999998877  89999999996 59998887544 489999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||+|++++++++|..
T Consensus       129 H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  205 (293)
T cd07843         129 HRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP  205 (293)
T ss_pred             eccCCHHHEEE---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCC
Confidence            99999999999   567889999999887665432 222334677899999887544 6889999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.++
T Consensus       206 ~f~~~~~  212 (293)
T cd07843         206 LFPGKSE  212 (293)
T ss_pred             CCCCCCh
Confidence            9986543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=3.7e-30  Score=189.18  Aligned_cols=161  Identities=26%  Similarity=0.464  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLGAG   78 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~   78 (180)
                      ....+.+|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++...          ...+...+..++.|++.+
T Consensus        52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  131 (288)
T cd05061          52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG  131 (288)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence            3456778999999999999999999999889999999999999999999643          224667889999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  155 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg  155 (180)
                      +++||++|++|+||+|+||++   +.++.++|+|||++.........   ....++..|+|||...+..++.++|+||+|
T Consensus       132 l~~lH~~~i~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG  208 (288)
T cd05061         132 MAYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG  208 (288)
T ss_pred             HHHHHhCCCcCCCCChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHH
Confidence            999999999999999999999   46778999999988655332211   112235679999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCC
Q 030256          156 AILFELLN-GYPPFSAYR  172 (180)
Q Consensus       156 ~~~~~~l~-g~~pf~~~~  172 (180)
                      +++|++++ |..||.+.+
T Consensus       209 ~~l~el~~~~~~p~~~~~  226 (288)
T cd05061         209 VVLWEITSLAEQPYQGLS  226 (288)
T ss_pred             HHHHHHHhCCCCCCCCCC
Confidence            99999998 788997644

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=1.8e-30  Score=190.47  Aligned_cols=161  Identities=32%  Similarity=0.659  Sum_probs=134.0

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEE-----eCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+.+|+.+++++ +|+|++++++++.     .++..+++|||+++++|.+++..    ...+++..+..++.|++.++
T Consensus        58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l  137 (286)
T cd06638          58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL  137 (286)
T ss_pred             HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence            45678899999999 7999999999873     34579999999999999988652    24588999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccc-----ccCCcchhHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWS  153 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-----~~~~~~~Di~s  153 (180)
                      .+||+.+++|+||+|+||++   ...+.++|+|||.+....... ......++..|+|||.+..     ..++.++|+||
T Consensus       138 ~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  214 (286)
T cd06638         138 QHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS  214 (286)
T ss_pred             HHHHhCCccccCCCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence            99999999999999999999   456679999999986654322 1223347788999998753     34788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030256          154 VGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~~  173 (180)
                      +|+++|++++|+.||.+.++
T Consensus       215 lGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         215 LGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             HHHHHHHHhcCCCCCCCCch
Confidence            99999999999999976544

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=3.6e-30  Score=187.34  Aligned_cols=161  Identities=30%  Similarity=0.590  Sum_probs=138.6

Q ss_pred             HHHHHHHHHHHHhc-CCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         9 ~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ...++.+|+.++++ ++|+|++++++++..++..++++||+++++|.+++..    ...+++..++.++.|++.++.+||
T Consensus        51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  130 (269)
T cd08528          51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH  130 (269)
T ss_pred             HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence            34456678888875 6999999999999999999999999999999988743    345899999999999999999999


Q ss_pred             h-CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           84 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~-~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      + .|++|+||+|+||++   +..+.++|+|||.+.............++..|++||...+..++.++|+||+|+++|+++
T Consensus       131 ~~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~  207 (269)
T cd08528         131 KEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC  207 (269)
T ss_pred             cCCceeecCCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH
Confidence            6 789999999999999   467789999999987765544334455788899999998888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|..||...+
T Consensus       208 ~g~~p~~~~~  217 (269)
T cd08528         208 TLQPPFYSTN  217 (269)
T ss_pred             hCCCcccccC
Confidence            9999997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=223.66  Aligned_cols=163  Identities=32%  Similarity=0.621  Sum_probs=144.2

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      ..+.+|+.+|..++|||+|+++++-...+..+|.||||+||+|.+.+....-.++.-...+..|++.+++|||+.|+||+
T Consensus      1279 ~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHR 1358 (1509)
T KOG4645|consen 1279 KLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHR 1358 (1509)
T ss_pred             cchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceec
Confidence            45778999999999999999999999999999999999999999998877778888888999999999999999999999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCccccccc---cCCcchhHHHHHHHHHHHH
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~~---~~~~~~Di~slg~~~~~~l  162 (180)
                      ||||.||++   +.++.++++|||.+.....+..     .....||+-|+|||++.+.   +...++||||||||+.||+
T Consensus      1359 DIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1359 DIKPANILL---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA 1435 (1509)
T ss_pred             CCCccceee---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee
Confidence            999999999   5777999999999988766531     2346799999999998654   4677999999999999999


Q ss_pred             hCCCCCCCCCcccc
Q 030256          163 NGYPPFSAYRPCFA  176 (180)
Q Consensus       163 ~g~~pf~~~~~~~~  176 (180)
                      ||+.||...+..|+
T Consensus      1436 tGkrPW~~~dne~a 1449 (1509)
T KOG4645|consen 1436 TGKRPWAELDNEWA 1449 (1509)
T ss_pred             cCCCchhhccchhH
Confidence            99999988776653

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=4.8e-30  Score=188.97  Aligned_cols=160  Identities=32%  Similarity=0.495  Sum_probs=133.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|++++++++|+|++++++++.+++..++++||++ ++|.+++.....  +++..+..++.|++.|+++||++|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  123 (294)
T PLN00009         45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV  123 (294)
T ss_pred             hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4567889999999999999999999999999999999995 588887765443  5788899999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++.  ..+..++++|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++|++++|.
T Consensus       124 ~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~  201 (294)
T PLN00009        124 LHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK  201 (294)
T ss_pred             eCCCCCcceEEEE--CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999995  3456799999999865533221 1223456789999987654 4788999999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||.+.+
T Consensus       202 ~pf~~~~  208 (294)
T PLN00009        202 PLFPGDS  208 (294)
T ss_pred             CCCCCCC
Confidence            9997654

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=4.5e-30  Score=186.01  Aligned_cols=160  Identities=26%  Similarity=0.545  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|+.++++++|+|++++.+++. .+..++++|++++++|.+++...  ..++...+..++.|++.++++||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i  123 (260)
T cd05067          45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            356888999999999999999998874 45689999999999999988653  358899999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.++.++++|||.+.........  ....++..|+|||......++.++|+||+|++++++++ |
T Consensus       124 ~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g  200 (260)
T cd05067         124 IHRDLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG  200 (260)
T ss_pred             ecccccHHhEEE---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCC
Confidence            999999999999   46778999999998665422211  12234567999999988889999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||.+.++
T Consensus       201 ~~p~~~~~~  209 (260)
T cd05067         201 RIPYPGMTN  209 (260)
T ss_pred             CCCCCCCCh
Confidence            999986654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.7e-30  Score=194.79  Aligned_cols=158  Identities=34%  Similarity=0.500  Sum_probs=135.8

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~d   91 (180)
                      .+.+|++++++++|+||+++++++...+..+++||++. ++|.+++.....+++..+..++.|++.++++||+.|++|+|
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d  144 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD  144 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            46789999999999999999999999999999999995 69999998777899999999999999999999999999999


Q ss_pred             CCCCCeeeecCCCCceEEEeecCCccccCCC---------------CcccccccCccccCcccccccc-CCcchhHHHHH
Q 030256           92 LKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVG  155 (180)
Q Consensus        92 l~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---------------~~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg  155 (180)
                      |+|+||++   +.++.++|+|||.+......               .......++..|+|||.+.+.. ++.++|+||+|
T Consensus       145 l~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  221 (335)
T PTZ00024        145 LSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG  221 (335)
T ss_pred             ccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence            99999999   56778999999988665411               1111223566799999887644 68899999999


Q ss_pred             HHHHHHHhCCCCCCCCCc
Q 030256          156 AILFELLNGYPPFSAYRP  173 (180)
Q Consensus       156 ~~~~~~l~g~~pf~~~~~  173 (180)
                      ++++++++|..||.+.++
T Consensus       222 ~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        222 CIFAELLTGKPLFPGENE  239 (335)
T ss_pred             HHHHHHHhCCCCCCCCCH
Confidence            999999999999986653

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=4.7e-30  Score=189.94  Aligned_cols=161  Identities=25%  Similarity=0.465  Sum_probs=135.7

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....++.+|+.++++++||||+++++++... ..+++++++++++|.+++.... .+++..+..++.|++.++++||++|
T Consensus        51 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~  129 (303)
T cd05110          51 KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR  129 (303)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            3345688899999999999999999988654 4678999999999999987654 5899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      ++|+||+|+||++   +.++.++|+|||.+.........   .....+..|++||...+..++.++|+||+|+++|++++
T Consensus       130 ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t  206 (303)
T cd05110         130 LVHRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT  206 (303)
T ss_pred             eeccccccceeee---cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence            9999999999999   45677999999998765432221   12224567999999988889999999999999999997


Q ss_pred             -CCCCCCCCC
Q 030256          164 -GYPPFSAYR  172 (180)
Q Consensus       164 -g~~pf~~~~  172 (180)
                       |..||.+..
T Consensus       207 ~g~~p~~~~~  216 (303)
T cd05110         207 FGGKPYDGIP  216 (303)
T ss_pred             CCCCCCCCCC
Confidence             999997654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=211.75  Aligned_cols=167  Identities=25%  Similarity=0.497  Sum_probs=149.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .+.++.+|..|+.||=+++||||+++.++.......+||.|||++|+|+.+|+++ +.|+..++..+++.|+.+++||.+
T Consensus       670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd  749 (996)
T KOG0196|consen  670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD  749 (996)
T ss_pred             cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence            4678899999999999999999999999999999999999999999999999876 469999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-cccc---cCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVC---GSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~---~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      .++|||||..+|||+   +.+..+|+.|||+++.+.+.... .+..   ...+|+|||.+...+++.+||+||+|+++||
T Consensus       750 m~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE  826 (996)
T KOG0196|consen  750 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE  826 (996)
T ss_pred             cCchhhhhhhhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence            999999999999999   78899999999999877554321 1111   2367999999999999999999999999999


Q ss_pred             HHh-CCCCCCCCCccc
Q 030256          161 LLN-GYPPFSAYRPCF  175 (180)
Q Consensus       161 ~l~-g~~pf~~~~~~~  175 (180)
                      .+. |..||.+.+.-+
T Consensus       827 VmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  827 VMSYGERPYWDMSNQD  842 (996)
T ss_pred             ecccCCCcccccchHH
Confidence            998 999998877643

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=4.4e-30  Score=196.39  Aligned_cols=160  Identities=29%  Similarity=0.542  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC---------------------------
Q 030256           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------------------   61 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------   61 (180)
                      .+.+.+|+.++.++. ||||+++++++...+..++++||+.+++|.+++..+.                           
T Consensus        84 ~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (401)
T cd05107          84 KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ  163 (401)
T ss_pred             HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence            456888999999997 9999999999999899999999999999999986432                           


Q ss_pred             -----------------------------------------------------------------------CCCHHHHHH
Q 030256           62 -----------------------------------------------------------------------RVPEQTARK   70 (180)
Q Consensus        62 -----------------------------------------------------------------------~~~~~~~~~   70 (180)
                                                                                             .++...+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  243 (401)
T cd05107         164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG  243 (401)
T ss_pred             cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence                                                                                   256677889


Q ss_pred             HHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCc
Q 030256           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  147 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~  147 (180)
                      ++.|++.+++|||+.+++|+||+|+||++.   ....++|+|||++.......   ......++..|+|||.+.+..++.
T Consensus       244 ~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  320 (401)
T cd05107         244 FSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT  320 (401)
T ss_pred             HHHHHHHHHHHHhcCCcCcccCCcceEEEe---CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc
Confidence            999999999999999999999999999994   57789999999987643221   111233567799999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCC
Q 030256          148 KVDMWSVGAILFELLN-GYPPFSAYR  172 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~-g~~pf~~~~  172 (180)
                      ++|+||+|++++|+++ |..||....
T Consensus       321 ~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         321 LSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             HhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999998 899997643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=4.7e-30  Score=187.73  Aligned_cols=156  Identities=34%  Similarity=0.565  Sum_probs=132.1

Q ss_pred             HHHHHHHHhcC-CCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           13 LDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        13 ~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+|+..++++ +|+|++++++++.++  +..++++||++ +++.+.+... ..+++..+..++.|++.++++||+.|++
T Consensus        44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~  122 (282)
T cd07831          44 NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF  122 (282)
T ss_pred             HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            34688889988 599999999999877  88999999996 4777777643 4689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc-cccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~-~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++.   . +.++|+|||.+.............++..|+|||... +..++.++|+||+|++++++++|..|
T Consensus       123 H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p  198 (282)
T cd07831         123 HRDIKPENILIK---D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL  198 (282)
T ss_pred             ecccCHHHEEEc---C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence            999999999995   4 889999999987765443333345678899999764 45578899999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       199 ~~~~~~  204 (282)
T cd07831         199 FPGTNE  204 (282)
T ss_pred             CCCCCH
Confidence            987654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=202.59  Aligned_cols=163  Identities=34%  Similarity=0.610  Sum_probs=147.7

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ..++.+++|+.||+++.||+||.+.-.|+..+.+++|||-+. |++.+.+-  ..+.+++.....+..||+.||+|||.+
T Consensus       605 kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k  683 (888)
T KOG4236|consen  605 KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK  683 (888)
T ss_pred             chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc
Confidence            456889999999999999999999999999999999999995 46655543  345799999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +++|+||||+||++.+.+.-.+++|||||+++.++.........|++.|+|||++++.+|...-|+||.|+++|.-+.|.
T Consensus       684 nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGT  763 (888)
T KOG4236|consen  684 NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGT  763 (888)
T ss_pred             ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEeccc
Confidence            99999999999999877777789999999999998877777888999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 030256          166 PPFSAY  171 (180)
Q Consensus       166 ~pf~~~  171 (180)
                      -||...
T Consensus       764 FPFNEd  769 (888)
T KOG4236|consen  764 FPFNED  769 (888)
T ss_pred             ccCCCc
Confidence            999763

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-31  Score=181.14  Aligned_cols=162  Identities=27%  Similarity=0.385  Sum_probs=135.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe-----CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLG   76 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~   76 (180)
                      ..+..+...+|++..++++|||+++++++...     ....|++++|...|+|.+.++..    ..+++.+++.|+.++.
T Consensus        58 ~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic  137 (302)
T KOG2345|consen   58 SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGIC  137 (302)
T ss_pred             chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHH
Confidence            45677889999999999999999999987532     34699999999999999988643    2499999999999999


Q ss_pred             HHHHHHHhCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----------cccccCccccCccccc---
Q 030256           77 AGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----------EKVCGSPLYMAPEVLQ---  141 (180)
Q Consensus        77 ~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~ape~~~---  141 (180)
                      +++++||+..  ++|+||||.||+++   +.+.+++.|||.+....-....          ....-+..|.|||.+.   
T Consensus       138 ~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~  214 (302)
T KOG2345|consen  138 RGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS  214 (302)
T ss_pred             HHHHHHhccCCcccccCCCcceeEec---CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc
Confidence            9999999998  99999999999995   5788999999988654321111          1233578899999985   


Q ss_pred             cccCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256          142 FQRYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       142 ~~~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      +...+.++|||||||++|.|+-|..||+.
T Consensus       215 ~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  215 HCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             CcccccccchhhhhHHHHHHHHcCCcchH
Confidence            44578999999999999999999999964

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=4.3e-30  Score=188.17  Aligned_cols=159  Identities=35%  Similarity=0.578  Sum_probs=136.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|++++++++|++++++++++.+.+..++++||+ +++|.+++....  .+++..+..++.|++.++++||+.++
T Consensus        42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~  120 (283)
T cd07835          42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV  120 (283)
T ss_pred             hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456788999999999999999999999999999999999 469999987665  68999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++.   .++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++|++++|.
T Consensus       121 ~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  197 (283)
T cd07835         121 LHRDLKPQNLLID---REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR  197 (283)
T ss_pred             eCCCCCHHHEEEc---CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999994   577899999999865432211 1223356789999987654 4688999999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||.+.+
T Consensus       198 ~pf~~~~  204 (283)
T cd07835         198 PLFPGDS  204 (283)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-31  Score=202.31  Aligned_cols=158  Identities=33%  Similarity=0.547  Sum_probs=136.6

Q ss_pred             HHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ....+|..++... +|||++++.+.+.+....++|||.+.|+.+.+.+...+.+. ..+..|+.+|+.++.+||++|++|
T Consensus       360 ~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvh  438 (612)
T KOG0603|consen  360 DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVH  438 (612)
T ss_pred             cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeee
Confidence            3455677677776 89999999999999999999999999998888777555555 777789999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  169 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~  169 (180)
                      ||++|+||++.  +..+.++|+|||.++.....  ..+...+..|.|||+....+++.++|+||||+++|+|++|+.||.
T Consensus       439 RDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~  514 (612)
T KOG0603|consen  439 RDLKPGNILLD--GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA  514 (612)
T ss_pred             cCCChhheeec--CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence            99999999995  46778999999998777655  333346888999999999999999999999999999999999998


Q ss_pred             CCCc
Q 030256          170 AYRP  173 (180)
Q Consensus       170 ~~~~  173 (180)
                      .-..
T Consensus       515 ~~P~  518 (612)
T KOG0603|consen  515 AHPA  518 (612)
T ss_pred             cCCc
Confidence            7443

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.3e-30  Score=186.58  Aligned_cols=161  Identities=35%  Similarity=0.635  Sum_probs=135.0

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCC------eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGA   77 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~   77 (180)
                      ..+.+.+|+.+++++ +|+||+++++++....      .+++++||+++++|.+++..    +..+++..+..++.|++.
T Consensus        45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~  124 (275)
T cd06608          45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR  124 (275)
T ss_pred             hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence            346788999999999 7999999999986543      58999999999999998764    346899999999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccc-----ccCCcchhH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-----QRYDEKVDM  151 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~-----~~~~~~~Di  151 (180)
                      ++++||+.|++|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||.+..     ..++.++|+
T Consensus       125 al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv  201 (275)
T cd06608         125 GLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV  201 (275)
T ss_pred             HHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence            9999999999999999999999   4677899999998866533221 223446778999998753     346788999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCC
Q 030256          152 WSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       152 ~slg~~~~~~l~g~~pf~~~~  172 (180)
                      ||+|++++++++|..||.+.+
T Consensus       202 ~slG~il~~l~~g~~p~~~~~  222 (275)
T cd06608         202 WSLGITAIELADGKPPLCDMH  222 (275)
T ss_pred             HHhHHHHHHHHhCCCCccccc
Confidence            999999999999999997644

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=4.2e-30  Score=188.31  Aligned_cols=159  Identities=33%  Similarity=0.575  Sum_probs=135.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|++++++++||||+++++++.+.+..++++||+. ++|.+++...  ..+++..+..++.|++.++++||+.|+
T Consensus        43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (284)
T cd07860          43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV  121 (284)
T ss_pred             chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4568889999999999999999999999999999999995 6898888653  458999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||...+.. ++.++|+||+|+++|++++|.
T Consensus       122 ~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  198 (284)
T cd07860         122 LHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR  198 (284)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999   5677899999998865543221 12233567899999876544 588999999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||.+.+
T Consensus       199 ~p~~~~~  205 (284)
T cd07860         199 ALFPGDS  205 (284)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=7.2e-31  Score=187.04  Aligned_cols=164  Identities=31%  Similarity=0.530  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....-||+.++++++|||++.+..++.. +..+++++||.+. +|...++-+     ..++...+..+++||+.++.|||
T Consensus        71 S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH  149 (438)
T KOG0666|consen   71 SMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH  149 (438)
T ss_pred             CHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh
Confidence            3456679999999999999999999877 7799999999965 888877532     34899999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeec-CCCCceEEEeecCCccccCCCC----cccccccCccccCcccccccc-CCcchhHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAI  157 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~  157 (180)
                      ++-++||||+|.||++.. -.+.++++|.|+|+++...++-    ......-|.+|.|||.+.+.. |+.+.|+|++||+
T Consensus       150 ~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCI  229 (438)
T KOG0666|consen  150 SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCI  229 (438)
T ss_pred             hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHH
Confidence            999999999999999853 2456889999999997765432    222344688999999987664 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030256          158 LFELLNGYPPFSAYRPC  174 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~~  174 (180)
                      +.|++|.++.|.+...+
T Consensus       230 faElLtl~PlF~g~E~k  246 (438)
T KOG0666|consen  230 FAELLTLEPLFKGREEK  246 (438)
T ss_pred             HHHHHccCccccchhhh
Confidence            99999999999776554

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=8.8e-30  Score=187.34  Aligned_cols=161  Identities=35%  Similarity=0.662  Sum_probs=134.4

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+.+|+.+++++ +|||++++++++...     +..++++||+++++|.+++..    ...+++..+..++.|++.++
T Consensus        62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al  141 (291)
T cd06639          62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL  141 (291)
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence            45677899999999 899999999988643     368999999999999998753    34689999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc-----cCCcchhHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-----RYDEKVDMWS  153 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-----~~~~~~Di~s  153 (180)
                      ++||+.|++|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+...     .++.++|+||
T Consensus       142 ~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s  218 (291)
T cd06639         142 QHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS  218 (291)
T ss_pred             HHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHH
Confidence            99999999999999999999   466779999999886654322 11233467789999987543     3678999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030256          154 VGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~~  173 (180)
                      +|+++|++++|+.||...++
T Consensus       219 lGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         219 LGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             HHHHHHHHhhCCCCCCCCcH
Confidence            99999999999999977554

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=1.3e-29  Score=187.95  Aligned_cols=157  Identities=34%  Similarity=0.576  Sum_probs=133.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|+++++.++|||++++.+++.+.+..++++||++ +++.+.+.. ..++++..+..++.|++.++.+||+.|+
T Consensus        58 ~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i  136 (307)
T cd06607          58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER  136 (307)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34568889999999999999999999999999999999996 577776653 4568999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc---cccCCcchhHHHHHHHHHHHHhC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|+||+|+||++   +.++.++|+|||++......   ....++..|+|||...   ...++.++|+||+|+++|++++|
T Consensus       137 ~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg  210 (307)
T cd06607         137 IHRDIKAGNILL---TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  210 (307)
T ss_pred             eecCCCcccEEE---CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence            999999999999   46778999999987554322   1234677899999874   34578899999999999999999


Q ss_pred             CCCCCCCC
Q 030256          165 YPPFSAYR  172 (180)
Q Consensus       165 ~~pf~~~~  172 (180)
                      ..||...+
T Consensus       211 ~~p~~~~~  218 (307)
T cd06607         211 KPPLFNMN  218 (307)
T ss_pred             CCCCCCcc
Confidence            99997644

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1e-29  Score=186.69  Aligned_cols=159  Identities=34%  Similarity=0.565  Sum_probs=137.9

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|+++++++ +|++++++.+.+..++..++++||+++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus        47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~  126 (288)
T cd05583          47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGI  126 (288)
T ss_pred             HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345677899999999 6999999999999999999999999999999998877789999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCcccccccc--CCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~--~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++   +.++.++++|||++........  .....++..|++||...+..  ++.++|+||+|++++++++
T Consensus       127 ~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t  203 (288)
T cd05583         127 IYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT  203 (288)
T ss_pred             eccCCCHHHeEE---CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence            999999999999   4567899999998866543321  11234678899999987654  7889999999999999999


Q ss_pred             CCCCCCC
Q 030256          164 GYPPFSA  170 (180)
Q Consensus       164 g~~pf~~  170 (180)
                      |..||..
T Consensus       204 g~~p~~~  210 (288)
T cd05583         204 GASPFTV  210 (288)
T ss_pred             CCCCccc
Confidence            9999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=4.9e-30  Score=187.63  Aligned_cols=161  Identities=38%  Similarity=0.610  Sum_probs=139.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|++++++++|++++++++++..++..++++||+++ ++.+.+... .++++..+..++.|++.++++||+.++
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  119 (283)
T cd05118          41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI  119 (283)
T ss_pred             hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456788899999999999999999999999999999999965 888877653 578999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++   +.++.++|+|||.+....... ......++..|.|||...+. .++.++|+||+|++++++++|+
T Consensus       120 ~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~  196 (283)
T cd05118         120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR  196 (283)
T ss_pred             eecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence            999999999999   467789999999887665443 22233467779999998776 6899999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||++.+.
T Consensus       197 ~~~~~~~~  204 (283)
T cd05118         197 PLFPGKSE  204 (283)
T ss_pred             CCCCCCCH
Confidence            99987653

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=5.7e-30  Score=186.93  Aligned_cols=162  Identities=38%  Similarity=0.697  Sum_probs=142.6

Q ss_pred             HHHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+.+|.+++++++ |+||+++++++.+++..+++||++++++|.+++.+.+.++...+..++.|++.++++||+.|
T Consensus        43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~  122 (280)
T cd05581          43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG  122 (280)
T ss_pred             HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34567888999999998 99999999999999999999999999999999988888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---------------------ccccccCccccCccccccccC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------AEKVCGSPLYMAPEVLQFQRY  145 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---------------------~~~~~~~~~~~ape~~~~~~~  145 (180)
                      ++|+|++|+||++   +.++.++++|||.+........                     .....++..|+|||...+..+
T Consensus       123 ~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~  199 (280)
T cd05581         123 IIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA  199 (280)
T ss_pred             eeecCCCHHHeEE---CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence            9999999999999   4677899999998866543221                     112335678999999888888


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          146 DEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       146 ~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      +.++|+||+|++++++++|+.||...+
T Consensus       200 ~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         200 GKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999999999998765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=7.2e-30  Score=186.96  Aligned_cols=162  Identities=31%  Similarity=0.624  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEE------eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQ------AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l   79 (180)
                      ...++..|+.+++++ +|+|++++++++.      ..+..+++|||+++++|.+++...  ..+++..+..++.|++.++
T Consensus        55 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al  134 (282)
T cd06636          55 EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL  134 (282)
T ss_pred             HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence            445688899999999 7999999999874      246889999999999999988753  3488889999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccc-----cccCCcchhHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWS  153 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~s  153 (180)
                      ++||+.|++|+|++|+||++   +..+.++|+|||.+...... .......++..|+|||.+.     ...++.++|+||
T Consensus       135 ~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvws  211 (282)
T cd06636         135 AHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWS  211 (282)
T ss_pred             HHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhH
Confidence            99999999999999999999   46677999999987654322 1222345778899999875     345788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030256          154 VGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~~  173 (180)
                      +|+++|++++|..||.+..+
T Consensus       212 lG~~l~el~~g~~p~~~~~~  231 (282)
T cd06636         212 LGITAIEMAEGAPPLCDMHP  231 (282)
T ss_pred             HHHHHHHHHhCCCCccccCH
Confidence            99999999999999976543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3e-30  Score=192.98  Aligned_cols=162  Identities=34%  Similarity=0.561  Sum_probs=140.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .....+.+|+.++++++|+||+++.+++...+     ..+++++|++ ++|.+++....++++..+..++.+++.++++|
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~L  119 (330)
T cd07834          41 IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL  119 (330)
T ss_pred             hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            34567888999999999999999999987664     7899999996 58999888777899999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC----cccccccCccccCccccccc-cCCcchhHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI  157 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~  157 (180)
                      |+.|++|+||+|.||++   +.++.++|+|||.+.......    ......++..|+|||.+.+. .++.++|+||+|++
T Consensus       120 H~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~i  196 (330)
T cd07834         120 HSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCI  196 (330)
T ss_pred             HhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHH
Confidence            99999999999999999   466889999999987765442    12334467789999999877 78999999999999


Q ss_pred             HHHHHhCCCCCCCCCc
Q 030256          158 LFELLNGYPPFSAYRP  173 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~  173 (180)
                      ++++++|..||.+.+.
T Consensus       197 l~~l~~g~~pf~~~~~  212 (330)
T cd07834         197 FAELLTRKPLFPGRDY  212 (330)
T ss_pred             HHHHHcCCCCcCCCCH
Confidence            9999999999987653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=1e-29  Score=188.74  Aligned_cols=164  Identities=29%  Similarity=0.517  Sum_probs=135.0

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .+.+.+|+.++++++||||+++++++.+.  +..++|+|++++ ++.+.+...     ..+++..+..++.|++.++++|
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  124 (316)
T cd07842          46 SQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL  124 (316)
T ss_pred             cHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence            45677899999999999999999999887  789999999954 777666422     2588999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeec-CCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccc-cCCcchhHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA  156 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~  156 (180)
                      |+.+++|+||+|+||++.. .+..+.++|+|||++........    .....++..|+|||...+. .++.++|+||+|+
T Consensus       125 H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  204 (316)
T cd07842         125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC  204 (316)
T ss_pred             HhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence            9999999999999999942 11278899999998876543322    1223467789999987664 4788999999999


Q ss_pred             HHHHHHhCCCCCCCCCcc
Q 030256          157 ILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~~  174 (180)
                      +++++++|+.||.+.+..
T Consensus       205 ~l~~l~~~~~~~~~~~~~  222 (316)
T cd07842         205 IFAELLTLEPIFKGREAK  222 (316)
T ss_pred             HHHHHHhcCCCCcCCccc
Confidence            999999999999876654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=7.7e-30  Score=190.74  Aligned_cols=161  Identities=24%  Similarity=0.378  Sum_probs=134.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+++|+.+++.++||||+++++++...+..++++||+.++++.+++....  .+++..+..++.|++.+|++||++|
T Consensus        42 ~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~  121 (328)
T cd08226          42 HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG  121 (328)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34678899999999999999999999999999999999999999999887643  4899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--------ccccccCccccCccccccc--cCCcchhHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGA  156 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~--~~~~~~Di~slg~  156 (180)
                      ++|+||+|+||++.   ..+.+++.||+.+........        .....++..|+|||.+.+.  .++.++|+||+|+
T Consensus       122 ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~  198 (328)
T cd08226         122 YIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI  198 (328)
T ss_pred             eecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHH
Confidence            99999999999994   567799999875433221110        0111234569999998763  4788999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 030256          157 ILFELLNGYPPFSAYR  172 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~  172 (180)
                      ++|++++|..||.+..
T Consensus       199 ~l~el~~g~~p~~~~~  214 (328)
T cd08226         199 TACELATGRVPFQDML  214 (328)
T ss_pred             HHHHHHhCCCCCCCcC
Confidence            9999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=8.7e-30  Score=186.42  Aligned_cols=160  Identities=28%  Similarity=0.502  Sum_probs=137.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+|++++++++|+|++++.+++..  ....++++||+++++|.+++.... .++...+..++.|++.++++||+.
T Consensus        49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~  128 (284)
T cd05038          49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ  128 (284)
T ss_pred             HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence            45678999999999999999999999876  558999999999999999997654 589999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+||+|+||++   +.++.++|+|||.+.........    ........|.+||...+..++.++|+||+|++++++
T Consensus       129 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el  205 (284)
T cd05038         129 RYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL  205 (284)
T ss_pred             CeecCCCCHHhEEE---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence            99999999999999   46688999999998766532111    112234569999999888899999999999999999


Q ss_pred             HhCCCCCCCC
Q 030256          162 LNGYPPFSAY  171 (180)
Q Consensus       162 l~g~~pf~~~  171 (180)
                      ++|..|+...
T Consensus       206 ~tg~~p~~~~  215 (284)
T cd05038         206 FTYGDPSQSP  215 (284)
T ss_pred             eccCCCcccc
Confidence            9999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-29  Score=186.14  Aligned_cols=161  Identities=35%  Similarity=0.563  Sum_probs=137.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+|++++++++|+|++++.+++.+.  +..+++++|++ ++|.+++... ..+++..+..++.|++.++++||+.
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~  119 (287)
T cd07840          41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN  119 (287)
T ss_pred             chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345678899999999999999999999887  89999999996 4898888654 4799999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l  162 (180)
                      |++|+||+|+||++   +.++.++++|||.+........  .....++..|+|||.+.+ ..++.++|+||+|+++++++
T Consensus       120 ~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~  196 (287)
T cd07840         120 GILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF  196 (287)
T ss_pred             CceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence            99999999999999   5678899999999876654431  222345677999997764 45789999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|+.||.+.+.
T Consensus       197 t~~~p~~~~~~  207 (287)
T cd07840         197 LGKPIFQGSTE  207 (287)
T ss_pred             hCCCCCCCCCh
Confidence            99999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.9e-31  Score=188.15  Aligned_cols=158  Identities=34%  Similarity=0.567  Sum_probs=146.3

Q ss_pred             HHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC
Q 030256           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK   93 (180)
Q Consensus        14 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~   93 (180)
                      ..|-++|+..+||.+..+..+|..++.+|+||||..||.|...++....+++.....+...|+.||.|||+++++++|++
T Consensus       216 lTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK  295 (516)
T KOG0690|consen  216 LTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLK  295 (516)
T ss_pred             hhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeech
Confidence            44778999999999999999999999999999999999999999888889999999999999999999999999999999


Q ss_pred             CCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256           94 PENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus        94 ~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      .+|+++   +.++.++|.|||+.+.-. ......+.+|++.|+|||++....|+.+.|.|.+|+++|||++|+.||...+
T Consensus       296 LENLlL---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d  372 (516)
T KOG0690|consen  296 LENLLL---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD  372 (516)
T ss_pred             hhhhee---ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence            999999   799999999999987644 3456677889999999999999999999999999999999999999998876


Q ss_pred             cc
Q 030256          173 PC  174 (180)
Q Consensus       173 ~~  174 (180)
                      ..
T Consensus       373 h~  374 (516)
T KOG0690|consen  373 HE  374 (516)
T ss_pred             hh
Confidence            54

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=4.1e-30  Score=192.64  Aligned_cols=161  Identities=33%  Similarity=0.529  Sum_probs=136.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....+.+|+.++++++||||+++.+++..    ....++++||+. ++|.+++.....+++..+..++.|++.++++||+
T Consensus        47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  125 (334)
T cd07855          47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS  125 (334)
T ss_pred             chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34567789999999999999999998753    357899999995 6999998877789999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCcccccc-ccCCcchhHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~  158 (180)
                      .|++|+||+|+||++   +.++.++|+|||++........     .....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus       126 ~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l  202 (334)
T cd07855         126 ANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF  202 (334)
T ss_pred             CCeecCCCCHHHEEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHH
Confidence            999999999999999   5678899999999866533221     123357788999998765 4578999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030256          159 FELLNGYPPFSAYRP  173 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~  173 (180)
                      |++++|+.||.+.+.
T Consensus       203 ~el~~g~~pf~~~~~  217 (334)
T cd07855         203 AEMLGRRQLFPGKNY  217 (334)
T ss_pred             HHHHcCCCccCCCCh
Confidence            999999999987653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=1.5e-29  Score=185.31  Aligned_cols=160  Identities=33%  Similarity=0.575  Sum_probs=135.5

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+|++++++++|+|++++++++.+.+..++++||+++ +|.+++....   ++++..+..++.|++.++++||+.|
T Consensus        42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (284)
T cd07836          42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR  120 (284)
T ss_pred             hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45667899999999999999999999999999999999965 8888876543   5899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++|+||+|+||++   ++++.++++|||.+........ .....++..|++||.+.+. .++.++|+||+|++++++++|
T Consensus       121 i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g  197 (284)
T cd07836         121 VLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG  197 (284)
T ss_pred             eeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999999999999   5677899999998865433221 1223356789999987653 568899999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||.+.+.
T Consensus       198 ~~~~~~~~~  206 (284)
T cd07836         198 RPLFPGTNN  206 (284)
T ss_pred             CCCCCCCCc
Confidence            999987654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=1.3e-29  Score=187.92  Aligned_cols=158  Identities=37%  Similarity=0.537  Sum_probs=132.9

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+|+.++++++|+|++++++++.+.  +..++++||+. ++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  130 (309)
T cd07845          52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFII  130 (309)
T ss_pred             hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456799999999999999999998754  57899999995 5888887753 5689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      |+||+|+||++   +..+.++|+|||.+....... .......+..|+|||.+.+ ..++.++|+||+|+++|++++|+.
T Consensus       131 H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  207 (309)
T cd07845         131 HRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP  207 (309)
T ss_pred             cCCCCHHHEEE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence            99999999999   567789999999987664432 1122234667999998765 457899999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.++
T Consensus       208 ~f~~~~~  214 (309)
T cd07845         208 LLPGKSE  214 (309)
T ss_pred             CCCCCCH
Confidence            9986654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=3.8e-29  Score=185.90  Aligned_cols=158  Identities=35%  Similarity=0.588  Sum_probs=134.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|++++++++|+|++++.+++.+.+..++++||+. +++.+.+.. ..++++..+..++.|++.++++||+.|+
T Consensus        64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi  142 (313)
T cd06633          64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM  142 (313)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999995 577776654 4568999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc---cccCCcchhHHHHHHHHHHHHhC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|+||+|+||++   ..++.++|+|||.+.....   .....++..|+|||.+.   +..++.++|+||+|+++|++++|
T Consensus       143 ~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g  216 (313)
T cd06633         143 IHRDIKAGNILL---TEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  216 (313)
T ss_pred             ecCCCChhhEEE---CCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999999   4667899999998754322   22345678899999874   35578899999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||.+.++
T Consensus       217 ~~p~~~~~~  225 (313)
T cd06633         217 KPPLFNMNA  225 (313)
T ss_pred             CCCCCCCCh
Confidence            999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=1.4e-29  Score=186.03  Aligned_cols=161  Identities=30%  Similarity=0.524  Sum_probs=134.8

Q ss_pred             HHHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.+|+.++.++. |+||+++++++...+..++++|++. .++.++..     ....+++..+..++.+++.++++
T Consensus        44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  122 (288)
T cd06616          44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY  122 (288)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            44567888999999995 9999999999988889999999984 56655432     23569999999999999999999


Q ss_pred             HHhC-CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc---cCCcchhHHHHHHH
Q 030256           82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAI  157 (180)
Q Consensus        82 lh~~-~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~---~~~~~~Di~slg~~  157 (180)
                      ||+. +++|+||+|+||++   +..+.++|+|||++.............++..|+|||.+.+.   .++.++|+||+|++
T Consensus       123 lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i  199 (288)
T cd06616         123 LKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT  199 (288)
T ss_pred             HhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence            9974 99999999999999   45678999999998765544333344577889999998765   68899999999999


Q ss_pred             HHHHHhCCCCCCCCC
Q 030256          158 LFELLNGYPPFSAYR  172 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~  172 (180)
                      +|++++|+.||...+
T Consensus       200 l~el~~g~~p~~~~~  214 (288)
T cd06616         200 LYEVATGKFPYPKWN  214 (288)
T ss_pred             HHHHHhCCCCchhcc
Confidence            999999999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-29  Score=195.13  Aligned_cols=168  Identities=34%  Similarity=0.637  Sum_probs=147.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+.+-.-++.|-+||.+.+.+.||+++-+|.+.+.+|+||||++||++-.+|-+.+-|.++.++.++..+.-|++..|..
T Consensus       669 ~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm  748 (1034)
T KOG0608|consen  669 MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM  748 (1034)
T ss_pred             hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc
Confidence            34445567889999999999999999999999999999999999999999998888899999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccC-----------CC---Cc---------------------------
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-----------PG---NY---------------------------  124 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-----------~~---~~---------------------------  124 (180)
                      |++|+||||+|||+   +.++.++|+|||+.....           +.   +.                           
T Consensus       749 GFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r  825 (1034)
T KOG0608|consen  749 GFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQR  825 (1034)
T ss_pred             cceecccCccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhh
Confidence            99999999999999   688999999999874320           00   00                           


Q ss_pred             --ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 030256          125 --AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA  176 (180)
Q Consensus       125 --~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~~~  176 (180)
                        .-...|+..|+|||++...+++...|.||.|++++||+-|+.||-+.+|-..
T Consensus       826 ~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  826 ILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             hhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence              0024588999999999999999999999999999999999999998887643

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=185.61  Aligned_cols=158  Identities=32%  Similarity=0.548  Sum_probs=136.8

Q ss_pred             HHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        12 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+|+..+++++ |+|++++++++.+++..+++|||+ +++|.+.+....  .+++..+..++.|++.++.+||++|++
T Consensus        43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~  121 (283)
T cd07830          43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF  121 (283)
T ss_pred             HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3456899999998 999999999999999999999999 779988887654  689999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc-cccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~-~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||.+.............++..|+|||.+. +..++.++|+||+|++++++++|+.|
T Consensus       122 H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~  198 (283)
T cd07830         122 HRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL  198 (283)
T ss_pred             cCCCChhhEEE---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence            99999999999   567889999999987665443333445677899999874 44578999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...+.
T Consensus       199 ~~~~~~  204 (283)
T cd07830         199 FPGSSE  204 (283)
T ss_pred             cCCCCh
Confidence            976543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-29  Score=185.05  Aligned_cols=160  Identities=38%  Similarity=0.584  Sum_probs=135.4

Q ss_pred             HHHHHHHHHHHhcC---CCccccccceEEEeCCe-----EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSV---NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus        10 ~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+.+|+.+++++   +|+|++++++++...+.     .++++|++. ++|.+++....  .+++..+..++.|++.++
T Consensus        42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al  120 (287)
T cd07838          42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV  120 (287)
T ss_pred             hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence            44566787777666   69999999999987765     999999995 58988887543  489999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      ++||+.+++|+|++|+||++   +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|++++
T Consensus       121 ~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~  197 (287)
T cd07838         121 DFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA  197 (287)
T ss_pred             HHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence            99999999999999999999   456889999999887764443333344677899999998888999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|..||.+.++
T Consensus       198 ~l~~~~~~~~~~~~  211 (287)
T cd07838         198 ELFRRRPLFRGTSE  211 (287)
T ss_pred             HHHhCCCcccCCCh
Confidence            99999999987653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=5.8e-29  Score=185.22  Aligned_cols=157  Identities=34%  Similarity=0.586  Sum_probs=133.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|++++++++|+|++++++++.+++..++++||+.| ++.+.+.. ..++++..+..++.+++.++.+||+.|+
T Consensus        68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i  146 (317)
T cd06635          68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM  146 (317)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345688899999999999999999999999999999999965 77776653 4568999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc---cccCCcchhHHHHHHHHHHHHhC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|+||+|+||++   +.++.++|+|||.+......   ....++..|+|||.+.   +...+.++|+||+|+++|++++|
T Consensus       147 ~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g  220 (317)
T cd06635         147 IHRDIKAGNILL---TEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  220 (317)
T ss_pred             ccCCCCcccEEE---CCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhC
Confidence            999999999999   46778999999987544322   2234677899999873   34578899999999999999999


Q ss_pred             CCCCCCCC
Q 030256          165 YPPFSAYR  172 (180)
Q Consensus       165 ~~pf~~~~  172 (180)
                      ..||...+
T Consensus       221 ~~p~~~~~  228 (317)
T cd06635         221 KPPLFNMN  228 (317)
T ss_pred             CCCCCCcc
Confidence            99987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.3e-29  Score=190.26  Aligned_cols=159  Identities=33%  Similarity=0.554  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+|+.+++.++|+||+++++++...     ...++++||+ +++|.+++...+++++..+..++.|++.++++||+
T Consensus        48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  126 (337)
T cd07858          48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS  126 (337)
T ss_pred             hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            44567899999999999999999987643     3589999999 57999998877889999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l  162 (180)
                      .+++|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++|+++
T Consensus       127 ~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  203 (337)
T cd07858         127 ANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL  203 (337)
T ss_pred             CCEecCCCCHHHEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence            999999999999999   46678999999998765433 22223446778999998764 45889999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|+.||.+.+
T Consensus       204 ~g~~pf~~~~  213 (337)
T cd07858         204 GRKPLFPGKD  213 (337)
T ss_pred             cCCCCCCCCC
Confidence            9999997653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-31  Score=186.78  Aligned_cols=163  Identities=31%  Similarity=0.584  Sum_probs=145.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..-+++..|+.++++++.|++|+++++|-.+..+++|||||..|++++.++.. .++++.++..+++..+.+|+|||...
T Consensus        70 sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~  149 (502)
T KOG0574|consen   70 TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK  149 (502)
T ss_pred             chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH
Confidence            34566788999999999999999999999998999999999999999998754 56999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      =+|+||+..||++   +..+..+|.|||.+-.+-... ...+..|++.|+|||+...-+|...+|+||||++..||..|+
T Consensus       150 KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~  226 (502)
T KOG0574|consen  150 KIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGR  226 (502)
T ss_pred             HHHhhcccccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCC
Confidence            9999999999999   688899999999986664322 223456999999999999999999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      +||.+..|
T Consensus       227 PPYsDIHP  234 (502)
T KOG0574|consen  227 PPYSDIHP  234 (502)
T ss_pred             CCcccccc
Confidence            99987655

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-30  Score=198.35  Aligned_cols=172  Identities=28%  Similarity=0.519  Sum_probs=149.2

Q ss_pred             hhhhhHHH--HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHH
Q 030256            2 LKKLNKHL--KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGA   77 (180)
Q Consensus         2 ~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~   77 (180)
                      ||.++++.  -++|..|..+++++.|||+|+++++|.....+|||.|||..|+|.++++...+  ++.-.++.++.||..
T Consensus       297 VKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsS  376 (1157)
T KOG4278|consen  297 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISS  376 (1157)
T ss_pred             hhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHH
Confidence            55555443  56788999999999999999999999999999999999999999999987654  777788999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccc--cccCccccCccccccccCCcchhHHHHH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVG  155 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~ape~~~~~~~~~~~Di~slg  155 (180)
                      +++||+.++++|+||..+|+++   .++..+++.|||+++.+.......+  ....+.|+|||.+....++.++|+|+||
T Consensus       377 aMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFG  453 (1157)
T KOG4278|consen  377 AMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFG  453 (1157)
T ss_pred             HHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHH
Confidence            9999999999999999999999   5788899999999987755544332  2245669999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcccc
Q 030256          156 AILFELLN-GYPPFSAYRPCFA  176 (180)
Q Consensus       156 ~~~~~~l~-g~~pf~~~~~~~~  176 (180)
                      +++||+.| |-.||++.+-+.+
T Consensus       454 VLLWEIATYGMsPYPGidlSqV  475 (1157)
T KOG4278|consen  454 VLLWEIATYGMSPYPGIDLSQV  475 (1157)
T ss_pred             HHHHHHHhcCCCCCCCccHHHH
Confidence            99999999 8899998776543

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=2.7e-29  Score=186.00  Aligned_cols=158  Identities=27%  Similarity=0.499  Sum_probs=131.0

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCC--------eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .+.+|++++++++||||+++++++...+        ..++++||+. ++|.+.+.... .+++..+..++.|++.++++|
T Consensus        57 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l  135 (310)
T cd07865          57 TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI  135 (310)
T ss_pred             HHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            4567999999999999999999876543        5699999995 58888776443 689999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCccccccc-cCCcchhHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA  156 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~  156 (180)
                      |+.|++|+||+|+||++   +.++.++|+|||.+........     .....++..|+|||.+.+. .++.++|+||+|+
T Consensus       136 H~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  212 (310)
T cd07865         136 HRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC  212 (310)
T ss_pred             HHCCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHH
Confidence            99999999999999999   5677899999998866543221     1223456779999987654 3688999999999


Q ss_pred             HHHHHHhCCCCCCCCCc
Q 030256          157 ILFELLNGYPPFSAYRP  173 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~  173 (180)
                      ++|++++|+.||.+.++
T Consensus       213 ~l~el~t~~~~~~~~~~  229 (310)
T cd07865         213 IMAEMWTRSPIMQGNTE  229 (310)
T ss_pred             HHHHHHhCCCCCCCCCH
Confidence            99999999999977653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-29  Score=184.38  Aligned_cols=160  Identities=36%  Similarity=0.625  Sum_probs=138.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|+.++++++|+|++++.+++.+.+..++++|+++ ++|.+++... ..+++..+..++.+++.++++||+.|+
T Consensus        41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  119 (282)
T cd07829          41 IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI  119 (282)
T ss_pred             ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34567789999999999999999999999999999999996 5999999866 579999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++   +.++.++|+|||.+....... .......+..|+|||...+. .++.++|+||+|++++++++|.
T Consensus       120 ~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~  196 (282)
T cd07829         120 LHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK  196 (282)
T ss_pred             ccCCCChheEEE---cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence            999999999999   467889999999886654332 22233356679999988766 7889999999999999999999


Q ss_pred             CCCCCCC
Q 030256          166 PPFSAYR  172 (180)
Q Consensus       166 ~pf~~~~  172 (180)
                      .||.+.+
T Consensus       197 ~~~~~~~  203 (282)
T cd07829         197 PLFPGDS  203 (282)
T ss_pred             CCCCCcc
Confidence            9997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=7.4e-29  Score=182.89  Aligned_cols=154  Identities=17%  Similarity=0.251  Sum_probs=125.8

Q ss_pred             HHHHHHhcCCCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           15 CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        15 ~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      .+...+..++|++++++++......    ..++++++. ..++.+.+......++..+..++.|++.++++||+.+++||
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr  150 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG  150 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            3445566779999999998765433    457888877 45777777665567889999999999999999999999999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCC--------cccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ||+|+||++   +.+..++|+|||+++......        ......++..|+|||...+..++.++|+||+|+++++++
T Consensus       151 DiKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~  227 (294)
T PHA02882        151 DIKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA  227 (294)
T ss_pred             CCCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999   456779999999987653211        111234788999999999989999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|..||.+.+
T Consensus       228 ~g~~P~~~~~  237 (294)
T PHA02882        228 GIKLPWKGFG  237 (294)
T ss_pred             hCCCCCCccc
Confidence            9999998764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=194.11  Aligned_cols=166  Identities=28%  Similarity=0.500  Sum_probs=145.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ..+..+.|..|..++++++||||++++|++.+.. .++|||.++-|.|..+++.+. .++......++.||..+++|||+
T Consensus       431 t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS  509 (974)
T KOG4257|consen  431 TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES  509 (974)
T ss_pred             ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh
Confidence            4566889999999999999999999999998765 899999999999999998765 48999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccc--cccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ..+|||||..+||++   .....++|+|||+++.......-..  ..-...|+|||...-..++.++|+|-||+++||++
T Consensus       510 krfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl  586 (974)
T KOG4257|consen  510 KRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEIL  586 (974)
T ss_pred             hchhhhhhhhhheee---cCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHH
Confidence            999999999999999   5778899999999988766533221  22345699999999999999999999999999998


Q ss_pred             h-CCCCCCCCCccc
Q 030256          163 N-GYPPFSAYRPCF  175 (180)
Q Consensus       163 ~-g~~pf~~~~~~~  175 (180)
                      . |..||.+-..++
T Consensus       587 ~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  587 SLGVKPFQGVKNSD  600 (974)
T ss_pred             HhcCCccccccccc
Confidence            8 999998766554

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=7.5e-29  Score=186.51  Aligned_cols=161  Identities=32%  Similarity=0.563  Sum_probs=133.0

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhcC-------------------------
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG-------------------------   61 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-------------------------   61 (180)
                      ..+.+.+|+.++.++ +|+||+++++++.. +...++++||+++++|.+++....                         
T Consensus        53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  132 (343)
T cd05103          53 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE  132 (343)
T ss_pred             HHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhh
Confidence            345678899999999 68999999998765 457899999999999999886421                         


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeee
Q 030256           62 ------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL   99 (180)
Q Consensus        62 ------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~   99 (180)
                                                                .++...+..++.|++.++++||++|++|+||+|.||++
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  212 (343)
T cd05103         133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL  212 (343)
T ss_pred             hhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE
Confidence                                                      25777889999999999999999999999999999999


Q ss_pred             ecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030256          100 SGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR  172 (180)
Q Consensus       100 ~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~  172 (180)
                         +.+..++|+|||++........   .....++..|+|||...+..++.++|+||+|+++|++++ |..||....
T Consensus       213 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  286 (343)
T cd05103         213 ---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  286 (343)
T ss_pred             ---cCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence               4677899999998866432211   111223456999999988889999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=2.3e-29  Score=182.20  Aligned_cols=160  Identities=33%  Similarity=0.607  Sum_probs=136.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....+.+|..++++++|||++++++++.+.+..++++||+++++|.+++..    ...+++..+..++.|++.++.+||+
T Consensus        45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  124 (260)
T cd08222          45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ  124 (260)
T ss_pred             hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            334566789999999999999999999988899999999999999988753    3468999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      .|++|+|++|+||++.    .+.++++|||.+....... ......++..|+|||...+..++.++|+||+|++++++++
T Consensus       125 ~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  200 (260)
T cd08222         125 RRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC  200 (260)
T ss_pred             cCccccCCChhheEee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999994    2459999999886654322 2223446778999999888888999999999999999999


Q ss_pred             CCCCCCCCC
Q 030256          164 GYPPFSAYR  172 (180)
Q Consensus       164 g~~pf~~~~  172 (180)
                      |..||.+.+
T Consensus       201 ~~~~~~~~~  209 (260)
T cd08222         201 LAHAFEGQN  209 (260)
T ss_pred             CCCCCCCcc
Confidence            999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=6.2e-29  Score=181.09  Aligned_cols=163  Identities=26%  Similarity=0.513  Sum_probs=133.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCC------eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL   75 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i   75 (180)
                      ...+++.+|++++++++|||++++++++...+      ..+++++|+.+++|..++...      ..++...+..++.|+
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i  122 (273)
T cd05074          43 SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI  122 (273)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Confidence            44566888999999999999999999875432      347889999999998876422      147889999999999


Q ss_pred             HHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHH
Q 030256           76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW  152 (180)
Q Consensus        76 ~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~  152 (180)
                      +.++++||+.|++|+||+|+||++   +.+..++++|||.+........   .....+...|++||...+..++.++|+|
T Consensus       123 ~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~  199 (273)
T cd05074         123 ASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVW  199 (273)
T ss_pred             HHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhH
Confidence            999999999999999999999999   4677899999999876543221   1112234568999998888889999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCc
Q 030256          153 SVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       153 slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+|+++|++++ |+.||.+.+.
T Consensus       200 slG~il~el~~~g~~p~~~~~~  221 (273)
T cd05074         200 AFGVTMWEIMTRGQTPYAGVEN  221 (273)
T ss_pred             HHHHHHHHHhhCCCCCCCCCCH
Confidence            99999999999 8999976554

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=3.9e-29  Score=187.51  Aligned_cols=159  Identities=32%  Similarity=0.557  Sum_probs=132.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....+.+|+.++++++|+||+++++++...     ...++++|++. ++|...+. ..++++..+..++.|++.++++||
T Consensus        46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH  123 (336)
T cd07849          46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIH  123 (336)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            445677899999999999999999986543     35899999995 58887765 567999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCcccccc-ccCCcchhHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~  158 (180)
                      +.|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||...+ ..++.++|+||+|+++
T Consensus       124 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil  200 (336)
T cd07849         124 SANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL  200 (336)
T ss_pred             hCCeeccCCCHHHEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence            9999999999999999   5678899999998866533221    122346778999998654 4688999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030256          159 FELLNGYPPFSAYR  172 (180)
Q Consensus       159 ~~~l~g~~pf~~~~  172 (180)
                      +++++|+.||.+.+
T Consensus       201 ~el~~G~~~f~~~~  214 (336)
T cd07849         201 AEMLSNRPLFPGKD  214 (336)
T ss_pred             HHHHhCCCCCCCCC
Confidence            99999999997653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3.2e-29  Score=178.82  Aligned_cols=158  Identities=48%  Similarity=0.877  Sum_probs=142.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|++.+++++|++++++.+++......++++|++++++|.+++.....++...+..++.+++.++.+||+.+++|
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  110 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH  110 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence            57889999999999999999999999999999999999998899999886666899999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  169 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~  169 (180)
                      +|++|+||++   +.++.++++|||.+.............+...|++||...+..++.++|+||+|++++++++|..||.
T Consensus       111 ~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~  187 (244)
T smart00220      111 RDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFP  187 (244)
T ss_pred             CCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999   4567899999999877665444444557788999999988888999999999999999999999997


Q ss_pred             C
Q 030256          170 A  170 (180)
Q Consensus       170 ~  170 (180)
                      .
T Consensus       188 ~  188 (244)
T smart00220      188 G  188 (244)
T ss_pred             C
Confidence            7

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=9.9e-29  Score=185.97  Aligned_cols=157  Identities=33%  Similarity=0.580  Sum_probs=132.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      .+.+.+|+.++++++|+||+++.+++...      +..+++++++ +++|.+++. ...+++..+..++.|++.|+++||
T Consensus        60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH  137 (345)
T cd07877          60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH  137 (345)
T ss_pred             HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45677899999999999999999987543      3478888887 889988776 456999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l  162 (180)
                      +.|++|+||+|+||++   +.++.++|+|||++......  .....++..|+|||...+ ..++.++|+||+|+++++++
T Consensus       138 ~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  212 (345)
T cd07877         138 SADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  212 (345)
T ss_pred             HCCeeecCCChHHEEE---cCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999   46778999999998665332  223446778999998765 45788999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|+.||.+.++
T Consensus       213 ~g~~pf~~~~~  223 (345)
T cd07877         213 TGRTLFPGTDH  223 (345)
T ss_pred             hCCCCCCCCCH
Confidence            99999976543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=7.4e-29  Score=181.56  Aligned_cols=157  Identities=30%  Similarity=0.530  Sum_probs=129.6

Q ss_pred             HHHHHHHHH-HhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256           11 SCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus        11 ~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ..+..|... ++.++|||++++++++..++..++++||++ ++|.+++..    ...+++..+..++.|++.++++||++
T Consensus        44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  122 (283)
T cd06617          44 KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK  122 (283)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            344455554 566699999999999999999999999995 688877653    23589999999999999999999997


Q ss_pred             -CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc----ccCCcchhHHHHHHHHHH
Q 030256           86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        86 -~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~----~~~~~~~Di~slg~~~~~  160 (180)
                       +++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+    ..++.++|+||+|+++|+
T Consensus       123 ~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~  199 (283)
T cd06617         123 LSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE  199 (283)
T ss_pred             CCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence             99999999999999   5677899999999876543333233456778999998764    346889999999999999


Q ss_pred             HHhCCCCCCCC
Q 030256          161 LLNGYPPFSAY  171 (180)
Q Consensus       161 ~l~g~~pf~~~  171 (180)
                      +++|+.||...
T Consensus       200 l~~g~~p~~~~  210 (283)
T cd06617         200 LATGRFPYDSW  210 (283)
T ss_pred             HHhCCCCCCcc
Confidence            99999999754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=7.4e-29  Score=185.48  Aligned_cols=158  Identities=37%  Similarity=0.590  Sum_probs=133.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ....+.+|++++++++|||++++.+++.. .+..++++|++ +++|..+++ ..++++..+..++.|++.++++||+.|+
T Consensus        52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i  129 (328)
T cd07856          52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGV  129 (328)
T ss_pred             hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45667789999999999999999999865 56789999998 678988776 4568888999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||.+.......  ....++..|+|||.+.+ ..++.++|+||+|++++++++|+.
T Consensus       130 iH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~  204 (328)
T cd07856         130 VHRDLKPSNILI---NENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP  204 (328)
T ss_pred             ccCCCCHHHEeE---CCCCCEEeCccccccccCCCc--CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999   567789999999886543221  22345678999998765 568999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.++
T Consensus       205 ~f~~~~~  211 (328)
T cd07856         205 LFPGKDH  211 (328)
T ss_pred             CCCCCCH
Confidence            9987553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-30  Score=190.00  Aligned_cols=163  Identities=34%  Similarity=0.633  Sum_probs=145.9

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.-..|-++|..- +-|.++++...|..-+.+|+||||+.||+|-..+++-+++.+..+..++..|+-+|-+||++|++
T Consensus       393 vectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIi  472 (683)
T KOG0696|consen  393 VECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGII  472 (683)
T ss_pred             ccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCee
Confidence            44455676676666 56788999999999999999999999999999999889999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|||+.+||++   +..+.++|.|||+...-.- ...+.+..|++.|+|||+...+.|+.+.|.||+|+++|||+.|++|
T Consensus       473 YRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpP  549 (683)
T KOG0696|consen  473 YRDLKLDNVML---DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP  549 (683)
T ss_pred             eeeccccceEe---ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCC
Confidence            99999999999   6889999999999876433 3455677899999999999999999999999999999999999999


Q ss_pred             CCCCCccc
Q 030256          168 FSAYRPCF  175 (180)
Q Consensus       168 f~~~~~~~  175 (180)
                      |++.++++
T Consensus       550 FdGeDE~e  557 (683)
T KOG0696|consen  550 FDGEDEDE  557 (683)
T ss_pred             CCCCCHHH
Confidence            99988764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=182.17  Aligned_cols=159  Identities=33%  Similarity=0.659  Sum_probs=147.3

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +..+.++.|..++.+. +||.+|-+..+|.....+++|.||++||+|--.+.++.+++++.+..+...|..||.+||++|
T Consensus       292 edidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg  371 (593)
T KOG0695|consen  292 EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG  371 (593)
T ss_pred             ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC
Confidence            3456778888888888 799999999999999999999999999999999998899999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCcccc-CCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++++|++.+|+++   +..+.++|+|+|+.+.- .+...+.+..|++.|.|||.+++.+|+...|.|+||++++||+.|+
T Consensus       372 iiyrdlkldnvll---daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagr  448 (593)
T KOG0695|consen  372 IIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR  448 (593)
T ss_pred             eeeeeccccceEE---ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCC
Confidence            9999999999999   68899999999998654 4556677888999999999999999999999999999999999999


Q ss_pred             CCCC
Q 030256          166 PPFS  169 (180)
Q Consensus       166 ~pf~  169 (180)
                      .||+
T Consensus       449 spfd  452 (593)
T KOG0695|consen  449 SPFD  452 (593)
T ss_pred             CCcc
Confidence            9996

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=7.5e-29  Score=186.49  Aligned_cols=157  Identities=34%  Similarity=0.585  Sum_probs=133.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ....+.+|++++++++|+||+++.+++..++      .++++++++ +++|.+++. ...+++..+..++.|++.++++|
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~L  134 (343)
T cd07880          57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            4556888999999999999999999886543      469999998 789988776 46799999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~  161 (180)
                      |+.|++|+||+|+||++   +.++.++++|||++.......  ....++..|++||.+.+ ..++.++|+||+|++++++
T Consensus       135 H~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l  209 (343)
T cd07880         135 HAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM  209 (343)
T ss_pred             HhCCeecCCCCHHHEEE---cCCCCEEEeecccccccccCc--cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence            99999999999999999   467789999999987654322  22346778999998875 4578899999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|+.||.+.+
T Consensus       210 ~~g~~pf~~~~  220 (343)
T cd07880         210 LTGKPLFKGHD  220 (343)
T ss_pred             HhCCCCCCCCC
Confidence            99999998654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=7.5e-29  Score=186.01  Aligned_cols=159  Identities=39%  Similarity=0.602  Sum_probs=133.3

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+|+.+++++ +|+||+++++++...  ...++++|+++ ++|.+++... .+++..+..++.|++.++++||+.
T Consensus        49 ~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~  126 (337)
T cd07852          49 DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG  126 (337)
T ss_pred             hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            445677899999999 999999999988643  46899999996 5999988754 788899999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC------cccccccCccccCcccccc-ccCCcchhHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~  158 (180)
                      |++|+||+|+||++   +.++.++|+|||.+.......      ......++..|+|||.+.+ ...+.++|+||+|+++
T Consensus       127 ~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l  203 (337)
T cd07852         127 NVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL  203 (337)
T ss_pred             CeecCCCCHHHEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHH
Confidence            99999999999999   577889999999886653322      1122346778999998754 4578899999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030256          159 FELLNGYPPFSAYR  172 (180)
Q Consensus       159 ~~~l~g~~pf~~~~  172 (180)
                      |++++|+.||.+..
T Consensus       204 ~el~tg~~pf~~~~  217 (337)
T cd07852         204 GEMLLGKPLFPGTS  217 (337)
T ss_pred             HHHHhCCCCCCCCC
Confidence            99999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=1.1e-28  Score=183.02  Aligned_cols=158  Identities=34%  Similarity=0.591  Sum_probs=133.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|+++++.++|+|++++.+++...+..++++||+. +++.+.+.. ..++++..+..++.|++.++.+||+.++
T Consensus        58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i  136 (308)
T cd06634          58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM  136 (308)
T ss_pred             HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567789999999999999999999999999999999996 578776653 4468999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc---cccCCcchhHHHHHHHHHHHHhC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|+||+|+||++   +.++.++++|||.+......   ....++..|+|||.+.   ....+.++|+||+|+++|++++|
T Consensus       137 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  210 (308)
T cd06634         137 IHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  210 (308)
T ss_pred             ccCCCCHHhEEE---CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcC
Confidence            999999999999   45678999999987654332   2234677899999874   34578899999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||...++
T Consensus       211 ~~p~~~~~~  219 (308)
T cd06634         211 KPPLFNMNA  219 (308)
T ss_pred             CCCCccccH
Confidence            999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=1.5e-28  Score=181.05  Aligned_cols=159  Identities=31%  Similarity=0.503  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHhcC-CCccccccceEEEeCCe-----EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l   79 (180)
                      ..+.+|+.+++++ +|+||+++++++...+.     .++++||+++ +|.+++...     ..+++..+..++.|++.+|
T Consensus        45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L  123 (295)
T cd07837          45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV  123 (295)
T ss_pred             hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHH
Confidence            4677899999999 56999999999876554     8999999975 888877543     3479999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccc-ccCCcchhHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI  157 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~  157 (180)
                      ++||+.|++|+||+|+||+++  ..++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||+|++
T Consensus       124 ~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~  201 (295)
T cd07837         124 AHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI  201 (295)
T ss_pred             HHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHH
Confidence            999999999999999999995  3377899999998865533211 122345677999998765 457899999999999


Q ss_pred             HHHHHhCCCCCCCCC
Q 030256          158 LFELLNGYPPFSAYR  172 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~  172 (180)
                      +|++++|..||.+.+
T Consensus       202 l~~l~~g~~~~~~~~  216 (295)
T cd07837         202 FAEMSRKQPLFPGDS  216 (295)
T ss_pred             HHHHHcCCCCCCCCC
Confidence            999999999997654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=1e-28  Score=185.03  Aligned_cols=159  Identities=33%  Similarity=0.514  Sum_probs=133.2

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+|+++++++ +|+||+++++....    ....+++++++ +++|.+.+.....+++..+..++.|++.+|++||+
T Consensus        45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~  123 (332)
T cd07857          45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS  123 (332)
T ss_pred             HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45677899999999 69999999987432    24678999998 56999998877889999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCcccccc-ccCCcchhHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~  158 (180)
                      .|++|+||+|+||++   +.++.++|+|||.+........     .....++..|+|||...+ ..++.++|+||+|+++
T Consensus       124 ~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l  200 (332)
T cd07857         124 ANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL  200 (332)
T ss_pred             CCcccCCCCHHHeEE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHH
Confidence            999999999999999   5677899999999876543221     122357788999998765 4678999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030256          159 FELLNGYPPFSAYR  172 (180)
Q Consensus       159 ~~~l~g~~pf~~~~  172 (180)
                      +++++|..||.+.+
T Consensus       201 ~~l~~g~~pf~~~~  214 (332)
T cd07857         201 AELLGRKPVFKGKD  214 (332)
T ss_pred             HHHHhCCcCCCCCC
Confidence            99999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=3.8e-29  Score=188.00  Aligned_cols=162  Identities=30%  Similarity=0.600  Sum_probs=132.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeC--------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ   73 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~   73 (180)
                      .....+.+|++++++++||||+++++++...              ...++++||++ ++|.+++. ...+++..+..++.
T Consensus        44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~  121 (342)
T cd07854          44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMY  121 (342)
T ss_pred             chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHH
Confidence            3445678899999999999999999876543              35799999995 58988776 45789999999999


Q ss_pred             HHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCcccccc-ccCCcc
Q 030256           74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEK  148 (180)
Q Consensus        74 ~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~-~~~~~~  148 (180)
                      |++.|+.+||+.|++|+||+|+||++.  ..+..++++|||.+........    .....++..|+|||.+.+ ..++.+
T Consensus       122 qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  199 (342)
T cd07854         122 QLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA  199 (342)
T ss_pred             HHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence            999999999999999999999999995  3556789999999876533211    112345778999997654 457889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          149 VDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       149 ~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      +|+||||+++|++++|+.||.+.++
T Consensus       200 ~DiwSlGvil~el~~g~~pf~~~~~  224 (342)
T cd07854         200 IDMWAAGCIFAEMLTGKPLFAGAHE  224 (342)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999976553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=5.7e-29  Score=187.15  Aligned_cols=158  Identities=33%  Similarity=0.570  Sum_probs=134.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCe------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ....+.+|+.++++++|+|++++.+++...+.      .+++++++ +++|.+++. ..++++..+..++.|++.++++|
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~l~~~~~~~~~~ql~~aL~~L  134 (343)
T cd07851          57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK-CQKLSDDHIQFLVYQILRGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            44557789999999999999999998765543      89999998 779999887 45799999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~  161 (180)
                      |+.|++|+||+|+||++   +.++.++|+|||.+......  .....++..|+|||...+ ..++.++|+||+|++++++
T Consensus       135 H~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~el  209 (343)
T cd07851         135 HSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  209 (343)
T ss_pred             HHCCeecCCCCHHHeEE---CCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHH
Confidence            99999999999999999   46778999999998765433  223346778999998765 3678899999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.++
T Consensus       210 ltg~~pf~~~~~  221 (343)
T cd07851         210 LTGKTLFPGSDH  221 (343)
T ss_pred             HhCCCCCCCCCh
Confidence            999999976553

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=9.2e-29  Score=183.22  Aligned_cols=159  Identities=28%  Similarity=0.519  Sum_probs=129.5

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeC--------CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ....+|++++++++|+||+++++++...        ..++++++|+. +++...+.. ...+++..+..++.|+++++++
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~  130 (311)
T cd07866          52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINY  130 (311)
T ss_pred             hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999887443        35799999995 477776654 3469999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc------------cccccCccccCccccccc-cCCcc
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------------EKVCGSPLYMAPEVLQFQ-RYDEK  148 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~~~~~ape~~~~~-~~~~~  148 (180)
                      ||+.|++|+|++|+||++   +.++.++|+|||++.........            ....++..|+|||...+. .++.+
T Consensus       131 lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (311)
T cd07866         131 LHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA  207 (311)
T ss_pred             HHhCCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence            999999999999999999   56788999999988655332111            112346679999987654 47889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          149 VDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       149 ~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      +|+||+|++++++++|..||.+.++
T Consensus       208 ~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         208 VDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             hHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999976543

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=1e-28  Score=182.44  Aligned_cols=159  Identities=30%  Similarity=0.480  Sum_probs=131.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCC----------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG   78 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~   78 (180)
                      ...+.+|++++++++|||++++++++.+..          .+++++||+++ ++...+... ..+++..+..++.|++.+
T Consensus        50 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~a  128 (302)
T cd07864          50 PITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG  128 (302)
T ss_pred             hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            346778999999999999999999886544          79999999965 777766643 468999999999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccc-cCCcchhHHHHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG  155 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg  155 (180)
                      +++||+.|++|+||+|+||++   +.++.++|+|||.+........  ......+..|+|||...+. ..+.++|+||+|
T Consensus       129 L~~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG  205 (302)
T cd07864         129 LNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG  205 (302)
T ss_pred             HHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHH
Confidence            999999999999999999999   5677899999998876543321  1122346679999987643 468899999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 030256          156 AILFELLNGYPPFSAYR  172 (180)
Q Consensus       156 ~~~~~~l~g~~pf~~~~  172 (180)
                      ++++++++|+.||...+
T Consensus       206 ~~~~el~~g~~~~~~~~  222 (302)
T cd07864         206 CILGELFTKKPIFQANQ  222 (302)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=3e-28  Score=179.66  Aligned_cols=158  Identities=30%  Similarity=0.558  Sum_probs=130.6

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS-HH   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~   86 (180)
                      ..++.+|..++.+. +|+||+++++++.+.+..++++|++ ++++.+++.. ...+++..+..++.|++.++++||+ .|
T Consensus        57 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~  135 (296)
T cd06618          57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG  135 (296)
T ss_pred             HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence            34455677766666 5999999999999999999999998 4577777654 3568999999999999999999997 59


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccccc----CCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~----~~~~~Di~slg~~~~~~l  162 (180)
                      ++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+..    ++.++|+||+|+++|+++
T Consensus       136 i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~  212 (296)
T cd06618         136 VIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA  212 (296)
T ss_pred             EecCCCcHHHEEE---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH
Confidence            9999999999999   567789999999986654333333334677899999886543    788999999999999999


Q ss_pred             hCCCCCCCC
Q 030256          163 NGYPPFSAY  171 (180)
Q Consensus       163 ~g~~pf~~~  171 (180)
                      +|+.||...
T Consensus       213 ~g~~p~~~~  221 (296)
T cd06618         213 TGQFPYKNC  221 (296)
T ss_pred             hCCCCCCcc
Confidence            999999763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=169.68  Aligned_cols=165  Identities=29%  Similarity=0.493  Sum_probs=138.2

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .+...+..+|+++..+. .+|.+|.+++.+-..+..++-||.| ..+|+.+-+    +++.+++..+-+++..+..|+.+
T Consensus        85 ~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~  163 (282)
T KOG0984|consen   85 SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEF  163 (282)
T ss_pred             hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHH
Confidence            34445566677766665 7999999999888888899999999 679987743    45679999999999999999999


Q ss_pred             HHhC-CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc----cccCCcchhHHHHHH
Q 030256           82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ----FQRYDEKVDMWSVGA  156 (180)
Q Consensus        82 lh~~-~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~----~~~~~~~~Di~slg~  156 (180)
                      ||++ .++|||+||+||++   +..+++++||||.+--+.+.....-..|...|+|||...    ...|+.++|+||||+
T Consensus       164 L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGI  240 (282)
T KOG0984|consen  164 LHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGI  240 (282)
T ss_pred             HHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhh
Confidence            9986 89999999999999   789999999999987666555554456888899999874    336899999999999


Q ss_pred             HHHHHHhCCCCCCCCCccc
Q 030256          157 ILFELLNGYPPFSAYRPCF  175 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~~~  175 (180)
                      .+.|+.+++.||+.+.-.+
T Consensus       241 tmiElA~lr~PY~~w~tpF  259 (282)
T KOG0984|consen  241 TMIEMAILRFPYESWGTPF  259 (282)
T ss_pred             hhhhhhhccccccccCCHH
Confidence            9999999999998775543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-29  Score=184.46  Aligned_cols=161  Identities=34%  Similarity=0.597  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEE-eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--C
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH--H   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~   86 (180)
                      ..-.-+|.+|-+.|+||.||++++++. +.+.+|.|+|||+|.+|+.+++.+.-+++.++..|..||+.||.||.+.  -
T Consensus       511 hKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpP  590 (775)
T KOG1151|consen  511 HKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPP  590 (775)
T ss_pred             HHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCC
Confidence            334567999999999999999999997 5678999999999999999999888899999999999999999999986  4


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--------cccccccCccccCccccccc----cCCcchhHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSV  154 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~----~~~~~~Di~sl  154 (180)
                      ++|.||+|.||++.+-...+.++|+|||++.......        .+....|+.+|++||.+.-+    +.+.+.||||+
T Consensus       591 IIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv  670 (775)
T KOG1151|consen  591 IIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV  670 (775)
T ss_pred             eeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence            9999999999999766778889999999987664332        22335688999999987533    35789999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 030256          155 GAILFELLNGYPPFSA  170 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~  170 (180)
                      |+++|+.+-|+.||..
T Consensus       671 GVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  671 GVIFYQCLYGRKPFGH  686 (775)
T ss_pred             ehhhhhhhccCCCCCC
Confidence            9999999999999975

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=4.2e-28  Score=171.58  Aligned_cols=159  Identities=45%  Similarity=0.787  Sum_probs=140.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|++.+++++|++++++++++...+..++++|++++++|.+++..... +++..+..++.+++.++.+||+.++
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  119 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI  119 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            567888999999999999999999999988999999999999999999987666 8999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCcccc-ccccCCcchhHHHHHHHHHHHHhC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~-~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|+|++|.|+++.   ....++|+|||.+.......  ......+...|++||.. ....++.++|+|++|++++++++|
T Consensus       120 ~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g  196 (225)
T smart00221      120 VHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG  196 (225)
T ss_pred             ecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence            9999999999994   55889999999887665442  22334567789999998 666678899999999999999999


Q ss_pred             CCCCCC
Q 030256          165 YPPFSA  170 (180)
Q Consensus       165 ~~pf~~  170 (180)
                      +.||++
T Consensus       197 ~~pf~~  202 (225)
T smart00221      197 PEPFSG  202 (225)
T ss_pred             CCCccc
Confidence            999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=194.47  Aligned_cols=163  Identities=24%  Similarity=0.406  Sum_probs=143.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.|.+|+.+|.+|+|+|+++++++..+ ....+|+|.+++|+|.+.+.+.  ..|-...+..++.||+.++.||..++
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr  232 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR  232 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence            45679999999999999999999999988 5688999999999999999862  34889999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccc----cccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~----~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|||+-.+|+++.   ....|||+|||+.+.++.++..+.    ..-...|.|||.++...++.++|+|++|+++|||+
T Consensus       233 lvHRDLAARNllla---sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMF  309 (1039)
T KOG0199|consen  233 LVHRDLAARNLLLA---SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMF  309 (1039)
T ss_pred             hhhhhhhhhhheec---ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhh
Confidence            99999999999994   577899999999998876654432    22345599999999999999999999999999999


Q ss_pred             h-CCCCCCCCCccc
Q 030256          163 N-GYPPFSAYRPCF  175 (180)
Q Consensus       163 ~-g~~pf~~~~~~~  175 (180)
                      + |+.||-+-+..+
T Consensus       310 tyGEePW~G~~g~q  323 (1039)
T KOG0199|consen  310 TYGEEPWVGCRGIQ  323 (1039)
T ss_pred             ccCCCCCCCCCHHH
Confidence            9 899998877653

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3.2e-28  Score=183.04  Aligned_cols=155  Identities=33%  Similarity=0.539  Sum_probs=129.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ...+.+|++++++++|+||+++.+++...      ..++++++++. .+|....  ...+++..+..++.|++.++++||
T Consensus        58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH  134 (342)
T cd07879          58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIH  134 (342)
T ss_pred             hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44577899999999999999999998654      25699999994 5777654  346899999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l  162 (180)
                      +.|++|+||+|+||++   +.++.++|+|||++.......  ....++..|+|||.+.+ ..++.++|+||+|+++|+++
T Consensus       135 ~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~  209 (342)
T cd07879         135 SAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAEM--TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML  209 (342)
T ss_pred             HCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCCCC--CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence            9999999999999999   567889999999986543221  22345778999998876 45788999999999999999


Q ss_pred             hCCCCCCCCC
Q 030256          163 NGYPPFSAYR  172 (180)
Q Consensus       163 ~g~~pf~~~~  172 (180)
                      +|+.||.+.+
T Consensus       210 ~g~~pf~~~~  219 (342)
T cd07879         210 TGKTLFKGKD  219 (342)
T ss_pred             hCCCCCCCCC
Confidence            9999998765

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-29  Score=191.39  Aligned_cols=163  Identities=35%  Similarity=0.586  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +--+.+.-|++||..++||+||++++.|-..+.+++..|||.||-.+..+- ....+++.++..+++|++.||.|||+++
T Consensus        71 EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~  150 (1187)
T KOG0579|consen   71 EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN  150 (1187)
T ss_pred             hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc
Confidence            334556779999999999999999999998999999999999999987764 4457999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccc-----cccCCcchhHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~~  160 (180)
                      ++|+||+..||++.   -++.++|.|||++....... ......|++.|+|||+..     ..+|+.++||||||+++.+
T Consensus       151 iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIE  227 (1187)
T KOG0579|consen  151 IIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIE  227 (1187)
T ss_pred             hhhhhccccceEEE---ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHH
Confidence            99999999999994   78889999999986654322 223466999999999864     5578999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030256          161 LLNGYPPFSAYRP  173 (180)
Q Consensus       161 ~l~g~~pf~~~~~  173 (180)
                      |..+.+|-..-+|
T Consensus       228 MAqiEPPHhelnp  240 (1187)
T KOG0579|consen  228 MAQIEPPHHELNP  240 (1187)
T ss_pred             HhccCCCccccch
Confidence            9999999876544

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=176.40  Aligned_cols=165  Identities=30%  Similarity=0.535  Sum_probs=140.1

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +++...++...++++.+- ++|.||+++++|..+....+-||.| +..+..++... +++++..+-++...++.||.||-
T Consensus       130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK  208 (391)
T KOG0983|consen  130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK  208 (391)
T ss_pred             CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence            344455566677766666 5899999999999999899999998 66777776543 57999999999999999999998


Q ss_pred             h-CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc---cccCCcchhHHHHHHHHH
Q 030256           84 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        84 ~-~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~  159 (180)
                      + +|++|||+||+||++   +..+.+++||||.+-++-.........|...|+|||.+.   ...|..++|+||||+.++
T Consensus       209 eKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlv  285 (391)
T KOG0983|consen  209 EKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLV  285 (391)
T ss_pred             HhcceeecccCccceEE---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchh
Confidence            7 589999999999999   789999999999998887777777777999999999985   345889999999999999


Q ss_pred             HHHhCCCCCCCCCcc
Q 030256          160 ELLNGYPPFSAYRPC  174 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~  174 (180)
                      |+.||+-||..-+-+
T Consensus       286 eLaTg~yPy~~c~td  300 (391)
T KOG0983|consen  286 ELATGQYPYKGCKTD  300 (391)
T ss_pred             hhhcccCCCCCCCcc
Confidence            999999999875544

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=182.26  Aligned_cols=164  Identities=26%  Similarity=0.432  Sum_probs=139.7

Q ss_pred             hHHHHHHHHHHHHHHhcCC--Cc----cccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVN--HP----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGA   77 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~--h~----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~   77 (180)
                      -...++..+-|+++|+++.  .|    .++.+.++|+..+..|+|+|.+ |.++.+++..++  +++...+..+++|+++
T Consensus       125 V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~  203 (415)
T KOG0671|consen  125 VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLE  203 (415)
T ss_pred             HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHH
Confidence            3566778888999999992  33    3788889999999999999988 889999998765  5899999999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCC-----------------CCceEEEeecCCccccCCCCcccccccCccccCcccc
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLD-----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL  140 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~-----------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~  140 (180)
                      ++++||+.+++|.||||+||++.+..                 +...|+++|||.+.......  .....|..|.|||++
T Consensus       204 sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEVi  281 (415)
T KOG0671|consen  204 SVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVI  281 (415)
T ss_pred             HHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchhe
Confidence            99999999999999999999985211                 24458999999986654332  445578889999999


Q ss_pred             ccccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          141 QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       141 ~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      .+-++|.+.|+||+||++.|+.+|...|..-+
T Consensus       282 LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  282 LGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             eccCcCCccCceeeeeEEEEeeccceecccCC
Confidence            99999999999999999999999999998755

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.5e-28  Score=168.78  Aligned_cols=164  Identities=27%  Similarity=0.467  Sum_probs=140.0

Q ss_pred             ChhhhhHHHHHHHHHHHHHHhcC-CCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHH
Q 030256            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGA   77 (180)
Q Consensus         1 ~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~   77 (180)
                      |+|.+++--+..+++|+.+|+.| .||||+++++...+  +....+|+|++++.+....   -+.++.-.+...+.+++.
T Consensus        67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLk  143 (338)
T KOG0668|consen   67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLK  143 (338)
T ss_pred             EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHH
Confidence            57888888899999999999999 59999999998765  4578899999988777654   356888899999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCcchhHHHHHH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA  156 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~  156 (180)
                      ||.|.|+.|+.|+|++|.|++++  .....++|+|||++.+.-+..--.....+..|-.||.+... .+...-|+||+||
T Consensus       144 ALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gc  221 (338)
T KOG0668|consen  144 ALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC  221 (338)
T ss_pred             HHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHH
Confidence            99999999999999999999997  57778999999999887655433344556678889987644 4788999999999


Q ss_pred             HHHHHHhCCCCCC
Q 030256          157 ILFELLNGYPPFS  169 (180)
Q Consensus       157 ~~~~~l~g~~pf~  169 (180)
                      +++.|+-.+.||=
T Consensus       222 mlA~miFrkepFF  234 (338)
T KOG0668|consen  222 MLASMIFRKEPFF  234 (338)
T ss_pred             HHHHHHhccCccc
Confidence            9999999999884

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-29  Score=190.93  Aligned_cols=155  Identities=36%  Similarity=0.625  Sum_probs=136.8

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      +.+..|+..|+++.|||.+.+.++|.-+...++|||||- |+-++++.-. .++.+..|..|..+.+.+|+|||+.+.+|
T Consensus        71 qDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IH  149 (948)
T KOG0577|consen   71 QDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIH  149 (948)
T ss_pred             HHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHh
Confidence            457789999999999999999999999999999999995 5888888754 46999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc---cccCCcchhHHHHHHHHHHHHhCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||+..||++   .+.+.|+|.|||.+....+   .....||+.|+|||++.   .+.|+-+.||||||++..|+...++
T Consensus       150 RDiKAGNILL---se~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkP  223 (948)
T KOG0577|consen  150 RDIKAGNILL---SEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  223 (948)
T ss_pred             hhccccceEe---cCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCC
Confidence            9999999999   5889999999998866533   33566999999999864   5679999999999999999999999


Q ss_pred             CCCCCC
Q 030256          167 PFSAYR  172 (180)
Q Consensus       167 pf~~~~  172 (180)
                      |+=..+
T Consensus       224 PlFnMN  229 (948)
T KOG0577|consen  224 PLFNMN  229 (948)
T ss_pred             CccCch
Confidence            975443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=6.4e-28  Score=202.24  Aligned_cols=147  Identities=29%  Similarity=0.483  Sum_probs=123.3

Q ss_pred             HHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCeee
Q 030256           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN---SHHIIHR   90 (180)
Q Consensus        14 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~~~h~   90 (180)
                      ..|++.+++++||||+++++++.+.+..++||||+++++|.+++.   .+++..+..++.|++.|++|||   +.+++|+
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~  807 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG  807 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence            456889999999999999999999999999999999999999985   3788999999999999999999   6699999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      |++|+||++.   .....++. ++........   ....++..|+|||...+..++.++||||+|+++||+++|+.||+.
T Consensus       808 dlkp~Nil~~---~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        808 NLSPEKIIID---GKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             CCCHHhEEEC---CCCceEEE-eccccccccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence            9999999994   44444443 4433221111   122467889999999988899999999999999999999999954

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-27  Score=189.63  Aligned_cols=164  Identities=32%  Similarity=0.574  Sum_probs=143.1

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHH
Q 030256            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA   68 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~   68 (180)
                      ....++.+..|+++++.+ .|+|++.+++.+...+..++|.||+..|+|.++++...                .++...+
T Consensus       341 ~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL  420 (609)
T KOG0200|consen  341 SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL  420 (609)
T ss_pred             CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence            345678899999999999 69999999999999999999999999999999998665                3888999


Q ss_pred             HHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccc--cCccccCcccccccc
Q 030256           69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVC--GSPLYMAPEVLQFQR  144 (180)
Q Consensus        69 ~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~--~~~~~~ape~~~~~~  144 (180)
                      +.++.||+.+++||++..++|||+-.+||++   ..+..++++|||+++...+...-.  ...  -...|+|||.+....
T Consensus       421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~  497 (609)
T KOG0200|consen  421 LSFAYQIANGMEYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV  497 (609)
T ss_pred             HHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence            9999999999999999999999999999999   577889999999998654433221  111  245599999999999


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030256          145 YDEKVDMWSVGAILFELLN-GYPPFSAYR  172 (180)
Q Consensus       145 ~~~~~Di~slg~~~~~~l~-g~~pf~~~~  172 (180)
                      ++.++|+||+|+++||+++ |..||++..
T Consensus       498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  498 FTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             ccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999 999998743

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=6.2e-28  Score=160.54  Aligned_cols=163  Identities=35%  Similarity=0.570  Sum_probs=142.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .-+...+|+-+++++.|.|||+++++...++.+.+|+|+| .-+|..+... ++.++.+.+..++.|+++++.+.|++++
T Consensus        44 vpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnv  122 (292)
T KOG0662|consen   44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNV  122 (292)
T ss_pred             CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhh
Confidence            3456788999999999999999999999999999999999 5589888864 4679999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~-g  164 (180)
                      .|+|++|.|+++   +.++.+++.|||+++..+-+.. -....-+.+|.+|.++.+.+ ++...|+||-||++.|+.. |
T Consensus       123 lhrdlkpqnlli---n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanag  199 (292)
T KOG0662|consen  123 LHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  199 (292)
T ss_pred             hhccCCcceEEe---ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence            999999999999   7899999999999987765432 23455688999999988776 7899999999999999987 8


Q ss_pred             CCCCCCCCccc
Q 030256          165 YPPFSAYRPCF  175 (180)
Q Consensus       165 ~~pf~~~~~~~  175 (180)
                      ++.|++.+-++
T Consensus       200 rplfpg~dvdd  210 (292)
T KOG0662|consen  200 RPLFPGNDVDD  210 (292)
T ss_pred             CCCCCCCcHHH
Confidence            88898876554

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=177.35  Aligned_cols=172  Identities=27%  Similarity=0.397  Sum_probs=145.7

Q ss_pred             ChhhhhHHHHHHHHHHHHHHhcC--CCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030256            1 MLKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (180)
Q Consensus         1 ~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~   74 (180)
                      +||+.....++...+|.++++..  +|+||+.+++....++    ++++|.+|.+.|||.|++.. ..++.+..++++..
T Consensus       238 AVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS  316 (513)
T KOG2052|consen  238 AVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALS  316 (513)
T ss_pred             EEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHH
Confidence            46888888899999999999987  9999999999875443    78999999999999999985 78999999999999


Q ss_pred             HHHHHHHHHhC--------CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-----CcccccccCccccCccccc
Q 030256           75 LGAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQ  141 (180)
Q Consensus        75 i~~~l~~lh~~--------~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~ape~~~  141 (180)
                      ++.+|++||..        .++|||||..||++   .+++.+-|.|+|++-+....     .......||.+|+|||++.
T Consensus       317 ~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd  393 (513)
T KOG2052|consen  317 IASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD  393 (513)
T ss_pred             HhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence            99999999963        39999999999999   68899999999998665433     2344677999999999986


Q ss_pred             ccc------CCcchhHHHHHHHHHHHHhC----------CCCCCCCCcccc
Q 030256          142 FQR------YDEKVDMWSVGAILFELLNG----------YPPFSAYRPCFA  176 (180)
Q Consensus       142 ~~~------~~~~~Di~slg~~~~~~l~g----------~~pf~~~~~~~~  176 (180)
                      +.-      .-..+||||||.++||+...          ++||.+..|++.
T Consensus       394 etin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  394 ETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             hhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            542      23579999999999998763          779987776654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-28  Score=191.36  Aligned_cols=173  Identities=32%  Similarity=0.522  Sum_probs=145.8

Q ss_pred             ChhhhhHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC----CCHHHHHHHHHHH
Q 030256            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQL   75 (180)
Q Consensus         1 ~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i   75 (180)
                      +||.+-.+-...+.+|++.|++- +||||+++++.-.++...|+..|.| ..+|.+++.....    ......+..+.|+
T Consensus       537 AVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~  615 (903)
T KOG1027|consen  537 AVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQI  615 (903)
T ss_pred             hHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHH
Confidence            36777777888899999999999 7999999999999999999999999 6799999986411    1224567789999


Q ss_pred             HHHHHHHHhCCCeeecCCCCCeeeecCC--CCceEEEeecCCccccCCCC----cccccccCccccCccccccccCCcch
Q 030256           76 GAGLEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        76 ~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      +.+|++||+.+++||||+|.||++...+  ...+++|.|||+++++....    ......|+.+|.|||.+.+...+.+.
T Consensus       616 ~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~av  695 (903)
T KOG1027|consen  616 ASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAV  695 (903)
T ss_pred             HHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCccc
Confidence            9999999999999999999999997532  34568999999998886543    23456789999999999998888999


Q ss_pred             hHHHHHHHHHHHHhC-CCCCCCCCcc
Q 030256          150 DMWSVGAILFELLNG-YPPFSAYRPC  174 (180)
Q Consensus       150 Di~slg~~~~~~l~g-~~pf~~~~~~  174 (180)
                      ||+|+||++|+.++| ..||.+.-..
T Consensus       696 DiFslGCvfyYvltgG~HpFGd~~~R  721 (903)
T KOG1027|consen  696 DIFSLGCVFYYVLTGGSHPFGDSLER  721 (903)
T ss_pred             chhhcCceEEEEecCCccCCCchHHh
Confidence            999999999999995 9999876544

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=4.8e-28  Score=184.34  Aligned_cols=152  Identities=30%  Similarity=0.595  Sum_probs=135.3

Q ss_pred             HHHHHHhcCC---CccccccceEEEeCCeEEEEEeccC-CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           15 CELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCA-GGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        15 ~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      .|++||..++   |+||++++++|++++.+|+++|-.. |.+|.+++...+.+++..+..|++|++.++++||+.|++||
T Consensus       615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhr  694 (772)
T KOG1152|consen  615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHR  694 (772)
T ss_pred             hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceec
Confidence            4999999996   9999999999999999999999763 46788999988899999999999999999999999999999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCCCCCC
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS  169 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~~pf~  169 (180)
                      |||-+|+.+   +.++.++|+|||.+.-..+ .+.....||..|.|||++.+..| +..-|||+||+++|.++-...||.
T Consensus       695 dikdenviv---d~~g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  695 DIKDENVIV---DSNGFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccccccEEE---ecCCeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999999   6899999999998754433 33345669999999999998886 677899999999999999999986


Q ss_pred             C
Q 030256          170 A  170 (180)
Q Consensus       170 ~  170 (180)
                      .
T Consensus       771 n  771 (772)
T KOG1152|consen  771 N  771 (772)
T ss_pred             C
Confidence            3

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=2.6e-26  Score=185.44  Aligned_cols=107  Identities=34%  Similarity=0.644  Sum_probs=98.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .....+.+|+.+++.++|++|+++++++...+.+++||||+.|++|.+++.....+++..++.++.||+.+|+|||.+|+
T Consensus        46 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gI  125 (669)
T cd05610          46 NMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI  125 (669)
T ss_pred             HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            34567889999999999999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      +|+||+|+||++   +..+.++|+|||++.
T Consensus       126 iHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610         126 IHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            999999999999   456789999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1e-26  Score=173.24  Aligned_cols=164  Identities=30%  Similarity=0.502  Sum_probs=139.6

Q ss_pred             ChhhhhHHHHHHHHHHHHHHhcC--CCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030256            1 MLKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (180)
Q Consensus         1 ~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~   74 (180)
                      +||++..+.++.+.+|-+|++..  .|+||+++++.-.-..    .+.+|++|.+.|+|.+++. ...++....++++..
T Consensus       237 AVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~-~ntisw~~~cria~S  315 (534)
T KOG3653|consen  237 AVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK-ANTISWNSLCRIAES  315 (534)
T ss_pred             EEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH-hccccHHHHHHHHHH
Confidence            47888999999999999999887  8999999998865443    8999999999999999998 667999999999999


Q ss_pred             HHHHHHHHHhC---------CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcccccc
Q 030256           75 LGAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        75 i~~~l~~lh~~---------~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~  142 (180)
                      ++++|++||+.         .|+||||+..|||+   .++...-|+|||++.++.....   .-...||.+|+|||++.+
T Consensus       316 marGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEg  392 (534)
T KOG3653|consen  316 MARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEG  392 (534)
T ss_pred             HHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence            99999999973         49999999999999   5788899999999987754322   223679999999999876


Q ss_pred             cc-CC-----cchhHHHHHHHHHHHHhCCCCC
Q 030256          143 QR-YD-----EKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus       143 ~~-~~-----~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      .. ..     .+.||||+|.++||++++-.-+
T Consensus       393 ainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  393 AINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             hcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            53 11     3789999999999999864433

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=9.9e-28  Score=171.19  Aligned_cols=162  Identities=36%  Similarity=0.500  Sum_probs=140.7

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .+..+|..+++.+.|+|+++++.+|.-..      ..|+|||+| ..+|...+.  ..++=.++..+..|++.++++||+
T Consensus        60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs  136 (369)
T KOG0665|consen   60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHS  136 (369)
T ss_pred             hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHh
Confidence            34677999999999999999999885432      579999999 669988775  457778999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      .|++||||+|+||++   +....+++.|||++......-.......+..|.|||+..+..+....||||+||++.||++|
T Consensus       137 ~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~  213 (369)
T KOG0665|consen  137 AGIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILG  213 (369)
T ss_pred             cceeecccCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhc
Confidence            999999999999999   67888999999999777665455566678889999999998899999999999999999999


Q ss_pred             CCCCCCCCcccccc
Q 030256          165 YPPFSAYRPCFASR  178 (180)
Q Consensus       165 ~~pf~~~~~~~~~~  178 (180)
                      ...|++.+.-+.+.
T Consensus       214 ~Vlf~g~d~idQ~~  227 (369)
T KOG0665|consen  214 TVLFPGKDHIDQWN  227 (369)
T ss_pred             eEEecCchHHHHHH
Confidence            99999887765543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-28  Score=170.76  Aligned_cols=161  Identities=30%  Similarity=0.496  Sum_probs=134.7

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .+.++..|.+...+- +.|+||+++|..-.++..++-||.| ..+|..+-+     ++..+++.-+-.+.-....||.||
T Consensus       105 eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yL  183 (361)
T KOG1006|consen  105 EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYL  183 (361)
T ss_pred             HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHH
Confidence            344466677655554 7999999999887888899999999 678877643     345688998888888899999999


Q ss_pred             HhC-CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc--cccCCcchhHHHHHHHHH
Q 030256           83 NSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        83 h~~-~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~--~~~~~~~~Di~slg~~~~  159 (180)
                      -+. .++|||+||+||++   +..+.++|||||..-.+........-.|...|+|||.+.  ..++..+||+||||++++
T Consensus       184 K~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~  260 (361)
T KOG1006|consen  184 KEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLY  260 (361)
T ss_pred             HHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEe
Confidence            864 79999999999999   688999999999987776666666667888999999875  335899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      |+.||.-||..++.
T Consensus       261 EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  261 EVATGNFPYRKWDS  274 (361)
T ss_pred             eeecCCCCcchHHH
Confidence            99999999988764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=4.4e-28  Score=182.81  Aligned_cols=165  Identities=31%  Similarity=0.468  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHHHHhcCC------CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGA   77 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~   77 (180)
                      +-....-..|+++|++|+      --+++.++..|...+++|+|+|.+ ..+|.+.+++-+.   +....+..++.|++.
T Consensus       469 E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLfl  547 (752)
T KOG0670|consen  469 EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFL  547 (752)
T ss_pred             hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHH
Confidence            334555677999999993      347899999999999999999988 7899999987653   788899999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  157 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~  157 (180)
                      ||..|-.+|++|.||+|+|||+.  .....++|||||.+...+.+..++.. -+..|.|||++.|..|+...|+||.||+
T Consensus       548 ALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~eneitPYL-VSRFYRaPEIiLG~~yd~~iD~WSvgct  624 (752)
T KOG0670|consen  548 ALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENEITPYL-VSRFYRAPEIILGLPYDYPIDTWSVGCT  624 (752)
T ss_pred             HHHHHHhcCeeecccCccceEec--cCcceeeeccCccccccccccccHHH-HHHhccCcceeecCcccCCccceeecee
Confidence            99999999999999999999996  56667899999999888777665443 4677999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCccc
Q 030256          158 LFELLNGYPPFSAYRPCF  175 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~~~  175 (180)
                      +||+.||+..|++.+...
T Consensus       625 LYElYtGkIlFpG~TNN~  642 (752)
T KOG0670|consen  625 LYELYTGKILFPGRTNNQ  642 (752)
T ss_pred             eEEeeccceecCCCCcHH
Confidence            999999999999987663

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=186.95  Aligned_cols=166  Identities=27%  Similarity=0.460  Sum_probs=144.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ++...++..|+..|.+++|||++++++++..+. ..+|++|+++|+|.++++.+. ++.....+.|..||++++.|||++
T Consensus       739 ~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q  817 (1177)
T KOG1025|consen  739 PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ  817 (1177)
T ss_pred             chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc
Confidence            345678899999999999999999999998776 889999999999999998664 699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccccc---ccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~---~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      +++||||-.+|+|+   .+...+++.|||+++-+.........   .-.+.|+|-|.+....++.++||||+|+++||++
T Consensus       818 rlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElm  894 (1177)
T KOG1025|consen  818 RLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELM  894 (1177)
T ss_pred             chhhhhhhhhheee---cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHH
Confidence            99999999999999   57888999999999877655443322   1235588889999999999999999999999999


Q ss_pred             h-CCCCCCCCCcccc
Q 030256          163 N-GYPPFSAYRPCFA  176 (180)
Q Consensus       163 ~-g~~pf~~~~~~~~  176 (180)
                      | |..||.+...++.
T Consensus       895 TFGa~Py~gi~~~eI  909 (1177)
T KOG1025|consen  895 TFGAKPYDGIPAEEI  909 (1177)
T ss_pred             hcCCCccCCCCHHHh
Confidence            9 9999998776643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-28  Score=173.02  Aligned_cols=163  Identities=33%  Similarity=0.517  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ..++-+|..+|..++|.|++..++...-..     .+|++.|.+. .+|...+-....++.+.+.-++.||+++++|||+
T Consensus        96 ~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs  174 (449)
T KOG0664|consen   96 CKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT  174 (449)
T ss_pred             HHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhh
Confidence            456778999999999999999998765332     4688899984 5998888777789999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccc-cCCcchhHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~  161 (180)
                      .++.|+||||.|+++   +++..++|||||+++.......  +....-+-.|.|||.+++. .|+.+.|+||.||++.|+
T Consensus       175 A~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaEL  251 (449)
T KOG0664|consen  175 ANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAEL  251 (449)
T ss_pred             cchhhccCCCccEEe---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHH
Confidence            999999999999999   6888899999999977654332  2334456779999999876 489999999999999999


Q ss_pred             HhCCCCCCCCCcccc
Q 030256          162 LNGYPPFSAYRPCFA  176 (180)
Q Consensus       162 l~g~~pf~~~~~~~~  176 (180)
                      +..+..|.+.+|-+.
T Consensus       252 LgRrILFQAq~PiqQ  266 (449)
T KOG0664|consen  252 LQRKILFQAAGPIEQ  266 (449)
T ss_pred             HhhhhhhhccChHHH
Confidence            999999999888654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-26  Score=181.32  Aligned_cols=166  Identities=32%  Similarity=0.659  Sum_probs=142.8

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCccccccceEEEe-----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGA   77 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~   77 (180)
                      +.+..++++.|.++++.. .|||++.+++++..     ++.+++|||||.||+..++++..  ..+.++.+..|+..++.
T Consensus        55 ~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lr  134 (953)
T KOG0587|consen   55 TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILR  134 (953)
T ss_pred             CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHH
Confidence            556678899999999999 79999999999743     46899999999999999998743  46899999999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCcccccc-----ccCCcchhH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-----QRYDEKVDM  151 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-----~~~~~~~Di  151 (180)
                      ++.+||.+.++|+|++-.||++   ..++.++|+|||++..+-.. ....+..|++.|+|||+...     ..++.++|+
T Consensus       135 gl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~  211 (953)
T KOG0587|consen  135 GLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDL  211 (953)
T ss_pred             HHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccch
Confidence            9999999999999999999999   58889999999998766432 23345669999999999753     347789999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCcc
Q 030256          152 WSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       152 ~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      ||||++..||..|.+|+-+.-|-
T Consensus       212 WsLGITaIEladG~PPl~DmHPm  234 (953)
T KOG0587|consen  212 WSLGITAIEMAEGAPPLCDMHPM  234 (953)
T ss_pred             hhccceeehhcCCCCCccCcchh
Confidence            99999999999999999876653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.3e-26  Score=160.11  Aligned_cols=159  Identities=26%  Similarity=0.490  Sum_probs=132.9

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEe--------CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ...+|+++|+.+.|+|++.+++.+..        ...+++||++|+ .+|.-.+... .+++..++.++++++..+|.|+
T Consensus        62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i  140 (376)
T KOG0669|consen   62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI  140 (376)
T ss_pred             HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHH
Confidence            45679999999999999999987632        236999999995 5898888644 4699999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-----cccccCccccCcccccc-ccCCcchhHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA  156 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~  156 (180)
                      |...++|||+++.|+++   +.++.++|.|||+++........     ..+.-+.+|.+||.+.+ ..++++.|+|.-||
T Consensus       141 Hr~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC  217 (376)
T KOG0669|consen  141 HRNKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC  217 (376)
T ss_pred             HHhhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence            99999999999999999   57889999999999665432211     12345788999998765 46899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcc
Q 030256          157 ILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~~  174 (180)
                      ++.+|+++.+.+.+.++-
T Consensus       218 imaeMwtrspimqgnteq  235 (376)
T KOG0669|consen  218 IMAEMWTRSPIMQGNTEQ  235 (376)
T ss_pred             HHHHHHccCccccCChHH
Confidence            999999999999886653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=2.3e-26  Score=189.20  Aligned_cols=150  Identities=17%  Similarity=0.200  Sum_probs=117.3

Q ss_pred             HhcCCC-ccccccceEE-------EeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           20 LSSVNH-PNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        20 l~~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      .+.++| .||+++++++       ..+..++.++|++ +++|.+++... ..+++..+..++.||+.||+|||++|++|+
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            345567 6888888887       2334688889988 67999999753 459999999999999999999999999999


Q ss_pred             cCCCCCeeeec----------------CCCCceEEEeecCCccccCCCC-----------------cccccccCccccCc
Q 030256           91 DLKPENILLSG----------------LDDDVMLKIADFGLSCTLYPGN-----------------YAEKVCGSPLYMAP  137 (180)
Q Consensus        91 dl~~~nil~~~----------------~~~~~~~~l~d~~~~~~~~~~~-----------------~~~~~~~~~~~~ap  137 (180)
                      ||||+||++..                .+....++++|||+++......                 ......++..|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999942                1234456777777765421100                 00112467789999


Q ss_pred             cccccccCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256          138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       138 e~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      |.+.+..++.++||||+||++|||++|..|+..
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            999988999999999999999999999988764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=6.9e-25  Score=153.01  Aligned_cols=149  Identities=46%  Similarity=0.812  Sum_probs=130.6

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|++.++.++|++++++++++......++++|++.|++|.+++... ..++...+..++.+++.++++||+.|++
T Consensus        35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~  114 (215)
T cd00180          35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII  114 (215)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            478999999999999999999999999989999999999989999998765 4789999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCC-CceEEEeecCCccccCCCC-cccccccCccccCccccccc-cCCcchhHHHHHHHHHHH
Q 030256           89 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        89 h~dl~~~nil~~~~~~-~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~  161 (180)
                      |+|++|.||++.   . ...++++||+.+....... ..........|.+||..... .++.++|+|++|++++++
T Consensus       115 H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         115 HRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             ccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            999999999995   4 6789999999887664432 12234467789999998877 788999999999999887

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.2e-25  Score=155.77  Aligned_cols=157  Identities=29%  Similarity=0.479  Sum_probs=126.6

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceE-EEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..++.+|+..=-.| .|.||+.-+++ |+..+.+++++||++.|+|.+-+. ...+.+.....++.|++.|+.++|++++
T Consensus        64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~-~~GigE~~~K~v~~ql~SAi~fMHsknl  142 (378)
T KOG1345|consen   64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE-AAGIGEANTKKVFAQLLSAIEFMHSKNL  142 (378)
T ss_pred             HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC-cccccHHHHHHHHHHHHHHHHHhhccch
Confidence            34577777766666 58999888765 788899999999999999988665 3458899999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc---c--cCCcchhHHHHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---Q--RYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~---~--~~~~~~Di~slg~~~~~~l  162 (180)
                      |||||+.+||++-+ .+..+++|||||.....+...  ...-....|.+||.+..   .  ...+.+|+|+||++++.++
T Consensus       143 VHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl  219 (378)
T KOG1345|consen  143 VHRDLKAENILIFD-ADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL  219 (378)
T ss_pred             hhcccccceEEEec-CCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence            99999999999865 334489999999887664322  22234567889987642   2  2467899999999999999


Q ss_pred             hCCCCCCC
Q 030256          163 NGYPPFSA  170 (180)
Q Consensus       163 ~g~~pf~~  170 (180)
                      ||..||..
T Consensus       220 tG~~PWQk  227 (378)
T KOG1345|consen  220 TGKFPWQK  227 (378)
T ss_pred             cCCCcchh
Confidence            99999973

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=2.9e-23  Score=152.39  Aligned_cols=163  Identities=28%  Similarity=0.492  Sum_probs=138.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEE-eCCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~   80 (180)
                      -..+..|--++..+.|||+..+.++.. +....++++.+..-++|..++...        ..++-.++..++.|++.|++
T Consensus       331 v~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~  410 (563)
T KOG1024|consen  331 VNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAME  410 (563)
T ss_pred             HHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHH
Confidence            445667777888889999999999876 456789999999889999999722        12667788899999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  157 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~  157 (180)
                      +||..|++|.||..+|+++   ++.-+++|+|=.+++.+.+.+..   ........|++||.+.+..++.++|+||||++
T Consensus       411 hlh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVl  487 (563)
T KOG1024|consen  411 HLHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVL  487 (563)
T ss_pred             HHHhcCcccchhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHH
Confidence            9999999999999999999   57789999999998887665432   22334567999999999999999999999999


Q ss_pred             HHHHHh-CCCCCCCCCccc
Q 030256          158 LFELLN-GYPPFSAYRPCF  175 (180)
Q Consensus       158 ~~~~l~-g~~pf~~~~~~~  175 (180)
                      +||++| |+.||..-+|.+
T Consensus       488 lWELmtlg~~PyaeIDPfE  506 (563)
T KOG1024|consen  488 LWELMTLGKLPYAEIDPFE  506 (563)
T ss_pred             HHHHHhcCCCCccccCHHH
Confidence            999999 999999988864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3.7e-23  Score=161.03  Aligned_cols=155  Identities=23%  Similarity=0.339  Sum_probs=115.6

Q ss_pred             HHHHHHHHhcCCCccc-----cccceEEEe--------CCeEEEEEeccCCCChHHHHHhcC------------------
Q 030256           13 LDCELNFLSSVNHPNI-----IRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHG------------------   61 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~------------------   61 (180)
                      ...|+.++.+++|.++     +++++++..        .+..++|+||+++++|.+++....                  
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            3446777777765543     667776643        346899999999999999886321                  


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccc--ccccCcc
Q 030256           62 ------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPL  133 (180)
Q Consensus        62 ------~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~  133 (180)
                            .++...+..++.|++.+++++|+.+++|+||+|+||++   +.+..++|+|||++..........  ....++.
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~  375 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR  375 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence                  13566788999999999999999999999999999999   456789999999986554322211  1223678


Q ss_pred             ccCcccccccc----------------------CCcchhHHHHHHHHHHHHhCCC-CCCC
Q 030256          134 YMAPEVLQFQR----------------------YDEKVDMWSVGAILFELLNGYP-PFSA  170 (180)
Q Consensus       134 ~~ape~~~~~~----------------------~~~~~Di~slg~~~~~~l~g~~-pf~~  170 (180)
                      |+|||.+....                      ...+.|+||+|+++++|+++.. ||.+
T Consensus       376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            99999875322                      1124699999999999999875 7753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.90  E-value=1.2e-23  Score=166.85  Aligned_cols=133  Identities=24%  Similarity=0.389  Sum_probs=101.5

Q ss_pred             EeCCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 030256           36 QAENCIFLVVEFCAGGNLSSYIRLHGR--------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE   95 (180)
Q Consensus        36 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~   95 (180)
                      ...+..+++++|+.+++|.+++.....                    .....+..++.|++.+|+|||+++++|+||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            345689999999999999998864321                    123446689999999999999999999999999


Q ss_pred             CeeeecCCCCceEEEeecCCccccCCC--CcccccccCccccCcccccccc----------------------CCcchhH
Q 030256           96 NILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQR----------------------YDEKVDM  151 (180)
Q Consensus        96 nil~~~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~----------------------~~~~~Di  151 (180)
                      ||+++  +....++|+|||++......  .......+++.|+|||.+....                      ++.++||
T Consensus       285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        285 NIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99995  34568999999999755322  2223455788999999653221                      2345699


Q ss_pred             HHHHHHHHHHHhCCCCCCC
Q 030256          152 WSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       152 ~slg~~~~~~l~g~~pf~~  170 (180)
                      ||+||++|||+++..++++
T Consensus       363 wSlGviL~el~~~~~~~~~  381 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDS  381 (566)
T ss_pred             HHHHHHHHHHHhCcCCCch
Confidence            9999999999987766543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2e-23  Score=150.36  Aligned_cols=163  Identities=21%  Similarity=0.337  Sum_probs=143.0

Q ss_pred             HHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..++.|.+.++.| ..++|+.++-+...+.+..+|+|.. |.+|.++..-.+ .|+..++..++.|++.-++++|++.++
T Consensus        68 PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LI  146 (449)
T KOG1165|consen   68 PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLI  146 (449)
T ss_pred             chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhccee
Confidence            3477789999999 6899999998888888999999988 999999998766 599999999999999999999999999


Q ss_pred             eecCCCCCeeeecCC--CCceEEEeecCCccccCCCCcc--------cccccCccccCccccccccCCcchhHHHHHHHH
Q 030256           89 HRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        89 h~dl~~~nil~~~~~--~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~  158 (180)
                      +|||||+|.|++...  ....+.++|||+++...++...        ....||-+|++-....+.+-|.+.|+-|||-++
T Consensus       147 YRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvF  226 (449)
T KOG1165|consen  147 YRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVF  226 (449)
T ss_pred             ecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhh
Confidence            999999999997532  3445899999999888765433        246689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCcc
Q 030256          159 FELLNGYPPFSAYRPC  174 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~~  174 (180)
                      .+.+.|..||.+-.++
T Consensus       227 mYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  227 MYFLRGSLPWQGLKAD  242 (449)
T ss_pred             hhhccCCCccccccCc
Confidence            9999999999876655

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-22  Score=151.52  Aligned_cols=161  Identities=26%  Similarity=0.326  Sum_probs=134.8

Q ss_pred             HHHHHHHHHhcCC----CccccccceEE-EeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 030256           12 CLDCELNFLSSVN----HPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        12 ~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .+..|..++..+.    .++++.+++.. ...+..++||+.. |.+|.++....+  .++..++..++.|++.+|+++|+
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~  140 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS  140 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence            5788899999986    36899999988 4778899999988 999999886554  69999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCC--CCceEEEeecCCcc--ccCCCC--------c-ccccccCccccCccccccccCCcchhH
Q 030256           85 HHIIHRDLKPENILLSGLD--DDVMLKIADFGLSC--TLYPGN--------Y-AEKVCGSPLYMAPEVLQFQRYDEKVDM  151 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~--~~~~~~l~d~~~~~--~~~~~~--------~-~~~~~~~~~~~ape~~~~~~~~~~~Di  151 (180)
                      .|++||||+|.|++++...  ....+.+.|||+++  ......        . .....||.+|.|+....+.+.+.+.|+
T Consensus       141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl  220 (322)
T KOG1164|consen  141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL  220 (322)
T ss_pred             cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence            9999999999999997432  12569999999998  321111        1 112348999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCc
Q 030256          152 WSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       152 ~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      ||+++++.+++.|..||.....
T Consensus       221 es~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  221 ESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             hhHHHHHHHHhcCCCCCccccc
Confidence            9999999999999999976553

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=1e-22  Score=139.46  Aligned_cols=107  Identities=32%  Similarity=0.403  Sum_probs=91.8

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccc
Q 030256           51 GNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC  129 (180)
Q Consensus        51 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  129 (180)
                      |+|.+++... .++++..+..++.|++.+++|||+.+      +|+||++   +.++.+++  ||.+.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence            5899998764 45999999999999999999999998      9999999   46667777  99876554322    24


Q ss_pred             cCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       130 ~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      ++..|+|||.+.+..++.++||||+|+++|++++|+.||....
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~  108 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER  108 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence            7889999999999999999999999999999999999997643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.89  E-value=2.7e-23  Score=169.25  Aligned_cols=121  Identities=36%  Similarity=0.656  Sum_probs=101.4

Q ss_pred             eEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           40 CIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        40 ~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      .+||-||||+..++.+++..+... .....++++.+|++||+|+|+.|++||||||.||++   +.+..|+|+|||++..
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATD  746 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchh
Confidence            469999999998888888765544 578899999999999999999999999999999999   5788899999999977


Q ss_pred             cC------------------CCC-cccccccCccccCcccccccc---CCcchhHHHHHHHHHHHHh
Q 030256          119 LY------------------PGN-YAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLN  163 (180)
Q Consensus       119 ~~------------------~~~-~~~~~~~~~~~~ape~~~~~~---~~~~~Di~slg~~~~~~l~  163 (180)
                      ..                  .+. ......||-.|+|||.+.+..   ++.+.|+||||++++||+.
T Consensus       747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence            21                  001 223355888899999987654   8999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.89  E-value=3.2e-23  Score=152.64  Aligned_cols=157  Identities=29%  Similarity=0.444  Sum_probs=132.4

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      -+++.+|+++|..+ .+.||+++.+.+..++...+|++|++..+..++..   .++...+..++..++.||+++|.+|++
T Consensus        78 p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIv  154 (418)
T KOG1167|consen   78 PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIV  154 (418)
T ss_pred             chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCcc
Confidence            35688999999999 79999999999999999999999999999888765   466889999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC----------------C-----------------------------C
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------G-----------------------------N  123 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~----------------~-----------------------------~  123 (180)
                      |+|+||+|++++  ....+-.|+|||++.....                .                             .
T Consensus       155 HRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~  232 (418)
T KOG1167|consen  155 HRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPS  232 (418)
T ss_pred             ccCCCccccccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccc
Confidence            999999999996  5666789999999862100                0                             0


Q ss_pred             cccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256          124 YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus       124 ~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                      ......||++|.|||++.. ...+++.|+||.|+++..+++++.||-..
T Consensus       233 ~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  233 ERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             eecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccC
Confidence            0012458899999998764 45788999999999999999999998543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.5e-22  Score=139.18  Aligned_cols=166  Identities=20%  Similarity=0.245  Sum_probs=142.1

Q ss_pred             HHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+..|..+++.|+ ..+|+.+.-+..+.....+|||.. |.+|.++.+-.. .++..+++-++-|++.-++|+|.+++
T Consensus        54 hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~f  132 (341)
T KOG1163|consen   54 HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNF  132 (341)
T ss_pred             CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcc
Confidence            345677899999995 578999998888899999999988 999999987544 58999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--------ccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      +|+||+|+|.+.+-.....++.++|||++++..+...        .....||.+|.+-....+.+.|.+.|+-|+|.++.
T Consensus       133 iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLm  212 (341)
T KOG1163|consen  133 IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLM  212 (341)
T ss_pred             ccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceee
Confidence            9999999999986445566799999999987754321        23467899999999988888999999999999999


Q ss_pred             HHHhCCCCCCCCCcccc
Q 030256          160 ELLNGYPPFSAYRPCFA  176 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~~~  176 (180)
                      +.-.|..||.+-.+.-.
T Consensus       213 YfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  213 YFNRGSLPWQGLKAATK  229 (341)
T ss_pred             eeecCCCcccccchhhH
Confidence            99999999998777643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5.8e-21  Score=143.42  Aligned_cols=94  Identities=31%  Similarity=0.525  Sum_probs=80.7

Q ss_pred             hHHHHHHHHHHHHHHhcCC-----C---ccccccceEEEeC----CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVN-----H---PNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKF   71 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~   71 (180)
                      .++..+....|+.+|++++     |   .+||++++.|...    .++|+|+|++ |..|..++....  .++...+..|
T Consensus       114 AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I  192 (590)
T KOG1290|consen  114 AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEI  192 (590)
T ss_pred             hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHH
Confidence            4566788889999999992     2   4699999998643    4899999998 889988887654  4999999999


Q ss_pred             HHHHHHHHHHHHh-CCCeeecCCCCCeeee
Q 030256           72 LQQLGAGLEILNS-HHIIHRDLKPENILLS  100 (180)
Q Consensus        72 ~~~i~~~l~~lh~-~~~~h~dl~~~nil~~  100 (180)
                      ++|++.+|.|||+ +|++|.||||+|||+.
T Consensus       193 ~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  193 CRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             HHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            9999999999997 5999999999999984

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=6.3e-20  Score=135.66  Aligned_cols=162  Identities=42%  Similarity=0.690  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHHhcCCCc-cccccceEEEeCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            9 LKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....+.+|..++..+.|+ +++++.+.+...+..+++++++.++++.+++....   .++......++.|++.++.++|+
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~  119 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS  119 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            466788899999999888 79999999977778899999999999997777664   79999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCc-eEEEeecCCccccCCCC-------cccccccCccccCcccccc---ccCCcchhHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQF---QRYDEKVDMWS  153 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~-~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~ape~~~~---~~~~~~~Di~s  153 (180)
                      .+++|+|++|.|+++.   ... .++++|||.+.......       ......++..|.+||...+   ...+...|+|+
T Consensus       120 ~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s  196 (384)
T COG0515         120 KGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS  196 (384)
T ss_pred             CCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence            9999999999999994   444 79999999987544332       2345668899999999987   57888999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030256          154 VGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~~  173 (180)
                      +|++++++++|..||.....
T Consensus       197 ~g~~~~~~~~~~~p~~~~~~  216 (384)
T COG0515         197 LGITLYELLTGLPPFEGEKN  216 (384)
T ss_pred             HHHHHHHHHhCCCCCCCCCc
Confidence            99999999999999877653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=3.3e-20  Score=128.34  Aligned_cols=150  Identities=17%  Similarity=0.132  Sum_probs=112.1

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+++|+++|+++ +++++++++++    +..+++|+|+.|.+|......       ....++.|+..+++++|++|++
T Consensus        45 ~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIv  113 (218)
T PRK12274         45 WWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVA  113 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCc
Confidence            34688999999999 45889999886    457999999999998654321       1235778999999999999999


Q ss_pred             eecC-CCCCeeeecCCCCceEEEeecCCccccCCCCcc--------------cccccCccccCccccccc-cCC-cchhH
Q 030256           89 HRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------------EKVCGSPLYMAPEVLQFQ-RYD-EKVDM  151 (180)
Q Consensus        89 h~dl-~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--------------~~~~~~~~~~ape~~~~~-~~~-~~~Di  151 (180)
                      |+|| +|.||+++   .++.++|+|||++.........              .....++.+++|+...-. ..+ .+.+.
T Consensus       114 HrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w  190 (218)
T PRK12274        114 HNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELW  190 (218)
T ss_pred             cCCCCCcceEEEc---CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHH
Confidence            9999 79999994   5667999999999754432210              012245556666544322 334 67889


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCc
Q 030256          152 WSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       152 ~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      ++.|+-+|.++|+..+..+.++
T Consensus       191 ~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        191 FATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHhcchHHHHHhccCCccccCC
Confidence            9999999999999988866443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.85  E-value=1.6e-22  Score=156.58  Aligned_cols=158  Identities=32%  Similarity=0.572  Sum_probs=137.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      +.-.-++.|+-+++..+|+|||.+++.+...+..++.||||.||+|.+.-.-.+++++.++....+..+.+++|||+.|=
T Consensus        54 dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk  133 (829)
T KOG0576|consen   54 DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGK  133 (829)
T ss_pred             ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCc
Confidence            34455677889999999999999999999999999999999999999977767889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-cccccCccccCcccc---ccccCCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~ape~~---~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|||||-.||++   .+.+.+++.|||.+..+...... ....|++.|+|||+.   +.+.+...+|+|++|+...|+-.
T Consensus       134 ~hRdiKGanill---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e  210 (829)
T KOG0576|consen  134 IHRDIKGANILL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE  210 (829)
T ss_pred             ccccccccceee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh
Confidence            999999999999   57888999999998776543322 345699999999975   45678999999999999998877


Q ss_pred             CCCCC
Q 030256          164 GYPPF  168 (180)
Q Consensus       164 g~~pf  168 (180)
                      -++|-
T Consensus       211 Lqppl  215 (829)
T KOG0576|consen  211 LQPPL  215 (829)
T ss_pred             cCCcc
Confidence            66664

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.5e-19  Score=135.71  Aligned_cols=122  Identities=21%  Similarity=0.201  Sum_probs=92.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+++|++++++++|+|+++.+..   .+..+++|||++|++|.. ..   +..   ...++.+++.+++++|+.|+
T Consensus        63 ~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gI  132 (365)
T PRK09188         63 LARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGI  132 (365)
T ss_pred             HHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCC
Confidence            346679999999999999999853322   245799999999999963 21   111   24678899999999999999


Q ss_pred             eeecC-CCCCeeeecCCCCceEEEeecCCccccCCCCcc---------cccccCccccCcccccc
Q 030256           88 IHRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------EKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        88 ~h~dl-~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~ape~~~~  142 (180)
                      +|||| ||+||++   +.++.++|+|||+++........         ....+++.|.+||....
T Consensus       133 iHrDL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        133 THNDLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eeCCCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999 8999999   45567999999999765443211         23346667889998753

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=1.5e-19  Score=127.27  Aligned_cols=126  Identities=17%  Similarity=0.236  Sum_probs=96.0

Q ss_pred             HHHHHHHHhcCCCccccccceEEEeC--------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      +++|++.+.++.|++|+.+.+++...        +..+++|||++|.+|.++..    +++    ....+++.+++.+|+
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~  153 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ  153 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH
Confidence            68899999999999999999886533        35799999999999988632    333    245689999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      .|++|||++|+|++++   .++ ++++|||...........           ........+..++|+|+||+.+...
T Consensus       154 ~gi~H~Dikp~Nili~---~~g-i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        154 HGMVSGDPHKGNFIVS---KNG-LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             cCCccCCCChHHEEEe---CCC-EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHH
Confidence            9999999999999995   344 999999977544211110           1123334456789999999987654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=2.8e-20  Score=147.75  Aligned_cols=160  Identities=34%  Similarity=0.544  Sum_probs=132.8

Q ss_pred             HHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL   92 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl   92 (180)
                      +..|+-+-..+.|+|++..+....+.....-.|||+++ +|..++.....+....+.-+++|++.+++|+|+.|+.|+|+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            56677777888999998888777666555555999998 99999887778999999999999999999999999999999


Q ss_pred             CCCCeeeecCCCCceEEEeecCCccccCCC-----CcccccccCccccCccccccccCCc-chhHHHHHHHHHHHHhCCC
Q 030256           93 KPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQRYDE-KVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        93 ~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~ape~~~~~~~~~-~~Di~slg~~~~~~l~g~~  166 (180)
                      +++|+++   ...+.++++|||.+......     .......|+..|+|||.+.+.++.+ ..|+||.|+++..|.+|+.
T Consensus       447 K~enll~---~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~  523 (601)
T KOG0590|consen  447 KLENLLV---TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF  523 (601)
T ss_pred             ccccEEE---ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence            9999999   46779999999987543221     1223456888899999999888765 5899999999999999999


Q ss_pred             CCCCCCcccc
Q 030256          167 PFSAYRPCFA  176 (180)
Q Consensus       167 pf~~~~~~~~  176 (180)
                      ||......++
T Consensus       524 ~Wk~a~~~~~  533 (601)
T KOG0590|consen  524 PWKVAKKSDN  533 (601)
T ss_pred             cccccccccc
Confidence            9976655544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=3.4e-18  Score=118.40  Aligned_cols=104  Identities=22%  Similarity=0.203  Sum_probs=83.6

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~~h   89 (180)
                      ...+.|.+.+.++.+++++.........  .++||||++|+++........+++...+..++.|++.+++++ |+.|++|
T Consensus        64 ~~~~~E~~~l~~l~~~~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiH  141 (190)
T cd05147          64 TWAEKEMRNLKRLVTAGIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVH  141 (190)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            3445699999999888875554433222  389999998877765544456799999999999999999999 7999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~  120 (180)
                      +||+|+||++.    ++.++|+|||++....
T Consensus       142 rDlkP~NIli~----~~~v~LiDFG~a~~~~  168 (190)
T cd05147         142 ADLSEYNLLYH----DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCCCHHHEEEE----CCcEEEEEccccccCC
Confidence            99999999994    3579999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.77  E-value=1.4e-19  Score=147.08  Aligned_cols=146  Identities=22%  Similarity=0.296  Sum_probs=118.7

Q ss_pred             HhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeee
Q 030256           20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL   99 (180)
Q Consensus        20 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~   99 (180)
                      +..+++||++++..+...+...|+|.+|. ..+|.|.+...+-+...+...++.|++.|+...|+.|++|||||.+||++
T Consensus        75 ~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi  153 (1431)
T KOG1240|consen   75 FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI  153 (1431)
T ss_pred             HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence            56669999999999988888999999999 55999999877768888999999999999999999999999999999999


Q ss_pred             ecCCCCceEEEeecCCccccCCCCccc--------ccccCccccCcccccccc-----------CCcchhHHHHHHHHHH
Q 030256          100 SGLDDDVMLKIADFGLSCTLYPGNYAE--------KVCGSPLYMAPEVLQFQR-----------YDEKVDMWSVGAILFE  160 (180)
Q Consensus       100 ~~~~~~~~~~l~d~~~~~~~~~~~~~~--------~~~~~~~~~ape~~~~~~-----------~~~~~Di~slg~~~~~  160 (180)
                      +   .-..+.|.||...+...-+....        +.....-|+|||.+....           .+++.||||+||+++|
T Consensus       154 T---SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaE  230 (1431)
T KOG1240|consen  154 T---SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAE  230 (1431)
T ss_pred             e---eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHH
Confidence            5   45568999998775543221111        112234499999875422           5678999999999999


Q ss_pred             HHh-CCCCCC
Q 030256          161 LLN-GYPPFS  169 (180)
Q Consensus       161 ~l~-g~~pf~  169 (180)
                      +++ |++||+
T Consensus       231 Lf~Eg~PlF~  240 (1431)
T KOG1240|consen  231 LFLEGRPLFT  240 (1431)
T ss_pred             HHhcCCCccc
Confidence            998 899995

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=3.7e-18  Score=119.51  Aligned_cols=105  Identities=21%  Similarity=0.292  Sum_probs=83.4

Q ss_pred             HHHHHHHHHHHHhcC-----CCccccccceEEEeCC---e-EEEEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSV-----NHPNIIRLFDAFQAEN---C-IFLVVEF--CAGGNLSSYIRLHGRVPEQTARKFLQQLGA   77 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~   77 (180)
                      ..+.+.+|+.+++++     +||||++++++++++.   . +.+|+||  +.+++|.+++.. ..+++.  ..++.+++.
T Consensus        39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~  115 (210)
T PRK10345         39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLK  115 (210)
T ss_pred             hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHH
Confidence            456799999999999     5799999999998763   3 3378999  556999999975 456655  356777777


Q ss_pred             HH-HHHHhCCCeeecCCCCCeeeecCC-CCceEEEeecCCc
Q 030256           78 GL-EILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLS  116 (180)
Q Consensus        78 ~l-~~lh~~~~~h~dl~~~nil~~~~~-~~~~~~l~d~~~~  116 (180)
                      ++ +|||+++++|+||+|+||+++..+ ....++|+|++.+
T Consensus       116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            76 999999999999999999996422 3457999994434

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.6e-18  Score=122.56  Aligned_cols=160  Identities=24%  Similarity=0.403  Sum_probs=125.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      .....+.+..|+-.|+-+.||||+++++.+.......++..||+.++|.+.+.....  .+-.++.+++.++++++++||
T Consensus       227 t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflh  306 (448)
T KOG0195|consen  227 TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLH  306 (448)
T ss_pred             chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHh
Confidence            345567788899999999999999999999999999999999999999999976544  678899999999999999999


Q ss_pred             hCC--CeeecCCCCCeeeecCCCCce--EEEeecCCccccCCCCcccccccCccccCcccccccc---CCcchhHHHHHH
Q 030256           84 SHH--IIHRDLKPENILLSGLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGA  156 (180)
Q Consensus        84 ~~~--~~h~dl~~~nil~~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~---~~~~~Di~slg~  156 (180)
                      +..  +.-..++..+++++   ++..  +-..|--++.      ........+.|++||.+....   --.++|+||+++
T Consensus       307 slep~ipr~~lns~hvmid---edltarismad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsfai  377 (448)
T KOG0195|consen  307 SLEPMIPRFYLNSKHVMID---EDLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAI  377 (448)
T ss_pred             hcchhhhhhhcccceEEec---chhhhheecccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHH
Confidence            975  34446788888884   3333  3333322211      111233567899999987554   245789999999


Q ss_pred             HHHHHHhCCCCCCCCCcc
Q 030256          157 ILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~~  174 (180)
                      ++||+.|...||.+.+|-
T Consensus       378 llwel~trevpfadlspm  395 (448)
T KOG0195|consen  378 LLWELNTREVPFADLSPM  395 (448)
T ss_pred             HHHHhhccccccccCCch
Confidence            999999999999987764

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=2.2e-17  Score=114.55  Aligned_cols=105  Identities=19%  Similarity=0.158  Sum_probs=84.7

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~h   89 (180)
                      ...++|.+.+.++.++++.....+....  .+++|||++|+++........+++......++.+++.++.++|+ .|++|
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givH  141 (190)
T cd05145          64 AWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVH  141 (190)
T ss_pred             HHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            4457899999999999886555544333  48999999887654433334578889999999999999999999 99999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~  121 (180)
                      +||+|.||++.    ++.++|+|||++.....
T Consensus       142 rDlkP~NIll~----~~~~~liDFG~a~~~~~  169 (190)
T cd05145         142 GDLSEYNILYH----DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCChhhEEEE----CCCEEEEEcccceecCC
Confidence            99999999994    56799999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.72  E-value=3.5e-17  Score=125.68  Aligned_cols=151  Identities=26%  Similarity=0.428  Sum_probs=125.7

Q ss_pred             HhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC-eeecCCCCCe
Q 030256           20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI-IHRDLKPENI   97 (180)
Q Consensus        20 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~-~h~dl~~~ni   97 (180)
                      |+.+.|.|+.++++.+.+++..++|.+++..|+|.+.+... .+++......+.++++.+++|+|.-.+ .||.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999999999999863 468888999999999999999998754 9999999999


Q ss_pred             eeecCCCCceEEEeecCCccccCCC---CcccccccCccccCcccccccc-------CCcchhHHHHHHHHHHHHhCCCC
Q 030256           98 LLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR-------YDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        98 l~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~ape~~~~~~-------~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      ++   +....+++.|||+.......   ..........-|.|||.+++..       .+.+.|+||+|++++|+++.+.|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   68999999999987665321   1111122345589999987642       46789999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |+....
T Consensus       158 ~~~~~~  163 (484)
T KOG1023|consen  158 FDLRNL  163 (484)
T ss_pred             cccccc
Confidence            987443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=4e-18  Score=131.69  Aligned_cols=151  Identities=33%  Similarity=0.513  Sum_probs=133.9

Q ss_pred             HHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        12 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      .-+.|..++...+ ||.++++...+..++..++++++..|+.|...+.+...+++.........++-++..+|+.+++++
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyr  121 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYR  121 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence            3445777888885 999999999999999999999999999998888777788899999999999999999999999999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      |+|++||++   +..+.+++.|||..+..-.....   .|+..|+|||+..  ....++|.||+|++.+++++|..||..
T Consensus       122 d~k~enill---d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  122 DYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             cccccceee---cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            999999999   68899999999988766444332   6899999999988  567889999999999999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=1.8e-16  Score=117.40  Aligned_cols=146  Identities=32%  Similarity=0.469  Sum_probs=108.7

Q ss_pred             CCccccccceEEEe---------------------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 030256           24 NHPNIIRLFDAFQA---------------------------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG   76 (180)
Q Consensus        24 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~   76 (180)
                      +|||||.+.+.|.+                           ....|++|... ..+|..++-.+ ..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            69999999866421                           23679999988 56999998744 445556667899999


Q ss_pred             HHHHHHHhCCCeeecCCCCCeeeec-CCCCceEEEeecCCccccCCC-------CcccccccCccccCcccccccc----
Q 030256           77 AGLEILNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPG-------NYAEKVCGSPLYMAPEVLQFQR----  144 (180)
Q Consensus        77 ~~l~~lh~~~~~h~dl~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~ape~~~~~~----  144 (180)
                      +++.+||++|+.|+|+|.+||++.- ++.-..+++.|||++-.-...       ......-|....+|||+.....    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            9999999999999999999999853 344555789999986332211       0111233555678999875322    


Q ss_pred             --CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256          145 --YDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus       145 --~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                        --.++|.|+.|.+.||+++...||.+.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~r  460 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKR  460 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCccccc
Confidence              134899999999999999999999873

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.68  E-value=6.1e-17  Score=117.36  Aligned_cols=127  Identities=24%  Similarity=0.349  Sum_probs=87.8

Q ss_pred             EEEEeccCCCChHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecC
Q 030256           42 FLVVEFCAGGNLSSYIRL---HGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG  114 (180)
Q Consensus        42 ~lv~e~~~~~~L~~~l~~---~~~----~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~  114 (180)
                      +++|+-+ -++|.+++..   ...    +.......+..|+++.+++||..|++|+||+|+|+++   +.++.+.|+||+
T Consensus       115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F~  190 (288)
T PF14531_consen  115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--GG
T ss_pred             hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcChH
Confidence            6788877 5699887542   222    2223334555788999999999999999999999999   578999999999


Q ss_pred             CccccCCCCcccccccCccccCcccccc--------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          115 LSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       115 ~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      .....+.....  ...+..|.|||....        ..++.+.|.|+||+++|.++++..||+...+.
T Consensus       191 ~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~  256 (288)
T PF14531_consen  191 SLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPE  256 (288)
T ss_dssp             GEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGG
T ss_pred             HHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcc
Confidence            87666543332  234567889987643        24688999999999999999999999866554

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=6.8e-16  Score=108.64  Aligned_cols=102  Identities=24%  Similarity=0.318  Sum_probs=88.6

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      +..+.+|++++..+.|++++....++.+.+..+++|||++|++|.+.+.....    ....++.+++.+++++|+.|++|
T Consensus        43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H  118 (211)
T PRK14879         43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIH  118 (211)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCccc
Confidence            45678899999999999998888887777788999999999999998864332    78889999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCcccc
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~  119 (180)
                      +|++|.||++.    .+.++++|||.+...
T Consensus       119 ~Dl~p~Nil~~----~~~~~liDf~~a~~~  144 (211)
T PRK14879        119 GDLTTSNMILS----GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CCCCcccEEEE----CCCEEEEECCcccCC
Confidence            99999999994    567899999987653

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=1.4e-17  Score=126.46  Aligned_cols=118  Identities=36%  Similarity=0.614  Sum_probs=103.1

Q ss_pred             eEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCc
Q 030256           40 CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS  116 (180)
Q Consensus        40 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~  116 (180)
                      ..++.|++|...+|.+++....   ..+......+..|++.++.|   ++.+|+|++|.||++.   .+..++|+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhhe
Confidence            5789999999999999997443   36778899999999999999   9999999999999994   5557999999998


Q ss_pred             cccCCCC-------cccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256          117 CTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus       117 ~~~~~~~-------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      .......       ......++..|++||.+.+..++.++||||||++++|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            7765444       3445679999999999999999999999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=3.2e-16  Score=128.32  Aligned_cols=141  Identities=27%  Similarity=0.333  Sum_probs=118.4

Q ss_pred             CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeec---
Q 030256           25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSG---  101 (180)
Q Consensus        25 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~---  101 (180)
                      -+.|.++...+...+.-+++++|.+.|+|-++++....+++..+..+..|++..+..||..+|+||||||+|.++..   
T Consensus       753 ~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~  832 (974)
T KOG1166|consen  753 LPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC  832 (974)
T ss_pred             hcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC
Confidence            35566666667778889999999999999999997778999999999999999999999999999999999999852   


Q ss_pred             -CCCCceEEEeecCCccccC---CCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256          102 -LDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus       102 -~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                       .....-++|+|||.+-.+.   ++......+++-.+--+|...|..++...|.|.++.+++.||.|+
T Consensus       833 ~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  833 ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence             1234458999999875442   222344556788889999999999999999999999999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=1.1e-15  Score=106.73  Aligned_cols=99  Identities=23%  Similarity=0.291  Sum_probs=83.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ..++.+|+++++.+.+++++.+..++...+..+++|||++|++|.+.+.....       .++.+++.+++++|+.|++|
T Consensus        41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H  113 (199)
T TIGR03724        41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVH  113 (199)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeec
Confidence            36678899999999988877666666667778999999999999988753221       78899999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCcccc
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~  119 (180)
                      +|++|.|+++.    .+.++++|||.+...
T Consensus       114 ~Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724       114 GDLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCCCcceEEEE----CCcEEEEECCCCcCC
Confidence            99999999994    577999999987553

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=1.9e-15  Score=120.04  Aligned_cols=98  Identities=20%  Similarity=0.279  Sum_probs=86.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+++.+|++++++++|++++.+..+..+.+..+++|||++|++|.+++.        ....++.+++.++++||+.|++|
T Consensus       380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH  451 (535)
T PRK09605        380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH  451 (535)
T ss_pred             HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence            4668899999999999999988877777777899999999999999875        35678999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCcccc
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~  119 (180)
                      +|++|+||++.    +..++++|||++...
T Consensus       452 rDlkp~NILl~----~~~~~liDFGla~~~  477 (535)
T PRK09605        452 GDLTTSNFIVR----DDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCChHHEEEE----CCcEEEEeCcccccC
Confidence            99999999993    457899999998664

>smart00090 RIO RIO-like kinase

Probab=99.62  E-value=2.4e-15  Score=107.57  Aligned_cols=104  Identities=20%  Similarity=0.205  Sum_probs=82.1

Q ss_pred             HHHHHHHHHHHhcCCCcc--ccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 030256           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH-   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-   86 (180)
                      +..+++|...++++.+.+  ++++++.   . ..++||||++|.+|.........+....+..++.|++.+++++|+.| 
T Consensus        94 ~~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~  169 (237)
T smart00090       94 RLWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE  169 (237)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC
Confidence            445788999999997533  3444432   2 34899999999888766544456677778899999999999999999 


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~  121 (180)
                      ++|+|++|+||++.    .+.++++|||.+.....
T Consensus       170 iiH~Dikp~NIli~----~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      170 LVHGDLSEYNILVH----DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEeCCCChhhEEEE----CCCEEEEEChhhhccCC
Confidence            99999999999994    56799999998865543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=4.7e-15  Score=106.21  Aligned_cols=104  Identities=19%  Similarity=0.244  Sum_probs=81.5

Q ss_pred             HHHHHHHHHHHHhcCCCccc--cccceEEEeC-Ce---EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNI--IRLFDAFQAE-NC---IFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .+.++.+|++++.+++|+++  ++++++.... ..   .++|+|+++| .+|.+++.. .++++..    +.+++.++++
T Consensus        83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~  157 (239)
T PRK01723         83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIAR  157 (239)
T ss_pred             hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHH
Confidence            45678889999999988875  6677664432 22   3599999997 689888763 4565543    5689999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccC
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~  120 (180)
                      ||++|++|+||+|.||+++   .++.++|+|||.+....
T Consensus       158 lH~~GI~HrDlkp~NILv~---~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        158 FHDAGVYHADLNAHNILLD---PDGKFWLIDFDRGELRT  193 (239)
T ss_pred             HHHCCCCCCCCCchhEEEc---CCCCEEEEECCCcccCC
Confidence            9999999999999999994   45579999999876543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.51  E-value=8.7e-14  Score=97.10  Aligned_cols=99  Identities=23%  Similarity=0.247  Sum_probs=78.0

Q ss_pred             HHHHHHHHHHHhcCCCcc--ccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      +....+|..++.++.+++  ++++++    ....+++|||++|++|.+...      ......++.+++.++.++|+.|+
T Consensus        77 ~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi  146 (198)
T cd05144          77 RLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGI  146 (198)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCC
Confidence            445778999999997774  344433    244689999999999876532      13456788999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~  121 (180)
                      +|+||+|.||++   +.++.++|+|||.+.....
T Consensus       147 ~H~Dl~p~Nill---~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         147 IHGDLSEFNILV---DDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcCCCCcccEEE---cCCCcEEEEECCccccCCC
Confidence            999999999999   4577899999998855543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.51  E-value=3e-13  Score=106.05  Aligned_cols=145  Identities=22%  Similarity=0.358  Sum_probs=115.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~   88 (180)
                      .+.+++-+.-|+.++||||+++++.++.++..|+|+|.+.  .|..+++..+   ...+..-+.||+.||.+|| +++++
T Consensus        53 ~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lv  127 (690)
T KOG1243|consen   53 TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLV  127 (690)
T ss_pred             hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCee
Confidence            3557778889999999999999999999999999999983  7887777544   6778888999999999997 67899


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      |+++.-..|++   +..+..+|++|.++........ .........|..|+.....+  -..|.|.||+++++++.|
T Consensus       128 HgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  128 HGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            99999999999   6899999999998765543321 12222334456666543322  347999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=2.9e-13  Score=91.29  Aligned_cols=101  Identities=21%  Similarity=0.228  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+-++|+.++.++.--+|+.+.-+.-+.+...++|||++|..|.+.+...       ...++..+-..+.-||..|++
T Consensus        42 rr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~giv  114 (204)
T COG3642          42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIV  114 (204)
T ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCee
Confidence            3667788999999998778877777777777788999999999999888754       245666777788899999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~  120 (180)
                      |||++++|+.++    +..+.++|||++....
T Consensus       115 HGDLTtsNiIl~----~~~i~~IDfGLg~~s~  142 (204)
T COG3642         115 HGDLTTSNIILS----GGRIYFIDFGLGEFSD  142 (204)
T ss_pred             cCCCccceEEEe----CCcEEEEECCcccccc
Confidence            999999999995    3449999999986543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.47  E-value=6.1e-13  Score=91.93  Aligned_cols=105  Identities=14%  Similarity=0.150  Sum_probs=78.1

Q ss_pred             HHHHHHHHHHHHHhcCCC--ccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-Hh
Q 030256            8 HLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~   84 (180)
                      ..+...++|++.|+++..  -.+++++++    ...+++|||+.+..+....-+...+++..+..+..+++.++..+ |+
T Consensus        68 ~~~~wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~  143 (197)
T cd05146          68 IIRMWAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE  143 (197)
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh
Confidence            344556699999999954  456666654    45689999996644422211233456667778889999999988 89


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~  120 (180)
                      .|++|||+++.||++.    ++.++++||+.+-...
T Consensus       144 ~glVHGDLs~~NIL~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         144 CNLVHADLSEYNMLWH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCeecCCCCHHHEEEE----CCcEEEEECCCceeCC
Confidence            9999999999999994    3569999999875554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.46  E-value=1.3e-12  Score=88.09  Aligned_cols=113  Identities=21%  Similarity=0.254  Sum_probs=91.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      -.+.+.++|.++|.++.--+|....-++.+...-.+.|||++| .++.+++....  .........+++.+-+.+.-||.
T Consensus        52 Ltr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~  131 (229)
T KOG3087|consen   52 LTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD  131 (229)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh
Confidence            3467788999999999777887777778787788999999976 47777776543  23334447889999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~  120 (180)
                      ++++||||+.+||++.+......+.++|||++....
T Consensus       132 ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~  167 (229)
T KOG3087|consen  132 NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR  167 (229)
T ss_pred             CCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence            999999999999999866666667999999875543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.45  E-value=1.6e-13  Score=91.08  Aligned_cols=98  Identities=22%  Similarity=0.360  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHhcCCC--ccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 030256           10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH--   85 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--   85 (180)
                      ...+.+|...++.+++  ..+++++.+....+..++++||++|.++...       +......++.+++++++.+|..  
T Consensus        35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~  107 (155)
T cd05120          35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL  107 (155)
T ss_pred             hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence            4578899999999976  5899999888888899999999988777653       4566777889999999999985  


Q ss_pred             -CCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        86 -~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                       +++|+|++|.|+++.   ....+++.||+.+.
T Consensus       108 ~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~  137 (155)
T cd05120         108 LVLCHGDLHPGNILVD---DGKILGIIDWEYAG  137 (155)
T ss_pred             eEEEecCCCcceEEEE---CCcEEEEEeccccc
Confidence             699999999999995   46789999999764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=8.7e-15  Score=116.73  Aligned_cols=162  Identities=31%  Similarity=0.527  Sum_probs=133.9

Q ss_pred             HHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCC
Q 030256           11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHG-RVPEQTARKFLQQLGAGLEILN-SHH   86 (180)
Q Consensus        11 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~~~   86 (180)
                      ..+..|..+-+.+. |+|++.+++...+.+..+++.++..|+++.+-. .... ..+....-..+.|+..++.++| ..+
T Consensus        65 ~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~  144 (601)
T KOG0590|consen   65 EHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG  144 (601)
T ss_pred             hhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc
Confidence            33455777777886 999999999999999999999999999998877 4333 5677788889999999999999 999


Q ss_pred             CeeecCCCCCeeeecCCCCc-eEEEeecCCccccCC-CC---ccccccc-CccccCccccccc-cCCcchhHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYP-GN---YAEKVCG-SPLYMAPEVLQFQ-RYDEKVDMWSVGAILF  159 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~-~~~l~d~~~~~~~~~-~~---~~~~~~~-~~~~~ape~~~~~-~~~~~~Di~slg~~~~  159 (180)
                      +.|+|++|+|.++.   ..+ .+++.|||++..... ..   ......+ +..|.+||...+. -.....|+||.|+++.
T Consensus       145 ~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~  221 (601)
T KOG0590|consen  145 VTHRDIKPSNSLLD---ESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLS  221 (601)
T ss_pred             cccCCCCCccchhc---cCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccc
Confidence            99999999999984   555 899999999977765 22   2234556 8899999998874 3467899999999999


Q ss_pred             HHHhCCCCCCCCCccc
Q 030256          160 ELLNGYPPFSAYRPCF  175 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~~  175 (180)
                      .+++|..||.......
T Consensus       222 ~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  222 AMLTGELPWDFPSRKD  237 (601)
T ss_pred             ccccCCCCcccccccc
Confidence            9999999998665543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.42  E-value=1.3e-13  Score=112.56  Aligned_cols=113  Identities=39%  Similarity=0.675  Sum_probs=90.0

Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-------
Q 030256           51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------  123 (180)
Q Consensus        51 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-------  123 (180)
                      |+-...++..++++...        +.+++|+|.-|++|+|++|+|.++   ..-+.++++|||+.+......       
T Consensus       136 gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhhhc
Confidence            34444455445555443        678999999999999999999999   478889999999875532211       


Q ss_pred             ---------cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          124 ---------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       124 ---------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                               ......+++.|.|||+..-++|+...|.|++|+++|+.+-|..||.+.+|.
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe  264 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE  264 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence                     011246899999999999999999999999999999999999999998765

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=1e-12  Score=95.67  Aligned_cols=154  Identities=17%  Similarity=0.258  Sum_probs=113.1

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      +..+.=+.-|.++-|.|+|+++.++.+.     ....++.+|+..+++..++++.    ..+......+|+.||+.|+.|
T Consensus       112 ek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~y  191 (458)
T KOG1266|consen  112 EKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSY  191 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhh
Confidence            3344445667777899999999987654     3578999999999999998753    248889999999999999999


Q ss_pred             HHhCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccC-----CCCcccccccCccccCccccccccCCcchhHHHH
Q 030256           82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-----PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  154 (180)
Q Consensus        82 lh~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-----~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~sl  154 (180)
                      ||+..  ++|++++.+.+++   ..++-+++..-.-...-.     ...-.....+...|.+|+.-.-...+.++|||++
T Consensus       192 Lhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f  268 (458)
T KOG1266|consen  192 LHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF  268 (458)
T ss_pred             hhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence            99986  8999999999999   455556654321110000     0011112335677889987665667789999999


Q ss_pred             HHHHHHHHhCCCC
Q 030256          155 GAILFELLNGYPP  167 (180)
Q Consensus       155 g~~~~~~l~g~~p  167 (180)
                      |.+..+|.-+..-
T Consensus       269 gmcAlemailEiq  281 (458)
T KOG1266|consen  269 GMCALEMAILEIQ  281 (458)
T ss_pred             hHHHHHHHHheec
Confidence            9999998776543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.31  E-value=4.7e-11  Score=86.74  Aligned_cols=107  Identities=16%  Similarity=0.162  Sum_probs=82.8

Q ss_pred             HHHHHHHHHhcCCCccc--cccceEEEe-----CCeEEEEEeccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSVNHPNI--IRLFDAFQA-----ENCIFLVVEFCAGG-NLSSYIRL--HGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .+.+|+..+.++...+|  ++++.+.+.     ....++|+|++++. +|.+++..  ..+.+......++.+++..++.
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            47789999999955555  444555543     23578999999876 79888753  2445667788899999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecC----CCCceEEEeecCCccc
Q 030256           82 LNSHHIIHRDLKPENILLSGL----DDDVMLKIADFGLSCT  118 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~----~~~~~~~l~d~~~~~~  118 (180)
                      ||+.|++|+|+++.||++...    ++...+.++||+.+..
T Consensus       154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999999999999999999631    2356799999997743

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.30  E-value=7.1e-11  Score=82.93  Aligned_cols=111  Identities=19%  Similarity=0.217  Sum_probs=87.2

Q ss_pred             HHHHHHHHHHHHhcCCCcc--ccccceEEEeCC----eEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPN--IIRLFDAFQAEN----CIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .+.+..+|...+..|...+  .++++.+.....    ..++|+|.+++. +|.+++......+......++.+++..++.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            4567888999888885444  466666655422    458999999874 799988865557777888999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCcccc
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~  119 (180)
                      ||++|++|+|+++.||++...+....+.++||+-+...
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999975444557999999976543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.25  E-value=4.5e-11  Score=92.71  Aligned_cols=103  Identities=23%  Similarity=0.262  Sum_probs=71.7

Q ss_pred             HHHHHHHHhcC-----CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 030256           13 LDCELNFLSSV-----NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGA-GLEILNSH   85 (180)
Q Consensus        13 ~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~-~l~~lh~~   85 (180)
                      +.+|.+.+.++     +++++.-..-+....+..+++|||++|++|.+..... ...+   ...++..++. .+..+|..
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence            55566655555     2344433333333455679999999999998876532 1222   2345555555 57889999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~  121 (180)
                      |++|+|++|.||++   ..++.++++|||++.....
T Consensus       277 g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 GFFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            99999999999999   4667899999999877643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.24  E-value=5.4e-11  Score=82.14  Aligned_cols=98  Identities=21%  Similarity=0.299  Sum_probs=69.5

Q ss_pred             HHHHHHHhcCCCcc--ccccceEEEeCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCee
Q 030256           14 DCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQLGAGLEILNS-HHIIH   89 (180)
Q Consensus        14 ~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~h   89 (180)
                      ..|.+.+.++.+.+  ++++++.    ...+++|||++++++.. .+. .... ...+..++.+++.++.++|. .|++|
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~-~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH  138 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLK-DVRL-LEDPEELYDQILELMRKLYREAGLVH  138 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhh-hhhh-cccHHHHHHHHHHHHHHHhhccCcCc
Confidence            45666777764443  4444432    23589999998844321 111 1111 16778899999999999999 99999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~  121 (180)
                      +|++|+||++.    ++.++++|||.+.....
T Consensus       139 ~Dl~p~Nili~----~~~~~liDfg~a~~~~~  166 (187)
T cd05119         139 GDLSEYNILVD----DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCCChhhEEEE----CCcEEEEECcccccccC
Confidence            99999999994    67799999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=1.3e-11  Score=83.90  Aligned_cols=94  Identities=23%  Similarity=0.260  Sum_probs=69.4

Q ss_pred             HHHHHHHHHHhcCCCccc-cccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--
Q 030256           11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI--   87 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~--   87 (180)
                      ...++|+.+++.+.+.++ ++++.+..  ...++||||++|.++...     ..   .....+.+++++++.||..++  
T Consensus        37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~  106 (170)
T cd05151          37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPD  106 (170)
T ss_pred             cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCC
Confidence            346789999999865554 45554433  234799999999888643     11   123356789999999999985  


Q ss_pred             ---eeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           88 ---IHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        88 ---~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                         +|+|++|.||++.    ++.++++||+.+..
T Consensus       107 ~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151         107 LVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             ceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence               9999999999994    45689999998743

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.23  E-value=7.4e-11  Score=81.25  Aligned_cols=104  Identities=20%  Similarity=0.338  Sum_probs=69.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCc--cccccceEEEeCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHH-HHH
Q 030256            7 KHLKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCA--GGNLSSYIRLHGRVPEQTARKFLQQLGAG-LEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~-l~~   81 (180)
                      ...+...++|.+.|+++...  ++++++++  .  ..++||||++  |..+..+...  .++......++.+++.. ...
T Consensus        49 ~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--~--~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   49 YLIREWAKKEFRNLKRLYEAGVPVPKPYDY--N--RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTT-SS--EEEE--E--TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccCCcEEEE--e--CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHH
Confidence            34567888999999999766  45666644  2  2479999998  7666554332  22234566677788884 444


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccC
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~  120 (180)
                      +|..|++|||+++.||++.   .+ .+.++|||.+....
T Consensus       123 ~~~~givHGDLs~~NIlv~---~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  123 LHKAGIVHGDLSEYNILVD---DG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHCTTEEESS-STTSEEEE---TT-CEEE--GTTEEETT
T ss_pred             HHhcCceecCCChhhEEee---cc-eEEEEecCcceecC
Confidence            6899999999999999995   22 89999999876554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=4.4e-10  Score=84.87  Aligned_cols=129  Identities=17%  Similarity=0.208  Sum_probs=97.9

Q ss_pred             eEEEEEeccCCC-ChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEee
Q 030256           40 CIFLVVEFCAGG-NLSSYIR------LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD  112 (180)
Q Consensus        40 ~~~lv~e~~~~~-~L~~~l~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d  112 (180)
                      .+.+.|..+.|. .+..+.+      ..+......+++.+..++.+.+.||+.|.+-||++++|++++   +.+.++|.|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEc
Confidence            367778777653 2333322      112377889999999999999999999999999999999994   677888888


Q ss_pred             cCCccccCCCCcccccccCccccCccccc-----cccCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q 030256          113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNG-YPPFSAY  171 (180)
Q Consensus       113 ~~~~~~~~~~~~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~~~l~g-~~pf~~~  171 (180)
                      -.....-.+........+...|++||...     +.+.+..+|.|.||+++++++.| +.||.+.
T Consensus       161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            66544433333333455788899999865     44567889999999999999885 9999754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=1.7e-10  Score=89.56  Aligned_cols=150  Identities=29%  Similarity=0.454  Sum_probs=121.7

Q ss_pred             HHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCC
Q 030256           14 DCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGA----GLEILNSHHI   87 (180)
Q Consensus        14 ~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~----~l~~lh~~~~   87 (180)
                      .+|+....++ .|++.++....++..+..++-.|.+ +.+|..+...... ++...++....+...    |+.++|..++
T Consensus       165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~  243 (524)
T KOG0601|consen  165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNI  243 (524)
T ss_pred             cchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcc
Confidence            4566677777 6999999888899999999999998 6788887765544 778888888888888    9999999999


Q ss_pred             eeecCCCCCeeeecCCCC-ceEEEeecCCccccCCCCccc------ccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDD-VMLKIADFGLSCTLYPGNYAE------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~-~~~~l~d~~~~~~~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +|.+++|.|++..   .+ ...+++||+....+.......      ...+...|++||...+ .++..+|+|++|.++.+
T Consensus       244 ~~~~~kp~~i~~~---~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~  319 (524)
T KOG0601|consen  244 VHDDLKPANIFTT---SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILE  319 (524)
T ss_pred             cccccchhheecc---cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHh
Confidence            9999999999984   44 678999999998887654322      1246677999998764 46889999999999999


Q ss_pred             HHhCCCCC
Q 030256          161 LLNGYPPF  168 (180)
Q Consensus       161 ~l~g~~pf  168 (180)
                      ..++..+.
T Consensus       320 ~~l~~~~~  327 (524)
T KOG0601|consen  320 AILGSHLP  327 (524)
T ss_pred             hHhhcccc
Confidence            98875554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.01  E-value=4.5e-10  Score=88.65  Aligned_cols=77  Identities=23%  Similarity=0.288  Sum_probs=52.6

Q ss_pred             CCeEEEEEeccCCCChHHHH--HhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecC-CCCceEEE
Q 030256           38 ENCIFLVVEFCAGGNLSSYI--RLHG----RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKI  110 (180)
Q Consensus        38 ~~~~~lv~e~~~~~~L~~~l--~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~~~~l  110 (180)
                      .+..+++|||++|+++.+.-  ...+    .+.+..+..++.       .+...|++|+|++|.||++... ...+++++
T Consensus       233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~-------Qif~~GffHaDpHPGNIlv~~~g~~~~~i~l  305 (537)
T PRK04750        233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT-------QVFRDGFFHADMHPGNIFVSYDPPENPRYIA  305 (537)
T ss_pred             CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-------HHHhCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence            45668999999999998753  2222    133333333333       4456999999999999999521 11238999


Q ss_pred             eecCCccccCC
Q 030256          111 ADFGLSCTLYP  121 (180)
Q Consensus       111 ~d~~~~~~~~~  121 (180)
                      +|||++..+..
T Consensus       306 lDFGivg~l~~  316 (537)
T PRK04750        306 LDFGIVGSLNK  316 (537)
T ss_pred             EecceEEECCH
Confidence            99999877644

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.99  E-value=4.6e-09  Score=81.06  Aligned_cols=135  Identities=19%  Similarity=0.337  Sum_probs=102.5

Q ss_pred             HHHHHHHHhcCCCccccccceEEE----eCCeEEEEEeccCC-CChHHHHH---------------hcCCCCHHHHHHHH
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAG-GNLSSYIR---------------LHGRVPEQTARKFL   72 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~---------------~~~~~~~~~~~~~~   72 (180)
                      ...-+++++++.|+|+|++.+++.    .+..+++|++|.++ ++|.+..-               .+...+++.++.++
T Consensus       320 ~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~  399 (655)
T KOG3741|consen  320 DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYI  399 (655)
T ss_pred             chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHH
Confidence            445588999999999999999886    34589999999986 55655431               12236789999999


Q ss_pred             HHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHH
Q 030256           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMW  152 (180)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~  152 (180)
                      .|+..||.++|+.|+..+-+.|.+|++.   .+.+++|..+|.......+.           .+|  +   +--.+.|.-
T Consensus       400 ~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~d~-----------~~~--l---e~~Qq~D~~  460 (655)
T KOG3741|consen  400 SQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQEDP-----------TEP--L---ESQQQNDLR  460 (655)
T ss_pred             HHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeecCCC-----------Ccc--h---hHHhhhhHH
Confidence            9999999999999999999999999994   44588888888664443322           011  0   012467888


Q ss_pred             HHHHHHHHHHhCCC
Q 030256          153 SVGAILFELLNGYP  166 (180)
Q Consensus       153 slg~~~~~~l~g~~  166 (180)
                      .||.++..+.+|..
T Consensus       461 ~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  461 DLGLLLLALATGTE  474 (655)
T ss_pred             HHHHHHHHHhhccc
Confidence            99999999999843

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.94  E-value=3.9e-09  Score=75.60  Aligned_cols=102  Identities=17%  Similarity=0.206  Sum_probs=80.4

Q ss_pred             HHHHHHHHHHHHhcCCCc--cccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .+...++|+++|++|...  .+++++++    +...++||+++|..|...-     ++.+..-.++..|+..++..-..|
T Consensus       152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G  222 (304)
T COG0478         152 SRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG  222 (304)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC
Confidence            356678899999999655  78888864    7788999999997776532     234556667777888887777999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG  122 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~  122 (180)
                      ++|||+++-||++   ++++.++++||..+.....+
T Consensus       223 iVHGDlSefNIlV---~~dg~~~vIDwPQ~v~~~hp  255 (304)
T COG0478         223 IVHGDLSEFNILV---TEDGDIVVIDWPQAVPISHP  255 (304)
T ss_pred             ccccCCchheEEE---ecCCCEEEEeCcccccCCCC
Confidence            9999999999999   56778999999977555443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.92  E-value=8e-10  Score=90.99  Aligned_cols=148  Identities=34%  Similarity=0.549  Sum_probs=115.7

Q ss_pred             CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCC
Q 030256           25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD  104 (180)
Q Consensus        25 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~  104 (180)
                      +|-++.....+......++++++..+++|...+...+..+.+-.......+....++||.....|+|++|.|.+.   ..
T Consensus       863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~  939 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AY  939 (1205)
T ss_pred             CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cc
Confidence            355554444445566789999999999999988877777777777788888999999999999999999999998   35


Q ss_pred             CceEEEeecCCccccC---------------------CC-----------CcccccccCccccCccccccccCCcchhHH
Q 030256          105 DVMLKIADFGLSCTLY---------------------PG-----------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMW  152 (180)
Q Consensus       105 ~~~~~l~d~~~~~~~~---------------------~~-----------~~~~~~~~~~~~~ape~~~~~~~~~~~Di~  152 (180)
                      .+...+.+|+.....+                     ..           .......++..|.+||...+......+|.|
T Consensus       940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen  940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred             cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence            6666777775322110                     00           111234577889999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCccc
Q 030256          153 SVGAILFELLNGYPPFSAYRPCF  175 (180)
Q Consensus       153 slg~~~~~~l~g~~pf~~~~~~~  175 (180)
                      +.|+++++.++|..||.+..+..
T Consensus      1020 ~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             hhhhhhhhhhcCCCCCCCcchhh
Confidence            99999999999999999887763

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.90  E-value=3e-09  Score=75.15  Aligned_cols=106  Identities=17%  Similarity=0.258  Sum_probs=75.5

Q ss_pred             HHHHHHHHHHHhcCCCc--cccccceEEEeC---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSVNHP--NIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+|.++++.+.+.  .+++++.+....   +..+++|++++|.++.+.+.. ..++......++.+++++++.||+
T Consensus        39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            45788999999999654  457777776553   366899999999888764421 345666666666666666666663


Q ss_pred             --------------------------------------------------------CCCeeecCCCCCeeeecCCCCceE
Q 030256           85 --------------------------------------------------------HHIIHRDLKPENILLSGLDDDVML  108 (180)
Q Consensus        85 --------------------------------------------------------~~~~h~dl~~~nil~~~~~~~~~~  108 (180)
                                                                              ..++|+|+.|.||++... ....+
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~  196 (223)
T cd05154         118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVV  196 (223)
T ss_pred             CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEE
Confidence                                                                    235899999999999521 14567


Q ss_pred             EEeecCCcc
Q 030256          109 KIADFGLSC  117 (180)
Q Consensus       109 ~l~d~~~~~  117 (180)
                      .++||+.+.
T Consensus       197 ~iID~e~~~  205 (223)
T cd05154         197 AVLDWELAT  205 (223)
T ss_pred             EEEeccccc
Confidence            899999763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK09902 hypothetical protein; Provisional

Probab=98.90  E-value=2e-08  Score=70.03  Aligned_cols=110  Identities=13%  Similarity=0.146  Sum_probs=81.9

Q ss_pred             HHHHHHHHHHHHHhcCCCcc--ccccceEEE-e----CCeEEEEEeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPN--IIRLFDAFQ-A----ENCIFLVVEFCAG-GNLSSYIRLH--GRVPEQTARKFLQQLGA   77 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~-~----~~~~~lv~e~~~~-~~L~~~l~~~--~~~~~~~~~~~~~~i~~   77 (180)
                      -.+..+.+|+..|++|...+  ++++. ++. .    .-..++|+|-++| .+|.+++...  .+.+......+..+++.
T Consensus        61 ~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~  139 (216)
T PRK09902         61 FGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVAL  139 (216)
T ss_pred             CCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHH
Confidence            34677889999999994333  55555 332 1    1256888887743 6888887642  24577777899999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCcccc
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~  119 (180)
                      +++.||+.|+.|+|+.+.||++.. +....+.++||...+..
T Consensus       140 ~ia~LH~~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        140 AFKKMHSVNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             HHHHHHHCCCcCCCCCHhheeecC-CCCeeEEEEEhhccchh
Confidence            999999999999999999999953 22445999999976544

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.82  E-value=2.9e-08  Score=69.54  Aligned_cols=67  Identities=22%  Similarity=0.359  Sum_probs=52.9

Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           39 NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        39 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      ...+++|||++|..|.+...    +++    .+...+.+++..+|+.|++|||.+|.|++++    +..++++|++...
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~iID~~~k~  182 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIRIIDTQGKR  182 (229)
T ss_pred             eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEEEEECcccc
Confidence            45679999999998877543    333    2445677889999999999999999999984    4459999998653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.76  E-value=4.1e-09  Score=82.00  Aligned_cols=151  Identities=25%  Similarity=0.304  Sum_probs=112.4

Q ss_pred             HHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC
Q 030256           15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK   93 (180)
Q Consensus        15 ~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~   93 (180)
                      .|+-+...+ .|.+++.+...+...+..++--||++++++.........+++...+++..|++.++.++|+..++|.|++
T Consensus       314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~  393 (524)
T KOG0601|consen  314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVK  393 (524)
T ss_pred             hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhccccc
Confidence            355555555 5888888888777777777999999999988776555568899999999999999999999999999999


Q ss_pred             CCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccc-cCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        94 ~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~-~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||++..  ......+.||+.......... .....+..| .++.......+-.+.|++|||.-+.+..++...-
T Consensus       394 psni~i~~--~~~~~~~~~~~~~t~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  394 PSNILISN--DGFFSKLGDFGCWTRLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ccceeecc--chhhhhccccccccccceecc-cccccccccccchhhccccccccccccccccccccccccCcccC
Confidence            99999952  226677888887755221111 111122233 3555556667788999999999999988876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.70  E-value=2.9e-07  Score=64.03  Aligned_cols=102  Identities=27%  Similarity=0.401  Sum_probs=77.8

Q ss_pred             HHHHHHHHHHHhcCC------CccccccceEEEeCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQLGA   77 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~   77 (180)
                      ..+..+|+..+.++.      +..|++++|+.+.+-+..+++|.+.+      .+|.+++. .+.++.    .+...+-+
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~----~~~~~L~~  129 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE----ELRQALDE  129 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH----HHHHHHHH
Confidence            556677777777766      88999999999999888888887753      56777774 445655    33445556


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCc-eEEEee-cCCc
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIAD-FGLS  116 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~-~~~l~d-~~~~  116 (180)
                      ...+|-+.+++.+|++|.||++...++.. .+.++| ||..
T Consensus       130 f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  130 FKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             HHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            67788999999999999999998655555 788888 6643

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.43  E-value=3.5e-06  Score=60.04  Aligned_cols=43  Identities=19%  Similarity=0.188  Sum_probs=34.0

Q ss_pred             HHHHHHHHHHHhcCCCcc--ccccceEEEeCCeEEEEEeccCCCC
Q 030256           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGN   52 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~   52 (180)
                      ...+++|.++++.+...+  +++++.+...++...++|++++|.+
T Consensus        36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172        36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            345788999999996444  4777877777778889999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=3.6e-08  Score=78.37  Aligned_cols=98  Identities=20%  Similarity=0.373  Sum_probs=75.3

Q ss_pred             HHHHHHHHHHHHh-CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC----------cccccccCccccCcccc
Q 030256           72 LQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------YAEKVCGSPLYMAPEVL  140 (180)
Q Consensus        72 ~~~i~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----------~~~~~~~~~~~~ape~~  140 (180)
                      +.+.+.++.++|. .++||++|.|++|.+   +..+..+++.|++......+.          ...-......|.+||+.
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3455688999997 589999999999999   688889999998765443311          01112345679999999


Q ss_pred             ccccCCcchhHHHHHHHHHHHH-hCCCCCCCCC
Q 030256          141 QFQRYDEKVDMWSVGAILFELL-NGYPPFSAYR  172 (180)
Q Consensus       141 ~~~~~~~~~Di~slg~~~~~~l-~g~~pf~~~~  172 (180)
                      .+...+.++|++|+|+++|.+. +|+..+.+..
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~  214 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANG  214 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccC
Confidence            9888899999999999999888 5666666553

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.39  E-value=1.4e-06  Score=62.80  Aligned_cols=46  Identities=13%  Similarity=0.088  Sum_probs=35.4

Q ss_pred             HHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHH
Q 030256           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY   56 (180)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   56 (180)
                      ..+.+|+++++.+ ++--+++++.+...++..+++|++++|.++...
T Consensus        36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            4577899999888 344567888877766778999999999887643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.35  E-value=3.8e-06  Score=59.88  Aligned_cols=107  Identities=19%  Similarity=0.153  Sum_probs=75.2

Q ss_pred             HHHHHHHHHHHHHHhcC--CCccccccceEEEeCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +......+.|+.-|+++  .+-.+++.+.+.    ...++|||+......- .|+ ..++.......+..++++.+..|-
T Consensus       109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHH
Confidence            44566778899999999  355667777653    3479999994421100 000 112333367778888888888887


Q ss_pred             h-CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC
Q 030256           84 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG  122 (180)
Q Consensus        84 ~-~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~  122 (180)
                      . .++||+||+.=||++.    .+.++++|++.+....++
T Consensus       184 ~~a~LVHgDLSEyNiL~~----~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         184 KEAGLVHGDLSEYNILVH----DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             HhcCcccccchhhheEEE----CCeEEEEECccccccCCC
Confidence            7 8999999999999993    677999999988666543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.33  E-value=3.2e-06  Score=66.86  Aligned_cols=104  Identities=21%  Similarity=0.264  Sum_probs=70.6

Q ss_pred             HHHHHHHhcC-----CCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           14 DCELNFLSSV-----NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        14 ~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+|..-+.++     +.+++.-..-+.+..+.-+++|||++|..+.+.... ...++...+.....++  .+..+=..|+
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgf  286 (517)
T COG0661         209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence            3444444444     456655555555667778999999999999988432 2345544433332222  2445556899


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG  122 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~  122 (180)
                      .|+|.+|.||++   +.++++.+.|||+...+...
T Consensus       287 fHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         287 FHADPHPGNILV---RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence            999999999999   56789999999998776543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.15  E-value=1.1e-05  Score=55.74  Aligned_cols=98  Identities=24%  Similarity=0.283  Sum_probs=75.5

Q ss_pred             HHHHHHHhcCCC-ccccccceEEEeCCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 030256           14 DCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFLQQLGAGLEILNS---HH   86 (180)
Q Consensus        14 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~   86 (180)
                      ..|..+++.+.+ +++++++|++..    +++.|+...+++...   +..-...++....+++.++++.+..++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458889999965 699999999833    568898865555321   1112346788999999999999999998   45


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      +...|++++|+.+   +++++++++|...+..
T Consensus        83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEE---eCCCcEEEEechhcch
Confidence            7889999999999   4667899999986643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.10  E-value=2e-05  Score=62.41  Aligned_cols=91  Identities=18%  Similarity=0.270  Sum_probs=61.1

Q ss_pred             ccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecC-CCC
Q 030256           28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDD  105 (180)
Q Consensus        28 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~  105 (180)
                      |++++  .......+++|||++|..+.+.-.- ...++...+..-+.+..  .+.+=..|++|+|-+|.||++... +.+
T Consensus       266 VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~  341 (538)
T KOG1235|consen  266 VPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGD  341 (538)
T ss_pred             CCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCC
Confidence            44444  2344567999999999888765332 23466665444333332  234446789999999999999732 357


Q ss_pred             ceEEEeecCCccccCCC
Q 030256          106 VMLKIADFGLSCTLYPG  122 (180)
Q Consensus       106 ~~~~l~d~~~~~~~~~~  122 (180)
                      ..+.+.|||+...+...
T Consensus       342 ~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  342 EEIVLLDHGLYAVISHK  358 (538)
T ss_pred             ccEEEEcccccccccHH
Confidence            77999999998776543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.10  E-value=8.4e-07  Score=70.56  Aligned_cols=151  Identities=25%  Similarity=0.359  Sum_probs=108.1

Q ss_pred             HHHHHHHHHHhcCCCcc-ccccceEEEeCCeEEEEEeccCCC-ChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           11 SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGG-NLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+-++++|.+++||| .+..++.++.++...+.++++.++ +-..... ....+.+-++..+...-.+.++++|+..=
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~  357 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK  357 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence            34556788999999999 777777778888999999998665 1111111 01123444555566666778888888765


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+|    ||+.    .....+..+++....+..........++..+++||......+....|.|+++.-..++..|.+|
T Consensus       358 ~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  358 VHRD----NILG----SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cCcc----cccc----cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            6776    7775    3456788999988777655445556688889999998888888899999999876677666665


Q ss_pred             CC
Q 030256          168 FS  169 (180)
Q Consensus       168 f~  169 (180)
                      =.
T Consensus       430 r~  431 (829)
T KOG0576|consen  430 RS  431 (829)
T ss_pred             CC
Confidence            43

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.08  E-value=5.4e-05  Score=64.28  Aligned_cols=157  Identities=25%  Similarity=0.275  Sum_probs=110.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .....-|...+.+..|+|++.+..+--...    ...+..+++.+.++...+..-+..+.+..+.+..++..+++++|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            344556778888999999999998864432    2345667888888888888778899999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEe--ecCCccccCCCCcccccccCccccCccccccccC--CcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIA--DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY--DEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~--~~~~Di~slg~~~~~~  161 (180)
                      ...|.-+..+...-...+....+...  ||+...................+.++|.......  +...|+|.+|.....+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            76666666553332222334444444  8887766655544333334455667776655443  3447999999999888


Q ss_pred             HhCCC
Q 030256          162 LNGYP  166 (180)
Q Consensus       162 l~g~~  166 (180)
                      ..|..
T Consensus       386 ~~~~~  390 (1351)
T KOG1035|consen  386 SQGED  390 (1351)
T ss_pred             hhcCc
Confidence            77654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.02  E-value=1.7e-05  Score=56.86  Aligned_cols=46  Identities=9%  Similarity=0.071  Sum_probs=30.4

Q ss_pred             HHHHHHHHHHHHhcCCCc---cccccceEEEeC---CeEEEEEeccCCCChH
Q 030256            9 LKSCLDCELNFLSSVNHP---NIIRLFDAFQAE---NCIFLVVEFCAGGNLS   54 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~~~~~~L~   54 (180)
                      ....+.+|.+.++.+...   -++++++.....   +..+++|++++|.++.
T Consensus        31 ~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~   82 (235)
T cd05155          31 YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT   82 (235)
T ss_pred             hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence            345789999999988532   345555443322   2358899999997774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.90  E-value=0.0001  Score=62.12  Aligned_cols=43  Identities=14%  Similarity=0.387  Sum_probs=32.8

Q ss_pred             HHHHHHHHHHhcCC-Cccc--cccceEEEeC---CeEEEEEeccCCCCh
Q 030256           11 SCLDCELNFLSSVN-HPNI--IRLFDAFQAE---NCIFLVVEFCAGGNL   53 (180)
Q Consensus        11 ~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~~~~~~L   53 (180)
                      ..+.+|+++++.+. |+++  ++++.++.+.   +..++|||+++|..+
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence            46889999999995 6765  7777766654   467899999988643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.88  E-value=8.6e-05  Score=52.63  Aligned_cols=47  Identities=17%  Similarity=0.226  Sum_probs=33.3

Q ss_pred             HHHHHHHHHHHHhcCCCc--cccccceEEE---eCCeEEEEEeccCCCChHH
Q 030256            9 LKSCLDCELNFLSSVNHP--NIIRLFDAFQ---AENCIFLVVEFCAGGNLSS   55 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~--~iv~~~~~~~---~~~~~~lv~e~~~~~~L~~   55 (180)
                      ....+.+|..+++.+...  -+++++....   .....+++|++++|.++..
T Consensus        33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            667788899999888433  3567776443   3346799999999988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.63  E-value=7e-05  Score=55.80  Aligned_cols=94  Identities=22%  Similarity=0.294  Sum_probs=67.7

Q ss_pred             HHHHHHHHHHHhcCCCcc--ccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      +-...+|+..|+.|....  +++.++    .+.-++||+++.|.+|.....   -.+..+   +...+...+.-|...|+
T Consensus       154 Rlaa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~---v~d~~~---ly~~lm~~Iv~la~~Gl  223 (465)
T KOG2268|consen  154 RLAATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH---VEDPPT---LYDDLMGLIVRLANHGL  223 (465)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee---cCChHH---HHHHHHHHHHHHHHcCc
Confidence            334667899999984433  455554    467789999999988876432   122233   33445556677889999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCc
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLS  116 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~  116 (180)
                      +|||++--||++.   +...++++||...
T Consensus       224 IHgDFNEFNimv~---dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  224 IHGDFNEFNIMVK---DDDKIVVIDFPQM  249 (465)
T ss_pred             eecccchheeEEe---cCCCEEEeechHh
Confidence            9999999999994   5777999999854

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.58  E-value=0.00036  Score=51.66  Aligned_cols=113  Identities=24%  Similarity=0.280  Sum_probs=63.2

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcCCCcc--ccccceE------EEeCCeEEEEEeccCCCChHH----HHH-----------
Q 030256            2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDA------FQAENCIFLVVEFCAGGNLSS----YIR-----------   58 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e~~~~~~L~~----~l~-----------   58 (180)
                      ||.........+..|++++..+...+  +++++..      ....+..+.++++++|.++..    ...           
T Consensus        42 Lr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~  121 (296)
T cd05153          42 LTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHL  121 (296)
T ss_pred             EEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHH
Confidence            34443334566778888888884333  4555542      233456789999999877532    100           


Q ss_pred             hcCCCC--------HHHHH------------HHHHHHHHHHHHHHh-------CCCeeecCCCCCeeeecCCCCceEEEe
Q 030256           59 LHGRVP--------EQTAR------------KFLQQLGAGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKIA  111 (180)
Q Consensus        59 ~~~~~~--------~~~~~------------~~~~~i~~~l~~lh~-------~~~~h~dl~~~nil~~~~~~~~~~~l~  111 (180)
                      ....+.        .....            .....+..++..+.+       .+++|+|+.|.|+++.   ++..+.|+
T Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~iI  198 (296)
T cd05153         122 AAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFD---GDELSGVI  198 (296)
T ss_pred             HhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEe---CCceEEEe
Confidence            000000        00000            011112233444443       4699999999999994   45556899


Q ss_pred             ecCCcc
Q 030256          112 DFGLSC  117 (180)
Q Consensus       112 d~~~~~  117 (180)
                      ||+.+.
T Consensus       199 Dfe~a~  204 (296)
T cd05153         199 DFYFAC  204 (296)
T ss_pred             ehhhhc
Confidence            998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.25  E-value=0.0015  Score=47.47  Aligned_cols=29  Identities=21%  Similarity=0.402  Sum_probs=23.2

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      .++|+|+.|.|+++.   .++ +.++||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~---~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVT---PQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEe---CCC-CEEEeccccCc
Confidence            489999999999995   233 78999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.04  E-value=0.0085  Score=44.91  Aligned_cols=30  Identities=33%  Similarity=0.633  Sum_probs=24.2

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      .+++|+|+.|.||++.   .+....++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFE---GDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEE---CCceEEEEeccccc
Confidence            3799999999999994   34445799998764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.03  E-value=0.0084  Score=45.73  Aligned_cols=73  Identities=25%  Similarity=0.288  Sum_probs=58.7

Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeeeecCCCCceEEEeecCCc
Q 030256           38 ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLS  116 (180)
Q Consensus        38 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~  116 (180)
                      ....|++|++. |+++...    ..-..+++..++++.+..+.-+... .+-|+++...||++   + .+.|.|+||.++
T Consensus       298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeee
Confidence            34778999987 7777542    2244678889999999988888875 68999999999999   4 788999999998


Q ss_pred             ccc
Q 030256          117 CTL  119 (180)
Q Consensus       117 ~~~  119 (180)
                      +-.
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            743

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.01  E-value=0.0023  Score=48.36  Aligned_cols=30  Identities=30%  Similarity=0.490  Sum_probs=24.8

Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      ++|+|+.+.||++.  +.++.++++||..+..
T Consensus       184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence            79999999999995  3456799999997743

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.01  E-value=0.0073  Score=46.16  Aligned_cols=105  Identities=23%  Similarity=0.214  Sum_probs=75.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~   87 (180)
                      .+-....|++-|++|...+|+-.--....+  .++||+++.......-.-+..+++...+..+-.+++.-++-|- .+++
T Consensus       209 Vk~WAEKE~RNLkRl~~aGIP~PePIlLk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~L  286 (520)
T KOG2270|consen  209 VKTWAEKEMRNLKRLNNAGIPCPEPILLKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRL  286 (520)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCceeeec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhce
Confidence            455677899999999888876665544433  4799999854333222222445777778877778877777664 5789


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCcccc
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~  119 (180)
                      ||.||+--|+++    ..+.++++|.+.+-..
T Consensus       287 VHADLSEfN~Ly----hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  287 VHADLSEFNLLY----HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             eccchhhhhheE----ECCEEEEEEccccccC
Confidence            999999999998    4678999999866444

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.87  E-value=0.0068  Score=41.48  Aligned_cols=100  Identities=17%  Similarity=0.163  Sum_probs=69.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccc-cccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+..++.|+++|+.+.-.++ ++++.+..+    ++.|||+.|.+|.+.....   +...+    ..+++..-.|...
T Consensus        56 ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~  124 (201)
T COG2112          56 DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG---DRKHL----LRVLEKAYKLDRL  124 (201)
T ss_pred             CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc---cHHHH----HHHHHHHHHHHHh
Confidence            3446778999999999987776 555544333    3459999998887754311   23333    3456666667788


Q ss_pred             CCeeecCCC--CCeeeecCCCCceEEEeecCCccccCC
Q 030256           86 HIIHRDLKP--ENILLSGLDDDVMLKIADFGLSCTLYP  121 (180)
Q Consensus        86 ~~~h~dl~~--~nil~~~~~~~~~~~l~d~~~~~~~~~  121 (180)
                      |+-|+.++-  .|+++    ++..+.|+||..++....
T Consensus       125 GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k~~  158 (201)
T COG2112         125 GIEHGELSRPWKNVLV----NDRDVYIIDFDSATFKKK  158 (201)
T ss_pred             ccchhhhcCCceeEEe----cCCcEEEEEccchhhccC
Confidence            999999986  46666    344899999999875433

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.78  E-value=0.0081  Score=45.02  Aligned_cols=28  Identities=21%  Similarity=0.529  Sum_probs=23.2

Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      ++|||+++.|+++.   ....+-++||+.+.
T Consensus       200 lvHGD~~~gNlii~---~~~~~gVlDwe~~~  227 (321)
T COG3173         200 LVHGDYRPGNLIID---PGRPTGVLDWELAT  227 (321)
T ss_pred             eeeCCcccCCEEEe---CCCeeEEEeccccc
Confidence            69999999999995   34448899999764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.74  E-value=0.012  Score=43.32  Aligned_cols=31  Identities=26%  Similarity=0.501  Sum_probs=23.4

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      .++|||++|.|+++.  +......|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~--~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILID--EDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEe--CCCCEEEEECcHhccc
Confidence            379999999999995  2233457999997643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.53  E-value=0.00042  Score=61.09  Aligned_cols=157  Identities=15%  Similarity=0.081  Sum_probs=107.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .++-...|.+-+++..|+++.....-.+.  +..-+..+.++.+|.+.+.+-++    +++.+.-+....++......-.
T Consensus      1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred             HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence            34444455556666789888776654432  34568889999999998887543    3355555555555534444444


Q ss_pred             HhC---C--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHH
Q 030256           83 NSH---H--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        83 h~~---~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      |..   |  .+|.++++.|.++   ..+..+++.++|+.+...+. ...+....++-|+.|+....-+++.++|+|..|+
T Consensus      1352 ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred             hhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence            432   2  6789999999998   46777999999998733222 2233344555677788877778888899999999


Q ss_pred             HHHHHHhCCCCC
Q 030256          157 ILFELLNGYPPF  168 (180)
Q Consensus       157 ~~~~~l~g~~pf  168 (180)
                      ..|..-.|..+|
T Consensus      1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHhcccHHH
Confidence            998887777666

>PTZ00384 choline kinase; Provisional

Probab=96.19  E-value=0.031  Score=43.21  Aligned_cols=37  Identities=19%  Similarity=0.427  Sum_probs=27.2

Q ss_pred             HHHHHHHhcCCCccc-cccceEEEeCCeEEEEEeccCCCChH
Q 030256           14 DCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLS   54 (180)
Q Consensus        14 ~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~   54 (180)
                      ++|.++++.+...++ +++++.+..    +++.||++|.+|.
T Consensus       100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~  137 (383)
T PTZ00384        100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG  137 (383)
T ss_pred             HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence            568889999965544 666666653    4899999987764

>PRK10593 hypothetical protein; Provisional

Probab=96.05  E-value=0.016  Score=43.20  Aligned_cols=71  Identities=13%  Similarity=0.071  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHhcCCC---ccccccceEEEe---CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNH---PNIIRLFDAFQA---ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ....+.+|.+.++.|.-   -.++++++++..   .+..++|||+++|.++.+.     ..+......+..+++++++.|
T Consensus        50 ~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~L  124 (297)
T PRK10593         50 TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAW  124 (297)
T ss_pred             cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHH
Confidence            34689999999999943   368888887754   3568999999998776431     112222333444445555555


Q ss_pred             Hh
Q 030256           83 NS   84 (180)
Q Consensus        83 h~   84 (180)
                      |+
T Consensus       125 H~  126 (297)
T PRK10593        125 HR  126 (297)
T ss_pred             hC
Confidence            54

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.05  E-value=0.11  Score=40.33  Aligned_cols=41  Identities=12%  Similarity=-0.011  Sum_probs=28.4

Q ss_pred             HHHHHHHHHHHhcCC---CccccccceEEEeCCeEEEEEeccCCCC
Q 030256           10 KSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN   52 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~   52 (180)
                      .++...|.+.|+.+.   ...+|+++.+.  .+..+++||++++..
T Consensus        74 ~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lVME~L~~~~  117 (401)
T PRK09550         74 LDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTVMEDLSDHK  117 (401)
T ss_pred             HHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEEEecCCCcc
Confidence            455677888888872   34577777763  345789999997643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.77  E-value=0.016  Score=41.37  Aligned_cols=30  Identities=23%  Similarity=0.418  Sum_probs=24.5

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      +++|+|+.+.||++.  +.+..+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~--~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYN--EEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEe--CCCCCEEEEEcccCC
Confidence            589999999999995  224579999999763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.43  E-value=0.035  Score=41.43  Aligned_cols=30  Identities=37%  Similarity=0.751  Sum_probs=24.7

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      .+++|+|+++.|+++.   .+....++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFD---GDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence            5799999999999995   34456899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.37  E-value=0.033  Score=40.86  Aligned_cols=50  Identities=32%  Similarity=0.395  Sum_probs=36.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhC--CCeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           66 QTARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        66 ~~~~~~~~~i~~~l~~lh~~--~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      ..+...+..+-..+...+..  -++|+|+.|.|++.+   +.+.++|+||..+..
T Consensus       132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t---~~~~l~LIDWEyAg~  183 (269)
T COG0510         132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLT---DKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEc---CCCcEEEEecccCCC
Confidence            34444555555566665555  589999999999983   558899999998743

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.31  E-value=0.052  Score=40.46  Aligned_cols=28  Identities=32%  Similarity=0.459  Sum_probs=23.4

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLS  116 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~  116 (180)
                      .+++|||+.+.|+++.   . +.+.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECccc
Confidence            4789999999999995   3 45789999955

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.28  E-value=0.039  Score=41.00  Aligned_cols=33  Identities=30%  Similarity=0.400  Sum_probs=24.8

Q ss_pred             CCeeecCCCCCeeeecC-CCCceEEEeecCCccc
Q 030256           86 HIIHRDLKPENILLSGL-DDDVMLKIADFGLSCT  118 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~-~~~~~~~l~d~~~~~~  118 (180)
                      +++|+|+.+.||++... .+...+.++||..+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            57999999999999510 0036789999998743

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.16  E-value=0.11  Score=37.31  Aligned_cols=52  Identities=17%  Similarity=0.218  Sum_probs=41.9

Q ss_pred             hhhhHHHHHHHHHHHHHHhcCC---CccccccceEEEeCCeEEEEEeccCCCChH
Q 030256            3 KKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (180)
Q Consensus         3 ~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   54 (180)
                      |.=++...+.+..|+.-|+.|.   --.+++++.+....+..|+|+||.+-+.+.
T Consensus        45 K~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          45 KCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             EecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            4445666788999999888883   356889998888999999999999876664

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=94.98  E-value=0.21  Score=35.09  Aligned_cols=84  Identities=21%  Similarity=0.310  Sum_probs=56.4

Q ss_pred             HHHHHHHHHhcC---CCccc--cccceEEEeC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHH
Q 030256           12 CLDCELNFLSSV---NHPNI--IRLFDAFQAE------------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTA   68 (180)
Q Consensus        12 ~~~~e~~~l~~l---~h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~   68 (180)
                      -+..|.+.+-+|   .+.++  |+++++..-.                  ....||.||.+...         .+....+
T Consensus       100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~  170 (207)
T PF13095_consen  100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDI  170 (207)
T ss_pred             hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHH
Confidence            456666666666   45566  8888886211                  13467888775533         2233333


Q ss_pred             HHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCc
Q 030256           69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS  116 (180)
Q Consensus        69 ~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~  116 (180)
                          .++.+-+..+|..|++-+|+++.|..=        -+|+|||.+
T Consensus       171 ----~~~~~dl~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  171 ----PQMLRDLKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             ----HHHHHHHHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence                456677888999999999999999863        378999853

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.69  E-value=0.058  Score=40.02  Aligned_cols=49  Identities=18%  Similarity=0.210  Sum_probs=31.4

Q ss_pred             hhhhHHHHHHHHHHHHHHhcC---CCccccccceEEEeCCeEEEEEeccCCC
Q 030256            3 KKLNKHLKSCLDCELNFLSSV---NHPNIIRLFDAFQAENCIFLVVEFCAGG   51 (180)
Q Consensus         3 ~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~   51 (180)
                      |.-.......+..|.+-|+.|   .--.+++++.+...++..++++||++.+
T Consensus        46 K~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   46 KVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            444455566788899988888   3456889999988777779999999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.68  E-value=0.19  Score=40.43  Aligned_cols=48  Identities=17%  Similarity=0.322  Sum_probs=38.9

Q ss_pred             HHHHHHHHhcCCCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhcC
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG   61 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~   61 (180)
                      +.-.+++++.+.|++...++++... .....+|+|++ +.+|.+.+..+.
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            4456789999999999999988764 45688999998 789999887544

>PLN02236 choline kinase

Probab=94.38  E-value=0.071  Score=40.60  Aligned_cols=31  Identities=23%  Similarity=0.454  Sum_probs=25.3

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      .++|+|+++.||++.  +.+..+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMID--EETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence            589999999999995  3346799999987743

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.97  E-value=0.087  Score=37.02  Aligned_cols=30  Identities=37%  Similarity=0.613  Sum_probs=19.9

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      .++|+|+.|.||++.  +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence            489999999999993  467789999999873

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1234 consensus ABC (ATP binding cassette) 1 protein [General function prediction only]

Probab=93.93  E-value=0.097  Score=38.53  Aligned_cols=101  Identities=18%  Similarity=0.203  Sum_probs=69.6

Q ss_pred             HHHHHHHHhcC-----CCcc--ccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHH-HHHHHHh
Q 030256           13 LDCELNFLSSV-----NHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGA-GLEILNS   84 (180)
Q Consensus        13 ~~~e~~~l~~l-----~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~-~l~~lh~   84 (180)
                      .++|....++.     ++|+  ++.+++  +-.....+.+|+..|.++...    ..++.+..-.|...+++ .|+.+-.
T Consensus       129 YqrEA~~~~kFr~LLs~~p~f~VP~Vv~--Elct~rvlt~el~~G~pid~~----~~~sQ~~rn~i~~~~l~lcLrEif~  202 (363)
T KOG1234|consen  129 YQREAASALKFRPLLSDDPNFYVPRVVD--ELCTVRVLTLELGQGLPIDKT----AKLSQETRNYIGYKLLELCLREIFE  202 (363)
T ss_pred             hHHHHHHHhhhHHHhcCCCCcchhHHHH--hhccchhhhhhhhcCccchhh----hcccHHHHHHHHHHHHHHHHHHHHH
Confidence            45565555554     4787  455543  233445788898888777653    34666777777776654 5666667


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~  121 (180)
                      -.+...|-+-+|.+++  .....+.|.|||-++....
T Consensus       203 f~fMQTDPNWsNFly~--~~tk~i~LlDFGAsr~y~~  237 (363)
T KOG1234|consen  203 FRFMQTDPNWSNFLYN--GRTKKIELLDFGASREYGE  237 (363)
T ss_pred             HhhhcCCCCHHHhccC--CCcceEEEEeccccccccH
Confidence            7788899999999996  4566799999998766543

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.89  E-value=0.051  Score=37.59  Aligned_cols=28  Identities=21%  Similarity=0.382  Sum_probs=22.8

Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      .+|+|+.|.|++++   +++ ++++||+.+..
T Consensus        79 p~H~D~~~~N~~~~---~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHS---ASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEE---CCC-EEEEeCCcccC
Confidence            68999999999984   333 88999998743

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.55  E-value=0.13  Score=38.41  Aligned_cols=30  Identities=17%  Similarity=0.207  Sum_probs=25.0

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      +++|+|+.++|+++   +.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence            79999999999999   4556788999987644

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=93.47  E-value=0.23  Score=34.60  Aligned_cols=34  Identities=29%  Similarity=0.337  Sum_probs=25.0

Q ss_pred             CCCeeecCCCCCeeeecCCC--CceEEEeecCCccc
Q 030256           85 HHIIHRDLKPENILLSGLDD--DVMLKIADFGLSCT  118 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~--~~~~~l~d~~~~~~  118 (180)
                      ..++|||+.+.|+++....+  ...+.++||..+..
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            45899999999999963111  12689999997644

subfamily of choline kinases

>KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism]

Probab=93.21  E-value=0.29  Score=36.52  Aligned_cols=97  Identities=19%  Similarity=0.222  Sum_probs=59.4

Q ss_pred             HHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHH--------------H------hc---C-CCCHHHH
Q 030256           14 DCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--------------R------LH---G-RVPEQTA   68 (180)
Q Consensus        14 ~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l--------------~------~~---~-~~~~~~~   68 (180)
                      ++|+..++.| .|-.-+++++-|..+    ++++|++|.+|.---              .      ..   + +.-...+
T Consensus       126 e~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL~p~~mr~pki~~lIAr~mak~H~~~~~g~~pkp~lw~km  201 (391)
T KOG4720|consen  126 ENEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTLEPEHMREPKIFRLIARRMAKIHSIVATGGNPKPPLWEKM  201 (391)
T ss_pred             HHHHHHHHHHHHcCcChhhhheecCc----eEEeeecCcccChhhccChHHHHHHHHHHHHhheeccCCCCCCCcHHHHH
Confidence            3566777777 577778888877766    899999998884210              0      00   0 0001111


Q ss_pred             H--------------------------HHHHHHHHHHHHHHhCC----CeeecCCCCCeeeecCCCCceEEEeecCCc
Q 030256           69 R--------------------------KFLQQLGAGLEILNSHH----IIHRDLKPENILLSGLDDDVMLKIADFGLS  116 (180)
Q Consensus        69 ~--------------------------~~~~~i~~~l~~lh~~~----~~h~dl~~~nil~~~~~~~~~~~l~d~~~~  116 (180)
                      .                          .+-..+...-+++...+    ++|.||=..||+++  +..+.+.++|+..+
T Consensus       202 ~~f~~lv~~~f~de~~kq~~~~~~~~~~L~~Ei~~l~E~l~~L~sPVVFcHNDLL~~Niiy~--~~~~~v~fIDYEYa  277 (391)
T KOG4720|consen  202 RKFLQLVPTSFEDEINKQNLFDEPSPEDLGEEISKLKEMLSMLKSPVVFCHNDLLCGNIIYD--SEKGSVEFIDYEYA  277 (391)
T ss_pred             HHHHHhcCchhhcccchhhcccCCCHHHHHHHHHHHHHHHHhhCCCeEEeecchhhcceeec--cccCcEEEEeeccc
Confidence            1                          11122222223333333    68999999999997  67788999999876

>PLN02756 S-methyl-5-thioribose kinase

Probab=92.91  E-value=0.85  Score=35.73  Aligned_cols=38  Identities=5%  Similarity=0.018  Sum_probs=26.0

Q ss_pred             HHHHHHHHHHhcCC---CccccccceEEEeCCeEEEEEeccCC
Q 030256           11 SCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAG   50 (180)
Q Consensus        11 ~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~   50 (180)
                      .+...|.+.|+.+.   ...+++++.++++.  .+++||++++
T Consensus        79 ~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvME~L~~  119 (418)
T PLN02756         79 ERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGMRYLEP  119 (418)
T ss_pred             cHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEEeecCC
Confidence            34455677777663   35788888877643  5778999976

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.76  E-value=0.24  Score=37.53  Aligned_cols=54  Identities=15%  Similarity=0.167  Sum_probs=33.6

Q ss_pred             ChhhhhHH-HHHHHHHHHHHHhcCCCcc--ccccceE------EEeCC--eEEEEEeccCCCChH
Q 030256            1 MLKKLNKH-LKSCLDCELNFLSSVNHPN--IIRLFDA------FQAEN--CIFLVVEFCAGGNLS   54 (180)
Q Consensus         1 ~~~~~~~~-~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~--~~~lv~e~~~~~~L~   54 (180)
                      |||...+. ...++..|...++-|.-.+  ++..+-.      ..-++  ....+++|++|..+.
T Consensus        52 iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~  116 (331)
T COG2334          52 ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLE  116 (331)
T ss_pred             EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcC
Confidence            45566553 6777888888888883222  2222211      11233  788899999998777

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=92.58  E-value=0.5  Score=39.13  Aligned_cols=86  Identities=19%  Similarity=0.221  Sum_probs=64.5

Q ss_pred             CCccccccceEEEeCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecC
Q 030256           24 NHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL  102 (180)
Q Consensus        24 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~  102 (180)
                      ++.+|+++++++...+.-++++|+... .+|.+.+. ....+.-+.+.|++||++.=.-|...|++-.-|.++|+.+   
T Consensus       178 ~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~-~~~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv---  253 (645)
T PRK14559        178 FPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQ-DQTLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRV---  253 (645)
T ss_pred             ccccCcchheeecCCCCcEEEeCCCCCCchHHHHhh-hcCCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheee---
Confidence            345699999999887777788887632 33444443 2245678899999999999999999999999999999998   


Q ss_pred             CCCceEEEeec
Q 030256          103 DDDVMLKIADF  113 (180)
Q Consensus       103 ~~~~~~~l~d~  113 (180)
                      +.+..+.|..+
T Consensus       254 ~~~~~~~l~~l  264 (645)
T PRK14559        254 DEDQTLGLQQL  264 (645)
T ss_pred             CCCceehHhhh
Confidence            34444555444

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	180
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-34
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-33
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-33
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-33
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-33
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-33
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-33
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-32
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-32
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-32
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-32
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-31
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-31
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-31
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-30
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-30
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-30
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-30
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-30
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-30
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-30
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-30
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-30
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-30
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-30
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-30
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-30
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-30
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-30
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-30
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-30
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-30
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-30
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-30
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-30
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-29
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-29
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-29
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-29
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-29
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-29
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-28
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-28
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-28
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-28
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-28
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-28
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-28
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-27
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-27
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-27
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-27
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-27
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-27
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-27
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-27
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-27
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-27
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-26
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-26
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-26
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-26
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-26
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-26
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-26
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-26
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-26
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-26
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-26
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-26
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-26
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-26
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-26
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-26
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-26
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-26
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-26
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-26
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-26
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-26
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-26
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-26
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-26
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-26
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-26
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-26
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-26
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-26
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-26
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-26
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-26
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-26
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-26
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-26
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-26
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-26
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-26
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-26
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-26
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-26
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-26
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-26
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-26
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-26
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-26
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-26
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-26
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-26
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-26
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-26
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-26
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-26
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-26
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-26
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-26
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-26
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-26
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-26
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-26
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-26
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-26
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-26
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-26
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-26
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-26
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-26
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-26
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-26
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-26
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-26
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-26
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-26
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-26
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-26
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-26
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-26
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-26
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-26
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-26
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-26
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-26
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-26
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-26
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-26
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-26
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-26
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-26
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-25
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-25
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-25
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-25
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-25
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-25
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-25
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-25
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-25
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-25
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-25
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-25
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-25
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-25
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-25
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-25
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-25
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-25
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-25
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-25
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-25
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-25
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-25
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-25
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-25
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-25
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-25
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-25
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-25
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-25
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-25
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-25
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-25
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-25
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-25
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-25
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-25
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-25
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-25
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-25
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-25
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-25
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-24
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-24
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-24
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-24
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-24
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-24
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-24
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-24
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-24
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-24
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-24
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-23
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-23
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-23
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-23
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-23
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-23
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-23
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-23
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-23
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-23
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-23
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-23
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-23
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-23
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-23
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-23
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-23
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-23
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-23
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-23
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-23
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-23
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-23
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-23
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-23
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-23
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-23
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-23
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-23
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-23
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-23
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-23
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-23
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-23
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-23
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-23
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-22
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-22
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-22
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-22
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-22
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-22
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-22
3soa_A	444	Full-Length Human Camkii Length = 444		3e-22
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-22
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-22
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-22
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-22
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-22
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-22
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-22
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-22
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-22
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-22
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-21
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-21
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-21
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-21
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-21
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-21
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-21
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-21
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-21
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-21
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-21
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-21
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-21
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-21
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-21
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-21
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-21
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-21
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-21
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-21
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-21
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-21
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-21
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-21
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-20
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-20
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-20
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-20
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-20
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-20
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-20
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-19
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-19
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-19
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-19
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-19
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-19
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-19
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-19
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-19
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-19
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-18
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-18
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-18
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-18
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-18
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-18
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-18
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-18
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-18
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-18
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-18
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-18
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-18
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-18
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-18
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-18
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-18
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-18
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-18
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-18
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-18
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-18
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-18
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-18
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-17
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-17
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-17
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-17
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-17
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-16
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-15
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-14
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-14
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-14
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-12
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-11
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-11
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-10
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-10

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  140 bits (352), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 65/156 (41%), Positives = 102/156 (65%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +  +I+HRDLK EN+LL G   D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 124 VSAVQYCHQKYIVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYA 180
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 65/156 (41%), Positives = 102/156 (65%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  ++ CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYA 179
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 65/156 (41%), Positives = 101/156 (64%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 65/156 (41%), Positives = 101/156 (64%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 65/156 (41%), Positives = 101/156 (64%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  136 bits (342), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 64/156 (41%), Positives = 101/156 (64%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  136 bits (342), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 63/156 (40%), Positives = 100/156 (64%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 120
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G   +  CGSP Y 
Sbjct: 121 VSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYA 177
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  134 bits (338), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 62/156 (39%), Positives = 100/156 (64%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G   +  CG+P Y 
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  134 bits (338), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 64/156 (41%), Positives = 100/156 (64%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HG + E+ AR   +Q+
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQI 115
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 116 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 172
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 208

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  134 bits (337), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 72/170 (42%), Positives = 108/170 (63%), Gaps = 7/170 (4%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +LKK + H++  ++ E+++L  + HP+II+L+D       I +V+E+ AGG L  YI   
Sbjct: 46  LLKKSDMHMR--VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK 102
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            R+ E   R+F QQ+   +E  + H I+HRDLKPEN+L   LDD++ +KIADFGLS  + 
Sbjct: 103 KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL---LDDNLNVKIADFGLSNIMT 159
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 169
            GN+ +  CGSP Y APEV+  + Y   +VD+WS G +L+ +L G  PF 
Sbjct: 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  133 bits (334), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 64/156 (41%), Positives = 97/156 (62%), Gaps = 4/156 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NHPNI++LF+  + E  ++LV E+ +GG +  Y+  HGR  E+ AR   +Q+
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D  +KIADFG S     GN  +  CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSA 170
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  132 bits (331), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 66/155 (42%), Positives = 97/155 (62%), Gaps = 1/155 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV+E   GG L   I L  +  E  A   ++Q+
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G   L+ H+I+HRDLKPEN+LL     D ++KI DFGLS     G   ++  G+  Y+
Sbjct: 131 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEVL+ ++YDEK D+WS G IL+ LL GYPPF  
Sbjct: 191 APEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGG 224

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  131 bits (330), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 66/155 (42%), Positives = 97/155 (62%), Gaps = 1/155 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV+E   GG L   I L  +  E  A   ++Q+
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G   L+ H+I+HRDLKPEN+LL     D ++KI DFGLS     G   ++  G+  Y+
Sbjct: 114 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 173
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEVL+ ++YDEK D+WS G IL+ LL GYPPF  
Sbjct: 174 APEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGG 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  131 bits (330), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 66/155 (42%), Positives = 98/155 (63%), Gaps = 1/155 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L+D F+ +   +LV+E   GG L   I    +  E  A   ++Q+
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  L+ H+I+HRDLKPEN+LL   + D ++KI DFGLS         ++  G+  Y+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEVL+ ++YDEK D+WS+G ILF LL GYPPF  
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG 239

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  129 bits (323), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/161 (41%), Positives = 106/161 (65%), Gaps = 5/161 (3%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 56  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 114
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           R+F QQ+ + +E  + H I+HRDLKPEN+L   LD+ + +KIADFGLS  +  GN+ +  
Sbjct: 115 RRFFQQIISAVEYCHRHKIVHRDLKPENLL---LDEHLNVKIADFGLSNIMTDGNFLKTS 171
Query: 129 CGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 168
           CGSP Y APEV+  + Y   +VD+WS G IL+ +L    PF
Sbjct: 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  129 bits (323), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/161 (41%), Positives = 106/161 (65%), Gaps = 5/161 (3%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 57  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 115
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           R+F QQ+ + +E  + H I+HRDLKPEN+L   LD+ + +KIADFGLS  +  GN+ +  
Sbjct: 116 RRFFQQIISAVEYCHRHKIVHRDLKPENLL---LDEHLNVKIADFGLSNIMTDGNFLKTS 172
Query: 129 CGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 168
           CGSP Y APEV+  + Y   +VD+WS G IL+ +L    PF
Sbjct: 173 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  129 bits (323), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/162 (41%), Positives = 106/162 (65%), Gaps = 5/162 (3%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 47  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 105
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           R+F QQ+ + +E  + H I+HRDLKPEN+L   LD+ + +KIADFGLS  +  GN+ +  
Sbjct: 106 RRFFQQIISAVEYCHRHKIVHRDLKPENLL---LDEHLNVKIADFGLSNIMTDGNFLKTS 162
Query: 129 CGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 169
           CGSP Y APEV+  + Y   +VD+WS G IL+ +L    PF 
Sbjct: 163 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  129 bits (323), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 71/175 (40%), Positives = 111/175 (63%), Gaps = 11/175 (6%)
Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK +NK       ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  
Sbjct: 38  LKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFD 96
Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YI    ++ EQ AR+F QQ+ + +E  + H I+HRDLKPEN+L   LD+ + +KIADFGL
Sbjct: 97  YIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL---LDEHLNVKIADFGL 153
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 169
           S  +  GN+ +  CGSP Y APEV+  + Y   +VD+WS G IL+ +L    PF 
Sbjct: 154 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  129 bits (323), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 66/163 (40%), Positives = 96/163 (58%), Gaps = 2/163 (1%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           NK   + L  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E
Sbjct: 62  NKDTSTIL-REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
             A + ++Q+ +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   G+  Y+APEVL+   YDEK D+WS G IL+ LL+G PPF
Sbjct: 181 KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  128 bits (322), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 92/153 (60%), Gaps = 1/153 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           APEVL+   YDEK D+WS G IL+ LL+G PPF
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  128 bits (322), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 92/153 (60%), Gaps = 1/153 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           APEVL+   YDEK D+WS G IL+ LL+G PPF
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  128 bits (322), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 66/155 (42%), Positives = 96/155 (61%), Gaps = 1/155 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S++HPNII+LFD F+ +   +LV EF  GG L   I    +  E  A   ++Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  L+ H+I+HRD+KPENILL   +  + +KI DFGLS             G+  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEVL+ ++Y+EK D+WS G I++ LL GYPPF  
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  128 bits (321), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/163 (41%), Positives = 101/163 (61%), Gaps = 4/163 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 133 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS +R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  128 bits (321), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 73/187 (39%), Positives = 108/187 (57%), Gaps = 11/187 (5%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+      + IF+V+E+ +GG L  
Sbjct: 46  VKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD 105
Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YI  +GR+ E+ +R+  QQ+ +G++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 106 YICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 162
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF-SAYRP 173
           S  +  G +    CGSP Y APEV+  + Y   +VD+WS G IL+ LL G  PF   + P
Sbjct: 163 SNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222
Query: 174 CFASRLC 180
               ++C
Sbjct: 223 TLFKKIC 229

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  128 bits (321), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/163 (41%), Positives = 101/163 (61%), Gaps = 4/163 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 133 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS +R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  128 bits (321), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/163 (41%), Positives = 101/163 (61%), Gaps = 4/163 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 133 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS +R
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 222

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  128 bits (321), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/163 (41%), Positives = 101/163 (61%), Gaps = 4/163 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 133 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS +R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  128 bits (321), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/163 (41%), Positives = 101/163 (61%), Gaps = 4/163 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 133 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS +R
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  127 bits (319), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 72/175 (41%), Positives = 99/175 (56%), Gaps = 10/175 (5%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+         F+V+E+ +GG L  
Sbjct: 41  VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100
Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YI  HGRV E  AR+  QQ+ + ++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 157
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 169
           S  +  G +    CGSP Y APEV+  + Y   +VD+WS G IL+ LL G  PF 
Sbjct: 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  127 bits (319), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 67/163 (41%), Positives = 101/163 (61%), Gaps = 4/163 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 133 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS +R
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  127 bits (319), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 67/163 (41%), Positives = 101/163 (61%), Gaps = 4/163 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 133 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS +R
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  127 bits (319), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 72/175 (41%), Positives = 99/175 (56%), Gaps = 10/175 (5%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+         F+V+E+ +GG L  
Sbjct: 41  VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100
Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YI  HGRV E  AR+  QQ+ + ++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 157
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 169
           S  +  G +    CGSP Y APEV+  + Y   +VD+WS G IL+ LL G  PF 
Sbjct: 158 SNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  127 bits (319), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/169 (40%), Positives = 99/169 (58%), Gaps = 10/169 (5%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 51  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 110
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           +  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L PG   
Sbjct: 111 KETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKL 167
Query: 126 EKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPF 168
            +VCG+P Y+APE+++         Y ++VDMWS G I++ LL G PPF
Sbjct: 168 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  127 bits (319), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/169 (40%), Positives = 99/169 (58%), Gaps = 10/169 (5%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           +  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L PG   
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 126 EKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPF 168
            +VCG+P Y+APE+++         Y ++VDMWS G I++ LL G PPF
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  126 bits (317), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 68/169 (40%), Positives = 98/169 (57%), Gaps = 10/169 (5%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           +  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L PG   
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 126 EKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPF 168
             VCG+P Y+APE+++         Y ++VDMWS G I++ LL G PPF
Sbjct: 181 RSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  126 bits (316), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 64/168 (38%), Positives = 100/168 (59%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + KK  +  +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   
Sbjct: 51  IAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK 110
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           G   E+ A + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    
Sbjct: 111 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 170
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           PG+     CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  125 bits (315), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 62/159 (38%), Positives = 96/159 (60%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  125 bits (315), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 62/159 (38%), Positives = 96/159 (60%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  125 bits (314), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 62/159 (38%), Positives = 96/159 (60%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  124 bits (312), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 65/180 (36%), Positives = 105/180 (58%), Gaps = 10/180 (5%)
Query: 7   KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + ++     E + L  V  HP+II L D++++ + +FLV +    G L  Y+     + E
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           +  R  ++ L   +  L++++I+HRDLKPENIL   LDD++ ++++DFG SC L PG   
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENIL---LDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 126 EKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRL 179
            ++CG+P Y+APE+L+         Y ++VD+W+ G ILF LL G PPF   R     R+
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  123 bits (308), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 64/166 (38%), Positives = 97/166 (58%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KK  K  +S ++ E+  L  + H NI+ L D +++ N ++LV++  +GG L   I   G 
Sbjct: 57  KKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF 116
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E+ A   ++Q+   +  L+   I+HRDLKPEN+L    D++  + I+DFGLS     G
Sbjct: 117 YTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG 176
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +     CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 177 DVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  122 bits (307), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 64/165 (38%), Positives = 94/165 (56%), Gaps = 1/165 (0%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 72  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 131
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
             A + ++Q+ +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 132 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 191
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+ 
Sbjct: 192 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNG 235

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  122 bits (306), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 64/165 (38%), Positives = 94/165 (56%), Gaps = 1/165 (0%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
             A + ++Q+ +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+ 
Sbjct: 186 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNG 229

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  122 bits (305), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 64/165 (38%), Positives = 94/165 (56%), Gaps = 1/165 (0%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 89  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 148
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
             A + ++Q+ +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 149 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 208
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+ 
Sbjct: 209 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNG 252

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  122 bits (305), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 64/165 (38%), Positives = 94/165 (56%), Gaps = 1/165 (0%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 90  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 149
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
             A + ++Q+ +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 150 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 209
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+ 
Sbjct: 210 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNG 253

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  120 bits (301), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 62/149 (41%), Positives = 92/149 (61%), Gaps = 5/149 (3%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
           LS V HP IIR++  FQ    IF+++++  GG L S +R   R P   A+ +  ++   L
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           E L+S  II+RDLKPENIL   LD +  +KI DFG +   Y  +    +CG+P Y+APEV
Sbjct: 120 EYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAK--YVPDVTYXLCGTPDYIAPEV 174
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +  + Y++ +D WS G +++E+L GY PF
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  120 bits (301), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 70/168 (41%), Positives = 97/168 (57%), Gaps = 1/168 (0%)
Query: 2   LKKLNKHL-KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           LK L K + K  +  E+  L  ++HPNII+L + F+    I LV+E   GG L   I   
Sbjct: 83  LKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK 142
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           G   E+ A   ++Q+   +  L+ + I+HRDLKPEN+L +    D  LKIADFGLS  + 
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                + VCG+P Y APE+L+   Y  +VDMWSVG I + LL G+ PF
Sbjct: 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  120 bits (300), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 64/165 (38%), Positives = 92/165 (55%), Gaps = 1/165 (0%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI +L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
             A + ++Q+ +G+   + + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 126 VDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX 185
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+ 
Sbjct: 186 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNG 229

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  119 bits (298), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 99/172 (57%), Gaps = 6/172 (3%)
Query: 3   KKLNKHLKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           KK+ K+    +D    E+  + S++HPNIIRL++ F+    I+LV+E C GG L   + +
Sbjct: 40  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-V 98
Query: 60  HGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           H RV  E  A + ++ + + +   +  ++ HRDLKPEN L      D  LK+ DFGL+  
Sbjct: 99  HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             PG       G+P Y++P+VL+   Y  + D WS G +++ LL GYPPFSA
Sbjct: 159 FKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSA 209

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  119 bits (297), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 99/172 (57%), Gaps = 6/172 (3%)
Query: 3   KKLNKHLKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           KK+ K+    +D    E+  + S++HPNIIRL++ F+    I+LV+E C GG L   + +
Sbjct: 57  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-V 115
Query: 60  HGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           H RV  E  A + ++ + + +   +  ++ HRDLKPEN L      D  LK+ DFGL+  
Sbjct: 116 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 175
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             PG       G+P Y++P+VL+   Y  + D WS G +++ LL GYPPFSA
Sbjct: 176 FKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSA 226

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  119 bits (297), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 59/158 (37%), Positives = 92/158 (58%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR  EQ +  F+
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           ++L   L   +   +IHRD+KPEN+L+    +   LKIADFG S    P      +CG+ 
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTL 176
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+W  G + +E L G PPF +
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  119 bits (297), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 59/158 (37%), Positives = 92/158 (58%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR  EQ +  F+
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 121
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           ++L   L   +   +IHRD+KPEN+L+    +   LKIADFG S    P      +CG+ 
Sbjct: 122 EELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTL 177
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+W  G + +E L G PPF +
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  117 bits (294), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 59/162 (36%), Positives = 98/162 (60%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 169
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 59/162 (36%), Positives = 98/162 (60%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 176
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 59/162 (36%), Positives = 98/162 (60%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 73  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 132
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 190
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  116 bits (290), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 104 KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 162
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGATWT- 218
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 219 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 265

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  116 bits (290), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 62/167 (37%), Positives = 95/167 (56%), Gaps = 1/167 (0%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           +KK      S L+ E+  L  + H NI+ L D +++    +LV++  +GG L   I   G
Sbjct: 42  IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG 101
Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
              E+ A   +QQ+ + ++ L+ + I+HRDLKPEN+L    +++  + I DFGLS  +  
Sbjct: 102 VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQ 160
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                  CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  115 bits (289), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 59/168 (35%), Positives = 105/168 (62%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG++ S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  115 bits (289), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 59/168 (35%), Positives = 105/168 (62%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG++ S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  115 bits (289), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 59/168 (35%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  115 bits (288), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 105/168 (62%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 70  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 128
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D+   +++ DFG +  +    +  
Sbjct: 129 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDEQGYIQVTDFGFAKRVKGRTWX- 184
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 185 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  115 bits (287), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KEIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFGL+  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGLAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/159 (36%), Positives = 93/159 (58%), Gaps = 4/159 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   R  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHA-PSSRRDTLCGTL 174
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A+
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAH 213

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 78  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 136
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 137 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 192
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 193 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 104 KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 162
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 218
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 219 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 265

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 62/157 (39%), Positives = 93/157 (59%), Gaps = 4/157 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L+ VNHP +++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 79  MERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 138
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           L  GL+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS   +     A   CG+  
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVE 195
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPEV+  Q +    D WS G ++FE+L G  PF  
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQG 232

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A  P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPI 244

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLI---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  114 bits (284), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 58/159 (36%), Positives = 92/159 (57%), Gaps = 4/159 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   R  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHA-PSSRRTTLCGTL 174
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A+
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAH 213

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 102/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 46  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N   + C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 165 AKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++++  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPI 244

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 92/158 (58%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDTLCGTL 171
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E     +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 47  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 105
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 106 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 165
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 166 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 46  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 165 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 104/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KEIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +++ DFGL+  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIQVTDFGLAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 92  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 150
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 151 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 62  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 120
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 121 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 180
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 181 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 53  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 111
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 112 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 171
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 172 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 52  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 110
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 111 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 170
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 171 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 54  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 112
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 113 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 172
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 173 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  113 bits (283), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  113 bits (283), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 91/166 (54%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 41  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 101 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 160
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 161 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 98  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 156
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 157 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 216
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 217 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWT- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 91/166 (54%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 91/166 (54%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 92/158 (58%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +   ++CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTELCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 69  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 127
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 128 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWT- 183
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 184 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 230

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 92/158 (58%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDDLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  113 bits (282), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 91/166 (54%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 76  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 134
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 135 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 190
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 191 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 237

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 54  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 113
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 114 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 169
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 174
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 92/158 (58%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDDLCGTL 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG SC   P +    + G+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSCHA-PSSRRTTLSGTL 171
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 104 KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 162
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 218
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 219 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 171
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 102/168 (60%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 102/168 (60%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 52  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 112 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 167
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTXLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+AP ++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  112 bits (281), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKKVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 175
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 172
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 76  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 134
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 135 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 190
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 191 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 237

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 72  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 131
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 132 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 187
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            + G+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 90/158 (56%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE ++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 102/168 (60%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 61/157 (38%), Positives = 93/157 (59%), Gaps = 4/157 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           L   L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPEV+  + + +  D WS G ++FE+L G  PF  
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 61/157 (38%), Positives = 93/157 (59%), Gaps = 4/157 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 76  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 135
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           L   L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 136 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 192
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPEV+  + + +  D WS G ++FE+L G  PF  
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 229

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            +CG+P  +APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 98/162 (60%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L+ E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 61/157 (38%), Positives = 93/157 (59%), Gaps = 4/157 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           L   L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPEV+  + + +  D WS G ++FE+L G  PF  
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 103/168 (61%), Gaps = 6/168 (3%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            + G+P Y+APE++  + Y++ VD W++G +++E+  GYPPF A +P 
Sbjct: 198 -LXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  111 bits (277), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 92/149 (61%), Gaps = 7/149 (4%)
Query: 26  PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79
           P+I+ + D ++     + C+ +++E   GG L S I+  G     E+ A + ++ +G  +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+APEV
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNALQTPCYTPYYVAPEV 181
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           L  ++YD+  DMWS+G I++ LL G+PPF
Sbjct: 182 LGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  111 bits (277), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 92/149 (61%), Gaps = 7/149 (4%)
Query: 26  PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79
           P+I+ + D ++     + C+ +++E   GG L S I+  G     E+ A + ++ +G  +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+APEV
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNALQTPCYTPYYVAPEV 200
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           L  ++YD+  DMWS+G I++ LL G+PPF
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 101/174 (58%), Gaps = 15/174 (8%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGAGLEILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            E+   + + QL   L+  +      H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 119 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
           L +  ++A++  G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+A+
Sbjct: 166 LNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  110 bits (276), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIA+FG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHA-PSSRRTTLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  110 bits (276), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 91/158 (57%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIA+FG S    P +    +CG+ 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHA-PSSRRTTLCGTL 172
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 59/157 (37%), Positives = 90/157 (57%), Gaps = 4/157 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +L +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           +   L  L+   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG+  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPE+L    ++  VD WS+GA+++++L G PPF+ 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 59/157 (37%), Positives = 90/157 (57%), Gaps = 4/157 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +L +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           +   L  L+   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG+  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           YMAPE+L    ++  VD WS+GA+++++L G PPF+ 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 100/174 (57%), Gaps = 15/174 (8%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGAGLEILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            E+   + + QL   L+  +      H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 119 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
           L +  ++A+   G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+A+
Sbjct: 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
           E+L+ + Y   VD W++G ++FE++ G  PF 
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 100/174 (57%), Gaps = 15/174 (8%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGAGLEILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            E+   + + QL   L+  +      H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 119 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
           L +  ++A+   G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+A+
Sbjct: 166 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 74  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 133
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 134 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 190
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
           E+L+ + Y   VD W++G ++FE++ G  PF 
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 100/167 (59%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 140
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + + G 
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEFDGE 197
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G IL+ LL G PPF  
Sbjct: 198 RKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 100/167 (59%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 65  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 124
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + + G 
Sbjct: 125 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEFDGE 181
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G IL+ LL G PPF  
Sbjct: 182 RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 100/167 (59%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 140
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + + G 
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEFDGE 197
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G IL+ LL G PPF  
Sbjct: 198 RKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 59  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 118
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 119 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 175
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
           E+L+ + Y   VD W++G ++FE++ G  PF 
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 100/167 (59%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 140
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + + G 
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEFDGE 197
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G IL+ LL G PPF  
Sbjct: 198 RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 179
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
           E+L+ + Y   VD W++G ++FE++ G  PF 
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    + G+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLXGTL 175
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 99/178 (55%), Gaps = 9/178 (5%)
Query: 1   MLKKLNKHLKSC----LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           ++K +NK         ++ E+  L S++HPNII++F+ F+  + +++V+E C GG L   
Sbjct: 51  VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 57  I---RLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           I   +  G+ + E    + ++Q+   L   +S H++H+DLKPENIL         +KI D
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           FGL+       ++    G+ LYMAPEV + +    K D+WS G +++ LL G  PF+ 
Sbjct: 171 FGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/170 (39%), Positives = 91/170 (53%), Gaps = 7/170 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             E  A   +QQ+   LE +N  H   I+HRDLKPEN+LL+       +K+ADFGL+  +
Sbjct: 100 YSEADASHCIQQI---LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV 156
Query: 120 YPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                A     G+P Y++PEVL+   Y + VDMW+ G IL+ LL GYPPF
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/170 (39%), Positives = 91/170 (53%), Gaps = 7/170 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             E  A   +QQ+   LE +N  H   I+HRDLKPEN+LL+       +K+ADFGL+  +
Sbjct: 100 YSEADASHCIQQI---LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV 156
Query: 120 YPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                A     G+P Y++PEVL+   Y + VDMW+ G IL+ LL GYPPF
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 93/157 (59%), Gaps = 5/157 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++  S ++H NI+ + D  + ++C +LV+E+  G  LS YI  HG +   TA  F  Q+
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI 120
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 133
             G++  +   I+HRD+KP+NIL   +D +  LKI DFG++  L   +  +   V G+  
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y +PE  + +  DE  D++S+G +L+E+L G PPF+ 
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/167 (37%), Positives = 89/167 (53%), Gaps = 1/167 (0%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 67  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 126
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   + Q+   +  ++ H I+HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 127 YSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 123 NYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             A     G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 187 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 95/159 (59%), Gaps = 5/159 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  V HPNII L D ++    + L++E  +GG L  ++     + E+ A  F+
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 129
           +Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   + + 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/173 (35%), Positives = 97/173 (56%), Gaps = 7/173 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V E   GG L S I
Sbjct: 92  LKXLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRI 150
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A +  + +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 151 QDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +      N     C +P Y+APEVL  ++YD+  D WS+G I + LL GYPPF
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 93/159 (58%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV---PEQTARKFL 72
           E+     + HP+I+ L++ F+  N ++LV+E C  G ++ Y++   RV    E  AR F+
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFM 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            Q+  G+  L+SH I+HRDL   N+LL+    ++ +KIADFGL+  L  P      +CG+
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGT 175
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           P Y++PE+     +  + D+WS+G + + LL G PPF  
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 62/167 (37%), Positives = 95/167 (56%), Gaps = 7/167 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KK  KH+ S  +     L +V HP ++ L  +FQ  + ++ V+++  GG L  +++    
Sbjct: 79  KKEEKHIMSERNV---LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC 135
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYP 121
             E  AR +  ++ + L  L+S +I++RDLKPENILL   D    + + DFGL    +  
Sbjct: 136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEH 192
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            +     CG+P Y+APEVL  Q YD  VD W +GA+L+E+L G PPF
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 97/167 (58%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 115
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 172
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF  
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 97/167 (58%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 115
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 172
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF  
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  106 bits (265), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 97/167 (58%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 60  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 119
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 120 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 176
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF  
Sbjct: 177 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  105 bits (263), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 97/167 (58%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 54  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 113
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 114 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 170
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF  
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  105 bits (262), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 97/167 (58%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 78  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 137
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 138 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 194
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF  
Sbjct: 195 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 241

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  105 bits (262), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 97/167 (58%), Gaps = 4/167 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 139
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 140 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 196
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF  
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 54/148 (36%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84
           HPNI++L + F  +   FLV+E   GG L   I+      E  A   +++L + +  ++ 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 85  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLYMAPEVLQFQ 143
             ++HRDLKPEN+L +  +D++ +KI DFG +    P N   K  C +  Y APE+L   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSAY 171
            YDE  D+WS+G IL+ +L+G  PF ++
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSH 212

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 94/166 (56%), Gaps = 10/166 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQ 73
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + +  + L   + E   +   +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q    L  L+ + IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTP 199
Query: 133 LYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            +MAPEV+     + + YD K D+WS+G  L E+    PP     P
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  104 bits (260), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 94/166 (56%), Gaps = 10/166 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQ 73
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + +  + L   + E   +   +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q    L  L+ + IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRXIQRRDSFIGTP 199
Query: 133 LYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            +MAPEV+     + + YD K D+WS+G  L E+    PP     P
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 95/162 (58%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 94/166 (56%), Gaps = 10/166 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQ 73
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + +  + L   + E   +   +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q    L  L+ + IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRXIQRRDXFIGTP 199
Query: 133 LYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            +MAPEV+     + + YD K D+WS+G  L E+    PP     P
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 95/162 (58%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 95/162 (58%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 95/162 (58%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 95/162 (58%), Gaps = 5/162 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 40  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 99
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 156
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/170 (35%), Positives = 94/170 (55%), Gaps = 13/170 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/170 (35%), Positives = 94/170 (55%), Gaps = 13/170 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 123
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 124 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 218

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 117 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 211

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 118 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  103 bits (256), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 119 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 213

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  103 bits (256), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 120 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 214

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  103 bits (256), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 144
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 145 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 239

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  103 bits (256), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 60/167 (35%), Positives = 88/167 (52%), Gaps = 1/167 (0%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 58  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 117
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +   ++HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 118 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE 177
Query: 123 NYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             A     G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  102 bits (255), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 61/148 (41%), Positives = 82/148 (55%), Gaps = 2/148 (1%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +++E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            +S  I HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 132 CHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 142 FQRYDEKV-DMWSVGAILFELLNGYPPF 168
            Q YD K+ D+WS G  L+ +L G  PF
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPF 218

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/162 (38%), Positives = 92/162 (56%), Gaps = 5/162 (3%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS + NHP + +LF  FQ  + +F V+EF  GG+L  +I+   R  E  AR
Sbjct: 68  ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR 127
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKV 128
            +  ++ + L  L+   II+RDLK +N+L   LD +   K+ADFG+    +  G      
Sbjct: 128 FYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           CG+P Y+APE+LQ   Y   VD W++G +L+E+L G+ PF A
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 146
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 147 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 241

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/149 (40%), Positives = 82/149 (55%), Gaps = 2/149 (1%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKIADFG S      +  +   G+P Y+APEVL 
Sbjct: 131 AHAMQVAHRDLKLENTLLDG-SPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 142 FQRYDEKV-DMWSVGAILFELLNGYPPFS 169
            + YD KV D+WS G  L+ +L G  PF 
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 86/146 (58%), Gaps = 4/146 (2%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L  +I+  GR  E  A  +  ++  GL  L S 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
            II+RDLK +N++L   D +  +KIADFG+    ++ G   +  CG+P Y+APE++ +Q 
Sbjct: 141 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 145 YDEKVDMWSVGAILFELLNGYPPFSA 170
           Y + VD W+ G +L+E+L G  PF  
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEG 223

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/167 (35%), Positives = 88/167 (52%), Gaps = 1/167 (0%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + H NI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +   ++HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 100 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD 159
Query: 123 NYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             A     G+P Y++PEVL+ + Y + VD+W+ G IL+ LL GYPPF
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 92/160 (57%), Gaps = 2/160 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL-SSYIRLHGRVPEQTA 68
           K  +  E++ ++ ++H N+I+L+DAF+++N I LV+E+  GG L    I     + E   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             F++Q+  G+  ++  +I+H DLKPENIL    D    +KI DFGL+    P    +  
Sbjct: 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN 248
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            G+P ++APEV+ +       DMWSVG I + LL+G  PF
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 86/146 (58%), Gaps = 4/146 (2%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L  +I+  GR  E  A  +  ++  GL  L S 
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
            II+RDLK +N++L   D +  +KIADFG+    ++ G   +  CG+P Y+APE++ +Q 
Sbjct: 462 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 145 YDEKVDMWSVGAILFELLNGYPPFSA 170
           Y + VD W+ G +L+E+L G  PF  
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEG 544

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 5/162 (3%)
Query: 11  SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   L+ ++ P  + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A 
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKV 128
            +  ++  GL  L+   II+RDLK +N++L   D +  +KIADFG+    +  G    + 
Sbjct: 124 FYAAEISIGLFFLHKRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREF 180
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G PPF  
Sbjct: 181 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 222

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 88/167 (52%), Gaps = 1/167 (0%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +   ++HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 123 NYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             A     G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  100 bits (250), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 94/166 (56%), Gaps = 10/166 (6%)
Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +
Sbjct: 74  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE+T  K+  QL + LE ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 190
Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            A   + G+P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/185 (33%), Positives = 99/185 (53%), Gaps = 14/185 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H +S +  E+  L     + NI+ L + F+ +   +LV E   GG++ ++I+ 
Sbjct: 45  IIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQK 104
Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL---- 115
                E+ A + ++ + A L+ L++  I HRDLKPENIL    +    +KI DF L    
Sbjct: 105 QKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGM 164
Query: 116 ----SCTLYPGNYAEKVCGSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYP 166
               SCT          CGS  YMAPEV+     Q   YD++ D+WS+G +L+ +L+GYP
Sbjct: 165 KLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224
Query: 167 PFSAY 171
           PF  +
Sbjct: 225 PFVGH 229

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  100 bits (249), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 91/160 (56%), Gaps = 5/160 (3%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS +  HP +  +F  FQ +  +F V+E+  GG+L  +I+   +     A 
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 122
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
            +  ++  GL+ L+S  I++RDLK +NILL   D D  +KIADFG+      G+    + 
Sbjct: 123 FYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEF 179
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           CG+P Y+APE+L  Q+Y+  VD WS G +L+E+L G  PF
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  100 bits (248), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 13/171 (7%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 169
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 90/160 (56%), Gaps = 5/160 (3%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS +  HP +  +F  FQ +  +F V+E+  GG+L  +I+   +     A 
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 121
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
            +  ++  GL+ L+S  I++RDLK +NILL   D D  +KIADFG+      G+      
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           CG+P Y+APE+L  Q+Y+  VD WS G +L+E+L G  PF
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 60/148 (40%), Positives = 82/148 (55%), Gaps = 2/148 (1%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 130 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 142 FQRYDEKV-DMWSVGAILFELLNGYPPF 168
            + YD KV D+WS G  L+ +L G  PF
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 60/148 (40%), Positives = 82/148 (55%), Gaps = 2/148 (1%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 142 FQRYDEKV-DMWSVGAILFELLNGYPPF 168
            + YD KV D+WS G  L+ +L G  PF
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 94/173 (54%), Gaps = 18/173 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--------LHGRVPEQT 67
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+          G + E T
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----- 122
               L+++  GLE L+ +  IHRD+K  NILL    +D  ++IADFG+S  L  G     
Sbjct: 118 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 174
Query: 123 NYAEKV-CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           N   K   G+P +MAPEV+ Q + YD K D+WS G    EL  G  P+  Y P
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 227

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Composition-based stats.
 Identities = 52/154 (33%), Positives = 89/154 (57%), Gaps = 2/154 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            APEV + +      DMWSVG + + LL+G  PF
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 91/162 (56%), Gaps = 2/162 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTA 68
           K  +  E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A
Sbjct: 92  KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 151
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
            ++++Q+  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +  
Sbjct: 152 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVT 210
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            G+  + APEV + +      DMWSVG + + LL+G  PF  
Sbjct: 211 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 252

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Composition-based stats.
 Identities = 58/166 (34%), Positives = 88/166 (53%), Gaps = 11/166 (6%)
Query: 12  CLDCELNFLSSVNHPNII---RLFDAFQ--AENCI-FLVVEFCAGGNLSSYIRLHGR--- 62
           CL  E+  +  +NHPN++    + D  Q  A N +  L +E+C GG+L  Y+        
Sbjct: 61  CL--EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 118
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E   R  L  + + L  L+ + IIHRDLKPENI+L      ++ KI D G +  L  G
Sbjct: 119 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 178
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               +  G+  Y+APE+L+ ++Y   VD WS G + FE + G+ PF
Sbjct: 179 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 94/173 (54%), Gaps = 18/173 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--------LHGRVPEQT 67
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+          G + E T
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----- 122
               L+++  GLE L+ +  IHRD+K  NILL    +D  ++IADFG+S  L  G     
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 179
Query: 123 NYAEKV-CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           N   K   G+P +MAPEV+ Q + YD K D+WS G    EL  G  P+  Y P
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 87/156 (55%), Gaps = 6/156 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +  + HP ++ L+ +FQ E  +F+VV+   GG+L  +++ +    E+T + F+ +L
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              L+ L +  IIHRD+KP+NIL   LD+   + I DF ++  L        + G+  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPF 168
           APE+   ++   Y   VD WS+G   +ELL G  P+
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 94/173 (54%), Gaps = 10/173 (5%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
           +KL K  +     E   L  + HPNI+R +D++++    + CI LV E    G L +Y++
Sbjct: 62  RKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLK 121
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                  +  R + +Q+  GL+ L++    IIHRDLK +NI ++G    V  KI D GL+
Sbjct: 122 RFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGLA 179
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
            TL   ++A+ V G+P + APE  + ++YDE VD+++ G    E      P+S
Sbjct: 180 -TLKRASFAKAVIGTPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYS 230

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 93/161 (57%), Gaps = 10/161 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  ++
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 182
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
              L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF A
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 280

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 93/161 (57%), Gaps = 10/161 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  ++
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 182
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
              L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF A
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 280

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 93/161 (57%), Gaps = 10/161 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  ++
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 177
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
              L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF A
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 95/171 (55%), Gaps = 11/171 (6%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA- 68
           K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A 
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 120
Query: 69  --RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             R+ LQ     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P     
Sbjct: 121 VCRECLQ----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKR 173
Query: 127 -KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
            ++ G+P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P  A
Sbjct: 174 SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 94/171 (54%), Gaps = 11/171 (6%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA- 68
           K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A 
Sbjct: 62  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 121
Query: 69  --RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             R+ LQ     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P     
Sbjct: 122 VCRECLQ----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKR 174
Query: 127 K-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
             + G+P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P  A
Sbjct: 175 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/148 (38%), Positives = 80/148 (54%), Gaps = 2/148 (1%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HPNII L D +     ++LV E   GG L   I       E+ A   L  +G  +E L+
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 84  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 141
           S  ++HRDLKP NIL +    +   L+I DFG +  L   N      C +  ++APEVL+
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFS 169
            Q YDE  D+WS+G +L+ +L GY PF+
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFA 226

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 95/161 (59%), Gaps = 10/161 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ A+ +  ++
Sbjct: 125 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 183
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
              L+ ++S  +IHRD+KP+N+L   LD    LK+ADFG    +      + +   G+P 
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD 240
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y++PEVL+ Q     Y  + D WSVG  LFE+L G  PF A
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 281

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/148 (38%), Positives = 80/148 (54%), Gaps = 2/148 (1%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HPNII L D +     ++LV E   GG L   I       E+ A   L  +G  +E L+
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 84  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 141
           S  ++HRDLKP NIL +    +   L+I DFG +  L   N      C +  ++APEVL+
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFS 169
            Q YDE  D+WS+G +L+ +L GY PF+
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFA 226

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 94/171 (54%), Gaps = 11/171 (6%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA- 68
           K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A 
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 120
Query: 69  --RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             R+ LQ     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P     
Sbjct: 121 VCRECLQ----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKR 173
Query: 127 K-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
             + G+P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P  A
Sbjct: 174 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 94/171 (54%), Gaps = 11/171 (6%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA- 68
           K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A 
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 120
Query: 69  --RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             R+ LQ     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P     
Sbjct: 121 VCRECLQ----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKR 173
Query: 127 K-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
             + G+P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P  A
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 5/161 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 127
             +++Q+   L   + ++IIHRD+KPEN+LL+  ++   +K+ DFG++  L   G  A  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             G+P +MAPEV++ + Y + VD+W  G ILF LL+G  PF
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 16  ELNFLSSVNHPNII---RLFDAFQA---ENCIFLVVEFCAGGNLSSYIRLHGR---VPEQ 66
           E+  +  +NHPN++    + D  Q     +   L +E+C GG+L  Y+        + E 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             R  L  + + L  L+ + IIHRDLKPENI+L      ++ KI D G +  L  G    
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +  G+  Y+APE+L+ ++Y   VD WS G + FE + G+ PF
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 4/155 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 116
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 117 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 173
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 59/148 (39%), Positives = 81/148 (54%), Gaps = 2/148 (1%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKI  FG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 142 FQRYDEKV-DMWSVGAILFELLNGYPPF 168
            + YD KV D+WS G  L+ +L G  PF
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 4/155 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 4/155 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 59/149 (39%), Positives = 81/149 (54%), Gaps = 2/149 (1%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKI  FG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 142 FQRYDEKV-DMWSVGAILFELLNGYPPFS 169
            + YD KV D+WS G  L+ +L G  PF 
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 4/155 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 4/155 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 4/155 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 4/155 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 118
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 119 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 175
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 89/159 (55%), Gaps = 5/159 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G+   PE  A  +  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G   +   G+  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           YMAPEV++ +RY    D W++G +L+E++ G  PF   +
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 90/158 (56%), Gaps = 4/158 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   + ++HPNI+RL++ F     I+L++E+   G L   ++      EQ     +
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           ++L   L   +   +IHRD+KPEN+LL        LKIADFG S    P    + +CG+ 
Sbjct: 130 EELADALMYCHGKKVIHRDIKPENLLLGLK---GELKIADFGWSVHA-PSLRRKTMCGTL 185
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y+ PE+++ + ++EKVD+W +G + +ELL G PPF +
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 89/159 (55%), Gaps = 5/159 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G+   PE  A  +  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G   +   G+  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           YMAPEV++ +RY    D W++G +L+E++ G  PF   +
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P I R F ++     +++++E+  GG+    ++  G + E      L+++
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 125
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 126 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNXFVGTPFW 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV++   YD K D+WS+G    EL  G PP S   P
Sbjct: 183 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 221

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 94/171 (54%), Gaps = 11/171 (6%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA- 68
           K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A 
Sbjct: 62  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 121
Query: 69  --RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             R+ LQ     LE L+S+ +IHR++K +NILL G+D  V  K+ DFG    + P     
Sbjct: 122 VCRECLQ----ALEFLHSNQVIHRNIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKR 174
Query: 127 K-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
             + G+P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P  A
Sbjct: 175 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 97/174 (55%), Gaps = 11/174 (6%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ +N ++LV+++  GG+L + + +   R+
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE+ AR +L ++   ++ ++  H +HRD+KP+NIL   +D +  +++ADFG    L    
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFGSCLKLMEDG 229
Query: 124 YAEK--VCGSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYPPFSA 170
             +     G+P Y++PE+LQ       RY  + D WS+G  ++E+L G  PF A
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 133
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 134 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 190
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV++   YD K D+WS+G    EL  G PP S   P
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 229

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 113
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 170
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV++   YD K D+WS+G    EL  G PP S   P
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 209

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 90/164 (54%), Gaps = 7/164 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ +   + P++++ + ++     +++V+E+C  G++S  IRL  +   E      LQ 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSP 132
              GLE L+    IHRD+K  NILL   + +   K+ADFG++  L     A++  V G+P
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT-DXMAKRNXVIGTP 189
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
            +MAPEV+Q   Y+   D+WS+G    E+  G PP++   P  A
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 93.2 bits (230), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/158 (37%), Positives = 87/158 (55%), Gaps = 13/158 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 161
Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P 
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 215
Query: 134 YMAPEV---LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +MAPEV   +   +YD KVD+WS+G    EL    PP 
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 113
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 170
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV++   YD K D+WS+G    EL  G PP S   P
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 185
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV++   YD K D+WS+G    EL  G PP S   P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/158 (37%), Positives = 87/158 (55%), Gaps = 13/158 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 122
Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 176
Query: 134 YMAPEV---LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +MAPEV   +   +YD KVD+WS+G    EL    PP 
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 5/159 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  +   + + + ++   + +++++E+  GG+    +R  G   E      L+++
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 129
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 186
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV+Q   YD K D+WS+G    EL  G PP S   P
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 225

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 88/162 (54%), Gaps = 2/162 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTA 68
           K  +  E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I     ++ E   
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             +++Q   GL+ ++ H I+H D+KPENI+         +KI DFGL+  L P    +  
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCE-TKKASSVKIIDFGLATKLNPDEIVKVT 210
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             +  + APE++  +      DMW++G + + LL+G  PF+ 
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/161 (40%), Positives = 88/161 (54%), Gaps = 16/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP-----EQTARK 70
           EL  LS VNHPNI++L+ A    N + LV+E+  GG+L  Y  LHG  P        A  
Sbjct: 51  ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSL--YNVLHGAEPLPYYTAAHAMS 106
Query: 71  FLQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
           +  Q   G+  L+S     +IHRDLKP N+LL  +    +LKI DFG +C +       K
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK 164
Query: 128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             GS  +MAPEV +   Y EK D++S G IL+E++    PF
Sbjct: 165 --GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/161 (40%), Positives = 88/161 (54%), Gaps = 16/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP-----EQTARK 70
           EL  LS VNHPNI++L+ A    N + LV+E+  GG+L  Y  LHG  P        A  
Sbjct: 52  ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSL--YNVLHGAEPLPYYTAAHAMS 107
Query: 71  FLQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
           +  Q   G+  L+S     +IHRDLKP N+LL  +    +LKI DFG +C +       K
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK 165
Query: 128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             GS  +MAPEV +   Y EK D++S G IL+E++    PF
Sbjct: 166 --GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 91/166 (54%), Gaps = 10/166 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E+  L++ +HP I++L  A+  +  +++++EFC GG + +  + L   + E   +   +
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 116
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q+   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S   L      +   G+P
Sbjct: 117 QMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKNLKTLQKRDSFIGTP 173
Query: 133 LYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            +MAPEV+  +      YD K D+WS+G  L E+    PP     P
Sbjct: 174 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 219

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 81/145 (55%), Gaps = 2/145 (1%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILN 83
           P +I L + ++  + I L++E+ AGG + S     L   V E    + ++Q+  G+  L+
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ 143
            ++I+H DLKP+NILLS +     +KI DFG+S  +       ++ G+P Y+APE+L + 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 144 RYDEKVDMWSVGAILFELLNGYPPF 168
                 DMW++G I + LL    PF
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L+
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 84  SHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEV 139
           +  ++HRDLKP NIL    SG  + +  +I DFG +  L   N      C +  ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESI--RICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
           L+ Q YD   D+WS+G +L+ +L GY PF+
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFA 221

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 91/166 (54%), Gaps = 10/166 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E+  L++ +HP I++L  A+  +  +++++EFC GG + +  + L   + E   +   +
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 124
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q+   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S   L      +   G+P
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 133 LYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            +MAPEV+  +      YD K D+WS+G  L E+    PP     P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 2/148 (1%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L+
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 84  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 141
           +  ++HRDLKP NIL +    +   ++I DFG +  L   N      C +  ++APEVL+
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLE 193
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFS 169
            Q YD   D+WS+G +L+  L GY PF+
Sbjct: 194 RQGYDAACDIWSLGVLLYTXLTGYTPFA 221

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 99/182 (54%), Gaps = 14/182 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H++S +  E+  L     H N++ L + F+ E+  +LV E   GG++ S+I  
Sbjct: 45  IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
                E  A   +Q + + L+ L++  I HRDLKPENIL    +    +KI DFGL   +
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGI 164
Query: 120 ------YPGNYAE--KVCGSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYP 166
                  P +  E    CGS  YMAPEV+     +   YD++ D+WS+G IL+ LL+GYP
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 167 PF 168
           PF
Sbjct: 225 PF 226

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 83/162 (51%), Gaps = 5/162 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID-SMANSFVGTRSY 188
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
           M+PE LQ   Y  + D+WS+G  L E+  G  P  +     A
Sbjct: 189 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMA 230

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 94/173 (54%), Gaps = 28/173 (16%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG- 165
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                   +A++  G            ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 166 --------FAKETTG------------EKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L     A +  G+  Y
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRSY 172
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
           M+PE LQ   Y  + D+WS+G  L E+  G  P    RP  A
Sbjct: 173 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP----RPPMA 210

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             +  Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             +  Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             +  Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 96/174 (55%), Gaps = 11/174 (6%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ EN ++LV+++  GG+L + + +   ++
Sbjct: 113 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL 172
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE  AR ++ ++   ++ ++  H +HRD+KP+N+L   LD +  +++ADFG    +    
Sbjct: 173 PEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL---LDVNGHIRLADFGSCLKMNDDG 229
Query: 124 YAEK--VCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             +     G+P Y++PE+LQ       +Y  + D WS+G  ++E+L G  PF A
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 283

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 5/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 5/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 5/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 5/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 5/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 96/174 (55%), Gaps = 11/174 (6%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ EN ++LV+++  GG+L + + +   ++
Sbjct: 129 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL 188
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE  AR ++ ++   ++ ++  H +HRD+KP+N+L   LD +  +++ADFG    +    
Sbjct: 189 PEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL---LDVNGHIRLADFGSCLKMNDDG 245
Query: 124 YAEK--VCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             +     G+P Y++PE+LQ       +Y  + D WS+G  ++E+L G  PF A
Sbjct: 246 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 299

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 5/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 5/153 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + HPN++ L + F+ +  + LV E+C    L    R    VPE   +    Q 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLY 134
              +   + H+ IHRD+KPENIL++      ++K+ DFG +  L  P +Y +    +  Y
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 135 MAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166
            +PE+L    +Y   VD+W++G +  ELL+G P
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/153 (36%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 231
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
           M+PE LQ   Y  + D+WS+G  L E+  G YP
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 87/161 (54%), Gaps = 5/161 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 127
             +++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             G+P +MAPEV++ + Y + VD+W  G ILF LL+G  PF
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 99/181 (54%), Gaps = 8/181 (4%)
Query: 2   LKKLN---KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           +KK++   +  +  L  E+  +   +H N++ ++ ++   + +++V+EF  GG L+  + 
Sbjct: 75  VKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV- 133
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            H R+ E+        +   L  L++  +IHRD+K ++ILL+    D  +K++DFG    
Sbjct: 134 THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQ 190
Query: 119 LYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFAS 177
           +       K + G+P +MAPEV+    Y  +VD+WS+G ++ E+++G PP+    P  A 
Sbjct: 191 VSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 250
Query: 178 R 178
           R
Sbjct: 251 R 251

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 87/161 (54%), Gaps = 5/161 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 127
             +++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             G+P +MAPEV++ + Y + VD+W  G ILF LL+G  PF
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 5/156 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 5/156 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 259
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 260 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 5/156 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 117 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 5/156 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 117
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 118 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 174
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 101/183 (55%), Gaps = 8/183 (4%)
Query: 2   LKKLN---KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           +KK++   +  +  L  E+  +    H N++ +++++   + +++V+EF  GG L+  + 
Sbjct: 54  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV- 112
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            H R+ E+        +   L +L++  +IHRD+K ++ILL+    D  +K++DFG    
Sbjct: 113 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQ 169
Query: 119 LYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFAS 177
           +       K + G+P +MAPE++    Y  +VD+WS+G ++ E+++G PP+    P  A 
Sbjct: 170 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 229
Query: 178 RLC 180
           ++ 
Sbjct: 230 KMI 232

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 87/149 (58%), Gaps = 6/149 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+  L+++ HPNI++  ++F+    +++V+++C GG+L   I     V   E     +  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 132
           Q+   L+ ++   I+HRD+K +NI L+    D  +++ DFG++  L       + C G+P
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            Y++PE+ + + Y+ K D+W++G +L+EL
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 101/183 (55%), Gaps = 8/183 (4%)
Query: 2   LKKLN---KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           +KK++   +  +  L  E+  +    H N++ +++++   + +++V+EF  GG L+  + 
Sbjct: 50  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV- 108
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            H R+ E+        +   L +L++  +IHRD+K ++ILL+    D  +K++DFG    
Sbjct: 109 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQ 165
Query: 119 LYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFAS 177
           +       K + G+P +MAPE++    Y  +VD+WS+G ++ E+++G PP+    P  A 
Sbjct: 166 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225
Query: 178 RLC 180
           ++ 
Sbjct: 226 KMI 228

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 5/156 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 119 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 175
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 89/161 (55%), Gaps = 8/161 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARK 70
            E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VC 129
           +  Q+ +GLE L+  +II+RDLKPEN+LL   DDD  ++I+D GL+  L  G    K   
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           G+P +MAPE+L  + YD  VD +++G  L+E++    PF A
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 89/161 (55%), Gaps = 8/161 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARK 70
            E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VC 129
           +  Q+ +GLE L+  +II+RDLKPEN+LL   DDD  ++I+D GL+  L  G    K   
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           G+P +MAPE+L  + YD  VD +++G  L+E++    PF A
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 89/161 (55%), Gaps = 8/161 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARK 70
            E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VC 129
           +  Q+ +GLE L+  +II+RDLKPEN+LL   DDD  ++I+D GL+  L  G    K   
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           G+P +MAPE+L  + YD  VD +++G  L+E++    PF A
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 101/183 (55%), Gaps = 8/183 (4%)
Query: 2   LKKLN---KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           +KK++   +  +  L  E+  +    H N++ +++++   + +++V+EF  GG L+  + 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV- 119
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            H R+ E+        +   L +L++  +IHRD+K ++ILL+    D  +K++DFG    
Sbjct: 120 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQ 176
Query: 119 LYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFAS 177
           +       K + G+P +MAPE++    Y  +VD+WS+G ++ E+++G PP+    P  A 
Sbjct: 177 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 236
Query: 178 RLC 180
           ++ 
Sbjct: 237 KMI 239

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 101/183 (55%), Gaps = 8/183 (4%)
Query: 2   LKKLN---KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           +KK++   +  +  L  E+  +    H N++ +++++   + +++V+EF  GG L+  + 
Sbjct: 59  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV- 117
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            H R+ E+        +   L +L++  +IHRD+K ++ILL+    D  +K++DFG    
Sbjct: 118 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQ 174
Query: 119 LYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFAS 177
           +       K + G+P +MAPE++    Y  +VD+WS+G ++ E+++G PP+    P  A 
Sbjct: 175 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 234
Query: 178 RLC 180
           ++ 
Sbjct: 235 KMI 237

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 85/156 (54%), Gaps = 7/156 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  ++HPNI+ L D   +E C+ LV EF               + +   + +L QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
             G+   + H I+HRDLKP+N+L++    D  LK+ADFGL+    +   +Y  +V  +  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 134 YMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y AP+VL   ++Y   VD+WS+G I  E++ G P F
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 85/156 (54%), Gaps = 7/156 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  ++HPNI+ L D   +E C+ LV EF               + +   + +L QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
             G+   + H I+HRDLKP+N+L++    D  LK+ADFGL+    +   +Y  +V  +  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 134 YMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y AP+VL   ++Y   VD+WS+G I  E++ G P F
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/182 (35%), Positives = 98/182 (53%), Gaps = 14/182 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H++S +  E+  L     H N++ L + F+ E+  +LV E   GG++ S+I  
Sbjct: 45  IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
                E  A   +Q + + L+ L++  I HRDLKPENIL    +    +KI DF L   +
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
Query: 120 ------YPGNYAE--KVCGSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYP 166
                  P +  E    CGS  YMAPEV+     +   YD++ D+WS+G IL+ LL+GYP
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 167 PF 168
           PF
Sbjct: 225 PF 226

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 89/160 (55%), Gaps = 8/160 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 130
             Q+ +GLE L+  +II+RDLKPEN+LL   DDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +P +MAPE+L  + YD  VD +++G  L+E++    PF A
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 91/170 (53%), Gaps = 17/170 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NIL+S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIARAIADSGNSVXQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
              V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+   P 
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 101/183 (55%), Gaps = 8/183 (4%)
Query: 2   LKKLN---KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           +KK++   +  +  L  E+  +    H N++ +++++   + +++V+EF  GG L+  + 
Sbjct: 104 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV- 162
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            H R+ E+        +   L +L++  +IHRD+K ++ILL+    D  +K++DFG    
Sbjct: 163 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQ 219
Query: 119 LYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFAS 177
           +       K + G+P +MAPE++    Y  +VD+WS+G ++ E+++G PP+    P  A 
Sbjct: 220 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 279
Query: 178 RLC 180
           ++ 
Sbjct: 280 KMI 282

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 85/156 (54%), Gaps = 2/156 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ L+   H NI+ L ++F++   + ++ EF +G ++   I      + E+    ++ Q
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +   L+ L+SH+I H D++PENI+         +KI +FG +  L PG+    +  +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            APEV Q        DMWS+G +++ LL+G  PF A
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/156 (42%), Positives = 88/156 (56%), Gaps = 11/156 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+  L  ++HPNII L DAF  ++ I LV +F    +L   I+ +  V  P       L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS 131
            L  GLE L+ H I+HRDLKP N+L   LD++ +LK+ADFGL+ +    N  Y  +V  +
Sbjct: 121 TL-QGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLAKSFGSPNRAYXHQVV-T 175
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
             Y APE+L   R Y   VDMW+VG IL ELL   P
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 84/155 (54%), Gaps = 5/155 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQ 74
           E+  LS V H NII++ D F+ +    LV+E    G +L ++I  H R+ E  A    +Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           L + +  L    IIHRD+K ENI+++   +D  +K+ DFG +  L  G      CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 135 MAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 168
            APEVL    Y   +++MWS+G  L+ L+    PF
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 90/171 (52%), Gaps = 8/171 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG- 61
           + L   LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G 
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA 208
Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           R+  +T  + +    AG+E L S   IHRDL   N L++   +  +LKI+DFG+S     
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD 265
Query: 122 GNYAEK--VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           G YA    +   P+ + APE L + RY  + D+WS G +L+E  + G  P+
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 88/171 (51%), Gaps = 11/171 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC 180
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++ Y   F   LC
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY---FRGPLC 265

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 88/171 (51%), Gaps = 11/171 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 173
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 174 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC 180
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++ Y   F   LC
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY---FRGPLC 279

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 89/157 (56%), Gaps = 5/157 (3%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 137 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           PEVLQ    YD   D +S+G +LF+LL G+ PF  ++
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 89/157 (56%), Gaps = 5/157 (3%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 137 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           PEVLQ    YD   D +S+G +LF+LL G+ PF  ++
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 88/171 (51%), Gaps = 11/171 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 175
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 176 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC 180
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++ Y   F   LC
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY---FRGPLC 281

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 89/157 (56%), Gaps = 5/157 (3%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 137 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           PEVLQ    YD   D +S+G +LF+LL G+ PF  ++
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 89/157 (56%), Gaps = 5/157 (3%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 302 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 357
Query: 137 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           PEVLQ    YD   D +S+G +LF+LL G+ PF  ++
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 394

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 91/170 (53%), Gaps = 17/170 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
              V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+   P 
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 91/170 (53%), Gaps = 17/170 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
              V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+   P 
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 101/182 (55%), Gaps = 8/182 (4%)
Query: 2   LKKLN---KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           +KK++   +  +  L  E+  +    H N++ +++++   + +++V+EF  GG L+  + 
Sbjct: 181 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV- 239
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            H R+ E+        +   L +L++  +IHRD+K ++ILL+    D  +K++DFG    
Sbjct: 240 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQ 296
Query: 119 LYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFAS 177
           +       K + G+P +MAPE++    Y  +VD+WS+G ++ E+++G PP+    P  A 
Sbjct: 297 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 356
Query: 178 RL 179
           ++
Sbjct: 357 KM 358

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 91/169 (53%), Gaps = 17/169 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
              V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+   P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 90/170 (52%), Gaps = 17/170 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G     T ++ 
Sbjct: 79  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRA 135
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 136 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 192
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
              V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+   P 
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 86/153 (56%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 86/153 (56%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 80/154 (51%), Gaps = 5/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++   R+PE+   K    +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 179
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           MAPE LQ   Y  + D+WS+G  L EL  G  P 
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 87/171 (50%), Gaps = 11/171 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + +  P I+ L+ A +    + + +E   GG+L   ++  G +PE  A  +L Q 
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 194
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L+S  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 195 LEGLEYLHSRRILHGDVKADNVLLS--SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC 180
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++ +   F   LC
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQF---FRGPLC 300

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +   +K +   
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++  E++ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 87/171 (50%), Gaps = 11/171 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + +  P I+ L+ A +    + + +E   GG+L   ++  G +PE  A  +L Q 
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 175
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L+S  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 176 LEGLEYLHSRRILHGDVKADNVLLS--SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASRLC 180
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++ +   F   LC
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQF---FRGPLC 281

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +   +K +   
Sbjct: 58  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++  E++ 
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATVKSRWSGSHQFEQLS 171
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 172 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 214

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 46/127 (36%), Positives = 74/127 (58%), Gaps = 5/127 (3%)
Query: 39  NCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN 96
            C+F+ +EFC  G L  +I  R   ++ +  A +  +Q+  G++ ++S  +IHRDLKP N
Sbjct: 107 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSN 166
Query: 97  ILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156
           I L    D   +KI DFGL  +L       +  G+  YM+PE +  Q Y ++VD++++G 
Sbjct: 167 IFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 223
Query: 157 ILFELLN 163
           IL ELL+
Sbjct: 224 ILAELLH 230

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 163
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 96/179 (53%), Gaps = 5/179 (2%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    +  +  L  E+  +    H N++ ++ ++     +++++EF  GG L+  +   
Sbjct: 77  MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-Q 135
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            R+ E+      + +   L  L++  +IHRD+K ++ILL+ LD  V  K++DFG    + 
Sbjct: 136 VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQIS 192
Query: 121 PGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCFASR 178
                 K + G+P +MAPEV+    Y  +VD+WS+G ++ E+++G PP+ +  P  A +
Sbjct: 193 KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 82/161 (50%), Gaps = 12/161 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPE----QTAR 69
           E++ +  + H NI+RL+D    EN + LV EF    +L  Y+  R  G  P        +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKV 128
            F  QL  GL   + + I+HRDLKP+N+L   ++    LK+ DFGL+     P N     
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 129 CGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
             +  Y AP+VL   R Y   +D+WS G IL E++ G P F
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 87/165 (52%), Gaps = 5/165 (3%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +K +K     E+  L  + H N++ L +  + +   +LV EF     L         +  
Sbjct: 64  DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY 123
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNY 124
           Q  +K+L Q+  G+   +SH+IIHRD+KPENIL+S      ++K+ DFG + TL  PG  
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 180
Query: 125 AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 168
            +    +  Y APE+L    +Y + VD+W++G ++ E+  G P F
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 116
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 173
Query: 132 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 163
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 91/163 (55%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +     + +V ++C G +L  Y  LH    +   +K +   
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++  E++ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 86/149 (57%), Gaps = 9/149 (6%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ ++   LE L+  
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---CGSPLYMAPEVLQF 142
            II+RD+K ENIL   LD +  + + DFGLS   +  +  E+    CG+  YMAP++++ 
Sbjct: 179 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRG 234
Query: 143 --QRYDEKVDMWSVGAILFELLNGYPPFS 169
               +D+ VD WS+G +++ELL G  PF+
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFT 263

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 86/153 (56%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTG-IPLPLIKSYL 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+     + H NI++   +F     I + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 131
           +Q+  GL+ L+ + I+HRD+K +N+L++      +LKI+DFG S  L   N   E   G+
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGT 186
Query: 132 PLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPF 168
             YMAPE++    + Y +  D+WS+G  + E+  G PPF
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 86/153 (56%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L +++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 94/171 (54%), Gaps = 9/171 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 118
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
           +    Y  +V  +  Y AP+VL   ++Y   +D+WSVG I  E++NG P F
Sbjct: 152 IPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 86/153 (56%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLSFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+     + H NI++   +F     I + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 55  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 131
           +Q+  GL+ L+ + I+HRD+K +N+L++      +LKI+DFG S  L   N   E   G+
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGT 172
Query: 132 PLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPF 168
             YMAPE++    + Y +  D+WS+G  + E+  G PPF
Sbjct: 173 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 88/166 (53%), Gaps = 21/166 (12%)
Query: 16  ELNFLSSVNHPNIIRL---FDAFQAE-------------NCIFLVVEFCAGGNLSSYI-- 57
           E+  L+ ++H NI+     +D F  +              C+F+ +EFC  G L  +I  
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           R   ++ +  A +  +Q+  G++ ++S  +I+RDLKP NI L    D   +KI DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVT 170
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
           +L       +  G+  YM+PE +  Q Y ++VD++++G IL ELL+
Sbjct: 171 SLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 94/171 (54%), Gaps = 9/171 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 118
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
           +    Y  +V  +  Y AP+VL   ++Y   +D+WSVG I  E++NG P F
Sbjct: 152 IPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLF 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 89/171 (52%), Gaps = 8/171 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG- 61
           + L   LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G 
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA 208
Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           R+  +T  + +    AG+E L S   IHRDL   N L++   +  +LKI+DFG+S     
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD 265
Query: 122 GNYAEK--VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           G  A    +   P+ + APE L + RY  + D+WS G +L+E  + G  P+
Sbjct: 266 GVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 167
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 116
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 173
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 113
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 170
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 91/170 (53%), Gaps = 7/170 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 120 YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
            P         +  Y AP+VL   ++Y   +D+WSVG I  E++NG P F
Sbjct: 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 113
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 170
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/155 (38%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--HMELDHERMS 127
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 128 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYV 184
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ EL+ G
Sbjct: 185 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 90/170 (52%), Gaps = 17/170 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++   +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
              V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+   P 
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 72  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 131
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 132 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADF 188
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 189 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 247
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 248 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 77  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 136
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 137 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 193
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 194 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 74  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 133
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 134 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 190
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 191 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 48/214 (22%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--- 58
           ++++N      +  E+  +  ++HPNI RL++ ++ E  I LV+E C GG+L   +    
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 59  ------------------------------LHG-------RVPEQTARKFLQQLGAGLEI 81
                                         +HG          E+     ++Q+ + L  
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 136
           L++  I HRD+KPEN L S  +    +K+ DFGLS   Y  N  E        G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 137 PEVLQF--QRYDEKVDMWSVGAILFELLNGYPPF 168
           PEVL    + Y  K D WS G +L  LL G  PF
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKXQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 85/153 (55%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV E     +L +++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 92/176 (52%), Gaps = 13/176 (7%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           L +   SC   E + L + +   I +L  AFQ EN ++LV+E+  GG+L + +   G R+
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           P + AR +L ++   ++ ++    +HRD+KP+NIL   LD    +++ADFG    L    
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFGSCLKLRADG 216
Query: 124 YAEKV--CGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
               +   G+P Y++PE+LQ          Y  + D W++G   +E+  G  PF A
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/179 (32%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL+K  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 123 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 178
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 179 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 81  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 137
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 138 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 195 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 237

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 74  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 130
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 131 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 188 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 230

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 138
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 85/161 (52%), Gaps = 9/161 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA-RKFLQQ 74
           E   +  ++HP +++ +     E  I++V E+ + G L +Y+R HG+  E +   +    
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L SH  IHRDL   N L   +D D+ +K++DFG++  +    Y   V G+   
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCL---VDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFP 168
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             + APEV  + +Y  K D+W+ G +++E+ + G  P+  Y
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 138
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ +++IADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 56  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 113 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 170 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 16  ELNFLSSVNH-PNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIR--LHGRVPEQ 66
           E+N L   +H  NI   + AF  +N       ++LV+EFC  G+++  I+      + E+
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
                 +++  GL  L+ H +IHRD+K +N+LL+   ++  +K+ DFG+S  L       
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 186
Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRPCFA 176
               G+P +MAPEV+         YD K D+WS+G    E+  G PP     P  A
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 167
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 174 LDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 94/185 (50%), Gaps = 22/185 (11%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK  + + +     E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG
Sbjct: 51  LKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 110
Query: 62  -------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVML 108
                         + +       QQ+ AG+  L S H +HRDL   N L+    +++++
Sbjct: 111 PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLV 167
Query: 109 KIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163
           KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS+G +L+E+   
Sbjct: 168 KIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 226
Query: 164 GYPPF 168
           G  P+
Sbjct: 227 GKQPW 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKXQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 174 LDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSP 132
            +GAG+  L+    +HRDL   N+L   +D +++ K++DFGLS  L    + A    G  
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           +   + APE + F+ +    D+WS G +++E+L
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 63  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 121
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 122 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 177
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 178 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 174 LDFGLA--RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 116 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 171
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 172 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLAR--HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 116 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 171
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 172 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV E     +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163
             Y APE+L   + Y   VD+WS+G I  E++ 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKC-AKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 163 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 117 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKI 172
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 173 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 113 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 169 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 50  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 108
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 109 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 164
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 165 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 91/172 (52%), Gaps = 13/172 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+  L  ++HPN+++L +      E+ +++V E    G +     L   + E  AR + Q
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQ 144
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGS 131
            L  G+E L+   IIHRD+KP N+L+    +D  +KIADFG+S   + G+ A      G+
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNE-FKGSDALLSNTVGT 200
Query: 132 PLYMAPEVLQFQRY---DEKVDMWSVGAILFELLNGYPPFSAYR-PCFASRL 179
           P +MAPE L   R     + +D+W++G  L+  + G  PF   R  C  S++
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 163 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 123 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 178
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 179 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 123 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 178
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 179 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 113 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 169 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 174 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 117 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 172
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 173 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 133
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 134 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 189
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 190 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 163 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 49  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 107
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 108 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 163
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 164 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 62  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 120
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 121 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 176
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 177 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 116 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 171
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 172 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 116 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 171
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 172 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 51  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 109
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 110 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 165
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 166 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 117 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 172
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 91/163 (55%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +     + +V ++C G +L  Y  LH    +    K +   
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 49  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 107
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 108 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 163
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 164 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSP 132
            +GAG+  L+    +HRDL   N+L   +D +++ K++DFGLS  L    + A    G  
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           +   + APE + F+ +    D+WS G +++E+L
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 163 LDFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 131 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 186
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 187 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 113 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 169 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 131 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 186
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 187 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 129
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 130 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 185
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 186 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 63  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 121
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 122 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 177
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 178 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 131 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 186
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 187 LDFGLA--RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +      L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 129
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 130 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 185
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 186 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 70  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 127
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 128 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 184
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 185 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 244

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 117 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 172
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 113 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 169 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 71  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 128
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 129 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 185
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 186 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 245

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 135
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 120
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 121 CYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 177
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 67  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 124
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 125 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 181
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 182 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 241

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQAREPPGLEY 135
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 133
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 134 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 189
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 190 LDFGLAR--HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E    + + HPNII L      E  + LV+EF  GG L+  +    R+P      +  Q+
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQI 114
Query: 76  GAGLEILNSHHI---IHRDLKPENILL-----SGLDDDVMLKIADFGLSCTLYPGNYAEK 127
             G+  L+   I   IHRDLK  NIL+     +G   + +LKI DFGL+   +       
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMS 173
Query: 128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             G+  +MAPEV++   + +  D+WS G +L+ELL G  PF
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 135
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 CYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/179 (32%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKSQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL C  +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGL-CR-HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++V + + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +  +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +  +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 176
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 233
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 93/177 (52%), Gaps = 23/177 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 58  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 117
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L++ ++    + ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I 
Sbjct: 118 DLNNIVKSQA-LSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDSELRIL 173
Query: 112 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 164
           DFGL+         E++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G
Sbjct: 174 DFGLAR-----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 93/177 (52%), Gaps = 25/177 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTA 68
           E    + + HPN++ L      +  + ++  +C+ G+L  ++ +   H  V     ++T 
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 69  RKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           +  L+         Q+ AG+E L+SHH++H+DL   N+L+    D + +KI+D GL   +
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFREV 195
Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
           Y  +Y  K+ G+ L    +MAPE + + ++    D+WS G +L+E+ + G  P+  Y
Sbjct: 196 YAADYY-KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 73  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--HMELDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y   VD+WSVG I+ EL+ G
Sbjct: 187 VTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 93/177 (52%), Gaps = 25/177 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTA 68
           E    + + HPN++ L      +  + ++  +C+ G+L  ++ +   H  V     ++T 
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 69  RKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           +  L+         Q+ AG+E L+SHH++H+DL   N+L+    D + +KI+D GL   +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFREV 178
Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
           Y  +Y  K+ G+ L    +MAPE + + ++    D+WS G +L+E+ + G  P+  Y
Sbjct: 179 YAADYY-KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 7/152 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ E+ A G+L  +++    G+V       F  
Sbjct: 58  EANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
           + + APE + F  +  K D+WS G +L+E++ 
Sbjct: 175 IKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 25/178 (14%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++V + + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 122
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 93/177 (52%), Gaps = 23/177 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 58  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 117
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L++ ++    + ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I 
Sbjct: 118 DLNNIVKCQA-LSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDSELRIL 173
Query: 112 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 164
           DFGL+         E++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G
Sbjct: 174 DFGLAR-----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 93/177 (52%), Gaps = 23/177 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 50  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 109
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L++ ++    + ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I 
Sbjct: 110 DLNNIVKCQA-LSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRIL 165
Query: 112 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 164
           DFGL+         E++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G
Sbjct: 166 DFGLA-----RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            D+GL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDYGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 92/165 (55%), Gaps = 19/165 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
           E+  L    H NI+ LF  +  ++ + +V ++C G +L  Y  LH  V E   + F    
Sbjct: 82  EVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSL--YKHLH--VQETKFQMFQLID 136
Query: 72  -LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGN-YAEK 127
             +Q   G++ L++ +IIHRD+K  NI L    + + +KI DFGL+   + + G+   E+
Sbjct: 137 IARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRWSGSQQVEQ 193
Query: 128 VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
             GS L+MAPEV++ Q    +  + D++S G +L+EL+ G  P+S
Sbjct: 194 PTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 7/152 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ EF A G+L  +++    G+V       F  
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
           + + APE + F  +  K ++WS G +L+E++ 
Sbjct: 174 IKWTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 78/155 (50%), Gaps = 5/155 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+RL D   ++  + LV EFC       +   +G +  +  + FL QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
             GL   +S +++HRDLKP+N+L   ++ +  LK+ADFGL+     P         +  Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLADFGLARAFGIPVRCYSAEVVTLWY 167
Query: 135 MAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
             P+VL   + Y   +DMWS G I  EL N   P 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 34/183 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCAGGNLSSYIRLHGRV 63
           E+  L+ + HP I+R F+A+  +N             +++ ++ C   NL  ++     +
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 64  PEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            E+     L    Q+   +E L+S  ++HRDLKP NI  + +DD  ++K+ DFGL   + 
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDD--VVKVGDFGLVTAMD 169
Query: 121 PGNYAEKV-------------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
                + V              G+ LYM+PE +    Y  KVD++S+G ILFELL    P
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P 226
Query: 168 FSA 170
           FS 
Sbjct: 227 FST 229

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+   +  +       +  Y APE+ L    Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T       E   
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 92/175 (52%), Gaps = 19/175 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 81  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-G 139
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 140 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 195
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 164
            DFGL+   +  +       +  Y APE+ L +  Y+  VD+WSVG I+ ELL G
Sbjct: 196 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+         + V 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALDPVV 172
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            +  Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 167
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 224
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T       E   
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMS 167
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 224
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 131
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 132 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFV 188
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 122
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 72  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 128
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 129 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 185
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 85/164 (51%), Gaps = 21/164 (12%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+       Y+ ++ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI-----YSYQMA 175
Query: 130 GSPL-----YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            +P+     Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++    +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---CVKLGDFGLS 158
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 90/180 (50%), Gaps = 29/180 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEF 135
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
           DFGL+  ++  +  +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 193 DFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 85/164 (51%), Gaps = 21/164 (12%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+       Y+ ++ 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI-----YSYQMA 167
Query: 130 GSPL-----YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            +P+     Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 481
Query: 58  RLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++    +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---CVKLGDFGLS 538
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +  +      +LV+ F  G
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-G 113
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   ++ H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL---AVNEDCELKI 169
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
            DFGL+           V  +  Y APEV L + RY + VD+WSVG I+ E++ G   F 
Sbjct: 170 LDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 170 A 170
Sbjct: 228 G 228

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             FGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LGFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            D GL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDAGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 19  FLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLG 76
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 102 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 161
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 133
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L 
Sbjct: 162 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 218
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 219 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 256

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 19  FLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLG 76
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 143
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 133
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L 
Sbjct: 144 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 19  FLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLG 76
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 140
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 133
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L 
Sbjct: 141 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 197
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 77  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 136
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 137 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 230

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 19  FLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLG 76
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 103 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 162
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 133
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L 
Sbjct: 163 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 219
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 220 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 257

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 140 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 145 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 144 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            D GL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDRGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 143 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/165 (35%), Positives = 83/165 (50%), Gaps = 23/165 (13%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------CTLYPGN 123
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+        L+P  
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFP-- 170
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               V  +  Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 171 ----VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            D GL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDGGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DF L+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 167 LDFYLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 134
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 135 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 191
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 10/163 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +  +++P I+RL    QAE  + LV+E   GG L  + +     +P     + L Q
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS- 131
           +  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L   +  Y  +  G  
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           PL + APE + F+++  + D+WS G  ++E L+ G  P+   +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 126 RSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 184
Query: 102 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 185 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 242
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 243 WEIFSLGASPYPGVK 257

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 80/172 (46%), Gaps = 12/172 (6%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K+ NK +   LD     L S + P I++ F  F     +F+ +E           R+ G 
Sbjct: 64  KEENKRILMDLDV---VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 63  VPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           +PE+   K    +   L  L   H +IHRD+KP NILL   D+   +K+ DFG+S  L  
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVD 177
Query: 122 GNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPF 168
               ++  G   YMAPE +         YD + D+WS+G  L EL  G  P+
Sbjct: 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 171
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRPC 174
               + APE L + ++  K D+W+ G +L+E+   G  P+    P 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 5/155 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+RL D   ++  + LV EFC       +   +G +  +  + FL QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
             GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+     P         +  Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 135 MAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
             P+VL   + Y   +DMWS G I  EL N   P 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 40  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 98
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 99  QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 155
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 45  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 103
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 104 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 160
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 161 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 219

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 71  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 129
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 130 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 186
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 187 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 245

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 46  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 104
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 105 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 161
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 162 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 220

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 48  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 106
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 107 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 163
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 481
Query: 58  RLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++    +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 538
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +Y  P    +     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 183 --EKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 241 WEIFSLGASPYPGVK 255

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 9/160 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
           CE + +   +HPN++ L         + +V+EF   G L +++R H G+         L+
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR 152
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 130
            + AG+  L     +HRDL   NIL   ++ +++ K++DFGLS  +       Y      
Sbjct: 153 GIAAGMRYLADMGYVHRDLAARNIL---VNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE +Q++++    D+WS G +++E+++ G  P+
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 249

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 40/192 (20%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+ +E+C  G L  Y 
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--YD 104
Query: 58  RLHGRVPEQTARKF---LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +H     Q   ++    +Q+   L  ++S  IIHRDLKP NI    +D+   +KI DFG
Sbjct: 105 LIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFG 161
Query: 115 LSCTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL 158
           L+  ++             PG+        G+ +Y+A EVL     Y+EK+DM+S+G I 
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221
Query: 159 FELLNGYPPFSA 170
           FE++    PFS 
Sbjct: 222 FEMIY---PFST 230

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKI 191
Query: 111 ADFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
           +DFGLS  +Y   +Y ++  G  P+ +MA E L    Y  + D+WS G +L+E++  G  
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 167 PFSAYRP 173
           P+    P
Sbjct: 252 PYPGIPP 258

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 143 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 146 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGFVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 126
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 101 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 160
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 161 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 219
Query: 102 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 220 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 278 WEIFSLGASPYPGVK 292

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 143
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 144 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 145 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 19  FLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLG 76
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 202
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 133
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L 
Sbjct: 203 KGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 145 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 102 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 183 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 241 WEIFSLGASPYPGVK 255

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 90  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 149
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 150 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 207 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 243

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 12/166 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 171
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRPC 174
               + APE L + ++  K D+W+ G +L+E+   G  P+    P 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 153
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 154 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 249

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S +NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                     + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S +NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                     + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 153
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 154 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 213
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 214 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 265

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 129 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 25/174 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG          P Q 
Sbjct: 67  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 68  ARKF--------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             +           Q+ +G+  L S H +HRDL   N L+     ++++KI DFG+S  +
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMSRDV 183
Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           Y  +Y  +V G  +    +M PE + ++++  + D+WS G IL+E+   G  P+
Sbjct: 184 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                     + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 144 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 203
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 204 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 255

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                     + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                     + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 31/187 (16%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKI 191
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
           +DFGLS  +Y  +   K     +   +MA E L    Y  + D+WS G +L+E++  G  
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 167 PFSAYRP 173
           P+    P
Sbjct: 252 PYPGIPP 258

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                     + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 164 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 223
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 224 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 275

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 19/163 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +  + HPN+++       +  +  + E+  GG L   I+ +  + P      F + 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 127
           + +G+  L+S +IIHRDL   N L+    ++  + +ADFGL+  +       +       
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 128 --------VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
                   V G+P +MAPE++  + YDEKVD++S G +L E++
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 133
           L  GL   +   ++HRDLKP+N+L++   +   LK+ADFGL+     P    +    +  
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 134 YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y  P++ L    Y  ++DMW VG I +E+  G P F
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 154
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 155 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 214
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
            Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 215 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 266

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 12/166 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTFTAHAGAK 171
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRPC 174
               + APE L + ++  K D+W+ G +L+E+   G  P+    P 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 102 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 174 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 232 WEIFSLGASPYPGVK 246

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
            Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 31/187 (16%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA---EGRKMKI 191
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
           +DFGLS  +Y  +   K     +   +MA E L    Y  + D+WS G +L+E++  G  
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 167 PFSAYRP 173
           P+    P
Sbjct: 252 PYPGIPP 258

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 102 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 174 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 232 WEIFSLGASPYPGVK 246

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                     + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+ +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 88/165 (53%), Gaps = 15/165 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +   +      + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 73  QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 128
             +  G+E + + +  I+HRDL+  NI L  LD++  V  K+ADFGLS      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGL 186
Query: 129 CGSPLYMAPEVL--QFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            G+  +MAPE +  + + Y EK D +S   IL+ +L G  PF  Y
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 96/194 (49%), Gaps = 25/194 (12%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 65  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
Query: 58  R------LHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGL 102
           R      +  + PE   + FL          Q+  G+E L S   IHRDL   NILLS  
Sbjct: 125 RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-- 182
Query: 103 DDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILF 159
            +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L+
Sbjct: 183 -EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 160 ELLN-GYPPFSAYR 172
           E+ + G  P+   +
Sbjct: 242 EIFSLGASPYPGVK 255

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 95/175 (54%), Gaps = 25/175 (14%)
Query: 16  ELNFLSSVNHPNIIRLFD--------------AFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++F+              +    N +++V E+    +L++ +   G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-QG 115
Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173
Query: 122 -----GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                G+ +E +  +  Y +P  +L    Y + +DMW+ G I  E+L G   F+ 
Sbjct: 174 HYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGL+  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 119
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 176
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 107
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 108 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 164
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 165 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 86/162 (53%), Gaps = 11/162 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPN+I L         + ++ EF   G+L S++R + G+         L+
Sbjct: 83  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 142
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVC 129
            + AG++ L   + +HRDL   NIL   ++ +++ K++DFGLS  L        Y   + 
Sbjct: 143 GIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199
Query: 130 GS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           G  P+ + APE +Q++++    D+WS G +++E+++ G  P+
Sbjct: 200 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 241

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E    G+L S++R H  +         L+ 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 126
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 109
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 166
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 114 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENXYKA 170
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 19/179 (10%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++    +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPFSAYR 172
             +      +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF   +
Sbjct: 159 RYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 114 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 170
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 19  FLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLG 76
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 142
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 133
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y           G+ L 
Sbjct: 143 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLP 199
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 10/163 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +  +++P I+RL    QAE  + LV+E   GG L  + +     +P     + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS- 131
           +  G++ L   + +HR+L   N+LL    +    KI+DFGLS  L   +  Y  +  G  
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           PL + APE + F+++  + D+WS G  ++E L+ G  P+   +
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 130 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 186
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 235

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 130 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 186
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 235

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E  A   L   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 174
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
               + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL 79
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYTXIQSRFYRAPEV 270
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYP 166
           +   RY   +DMWS+G IL ELL GYP
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 127
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 128 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 184
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 185 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 233

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E    G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGAVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL 79
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYTXIQSRFYRAPEV 270
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYP 166
           +   RY   +DMWS+G IL ELL GYP
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 17/166 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFL 72
           E+  L  + H N+I+L D    + +  +++V+E+C  G       +   R P   A  + 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC--- 129
            QL  GLE L+S  I+H+D+KP N+LL+       LKI+  G++  L+P   A+  C   
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHP-FAADDTCRTS 171
Query: 130 -GSPLYMAPEVLQ----FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            GSP +  PE+      F  +  KVD+WS G  L+ +  G  PF  
Sbjct: 172 QGSPAFQPPEIANGLDTFSGF--KVDIWSAGVTLYNITTGLYPFEG 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 97/191 (50%), Gaps = 22/191 (11%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RLHGR--VPEQTARK-FLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
           R      VP +   K FL          Q+  G+E L S   IHRDL   NILLS   + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EK 180
Query: 106 VMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L+E+ 
Sbjct: 181 NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 163 N-GYPPFSAYR 172
           + G  P+   +
Sbjct: 241 SLGASPYPGVK 251

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGL   L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 20/165 (12%)
Query: 20  LSSVNHPNIIRLFD-----AFQAENCIFLVVEFCAGGNLSSYIRLHGR-------VPEQT 67
           +   +HPN+IRL       + Q      +++ F   G+L +Y+ L+ R       +P QT
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQT 148
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 126
             KF+  +  G+E L++ + +HRDL   N +L    DD+ + +ADFGLS  +Y G+Y   
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 127 -KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL-LNGYPPF 168
            ++   P+ ++A E L  + Y  K D+W+ G  ++E+   G  P+
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E    G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL 79
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYXXIQSRFYRAPEV 270
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYP 166
           +   RY   +DMWS+G IL ELL GYP
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 49  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 108
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEVL + ++  K D+W+ G +++E+ + G  P+  +
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 53  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 112
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 113 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 168
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEVL + ++  K D+W+ G +++E+ + G  P+  +
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 209

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 119
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 120 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 175
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEVL + ++  K D+W+ G +++E+ + G  P+  +
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 216

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 85/160 (53%), Gaps = 10/160 (6%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           +S    E++ L ++ H +II+       Q E  + LV+E+   G+L  Y+  H     Q 
Sbjct: 60  RSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL 119
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
              F QQ+  G+  L+S H IHR+L   N+L   LD+D ++KI DFGL+  +  G+   +
Sbjct: 120 LL-FAQQICEGMAYLHSQHYIHRNLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 128 V---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
           V     SP++  APE L+  ++    D+WS G  L+ELL 
Sbjct: 176 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 169
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEVL + ++  K D+W+ G +++E+ + G  P+  +
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 178
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
               + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 97/191 (50%), Gaps = 22/191 (11%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RLHGR--VPEQTARK-FLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
           R      VP +   K FL          Q+  G+E L S   IHRDL   NILLS   + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EK 180
Query: 106 VMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L+E+ 
Sbjct: 181 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 163 N-GYPPFSAYR 172
           + G  P+   +
Sbjct: 241 SLGASPYPGVK 251

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 414 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 472
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 473 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 529
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 530 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 578

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 174 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 232 WEIFSLGASPYPGVK 246

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 413 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 471
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 472 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 528
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+   +
Sbjct: 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 130
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 131 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 188 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAPAGAKF 175
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 118
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           +G+G++ L+    +HRDL   NIL+   + +++ K++DFG+S  L       Y  +    
Sbjct: 119 IGSGMKYLSDMSYVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 175
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 176 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 214

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 124
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           +G+G++ L+    +HRDL   NIL+   + +++ K++DFG+S  L       Y  +    
Sbjct: 125 IGSGMKYLSDMSYVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 181
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 182 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 220

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAPAGAKF 176
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 184
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEVL + ++  K D+W+ G +++E+ + G  P+  +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 121
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 94/193 (48%), Gaps = 24/193 (12%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 58  RLHGR-----VPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLD 103
           R          PE   + FL          Q+  G+E L S   IHRDL   NILLS   
Sbjct: 126 RSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS--- 182
Query: 104 DDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFE 160
           +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L+E
Sbjct: 183 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 161 LLN-GYPPFSAYR 172
           + + G  P+   +
Sbjct: 243 IFSLGASPYPGVK 255

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 183 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 241 WEIFSLGASPYPGVK 255

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 139
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           +G+G++ L+    +HRDL   NIL+   + +++ K++DFG+S  L       Y  +    
Sbjct: 140 IGSGMKYLSDMSAVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 196
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 197 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 235

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 40/192 (20%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+ +E+C   N + Y 
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCE--NRTLYD 104
Query: 58  RLHGRVPEQTARKF---LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +H     Q   ++    +Q+   L  ++S  IIHRDLKP NI    +D+   +KI DFG
Sbjct: 105 LIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFG 161
Query: 115 LSCTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL 158
           L+  ++             PG+        G+ +Y+A EVL     Y+EK+DM+S+G I 
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221
Query: 159 FELLNGYPPFSA 170
           FE++    PFS 
Sbjct: 222 FEMIY---PFST 230

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 11/162 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +    HPNIIRL         + ++ EF   G L S++RL+ G+         L+
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVC 129
            + +G+  L     +HRDL   NIL   ++ +++ K++DFGLS  L   +    Y   + 
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 130 GS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           G  P+ + APE + F+++    D WS G +++E+++ G  P+
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 222

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++V E+   GNL  Y+R   R  E TA   L   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR-EEVTAVVLLYMA 136
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 137 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHVVKVADFGLSRLMTGDTYTAHAGAKF 193
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L +  +  K D+W+ G +L+E+   G  P+
Sbjct: 194 PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ-- 73
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 74  -QLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKV 128
             +  G+  L++ +  I+HRDLK  N+L+   D    +K+ DFGLS  L    +  ++  
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLS-RLKASXFLXSKXA 199
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            G+P +MAPEVL+ +  +EK D++S G IL+EL     P+    P 
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 87/165 (52%), Gaps = 15/165 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +   +      + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 73  QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 128
             +  G+E + + +  I+HRDL+  NI L  LD++  V  K+ADFG S      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV--HSVSGL 186
Query: 129 CGSPLYMAPEVL--QFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            G+  +MAPE +  + + Y EK D +S   IL+ +L G  PF  Y
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 11/157 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +    +       G+ L  
Sbjct: 146 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 10/160 (6%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           +S    E++ L ++ H +II+       Q E  + LV+E+   G+L  Y+  H     Q 
Sbjct: 60  RSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL 119
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
              F QQ+  G+  L++ H IHR+L   N+L   LD+D ++KI DFGL+  +  G+   +
Sbjct: 120 LL-FAQQICEGMAYLHAQHYIHRNLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 128 V---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
           V     SP++  APE L+  ++    D+WS G  L+ELL 
Sbjct: 176 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 24/187 (12%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 56  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 115
Query: 62  RVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
              +  A                    Q+ AG+  L   H +HRDL   N L+      +
Sbjct: 116 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 172
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 173 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 231
Query: 163 N-GYPPF 168
             G  P+
Sbjct: 232 TYGKQPW 238

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 24/187 (12%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 50  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 109
Query: 62  RVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
              +  A                    Q+ AG+  L   H +HRDL   N L+      +
Sbjct: 110 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 166
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 167 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 225
Query: 163 N-GYPPF 168
             G  P+
Sbjct: 226 TYGKQPW 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 24/187 (12%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 79  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 62  RVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
              +  A                    Q+ AG+  L   H +HRDL   N L+      +
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 195
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 196 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 163 N-GYPPF 168
             G  P+
Sbjct: 255 TYGKQPW 261

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 87/165 (52%), Gaps = 15/165 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +   +      + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 73  QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 128
             +  G+E + + +  I+HRDL+  NI L  LD++  V  K+ADF LS      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV--HSVSGL 186
Query: 129 CGSPLYMAPEVL--QFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            G+  +MAPE +  + + Y EK D +S   IL+ +L G  PF  Y
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 59  AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 131
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    
Sbjct: 118 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
           P+ + APE + F  +  K D+WS G +L E++ 
Sbjct: 175 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 232 AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 131
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKF 347
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
           P+ + APE + F  +  K D+WS G +L E++ 
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/175 (37%), Positives = 83/175 (47%), Gaps = 22/175 (12%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 103 LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 149
Query: 59  -LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
              G V     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG 
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGS 207
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           SC L  G    +   S  Y +PEVL    YD  +DMWS+G IL E+  G P FS 
Sbjct: 208 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/175 (37%), Positives = 83/175 (47%), Gaps = 22/175 (12%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 103 LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 149
Query: 59  -LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
              G V     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG 
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRXAIKIVDFGS 207
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           SC L  G    +   S  Y +PEVL    YD  +DMWS+G IL E+  G P FS 
Sbjct: 208 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + +V E+   G+L ++++ + G+         L+ 
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRG 132
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + AG++ L+    +HRDL   NIL+   + +++ K++DFGLS  L       Y  +    
Sbjct: 133 ISAGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE + F+++    D+WS G +++E+++ G  P+
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 26/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAIL 158
             +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 174 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 159 FELLN-GYPPFSAYR 172
           +E+ + G  P+   +
Sbjct: 232 WEIFSLGASPYPGVK 246

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/175 (37%), Positives = 83/175 (47%), Gaps = 22/175 (12%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 84  LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 130
Query: 59  -LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
              G V     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG 
Sbjct: 131 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGS 188
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           SC L  G    +   S  Y +PEVL    YD  +DMWS+G IL E+  G P FS 
Sbjct: 189 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 241

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ-- 73
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 74  -QLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKV 128
             +  G+  L++ +  I+HR+LK  N+L+   D    +K+ DFGLS  L    +  ++  
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS-RLKASTFLSSKSA 199
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            G+P +MAPEVL+ +  +EK D++S G IL+EL     P+    P 
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 85/159 (53%), Gaps = 11/159 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--- 161
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L+ +++  K D+WS G +L+E+ + G  P+
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 85/159 (53%), Gaps = 11/159 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--- 176
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L+ +++  K D+WS G +L+E+ + G  P+
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 85/162 (52%), Gaps = 11/162 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPN+I L         + ++ EF   G+L S++R + G+         L+
Sbjct: 57  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 116
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVC 129
            + AG++ L   + +HR L   NIL   ++ +++ K++DFGLS  L        Y   + 
Sbjct: 117 GIAAGMKYLADMNYVHRALAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 130 GS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           G  P+ + APE +Q++++    D+WS G +++E+++ G  P+
Sbjct: 174 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 215

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 5/157 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + H NII L       + + L+ E+ A  +L  Y+  +  V  +  + FL QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTL-YPGNYAEKVCGSP 132
             G+   +S   +HRDLKP+N+LLS  D  +  +LKI DFGL+     P         + 
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
            Y  PE+L   R Y   VD+WS+  I  E+L   P F
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +    HPNIIRL         + ++ EF   G L S++RL+ G+         L+
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
            + +G+  L     +HRDL   NIL   ++ +++ K++DFGLS  L   N ++    S L
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEE-NSSDPTETSSL 181
Query: 134 -------YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
                  + APE + F+++    D WS G +++E+++ G  P+
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 224

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 324
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHR+L   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 85/159 (53%), Gaps = 11/159 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--- 348
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L+ +++  K D+WS G +L+E+ + G  P+
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 83/161 (51%), Gaps = 9/161 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y     GS   
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSR-GSKFP 169
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEVL + ++  K D+W+ G +++E+ + G  P+  +
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 210

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII + D  +A        ++LV     G +L   ++      +     
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICY- 148
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 205
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 11/160 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 52  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 109
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 110 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE + +  +  K D+WS G +L E++  G  P+
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 14/162 (8%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLF----DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +S    E++ L ++ H +II+      DA  A   + LV+E+   G+L  Y+  H     
Sbjct: 77  RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA--SLQLVMEYVPLGSLRDYLPRHSIGLA 134
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           Q    F QQ+  G+  L++ H IHRDL   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 135 QLLL-FAQQICEGMAYLHAQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEX 190
Query: 126 EKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
            +V     SP++  APE L+  ++    D+WS G  L+ELL 
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 62  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 119
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 120 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 63  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 120
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 91/175 (52%), Gaps = 20/175 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   + +      +LV+ F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 113
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   + L  +  E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 114 -DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKI 167
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 164
            DFGL+   +          +  Y APEV L +  Y++ VD+WSVG I+ E+L G
Sbjct: 168 LDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 67  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 124
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 125 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 18/170 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
           E+  L  + HPN+I L   F   A+  ++L+ ++ A  +L   I+ H          ++P
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 126
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
               +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
            P    + V  +  Y APE+L   R Y + +D+W++G I  ELL   P F
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 363
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHR+L   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 364 TQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 420
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 421 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            L+S    E+  L ++ H +I++       Q E  + LV+E+   G+L  Y+  H  V  
Sbjct: 53  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGL 111
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
                F QQ+  G+  L++ H IHR L   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 112 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVL---LDNDRLVKIGDFGLAKAVPEGHEY 168
Query: 126 EKV---CGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +V     SP+ + APE L+  ++    D+WS G  L+ELL 
Sbjct: 169 YRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            L+S    E+  L ++ H +I++       Q E  + LV+E+   G+L  Y+  H  V  
Sbjct: 52  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGL 110
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
                F QQ+  G+  L++ H IHR L   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 111 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVL---LDNDRLVKIGDFGLAKAVPEGHEY 167
Query: 126 EKV---CGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +V     SP+ + APE L+  ++    D+WS G  L+ELL 
Sbjct: 168 YRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 167
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 10/178 (5%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 61  GRVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 115
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 181
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            S          ++ G+  YMAPE L+ +    K D++S G +L E++ G P    +R
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHR 238

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 168
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 83/161 (51%), Gaps = 9/161 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +        V GS   
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFP 184
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
             +  PEVL + ++  K D+W+ G +++E+ + G  P+  +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++EF   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI 114
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 10/178 (5%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 61  GRVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 115
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 181
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            S          ++ G+  YMAPE L+ +    K D++S G +L E++ G P    +R
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHR 238

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 26/165 (15%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------Q 66
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E                 Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
               F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS       Y +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 197
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           K  G  P+ +MA E L +  Y    D+WS G +L+E+++ G  P+
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 10/178 (5%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 59  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 118
Query: 61  GRVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 115
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 175
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            S          ++ G+  YMAPE L+ +    K D++S G +L E++ G P    +R
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHR 232

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 42/186 (22%)
Query: 14  DCELNFLSSVNHPNI-IRLFDAFQAENCI------------FLVVEFCAGGNLSSYI--- 57
           D  L+  S ++ P++ IR  D F  +N +            ++ ++ C   NL  ++   
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 58  -----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
                R HG            Q+   +E L+S  ++HRDLKP NI  + +DD  ++K+ D
Sbjct: 156 CSLEDREHG-----VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDD--VVKVGD 207
Query: 113 FGLSCTLYPGNYAEKV-------------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159
           FGL   +      + V              G+ LYM+PE +    Y  KVD++S+G ILF
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 160 ELLNGY 165
           ELL  +
Sbjct: 268 ELLYSF 273

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 26/165 (15%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------Q 66
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E                 Q
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 132
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
               F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS       Y +
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 187
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           K  G  P+ +MA E L +  Y    D+WS G +L+E+++ G  P+
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 17/162 (10%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 127
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 170
Query: 128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
                 + APE L+   +  K D+WS G +L+E+ + G  P+
Sbjct: 171 ------WTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI 114
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 55  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 114
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 170
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 171 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 208

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 50  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 165
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 72  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 187
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 188 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 167
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 76/140 (54%), Gaps = 15/140 (10%)
Query: 42  FLVVEFCAGGNLSSYIRLHGRV-------PEQTARKFLQQLGAGLEILNSHHIIHRDLKP 94
            +++ F   G+L +++ L  R+       P QT  +F+  +  G+E L+S + IHRDL  
Sbjct: 107 MVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165
Query: 95  ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDM 151
            N +L+   +D+ + +ADFGLS  +Y G+Y  + C S L   ++A E L    Y    D+
Sbjct: 166 RNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV 222
Query: 152 WSVGAILFELLN-GYPPFSA 170
           W+ G  ++E++  G  P++ 
Sbjct: 223 WAFGVTMWEIMTRGQTPYAG 242

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 90/175 (51%), Gaps = 20/175 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   + +      +LV+ F   
Sbjct: 72  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 131
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   + +     E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 132 -DLQKIMGME--FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKI 185
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 164
            DFGL+   +          +  Y APEV L +  Y++ VD+WSVG I+ E+L G
Sbjct: 186 LDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 53  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 110
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHR+L+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 111 AAQIAEGMAFIEERNYIHRNLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI---FLVVEFCAGGNLSSYIRLHGR---VPEQTAR 69
           E   L  +NH NI++LF A + E       L++EFC  G+L + +        +PE    
Sbjct: 57  EFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             L+ +  G+  L  + I+HR++KP NI+ + G D   + K+ DFG +  L        +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 129 CGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            G+  Y+ P++ +         ++Y   VD+WS+G   +    G  PF  +
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 84  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 142
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 199
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 200 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 32/197 (16%)
Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR- 58
           MLK+  +  +++    E   ++  ++PNI++L         + L+ E+ A G+L+ ++R 
Sbjct: 84  MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 59  ---------------LHGRV------PEQTARKF--LQQLGAGLEILNSHHIIHRDLKPE 95
                             RV      P   A +    +Q+ AG+  L+    +HRDL   
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203
Query: 96  NILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-YMAPEVLQFQRYDEKVDMW 152
           N L+    +++++KIADFGLS  +Y  +Y  A+     P+ +M PE + + RY  + D+W
Sbjct: 204 NCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260
Query: 153 SVGAILFELLN-GYPPF 168
           + G +L+E+ + G  P+
Sbjct: 261 AYGVVLWEIFSYGLQPY 277

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 59  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 117
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 118 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 174
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 175 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 71  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 186
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 71  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 186
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 58  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 173
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 174 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 60  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 175
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 176 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI---FLVVEFCAGGNLSSYIRLHGR---VPEQTAR 69
           E   L  +NH NI++LF A + E       L++EFC  G+L + +        +PE    
Sbjct: 57  EFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             L+ +  G+  L  + I+HR++KP NI+ + G D   + K+ DFG +  L        +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXL 175
Query: 129 CGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPFSAY 171
            G+  Y+ P++ +         ++Y   VD+WS+G   +    G  PF  +
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 52  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 110
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 111 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 167
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 168 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVADPDHDHTGFLT 187
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 114
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 57  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 115
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 116 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 172
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 173 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 51  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 109
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 110 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 166
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 18/151 (11%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 138
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 139 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 18/151 (11%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 18/160 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L    H NII + D  +          +++V++     +L   I     +  +  R
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 161
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGN--- 123
            FL QL  GL+ ++S  +IHRDLKP N+L   ++++  LKI DFG++   CT  P     
Sbjct: 162 YFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT-SPAEHQY 217
Query: 124 YAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELL 162
           +  +   +  Y APE +L    Y + +D+WSVG I  E+L
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 58  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 115
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 116 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 171
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
                + APE + +  +  K D+WS G +L E++ 
Sbjct: 172 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 11/163 (6%)
Query: 19  FLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLG 76
            +  +NHPN++ L       E    +++ +   G+L  +IR   R P  +    F  Q+ 
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSP 132
            G+E L     +HRDL   N +L   D+   +K+ADFGL+  +    Y      +    P
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRP 173
           + + A E LQ  R+  K D+WS G +L+ELL  G PP+    P
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 59  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 116
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 117 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 172
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
                + APE + +  +  K D+WS G +L E++ 
Sbjct: 173 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 170
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
                + APE + +  +  K D+WS G +L E++ 
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 63  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 120
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 176
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
                + APE + +  +  K D+WS G +L E++ 
Sbjct: 177 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 144
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 145 YDEK-----------VDMWSVGAILFELLNGYPPF 168
              +            D+WS+G IL+ +  G  PF
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 71  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 144
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 130 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 145 YDEK-----------VDMWSVGAILFELLNGYPPF 168
              +            D+WS+G IL+ +  G  PF
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 65  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 122
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +       +    
Sbjct: 123 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 132 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 170
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
                + APE + +  +  K D+WS G +L E++ 
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 66  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 123
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 124 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 26/165 (15%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------Q 66
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E                 Q
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 139
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
               F   +  G++ L+    IHR+L   NIL+    ++ + KIADFGLS       Y +
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 194
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           K  G  P+ +MA E L +  Y    D+WS G +L+E+++ G  P+
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 144
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 149 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 145 YDEK-----------VDMWSVGAILFELLNGYPPF 168
              +            D+WS+G IL+ +  G  PF
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 144
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 145 YDEK-----------VDMWSVGAILFELLNGYPPF 168
              +            D+WS+G IL+ +  G  PF
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 18/160 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L    H NII + D  +          +++V++     +L   I     +  +  R
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 162
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGN--- 123
            FL QL  GL+ ++S  +IHRDLKP N+L   ++++  LKI DFG++   CT  P     
Sbjct: 163 YFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT-SPAEHQY 218
Query: 124 YAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELL 162
           +  +   +  Y APE +L    Y + +D+WSVG I  E+L
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 258

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 19/156 (12%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 74  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 132
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 144
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 133 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 145 YDEK-----------VDMWSVGAILFELLNGYPPFS 169
              +            D+WS+G IL+ +  G  PF 
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 144
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 145 YDEK-----------VDMWSVGAILFELLNGYPPF 168
              +            D+WS+G IL+ +  G  PF
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 19/156 (12%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 70  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 128
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 144
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 129 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 145 YDEK-----------VDMWSVGAILFELLNGYPPFS 169
              +            D+WS+G IL+ +  G  PF 
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q+  G
Sbjct: 69  IGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPL- 133
           +  L  H ++HR+L   N+LL        +++ADFG++  L P +    Y+E    +P+ 
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIK 182
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +MA E + F +Y  + D+WS G  ++EL+  G  P++  R
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 5/147 (3%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
            HP +IRL D F+ +    LV+E      +L  YI   G + E  +R F  Q+ A ++  
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 142
           +S  ++HRD+K ENIL+         K+ DFG    L+   Y +   G+ +Y  PE +  
Sbjct: 156 HSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISR 212
Query: 143 QRYDE-KVDMWSVGAILFELLNGYPPF 168
            +Y      +WS+G +L++++ G  PF
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 18/151 (11%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y   Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV 196
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q+  G
Sbjct: 87  IGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 145
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPL- 133
           +  L  H ++HR+L   N+LL        +++ADFG++  L P +    Y+E    +P+ 
Sbjct: 146 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIK 200
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
           +MA E + F +Y  + D+WS G  ++EL+  G  P++  R
Sbjct: 201 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 240

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +H NIIRL         + ++ E+   G L  ++R   G          L+ 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + AG++ L + + +HRDL   NIL+   + +++ K++DFGLS  L       Y       
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE + ++++    D+WS G +++E++  G  P+
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 187
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLX 189
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLX 190
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 191 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 187
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 183
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 190
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 135 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 191
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 126 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 182
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 183
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 137 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 193
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 194 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 205
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 40/192 (20%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+  E+C   N + Y 
Sbjct: 47  STILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCE--NRTLYD 104
Query: 58  RLHGRVPEQTARKF---LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +H     Q   ++    +Q+   L  ++S  IIHR+LKP NI    +D+   +KI DFG
Sbjct: 105 LIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIF---IDESRNVKIGDFG 161
Query: 115 LSCTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL 158
           L+  ++             PG+        G+  Y+A EVL     Y+EK+D +S+G I 
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIF 221
Query: 159 FELLNGYPPFSA 170
           FE +    PFS 
Sbjct: 222 FEXIY---PFST 230

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 47/222 (21%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+ +  +  +DC     E+  L+ +NH +++++ D    ++      +++V+E  A  
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +     R    + E   +  L  L  G++ ++S  I+HRDLKP N L   ++ D  +K+ 
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198
Query: 112 DFGLSCTL-YPGNYAEKVCGSP---------------------------LYMAPEVLQFQ 143
           DFGL+ T+ YP N   ++  SP                            Y APE++  Q
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258
Query: 144 R-YDEKVDMWSVGAILFELLNGYPPFSAYR----PCFASRLC 180
             Y E +D+WS+G I  ELLN      AY     P F    C
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR 144
           +H DLKP N L+     D MLK+ DFG++  + P       +   G+  YM PE ++   
Sbjct: 149 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 145 YDEK-----------VDMWSVGAILFELLNGYPPFS 169
              +            D+WS+G IL+ +  G  PF 
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 18/151 (11%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 140
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HR+L   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 141 ADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 226 AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 284
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL         A      P
Sbjct: 285 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGL---------ARVGAKFP 332
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
           + + APE + F  +  K D+WS G +L E++ 
Sbjct: 333 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 18/151 (11%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HR+L   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 10  KSCLDCELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLH 60
           K+  + EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R  
Sbjct: 57  KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAK 116
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
             +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV 174
Query: 121 PGNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            G        S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 175 RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 10/178 (5%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-L 59
           M+    + LK   D E+   +   H N++ L       + + LV  +   G+L   +  L
Sbjct: 56  MVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL 115
Query: 60  HGRVPEQTAR--KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 115
            G  P       K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 172
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
            S          ++ G+  Y APE L+ +    K D++S G +L E++ G P    +R
Sbjct: 173 ASEKFAQXVXXSRIVGTTAYXAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHR 229

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 54  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 112
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHR+L   NIL+   +++  +KI DFGL+  L    
Sbjct: 113 DHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILV---ENENRVKIGDFGLTKVLPQDK 169
Query: 124 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 170 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 63/119 (52%), Gaps = 3/119 (2%)
Query: 53  LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           L S+IR    +P      ++ QL   +  ++S  I HRD+KP+N+L++  D+   LK+ D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCD 185
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           FG +  L P   +     S  Y APE +L    Y   +D+WS+G +  EL+ G P FS 
Sbjct: 186 FGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQT 67
           E+  L+  +HPNI+ L D F      A + ++LV E     +L+  I  H +   +  Q 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
            + F+  +  GL +L+   ++HRDL P NILL+  +D   + I DF L+           
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTH 192
Query: 128 VCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLN 163
                 Y APE V+QF+ + + VDMWS G ++ E+ N
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQT 67
           E+  L+  +HPNI+ L D F      A + ++LV E     +L+  I  H +   +  Q 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
            + F+  +  GL +L+   ++HRDL P NILL+  +D   + I DF L+           
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTH 192
Query: 128 VCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLN 163
                 Y APE V+QF+ + + VDMWS G ++ E+ N
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 8/103 (7%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAE 126
           FL Q+  GL+ ++S +++HRDLKP N+L++   D   LKI DFGL+    P      +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARIADPEHDHTGFLT 205
Query: 127 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 41/199 (20%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL D    E+ +     ++V+E  A  
Sbjct: 58  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEI-ADS 116
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L    +    + EQ  +  L  L  G + ++   IIHRDLKP N L   L+ D  +KI 
Sbjct: 117 DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCL---LNQDCSVKIC 173
Query: 112 DFGLSCTL-------------------YPGNYAEKV-------CGSPLYMAPEVLQFQR- 144
           DFGL+ T+                    PG + + +         +  Y APE++  Q  
Sbjct: 174 DFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN 233
Query: 145 YDEKVDMWSVGAILFELLN 163
           Y   +D+WS G I  ELLN
Sbjct: 234 YTNSIDIWSTGCIFAELLN 252

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 124 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 181
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 182 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 10  KSCLDCELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLH 60
           K+  + EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R  
Sbjct: 57  KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
             +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV 174
Query: 121 PGNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            G        S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 86/179 (48%), Gaps = 25/179 (13%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE--- 65
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 66  ------QTARK-----FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
                  TA       F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFG 209
Query: 115 LSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 166
           L+  +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN YP
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 131 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 188
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 189 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 193 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 10  KSCLDCELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLH 60
           K+  + EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R  
Sbjct: 57  KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
             +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV 174
Query: 121 PGNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            G        S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 127 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 184
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 185 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 193 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 142 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 199
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 200 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS---YIRLHGRVPEQ 66
           EL  +  V HPN++ L   F      + E  + LV+E+       +   Y +L   +P  
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL       +LK+ DFG +  L  G    
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPNV 199
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G ++ EL+ G P F
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 136 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 193
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 194 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKIRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 86/179 (48%), Gaps = 25/179 (13%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-- 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 67  ---------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
                    + R  L    Q+  G+  L S + IHRD+   N+LL+   +  + KI DFG
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFG 209
Query: 115 LSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 166
           L+  +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN YP
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 83/154 (53%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 215 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 128 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 185
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 186 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 150
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 151 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 208
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 209 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 158
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 159 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 216
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 217 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 285
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 285
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 201
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 202 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 259
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 260 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 160
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 161 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 218
Query: 127 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 219 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 56  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 112
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 113 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 169
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 170 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---- 75
           LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRLEICI 146
Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGNYAEKVCG 130
           GA  GL  L++  IIHRD+K  NILL   D++ + KI DFG+S     L   +    V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           +  Y+ PE     R  EK D++S G +LFE+L
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---- 75
           LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRLEICI 146
Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGNYAEKVCG 130
           GA  GL  L++  IIHRD+K  NILL   D++ + KI DFG+S     L   +    V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           +  Y+ PE     R  EK D++S G +LFE+L
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 54  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 110
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 111 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 167
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 168 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 52  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 108
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 109 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 165
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 166 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 312 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 368
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG--NLSSYIR--LHGRVPEQTARKFLQQL 75
           + S + P I++ + A   E   ++ +E  +        Y+   L   +PE+   K     
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 76  GAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
              L  L  +  IIHRD+KP NILL   D    +K+ DFG+S  L       +  G   Y
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPY 191
Query: 135 MAPEVLQ----FQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCF 175
           MAPE +      Q YD + D+WS+G  L+EL  G  P+  +   F
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 38/196 (19%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL+D    ++ +     ++V+E  A  
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L    +    + E+  +  L  L  G   ++   IIHRDLKP N L   L+ D  +K+ 
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171
Query: 112 DFGLSCTL----------------YPGNYAEKV-------CGSPLYMAPEVLQFQR-YDE 147
           DFGL+ T+                 PG + + +         +  Y APE++  Q  Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231
Query: 148 KVDMWSVGAILFELLN 163
            +D+WS G I  ELLN
Sbjct: 232 SIDIWSTGCIFAELLN 247

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 86/174 (49%), Gaps = 21/174 (12%)
Query: 11  SCLDCELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVP 64
           S  D E+  L  S  HPN+IR F   +     ++ +E CA   L  Y+        G  P
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEP 120
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK--IADFGLSCTLYPG 122
                  LQQ  +GL  L+S +I+HRDLKP NIL+S  +    +K  I+DFGL   L  G
Sbjct: 121 ----ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 123 NYA----EKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN-GYPPF 168
            ++      V G+  ++APE+L     +     VD++S G + + +++ G  PF
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 230 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 286
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL   +    Y A +   
Sbjct: 287 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLGRLIEDNEYTARQGAK 343
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 344 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 383

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHXVMQEHRK 175
Query: 132 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P  + APE L+ + +    D W  G  L+E+   G  P+
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHXVMQEHRK 185
Query: 132 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P  + APE L+ + +    D W  G  L+E+   G  P+
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLV--DM 285
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P+ + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 6/139 (4%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82
            HP  +RL  A++    ++L  E C G +L  +    G  +PE     +L+     L  L
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 142
           +S  ++H D+KP NI L         K+ DFGL   L      E   G P YMAPE+LQ 
Sbjct: 174 HSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 143 QRYDEKVDMWSVGAILFEL 161
             Y    D++S+G  + E+
Sbjct: 231 S-YGTAADVFSLGLTILEV 248

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 24  NHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYI-RLHGR---VPEQTARKFLQQL 75
           NHPNI+RL         A++  +L++ F   G L + I RL  +   + E      L  +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEK 127
             GLE +++    HRDLKP NILL      V++ +     +C    G        ++A +
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 128 VCGSPLYMAPEVLQFQRY---DEKVDMWSVGAILFELLNGYPPFS 169
            C +  Y APE+   Q +   DE+ D+WS+G +L+ ++ G  P+ 
Sbjct: 204 RC-TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 175
Query: 132 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P  + APE L+ + +    D W  G  L+E+   G  P+
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 179
Query: 132 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P  + APE L+ + +    D W  G  L+E+   G  P+
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 175
Query: 132 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P  + APE L+ + +    D W  G  L+E+   G  P+
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL   NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLAAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 136
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 137 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 179
Query: 132 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P  + APE L+ + +    D W  G  L+E+   G  P+
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++       R+P+      
Sbjct: 60  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DM 116
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 117 SAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 173
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 185
Query: 132 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            P  + APE L+ + +    D W  G  L+E+   G  P+
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 134 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 190
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 83/178 (46%), Gaps = 13/178 (7%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L+  +  + + L  EL+     NHPNI+     F A+N +++V  F A G+    I  H 
Sbjct: 62  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121
Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              + E      LQ +   L+ ++    +HR +K  +IL+S +D  V L      LS   
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMIS 180
Query: 120 YPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
           + G     V   P Y       ++PEVLQ   Q YD K D++SVG    EL NG+ PF
Sbjct: 181 H-GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  L   N      G+
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA-RLIEDNEXTARQGA 175
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
                + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 83/178 (46%), Gaps = 13/178 (7%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L+  +  + + L  EL+     NHPNI+     F A+N +++V  F A G+    I  H 
Sbjct: 46  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 105
Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              + E      LQ +   L+ ++    +HR +K  +IL+S +D  V L      LS   
Sbjct: 106 MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMIS 164
Query: 120 YPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
           + G     V   P Y       ++PEVLQ   Q YD K D++SVG    EL NG+ PF
Sbjct: 165 H-GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 128
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 185
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 157
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 214
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 129
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 186
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 122
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 179
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 32/170 (18%)
Query: 25  HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL-QQLGAGLEI 81
           H NI+ L +  +A+N   ++LV ++    +L + IR    + E   ++++  QL   ++ 
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR--ANILEPVHKQYVVYQLIKVIKY 124
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---------PGNYAEKV---- 128
           L+S  ++HRD+KP NILL+    +  +K+ADFGLS +           P +  E      
Sbjct: 125 LHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 129 ---------CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                      +  Y APE+ L   +Y + +DMWS+G IL E+L G P F
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 126
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 183
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 132
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 133 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 189
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 190 HGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+    +   LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 149 GVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 205
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 128
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 185
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 134 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 190
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 122 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 181
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 182 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 238
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 239 HGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+    +   LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+    +   LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQ 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R      + ++
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 67  TAR--------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
             R         F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARD 209
Query: 119 LY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 166
           +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN YP
Sbjct: 210 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 264

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQ 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R      + ++
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 67  TAR--------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
             R         F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARD 201
Query: 119 LY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 166
           +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN YP
Sbjct: 202 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 256

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 135
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 192
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 156
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 157 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 213
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 214 HGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 149 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 205
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+    +   LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 169 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 225
Query: 146 DEK-VDMWSVGAILFELLNGYPPFS 169
             +   +WS+G +L++++ G  PF 
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTA 68
           L  E+  L ++ H NI++ +     E   N I L++EF   G+L  Y+ +   ++  +  
Sbjct: 58  LKKEIEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 116
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
            K+  Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+  +        V
Sbjct: 117 LKYAVQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 129 C---GSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
                SP++  APE L   ++    D+WS G  L ELL 
Sbjct: 174 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191
Query: 146 DEK-VDMWSVGAILFELLNGYPPF 168
             +   +WS+G +L++++ G  PF
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------HGRVPEQTA 68
           E + +   N  +++RL           +++E    G+L SY+R        +  +   + 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 69  RKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
            K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 128 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 184
Query: 126 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTA 68
           L  E+  L ++ H NI++ +     E   N I L++EF   G+L  Y+ +   ++  +  
Sbjct: 70  LKKEIEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
            K+  Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+  +        V
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 129 C---GSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 163
                SP++  APE L   ++    D+WS G  L ELL 
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEF-CAGGNLSSYIRL--HG 61
           K L+   D +     S+   +I++L D F  +  N + +V+ F   G NL + I+   H 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 62  RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDD---VMLKIADFGLSC 117
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KIAD G +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
             Y  +Y   +  +  Y +PEVL    +    D+WS   ++FEL+ G
Sbjct: 187 -WYDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++       R+P+      
Sbjct: 60  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DM 116
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    + A +   
Sbjct: 117 SAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEWTARQGAK 173
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
            P+ + APE   + R+  K D+WS G +L EL  
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEF-CAGGNLSSYIRL--HG 61
           K L+   D +     S+   +I++L D F  +  N + +V+ F   G NL + I+   H 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 62  RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDD---VMLKIADFGLSC 117
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KIAD G +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
             Y  +Y   +  +  Y +PEVL    +    D+WS   ++FEL+ G
Sbjct: 187 -WYDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------HGRVPEQTA 68
           E + +   N  +++RL           +++E    G+L SY+R        +  +   + 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 69  RKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
            K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194
Query: 126 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+L+    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVLIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 74/157 (47%), Gaps = 5/157 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E      +  P+++ + D  + +  +++      G +L++ +R  G +    A   ++Q+
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQI 143
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPL 133
           G+ L+  ++    HRD+KPENIL+S    D    + DFG++         +     G+  
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSA---DDFAYLVDFGIASATTDEKLTQLGNTVGTLY 200
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           Y APE         + D++++  +L+E L G PP+  
Sbjct: 201 YXAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 35  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYG 93
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 94  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 150
Query: 111 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    D+W     ++E+L+ G  P
Sbjct: 151 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210
Query: 168 F 168
           F
Sbjct: 211 F 211

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 51  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYG 109
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 110 ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 166
Query: 111 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    D+W     ++E+L+ G  P
Sbjct: 167 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226
Query: 168 F 168
           F
Sbjct: 227 F 227

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 39  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 97
Query: 55  SYIRLHGRV----PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS---------- 100
             I  + R+     E   +  L Q+G GL  ++S  ++H D+KP NI +S          
Sbjct: 98  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 157
Query: 101 -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 158 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 201

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 35/198 (17%)
Query: 1   MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           MLK K +   +  L  EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R
Sbjct: 82  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141
Query: 59  L--------------HGRVPEQTARK---------FLQQLGAGLEILNSHHIIHRDLKPE 95
                            R+ E+             F  Q+  G+E L     +HRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201
Query: 96  NILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMW 152
           N+L++      ++KI DFGL+  +    NY  +     P+ +MAPE L    Y  K D+W
Sbjct: 202 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258
Query: 153 SVGAILFEL----LNGYP 166
           S G +L+E+    +N YP
Sbjct: 259 SYGILLWEIFSLGVNPYP 276

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 39  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYG 97
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 98  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 154
Query: 111 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    D+W     ++E+L+ G  P
Sbjct: 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
Query: 168 F 168
           F
Sbjct: 215 F 215

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 41  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 99
Query: 55  SYIRLHGRV----PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS---------- 100
             I  + R+     E   +  L Q+G GL  ++S  ++H D+KP NI +S          
Sbjct: 100 DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159
Query: 101 -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 203

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 39  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 97
Query: 55  SYIRLHGRV----PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS---------- 100
             I  + R+     E   +  L Q+G GL  ++S  ++H D+KP NI +S          
Sbjct: 98  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 157
Query: 101 -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 158 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 201

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 37  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 95
Query: 55  SYIRLHGRV----PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS---------- 100
             I  + R+     E   +  L Q+G GL  ++S  ++H D+KP NI +S          
Sbjct: 96  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 155
Query: 101 -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 156 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 199

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 122
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N  ++   +D  +KI DFG++  +Y  +
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVA---EDFTVKIGDFGMTRDIYETD 179
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 144 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 201
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 202 QDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---- 64
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   R P    
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKRPPGLEY 151
Query: 65  ---------EQTARK----FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + +    F  Q+  G+  L S + IHRD+   N+LL+   +  + KI 
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIG 208
Query: 112 DFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNG 164
           DFGL+  +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN 
Sbjct: 209 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 268
Query: 165 YP 166
           YP
Sbjct: 269 YP 270

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 9/163 (5%)
Query: 10  KSCLDCELNFLSSVNH-PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K+ +  E+  L ++   PNII L D  +        LV E     N + + +L+  + + 
Sbjct: 75  KNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDY 131
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             R ++ ++   L+  +S  I+HRD+KP N+++    +   L++ D+GL+   +PG    
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYN 189
Query: 127 KVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
               S  +  PE+L  +Q YD  +DMWS+G +L  ++    PF
Sbjct: 190 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 144 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 201
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 202 QDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 163
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 164 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 220
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPF 168
            Q YD  +DMWS+G +   ++    PF
Sbjct: 221 LQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 144
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 145 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 202
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 203 QDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 147 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +   ++    PF
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 10/127 (7%)
Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
           LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   NIL   
Sbjct: 87  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL--- 143
Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQFQRYDEKVDMWSVGA 156
           ++ +  +KIADFGL+  L P +    V   P      + APE L    +  + D+WS G 
Sbjct: 144 VESEAHVKIADFGLA-KLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 202
Query: 157 ILFELLN 163
           +L+EL  
Sbjct: 203 VLYELFT 209

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 153
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 154 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/112 (41%), Positives = 63/112 (56%), Gaps = 9/112 (8%)
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
           Q+  G+E L+S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  K     
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP-PFSAYRPCFASRL 179
           PL +MAPE +  + Y  K D+WS G +L+E+  L G P P       F SRL
Sbjct: 264 PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRL 315

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPE-QTARKFLQ 73
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++   GR  +         
Sbjct: 54  EAQIMKKLKHDKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAA 112
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+ AG+  +   + IHRDL+  NIL+    + ++ KIADFGL+  L   N      G+  
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVG---NGLICKIADFGLA-RLIEDNEXTARQGAKF 168
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
              + APE   + R+  K D+WS G +L EL+  G  P+
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 207

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 20  LSSVNHPNIIRLFDAF-----QAENCIFL--VVEFCAGG---NLSSYIRLHGRVPEQTAR 69
           L+ ++HPNI++L   F     +    I+L  V+E+          +Y R     P    +
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 70  KFLQQL--GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
            FL QL    G   L S ++ HRD+KP N+L++  + D  LK+ DFG +  L P      
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 128 VCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
              S  Y APE +   Q Y   VD+WSVG I  E++ G P F
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L   + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLRQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
           Q YD  +DMWS+G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 34/188 (18%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------- 60
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R          
Sbjct: 78  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPS 137
Query: 61  ---GRVPEQTARK------------FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
              G+ PE   ++            F  Q+  G+  L S + IHRD+   N+LL+   + 
Sbjct: 138 LAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NG 194
Query: 106 VMLKIADFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL- 161
            + KI DFGL+  +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+ 
Sbjct: 195 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254
Query: 162 ---LNGYP 166
              LN YP
Sbjct: 255 SLGLNPYP 262

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 25/169 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 122
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 119
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 179
Query: 120 -YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
             P  Y  +V  +  Y  PE+L  +R Y   +D+W  G I+ E+    P
Sbjct: 180 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 25/169 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFT 123
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 119
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 120 -YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
             P  Y  +V  +  Y  PE+L  +R Y   +D+W  G I+ E+    P
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I +V E+ + G+L  +++       R+P+      
Sbjct: 53  EAQVMKKLRHEKLVQLY-AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 109
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  L   N      G+
Sbjct: 110 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA-RLIEDNEXTARQGA 165
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
                + APE   + R+  K D+WS G +L EL  
Sbjct: 166 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGA 77
            ++S++HP+++RL     +   I LV +    G L  Y+  H   +  Q    +  Q+  
Sbjct: 70  IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 128
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---Y 134
           G+  L    ++HRDL   N+L+   +    +KI DFGL+  L          G  +   +
Sbjct: 129 GMMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           MA E + ++++  + D+WS G  ++EL+  G  P+  
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGA 77
            ++S++HP+++RL     +   I LV +    G L  Y+  H   +  Q    +  Q+  
Sbjct: 93  IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 151
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---Y 134
           G+  L    ++HRDL   N+L+   +    +KI DFGL+  L          G  +   +
Sbjct: 152 GMMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKW 208
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSA 170
           MA E + ++++  + D+WS G  ++EL+  G  P+  
Sbjct: 209 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 10/133 (7%)
Query: 37  AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE 95
               + LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   
Sbjct: 97  GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 156
Query: 96  NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQFQRYDEKVD 150
           NIL   ++ +  +KIADFGL+  L P +    V   P      + APE L    +  + D
Sbjct: 157 NIL---VESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 212
Query: 151 MWSVGAILFELLN 163
           +WS G +L+EL  
Sbjct: 213 VWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 10/133 (7%)
Query: 37  AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE 95
               + LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   
Sbjct: 84  GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 143
Query: 96  NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQFQRYDEKVD 150
           NIL   ++ +  +KIADFGL+  L P +    V   P      + APE L    +  + D
Sbjct: 144 NIL---VESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 199
Query: 151 MWSVGAILFELLN 163
           +WS G +L+EL  
Sbjct: 200 VWSFGVVLYELFT 212

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 25/169 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 123
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 119
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 120 -YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
             P  Y  +V  +  Y  PE+L  +R Y   +D+W  G I+ E+    P
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 10/133 (7%)
Query: 37  AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE 95
               + LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   
Sbjct: 85  GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 144
Query: 96  NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQFQRYDEKVD 150
           NIL   ++ +  +KIADFGL+  L P +    V   P      + APE L    +  + D
Sbjct: 145 NIL---VESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 200
Query: 151 MWSVGAILFELLN 163
           +WS G +L+EL  
Sbjct: 201 VWSFGVVLYELFT 213

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 25/169 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--------IFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL---VKFT 123
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 119
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 120 -YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
             P  Y  +V  +  Y  PE+L  +R Y   +D+W  G I+ E+    P
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 28/180 (15%)
Query: 16  ELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK---- 70
           E+  L+ S +HPN+IR + +   +  +++ +E C   NL   +       E    +    
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 134
Query: 71  ---FLQQLGAGLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGLSC 117
               L+Q+ +G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL  
Sbjct: 135 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 118 TLYPGNYAEKV-----CGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN-GYPPF 168
            L  G    +       G+  + APE+L+    +R    +D++S+G + + +L+ G  PF
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 28/180 (15%)
Query: 16  ELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK---- 70
           E+  L+ S +HPN+IR + +   +  +++ +E C   NL   +       E    +    
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 134
Query: 71  ---FLQQLGAGLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGLSC 117
               L+Q+ +G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL  
Sbjct: 135 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 118 TLYPGNYAEKV-----CGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN-GYPPF 168
            L  G    +       G+  + APE+L+    +R    +D++S+G + + +L+ G  PF
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 27  NIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84
           NII+L D  +        LV E+    N + + +L+  + +   R ++ +L   L+  +S
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYI---NNTDFKQLYQILTDFDIRFYMYELLKALDYCHS 150
Query: 85  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QFQ 143
             I+HRD+KP N+++        L++ D+GL+   +P         S  +  PE+L  +Q
Sbjct: 151 KGIMHRDVKPHNVMIDH--QQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 208
Query: 144 RYDEKVDMWSVGAILFELLNGYPPF 168
            YD  +DMWS+G +L  ++    PF
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPF 233
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	180
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-70
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-69
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-67
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-66
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-66
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-66
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-65
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-65
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-65
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-65
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-65
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-64
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-64
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-64
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-63
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-63
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-62
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-62
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-62
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-62
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-61
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-61
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-61
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-61
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-61
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-61
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-61
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-61
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-60
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-60
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-60
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-60
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-60
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-60
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-60
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-60
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-59
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-58
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-58
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-58
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-58
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-58
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-58
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-58
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-58
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-58
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-57
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-57
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-57
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-57
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-57
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-57
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-57
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-57
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-56
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-55
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-55
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-55
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-54
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-54
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-54
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-54
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-53
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-52
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-52
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-51
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-51
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-50
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-50
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-50
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-49
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-49
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-48
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-48
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-48
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-47
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-47
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-46
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-45
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-45
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-45
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-45
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-45
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-44
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-44
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-44
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-44
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-44
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-44
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-43
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-43
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-43
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-43
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-43
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-43
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-42
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-42
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-42
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-42
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-41
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-41
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-41
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-40
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-40
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-40
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-39
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-39
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-39
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-39
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-39
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-39
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-39
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-39
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-38
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-38
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-38
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-38
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-38
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-38
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-38
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-38
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-37
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-37
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-36
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-36
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-36
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-35
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-35
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-34
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-33
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-33
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-33
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-32
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-32
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-31
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-31
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-31
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-31
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-31
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-31
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-31
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-31
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-31
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-31
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-31
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-30
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-30
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-30
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-30
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-29
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-29
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-28
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-27
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-26
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-26
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-26
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-26
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-25
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-24
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-20
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-06

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  222 bits (567), Expect = 8e-70
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 9/175 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSY 56
           ++L+   +     E+  +  +NHPN++   +       +       L +E+C GG+L  Y
Sbjct: 49  QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY 108

Query: 57  IRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
           +        + E   R  L  + + L  L+ + IIHRDLKPENI+L      ++ KI D 
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168

Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G +  L  G    +  G+  Y+APE+L+ ++Y   VD WS G + FE + G+ PF
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  210 bits (537), Expect = 9e-69
 Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 15/183 (8%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLH 60
               + +      E   L  +NH NI++LF   +        L++EFC  G+L + +   
Sbjct: 45  ISFLRPVDV-QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103

Query: 61  GR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLS 116
                +PE      L+ +  G+  L  + I+HR++KP NI+   G D   + K+ DFG +
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 168
             L        + G+  Y+ P++ +         ++Y   VD+WS+G   +    G  PF
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

Query: 169 SAY 171
             +
Sbjct: 224 RPF 226

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  208 bits (530), Expect = 8e-67
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 14/170 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
           E   L  +NH NI++LF   +        L++EFC  G+L + +        +PE     
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
            L+ +  G+  L  + I+HR++KP NI+   G D   + K+ DFG +  L        + 
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176

Query: 130 GSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPFSAY 171
           G+  Y+ P++ +         ++Y   VD+WS+G   +    G  PF  +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  204 bits (522), Expect = 2e-66
 Identities = 66/158 (41%), Positives = 97/158 (61%), Gaps = 4/158 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + +  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183

Query: 136 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEVL       Y+  VD WS+G ILF  L+GYPPFS 
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  203 bits (518), Expect = 3e-66
 Identities = 56/165 (33%), Positives = 91/165 (55%), Gaps = 8/165 (4%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
            +   L+     E+   S + HPNI+RL+  F     ++L++E+   G +   ++   + 
Sbjct: 51  GVEHQLRR----EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF 106

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
            EQ    ++ +L   L   +S  +IHRD+KPEN+L   L     LKIADFG S    P +
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWS-VHAPSS 162

Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               +CG+  Y+ PE+++ + +DEKVD+WS+G + +E L G PPF
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  206 bits (527), Expect = 5e-66
 Identities = 66/158 (41%), Positives = 97/158 (61%), Gaps = 4/158 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + +  Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308

Query: 136 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEVL       Y+  VD WS+G ILF  L+GYPPFS 
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  201 bits (514), Expect = 1e-65
 Identities = 59/165 (35%), Positives = 92/165 (55%), Gaps = 8/165 (4%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
            +   L+     E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR 
Sbjct: 56  GVEHQLRR----EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
            EQ +  F+++L   L   +   +IHRD+KPEN+L   +     LKIADFG S    P  
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLL---MGYKGELKIADFGWS-VHAPSL 167

Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
               +CG+  Y+ PE+++ + +DEKVD+W  G + +E L G PPF
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  200 bits (512), Expect = 2e-65
 Identities = 58/155 (37%), Positives = 88/155 (56%), Gaps = 1/155 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  + S++HPNIIRL++ F+    I+LV+E C GG L   +       E  A + ++ +
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + +   +  ++ HRDLKPEN L      D  LK+ DFGL+    PG       G+P Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +P+VL+   Y  + D WS G +++ LL GYPPFSA
Sbjct: 176 SPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSA 209

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  200 bits (511), Expect = 4e-65
 Identities = 62/168 (36%), Positives = 91/168 (54%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF  
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  202 bits (515), Expect = 4e-65
 Identities = 54/154 (35%), Positives = 93/154 (60%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++   S+ H +++     F+  + +F+V+E C   +L    +    + E  AR +L+Q+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
             G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G   + +CG+P Y
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +APEVL  + +  +VD+WS+G I++ LL G PPF
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  200 bits (510), Expect = 6e-65
 Identities = 54/154 (35%), Positives = 93/154 (60%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++   S+ H +++     F+  + +F+V+E C   +L    +    + E  AR +L+Q+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
             G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G   + +CG+P Y
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +APEVL  + +  +VD+WS+G I++ LL G PPF
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  199 bits (508), Expect = 1e-64
 Identities = 64/168 (38%), Positives = 94/168 (55%), Gaps = 1/168 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
                   S +  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A + ++Q+ +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS      
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              +   G+  Y+APEVL+   YDEK D+WS G IL+ LL+G PPF  
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYG 224

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  201 bits (513), Expect = 2e-64
 Identities = 62/168 (36%), Positives = 91/168 (54%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF  
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  197 bits (502), Expect = 9e-64
 Identities = 56/172 (32%), Positives = 93/172 (54%), Gaps = 5/172 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----R 58
           K  ++     ++ E+  L S++HPNII++F+ F+  + +++V+E C GG L   I     
Sbjct: 57  KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
               + E    + ++Q+   L   +S H++H+DLKPENIL         +KI DFGL+  
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176

Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                ++    G+ LYMAPEV + +    K D+WS G +++ LL G  PF+ 
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  200 bits (511), Expect = 5e-63
 Identities = 64/168 (38%), Positives = 94/168 (55%), Gaps = 1/168 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
                   S +  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A + ++Q+ +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS      
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              +   G+  Y+APEVL+   YDEK D+WS G IL+ LL+G PPF  
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYG 224

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  195 bits (498), Expect = 6e-63
 Identities = 63/170 (37%), Positives = 96/170 (56%), Gaps = 1/170 (0%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            +KK      S L+ E+  L  + H NI+ L D +++    +LV++  +GG L   I   
Sbjct: 41  CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           G   E+ A   +QQ+ + ++ L+ + I+HRDLKPEN+L    +++  + I DFGLS    
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160

Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            G  +   CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF  
Sbjct: 161 NGIMST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  199 bits (509), Expect = 1e-62
 Identities = 61/155 (39%), Positives = 91/155 (58%), Gaps = 1/155 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A + ++Q+
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   G+  Y+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEVL    YDEK D+WS G IL+ LL+G PPF+ 
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNG 229

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  199 bits (509), Expect = 1e-62
 Identities = 66/155 (42%), Positives = 96/155 (61%), Gaps = 1/155 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S++HPNII+LFD F+ +   +LV EF  GG L   I    +  E  A   ++Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  L+ H+I+HRD+KPENILL   +  + +KI DFGLS             G+  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEVL+ ++Y+EK D+WS G I++ LL GYPPF  
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  199 bits (508), Expect = 2e-62
 Identities = 68/168 (40%), Positives = 102/168 (60%), Gaps = 1/168 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             ++    S L  E+  L  ++HPNI++L+D F+ +   +LV+E   GG L   I    +
Sbjct: 73  TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK 132

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   ++Q+ +G+  L+ H+I+HRDLKPEN+LL   + D ++KI DFGLS      
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              ++  G+  Y+APEVL+ ++YDEK D+WS+G ILF LL GYPPF  
Sbjct: 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG 239

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  194 bits (496), Expect = 3e-62
 Identities = 65/155 (41%), Positives = 90/155 (58%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNII+L + F+    I LV+E   GG L   I   G   E+ A   ++Q+
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              +  L+ + I+HRDLKPEN+L +    D  LKIADFGLS  +      + VCG+P Y 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APE+L+   Y  +VDMWSVG I + LL G+ PF  
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  191 bits (487), Expect = 1e-61
 Identities = 55/155 (35%), Positives = 90/155 (58%), Gaps = 5/155 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+     + HP+I+ L++ F+  N ++LV+E C  G ++ Y++       E  AR F+ Q
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
           +  G+  L+SH I+HRDL   N+LL     ++ +KIADFGL+  L  P      +CG+P 
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           Y++PE+     +  + D+WS+G + + LL G PPF
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  192 bits (491), Expect = 2e-61
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 21/187 (11%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 43  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 101

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 102 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 157

Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
            P       +   G+  YM PE ++             +   K D+WS+G IL+ +  G 
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

Query: 166 PPFSAYR 172
            PF    
Sbjct: 218 TPFQQII 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  191 bits (488), Expect = 2e-61
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 21/187 (11%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 176

Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
            P       +   G+  YM PE ++             +   K D+WS+G IL+ +  G 
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

Query: 166 PPFSAYR 172
            PF    
Sbjct: 237 TPFQQII 243

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  190 bits (486), Expect = 3e-61
 Identities = 67/162 (41%), Positives = 96/162 (59%), Gaps = 10/162 (6%)

Query: 16  ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E+  RK ++ 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L PG    +VCG+P Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189

Query: 135 MAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +APE+++         Y ++VDMWS G I++ LL G PPF  
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  191 bits (487), Expect = 4e-61
 Identities = 57/169 (33%), Positives = 94/169 (55%), Gaps = 2/169 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +K ++K +++    E+  L     HPNI++L + F  +   FLV+E   GG L   I+  
Sbjct: 41  VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
               E  A   +++L + +  ++   ++HRDLKPEN+L +  +D++ +KI DFG +    
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160

Query: 121 PGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           P N   +  C +  Y APE+L    YDE  D+WS+G IL+ +L+G  PF
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  192 bits (490), Expect = 4e-61
 Identities = 60/153 (39%), Positives = 95/153 (62%), Gaps = 9/153 (5%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HP+II L D++++ + +FLV +    G L  Y+     + E+  R  ++ L   +  L+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-- 141
           +++I+HRDLKPENIL   LDD++ ++++DFG SC L PG    ++CG+P Y+APE+L+  
Sbjct: 218 ANNIVHRDLKPENIL---LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274

Query: 142 ----FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                  Y ++VD+W+ G ILF LL G PPF  
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  194 bits (495), Expect = 6e-61
 Identities = 59/169 (34%), Positives = 88/169 (52%), Gaps = 1/169 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +   ++HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166

Query: 123 NYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             A     G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF  
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  189 bits (482), Expect = 9e-61
 Identities = 56/156 (35%), Positives = 92/156 (58%), Gaps = 1/156 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A +FL+Q+
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117

Query: 76  GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L+S  I H DLKPENI+L      +  +K+ DFG++  +  GN  + + G+P +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +APE++ ++    + DMWS+G I + LL+G  PF  
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  190 bits (484), Expect = 1e-60
 Identities = 51/171 (29%), Positives = 90/171 (52%), Gaps = 3/171 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RL 59
           ++  +  ++ +  E+  L      P +I L + ++  + I L++E+ AGG + S     L
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              V E    + ++Q+  G+  L+ ++I+H DLKP+NILLS +     +KI DFG+S  +
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                  ++ G+P Y+APE+L +       DMW++G I + LL    PF  
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  192 bits (489), Expect = 1e-60
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 21/187 (11%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 90  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 204

Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
            P       +   G+  YM PE ++             +   K D+WS+G IL+ +  G 
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

Query: 166 PPFSAYR 172
            PF    
Sbjct: 265 TPFQQII 271

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  190 bits (484), Expect = 1e-60
 Identities = 55/154 (35%), Positives = 92/154 (59%), Gaps = 1/154 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL+Q+
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 76  GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L+S  I H DLKPENI+L         +KI DFGL+  +  GN  + + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  189 bits (483), Expect = 1e-60
 Identities = 51/156 (32%), Positives = 88/156 (56%), Gaps = 1/156 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A  F++Q+
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 76  GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L++  I H DLKPENI+L         +K+ DFGL+  +  G   + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +APE++ ++    + DMWS+G I + LL+G  PF  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  190 bits (484), Expect = 3e-60
 Identities = 53/156 (33%), Positives = 89/156 (57%), Gaps = 1/156 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  V HPNII L D ++    + L++E  +GG L  ++     + E+ A  F++Q+
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 76  GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L++  I H DLKPENI+L         +K+ DFGL+  +  G   + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +APE++ ++    + DMWS+G I + LL+G  PF  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  189 bits (481), Expect = 4e-60
 Identities = 65/167 (38%), Positives = 104/167 (62%), Gaps = 4/167 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
            +LN      L  E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR
Sbjct: 51  TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E+ AR   +Q+ + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVG 167

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
              +  CG+P Y APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  189 bits (482), Expect = 5e-60
 Identities = 50/158 (31%), Positives = 86/158 (54%), Gaps = 5/158 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
           E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A  +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCG 130
           ++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A    G
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +P +MAPEV++ + Y + VD+W  G ILF LL+G  PF
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  188 bits (479), Expect = 9e-60
 Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 2/150 (1%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
             HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 83  NSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVL 140
           ++  ++HRDLKP NIL      +   ++I DFG +  L   N      C +  ++APEVL
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192

Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           + Q YD   D+WS+G +L+ +L GY PF+ 
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  185 bits (471), Expect = 3e-59
 Identities = 67/154 (43%), Positives = 92/154 (59%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L    HP+II+L+         F+V+E+ +GG L  YI  HGRV E  AR+  QQ+
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  + H ++HRDLKPEN+L   LD  +  KIADFGLS  +  G +    CGSP Y 
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177

Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
           APEV+  + Y   +VD+WS G IL+ LL G  PF
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  185 bits (472), Expect = 1e-58
 Identities = 33/164 (20%), Positives = 70/164 (42%), Gaps = 15/164 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
           EL  ++ + +   +         + ++++ E+    ++  +              +P Q 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 68  ARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            +  ++ +      +++  +I HRD+KP NIL   +D +  +K++DFG S         +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGES-EYMVDKKIK 208

Query: 127 KVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPF 168
              G+  +M PE    +      KVD+WS+G  L+ +     PF
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  185 bits (472), Expect = 1e-58
 Identities = 45/172 (26%), Positives = 91/172 (52%), Gaps = 6/172 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           + +++   +     E+  L+++ HPNI++  ++F+    +++V+++C GG+L   I    
Sbjct: 59  ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
                E     +  Q+   L+ ++   I+HRD+K +NI L     D  +++ DFG++  L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVL 175

Query: 120 YPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                 A    G+P Y++PE+ + + Y+ K D+W++G +L+EL      F A
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  182 bits (465), Expect = 2e-58
 Identities = 58/157 (36%), Positives = 90/157 (57%), Gaps = 7/157 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NH N+++ +   +  N  +L +E+C+GG L   I     +PE  A++F  QL
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
            AG+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+      N      K+CG+ 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 133 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
            Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  184 bits (468), Expect = 4e-58
 Identities = 56/159 (35%), Positives = 84/159 (52%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E+  LS V H NII++ D F+ +    LV+E   +G +L ++I  H R+ E  A    +Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           L + +  L    IIHRD+K ENI+   + +D  +K+ DFG +  L  G      CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIV---IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195

Query: 135 MAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSAYR 172
            APEVL    Y   +++MWS+G  L+ L+    PF    
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  185 bits (472), Expect = 5e-58
 Identities = 56/153 (36%), Positives = 89/153 (58%), Gaps = 6/153 (3%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
             P+I+R+ D ++       C+ +V+E   GG L S I  R      E+ A + ++ +G 
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
            ++ L+S +I HRD+KPEN+L +    + +LK+ DFG +      N     C +P Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           EVL  ++YD+  DMWS+G I++ LL GYPPF +
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  184 bits (469), Expect = 8e-58
 Identities = 57/154 (37%), Positives = 90/154 (58%), Gaps = 2/154 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ ++ ++H N+I+L+DAF+++N I LV+E+  GG L   I      + E     F++Q
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  G+  ++  +I+H DLKPENIL    D    +KI DFGL+    P    +   G+P +
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEF 254

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +APEV+ +       DMWSVG I + LL+G  PF
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  184 bits (470), Expect = 8e-58
 Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 2/156 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I        E     +++Q
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
              GL+ ++ H I+H D+KPENI+         +KI DFGL+  L P    +    +  +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEF 216

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            APE++  +      DMW++G + + LL+G  PF+ 
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  182 bits (465), Expect = 8e-58
 Identities = 58/157 (36%), Positives = 90/157 (57%), Gaps = 7/157 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NH N+++ +   +  N  +L +E+C+GG L   I     +PE  A++F  QL
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
            AG+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+      N      K+CG+ 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 133 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
            Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  182 bits (465), Expect = 2e-57
 Identities = 61/154 (39%), Positives = 83/154 (53%), Gaps = 2/154 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+    S+ HPNI+R  +       + +++E+ +GG L   I   GR  E  AR F QQL
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+   +S  I HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184

Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
           APEVL  Q YD +  D+WS G  L+ +L G  PF
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  187 bits (477), Expect = 2e-57
 Identities = 52/156 (33%), Positives = 89/156 (57%), Gaps = 2/156 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            APEV + +      DMWSVG + + LL+G  PF  
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  181 bits (461), Expect = 3e-57
 Identities = 57/160 (35%), Positives = 84/160 (52%), Gaps = 13/160 (8%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            H N++ L + F+ E+  +LV E   GG++ S+I       E  A   +Q + + L+ L+
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--------CGSPLYM 135
           +  I HRDLKPENIL    +    +KI DF L   +        +        CGS  YM
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 136 APEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           APEV+     +   YD++ D+WS+G IL+ LL+GYPPF  
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  180 bits (458), Expect = 3e-57
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 22/185 (11%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE----------------NCIFLVV 45
           +K++  + +     E+  L+ ++H NI+     +                    C+F+ +
Sbjct: 41  IKRVKYNNEKAER-EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99

Query: 46  EFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
           EFC  G L  +I  R   ++ +  A +  +Q+  G++ ++S  +I+RDLKP NI L    
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---V 156

Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
           D   +KI DFGL  +L       +  G+  YM+PE +  Q Y ++VD++++G IL ELL+
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

Query: 164 GYPPF 168
                
Sbjct: 217 VCDTA 221

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  185 bits (471), Expect = 4e-57
 Identities = 66/154 (42%), Positives = 96/154 (62%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L    HP+II+L+      + IF+V+E+ +GG L  YI  +GR+ E+ +R+  QQ+
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G++  + H ++HRDLKPEN+L   LD  +  KIADFGLS  +  G +    CGSP Y 
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182

Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
           APEV+  + Y   +VD+WS G IL+ LL G  PF
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  180 bits (459), Expect = 6e-57
 Identities = 48/154 (31%), Positives = 84/154 (54%), Gaps = 2/154 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ L+   H NI+ L ++F++   + ++ EF +G ++   I      + E+    ++ Q
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +   L+ L+SH+I H D++PENI+         +KI +FG +  L PG+    +  +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEY 169

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            APEV Q        DMWS+G +++ LL+G  PF
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  180 bits (459), Expect = 8e-57
 Identities = 68/154 (44%), Positives = 98/154 (63%), Gaps = 5/154 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+++L  + HP+II+L+D       I +V+E+ AGG L  YI    R+ E   R+F QQ+
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              +E  + H I+HRDLKPEN+L   LDD++ +KIADFGLS  +  GN+ +  CGSP Y 
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLL---LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174

Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
           APEV+  + Y   +VD+WS G +L+ +L G  PF
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  181 bits (460), Expect = 8e-57
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 48/216 (22%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           ++++N      +  E+  +  ++HPNI RL++ ++ E  I LV+E C GG+L   + +  
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123

Query: 62  RVP----------------------------------------EQTARKFLQQLGAGLEI 81
                                                      E+     ++Q+ + L  
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 136
           L++  I HRD+KPEN L S  +    +K+ DFGLS   Y  N  E        G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 137 PEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSA 170
           PEVL    + Y  K D WS G +L  LL G  PF  
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  180 bits (458), Expect = 1e-56
 Identities = 55/153 (35%), Positives = 92/153 (60%), Gaps = 7/153 (4%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
             P+I+ + D ++     + C+ +++E   GG L S I  R      E+ A + ++ +G 
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
            ++ L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAP 198

Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           EVL  ++YD+  DMWS+G I++ LL G+PPF +
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  175 bits (446), Expect = 2e-55
 Identities = 60/181 (33%), Positives = 96/181 (53%), Gaps = 15/181 (8%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL 59
              + +  K  L  E+N L  + HPNI+R +D         +++V+E+C GG+L+S I  
Sbjct: 41  YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100

Query: 60  HGR----VPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
             +    + E+   + + QL   L+         H ++HRDLKP N+ L   D    +K+
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 157

Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
            DFGL+  L     +A+   G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217

Query: 170 A 170
           A
Sbjct: 218 A 218

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  175 bits (445), Expect = 4e-55
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 35/186 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-------------CIFLVVEFCAGGNLSSYIRLHGR 62
           E+  L+S+NH  ++R + A+                  +F+ +E+C  G L   I     
Sbjct: 52  EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111

Query: 63  -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-- 119
                   +  +Q+   L  ++S  IIHRDLKP NI    +D+   +KI DFGL+  +  
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLAKNVHR 168

Query: 120 -------------YPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165
                           +      G+ +Y+A EVL     Y+EK+DM+S+G I FE++  Y
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--Y 226

Query: 166 PPFSAY 171
           P  +  
Sbjct: 227 PFSTGM 232

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  175 bits (446), Expect = 5e-55
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFL 72
           E+  L  V+     +IRL D F+  +   L++E      +L  +I   G + E+ AR F 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGS 131
            Q+   +   ++  ++HRD+K ENIL   +D +   LK+ DFG    L          G+
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211

Query: 132 PLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
            +Y  PE +++ RY      +WS+G +L++++ G  PF
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  173 bits (442), Expect = 1e-54
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 10/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+  L  ++HPN+++L +      E+ +++V E    G +         + E  AR + Q
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQ 144

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSP 132
            L  G+E L+   IIHRD+KP N+L   + +D  +KIADFG+S      +       G+P
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201

Query: 133 LYMAPEVLQFQR--YD-EKVDMWSVGAILFELLNGYPPF 168
            +MAPE L   R  +  + +D+W++G  L+  + G  PF
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  174 bits (442), Expect = 2e-54
 Identities = 49/179 (27%), Positives = 74/179 (41%), Gaps = 12/179 (6%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K+     +   D      E+     V  HP  +RL  A++    ++L  E C G +L  
Sbjct: 87  VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ 145

Query: 56  YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
           +    G  +PE     +L+     L  L+S  ++H D+KP NI    L      K+ DFG
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF---LGPRGRCKLGDFG 202

Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           L   L      E   G P YMAPE+LQ   Y    D++S+G  + E+            
Sbjct: 203 LLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEG 260

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  172 bits (438), Expect = 6e-54
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 5/154 (3%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
           +   HP +IRL D F+ +    LV+E      +L  YI   G + E  +R F  Q+ A +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           +  +S  ++HRD+K ENIL+         K+ DFG    L          G+ +Y  PE 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSG-ALLHDEPYTDFDGTRVYSPPEW 209

Query: 140 LQFQRYD-EKVDMWSVGAILFELLNGYPPFSAYR 172
           +   +Y      +WS+G +L++++ G  PF   +
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  172 bits (438), Expect = 8e-54
 Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 8/160 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +PE+T  K+
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCG 130
             QL + LE ++S  ++HRD+KP N+ +       ++K+ D GL          A  + G
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVG 198

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +P YM+PE +    Y+ K D+WS+G +L+E+     PF  
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  170 bits (432), Expect = 5e-53
 Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 13/162 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGN--LSSYIRLHGRVPEQTARKF 71
           E+  L  + H N+I+L D    E    +++V+E+C  G   +   +    R P   A  +
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGY 114

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKV 128
             QL  GLE L+S  I+H+D+KP N+L   L     LKI+  G++  L+P    +     
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLL---LTTGGTLKISALGVAEALHPFAADDTCRTS 171

Query: 129 CGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELLNGYPPF 168
            GSP +  PE+      +   KVD+WS G  L+ +  G  PF
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  167 bits (426), Expect = 4e-52
 Identities = 53/158 (33%), Positives = 91/158 (57%), Gaps = 6/158 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +   +     G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  169 bits (429), Expect = 8e-52
 Identities = 53/156 (33%), Positives = 87/156 (55%), Gaps = 6/156 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +  + HP ++ L+ +FQ E  +F+VV+   GG+L  +++ +    E+T + F+ +L
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              L+ L +  IIHRD+KP+NIL   LD+   + I DF ++  L        + G+  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPF 168
           APE+   ++   Y   VD WS+G   +ELL G  P+
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  170 bits (432), Expect = 1e-51
 Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 13/180 (7%)

Query: 3   KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           K++     S  D E+  L  S  HPN+IR F   +     ++ +E C    L  Y+    
Sbjct: 54  KRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112

Query: 62  RV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCT 118
                      LQQ  +GL  L+S +I+HRDLKP NIL+S       +   I+DFGL   
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172

Query: 119 LYPGNYAEK----VCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL-NGYPPFSA 170
           L  G ++      V G+  ++APE+L     +     VD++S G + + ++  G  PF  
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  168 bits (428), Expect = 3e-51
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 32/199 (16%)

Query: 3   KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           K++          E+  L+ S +HPN+IR + +   +  +++ +E C   NL   +    
Sbjct: 45  KRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN 103

Query: 62  -------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS----------GLDD 104
                     E      L+Q+ +G+  L+S  IIHRDLKP+NIL+S             +
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163

Query: 105 DVMLKIADFGLSCTLYPGNYAEK-----VCGSPLYMAPEVLQ-------FQRYDEKVDMW 152
           ++ + I+DFGL   L  G  + +       G+  + APE+L+        +R    +D++
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223

Query: 153 SVGAILFELL-NGYPPFSA 170
           S+G + + +L  G  PF  
Sbjct: 224 SMGCVFYYILSKGKHPFGD 242

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  164 bits (417), Expect = 2e-50
 Identities = 53/171 (30%), Positives = 87/171 (50%), Gaps = 8/171 (4%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           L+     EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A
Sbjct: 93  LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 127
             +L Q   GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +  
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSL 210

Query: 128 -----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
                + G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++ Y  
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  162 bits (413), Expect = 2e-50
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 34/197 (17%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCA 49
           L       +  +  E+  L+ + HP I+R F+A+  +N             +++ ++ C 
Sbjct: 40  LPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98

Query: 50  GGNLSSYIRLHGRV---PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
             NL  ++     +             Q+   +E L+S  ++HRDLKP NI       D 
Sbjct: 99  KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 155

Query: 107 MLKIADFGLSCTL-------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153
           ++K+ DFGL   +                       G+ LYM+PE +    Y  KVD++S
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215

Query: 154 VGAILFELLNGYPPFSA 170
           +G ILFELL  YP  + 
Sbjct: 216 LGLILFELL--YPFSTQ 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  163 bits (414), Expect = 9e-50
 Identities = 37/184 (20%), Positives = 70/184 (38%), Gaps = 16/184 (8%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + K  N          +  L        ++ + A   +N   LV E  + G L + I L+
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161

Query: 61  GR-----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL--------SGLDDDVM 107
                  +P+     F  ++   +E ++   IIH D+KP+N +L           D    
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 108 LKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
           L + D G S  +     G      C +  +   E+L  + ++ ++D + V A ++ +L G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281

Query: 165 YPPF 168
               
Sbjct: 282 TYMK 285

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  160 bits (408), Expect = 2e-49
 Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 27/193 (13%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLS 54
           LK++  H +   +    E +     NHPNI+RL      E    +  +L++ F   G L 
Sbjct: 59  LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 55  SYI----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
           + I         + E      L  +  GLE +++    HRDLKP NIL   L D+    +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL---LGDEGQPVL 175

Query: 111 ADFGLSCTL--YPGNYAE--------KVCGSPLYMAPEVLQFQRY---DEKVDMWSVGAI 157
            D G       +     +            +  Y APE+   Q +   DE+ D+WS+G +
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

Query: 158 LFELLNGYPPFSA 170
           L+ ++ G  P+  
Sbjct: 236 LYAMMFGEGPYDM 248

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  160 bits (408), Expect = 6e-49
 Identities = 58/179 (32%), Positives = 102/179 (56%), Gaps = 19/179 (10%)

Query: 2   LKKLNK----------HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K L+K          H  +    E   L +VN P +++L  +F+  + +++V+E+ AGG
Sbjct: 71  MKILDKQKVVKLKQIEHTLN----EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
            + S++R  GR  E  AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVT 183

Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           DFG +  +        +CG+P  +APE++  + Y++ VD W++G +++E+  GYPPF A
Sbjct: 184 DFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  159 bits (404), Expect = 1e-48
 Identities = 64/160 (40%), Positives = 92/160 (57%), Gaps = 19/160 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   LS V HP IIR++  FQ    IF+++++  GG L S +R   R P   A+ +  ++
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-------CTLYPGNYAEKV 128
              LE L+S  II+RDLKPENIL   LD +  +KI DFG +        TL         
Sbjct: 116 CLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAKYVPDVTYTL--------- 163

Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           CG+P Y+APEV+  + Y++ +D WS G +++E+L GY PF
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  156 bits (397), Expect = 5e-48
 Identities = 59/178 (33%), Positives = 98/178 (55%), Gaps = 10/178 (5%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF----QAENCIFLVVEFCAGGNLSSYI 57
            +KL K  +     E   L  + HPNI+R +D++    + + CI LV E    G L +Y+
Sbjct: 61  DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +    +  +  R + +Q+  GL+ L++    IIHRDLK +NI ++G    V  KI D GL
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGL 178

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             TL   ++A+ V G+P +MAPE+ + ++YDE VD+++ G  + E+     P+S  + 
Sbjct: 179 -ATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  157 bits (400), Expect = 6e-48
 Identities = 59/160 (36%), Positives = 90/160 (56%), Gaps = 4/160 (2%)

Query: 12  CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
               E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCG 130
           L ++   L  L+   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183

Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +  YMAPE+L    ++  VD WS+GA+++++L G PPF+ 
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  156 bits (397), Expect = 2e-47
 Identities = 56/173 (32%), Positives = 91/173 (52%), Gaps = 7/173 (4%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           L+K   + K   +    E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++ 
Sbjct: 38  LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-C 117
                 E+ AR +  ++ + LE L+S  +++RD+K EN++   LD D  +KI DFGL   
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKE 154

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            +  G   +  CG+P Y+APEVL+   Y   VD W +G +++E++ G  PF  
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  155 bits (395), Expect = 2e-47
 Identities = 61/156 (39%), Positives = 93/156 (59%), Gaps = 4/156 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +L
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLY 134
              L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           MAPEV+  + + +  D WS G ++FE+L G  PF  
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  158 bits (401), Expect = 3e-46
 Identities = 60/177 (33%), Positives = 94/177 (53%), Gaps = 11/177 (6%)

Query: 2   LKKLNK-HLKS-----CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
            KKL K  +K          E   L  VN   ++ L  A++ ++ + LV+    GG+L  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273

Query: 56  YIRLHGRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
           +I   G+   PE  A  +  ++  GLE L+   I++RDLKPENILL   DD   ++I+D 
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDL 330

Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           GL+  +  G   +   G+  YMAPEV++ +RY    D W++G +L+E++ G  PF  
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  155 bits (393), Expect = 7e-46
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 8/175 (4%)

Query: 1   MLKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +LKK   + K   +    E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                  E  AR +  ++ + L+ L+S   +++RDLK EN++L   D D  +KI DFGL 
Sbjct: 240 SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLC 296

Query: 117 -CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              +  G   +  CG+P Y+APEVL+   Y   VD W +G +++E++ G  PF  
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  151 bits (383), Expect = 1e-45
 Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 27/153 (17%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
             P+I+R+ D ++       C+ +V+E   GG L S I  R      E+ A + ++ +G 
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
            ++ L+S +I HRD+KPEN+L +    + +LK+ DFG                     A 
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AK 168

Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           E    ++YD+  DMWS+G I++ LL GYPPF +
Sbjct: 169 ETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYS 200

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  150 bits (381), Expect = 1e-45
 Identities = 41/180 (22%), Positives = 77/180 (42%), Gaps = 25/180 (13%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARK 70
           E+   + +  H +++R F A+  ++ + +  E+C GG+L+  I  + R+     E   + 
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFG 114
            L Q+G GL  ++S  ++H D+KP NI +S                   + VM KI D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
               +   +  +   G   ++A EVLQ    +  K D++++   +       P       
Sbjct: 180 HVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  151 bits (385), Expect = 1e-45
 Identities = 61/174 (35%), Positives = 91/174 (52%), Gaps = 8/174 (4%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   L      C   E      +  HP +  +F  FQ +  +F V+E+  GG+L  +I
Sbjct: 50  LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
           +   +     A  +  ++  GL+ L+S  I++RDLK +NIL   LD D  +KIADFG+  
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCK 166

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             +         CG+P Y+APE+L  Q+Y+  VD WS G +L+E+L G  PF  
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  152 bits (385), Expect = 3e-45
 Identities = 63/174 (36%), Positives = 98/174 (56%), Gaps = 8/174 (4%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           L+K   L K  +  +  E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  ++
Sbjct: 71  LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 130

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
           +      E  AR +  ++ + L  L+S +I++RDLKPENIL   LD    + + DFGL  
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---LDSQGHIVLTDFGLCK 187

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             +   +     CG+P Y+APEVL  Q YD  VD W +GA+L+E+L G PPF +
Sbjct: 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  149 bits (378), Expect = 6e-45
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 9/164 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G    + E+      
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143

Query: 73  QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVC 129
             +  G+  L++ +  I+HR+LK  N+L+   D    +K+ DFGLS         ++   
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAA 200

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           G+P +MAPEVL+ +  +EK D++S G IL+EL     P+    P
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  151 bits (383), Expect = 9e-45
 Identities = 61/181 (33%), Positives = 100/181 (55%), Gaps = 16/181 (8%)

Query: 2   LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L+K   +K    +    E + ++  N P +++LF AFQ +  +++V+E+  GG+L +
Sbjct: 99  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            +  +  VPE+ AR +  ++   L+ ++S   IHRD+KP+N+L   LD    LK+ADFG 
Sbjct: 159 LMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGT 214

Query: 116 S--CTLYPGNYAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFS 169
                       +   G+P Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF 
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

Query: 170 A 170
           A
Sbjct: 275 A 275

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  150 bits (380), Expect = 1e-44
 Identities = 60/175 (34%), Positives = 95/175 (54%), Gaps = 10/175 (5%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   +      C   E   L+     P + +L   FQ  + ++ V+E+  GG+L  +I
Sbjct: 53  LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           +  GR  E  A  +  ++  GL  L S  II+RDLK +N++   LD +  +KIADFG+ C
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 168

Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              ++ G   +  CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G  PF  
Sbjct: 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  147 bits (372), Expect = 2e-44
 Identities = 56/163 (34%), Positives = 81/163 (49%), Gaps = 12/163 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E    + + HPNII L      E  + LV+EF  GG L+    L G+ +P      +  Q
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQ 113

Query: 75  LGAGLEILNSHH---IIHRDLKPENILLS-----GLDDDVMLKIADFGLSCTLYPGNYAE 126
           +  G+  L+      IIHRDLK  NIL+      G   + +LKI DFGL+   +      
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKM 172

Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
              G+  +MAPEV++   + +  D+WS G +L+ELL G  PF 
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  152 bits (386), Expect = 2e-44
 Identities = 56/177 (31%), Positives = 90/177 (50%), Gaps = 11/177 (6%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
           L K     +        E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I 
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277

Query: 58  ---RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
                +    E  A  +  Q+ +GLE L+  +II+RDLKPEN+LL   DDD  ++I+D G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLG 334

Query: 115 LSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           L+          +   G+P +MAPE+L  + YD  VD +++G  L+E++    PF A
Sbjct: 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  148 bits (375), Expect = 4e-44
 Identities = 57/174 (32%), Positives = 99/174 (56%), Gaps = 8/174 (4%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +KK    +      +  E + F  + NHP ++ L   FQ E+ +F V+E+  GG+L  ++
Sbjct: 42  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 101

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
           +   ++PE+ AR +  ++   L  L+   II+RDLK +N+L   LD +  +K+ D+G+  
Sbjct: 102 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCK 158

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             L PG+     CG+P Y+APE+L+ + Y   VD W++G ++FE++ G  PF  
Sbjct: 159 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  147 bits (373), Expect = 4e-44
 Identities = 60/160 (37%), Positives = 86/160 (53%), Gaps = 12/160 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---KFL 72
           EL  LS VNHPNI++L+ A     C+  V+E+  GG+L + +     +P  TA     + 
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108

Query: 73  QQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
            Q   G+  L+S     +IHRDLKP N+LL       +LKI DFG +C +    +     
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNK 164

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
           GS  +MAPEV +   Y EK D++S G IL+E++    PF 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  150 bits (380), Expect = 4e-44
 Identities = 60/184 (32%), Positives = 103/184 (55%), Gaps = 19/184 (10%)

Query: 2   LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LNK   LK    +C   E + L + +   I  L  AFQ +N ++LV+++  GG+L +
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163

Query: 56  YI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            + +   R+PE+ AR +L ++   ++ ++  H +HRD+KP+NIL   +D +  +++ADFG
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG 220

Query: 115 LSCTLYPGNYAEK---VCGSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYP 166
             C     +   +     G+P Y++PE+LQ       RY  + D WS+G  ++E+L G  
Sbjct: 221 S-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

Query: 167 PFSA 170
           PF A
Sbjct: 280 PFYA 283

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  148 bits (375), Expect = 4e-44
 Identities = 66/174 (37%), Positives = 95/174 (54%), Gaps = 8/174 (4%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   L      C   E   LS   NHP + +LF  FQ  + +F V+EF  GG+L  +I
Sbjct: 56  LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
           +   R  E  AR +  ++ + L  L+   II+RDLK +N+L   LD +   K+ADFG+  
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCK 172

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             +  G      CG+P Y+APE+LQ   Y   VD W++G +L+E+L G+ PF A
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  148 bits (375), Expect = 1e-43
 Identities = 57/174 (32%), Positives = 99/174 (56%), Gaps = 8/174 (4%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +KK    +      +  E + F  + NHP ++ L   FQ E+ +F V+E+  GG+L  ++
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
           +   ++PE+ AR +  ++   L  L+   II+RDLK +N+L   LD +  +K+ D+G+  
Sbjct: 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCK 201

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
             L PG+     CG+P Y+APE+L+ + Y   VD W++G ++FE++ G  PF  
Sbjct: 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  152 bits (386), Expect = 1e-43
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 14/177 (7%)

Query: 2   LKKLNK-HLKS-----CLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN 52
           +K L+K  +K          E   LS V+    P I+ +  AF   + +  +++   GG+
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278

Query: 53  LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           L  ++  HG   E   R +  ++  GLE +++  +++RDLKP NIL   LD+   ++I+D
Sbjct: 279 LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISD 335

Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 168
            GL+C            G+  YMAPEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 336 LGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  146 bits (370), Expect = 1e-43
 Identities = 40/182 (21%), Positives = 70/182 (38%), Gaps = 19/182 (10%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLH 60
             +         ++  +   +  N +        +  +++ ++ C   NL  ++      
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
                        Q+   +E L+S  ++HRDLKP NI       D ++K+ DFGL   + 
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMD 215

Query: 120 ------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
                                 G+ LYM+PE +    Y  KVD++S+G ILFELL  +  
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

Query: 168 FS 169
             
Sbjct: 276 QM 277

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  146 bits (371), Expect = 2e-43
 Identities = 52/160 (32%), Positives = 86/160 (53%), Gaps = 8/160 (5%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E   L  +   P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
           +   LE L+   II+RD+K ENIL   LD +  + + DFGLS          A   CG+ 
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 133 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSA 170
            YMAP++++     +D+ VD WS+G +++ELL G  PF+ 
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  144 bits (365), Expect = 3e-43
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 11/165 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  +S++NHPNI++L+        +  V+EF   G+L   +      +      + +  
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130

Query: 75  LGAGLEILNSHH--IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCG 130
           +  G+E + + +  I+HRDL+  NI L  LD    V  K+ADFGLS      +    + G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLG 188

Query: 131 SPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +  +MAPE +  +   Y EK D +S   IL+ +L G  PF  Y  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  146 bits (369), Expect = 4e-43
 Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140

Query: 76  GAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           M+PE LQ   Y  + D+WS+G  L E+  G  P      
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  144 bits (365), Expect = 4e-43
 Identities = 52/163 (31%), Positives = 86/163 (52%), Gaps = 8/163 (4%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVP--EQTAR 69
           L  E+     + H NI++   +F     I + +E   GG+LS+ +R   G +   EQT  
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-V 128
            + +Q+  GL+ L+ + I+HRD+K +N+L++     +  KI+DFG S  L   N   +  
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL--KISDFGTSKRLAGINPCTETF 183

Query: 129 CGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFS 169
            G+  YMAPE++      Y +  D+WS+G  + E+  G PPF 
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  147 bits (372), Expect = 4e-43
 Identities = 56/185 (30%), Positives = 96/185 (51%), Gaps = 19/185 (10%)

Query: 2   LKKLNKHL---KSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K +NK     +  + C   E + L + +   I +L  AFQ EN ++LV+E+  GG+L +
Sbjct: 91  MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150

Query: 56  YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +   G R+P + AR +L ++   ++ ++    +HRD+KP+NIL   LD    +++ADFG
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFG 207

Query: 115 LSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSVGAILFELLNGY 165
               L       +    G+P Y++PE+LQ          Y  + D W++G   +E+  G 
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

Query: 166 PPFSA 170
            PF A
Sbjct: 268 TPFYA 272

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  142 bits (360), Expect = 2e-42
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 13/166 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQ 73
           E+  L    H NI+       A    I  V ++C G +L  ++     +   +      +
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC---TLYPGNYAEKVCG 130
           Q   G++ L++  IIHRDLK  NI    L +D  +KI DFGL+         +  E++ G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIF---LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 131 SPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           S L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S    
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  142 bits (360), Expect = 3e-42
 Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 19/174 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  +  + HPN+++       +  +  + E+  GG L   I+      P      F + 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 127
           + +G+  L+S +IIHRDL   N L+    ++  + +ADFGL+  +       +       
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 128 --------VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
                   V G+P +MAPE++  + YDEKVD++S G +L E++        Y P
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  142 bits (360), Expect = 4e-42
 Identities = 48/199 (24%), Positives = 79/199 (39%), Gaps = 35/199 (17%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSV-NHPNIIRLFDAF-------QAENCIFLVVEFCAG 50
           LK+L  + +        E+ F+  +  HPNI++   A              FL++     
Sbjct: 58  LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117

Query: 51  GNLSSYI---RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD 105
           G L  ++      G +   T  K   Q    ++ ++     IIHRDLK EN+LL    + 
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQ 174

Query: 106 VMLKIADFGLSCTLYPGNYAEK-------------VCGSPLYMAPEVLQFQR---YDEKV 149
             +K+ DFG + T+                        +P+Y  PE++         EK 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234

Query: 150 DMWSVGAILFELLNGYPPF 168
           D+W++G IL+ L     PF
Sbjct: 235 DIWALGCILYLLCFRQHPF 253

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  147 bits (372), Expect = 8e-42
 Identities = 60/175 (34%), Positives = 95/175 (54%), Gaps = 10/175 (5%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   +      C   E   L+     P + +L   FQ  + ++ V+E+  GG+L  +I
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           +  GR  E  A  +  ++  GL  L S  II+RDLK +N++   LD +  +KIADFG+ C
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 489

Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              ++ G   +  CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G  PF  
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  142 bits (359), Expect = 2e-41
 Identities = 24/174 (13%), Positives = 53/174 (30%), Gaps = 25/174 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCA------GGNLSSYIRLHGRVPEQT 67
             + +       +IR+    +       F +           G  L S+   H  +    
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
             +   Q+   L  L+ + ++H  L+P +I+   LD    + +  F              
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLV---RDGARVV 261

Query: 128 VCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPFSA 170
              S  +  PE+   +                 D W++G +++ +     P + 
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  140 bits (355), Expect = 2e-41
 Identities = 37/170 (21%), Positives = 70/170 (41%), Gaps = 20/170 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+       H N++    A  +   + ++   C G  L S +R    V      R+  Q+
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------V 128
           +  G+  L++  I+H+DLK +N+      D+  + I DFGL           +       
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 129 CGSPLYMAPEVLQFQR---------YDEKVDMWSVGAILFELLNGYPPFS 169
            G   ++APE+++            + +  D++++G I +EL     PF 
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  138 bits (351), Expect = 4e-41
 Identities = 55/155 (35%), Positives = 88/155 (56%), Gaps = 11/155 (7%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
           S ++H NI+ + D  + ++C +LV+E+  G  LS YI  HG +   TA  F  Q+  G++
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 81  ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYM 135
             +   I+HRD+KP+NIL   +D +  LKI DFG+       +L        V G+  Y 
Sbjct: 126 HAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSL---TQTNHVLGTVQYF 179

Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +PE  + +  DE  D++S+G +L+E+L G PPF+ 
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  139 bits (353), Expect = 5e-41
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 10/167 (5%)

Query: 16  ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           +L+ +  S + P I++ F  F     +F+ +E           R+ G +PE+   K    
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA 132

Query: 75  LGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           +   L  L   H +IHRD+KP NILL        +K+ DFG+S  L      ++  G   
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRPCF 175
           YMAPE +         YD + D+WS+G  L EL  G  P+   +  F
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  140 bits (353), Expect = 1e-40
 Identities = 24/160 (15%), Positives = 43/160 (26%), Gaps = 15/160 (9%)

Query: 24  NHPNIIRLFDAFQAENC--IFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQL 75
           + P   +L             L++   +         L       G            QL
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
                 L S  ++H    P+N+    +  D  L + D         G           Y 
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLF---IMPDGRLMLGDVSAL--WKVGTRGPASSVPVTYA 258

Query: 136 APEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             E L      +   ++ W +G  ++ +   + PF    P
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  137 bits (347), Expect = 4e-40
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 25/167 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + H NII L       + + L+ E+    +L  Y+  +  V  +  + FL QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 76  GAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
             G+   +S   +HRDLKP+N+LLS     +  +LKI DFGL+          +  G P+
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAFGIPI 191

Query: 134 -----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                      Y  PE+L   + Y   VD+WS+  I  E+L   P F
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  135 bits (342), Expect = 1e-39
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV++   YD K D+WS+G    EL  G PP S   P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  135 bits (342), Expect = 1e-39
 Identities = 51/160 (31%), Positives = 86/160 (53%), Gaps = 5/160 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E++ +   + P++++ + ++     +++V+E+C  G++S  IRL    + E      LQ 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 133
              GLE L+    IHRD+K  NILL+  +     K+ADFG++  L         V G+P 
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLN-TEGHA--KLADFGVAGQLTDTMAKRNTVIGTPF 190

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +MAPEV+Q   Y+   D+WS+G    E+  G PP++   P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  135 bits (342), Expect = 2e-39
 Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 27/166 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  ++HPNI+ L D   +E C+ LV EF    +L   +  +     +   + +L Q
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+          +  G P+ 
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLA----------RAFGIPVR 174

Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                     Y AP+VL   ++Y   VD+WS+G I  E++ G P F
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  134 bits (341), Expect = 2e-39
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 27/166 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  + HPN++ L + F+ +  + LV E+C    +   +  + R VPE   +    Q
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
               +   + H+ IHRD+KPENIL   +    ++K+ DFG +          ++   P  
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENIL---ITKHSVIKLCDFGFA----------RLLTGPSD 157

Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                     Y +PE+L    +Y   VD+W++G +  ELL+G P +
Sbjct: 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  135 bits (341), Expect = 2e-39
 Identities = 46/159 (28%), Positives = 89/159 (55%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ ++ ++     +++++EF  GG L+  +    R+ E+      + +
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAV 150

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L  L++  +IHRD+K ++ILL+ LD  V  K++DFG    +       K + G+P +
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV+    Y  +VD+WS+G ++ E+++G PP+ +  P
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  134 bits (340), Expect = 2e-39
 Identities = 53/166 (31%), Positives = 84/166 (50%), Gaps = 27/166 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  + H NI++L+D    +  + LV E     +L   + +        TA+ FL Q
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+          +  G P+ 
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLA----------RAFGIPVR 155

Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                     Y AP+VL   ++Y   +D+WSVG I  E++NG P F
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  134 bits (340), Expect = 2e-39
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +     + E       ++ 
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCREC 125

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              LE L+S+ +IHRD+K +NILL  +D  V  K+ DFG    + P       + G+P +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLG-MDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  133 bits (338), Expect = 3e-39
 Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 16/167 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
           E   L   +HPN++ +  A Q+       L+  +   G+L + +       V +  A KF
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116

Query: 72  LQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
              +  G+  L++    I    L   ++++   D+D+  +I+   +  +           
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSPG----RM 169

Query: 130 GSPLYMAPEVLQFQRYD---EKVDMWSVGAILFELLNGYPPFSAYRP 173
            +P ++APE LQ +  D      DMWS   +L+EL+    PF+    
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  135 bits (341), Expect = 5e-39
 Identities = 63/166 (37%), Positives = 86/166 (51%), Gaps = 27/166 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L  ++HPNII L DAF  ++ I LV +F    +L   I+ +  V      + ++  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
              GLE L+ H I+HRDLKP N+L   LD++ +LK+ADFGL+          K  GSP  
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLA----------KSFGSPNR 167

Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                     Y APE+L   + Y   VDMW+VG IL ELL   P  
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  132 bits (335), Expect = 2e-38
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 27/166 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  + H N++ L +  + +   +LV EF     +   + L    +  Q  +K+L Q
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+   +SH+IIHRD+KPENIL   +    ++K+ DFG +          +   +P  
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENIL---VSQSGVVKLCDFGFA----------RTLAAPGE 179

Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                     Y APE+L    +Y + VD+W++G ++ E+  G P F
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  132 bits (333), Expect = 3e-38
 Identities = 57/173 (32%), Positives = 91/173 (52%), Gaps = 18/173 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+      E  +       
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 72  ----LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
               L+++  GLE L+ +  IHRD+K  NIL   L +D  ++IADFG+S  L  G    +
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNIL---LGEDGSVQIADFGVSAFLATGGDITR 179

Query: 128 ------VCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
                   G+P +MAPEV+ Q + YD K D+WS G    EL  G  P+  Y P
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  133 bits (336), Expect = 3e-38
 Identities = 55/161 (34%), Positives = 76/161 (47%), Gaps = 9/161 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G            + E          
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 163

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
             GL  L+SH++IHRD+K  NILLS     V  K+ DFG +  + P N      G+P +M
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS-EPGLV--KLGDFGSASIMAPAN---SFVGTPYWM 217

Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           APEV+       YD KVD+WS+G    EL    PP      
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  131 bits (332), Expect = 4e-38
 Identities = 54/167 (32%), Positives = 90/167 (53%), Gaps = 14/167 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L++ +HP I++L  A+  +  +++++EFC GG + + +    R   E   +   +Q
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGS 131
           +   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S         +K     G+
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKN--LKTLQKRDSFIGT 180

Query: 132 PLYMAPEV-----LQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           P +MAPEV     ++   YD K D+WS+G  L E+    PP     P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  131 bits (331), Expect = 5e-38
 Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 27/166 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L  + H NI+RL D   ++  + LV EFC   +L  Y          +  + FL Q
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+          +  G P+ 
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA----------RAFGIPVR 156

Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                     Y  P+VL   + Y   +DMWS G I  EL N   P 
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  133 bits (335), Expect = 5e-38
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 15/170 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           EL+     NHPNI+     F A+N +++V  F A G+    I  H    + E      LQ
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---- 129
            +   L+ ++    +HR +K  +IL+S  D  V   ++    + ++      ++V     
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISV-DGKV--YLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 130 ----GSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
                   +++PEVLQ   Q YD K D++SVG    EL NG+ PF     
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  131 bits (332), Expect = 8e-38
 Identities = 55/166 (33%), Positives = 80/166 (48%), Gaps = 31/166 (18%)

Query: 20  LSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFL 72
           L +  HPN++RLFD         E  + LV E     +L++Y+        P +T +  +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            QL  GL+ L+SH ++HRDLKP+NIL   +     +K+ADFGL+          ++    
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNIL---VTSSGQIKLADFGLA----------RIYSFQ 173

Query: 133 L----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           +          Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (330), Expect = 9e-38
 Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 11/158 (6%)

Query: 21  SSVNHPNIIRLFD----AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           +++NHP I+ ++D       A    ++V+E+  G  L   +   G +  + A + +    
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEKVCGSP 132
             L   + + IIHRD+KP NI++S       +K+ DFG+    + +         V G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            Y++PE  +    D + D++S+G +L+E+L G PPF+ 
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  131 bits (331), Expect = 9e-38
 Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 27/166 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  GL   +   ++HRDLKP+N+L   +++   LK+ADFGL+          +    P  
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLL---INERGELKLADFGLA----------RAKSIPTK 155

Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
                     Y  P++L     Y  ++DMW VG I +E+  G P F
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  130 bits (329), Expect = 1e-37
 Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 31/169 (18%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRV--PEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+        P +T +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             ++Q   GL+ L+++ I+HRDLKPENIL   +     +K+ADFGL+          ++ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENIL---VTSGGTVKLADFGLA----------RIY 170

Query: 130 GSPL----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
              +          Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  130 bits (329), Expect = 1e-37
 Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 32/171 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------PEQTAR 69
           E++ +  + H NI+RL+D    EN + LV EF    +L  Y+                 +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
            F  QL  GL   + + I+HRDLKP+N+L   ++    LK+ DFGL+          +  
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLA----------RAF 158

Query: 130 GSPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
           G P+           Y AP+VL   + Y   +D+WS G IL E++ G P F
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  130 bits (328), Expect = 2e-37
 Identities = 39/154 (25%), Positives = 75/154 (48%), Gaps = 11/154 (7%)

Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
            +  P+++ + D  + +  +++ +    G +L++ +R  G +    A   ++Q+G+ L+ 
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYMA 136
            ++    HRD+KPENIL+S  DD     + DFG+        L          G+  YMA
Sbjct: 150 AHAAGATHRDVKPENILVSA-DDFA--YLVDFGIASATTDEKL---TQLGNTVGTLYYMA 203

Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           PE         + D++++  +L+E L G PP+  
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  128 bits (323), Expect = 6e-37
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 12/169 (7%)

Query: 16  ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKF 71
           +L+  + +V+ P  +  + A   E  +++ +E         Y   I     +PE    K 
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 72  LQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
              +   LE L+S   +IHRD+KP N+L++     V  K+ DFG+S  L      +   G
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQV--KMCDFGISGYLVDDVAKDIDAG 171

Query: 131 SPLYMAPEV----LQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPCF 175
              YMAPE     L  + Y  K D+WS+G  + EL     P+ ++   F
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  127 bits (321), Expect = 2e-36
 Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 13/170 (7%)

Query: 16  ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARK 70
           +L+  + S + P I++ + A   E   ++ +E  +      Y      L   +PE+   K
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129

Query: 71  FLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
                   L  L     IIHRD+KP NILL     ++  K+ DFG+S  L       +  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNI--KLCDFGISGQLVDSIAKTRDA 186

Query: 130 GSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPFSAYRPCF 175
           G   YMAPE +        YD + D+WS+G  L+EL  G  P+  +   F
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  128 bits (324), Expect = 5e-36
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 17/179 (9%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
           +KK+ +  +     EL  +  ++H NI+RL   F      + E  + LV+++     +  
Sbjct: 84  IKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYR 141

Query: 56  YIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
             R + R    +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ 
Sbjct: 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199

Query: 112 DFGLSCTLYPGN-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           DFG +  L  G      +C S  Y APE+      Y   +D+WS G +L ELL G P F
Sbjct: 200 DFGSAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  128 bits (323), Expect = 6e-36
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 38/181 (20%)

Query: 15  CELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR---------V 63
            E+  L  + HPN+I L   F   A+  ++L+ ++    +L   I+ H           +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG 122
           P    +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179

Query: 123 NYAEKVCGSPL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPP 167
               ++  SPL              Y APE+L   + Y + +D+W++G I  ELL   P 
Sbjct: 180 ----RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235

Query: 168 F 168
           F
Sbjct: 236 F 236

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  127 bits (320), Expect = 1e-35
 Identities = 24/170 (14%), Positives = 54/170 (31%), Gaps = 18/170 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI--FLVVEFCAG------GNLSSYIRLHGRVPEQT 67
             + +       +IR+    +    +  F +              L S+   H  +    
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 126
             +   Q+   L  L+ + ++H  L+P +I+   LD    + +  F           +  
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLVRDGASAVSPI 269

Query: 127 -KVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSA 170
            +    P   A  +L F +          D W++G  ++ +     P + 
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  126 bits (318), Expect = 3e-35
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGR----VPE 65
           EL  +  V HPN++ L   F      + E  + LV+E+     +    R + +    +P 
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y 124
              + ++ QL   L  ++S  I HRD+KP+N+LL       +LK+ DFG +  L  G   
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPN 198

Query: 125 AEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
              +C S  Y APE+      Y   +D+WS G ++ EL+ G P F
Sbjct: 199 VSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (324), Expect = 4e-35
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 15/157 (9%)

Query: 19  FLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           FL+ V HP+I+++F+  +  +       ++V+E+  G +L        ++P   A  +L 
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLL 189

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++   L  L+S  +++ DLKPENI+L+  ++ +  K+ D G    +   N    + G+P 
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT--EEQL--KLIDLGAVSRI---NSFGYLYGTPG 242

Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           + APE+++        D+++VG  L  L    P  + 
Sbjct: 243 FQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNG 278

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (309), Expect = 1e-34
 Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 18/173 (10%)

Query: 16  ELNFLSSV-NHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQ 66
           E+N L    +H NI   + AF        ++ ++LV+EFC  G+++  I+      + E+
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
                 +++  GL  L+ H +IHRD+K +N+LL+  + +V  K+ DFG+S  L       
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEV--KLVDFGVSAQLDRTVGRR 186

Query: 127 K-VCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
               G+P +MAPEV+         YD K D+WS+G    E+  G PP     P
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  120 bits (304), Expect = 5e-34
 Identities = 42/181 (23%), Positives = 72/181 (39%), Gaps = 27/181 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           EL     + H NI+    +      +   ++L+  +   G+L  Y++L   +   +  + 
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRI 110

Query: 72  LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  + +GL  L+           I HRDLK +NIL   +  +    IAD GL+       
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQST 167

Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
               V      G+  YMAPEVL            ++VD+W+ G +L+E+           
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

Query: 173 P 173
            
Sbjct: 228 D 228

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  121 bits (306), Expect = 1e-33
 Identities = 59/178 (33%), Positives = 88/178 (49%), Gaps = 17/178 (9%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        +++V+E    
Sbjct: 55  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MD 113

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            NL   I++   +  +     L Q+  G++ L+S  IIHRDLKP NI++     D  LKI
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 168

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+ T            +  Y APEV+    Y E VD+WSVG I+ E++ G   F
Sbjct: 169 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  120 bits (303), Expect = 1e-33
 Identities = 40/181 (22%), Positives = 70/181 (38%), Gaps = 27/181 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+     + H NI+    A          ++LV ++   G+L  Y+  +  V  +   K 
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKL 144

Query: 72  LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                +GL  L+           I HRDLK +NIL+     +    IAD GL+       
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSAT 201

Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
               +      G+  YMAPEVL      +     ++ D++++G + +E+         + 
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

Query: 173 P 173
            
Sbjct: 262 D 262

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  121 bits (306), Expect = 3e-33
 Identities = 59/178 (33%), Positives = 86/178 (48%), Gaps = 17/178 (9%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        ++LV+E    
Sbjct: 92  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MD 150

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            NL   I+    +  +     L Q+  G++ L+S  IIHRDLKP NI++     D  LKI
Sbjct: 151 ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+ T            +  Y APEV+    Y E VD+WSVG I+ E++     F
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  119 bits (299), Expect = 5e-33
 Identities = 42/182 (23%), Positives = 70/182 (38%), Gaps = 27/182 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+     + H NI+    A      +   ++L+ ++   G+L  Y++    +  ++  K 
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKL 139

Query: 72  LQQLGAGL-----EILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                +GL     EI ++     I HRDLK +NIL   +  +    IAD GL+       
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVKFISDT 196

Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
               +      G+  YM PEVL         +     DM+S G IL+E+           
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

Query: 173 PC 174
             
Sbjct: 257 EY 258

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  119 bits (300), Expect = 7e-33
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 35/187 (18%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +         +LV+ F  G
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MG 113

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   ++ H ++ E   +  + Q+  GL  +++  IIHRDLKP N+ +   ++D  LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKI 169

Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 161
            DFGL+          +   S +        Y APEV L + RY + VD+WSVG I+ E+
Sbjct: 170 LDFGLA----------RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

Query: 162 LNGYPPF 168
           + G   F
Sbjct: 220 ITGKTLF 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  118 bits (297), Expect = 2e-32
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 20/179 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   +        +LV+ F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQ 112

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   +    +  E+  +  + Q+  GL+ ++S  ++HRDLKP N+ +   ++D  LKI
Sbjct: 113 TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKI 167

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            DFGL+           V  +  Y APEV L +  Y++ VD+WSVG I+ E+L G   F
Sbjct: 168 LDFGLARHADA-EMTGYV-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  116 bits (294), Expect = 4e-32
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 28/189 (14%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+       L       E+  L    H NII +F+  + ++      ++++ E     
Sbjct: 41  IKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-MQT 98

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L   I     + +   + F+ Q    +++L+  ++IHRDLKP N+L+   + +  LK+ 
Sbjct: 99  DLHRVIS-TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVC 154

Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------YMAPEV-LQFQRYDEKVDMWSVGAILF 159
           DFGL+  +                         Y APEV L   +Y   +D+WS G IL 
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214

Query: 160 ELLNGYPPF 168
           EL    P F
Sbjct: 215 ELFLRRPIF 223

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  115 bits (289), Expect = 1e-31
 Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 26/180 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+  L  + H NI++   A +    +    +L+  F   G+LS +++ +  V        
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126

Query: 72  LQQLGAGLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + +  GL  L+             I HRD+K +N+L   L +++   IADFGL+     
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEA 183

Query: 122 GNYAEK---VCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           G  A       G+  YMAPEVL+      +    ++DM+++G +L+EL +          
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  114 bits (288), Expect = 1e-31
 Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 11/162 (6%)

Query: 15  CELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFL 72
            E   +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F 
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCG 130
            Q+  G++ L S   +HRDL   N +L   +   + K+ADFGL+  +Y   Y       G
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEYYSVHNKTG 191

Query: 131 SPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           + L   +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  115 bits (291), Expect = 1e-31
 Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 19/168 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA-------ENCIFLVVEFCAGGNLSSYIRLHGR----VP 64
            +  L+ ++HPNI++L   F         +  + +V+E+     L    R + R     P
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127

Query: 65  EQTARKFLQQLGAGLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
               + FL QL   +  L   S ++ HRD+KP N+L++  D    LK+ DFG +  L P 
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPS 185

Query: 123 N-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                 +C S  Y APE+    Q Y   VD+WSVG I  E++ G P F
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  115 bits (289), Expect = 1e-31
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 10/149 (6%)

Query: 24  NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
             PNII L D  +        LV E     +     +    + +   R ++ ++   L+ 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 145

Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVL 140
            +S  I+HRD+KP N+++        L++ D+GL+   +PG  Y  +V  S  +  PE+L
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELL 202

Query: 141 -QFQRYDEKVDMWSVGAILFELLNGYPPF 168
             +Q YD  +DMWS+G +L  ++    PF
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  115 bits (290), Expect = 1e-31
 Identities = 42/171 (24%), Positives = 79/171 (46%), Gaps = 25/171 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYI-RLHGRVPEQ 66
           E+  L  + H N++ L +  + +          I+LV +FC   +L+  +  +  +    
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             ++ +Q L  GL  ++ + I+HRD+K  N+L   +  D +LK+ADFGL+   +  + A+
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADFGLA-RAF--SLAK 178

Query: 127 KVCGSPL--------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
               +          Y  PE+L   + Y   +D+W  G I+ E+    P  
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  115 bits (291), Expect = 1e-31
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 35/187 (18%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F           ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 117

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKI 173

Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 161
            DFGL+          +     +        Y APE+ L +  Y++ VD+WSVG I+ EL
Sbjct: 174 LDFGLA----------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

Query: 162 LNGYPPF 168
           L G   F
Sbjct: 224 LTGRTLF 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  116 bits (293), Expect = 2e-31
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 42/212 (19%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL+D    ++      +++V+E  A  
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L    +    + E+  +  L  L  G   ++   IIHRDLKP N L   L+ D  +K+ 
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171

Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------------------YMAPEV-LQFQRYDE 147
           DFGL+ T+        V                            Y APE+ L  + Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231

Query: 148 KVDMWSVGAILFELLNG----YPPFSAYRPCF 175
            +D+WS G I  ELLN         +   P F
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  115 bits (290), Expect = 2e-31
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 11/161 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
           E   +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
           Q+  G++ L S   +HRDL   N +L   +   + K+ADFGL+  +Y   +       G+
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEFDSVHNKTGA 256

Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            L   +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  114 bits (287), Expect = 2e-31
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q    +  Q
Sbjct: 67  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
           +  G+  L    ++HRDL   N+L+        +KI DFGL+  L          G   P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           + +MA E +  + Y  + D+WS G  ++EL+  G  P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  115 bits (289), Expect = 3e-31
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 29/186 (15%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK++   +    C     E+  L    H NII + D  +A        +++V +     
Sbjct: 57  IKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-MET 114

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L   ++    +       FL Q+  GL+ ++S +++HRDLKP N+LL   +    LKI 
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKIC 170

Query: 112 DFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELL 162
           DFGL+    P    +      L        Y APE+ L  + Y + +D+WSVG IL E+L
Sbjct: 171 DFGLARVADP----DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

Query: 163 NGYPPF 168
           +  P F
Sbjct: 227 SNRPIF 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  116 bits (292), Expect = 3e-31
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 47/217 (21%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+ +  +  +DC     E+  L+ +NH +++++ D    ++      +++V+E  A  
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +     R    + E   +  L  L  G++ ++S  I+HRDLKP N L   ++ D  +K+ 
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198

Query: 112 DFGLSCTLYPGNYAEKVCGSPL----------------------------YMAPEV-LQF 142
           DFGL+ T+                                          Y APE+ L  
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258

Query: 143 QRYDEKVDMWSVGAILFELLNGYPPFSAY----RPCF 175
           + Y E +D+WS+G I  ELLN      AY     P F
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  113 bits (285), Expect = 3e-31
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 11/161 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
           E   +  +NHPN++ L       E    +++ +   G+L  +IR   R P  +    F  
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
           Q+  G+E L     +HRDL   N +L    +   +K+ADFGL+  +    Y   ++   +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            L   + A E LQ  R+  K D+WS G +L+ELL  G PP+
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  114 bits (288), Expect = 4e-31
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 36/198 (18%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNL 53
           +KK+    ++  D      E+  L+ ++ H NI+ L +  +A+N   ++LV ++    +L
Sbjct: 39  VKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL 97

Query: 54  SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
            + IR    +     +  + QL   ++ L+S  ++HRD+KP NILL   + +  +K+ADF
Sbjct: 98  HAVIR-ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADF 153

Query: 114 GLSCTLYPGNYAEKVCGSPL----------------------YMAPEV-LQFQRYDEKVD 150
           GLS +              +                      Y APE+ L   +Y + +D
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213

Query: 151 MWSVGAILFELLNGYPPF 168
           MWS+G IL E+L G P F
Sbjct: 214 MWSLGCILGEILCGKPIF 231

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  113 bits (285), Expect = 5e-31
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 20/185 (10%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNL 53
            +K  N   +   +   E   +   +HPN+IRL       + Q      +++ F   G+L
Sbjct: 69  TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128

Query: 54  SSYIRLH------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
            +Y+           +P QT  KF+  +  G+E L++ + +HRDL   N +L   DD  +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--DDMTV 186

Query: 108 LKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163
             +ADFGLS  +Y G+Y  +   + +   ++A E L  + Y  K D+W+ G  ++E+   
Sbjct: 187 -CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

Query: 164 GYPPF 168
           G  P+
Sbjct: 246 GMTPY 250

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  113 bits (285), Expect = 5e-31
 Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 31/176 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--------------IFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++F+                     +++V E+    +L++ +   G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLE-QG 115

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173

Query: 122 GNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                      L        Y +P + L    Y + +DMW+ G I  E+L G   F
Sbjct: 174 ----HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  114 bits (287), Expect = 5e-31
 Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 20/180 (11%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSY 56
           +L+++N    +  D            +I++L D F  +      + +V E   G NL + 
Sbjct: 68  LLQRVNDADNTKEDSM-------GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119

Query: 57  IRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDD---DVMLKI 110
           I+   H  +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           AD G +C  +   +      +  Y +PEVL    +    D+WS   ++FEL+ G   F  
Sbjct: 180 ADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  113 bits (284), Expect = 6e-31
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 21/170 (12%)

Query: 16  ELNFLSSVNHPNIIRLF------DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           E   +   +HP++ +L        A        +++ F   G+L +++    R+ E    
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFN 133

Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                  +F+  +  G+E L+S + IHRDL   N +L+   +D+ + +ADFGLS  +Y G
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSG 190

Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           +Y  + C S L   ++A E L    Y    D+W+ G  ++E++  G  P+
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  113 bits (286), Expect = 6e-31
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 13/161 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVP--EQTA 68
           E+  L+  +HPNI+ L D F          ++LV E     +L+  I    R+    Q  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIH-DQRIVISPQHI 136

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           + F+  +  GL +L+   ++HRDL P NILL    D+  + I DF L+            
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHY 193

Query: 129 CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
                Y APE+ +QF+ + + VDMWS G ++ E+ N    F
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  112 bits (282), Expect = 2e-30
 Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
            +  + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q
Sbjct: 65  HMLAIGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L  H ++HR+L   N+LL        +++ADFG++  L P +       +   
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +MA E + F +Y  + D+WS G  ++EL+  G  P+
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  112 bits (283), Expect = 2e-30
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 49/211 (23%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------------------------ 37
           LKK+ +  +     EL+ +  ++H NII+L D F                          
Sbjct: 37  LKKVLQDPRYKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95

Query: 38  --------------ENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQLGAGL 79
                            + +++E+     L   ++   R    +P      ++ QL   +
Sbjct: 96  VNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154

Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPE 138
             ++S  I HRD+KP+N+L++  D+   LK+ DFG +  L P       +C S  Y APE
Sbjct: 155 GFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPE 211

Query: 139 V-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           + L    Y   +D+WS+G +  EL+ G P F
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGKPLF 242

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  110 bits (278), Expect = 3e-30
 Identities = 43/151 (28%), Positives = 81/151 (53%), Gaps = 10/151 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFL 72
           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR         KF 
Sbjct: 64  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
             +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 177

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           + + APE L+ +++  K D+WS G +L+E+ 
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIY 208

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  111 bits (279), Expect = 3e-30
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q    +  Q
Sbjct: 67  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    ++HRDL   N+L+        +KI DFGL+  L          G  + 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +MA E +  + Y  + D+WS G  ++EL+  G  P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  111 bits (279), Expect = 3e-30
 Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 17/170 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
           E + +   N  +++RL           +++E    G+L SY+R                 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 70  ----KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
               +   ++  G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194

Query: 126 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAY 171
            K     L   +M+PE L+   +    D+WS G +L+E+      P+   
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  111 bits (279), Expect = 4e-30
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 10/156 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
           E   +S  NH NI+R           F+++E  AGG+L S++R     P Q +       
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 70  -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
               + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  +Y  K 
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202

Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
             + L   +M PE      +  K D WS G +L+E+
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  112 bits (283), Expect = 5e-30
 Identities = 43/151 (28%), Positives = 82/151 (54%), Gaps = 10/151 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF 
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
             +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 349

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           + + APE L+ +++  K D+WS G +L+E+ 
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIY 380

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  112 bits (282), Expect = 5e-30
 Identities = 59/170 (34%), Positives = 76/170 (44%), Gaps = 18/170 (10%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ L K  K             N  N+I + + F   N I +  E     NL   I+ +
Sbjct: 146 ILEHLRKQDKD------------NTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKN 192

Query: 61  G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                     RKF   +   L+ L+ + IIH DLKPENILL        +K+ DFG SC 
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSC- 250

Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            Y          S  Y APEV+   RY   +DMWS+G IL ELL GYP  
Sbjct: 251 -YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  111 bits (279), Expect = 7e-30
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
           E   +S  NH NI+R           F+++E  AGG+L S++R     P Q +       
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 70  -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
               + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y   Y  K 
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243

Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPF 168
             + L   +M PE      +  K D WS G +L+E+   GY P+
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (272), Expect = 2e-29
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R             
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
              + APE L + ++  K D+W+ G +L+E+ 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  110 bits (276), Expect = 2e-29
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 8/150 (5%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEIL 82
           +HPNI+RL      +  I++V+E   GG+  +++R  G  +  +T  + +    AG+E L
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEV 139
            S   IHRDL   N L++   +  +LKI+DFG+S     G YA       +   + APE 
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286

Query: 140 LQFQRYDEKVDMWSVGAILFELL-NGYPPF 168
           L + RY  + D+WS G +L+E    G  P+
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPY 316

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  108 bits (272), Expect = 4e-29
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 21/164 (12%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
           EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E         
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 67  ---TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
              + R  L    Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  + 
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIM 215

Query: 121 PGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
             +       + L   +MAPE +    Y  + D+WS G +L+E+
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  110 bits (276), Expect = 6e-29
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 10/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  V          
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+ + +E L   + IHR+L   N L+    ++ ++K+ADFGLS  L  G+      G+  
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 381

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPF 168
              + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  106 bits (267), Expect = 7e-29
 Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 7/157 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E   +  ++HP +++ +     E  I++V E+ + G L +Y+R HG+ +      +    
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
           +  G+  L SH  IHRDL   N L+     D+ +K++DFG++  +    Y   V    P+
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169

Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            + APEV  + +Y  K D+W+ G +++E+ + G  P+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  109 bits (273), Expect = 7e-29
 Identities = 60/172 (34%), Positives = 74/172 (43%), Gaps = 20/172 (11%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ +NKH                   I+ L   F   N + LV E     NL   +R  
Sbjct: 103 LLELMNKHDTE------------MKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT 149

Query: 61  GRVP--EQTARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG S
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
           C    G    +   S  Y +PEVL    YD  +DMWS+G IL E+  G P F
Sbjct: 209 C--QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  108 bits (270), Expect = 8e-29
 Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 34/190 (17%)

Query: 15  CELNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
             +  +  + H NI R                 LV+E+   G+L  Y+ LH      ++ 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 70  KFLQQLGAGL-----EILNSHH----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           +    +  GL     E+    H    I HRDL   N+L   + +D    I+DFGLS  L 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL---VKNDGTCVISDFGLSMRLT 171

Query: 121 PGNYAEK---------VCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAILFELLNG 164
                             G+  YMAPEVL+        +   ++VDM+++G I +E+   
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 165 YPPFSAYRPC 174
                     
Sbjct: 232 CTDLFPGESV 241

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  109 bits (275), Expect = 9e-29
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++       +  +      
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
           Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y  +     P
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 427

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (266), Expect = 1e-28
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 7/157 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y        P+
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169

Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  107 bits (269), Expect = 1e-28
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 21/180 (11%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R H
Sbjct: 78  ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137

Query: 61  GRVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
           G   +  A                    Q+ AG+  L   H +HRDL   N L+      
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QG 194

Query: 106 VMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           +++KI DFG+S  +Y  +Y      + L   +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  108 bits (272), Expect = 2e-28
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++       +  +      
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
           Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y  +     P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (266), Expect = 2e-28
 Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 23/182 (12%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
            LK      L+     E    + + HPN++ L      +  + ++  +C+ G+L  ++ +
Sbjct: 46  TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105

Query: 60  HGRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
                +  +                   + Q+ AG+E L+SHH++H+DL   N+L+    
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 162

Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFE 160
           D + +KI+D GL   +Y  +Y + +  S L   +MAPE + + ++    D+WS G +L+E
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222

Query: 161 LL 162
           + 
Sbjct: 223 VF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  106 bits (266), Expect = 2e-28
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 10/155 (6%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L ++ H NI++          N I L++EF   G+L  Y+  +  ++  +   K+
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
             Q+  G++ L S   +HRDL   N+L+     +  +KI DFGL+  +      Y  K  
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDD 188

Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
             SP+ + APE L   ++    D+WS G  L ELL
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  105 bits (265), Expect = 3e-28
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 24/167 (14%)

Query: 16  ELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
           EL  L  + +H N++ L  A  +    + ++VEFC  GNLS+Y+R               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 61  GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
                 T    +    Q+  G+E L S   IHRDL   NILLS   +  ++KI DFGL+ 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLAR 196

Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            +Y      +   + L   +MAPE +  + Y  + D+WS G +L+E+
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  105 bits (264), Expect = 4e-28
 Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 22/181 (12%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK      +     E   L+++ H +I++ +      + + +V E+   G+L+ ++R H
Sbjct: 52  ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111

Query: 61  GRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD 104
           G                            Q+ +G+  L S H +HRDL   N L+     
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---A 168

Query: 105 DVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           ++++KI DFG+S  +Y  +Y      + L   +M PE + ++++  + D+WS G IL+E+
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

Query: 162 L 162
            
Sbjct: 229 F 229

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  105 bits (265), Expect = 4e-28
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 10/154 (6%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
            E++ L ++ H +II+            + LV+E+   G+L  Y+  H  +       F 
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-- 130
           QQ+  G+  L++ H IHRDL   N+LL    +D ++KI DFGL+  +  G+   +V    
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG 197

Query: 131 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
            SP+ + APE L+  ++    D+WS G  L+ELL
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  104 bits (262), Expect = 6e-28
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 11/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    +     +      
Sbjct: 58  EANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y  +  G+  
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTARE-GAKF 172

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
              + APE + +  +  K D+WS G +L E++  G  P+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  104 bits (261), Expect = 9e-28
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E N +  +++P I+R+    +AE+   LV+E    G L+ Y++ +  V ++   + + Q+
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS--P 132
             G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY +       P
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           + + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  107 bits (269), Expect = 9e-28
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 8/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +HP+I++L         +++++E C  G L S++++    +   +   +  Q
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
           L   L  L S   +HRD+   N+L+S    +  +K+ DFGLS  +    Y +   G  P+
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556

Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MAPE + F+R+    D+W  G  ++E+L  G  PF
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  104 bits (261), Expect = 9e-28
 Identities = 46/172 (26%), Positives = 86/172 (50%), Gaps = 13/172 (7%)

Query: 7   KHLKSCLDCELNFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           K +K     E  F+       +++H  +++L+     +  IF++ E+ A G L +Y+R  
Sbjct: 54  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             R   Q   +  + +   +E L S   +HRDL   N L++   D  ++K++DFGLS  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV 170

Query: 120 YPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
               Y   V    P+ +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  104 bits (261), Expect = 1e-27
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 30/173 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135

Query: 67  ------------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                       T    +    Q+  G++ L    ++HRDL   NIL++  +   M KI+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKM-KIS 192

Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           DFGLS  +Y  +   K     +   +MA E L    Y  + D+WS G +L+E+
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  104 bits (261), Expect = 2e-27
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 9/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+ 
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +GAG+  L+    +HRDL   N+L+     +++ K++DFGLS  L     A         
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           P+ + APE + F+ +    D+WS G +++E+L  G  P+
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  104 bits (261), Expect = 2e-27
 Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 11/173 (6%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
           E+  L +++   I++            + LV+E+   G L  +++ H  R+       + 
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG- 130
            Q+  G+E L S   +HRDL   NIL+     +  +KIADFGL+  L    +Y       
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPG 190

Query: 131 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRPCFASRLC 180
            SP+ + APE L    +  + D+WS G +L+EL        S          C
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  103 bits (258), Expect = 2e-27
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 9/152 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
           +  G+  L S   IHRDL   N+LL+      ++KI DFGL   L    ++        +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
              + APE L+ + +    D W  G  L+E+ 
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 2e-27
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+      ++
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
             Q+  G+E L +   IHRDL   NIL+    ++  +KI DFGL+  L      Y  K  
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEP 207

Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           G SP+ + APE L   ++    D+WS G +L+EL 
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  103 bits (258), Expect = 2e-27
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 8/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +HP+I++L         +++++E C  G L S++++    +   +   +  Q
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
           L   L  L S   +HRD+   N+L+S    +  +K+ DFGLS  +    Y +   G  P+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181

Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
            +MAPE + F+R+    D+W  G  ++E+L  G  PF
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  105 bits (264), Expect = 2e-27
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 8/151 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E N + ++ H  +++L  A   +  I+++ EF A G+L  +++      +   +   F  
Sbjct: 233 EANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
           Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y  +     P
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFP 348

Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           + + APE + F  +  K D+WS G +L E++
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  103 bits (258), Expect = 3e-27
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+      ++
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
             Q+  G+E L +   IHRDL   NIL+    ++  +KI DFGL+  L      +  K  
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEP 176

Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
           G SP+ + APE L   ++    D+WS G +L+EL 
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  103 bits (259), Expect = 4e-27
 Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 33/186 (17%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +LKK+ +  K             N    + + D F     + +  E   G N   +++ +
Sbjct: 69  VLKKIKEKDKE------------NKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKEN 115

Query: 61  GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM----------- 107
                P    R    QL   L  L+ + + H DLKPENIL    + + +           
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175

Query: 108 -----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
                +++ADFG +   +   +   +  +  Y  PEV+    + +  D+WS+G ILFE  
Sbjct: 176 VKNTSIRVADFGSAT--FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233

Query: 163 NGYPPF 168
            G+  F
Sbjct: 234 RGFTLF 239

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  103 bits (258), Expect = 4e-27
 Identities = 53/185 (28%), Positives = 78/185 (42%), Gaps = 28/185 (15%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           MLK  + HL        EL  LS + NH NI+ L  A        ++ E+C  G+L +++
Sbjct: 60  MLKP-SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118

Query: 58  R---------------LHGRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILL 99
           R               +            L    Q+  G+  L S + IHRDL   NILL
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178

Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGA 156
           +     +  KI DFGL+  +   +       + L   +MAPE +    Y  + D+WS G 
Sbjct: 179 T--HGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235

Query: 157 ILFEL 161
            L+EL
Sbjct: 236 FLWEL 240

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  101 bits (255), Expect = 7e-27
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 10/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  +++P I+RL         + LV+E   GG L  ++      +P     + L Q
Sbjct: 60  EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
           +  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L    +Y         
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
              + APE + F+++  + D+WS G  ++E L+ G  P+
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (258), Expect = 9e-27
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 9/160 (5%)

Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP 132
            + +G++ L+    +HRDL   NIL++    +++ K++DFGL   L     A     G  
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211

Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
           +   + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  101 bits (253), Expect = 1e-26
 Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 10/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   + +++HP+I++L    + E   ++++E    G L  Y+  +   +   T   +  Q
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +  L S + +HRD+   NIL++       +K+ DFGLS  +   +Y  K   + L 
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177

Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
             +M+PE + F+R+    D+W     ++E+L+ G  PF
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  102 bits (255), Expect = 1e-26
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 9/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +H NIIRL         + ++ E+   G L  ++R   G          L+ 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSPL 133
           + AG++ L + + +HRDL   NIL++    +++ K++DFGLS  L     A     G  +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
              + APE + ++++    D+WS G +++E++  G  P+
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  101 bits (255), Expect = 2e-26
 Identities = 43/186 (23%), Positives = 76/186 (40%), Gaps = 33/186 (17%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ LN    +            +    +++ + F+    I +V E   G +   +I+ +
Sbjct: 64  VLEHLNTTDPN------------STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110

Query: 61  GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------SGL 102
           G +       RK   Q+   +  L+S+ + H DLKPENIL                    
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170

Query: 103 DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
             +  +K+ DFG +   Y   +   +  +  Y APEV+    + +  D+WS+G IL E  
Sbjct: 171 LINPDIKVVDFGSAT--YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228

Query: 163 NGYPPF 168
            G+  F
Sbjct: 229 LGFTVF 234

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (253), Expect = 3e-26
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 30/174 (17%)

Query: 15  CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
            EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R               
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 61  -------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                    +   T    L    Q+  G+E L     +HRDL   N+L++     V+ KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVV-KI 213

Query: 111 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            DFGL+  +   +       + L   +MAPE L    Y  K D+WS G +L+E+
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  100 bits (252), Expect = 4e-26
 Identities = 45/190 (23%), Positives = 86/190 (45%), Gaps = 31/190 (16%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           MLK+  +  +++    E   ++  ++PNI++L         + L+ E+ A G+L+ ++R 
Sbjct: 84  MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143

Query: 60  HGRVPEQTAR------------------------KFLQQLGAGLEILNSHHIIHRDLKPE 95
                  +                             +Q+ AG+  L+    +HRDL   
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203

Query: 96  NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMW 152
           N L+   ++ V+ KIADFGLS  +Y  +Y +      +   +M PE + + RY  + D+W
Sbjct: 204 NCLVG--ENMVV-KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260

Query: 153 SVGAILFELL 162
           + G +L+E+ 
Sbjct: 261 AYGVVLWEIF 270

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 99.8 bits (249), Expect = 4e-26
 Identities = 29/151 (19%), Positives = 48/151 (31%), Gaps = 31/151 (20%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
           LS ++ P + R+ D         +V E+  GG+L          P    R  +Q L A  
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIR-AMQSLAAAA 142

Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           +  +   +      P  + +S  D DV   +A                       M    
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSI-DGDV--VLAYPA-------------------TMPDA- 179

Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                 + + D+  +GA L+ LL    P   
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWPLPE 204

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  100 bits (250), Expect = 6e-26
 Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 26/167 (15%)

Query: 15  CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---- 69
            EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R    +    A     
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 70  ------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
                        F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS 
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSR 190

Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
                    K     L   +MA E L +  Y    D+WS G +L+E+
Sbjct: 191 G---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  100 bits (251), Expect = 6e-26
 Identities = 43/182 (23%), Positives = 69/182 (37%), Gaps = 32/182 (17%)

Query: 16  ELNFLSSVNH-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTA 68
           E + L  + +      NI++    F   + + L+ E   G +L   I  +       +  
Sbjct: 81  EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------------SGLDDDV 106
           + +  ++   L  L    + H DLKPENILL                             
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
            +K+ DFG +   +  +Y   +  +  Y APEV+    +D   DMWS G +L EL  G  
Sbjct: 200 GIKLIDFGCAT--FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257

Query: 167 PF 168
            F
Sbjct: 258 LF 259

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 99.7 bits (249), Expect = 1e-25
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 23/166 (13%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R       +        
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 67  -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADFGL+  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARD 206

Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  101 bits (253), Expect = 1e-25
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 10/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  +++P I+RL         + LV+E   GG L  ++      +P     + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
           +  G++ L   + +HR+L   N+LL    +    KI+DFGLS  L    +Y         
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501

Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
              + APE + F+++  + D+WS G  ++E L+ G  P+
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 1e-25
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 23/166 (13%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR----- 69
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R       + +      
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 70  -----------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                          QL  G+E L S   IHRDL   N+L++  +++VM KIADFGL+  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARD 252

Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 99.8 bits (249), Expect = 2e-25
 Identities = 48/166 (28%), Positives = 85/166 (51%), Gaps = 23/166 (13%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y++       +        
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 67  -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                +++  +    Q+  G+E L S   IHRDL   N+L++   +D ++KIADFGL+  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARD 240

Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
           ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.7 bits (244), Expect = 3e-25
 Identities = 39/180 (21%), Positives = 85/180 (47%), Gaps = 13/180 (7%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L K +++         + +S ++H +++  +      +   LV EF   G+L +Y++ +
Sbjct: 47  VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD-----DDVMLKIADFG 114
              +      +  +QL A +  L  + +IH ++  +NILL   +     +   +K++D G
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166

Query: 115 LSCTLYPGNYAEKVCGSPL-YMAPEVLQ-FQRYDEKVDMWSVGAILFELL-NGYPPFSAY 171
           +S T+ P +  ++     + ++ PE ++  +  +   D WS G  L+E+   G  P SA 
Sbjct: 167 ISITVLPKDILQE----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 95.7 bits (239), Expect = 2e-24
 Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 16/168 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRL 142

Query: 76  ----GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--- 126
               GA  GL  L++  IIHRD+K  NIL   LD++ + KI DFG+S             
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGIS-KKGTELDQTHLS 198

Query: 127 -KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             V G+  Y+ PE     R  EK D++S G +LFE+L          P
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 84.9 bits (211), Expect = 2e-20
 Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 30/174 (17%)

Query: 16  ELNFLSSVNHPNIIRL--FDAFQAENCI-----FLVVEFCAGGNLSSYIRLHGRVPEQT- 67
           E+  ++   H N++ L  F               LV  +   G+L    RL         
Sbjct: 80  EIKVMAKCQHENLVELLGF-------SSDGDDLCLVYVYMPNGSLLD--RLSCLDGTPPL 130

Query: 68  --ARKFLQQLGA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
               +     GA  G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL+       
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLA-RASEKF 186

Query: 124 YAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
                  ++ G+  YMAPE L+      K D++S G +L E++ G P    +R 
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 84.2 bits (209), Expect = 5e-20
 Identities = 52/180 (28%), Positives = 74/180 (41%), Gaps = 38/180 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E+  +S   H N++RL           LV  + A G+++S   L  R   Q         
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQ 134

Query: 67  -----TARKFLQQLGAGLEILNSH-----HIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                +AR        GL  L  H      IIHRD+K  NIL   LD++    + DFGL+
Sbjct: 135 RIALGSAR--------GLAYL--HDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLA 181

Query: 117 CTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             L           V G+  ++APE L   +  EK D++  G +L EL+ G   F   R 
Sbjct: 182 -KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 85.0 bits (210), Expect = 5e-20
 Identities = 57/237 (24%), Positives = 89/237 (37%), Gaps = 70/237 (29%)

Query: 2   LK--KLNKHLKSCLDCELNFLSSV-----NHPN---IIRLFDAFQAEN------CIFLVV 45
           +K  K  +H       E+  L SV     N PN   +++L D F+         C  +V 
Sbjct: 67  MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVF 124

Query: 46  EFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGL 102
           E   G +L  +I    +  +P    +K +QQ+  GL+ L++   IIH D+KPENILLS  
Sbjct: 125 EV-LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183

Query: 103 DDDVM----------------------------------------------LKIADFGLS 116
           +  +                                               +KIAD G +
Sbjct: 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           C  +   +  +   +  Y + EVL    Y+   D+WS   + FEL  G   F  +  
Sbjct: 244 C--WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.0 bits (192), Expect = 1e-17
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
            +  Q+  G+E L S   IHRDL   NILLS   +  ++KI DFGL+  +Y      +  
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 130 GSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
            + L   +MAPE +  + Y  + D+WS G +L+E+
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 39.9 bits (93), Expect = 2e-04
 Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 7/136 (5%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+         L  EL  L  + +H N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 59  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           R           K  +      +  +    I  DLK     ++           +     
Sbjct: 119 RSKRNEFVPYKTKGARF----RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174

Query: 118 TLYPGNYAEKVCGSPL 133
            +      E +    L
Sbjct: 175 DVEEEEAPEDLYKDFL 190

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 5e-11
 Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 3/117 (2%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRL-FDAFQAENCIFLVVEFCAGGNLSSYIRL 59
             +++ K        E   L  +  P         F+  +  F+V+E   G +L      
Sbjct: 86  FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +G   + T  +   ++   LE ++ +  +H D+K  N+LL G  +   + +AD+GLS
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLS 200

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 2e-10
 Identities = 32/192 (16%), Positives = 68/192 (35%), Gaps = 30/192 (15%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-------------------FLV 44
           K+       L  EL F      P  I+ +   +    +                   F++
Sbjct: 71  KVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130

Query: 45  VEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
           ++   G +L      + +    +T  +   ++   LE ++ H  +H D+K  N+LL    
Sbjct: 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYK 188

Query: 104 DDVMLKIADFGLSCTLYPGN------YAEKVC--GSPLYMAPEVLQFQRYDEKVDMWSVG 155
           +   + + D+GL+    P           K C  G+  + + +         + D+  +G
Sbjct: 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248

Query: 156 AILFELLNGYPP 167
             + + L G+ P
Sbjct: 249 YCMIQWLTGHLP 260

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.8 bits (135), Expect = 7e-10
 Identities = 35/154 (22%), Positives = 59/154 (38%), Gaps = 16/154 (10%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS 84
             I  +       +   +V+E   G +L        R    +T      Q+ + +E ++S
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 85  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLYMA 136
            + IHRD+KP+N L+       ++ I DFGL+             Y E   + G+  Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 137 PEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 167
                     R D   D+ S+G +L     G  P
Sbjct: 184 INTHLGIEQSRRD---DLESLGYVLMYFNLGSLP 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.2 bits (135), Expect = 7e-10
 Identities = 35/156 (22%), Positives = 58/156 (37%), Gaps = 16/156 (10%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEIL 82
               I  +       +   LV++   G +L        R    +T      Q+   +E +
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLY 134
           +S   +HRD+KP+N L+        + I DFGL+      +      Y E   + G+  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 135 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 167
            +          R D   D+ S+G +L   L G  P
Sbjct: 180 ASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.0 bits (125), Expect = 1e-08
 Identities = 36/156 (23%), Positives = 67/156 (42%), Gaps = 18/156 (11%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
             I  ++   Q      LV++   G +L   + L GR    +T     +Q+ A ++ ++ 
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 85  HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS------CTLYPGNYAEK--VCGSPLY 134
             +++RD+KP+N L+      +  M+ + DFG+        T     Y EK  + G+  Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 135 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 167
           M+      +   R D   D+ ++G +    L G  P
Sbjct: 185 MSINTHLGREQSRRD---DLEALGHVFMYFLRGSLP 217

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 51.7 bits (124), Expect = 2e-08
 Identities = 18/77 (23%), Positives = 39/77 (50%), Gaps = 4/77 (5%)

Query: 42  FLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
           FLV+    G +L S + +  +  + E++  +   +L   LE L+ +  +H ++  ENI +
Sbjct: 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192

Query: 100 SGLDDDVMLKIADFGLS 116
              +D   + +A +G +
Sbjct: 193 -DPEDQSQVTLAGYGFA 208

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 51.2 bits (123), Expect = 2e-08
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 20/157 (12%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
             I +++          +V+E   G +L     L  R    +T      QL + +E ++S
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 85  HHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLY--PGN-----YAEK--VCGSPL 133
            ++I+RD+KPEN L+   G     ++ I DF L+   Y  P       Y E   + G+  
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA-KEYIDPETKKHIPYREHKSLTGTAR 182

Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 167
           YM+      +   R D   D+ ++G +    L G  P
Sbjct: 183 YMSINTHLGKEQSRRD---DLEALGHMFMYFLRGSLP 216

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.4 bits (109), Expect = 1e-06
 Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 5/88 (5%)

Query: 38  ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPEN 96
           ++ +F+V+EF  GG     +R         A+  L QL A L +   S    HRDL   N
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLAT-AKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 97  ILLSGLDDDVMLKIADFGLSCTLYPGNY 124
           +L   L    + K+       +    + 
Sbjct: 193 VL---LKKTSLKKLHYTLNGKSSTIPSC 217

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	180
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.98
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.98
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.36
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.09
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.0
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.74
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.1
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.0
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.79
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.34
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.25
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.02
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.74
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.56
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.06
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.36
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.67
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.03
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.15
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.25
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.94
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	90.94
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.16
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	89.12
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	86.08
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.84
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.25

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-47  Score=279.66  Aligned_cols=163  Identities=33%  Similarity=0.634  Sum_probs=149.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|++++++++|||||++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++|++
T Consensus        75 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~Ii  154 (311)
T 4aw0_A           75 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII  154 (311)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            45678999999999999999999999999999999999999999999999889999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC---CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ||||||+|||+   +.++.++|+|||+++.....   .......||+.|+|||++.+..++.++|+||+||++|+|++|+
T Consensus       155 HRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  231 (311)
T 4aw0_A          155 HRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL  231 (311)
T ss_dssp             CSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999   57788999999999876432   2334567999999999999999999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.+..
T Consensus       232 ~PF~~~~~~  240 (311)
T 4aw0_A          232 PPFRAGNEG  240 (311)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCCCHH
Confidence            999886654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-46  Score=279.52  Aligned_cols=164  Identities=27%  Similarity=0.595  Sum_probs=148.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...++.+.+|++++++++|||||++++++.+++.+|+||||++||+|.+++. ..++++..+..++.||+.||+|||++|
T Consensus       112 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~l~e~~~~~~~~qi~~aL~ylH~~~  190 (346)
T 4fih_A          112 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG  190 (346)
T ss_dssp             CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3445678899999999999999999999999999999999999999999887 467999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++||||||+|||+   +.++.++|+|||++...... .......||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus       191 IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  267 (346)
T 4fih_A          191 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  267 (346)
T ss_dssp             EECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            9999999999999   57788999999999876543 3344567999999999999999999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.++.
T Consensus       268 ~PF~~~~~~  276 (346)
T 4fih_A          268 PPYFNEPPL  276 (346)
T ss_dssp             CTTTTSCHH
T ss_pred             CCCCCcCHH
Confidence            999886654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-45  Score=269.42  Aligned_cols=164  Identities=32%  Similarity=0.626  Sum_probs=144.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .+...+.+.+|++++++++|||||++++++.+    ++.+++||||++||+|.+++.+.+.+++..+..++.||+.||+|
T Consensus        65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~y  144 (290)
T 3fpq_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            44556789999999999999999999999865    35689999999999999999988999999999999999999999


Q ss_pred             HHhCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        82 lh~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      ||++|  ++||||||+|||+.  +.++.++|+|||+++.... .......||+.|+|||.+.+ .++.++||||+|+++|
T Consensus       145 lH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvily  220 (290)
T 3fpq_A          145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML  220 (290)
T ss_dssp             HHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred             HHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHH
Confidence            99998  99999999999994  3467899999999965433 33445679999999998865 6999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      +|++|+.||.+.+.
T Consensus       221 elltg~~Pf~~~~~  234 (290)
T 3fpq_A          221 EMATSEYPYSECQN  234 (290)
T ss_dssp             HHHHSSCTTTTCSS
T ss_pred             HHHHCCCCCCCCCc
Confidence            99999999976543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-46  Score=278.95  Aligned_cols=166  Identities=27%  Similarity=0.564  Sum_probs=148.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +....+.+.+|++++++++|||||++++++.+++.+|+||||++||+|.+++....  .+++..++.++.||+.||+|||
T Consensus        63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH  142 (350)
T 4b9d_A           63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH  142 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44567789999999999999999999999999999999999999999999997543  4799999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|++||||||+|||+   +.++.++|+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|+|+
T Consensus       143 ~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml  219 (350)
T 4b9d_A          143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC  219 (350)
T ss_dssp             HTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999999   567889999999997764432 223456999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCcc
Q 030256          163 NGYPPFSAYRPC  174 (180)
Q Consensus       163 ~g~~pf~~~~~~  174 (180)
                      +|+.||.+.+..
T Consensus       220 tG~~PF~~~~~~  231 (350)
T 4b9d_A          220 TLKHAFEAGSMK  231 (350)
T ss_dssp             HSSCSCCCSSHH
T ss_pred             HCCCCCCCcCHH
Confidence            999999886654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.2e-46  Score=268.33  Aligned_cols=164  Identities=40%  Similarity=0.751  Sum_probs=137.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ......+.+|++++++++||||+++++++.+++.+++||||+ +|+|.+++.+.+++++..+..++.|++.|++|||++|
T Consensus        54 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~  132 (275)
T 3hyh_A           54 SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK  132 (275)
T ss_dssp             --CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            344667999999999999999999999999999999999999 6799999998899999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++||||||+||++   +.++.++|+|||+++............||+.|+|||.+.+..+ +.++|+||+|+++|+|++|+
T Consensus       133 IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~  209 (275)
T 3hyh_A          133 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR  209 (275)
T ss_dssp             CCCCCCCTTTEEE---CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccccCChHHeEE---CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCC
Confidence            9999999999999   5778899999999987766555556779999999999988876 57999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.+..
T Consensus       210 ~PF~~~~~~  218 (275)
T 3hyh_A          210 LPFDDESIP  218 (275)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCCCHH
Confidence            999876543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-46  Score=274.02  Aligned_cols=162  Identities=38%  Similarity=0.613  Sum_probs=141.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ...+.+|++++++++|||||++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++|++|
T Consensus        70 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiH  149 (304)
T 3ubd_A           70 RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY  149 (304)
T ss_dssp             CC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence            34678899999999999999999999999999999999999999999998899999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |||||+||++   +.++.++|+|||+++..... .......||+.|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus       150 RDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF  226 (304)
T 3ubd_A          150 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF  226 (304)
T ss_dssp             SSCCGGGEEE---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCHHHeEE---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCC
Confidence            9999999999   57788999999999765433 3334567999999999999999999999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+.++.
T Consensus       227 ~~~~~~  232 (304)
T 3ubd_A          227 QGKDRK  232 (304)
T ss_dssp             CCSSHH
T ss_pred             CCcCHH
Confidence            987654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-45  Score=273.28  Aligned_cols=158  Identities=33%  Similarity=0.549  Sum_probs=141.3

Q ss_pred             HHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC
Q 030256           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK   93 (180)
Q Consensus        14 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~   93 (180)
                      .+|+.++++++|||||++++++.+++.+|+||||++||+|.+++.+.+++++..+..++.|++.||+|||++|++|||||
T Consensus        98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK  177 (336)
T 4g3f_A           98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK  177 (336)
T ss_dssp             THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence            46999999999999999999999999999999999999999999988999999999999999999999999999999999


Q ss_pred             CCCeeeecCCCCc-eEEEeecCCccccCCCCc------ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           94 PENILLSGLDDDV-MLKIADFGLSCTLYPGNY------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        94 ~~nil~~~~~~~~-~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      |+|||++   .++ .++|+|||+++.......      .....||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus       178 p~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~  254 (336)
T 4g3f_A          178 ADNVLLS---SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH  254 (336)
T ss_dssp             GGGEEEC---TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             HHHEEEe---CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence            9999994   444 699999999977644321      123458999999999999999999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.++.
T Consensus       255 Pf~~~~~~  262 (336)
T 4g3f_A          255 PWTQYFRG  262 (336)
T ss_dssp             SSTTTCCS
T ss_pred             CCCCCCHH
Confidence            99876654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=280.76  Aligned_cols=164  Identities=27%  Similarity=0.595  Sum_probs=148.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...++.+.+|+.+|++++|||||++++++.+++.+|+||||++||+|.+++. ...+++..+..++.||+.||+|||++|
T Consensus       189 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~  267 (423)
T 4fie_A          189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG  267 (423)
T ss_dssp             CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3445678899999999999999999999999999999999999999999886 567999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++||||||+|||+   +.++.++|+|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       268 IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  344 (423)
T 4fie_A          268 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  344 (423)
T ss_dssp             EECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             eecccCCHHHEEE---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            9999999999999   57788999999999876543 3344567999999999999999999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.++.
T Consensus       345 ~PF~~~~~~  353 (423)
T 4fie_A          345 PPYFNEPPL  353 (423)
T ss_dssp             CTTTTSCHH
T ss_pred             CCCCCcCHH
Confidence            999876653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.6e-46  Score=272.66  Aligned_cols=166  Identities=25%  Similarity=0.588  Sum_probs=147.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------GRVPEQTARKFL   72 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~   72 (180)
                      ....++++.+|++++++++|||||++++++.+++..++||||+++|+|.+++...             .++++..+..++
T Consensus        55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~  134 (299)
T 4asz_A           55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA  134 (299)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence            4556778999999999999999999999999999999999999999999999754             258999999999


Q ss_pred             HHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcch
Q 030256           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      .|++.|++|||+++++||||||+||++   +.+..++|+|||+++.......   .....+++.|+|||.+.+..++.++
T Consensus       135 ~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~  211 (299)
T 4asz_A          135 QQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  211 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh
Confidence            999999999999999999999999999   5788899999999976543322   2234578899999999999999999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          150 DMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       150 Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      ||||+|+++|||+| |+.||.+.++.
T Consensus       212 DVwS~Gvvl~Ellt~G~~Pf~~~~~~  237 (299)
T 4asz_A          212 DVWSLGVVLWEIFTYGKQPWYQLSNN  237 (299)
T ss_dssp             HHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999 89999887654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=264.61  Aligned_cols=164  Identities=27%  Similarity=0.506  Sum_probs=139.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      +++..+.+.+|++++++++|||||++++++.+ +.+++||||++||+|.+++... .++++..+..++.|++.||+|||+
T Consensus        72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~  150 (307)
T 3omv_A           72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA  150 (307)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35566789999999999999999999998765 4589999999999999999754 569999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC---CcccccccCccccCcccccc---ccCCcchhHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~ape~~~~---~~~~~~~Di~slg~~~  158 (180)
                      ++++||||||+|||+   +.++.++|+|||+++.....   .......||+.|+|||.+.+   ..++.++||||||+++
T Consensus       151 ~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl  227 (307)
T 3omv_A          151 KNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL  227 (307)
T ss_dssp             TTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred             CCccCCccCHHHEEE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence            999999999999999   57889999999999765432   22334568999999999864   3589999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030256          159 FELLNGYPPFSAYRP  173 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~  173 (180)
                      |||+||+.||.+.++
T Consensus       228 ~Elltg~~Pf~~~~~  242 (307)
T 3omv_A          228 YELMTGELPYSHINN  242 (307)
T ss_dssp             HHHHHSSCTTTTCCC
T ss_pred             HHHHHCCCCCCCCCh
Confidence            999999999987654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.2e-45  Score=269.46  Aligned_cols=166  Identities=25%  Similarity=0.542  Sum_probs=141.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------GRVPEQTARK   70 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~   70 (180)
                      +...++++.+|++++++++|||||++++++.+.+.+++||||+++|+|.+++...               .++++..++.
T Consensus        83 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  162 (329)
T 4aoj_A           83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA  162 (329)
T ss_dssp             SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHH
Confidence            4566788999999999999999999999999999999999999999999998753               3589999999


Q ss_pred             HHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCc
Q 030256           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  147 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~  147 (180)
                      ++.|++.|++|||+++++||||||+||++   +.+..++|+|||+++......   ......+++.|+|||.+.+..++.
T Consensus       163 i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~  239 (329)
T 4aoj_A          163 VASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT  239 (329)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHhcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCc
Confidence            99999999999999999999999999999   578899999999997664332   223455889999999999999999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          148 KVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      ++||||||+++|||+| |+.||.+.++.
T Consensus       240 ~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          240 ESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             cccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999 89999876654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-44  Score=265.38  Aligned_cols=164  Identities=26%  Similarity=0.580  Sum_probs=145.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~   71 (180)
                      ..++++.+|+.++++++|||||++++++.+++.+++||||+++|+|.+++...                ..+++..+..+
T Consensus        71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i  150 (308)
T 4gt4_A           71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL  150 (308)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence            34678999999999999999999999999999999999999999999999642                34899999999


Q ss_pred             HHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCcc
Q 030256           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEK  148 (180)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~  148 (180)
                      +.|++.|++|||+++++||||||+||++   +++..++|+|||+++......   ......+++.|+|||.+.+..++.+
T Consensus       151 ~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k  227 (308)
T 4gt4_A          151 VAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID  227 (308)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence            9999999999999999999999999999   578889999999987654322   2234568899999999999999999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          149 VDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       149 ~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      +||||+|+++||++| |..||.+.++.
T Consensus       228 sDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          228 SDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             HHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             chhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999998 89999887654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-41  Score=249.51  Aligned_cols=158  Identities=32%  Similarity=0.603  Sum_probs=130.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCC------------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF   71 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~   71 (180)
                      +..++.+.+|++++++++|||||++++++.+.+            .+|++|||++|++|.+++.....   .+...++.+
T Consensus        44 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i  123 (299)
T 4g31_A           44 ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI  123 (299)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHH
Confidence            445677899999999999999999999987544            37999999999999999986654   456678999


Q ss_pred             HHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-------------ccccccCccccCcc
Q 030256           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------------AEKVCGSPLYMAPE  138 (180)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-------------~~~~~~~~~~~ape  138 (180)
                      +.|++.||+|||++|++||||||+||++   +.++.++|+|||+++.......             .....||+.|+|||
T Consensus       124 ~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE  200 (299)
T 4g31_A          124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE  200 (299)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred             HHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence            9999999999999999999999999999   5677899999999977644321             12345899999999


Q ss_pred             ccccccCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256          139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       139 ~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      .+.+..++.++||||+||++|||++   ||.+
T Consensus       201 ~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          201 QIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             HHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            9999999999999999999999996   7764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.2e-42  Score=256.66  Aligned_cols=164  Identities=32%  Similarity=0.538  Sum_probs=142.8

Q ss_pred             HHHHHHHHHHHHHhcCCC-ccccccceEEEe-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNH-PNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~   69 (180)
                      ...+.+.+|++++++++| ||||++++++.. ++.+++|||||++|+|.+++...                ..+++..+.
T Consensus       109 ~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~  188 (353)
T 4ase_A          109 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  188 (353)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHH
Confidence            446678999999999965 899999999876 45789999999999999999753                238899999


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCC
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  146 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~  146 (180)
                      .++.||+.|++|||+++++||||||+||++   +.++.+||+|||+++......   ......+++.|+|||.+.+..++
T Consensus       189 ~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~  265 (353)
T 4ase_A          189 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  265 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence            999999999999999999999999999999   577899999999998764432   22334578899999999999999


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          147 EKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      .++||||+|+++|||+| |..||.+.+..
T Consensus       266 ~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          266 IQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             CcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999998 99999886543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-41  Score=267.57  Aligned_cols=168  Identities=32%  Similarity=0.562  Sum_probs=151.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....++.+.+|+++|++++||||+++++++.+.+.++++|||++||+|.+++.. .+.+++..+..++.||+.||+|||+
T Consensus       194 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~  273 (573)
T 3uto_A          194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE  273 (573)
T ss_dssp             SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            344567789999999999999999999999999999999999999999998864 4579999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|++||||||+||++.. +..+.++|+|||++.............||+.|+|||++.+..++.++|+||+||++|+|++|
T Consensus       274 ~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G  352 (573)
T 3uto_A          274 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG  352 (573)
T ss_dssp             TTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             CCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            99999999999999952 23468999999999888776666667799999999999999999999999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ..||.+.++.
T Consensus       353 ~~Pf~~~~~~  362 (573)
T 3uto_A          353 LSPFGGENDD  362 (573)
T ss_dssp             CCSSCCSSHH
T ss_pred             CCCCCCcCHH
Confidence            9999876654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6e-41  Score=266.01  Aligned_cols=156  Identities=33%  Similarity=0.588  Sum_probs=140.8

Q ss_pred             HHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC
Q 030256           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK   93 (180)
Q Consensus        14 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~   93 (180)
                      +.++.+++.++|||||++++++.+.+.+|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++|++|||||
T Consensus       240 ~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK  319 (689)
T 3v5w_A          240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK  319 (689)
T ss_dssp             HHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred             HHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence            34467778889999999999999999999999999999999999988999999999999999999999999999999999


Q ss_pred             CCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc-cccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256           94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus        94 ~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~-~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      |+|||+   +.++.++|+|||++....... .....||+.|+|||++. +..++.++|+|||||++|+|++|+.||.+.+
T Consensus       320 PeNILl---d~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          320 PANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             GGGEEE---CTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             hHHeEE---eCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999   578899999999998765443 33457999999999986 4578999999999999999999999998654


Q ss_pred             c
Q 030256          173 P  173 (180)
Q Consensus       173 ~  173 (180)
                      .
T Consensus       396 ~  396 (689)
T 3v5w_A          396 T  396 (689)
T ss_dssp             C
T ss_pred             h
Confidence            4

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=254.13  Aligned_cols=163  Identities=30%  Similarity=0.504  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEe------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.+|+++|++++|||||++++++..      .+.+|+||||++ |+|.+++...+++++..+..++.||+.||+|
T Consensus        95 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~y  173 (398)
T 4b99_A           95 TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY  173 (398)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            445678899999999999999999998753      357899999995 6899999888899999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-----CcccccccCccccCcccccccc-CCcchhHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVG  155 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg  155 (180)
                      ||++|++||||||+||++   +.++.++|+|||+++.....     .......||+.|+|||++.+.. ++.++||||+|
T Consensus       174 lH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG  250 (398)
T 4b99_A          174 MHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG  250 (398)
T ss_dssp             HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             HHHCcCcCCCcCcccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhH
Confidence            999999999999999999   57888999999999765432     2234567999999999987754 68999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcc
Q 030256          156 AILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       156 ~~~~~~l~g~~pf~~~~~~  174 (180)
                      |++|||++|+.||.+.+..
T Consensus       251 ~il~ell~G~~pF~g~~~~  269 (398)
T 4b99_A          251 CIFGEMLARRQLFPGKNYV  269 (398)
T ss_dssp             HHHHHHHHTSCSSCCSSHH
T ss_pred             HHHHHHHHCCCCCCCCCHH
Confidence            9999999999999886643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.3e-41  Score=250.97  Aligned_cols=159  Identities=25%  Similarity=0.416  Sum_probs=137.3

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...++.+|+++++++ +||||+++++++.+.+.+++||||++|++|.++++   ++++..+..++.|++.||+|||++|+
T Consensus        62 ~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gI  138 (361)
T 4f9c_A           62 HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGI  138 (361)
T ss_dssp             CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345678899999999 79999999999999999999999999999999874   59999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-----------------------------cccccccCccccCcc
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------------YAEKVCGSPLYMAPE  138 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ape  138 (180)
                      +||||||+||+++  ...+.++|+|||+++......                             ......||+.|+|||
T Consensus       139 iHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE  216 (361)
T 4f9c_A          139 VHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE  216 (361)
T ss_dssp             ECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred             EeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            9999999999996  344789999999997543221                             112346899999999


Q ss_pred             ccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          139 VLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       139 ~~~~~-~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      .+.+. .++.++|+||+||++|+|++|+.||...+
T Consensus       217 ~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          217 VLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             HHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            98765 48999999999999999999999996544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.4e-41  Score=247.60  Aligned_cols=165  Identities=25%  Similarity=0.367  Sum_probs=133.3

Q ss_pred             hhhhhHHHHHHHH--HHHHHHhcCCCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLD--CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (180)
Q Consensus         2 ~~~~~~~~~~~~~--~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i   75 (180)
                      +|.++....+.+.  +|+..+.+++|||||++++++.+++    .+++||||+++|+|.++++ ..+++++.+.+++.|+
T Consensus        31 vK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~-~~~l~~~~~~~i~~~i  109 (303)
T 3hmm_A           31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALST  109 (303)
T ss_dssp             EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH-HCCBCHHHHHHHHHHH
T ss_pred             EEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHH-hCCCCHHHHHHHHHHH
Confidence            4555444444444  4555567889999999999987653    6899999999999999997 4578999999999999


Q ss_pred             HHHHHHHHhC--------CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCcccccc
Q 030256           76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        76 ~~~l~~lh~~--------~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~  142 (180)
                      +.|++|||++        +++||||||+|||+   +.++.++|+|||+++.......     .....||+.|+|||.+.+
T Consensus       110 a~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~  186 (303)
T 3hmm_A          110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  186 (303)
T ss_dssp             HHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcc
Confidence            9999999987        89999999999999   5788999999999876543321     123468999999999865


Q ss_pred             c------cCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256          143 Q------RYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       143 ~------~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      .      .++.++||||+|+++|||+||..||..
T Consensus       187 ~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            4      467899999999999999999876643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-38  Score=236.76  Aligned_cols=166  Identities=39%  Similarity=0.733  Sum_probs=150.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +....+.+.+|++++++++||||+++++++...+..++||||+++++|.+++...+++++..+..++.|++.++++||++
T Consensus        54 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~  133 (328)
T 3fe3_A           54 NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK  133 (328)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34456678899999999999999999999999999999999999999999998888999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCC-cchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Di~slg~~~~~~l~g  164 (180)
                      |++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++ .++|+||+|+++|+|++|
T Consensus       134 ~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  210 (328)
T 3fe3_A          134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG  210 (328)
T ss_dssp             TCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHS
T ss_pred             CEeccCCCHHHEEE---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhC
Confidence            99999999999999   57788999999999877655555566789999999999887764 789999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      +.||++.+..
T Consensus       211 ~~pf~~~~~~  220 (328)
T 3fe3_A          211 SLPFDGQNLK  220 (328)
T ss_dssp             SCSSCCSSHH
T ss_pred             CCCCCCCCHH
Confidence            9999876643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.2e-38  Score=238.61  Aligned_cols=167  Identities=35%  Similarity=0.587  Sum_probs=150.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+.+.....+++..+..++.|++.+++|||++|
T Consensus        69 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~  148 (362)
T 2bdw_A           69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  148 (362)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34557789999999999999999999999999999999999999999999987788999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+||+|+||++........++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus       149 ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  228 (362)
T 2bdw_A          149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  228 (362)
T ss_dssp             CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence            99999999999996444456799999999987765544445668999999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       229 Pf~~~~~  235 (362)
T 2bdw_A          229 PFWDEDQ  235 (362)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCCH
Confidence            9987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6e-38  Score=234.16  Aligned_cols=163  Identities=33%  Similarity=0.540  Sum_probs=147.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|..++++++||||+++++++.+.+..++||||++|++|..++.....+++..+..++.|++.||++||++|++
T Consensus        48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  127 (337)
T 1o6l_A           48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  127 (337)
T ss_dssp             CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            35668889999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      ||||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       128 HrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  204 (337)
T 1o6l_A          128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  204 (337)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCHHHEEE---CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCC
Confidence            99999999999   5678899999999876432 3334456689999999999988999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.+..
T Consensus       205 f~~~~~~  211 (337)
T 1o6l_A          205 FYNQDHE  211 (337)
T ss_dssp             SCCSSHH
T ss_pred             CCCCCHH
Confidence            9876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.1e-38  Score=241.29  Aligned_cols=168  Identities=33%  Similarity=0.541  Sum_probs=150.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .....+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+.+.....+++..+..++.|++.+++|||++
T Consensus        50 ~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~  129 (444)
T 3soa_A           50 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM  129 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            44556779999999999999999999999999999999999999999999998888999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      |++|+||+|+||++.....++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       130 givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G  209 (444)
T 3soa_A          130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG  209 (444)
T ss_dssp             TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhC
Confidence            999999999999996544567899999999976654332 2345689999999999988899999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||.+.+.
T Consensus       210 ~~Pf~~~~~  218 (444)
T 3soa_A          210 YPPFWDEDQ  218 (444)
T ss_dssp             SCSCCCSSH
T ss_pred             CCCCCCccH
Confidence            999977554

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.2e-38  Score=236.91  Aligned_cols=164  Identities=32%  Similarity=0.614  Sum_probs=147.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+++...+.+++..+..++.|++.+++|||++|++|
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  138 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            46789999999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCC-CceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++..... ...++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf  218 (361)
T 2yab_A          139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  218 (361)
T ss_dssp             CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999952111 1279999999998776655455566899999999999888999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       219 ~~~~~  223 (361)
T 2yab_A          219 LGDTK  223 (361)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7e-38  Score=229.76  Aligned_cols=165  Identities=34%  Similarity=0.610  Sum_probs=144.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .....+.+.+|+.++++++||||+++++++.+++..+++|||++|++|.+++...+++++..+..++.|++.++++||++
T Consensus        51 ~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  130 (294)
T 4eqm_A           51 KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM  130 (294)
T ss_dssp             CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34556778999999999999999999999999999999999999999999999888999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      |++|+||+|+||++   +.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+||+|+++|++++
T Consensus       131 ~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~  207 (294)
T 4eqm_A          131 RIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV  207 (294)
T ss_dssp             TCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             CcccCCCCHHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence            99999999999999   567789999999987664332  2233458899999999999889999999999999999999


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |+.||.+.++
T Consensus       208 g~~pf~~~~~  217 (294)
T 4eqm_A          208 GEPPFNGETA  217 (294)
T ss_dssp             SSCSSCSSCH
T ss_pred             CCCCCCCCCh
Confidence            9999987664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=236.14  Aligned_cols=161  Identities=33%  Similarity=0.590  Sum_probs=146.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++.....+++..+..++.|++.||+|||++|++|
T Consensus        59 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH  138 (384)
T 4fr4_A           59 VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIH  138 (384)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            46688899999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc---ccCCcchhHHHHHHHHHHHHhCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~---~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||+|+||++   +.++.++|+|||++.............++..|+|||.+.+   ..++.++|+||||+++|+|++|..
T Consensus       139 rDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~  215 (384)
T 4fr4_A          139 RDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR  215 (384)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcHHHeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence            9999999999   5778899999999987766655566779999999999863   458899999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||...+.
T Consensus       216 Pf~~~~~  222 (384)
T 4fr4_A          216 PYHIRSS  222 (384)
T ss_dssp             SSCCCTT
T ss_pred             CCCCCCC
Confidence            9986543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.6e-38  Score=235.64  Aligned_cols=164  Identities=38%  Similarity=0.603  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|..+++.+ +||||+++++++.+.+..++||||++|++|..++.....+++..+..++.|++.||++||++|
T Consensus        65 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g  144 (353)
T 3txo_A           65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG  144 (353)
T ss_dssp             TTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456678899999998 799999999999999999999999999999999998889999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++||||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus       145 ivHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~  221 (353)
T 3txo_A          145 IIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH  221 (353)
T ss_dssp             CBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CcccCCCHHHEEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCC
Confidence            9999999999999   5778899999999876432 23334556899999999999888999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.++.
T Consensus       222 ~Pf~~~~~~  230 (353)
T 3txo_A          222 APFEAENED  230 (353)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCCCHH
Confidence            999887654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.1e-38  Score=234.03  Aligned_cols=172  Identities=33%  Similarity=0.602  Sum_probs=133.1

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~   80 (180)
                      +|.+.+.....+.+|+.+++++. ||||+++++++.+.+..++||||+++++|.+++.....+++..+..++.|++.+++
T Consensus        41 vK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~  120 (325)
T 3kn6_A           41 VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS  120 (325)
T ss_dssp             EEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence            56666777788899999999996 99999999999999999999999999999999998888999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      +||++|++|+||+|+||++...+....++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|
T Consensus       121 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~  200 (325)
T 3kn6_A          121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILY  200 (325)
T ss_dssp             HHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHH
T ss_pred             HHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHH
Confidence            9999999999999999999743344479999999987654332 223445788999999999889999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|+.||.+.+.
T Consensus       201 ~ll~g~~pf~~~~~  214 (325)
T 3kn6_A          201 TMLSGQVPFQSHDR  214 (325)
T ss_dssp             HHHHSSCTTC----
T ss_pred             HHHhCCCCCCCCcc
Confidence            99999999987554

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=230.77  Aligned_cols=165  Identities=33%  Similarity=0.628  Sum_probs=147.2

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.+|++||+.|++
T Consensus        57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv  136 (326)
T 2y0a_A           57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA  136 (326)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            35678999999999999999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCC-CCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++.... ....++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus       137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  216 (326)
T 2y0a_A          137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  216 (326)
T ss_dssp             CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence            999999999995311 1237999999999877554444456689999999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.+.
T Consensus       217 f~~~~~  222 (326)
T 2y0a_A          217 FLGDTK  222 (326)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987554

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-37  Score=236.35  Aligned_cols=160  Identities=33%  Similarity=0.670  Sum_probs=144.5

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|..+++++ +||||+++++++.+.+..++||||++|++|..++.....+++..+..++.|++.+|++||++|+
T Consensus        95 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi  174 (396)
T 4dc2_A           95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI  174 (396)
T ss_dssp             -CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            345578899999887 8999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||||+|+||++   +.++.++|+|||++.... .........+++.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus       175 vHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~  251 (396)
T 4dc2_A          175 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS  251 (396)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             EeccCCHHHEEE---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence            999999999999   577889999999987632 3344455678999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 030256          167 PFSAY  171 (180)
Q Consensus       167 pf~~~  171 (180)
                      ||...
T Consensus       252 Pf~~~  256 (396)
T 4dc2_A          252 PFDIV  256 (396)
T ss_dssp             SSTTT
T ss_pred             CCccc
Confidence            99743

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-37  Score=229.53  Aligned_cols=160  Identities=39%  Similarity=0.693  Sum_probs=145.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|..+++.++||||+++++++.+.+..+++|||++|++|.+++.....+++..+..++.|++.+|++||++|++
T Consensus        49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  128 (318)
T 1fot_A           49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII  128 (318)
T ss_dssp             CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34667889999999999999999999999999999999999999999999888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++   +.++.++|+|||++......  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       129 HrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  203 (318)
T 1fot_A          129 YRDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF  203 (318)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCChheEEE---cCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence            99999999999   57788999999998765432  23456899999999999889999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       204 ~~~~~  208 (318)
T 1fot_A          204 YDSNT  208 (318)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-37  Score=230.82  Aligned_cols=165  Identities=30%  Similarity=0.528  Sum_probs=147.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+.+|+.++++++||||+++++++.+.+..+++|||++|++|.+++.... .+++..+..++.|++.++++||++|
T Consensus        43 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g  122 (321)
T 1tki_A           43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN  122 (321)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            445678899999999999999999999999999999999999999999997554 6999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+||+|+||++.. +.++.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       123 ivH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  201 (321)
T 1tki_A          123 IGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN  201 (321)
T ss_dssp             EECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999952 2267899999999987766555555668999999999998888999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       202 pf~~~~~  208 (321)
T 1tki_A          202 PFLAETN  208 (321)
T ss_dssp             TTCCSSH
T ss_pred             CCcCCCH
Confidence            9987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-37  Score=227.77  Aligned_cols=162  Identities=31%  Similarity=0.601  Sum_probs=145.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|+.++++++||||+++++++...+..++||||++|++|.+++.. ..+++..+..++.|++.++++||++|+
T Consensus        59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  137 (297)
T 3fxz_A           59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV  137 (297)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3456788999999999999999999999999999999999999999999874 579999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       138 ~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  214 (297)
T 3fxz_A          138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP  214 (297)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eeCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999   567789999999987665432 2334568899999999999999999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.++
T Consensus       215 pf~~~~~  221 (297)
T 3fxz_A          215 PYLNENP  221 (297)
T ss_dssp             TTTTSCH
T ss_pred             CCCCCCH
Confidence            9987654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=226.76  Aligned_cols=166  Identities=28%  Similarity=0.538  Sum_probs=146.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      +....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.++++||+
T Consensus        47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (310)
T 3s95_A           47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS  126 (310)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            456678899999999999999999999999999999999999999999999986 4579999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---------------cccccCccccCccccccccCCcch
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------------EKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---------------~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      +|++|+||+|+||++   +.++.++|+|||.+.........               ....++..|+|||.+.+..++.++
T Consensus       127 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  203 (310)
T 3s95_A          127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV  203 (310)
T ss_dssp             TTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred             CCccCCCCCcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH
Confidence            999999999999999   56788999999998765433211               134588899999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          150 DMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       150 Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      |+||+|+++|++++|..||....+.
T Consensus       204 Di~slG~~l~el~~g~~~~~~~~~~  228 (310)
T 3s95_A          204 DVFSFGIVLCEIIGRVNADPDYLPR  228 (310)
T ss_dssp             HHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred             HHHHHHHHHHHHhcCCCCCcchhhh
Confidence            9999999999999999999876554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.9e-37  Score=230.48  Aligned_cols=161  Identities=33%  Similarity=0.670  Sum_probs=145.5

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+.+|..+++++ +||||+++++++.+.+..++||||++|++|.+++.....+++..+..++.|++.||++||++
T Consensus        50 ~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~  129 (345)
T 3a8x_A           50 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER  129 (345)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34456788999999998 89999999999999999999999999999999998888999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      |++|+||+|+||++   +.++.++|+|||++.... .........++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       130 ~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  206 (345)
T 3a8x_A          130 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG  206 (345)
T ss_dssp             TCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CceecCCCHHHEEE---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhC
Confidence            99999999999999   577889999999987643 23334455689999999999998999999999999999999999


Q ss_pred             CCCCCC
Q 030256          165 YPPFSA  170 (180)
Q Consensus       165 ~~pf~~  170 (180)
                      +.||..
T Consensus       207 ~~pf~~  212 (345)
T 3a8x_A          207 RSPFDI  212 (345)
T ss_dssp             SCTTTT
T ss_pred             CCCcCC
Confidence            999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-37  Score=231.38  Aligned_cols=161  Identities=34%  Similarity=0.638  Sum_probs=146.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+++...+.+++..+..++.|++.+|++||++|++
T Consensus        84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  163 (350)
T 1rdq_E           84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI  163 (350)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34568889999999999999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++   +.++.++|+|||++......  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       164 HrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  238 (350)
T 1rdq_E          164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             CCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccCccceEEE---CCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCC
Confidence            99999999999   56788999999999776443  23456899999999999889999999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+.++.
T Consensus       239 ~~~~~~  244 (350)
T 1rdq_E          239 FADQPI  244 (350)
T ss_dssp             CCSSHH
T ss_pred             CCCCHH
Confidence            876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-37  Score=238.41  Aligned_cols=161  Identities=34%  Similarity=0.637  Sum_probs=143.6

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ..+++|..++++++||||+++++++.+.+..++||||++|++|.+++.. ...+++..+..++.|++.|++|||++|++|
T Consensus       119 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiH  198 (437)
T 4aw2_A          119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH  198 (437)
T ss_dssp             CCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            3488899999999999999999999999999999999999999999986 467999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccc-----cccCCcchhHHHHHHHHHHHH
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |||+|+||++   +.++.++|+|||++.........  ....|++.|+|||.+.     ...++.++|+||+|+++|||+
T Consensus       199 rDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell  275 (437)
T 4aw2_A          199 RDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML  275 (437)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred             cccCHHHeeE---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence            9999999999   57788999999999766543322  2356899999999986     456899999999999999999


Q ss_pred             hCCCCCCCCCcc
Q 030256          163 NGYPPFSAYRPC  174 (180)
Q Consensus       163 ~g~~pf~~~~~~  174 (180)
                      +|+.||.+.++.
T Consensus       276 tG~~Pf~~~~~~  287 (437)
T 4aw2_A          276 YGETPFYAESLV  287 (437)
T ss_dssp             HSSCTTCCSSHH
T ss_pred             hCCCCCCCCChh
Confidence            999999876644

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.1e-37  Score=230.14  Aligned_cols=161  Identities=42%  Similarity=0.756  Sum_probs=146.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ...+.+|+.+++.++||||+++++++...+..++||||+ +++|.+++...+++++..+..++.|++.++++||+.|++|
T Consensus        53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  131 (336)
T 3h4j_B           53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH  131 (336)
T ss_dssp             SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            457899999999999999999999999999999999999 7899999988889999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++   +.++.++|+|||++.............+++.|+|||.+.+..+ +.++|+||+|+++|++++|+.||
T Consensus       132 ~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf  208 (336)
T 3h4j_B          132 RDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF  208 (336)
T ss_dssp             CCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCchhhEEE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence            9999999999   5677899999999987766555556678999999999987775 78999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+.+..
T Consensus       209 ~~~~~~  214 (336)
T 3h4j_B          209 DDEFIP  214 (336)
T ss_dssp             BCSSST
T ss_pred             CCccHH
Confidence            875443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.9e-37  Score=223.65  Aligned_cols=166  Identities=35%  Similarity=0.662  Sum_probs=149.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.++++||++|+
T Consensus        48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  127 (277)
T 3f3z_A           48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV  127 (277)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34567889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++...+.+..++|+|||.+.............++..|+|||.+.+. ++.++|+||+|++++++++|..|
T Consensus       128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p  206 (277)
T 3f3z_A          128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP  206 (277)
T ss_dssp             ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCC
Confidence            99999999999965456778999999999877665555566789999999988654 89999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       207 ~~~~~~~  213 (277)
T 3f3z_A          207 FSAPTDS  213 (277)
T ss_dssp             SCCSSHH
T ss_pred             CCCCCHH
Confidence            9876543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.9e-37  Score=230.38  Aligned_cols=163  Identities=36%  Similarity=0.602  Sum_probs=146.1

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|..+++++ +||||+++++++.+.+..++||||++|++|.+++.....+++..+..++.|++.||++||++|+
T Consensus        60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  139 (345)
T 1xjd_A           60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI  139 (345)
T ss_dssp             CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345678899999887 9999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       140 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  216 (345)
T 1xjd_A          140 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS  216 (345)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             EeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCC
Confidence            999999999999   5677899999999876432 223345568999999999999899999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.++.
T Consensus       217 Pf~~~~~~  224 (345)
T 1xjd_A          217 PFHGQDEE  224 (345)
T ss_dssp             SSCCSSHH
T ss_pred             CCCCCCHH
Confidence            99876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.1e-37  Score=230.39  Aligned_cols=163  Identities=34%  Similarity=0.610  Sum_probs=146.8

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|..+++.+ +||+|+++++++.+.+..++||||++|++|.+++...+.+++..+..++.|++.||++||++|+
T Consensus        63 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi  142 (353)
T 2i0e_A           63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI  142 (353)
T ss_dssp             CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            356678899999998 8999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||||+|+||++   +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus       143 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~  219 (353)
T 2i0e_A          143 IYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA  219 (353)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             EeccCCHHHEEE---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCC
Confidence            999999999999   5778899999999876432 233445568999999999998899999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.++.
T Consensus       220 Pf~~~~~~  227 (353)
T 2i0e_A          220 PFEGEDED  227 (353)
T ss_dssp             SSCCSSHH
T ss_pred             CCCCCCHH
Confidence            99876643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.3e-37  Score=232.21  Aligned_cols=163  Identities=31%  Similarity=0.576  Sum_probs=143.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+.+.+|+.++++++||||+++++++.+++..++||||++|++|.+.+...    ..+++..+..++.|++.+|+|||++
T Consensus        70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~  149 (351)
T 3c0i_A           70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN  149 (351)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            567899999999999999999999999999999999999999998877543    2489999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      |++|+||+|+||++........++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|++++|
T Consensus       150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  229 (351)
T 3c0i_A          150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG  229 (351)
T ss_dssp             TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence            999999999999996444455699999999977654432 3345689999999999988899999999999999999999


Q ss_pred             CCCCCCCC
Q 030256          165 YPPFSAYR  172 (180)
Q Consensus       165 ~~pf~~~~  172 (180)
                      ..||.+.+
T Consensus       230 ~~pf~~~~  237 (351)
T 3c0i_A          230 CLPFYGTK  237 (351)
T ss_dssp             SCSSCSSH
T ss_pred             CCCCCCcH
Confidence            99998743

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.5e-38  Score=234.14  Aligned_cols=165  Identities=41%  Similarity=0.623  Sum_probs=132.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++...+.+++..+..++.|++.+|++||+.|++
T Consensus        91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  170 (349)
T 2w4o_A           91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV  170 (349)
T ss_dssp             --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45668889999999999999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++...+.++.++|+|||++.............++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  250 (349)
T 2w4o_A          171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF  250 (349)
T ss_dssp             CCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence            99999999999643457889999999987765544444556899999999999888999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       251 ~~~~~  255 (349)
T 2w4o_A          251 YDERG  255 (349)
T ss_dssp             CCTTC
T ss_pred             CCCcc
Confidence            76554

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.7e-37  Score=222.47  Aligned_cols=167  Identities=35%  Similarity=0.587  Sum_probs=150.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+.+.....+++..+..++.|++.++++||++|
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  125 (284)
T 3kk8_A           46 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  125 (284)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34557788999999999999999999999999999999999999999999988888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+||+|+||++........++|+|||.+.............++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus       126 i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~  205 (284)
T 3kk8_A          126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  205 (284)
T ss_dssp             EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCC
Confidence            99999999999996544455699999999977765555455668999999999999889999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       206 pf~~~~~  212 (284)
T 3kk8_A          206 PFWDEDQ  212 (284)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCch
Confidence            9976554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-37  Score=234.42  Aligned_cols=165  Identities=30%  Similarity=0.566  Sum_probs=147.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      .....+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.... .+++..+..++.|++.+|++||++|
T Consensus        90 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  169 (387)
T 1kob_A           90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS  169 (387)
T ss_dssp             HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345678999999999999999999999999999999999999999999887544 6999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+||+|+||++.. +..+.++|+|||++.............++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       170 ivHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~  248 (387)
T 1kob_A          170 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS  248 (387)
T ss_dssp             EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred             eeecccchHHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCC
Confidence            999999999999952 2346799999999988766555555678999999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       249 Pf~~~~~  255 (387)
T 1kob_A          249 PFAGEDD  255 (387)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCCH
Confidence            9987653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.6e-37  Score=228.54  Aligned_cols=162  Identities=36%  Similarity=0.612  Sum_probs=137.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+.++++++||||+++++++...+..++||||++|++|.+++...+.+++..+..++.|++.+|++||++|++
T Consensus        64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  143 (327)
T 3a62_A           64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII  143 (327)
T ss_dssp             -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            45567889999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       144 H~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  220 (327)
T 3a62_A          144 YRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP  220 (327)
T ss_dssp             CCCCCTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCC
Confidence            99999999999   56778999999998654322 223345688999999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.+.
T Consensus       221 f~~~~~  226 (327)
T 3a62_A          221 FTGENR  226 (327)
T ss_dssp             CCCSSH
T ss_pred             CCCCCH
Confidence            987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.3e-37  Score=231.90  Aligned_cols=166  Identities=35%  Similarity=0.585  Sum_probs=147.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.+|++||+.|
T Consensus       128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  207 (373)
T 2x4f_A          128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY  207 (373)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678999999999999999999999999999999999999999999888654 46999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+||+|+||++.. +..+.++|+|||++.............++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       208 ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  286 (373)
T 2x4f_A          208 ILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS  286 (373)
T ss_dssp             EECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence            999999999999853 3456899999999987765555555568999999999988889999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.++.
T Consensus       287 pf~~~~~~  294 (373)
T 2x4f_A          287 PFLGDNDA  294 (373)
T ss_dssp             TTCCSSHH
T ss_pred             CCCCCCHH
Confidence            99876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=233.63  Aligned_cols=170  Identities=21%  Similarity=0.282  Sum_probs=146.3

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcCC---CccccccceEEEeCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQ   73 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~   73 (180)
                      +|.++.....++.+|.+++++++   |++++++++++...+..++||||+++++|.+++..     ...+++..+..++.
T Consensus       100 vK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~  179 (365)
T 3e7e_A          100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM  179 (365)
T ss_dssp             EEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHH
T ss_pred             EEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHH
Confidence            56666666778888999999996   99999999999999999999999999999999974     45699999999999


Q ss_pred             HHHHHHHHHHhCCCeeecCCCCCeeeec--------CCCCceEEEeecCCccccC---CCCcccccccCccccCcccccc
Q 030256           74 QLGAGLEILNSHHIIHRDLKPENILLSG--------LDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        74 ~i~~~l~~lh~~~~~h~dl~~~nil~~~--------~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~~~~~ape~~~~  142 (180)
                      |++.||+|||++|++||||||+||++..        ....+.++|+|||++....   .........++..|+|||.+.+
T Consensus       180 qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  259 (365)
T 3e7e_A          180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN  259 (365)
T ss_dssp             HHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred             HHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence            9999999999999999999999999952        1126789999999996543   2233344568999999999999


Q ss_pred             ccCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256          143 QRYDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus       143 ~~~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                      ..++.++|+||||+++|+|++|+.||...
T Consensus       260 ~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          260 KPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             CCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCccccC
Confidence            88999999999999999999999999643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-37  Score=236.38  Aligned_cols=161  Identities=35%  Similarity=0.634  Sum_probs=143.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|..+++.++||||+++++++.+.+..++||||++|++|.+++. ...+++..+..++.|++.||+|||++|++|
T Consensus       113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~-~~~~~e~~~~~~~~qi~~aL~~LH~~givH  191 (410)
T 3v8s_A          113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIH  191 (410)
T ss_dssp             CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3447889999999999999999999999999999999999999999887 467999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCcccccccc----CCcchhHHHHHHHHHHHHh
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~----~~~~~Di~slg~~~~~~l~  163 (180)
                      |||+|+||++   +.++.++|+|||++........  .....+++.|+|||.+.+..    ++.++|+||||+++|+|++
T Consensus       192 rDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~  268 (410)
T 3v8s_A          192 RDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  268 (410)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred             ccCCHHHeeE---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence            9999999999   5778899999999977654432  23456899999999987655    7889999999999999999


Q ss_pred             CCCCCCCCCcc
Q 030256          164 GYPPFSAYRPC  174 (180)
Q Consensus       164 g~~pf~~~~~~  174 (180)
                      |+.||.+.++.
T Consensus       269 G~~Pf~~~~~~  279 (410)
T 3v8s_A          269 GDTPFYADSLV  279 (410)
T ss_dssp             SSCTTCCSSHH
T ss_pred             CCCCCCCCChh
Confidence            99999876643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-36  Score=225.06  Aligned_cols=161  Identities=32%  Similarity=0.631  Sum_probs=146.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.++++||+.|++|
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH  138 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            56789999999999999999999999999999999999999999999988788999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCc----eEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           90 RDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +||+|+||++.   .++    .++|+|||.+.............++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus       139 ~dikp~NIl~~---~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  215 (321)
T 2a2a_A          139 FDLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  215 (321)
T ss_dssp             CCCSGGGEEES---CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred             CCCChHHEEEe---cCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCC
Confidence            99999999995   333    79999999998776554445556899999999999888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.+.
T Consensus       216 ~pf~~~~~  223 (321)
T 2a2a_A          216 SPFLGDTK  223 (321)
T ss_dssp             CSSCCSSH
T ss_pred             CCCCCCCH
Confidence            99987553

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.9e-36  Score=235.93  Aligned_cols=165  Identities=39%  Similarity=0.683  Sum_probs=146.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|++++++++||||+++++++.+.+.+++++||+.+++|.+.+.....+++..+..++.|++.+|+|||++|++
T Consensus        64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv  143 (486)
T 3mwu_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV  143 (486)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            35678899999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++...+....++|+|||++.............+++.|+|||.+.+ .++.++|+||+|+++|++++|..||
T Consensus       144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf  222 (486)
T 3mwu_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF  222 (486)
T ss_dssp             CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999996545566799999999987765555555678999999999875 5899999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+.++.
T Consensus       223 ~~~~~~  228 (486)
T 3mwu_A          223 YGKNEY  228 (486)
T ss_dssp             CCSSHH
T ss_pred             CCCCHH
Confidence            876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.1e-37  Score=230.79  Aligned_cols=162  Identities=36%  Similarity=0.650  Sum_probs=138.2

Q ss_pred             HHHHHHHHHH-HhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ...+.+|..+ ++.++||||+++++++.+.+..++||||++|++|.+++.....+++..+..++.|++.+|++||++|++
T Consensus        82 ~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~giv  161 (373)
T 2r5t_A           82 EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV  161 (373)
T ss_dssp             ---------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            4455667666 567899999999999999999999999999999999999888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      ||||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       162 HrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P  238 (373)
T 2r5t_A          162 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP  238 (373)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ecCCCHHHEEE---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence            99999999999   5778899999999876432 3334456689999999999998999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.+..
T Consensus       239 f~~~~~~  245 (373)
T 2r5t_A          239 FYSRNTA  245 (373)
T ss_dssp             TCCSBHH
T ss_pred             CCCCCHH
Confidence            9876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=232.54  Aligned_cols=162  Identities=33%  Similarity=0.612  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+++|..++.+++||+|+++++++.+.+..++||||++|++|.+++.+.+ .+++..+..++.|++.||++||++|++
T Consensus       105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gii  184 (412)
T 2vd5_A          105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV  184 (412)
T ss_dssp             GCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4558899999999999999999999999999999999999999999998754 799999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccc-------cccCCcchhHHHHHHHHH
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~-------~~~~~~~~Di~slg~~~~  159 (180)
                      ||||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.       ...++.++|+||||+++|
T Consensus       185 HrDLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvily  261 (412)
T 2vd5_A          185 HRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY  261 (412)
T ss_dssp             CCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHH
T ss_pred             ecccCHHHeee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHH
Confidence            99999999999   5778899999999977654332  22346899999999987       356899999999999999


Q ss_pred             HHHhCCCCCCCCCcc
Q 030256          160 ELLNGYPPFSAYRPC  174 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~  174 (180)
                      ||++|+.||.+.++.
T Consensus       262 elltG~~Pf~~~~~~  276 (412)
T 2vd5_A          262 EMFYGQTPFYADSTA  276 (412)
T ss_dssp             HHHHSSCTTCCSSHH
T ss_pred             HHHhCCCCCCCCCHH
Confidence            999999999886654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-36  Score=239.20  Aligned_cols=162  Identities=34%  Similarity=0.568  Sum_probs=147.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+|++++++++||||+++++++.+.+..++||||++|++|.+++...+.  +++..+..++.||+.||+|||++|
T Consensus       227 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g  306 (576)
T 2acx_A          227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER  306 (576)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678899999999999999999999999999999999999999999876543  999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+|++|+.
T Consensus       307 IvHrDLKPeNILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~  383 (576)
T 2acx_A          307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS  383 (576)
T ss_dssp             EECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSC
T ss_pred             EeccCCchheEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence            9999999999999   5778899999999987765554455678999999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||.+.+.
T Consensus       384 PF~~~~~  390 (576)
T 2acx_A          384 PFQQRKK  390 (576)
T ss_dssp             SSSCSSS
T ss_pred             CCccccc
Confidence            9987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-36  Score=228.48  Aligned_cols=163  Identities=38%  Similarity=0.584  Sum_probs=132.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...+++++..+..++.|++.+|++||++|++|
T Consensus        60 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH  139 (361)
T 3uc3_A           60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH  139 (361)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCS
T ss_pred             cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            46688999999999999999999999999999999999999999999988889999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcc-hhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK-VDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~-~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++.. +....++|+|||++.............++..|+|||.+.+..++.+ +|+||+|+++|++++|+.||
T Consensus       140 ~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf  218 (361)
T 3uc3_A          140 RDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF  218 (361)
T ss_dssp             CCCCGGGEEECS-SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCCHHHEEEcC-CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCC
Confidence            999999999952 2233599999999875544444445568999999999988777655 89999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       219 ~~~~~  223 (361)
T 3uc3_A          219 EDPEE  223 (361)
T ss_dssp             C----
T ss_pred             CCCcc
Confidence            87554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-36  Score=235.81  Aligned_cols=161  Identities=41%  Similarity=0.746  Sum_probs=147.0

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|+.+++.++||||+++++++...+..++||||++|++|.+++...+++++..+..++.|++.|+++||++|++|
T Consensus        60 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  139 (476)
T 2y94_A           60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH  139 (476)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCc
Confidence            46789999999999999999999999999999999999999999999987888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++   +.++.++|+|||++.............+++.|+|||.+.+..+ +.++|+||+|+++|++++|..||
T Consensus       140 rDLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf  216 (476)
T 2y94_A          140 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF  216 (476)
T ss_dssp             SCCSGGGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccHHHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC
Confidence            9999999999   5677899999999987765555556678999999999987765 68999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       217 ~~~~~  221 (476)
T 2y94_A          217 DDDHV  221 (476)
T ss_dssp             CCSSS
T ss_pred             CCCCH
Confidence            87654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-36  Score=236.29  Aligned_cols=165  Identities=41%  Similarity=0.712  Sum_probs=148.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+.+....++++..+..++.|++.+|+|||++|++
T Consensus        79 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  158 (494)
T 3lij_A           79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV  158 (494)
T ss_dssp             TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            45678899999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++...+....++|+|||++.............++..|+|||.+. ..++.++|+||+|+++|++++|..||
T Consensus       159 H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf  237 (494)
T 3lij_A          159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF  237 (494)
T ss_dssp             CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCC
Confidence            99999999999644445669999999998776655555667899999999886 46899999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+.++.
T Consensus       238 ~~~~~~  243 (494)
T 3lij_A          238 GGQTDQ  243 (494)
T ss_dssp             CCSSHH
T ss_pred             CCCCHH
Confidence            876543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-36  Score=224.28  Aligned_cols=165  Identities=28%  Similarity=0.489  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++.....   +++..+..++.|++.++++||
T Consensus        75 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  154 (309)
T 3p86_A           75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH  154 (309)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44556788999999999999999999999999999999999999999999986543   999999999999999999999


Q ss_pred             hCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           84 SHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        84 ~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +.|  ++|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus       155 ~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  231 (309)
T 3p86_A          155 NRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE  231 (309)
T ss_dssp             TSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cCCCCEECCCCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHH
Confidence            999  9999999999999   567789999999986543332 2234558899999999999889999999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030256          161 LLNGYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~g~~pf~~~~~~  174 (180)
                      +++|+.||...++.
T Consensus       232 lltg~~Pf~~~~~~  245 (309)
T 3p86_A          232 LATLQQPWGNLNPA  245 (309)
T ss_dssp             HHHCCCTTTTSCHH
T ss_pred             HHhCCCCCCCCCHH
Confidence            99999999876654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.1e-36  Score=228.06  Aligned_cols=165  Identities=28%  Similarity=0.420  Sum_probs=144.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...  ..+++..+..++.|++.+|+|||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  146 (389)
T 3gni_B           67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH  146 (389)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            455678899999999999999999999999999999999999999999999865  569999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC--------CcccccccCccccCcccccc--ccCCcchhHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSV  154 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~--------~~~~~~~~~~~~~ape~~~~--~~~~~~~Di~sl  154 (180)
                      +|++|+||+|+||++   +.++.++|+|||.+......        .......++..|+|||.+.+  ..++.++|+||+
T Consensus       147 ~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  223 (389)
T 3gni_B          147 MGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV  223 (389)
T ss_dssp             TTEECCCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred             CCeecCCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence            999999999999999   56778999999987543221        11222357888999999987  578999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcc
Q 030256          155 GAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~~~  174 (180)
                      |+++|+|++|+.||.+.+..
T Consensus       224 G~il~el~~g~~pf~~~~~~  243 (389)
T 3gni_B          224 GITACELANGHVPFKDMPAT  243 (389)
T ss_dssp             HHHHHHHHHSSCTTTTCCST
T ss_pred             HHHHHHHHHCCCCCCCCCHH
Confidence            99999999999999876554

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=224.90  Aligned_cols=163  Identities=28%  Similarity=0.549  Sum_probs=142.0

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCC--eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .+.+.+|++++++++||||+++++++...+  ..++||||+++++|.+++.....   +++..+..++.|++.+|++||+
T Consensus        51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  130 (319)
T 4euu_A           51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (319)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            566789999999999999999999988654  78999999999999999975443   9999999999999999999999


Q ss_pred             CCCeeecCCCCCeeee-cCCCCceEEEeecCCccccCCCCcccccccCccccCccccc--------cccCCcchhHHHHH
Q 030256           85 HHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--------FQRYDEKVDMWSVG  155 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~-~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~--------~~~~~~~~Di~slg  155 (180)
                      +|++|+||+|+||++. ..+....++|+|||++.............++..|+|||.+.        +..++.++|+||+|
T Consensus       131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG  210 (319)
T 4euu_A          131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG  210 (319)
T ss_dssp             TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHH
T ss_pred             CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHH
Confidence            9999999999999973 22456679999999998776655555566899999999876        46788999999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 030256          156 AILFELLNGYPPFSAYR  172 (180)
Q Consensus       156 ~~~~~~l~g~~pf~~~~  172 (180)
                      +++|++++|+.||...+
T Consensus       211 ~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          211 VTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             HHHHHHHHSSCSEECTT
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999997544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.1e-36  Score=235.68  Aligned_cols=165  Identities=40%  Similarity=0.718  Sum_probs=148.2

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+.+.....+++..+..++.|++.+|+|||+.|++
T Consensus        89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  168 (504)
T 3q5i_A           89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIV  168 (504)
T ss_dssp             THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45678999999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++........++|+|||++.............+++.|+|||.+. ..++.++|+||+|+++|++++|..||
T Consensus       169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf  247 (504)
T 3q5i_A          169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF  247 (504)
T ss_dssp             CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999643333479999999998776655555667899999999987 46899999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+.++.
T Consensus       248 ~~~~~~  253 (504)
T 3q5i_A          248 GGQNDQ  253 (504)
T ss_dssp             CCSSHH
T ss_pred             CCCCHH
Confidence            886643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-36  Score=236.50  Aligned_cols=166  Identities=38%  Similarity=0.673  Sum_probs=150.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|+.++++++||||+++++++.+.+..++++|++.+++|.+.+.....+++..+..++.|++.+|+|||++|+
T Consensus        68 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  147 (484)
T 3nyv_A           68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI  147 (484)
T ss_dssp             SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34677899999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++...+..+.++|+|||++.............+++.|+|||.+.+ .++.++|+||+|+++|++++|..|
T Consensus       148 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p  226 (484)
T 3nyv_A          148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP  226 (484)
T ss_dssp             CCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCC
Confidence            9999999999996545677899999999987766555556678999999999876 689999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       227 f~~~~~~  233 (484)
T 3nyv_A          227 FNGANEY  233 (484)
T ss_dssp             SCCSSHH
T ss_pred             CCCCCHH
Confidence            9876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.9e-37  Score=235.26  Aligned_cols=162  Identities=32%  Similarity=0.539  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~   88 (180)
                      ...+.+|+.++++++||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.+|+|||+ .|++
T Consensus       192 ~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gii  271 (446)
T 4ejn_A          192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV  271 (446)
T ss_dssp             ---------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEE
Confidence            456778999999999999999999999999999999999999999999888899999999999999999999998 9999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       272 HrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  348 (446)
T 4ejn_A          272 YRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  348 (446)
T ss_dssp             CCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ECCCCHHHEEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCC
Confidence            99999999999   5677899999999876433 2233445689999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.+..
T Consensus       349 f~~~~~~  355 (446)
T 4ejn_A          349 FYNQDHE  355 (446)
T ss_dssp             SCCSSHH
T ss_pred             CCCCCHH
Confidence            9876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-36  Score=218.98  Aligned_cols=163  Identities=34%  Similarity=0.650  Sum_probs=139.2

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+.+...    ..+++..+..++.|++.+|++||++
T Consensus        64 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  143 (285)
T 3is5_A           64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ  143 (285)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            467899999999999999999999999999999999999999999988533    6799999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      |++|+||+|+||++...+..+.++|+|||++.............++..|+|||.+. ..++.++|+||||++++++++|.
T Consensus       144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~  222 (285)
T 3is5_A          144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC  222 (285)
T ss_dssp             TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCC
Confidence            99999999999999654556789999999997765554445566889999999876 46889999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.+.
T Consensus       223 ~pf~~~~~  230 (285)
T 3is5_A          223 LPFTGTSL  230 (285)
T ss_dssp             CSSCCSSH
T ss_pred             CCCCCCCH
Confidence            99987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.3e-36  Score=226.72  Aligned_cols=165  Identities=30%  Similarity=0.529  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~   69 (180)
                      ....+.+.+|+++++++ +||||+++++++.+.+.+++||||+++++|.+++....                .++...+.
T Consensus       127 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (370)
T 2psq_A          127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV  206 (370)
T ss_dssp             HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHH
Confidence            34556789999999999 89999999999999999999999999999999997643                37899999


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCC
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD  146 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~  146 (180)
                      .++.|++.+|+|||++|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++
T Consensus       207 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  283 (370)
T 2psq_A          207 SCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT  283 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC
Confidence            999999999999999999999999999999   5678899999999976544321   2223456789999999988999


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          147 EKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      .++|+||||+++|+|++ |..||.+.+..
T Consensus       284 ~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             cHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999 99999876544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.1e-36  Score=217.90  Aligned_cols=164  Identities=34%  Similarity=0.661  Sum_probs=142.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|+.++++++||||+++++++.+.+..+++||++++++|.+++.....+++..+..++.|++.++++||+.|++|
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  131 (283)
T 3bhy_A           52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH  131 (283)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            57789999999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCC-CCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++.... ....++|+|||.+.............++..|+|||.+.+..++.++|+||||++++++++|..||
T Consensus       132 ~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  211 (283)
T 3bhy_A          132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  211 (283)
T ss_dssp             SCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence            99999999995311 12379999999997765544444556888999999999888999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       212 ~~~~~  216 (283)
T 3bhy_A          212 LGETK  216 (283)
T ss_dssp             CCSSH
T ss_pred             CCcch
Confidence            87654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5e-37  Score=226.76  Aligned_cols=165  Identities=28%  Similarity=0.530  Sum_probs=138.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      +.....+.+|+.++++++||||+++++++...+    ..++||||++|++|.+++...+++++..+..++.|++.+|++|
T Consensus        53 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~l  132 (311)
T 3ork_A           53 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS  132 (311)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            345567899999999999999999999987543    4599999999999999998888999999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC----cccccccCccccCccccccccCCcchhHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~  158 (180)
                      |++|++|+||+|+||++.   .++.++|+|||++.......    ......++..|+|||.+.+..++.++|+||||+++
T Consensus       133 H~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l  209 (311)
T 3ork_A          133 HQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL  209 (311)
T ss_dssp             HHTTCCCCCCCGGGEEEE---TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred             HHCCCCcCCCCHHHEEEc---CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHH
Confidence            999999999999999994   66789999999987654322    12234578999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCCcc
Q 030256          159 FELLNGYPPFSAYRPC  174 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~~  174 (180)
                      |+|++|+.||.+.++.
T Consensus       210 ~~ll~g~~pf~~~~~~  225 (311)
T 3ork_A          210 YEVLTGEPPFTGDSPV  225 (311)
T ss_dssp             HHHHHSSCSCCCSSHH
T ss_pred             HHHHhCCCCCCCCChH
Confidence            9999999999876643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-35  Score=217.28  Aligned_cols=164  Identities=32%  Similarity=0.622  Sum_probs=147.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...++.+.+|+.++++++||||+++++++.+.+..+++||++++++|.+++.....+++..+..++.|++.++++||++|
T Consensus        56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  135 (294)
T 2rku_A           56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR  135 (294)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45677889999999999999999999999999999999999999999999988888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|++++++++|+
T Consensus       136 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  212 (294)
T 2rku_A          136 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK  212 (294)
T ss_dssp             EECCCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999   56778999999998765432 2233455788999999999888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...+.
T Consensus       213 ~p~~~~~~  220 (294)
T 2rku_A          213 PPFETSCL  220 (294)
T ss_dssp             CTTCCSSH
T ss_pred             CCCCCCCH
Confidence            99987543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4e-36  Score=222.96  Aligned_cols=161  Identities=27%  Similarity=0.573  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++. ...+++..+..++.|++.++++||+.|++
T Consensus        85 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iv  163 (321)
T 2c30_A           85 RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVI  163 (321)
T ss_dssp             SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678899999999999999999999999999999999999999999886 45799999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       164 H~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          164 HRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             CCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   567789999999987664432 22345688999999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       241 f~~~~~  246 (321)
T 2c30_A          241 YFSDSP  246 (321)
T ss_dssp             TTTSCH
T ss_pred             CCCCCH
Confidence            987654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.4e-36  Score=234.36  Aligned_cols=161  Identities=35%  Similarity=0.514  Sum_probs=144.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+.+.+|.+++++++||||+++++++.+.+..++||||++|++|.+++...    ..+++..+..++.||+.||+|||++
T Consensus       229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~  308 (543)
T 3c4z_A          229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR  308 (543)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc
Confidence            456888999999999999999999999999999999999999999998753    3599999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      |++|+||+|+||++   +.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       309 gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG  385 (543)
T 3c4z_A          309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA  385 (543)
T ss_dssp             TEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CCcccCCChHHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhC
Confidence            99999999999999   5778899999999977654432 2334689999999999998999999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||.+.+.
T Consensus       386 ~~PF~~~~~  394 (543)
T 3c4z_A          386 RGPFRARGE  394 (543)
T ss_dssp             SCSSCCTTC
T ss_pred             CCCCCCCcc
Confidence            999987643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.4e-36  Score=229.40  Aligned_cols=163  Identities=35%  Similarity=0.675  Sum_probs=134.6

Q ss_pred             HHHHHHHHHHhc-CCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSS-VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        11 ~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ..+.+|++++.+ .+||||+++++++..    .+.+++||||++|++|.+++....  .+++..+..++.|++.+|+|||
T Consensus        99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH  178 (400)
T 1nxk_A           99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  178 (400)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            456778888754 489999999999875    567999999999999999998653  4999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      ++|++|+||+|+||++.....++.++|+|||++.............++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus       179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  258 (400)
T 1nxk_A          179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC  258 (400)
T ss_dssp             HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH
T ss_pred             HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh
Confidence            99999999999999996433377899999999987655444455668999999999998899999999999999999999


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||.+.+.
T Consensus       259 g~~pf~~~~~  268 (400)
T 1nxk_A          259 GYPPFYSNHG  268 (400)
T ss_dssp             SSCSCCCCTT
T ss_pred             CCCCCCCCcc
Confidence            9999987654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.3e-35  Score=221.34  Aligned_cols=164  Identities=32%  Similarity=0.622  Sum_probs=147.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...++.+.+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.++++||++|
T Consensus        82 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  161 (335)
T 2owb_A           82 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR  161 (335)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45677899999999999999999999999999999999999999999999988888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ++|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|++++|+
T Consensus       162 ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  238 (335)
T 2owb_A          162 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK  238 (335)
T ss_dssp             EECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CEecCCCchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence            9999999999999   56778999999998766432 2233455888999999999888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||...+.
T Consensus       239 ~pf~~~~~  246 (335)
T 2owb_A          239 PPFETSCL  246 (335)
T ss_dssp             CTTCCSSH
T ss_pred             CCCCCCCH
Confidence            99987543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.5e-36  Score=217.19  Aligned_cols=162  Identities=35%  Similarity=0.634  Sum_probs=142.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++....++++..+..++.|++.++++||+.|++
T Consensus        52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~  131 (279)
T 3fdn_A           52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI  131 (279)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCE
T ss_pred             HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            35678899999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|..||
T Consensus       132 H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  207 (279)
T 3fdn_A          132 HRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF  207 (279)
T ss_dssp             ECCCCGGGEEE---CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccCChHhEEE---cCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence            99999999999   567789999999875543332 23445789999999999888999999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      ...+..
T Consensus       208 ~~~~~~  213 (279)
T 3fdn_A          208 EANTYQ  213 (279)
T ss_dssp             CCSSHH
T ss_pred             CCCcHH
Confidence            876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.6e-37  Score=226.49  Aligned_cols=163  Identities=36%  Similarity=0.636  Sum_probs=142.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.+|++||++|++
T Consensus        48 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~giv  127 (323)
T 3tki_A           48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  127 (323)
T ss_dssp             ---CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34678899999999999999999999999999999999999999999988777899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g  164 (180)
                      |+||+|+||++   +.++.++|+|||++.......   ......++..|+|||.+.+..+ +.++|+||||+++|+|++|
T Consensus       128 H~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  204 (323)
T 3tki_A          128 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (323)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             ccccchHHEEE---eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence            99999999999   567789999999987553221   2234568899999999987765 7789999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      +.||...+..
T Consensus       205 ~~pf~~~~~~  214 (323)
T 3tki_A          205 ELPWDQPSDS  214 (323)
T ss_dssp             SCSCSSSCTT
T ss_pred             CCCCCCCchH
Confidence            9999876553

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=224.02  Aligned_cols=166  Identities=28%  Similarity=0.512  Sum_probs=143.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....++.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.+|++||+
T Consensus        90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  169 (325)
T 3kul_A           90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD  169 (325)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3455678999999999999999999999999999999999999999999999754 579999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      .|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus       170 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e  246 (325)
T 3kul_A          170 LGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE  246 (325)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             CCeeCCCCCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHH
Confidence            999999999999999   5678899999999977644321    112234567999999998889999999999999999


Q ss_pred             HHh-CCCCCCCCCcc
Q 030256          161 LLN-GYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~-g~~pf~~~~~~  174 (180)
                      +++ |..||.+.+..
T Consensus       247 ll~~g~~p~~~~~~~  261 (325)
T 3kul_A          247 VLAYGERPYWNMTNR  261 (325)
T ss_dssp             HHTTSCCTTTTSCHH
T ss_pred             HHcCCCCCcccCCHH
Confidence            999 99999776543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.2e-36  Score=221.61  Aligned_cols=161  Identities=21%  Similarity=0.298  Sum_probs=142.9

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|+++++++ +||||+++++++...+..+++||++ +++|.+++... ..+++..+..++.|++.+|++||+.|+
T Consensus        48 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  126 (330)
T 2izr_A           48 APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL  126 (330)
T ss_dssp             SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            44688999999999 9999999999999999999999999 99999999864 579999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCce-----EEEeecCCccccCCCCc--------ccccccCccccCccccccccCCcchhHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  154 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~-----~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Di~sl  154 (180)
                      +|+||+|+||++.   .++.     ++|+|||++........        .....++..|+|||.+.+..++.++|+|||
T Consensus       127 iHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  203 (330)
T 2izr_A          127 IYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEAL  203 (330)
T ss_dssp             ECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             eccCCCHHHeeec---cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHH
Confidence            9999999999994   4444     99999999976544322        234568899999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcc
Q 030256          155 GAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~~~  174 (180)
                      |+++|++++|..||.+.+..
T Consensus       204 G~il~ell~g~~Pf~~~~~~  223 (330)
T 2izr_A          204 GHMFMYFLRGSLPWQGLKAD  223 (330)
T ss_dssp             HHHHHHHHHSSCTTTTCCCS
T ss_pred             HHHHHHHhcCCCCccccccc
Confidence            99999999999999986554

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.6e-36  Score=220.86  Aligned_cols=162  Identities=33%  Similarity=0.581  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|++++++++||||+++++++.+.+..++||||+++ +|.+.+.... .+++..+..++.|++.+|++||++|+
T Consensus        62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  140 (311)
T 3niz_A           62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI  140 (311)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            356788999999999999999999999999999999999965 8888776544 59999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++|++++|+
T Consensus       141 vH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  217 (311)
T 3niz_A          141 LHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK  217 (311)
T ss_dssp             ECCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCchHhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence            999999999999   56778999999999776433 22234457889999999876 45799999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.++.
T Consensus       218 ~pf~~~~~~  226 (311)
T 3niz_A          218 PLFPGVTDD  226 (311)
T ss_dssp             CSCCCSSTT
T ss_pred             CCCCCCChH
Confidence            999876654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-35  Score=223.77  Aligned_cols=163  Identities=39%  Similarity=0.801  Sum_probs=146.8

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|+.+++++ +||||+++++++...+..++||||++|++|.+++.....+++..+..++.|++.+|++||+.|
T Consensus       141 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g  220 (365)
T 2y7j_A          141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN  220 (365)
T ss_dssp             HHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4467788999999999 899999999999999999999999999999999988888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc------ccCCcchhHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~------~~~~~~~Di~slg~~~~~  160 (180)
                      ++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+      ..++.++|+||||+++|+
T Consensus       221 i~H~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e  297 (365)
T 2y7j_A          221 IVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT  297 (365)
T ss_dssp             EECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHH
Confidence            9999999999999   5678899999999987765555555678999999998863      357889999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030256          161 LLNGYPPFSAYRP  173 (180)
Q Consensus       161 ~l~g~~pf~~~~~  173 (180)
                      |++|..||.+.+.
T Consensus       298 ll~g~~pf~~~~~  310 (365)
T 2y7j_A          298 LLAGSPPFWHRRQ  310 (365)
T ss_dssp             HHHSSCSSCCSSH
T ss_pred             HHHCCCCCCCCCH
Confidence            9999999987543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.7e-36  Score=219.84  Aligned_cols=165  Identities=30%  Similarity=0.559  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.++++||++|
T Consensus        43 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~  122 (311)
T 4agu_A           43 PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN  122 (311)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44567788999999999999999999999999999999999999999998887788999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++|+||+|+||++   +.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|++++++++|
T Consensus       123 ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  199 (311)
T 4agu_A          123 CIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG  199 (311)
T ss_dssp             EECCCCSGGGEEE---CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence            9999999999999   56778999999998766532 22234457888999999876 5679999999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ..||.+.++.
T Consensus       200 ~~p~~~~~~~  209 (311)
T 4agu_A          200 VPLWPGKSDV  209 (311)
T ss_dssp             SCSCCCSSHH
T ss_pred             CCCCCCCCHH
Confidence            9999876543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.2e-36  Score=217.11  Aligned_cols=161  Identities=34%  Similarity=0.674  Sum_probs=124.0

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|+.++++++||||+++++++.+.+..++++||+++++|.+++... .++++..+..++.|++.++++||++|++
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  134 (278)
T 3cok_A           55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL  134 (278)
T ss_dssp             HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            467889999999999999999999999999999999999999999998865 5699999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus       135 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  211 (278)
T 3cok_A          135 HRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP  211 (278)
T ss_dssp             CSSCCGGGEEE---CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCCHHHEEE---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   567789999999987654322 22234578899999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...+.
T Consensus       212 ~~~~~~  217 (278)
T 3cok_A          212 FDTDTV  217 (278)
T ss_dssp             SCCCSC
T ss_pred             CCChhH
Confidence            987554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-35  Score=219.50  Aligned_cols=166  Identities=36%  Similarity=0.600  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.....+++..+..++.|++.+|++||++|+
T Consensus        53 ~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  132 (316)
T 2ac3_A           53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI  132 (316)
T ss_dssp             CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            456788999999995 7999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--------cccccccCccccCcccccc-----ccCCcchhHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSV  154 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~-----~~~~~~~Di~sl  154 (180)
                      +|+||+|+||++........++|+|||++.......        ......++..|+|||.+.+     ..++.++|+|||
T Consensus       133 vH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  212 (316)
T 2ac3_A          133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL  212 (316)
T ss_dssp             CCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHH
T ss_pred             eeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhH
Confidence            999999999999643333459999999986553211        1123348889999999875     457899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcc
Q 030256          155 GAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~~~  174 (180)
                      |+++|+|++|+.||.+.+..
T Consensus       213 G~il~~l~~g~~pf~~~~~~  232 (316)
T 2ac3_A          213 GVILYILLSGYPPFVGRCGS  232 (316)
T ss_dssp             HHHHHHHHHSSCSCCCCCCS
T ss_pred             HHHHHHHHHCCCCCcccccc
Confidence            99999999999999876543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.4e-35  Score=216.31  Aligned_cols=160  Identities=36%  Similarity=0.682  Sum_probs=144.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.++++||++|++|
T Consensus        58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  137 (284)
T 2vgo_A           58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH  137 (284)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            56789999999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  169 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~  169 (180)
                      +||+|+||++   +.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||||++++++++|..||.
T Consensus       138 ~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  213 (284)
T 2vgo_A          138 RDIKPENLLM---GYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD  213 (284)
T ss_dssp             CCCSGGGEEE---CTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cCCCHHHEEE---cCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence            9999999999   567789999999886554322 234457889999999998889999999999999999999999998


Q ss_pred             CCCc
Q 030256          170 AYRP  173 (180)
Q Consensus       170 ~~~~  173 (180)
                      ..+.
T Consensus       214 ~~~~  217 (284)
T 2vgo_A          214 SPSH  217 (284)
T ss_dssp             CSSH
T ss_pred             CCCH
Confidence            7554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=228.41  Aligned_cols=169  Identities=26%  Similarity=0.432  Sum_probs=144.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAG   78 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~   78 (180)
                      .......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++....       .++...++.++.|++.+
T Consensus       114 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a  193 (367)
T 3l9p_A          114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG  193 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHH
T ss_pred             ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHH
Confidence            34556678899999999999999999999999989999999999999999997653       48999999999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCC---CCcccccccCccccCccccccccCCcchhHHHHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  155 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg  155 (180)
                      |++||++|++||||+|+||++........++|+|||++.....   ........++..|+|||.+.+..++.++|+||||
T Consensus       194 L~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG  273 (367)
T 3l9p_A          194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG  273 (367)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH
Confidence            9999999999999999999996433455699999999865421   1222234467889999999888999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcc
Q 030256          156 AILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       156 ~~~~~~l~-g~~pf~~~~~~  174 (180)
                      +++|+|++ |..||.+.+..
T Consensus       274 ~il~ellt~g~~pf~~~~~~  293 (367)
T 3l9p_A          274 VLLWEIFSLGYMPYPSKSNQ  293 (367)
T ss_dssp             HHHHHHHTTSCCSSTTCCHH
T ss_pred             HHHHHHHhCCCCCCCCCCHH
Confidence            99999998 99999876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.5e-36  Score=219.39  Aligned_cols=164  Identities=37%  Similarity=0.645  Sum_probs=144.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+..+++||++++++|.+++...+.+++..+..++.|++.++++||+.|++
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (304)
T 2jam_A           49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV  128 (304)
T ss_dssp             ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            44668899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++...+.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  207 (304)
T 2jam_A          129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF  207 (304)
T ss_dssp             CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999954456778999999998654332 223445889999999999888999999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       208 ~~~~~  212 (304)
T 2jam_A          208 YEETE  212 (304)
T ss_dssp             TTSCH
T ss_pred             CCCCH
Confidence            87554

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.4e-36  Score=230.04  Aligned_cols=162  Identities=41%  Similarity=0.722  Sum_probs=134.7

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      ..+.+|++++++++||||+++++++.. +..++||||+++++|.+++.....+++..+..++.|++.+++|||++|++|+
T Consensus       185 ~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr  263 (419)
T 3i6u_A          185 LNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR  263 (419)
T ss_dssp             CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            357899999999999999999999854 4579999999999999988877889999999999999999999999999999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc---ccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~---~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      ||+|+||++...+....++|+|||++.............++..|+|||.+.+   ..++.++|+||+|+++|+|++|+.|
T Consensus       264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p  343 (419)
T 3i6u_A          264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  343 (419)
T ss_dssp             CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999996444455699999999987765555556678999999999853   5578899999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.....
T Consensus       344 f~~~~~  349 (419)
T 3i6u_A          344 FSEHRT  349 (419)
T ss_dssp             SCCCSS
T ss_pred             CCCCcc
Confidence            986543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=220.84  Aligned_cols=160  Identities=35%  Similarity=0.583  Sum_probs=144.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|+.++++++||||+++++++.+.+..+++||++.++ +|.+++...+.+++..+..++.|++.+|++||++|++
T Consensus        73 ~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv  152 (335)
T 3dls_A           73 LGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDII  152 (335)
T ss_dssp             TEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            345678999999999999999999999999999999998666 9999999888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..+ +.++|+||||+++|++++|..|
T Consensus       153 H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  229 (335)
T 3dls_A          153 HRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP  229 (335)
T ss_dssp             CSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EeccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCc
Confidence            99999999999   5678899999999987766555556668999999999987776 7899999999999999999999


Q ss_pred             CCCCC
Q 030256          168 FSAYR  172 (180)
Q Consensus       168 f~~~~  172 (180)
                      |....
T Consensus       230 f~~~~  234 (335)
T 3dls_A          230 FCELE  234 (335)
T ss_dssp             CSSGG
T ss_pred             hhhHH
Confidence            97644

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.6e-36  Score=231.61  Aligned_cols=162  Identities=35%  Similarity=0.499  Sum_probs=136.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l   79 (180)
                      .......+.+|+.+++.++||||+++++++...      ...++||||+++ +|.+.+.  ..+++..+..++.|++.||
T Consensus       101 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL  177 (464)
T 3ttj_A          101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI  177 (464)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHH
Confidence            345567788999999999999999999998654      467999999965 6766664  4599999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      +|||++|++||||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|
T Consensus       178 ~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  254 (464)
T 3ttj_A          178 KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG  254 (464)
T ss_dssp             HHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             HHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence            99999999999999999999   567889999999998776655555667899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      +|++|+.||.+.+.
T Consensus       255 ell~g~~pF~g~~~  268 (464)
T 3ttj_A          255 EMVRHKILFPGRDY  268 (464)
T ss_dssp             HHHHSSCSSCCSSH
T ss_pred             HHHhCCCCCCCCCH
Confidence            99999999988653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-36  Score=223.50  Aligned_cols=165  Identities=25%  Similarity=0.529  Sum_probs=143.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc------------------------CC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GR   62 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~   62 (180)
                      ....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++...                        .+
T Consensus        91 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (343)
T 1luf_A           91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP  170 (343)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCC
Confidence            445678999999999999999999999999999999999999999999999763                        56


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccc
Q 030256           63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEV  139 (180)
Q Consensus        63 ~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~  139 (180)
                      +++..++.++.|++.++++||++|++|+||+|+||++   +.++.++|+|||++.......   ......++..|+|||.
T Consensus       171 l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            8999999999999999999999999999999999999   567889999999986653321   1223446788999999


Q ss_pred             cccccCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          140 LQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       140 ~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      +.+..++.++|+||||+++|++++ |..||.+.+..
T Consensus       248 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  283 (343)
T 1luf_A          248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  283 (343)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             hccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence            988889999999999999999999 99999876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-35  Score=218.07  Aligned_cols=164  Identities=23%  Similarity=0.452  Sum_probs=136.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +...+.+.+|+.++++++||||+++++++..++..++++|++++++|.+++....++++..+..++.|++.++++||++|
T Consensus        75 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  154 (309)
T 2h34_A           75 PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG  154 (309)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence            34457899999999999999999999999999999999999999999999998888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++|+||+|+||++   +.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus       155 i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (309)
T 2h34_A          155 ATHRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG  231 (309)
T ss_dssp             CCCSCCCGGGEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS
T ss_pred             CCcCCCChHHEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC
Confidence            9999999999999   567789999999986654332  22234578899999999988899999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      ..||.+.+.
T Consensus       232 ~~pf~~~~~  240 (309)
T 2h34_A          232 SPPYQGDQL  240 (309)
T ss_dssp             SCSSCSCHH
T ss_pred             CCCCCCchH
Confidence            999987543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-35  Score=239.08  Aligned_cols=163  Identities=34%  Similarity=0.618  Sum_probs=147.3

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|..++..+ +|++|+++++++.+.+.+++||||++|++|.+++...+.+++..+..++.||+.||+|||++|+
T Consensus       384 ~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gI  463 (674)
T 3pfq_A          384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI  463 (674)
T ss_dssp             TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSE
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            456678899999998 7999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccC-CCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||||+|+||++   +.++.++|+|||++.... .........|++.|+|||.+.+..++.++|+||||+++|||++|+.
T Consensus       464 iHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~  540 (674)
T 3pfq_A          464 IYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA  540 (674)
T ss_dssp             ECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             EeccCChhhEEE---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCC
Confidence            999999999999   577889999999987643 2333445668999999999999999999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.++.
T Consensus       541 Pf~~~~~~  548 (674)
T 3pfq_A          541 PFEGEDED  548 (674)
T ss_dssp             SSCCSSHH
T ss_pred             CCCCCCHH
Confidence            99887654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-35  Score=219.40  Aligned_cols=165  Identities=30%  Similarity=0.524  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC------------------------
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR------------------------   62 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------   62 (180)
                      ....+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++.....                        
T Consensus        67 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (314)
T 2ivs_A           67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA  146 (314)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred             HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence            34557788999999999999999999999999999999999999999999986543                        


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccc
Q 030256           63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEV  139 (180)
Q Consensus        63 ~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~  139 (180)
                      +++..+..++.|++.++++||++|++|+||+|+||++.   .++.++|+|||++........   .....++..|+|||.
T Consensus       147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            88999999999999999999999999999999999994   677899999999876644322   122335677999999


Q ss_pred             cccccCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          140 LQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       140 ~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      +.+..++.++|+||||+++|++++ |..||.+.++.
T Consensus       224 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            988889999999999999999999 99999876654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-35  Score=214.67  Aligned_cols=161  Identities=42%  Similarity=0.741  Sum_probs=136.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|++++++++||||+++++++...+..++++|++++++|.+++....++++..+..++.|++.++++||++|++|
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  134 (276)
T 2h6d_A           55 VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH  134 (276)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            45788999999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      +||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+..+ +.++|+||||++++++++|..||
T Consensus       135 ~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          135 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCChhhEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            9999999999   5677899999999877655544445567889999999887665 68999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       212 ~~~~~  216 (276)
T 2h6d_A          212 DDEHV  216 (276)
T ss_dssp             CCSSH
T ss_pred             CCCcH
Confidence            87543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.1e-36  Score=225.39  Aligned_cols=161  Identities=16%  Similarity=0.213  Sum_probs=136.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ......|+..++.++|+||+++++++...    ...+++|||+ |++|.+++... ..+++..+..++.|++.+|+|||+
T Consensus        92 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~  170 (364)
T 3op5_A           92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE  170 (364)
T ss_dssp             CHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34455567778888999999999998764    4689999999 99999999866 579999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--------ccccccCccccCccccccccCCcchhHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      +|++|+||+|+||+++. +..+.++|+|||++........        .....++..|+|||.+.+..++.++|+||||+
T Consensus       171 ~~iiHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  249 (364)
T 3op5_A          171 HEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY  249 (364)
T ss_dssp             TTEECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             CCeEEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence            99999999999999952 2567899999999966543211        12334889999999999989999999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 030256          157 ILFELLNGYPPFSAYR  172 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~  172 (180)
                      ++|+|++|+.||.+..
T Consensus       250 ~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          250 CMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             HHHHHHHSCCTTGGGT
T ss_pred             HHHHHHhCCCCccccc
Confidence            9999999999998643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4e-36  Score=222.73  Aligned_cols=164  Identities=29%  Similarity=0.413  Sum_probs=143.7

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ...+.+.+|++++++++||||+++++++...+..+++|||+++++|.+++....    .+++..+..++.|++.++++||
T Consensus        77 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  156 (321)
T 2qkw_B           77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH  156 (321)
T ss_dssp             SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence            345678999999999999999999999999999999999999999999886443    4899999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      ++|++|+||+|+||++   +.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus       157 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  233 (321)
T 2qkw_B          157 TRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE  233 (321)
T ss_dssp             HTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHH
T ss_pred             CCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHH
Confidence            9999999999999999   577889999999987643221   2223447889999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030256          161 LLNGYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~g~~pf~~~~~~  174 (180)
                      +++|+.||....+.
T Consensus       234 ll~g~~p~~~~~~~  247 (321)
T 2qkw_B          234 VLCARSAIVQSLPR  247 (321)
T ss_dssp             HHHCCTTCSCSSSS
T ss_pred             HHhCCCcccccCcH
Confidence            99999999876554

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.6e-35  Score=212.95  Aligned_cols=164  Identities=32%  Similarity=0.608  Sum_probs=143.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.+.+|+.++++++||||+++++++..    .+..++||||+++++|.+++.....+++..+..++.|++.++++
T Consensus        65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~  144 (290)
T 1t4h_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence            45567789999999999999999999999875    35789999999999999999988889999999999999999999


Q ss_pred             HHhCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        82 lh~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      ||+.|  ++|+||+|+||++.  ...+.++|+|||++....... .....++..|+|||.+.+ .++.++|+||+|++++
T Consensus       145 lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~  220 (290)
T 1t4h_A          145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML  220 (290)
T ss_dssp             HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTTS-BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred             HHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcccccccc-cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHH
Confidence            99999  99999999999994  366789999999986554332 234458899999998764 5899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|+.||.....
T Consensus       221 ~l~~g~~pf~~~~~  234 (290)
T 1t4h_A          221 EMATSEYPYSECQN  234 (290)
T ss_dssp             HHHHSSCTTTTCSS
T ss_pred             HHHhCCCCCCCcCc
Confidence            99999999987443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-35  Score=215.10  Aligned_cols=162  Identities=27%  Similarity=0.533  Sum_probs=142.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|++++++++||||+++++++.+++..+++|||+++++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~  128 (269)
T 4hcu_A           49 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI  128 (269)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            466899999999999999999999999999999999999999999999754 4589999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      |+||+|+||++   +.++.++|+|||.+........  .....++..|+|||.+.+..++.++|+||+|++++++++ |.
T Consensus       129 H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~  205 (269)
T 4hcu_A          129 HRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK  205 (269)
T ss_dssp             CSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCcchheEEE---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCC
Confidence            99999999999   5677899999999876543321  122335667999999998889999999999999999999 99


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||...+..
T Consensus       206 ~p~~~~~~~  214 (269)
T 4hcu_A          206 IPYENRSNS  214 (269)
T ss_dssp             CTTTTCCHH
T ss_pred             CCCCCCCHH
Confidence            999876554

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.7e-36  Score=221.20  Aligned_cols=164  Identities=30%  Similarity=0.511  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~   69 (180)
                      +...+.+.+|+++++++ +||||+++++++.+.+..+++|||+++++|.+++....                .+++..++
T Consensus        66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (327)
T 1fvr_A           66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  145 (327)
T ss_dssp             ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence            34556788999999999 99999999999999999999999999999999997653                69999999


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcch
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      .++.|++.+|++||++|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++
T Consensus       146 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  222 (327)
T 1fvr_A          146 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchh
Confidence            999999999999999999999999999999   56778999999998654332222333467789999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          150 DMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       150 Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+||||+++|++++ |..||.+.+.
T Consensus       223 Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          223 DVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             cchHHHHHHHHHHcCCCCCCCCCcH
Confidence            99999999999998 9999987654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.7e-36  Score=218.15  Aligned_cols=162  Identities=25%  Similarity=0.527  Sum_probs=142.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++.. ...+++..+..++.|++.++++||++|++
T Consensus        63 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  142 (283)
T 3gen_A           63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL  142 (283)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            46688999999999999999999999999999999999999999999976 45799999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      |+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||.+.+..++.++|+||+|+++|++++ |.
T Consensus       143 H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~  219 (283)
T 3gen_A          143 HRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK  219 (283)
T ss_dssp             CSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCccceEEE---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999   56778999999998765433211  12335667999999998889999999999999999998 99


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||...+..
T Consensus       220 ~p~~~~~~~  228 (283)
T 3gen_A          220 MPYERFTNS  228 (283)
T ss_dssp             CTTTTSCHH
T ss_pred             CCccccChh
Confidence            999876543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-35  Score=214.29  Aligned_cols=162  Identities=27%  Similarity=0.572  Sum_probs=142.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++...+ .+++..+..++.|++.++++||+.|++
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  126 (268)
T 3sxs_A           47 EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI  126 (268)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4668899999999999999999999999999999999999999999997654 499999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      |+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|++++++++ |.
T Consensus       127 H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  203 (268)
T 3sxs_A          127 HRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK  203 (268)
T ss_dssp             ESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTC
T ss_pred             cCCcCcceEEE---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCC
Confidence            99999999999   56778999999998766544322  12334567999999998889999999999999999999 99


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||...+..
T Consensus       204 ~p~~~~~~~  212 (268)
T 3sxs_A          204 MPYDLYTNS  212 (268)
T ss_dssp             CTTTTSCHH
T ss_pred             CCccccChH
Confidence            999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.2e-35  Score=215.18  Aligned_cols=157  Identities=34%  Similarity=0.574  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|+.++++++||||+++++++.+++..++||||+++ ++.+.+. ..+.+++..+..++.|++.++++||++|
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~  121 (292)
T 3o0g_A           43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456788999999999999999999999999999999999976 5555554 4567999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++|+||+|+||++   +.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+|++++++++|
T Consensus       122 ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~  198 (292)
T 3o0g_A          122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             EECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             eecCCCCHHHEEE---cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence            9999999999999   56778999999999766433 2233455788999999987765 79999999999999999988


Q ss_pred             CCCC
Q 030256          165 YPPF  168 (180)
Q Consensus       165 ~~pf  168 (180)
                      ..||
T Consensus       199 ~~p~  202 (292)
T 3o0g_A          199 GRPL  202 (292)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            7775

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4e-35  Score=217.20  Aligned_cols=160  Identities=33%  Similarity=0.545  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      .+.+.+|++++++++||||+++++++.+++..++||||++ ++|.+++...      ..+++..+..++.|++.+|++||
T Consensus        47 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH  125 (317)
T 2pmi_A           47 PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH  125 (317)
T ss_dssp             CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4568889999999999999999999999999999999996 5999988654      35899999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccc-cCCcchhHHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~  161 (180)
                      ++|++|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+. .++.++|+||||+++|+|
T Consensus       126 ~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  202 (317)
T 2pmi_A          126 ENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM  202 (317)
T ss_dssp             HTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             HCCeeeCCCChHHeEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999   56778999999998766432 222344578999999998764 579999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.+.
T Consensus       203 ~~g~~pf~~~~~  214 (317)
T 2pmi_A          203 ITGKPLFPGTND  214 (317)
T ss_dssp             HHSSCSCCCSSH
T ss_pred             HhCCCCCCCCCh
Confidence            999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-35  Score=221.04  Aligned_cols=164  Identities=26%  Similarity=0.380  Sum_probs=143.1

Q ss_pred             HHHHHHHHHHHHHHhcCC-----CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l   79 (180)
                      ....+...+|+.+++++.     ||||+++++++...+..++|||++ +++|.+++....  .+++..+..++.|++.+|
T Consensus        72 ~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL  150 (360)
T 3llt_A           72 KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKAL  150 (360)
T ss_dssp             HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            455667788999999996     999999999999999999999999 899999998654  499999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecC----------------------CCCceEEEeecCCccccCCCCcccccccCccccCc
Q 030256           80 EILNSHHIIHRDLKPENILLSGL----------------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP  137 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~----------------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ap  137 (180)
                      ++||++|++|+||+|+||++...                      .....++|+|||++......  .....++..|+||
T Consensus       151 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aP  228 (360)
T 3llt_A          151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAP  228 (360)
T ss_dssp             HHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCH
T ss_pred             HHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCc
Confidence            99999999999999999999521                      12667999999998765432  2345578999999


Q ss_pred             cccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       138 e~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      |.+.+..++.++|+||+|+++|+|++|+.||.+.+.
T Consensus       229 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          229 EVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence            999999999999999999999999999999987654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-35  Score=222.40  Aligned_cols=160  Identities=33%  Similarity=0.580  Sum_probs=140.3

Q ss_pred             HHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        12 ~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      ...+|++++.++ +||||+++++++.+.+..++||||++|++|.+.+.....+++..+..++.|++.++++||++|++|+
T Consensus        61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHr  140 (342)
T 2qr7_A           61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHR  140 (342)
T ss_dssp             CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence            345788888888 7999999999999999999999999999999999888889999999999999999999999999999


Q ss_pred             cCCCCCeeeecCC-CCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           91 DLKPENILLSGLD-DDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        91 dl~~~nil~~~~~-~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      ||+|+||++.+.+ ....++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       141 Dlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  220 (342)
T 2qr7_A          141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF  220 (342)
T ss_dssp             CCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence            9999999985322 2345999999999766443 2233456789999999998888899999999999999999999999


Q ss_pred             CCC
Q 030256          169 SAY  171 (180)
Q Consensus       169 ~~~  171 (180)
                      ...
T Consensus       221 ~~~  223 (342)
T 2qr7_A          221 ANG  223 (342)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4e-35  Score=216.17  Aligned_cols=160  Identities=34%  Similarity=0.552  Sum_probs=140.2

Q ss_pred             HHHHHHHHHHhcC---CCccccccceEEEeCC-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSV---NHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLE   80 (180)
Q Consensus        11 ~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~   80 (180)
                      ..+.+|+.+++++   +||||+++++++....     ..++++|++. ++|.+++.....  +++..+..++.|++.+|+
T Consensus        56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~  134 (308)
T 3g33_A           56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD  134 (308)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            4566777777777   4999999999998754     5899999995 599999986654  999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +||++|++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||||+++|+
T Consensus       135 ~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  211 (308)
T 3g33_A          135 FLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE  211 (308)
T ss_dssp             HHHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHH
T ss_pred             HHHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHH
Confidence            9999999999999999999   5677899999999987765555556678999999999998899999999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030256          161 LLNGYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~g~~pf~~~~~~  174 (180)
                      +++|+.||.+.++.
T Consensus       212 l~~g~~pf~~~~~~  225 (308)
T 3g33_A          212 MFRRKPLFCGNSEA  225 (308)
T ss_dssp             TTTSSCSCCCSSHH
T ss_pred             HHhCCCCCCCCCHH
Confidence            99999999876543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.9e-36  Score=221.71  Aligned_cols=162  Identities=27%  Similarity=0.428  Sum_probs=138.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ......+|+.++++++||||+++++++....    .+++||||+++++|.+++.. ..+++..+..++.|++.+++|||+
T Consensus        61 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~  139 (322)
T 3soc_A           61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHE  139 (322)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3445566888899999999999999988743    47999999999999999974 569999999999999999999999


Q ss_pred             C----------CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcccccc-----ccCC
Q 030256           85 H----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----QRYD  146 (180)
Q Consensus        85 ~----------~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~-----~~~~  146 (180)
                      .          |++|+||+|+||++   +..+.++|+|||++........   .....++..|+|||.+.+     ..++
T Consensus       140 ~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  216 (322)
T 3soc_A          140 DIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF  216 (322)
T ss_dssp             CEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHH
T ss_pred             hccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCC
Confidence            9          99999999999999   5677899999999976543322   223458899999999876     3566


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          147 EKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      .++|+||+|+++|++++|+.||.+..+.
T Consensus       217 ~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          217 LRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             ccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            7899999999999999999999876543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.7e-35  Score=213.84  Aligned_cols=164  Identities=41%  Similarity=0.787  Sum_probs=146.5

Q ss_pred             HHHHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +..++.+.+|+++++++. ||||+++++++...+..+++||++++++|.+++.....+++..+..++.|++.++++||++
T Consensus        64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  143 (298)
T 1phk_A           64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL  143 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345677889999999995 9999999999999999999999999999999999888899999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc------cccCCcchhHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~------~~~~~~~~Di~slg~~~~  159 (180)
                      |++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.      ...++.++|+||||++++
T Consensus       144 ~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~  220 (298)
T 1phk_A          144 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY  220 (298)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred             CcccCCCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHH
Confidence            99999999999999   567789999999987766555445566889999999875      345788999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|..||...+.
T Consensus       221 ~l~~g~~p~~~~~~  234 (298)
T 1phk_A          221 TLLAGSPPFWHRKQ  234 (298)
T ss_dssp             HHHHSSCSSCCSSH
T ss_pred             HHHHCCCCCcCccH
Confidence            99999999976553

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-35  Score=224.15  Aligned_cols=164  Identities=26%  Similarity=0.499  Sum_probs=134.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...++.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.+|++||++
T Consensus        87 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (373)
T 2qol_A           87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM  166 (373)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4566789999999999999999999999999999999999999999999998654 699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+||+|+||++   +.++.++|+|||++.........    ....++..|+|||.+.+..++.++|+||||+++|++
T Consensus       167 ~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~el  243 (373)
T 2qol_A          167 GYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV  243 (373)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCCcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHH
Confidence            99999999999999   56788999999998765433211    112245679999999988999999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030256          162 LN-GYPPFSAYRP  173 (180)
Q Consensus       162 l~-g~~pf~~~~~  173 (180)
                      ++ |+.||.+.+.
T Consensus       244 lt~g~~P~~~~~~  256 (373)
T 2qol_A          244 MSYGERPYWEMSN  256 (373)
T ss_dssp             HTTC-CTTTTCCH
T ss_pred             HhCCCCCCCCCCH
Confidence            98 9999977654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=223.06  Aligned_cols=165  Identities=30%  Similarity=0.508  Sum_probs=144.7

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~   69 (180)
                      ....+.+.+|+++++++ +||||+++++++...+..++||||+++++|.+++....                .+++..+.
T Consensus       115 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  194 (382)
T 3tt0_A          115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV  194 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence            44557788999999999 99999999999999999999999999999999998653                48999999


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCC
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  146 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~  146 (180)
                      .++.|++.+|++||+.|++|+||+|+||++   +.++.++|+|||++.......   ......++..|+|||.+.+..++
T Consensus       195 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  271 (382)
T 3tt0_A          195 SCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT  271 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred             HHHHHHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence            999999999999999999999999999999   567789999999997665432   12233456789999999998999


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          147 EKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      .++|+||||++++++++ |..||.+.+..
T Consensus       272 ~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999 99999876543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.7e-35  Score=219.48  Aligned_cols=163  Identities=41%  Similarity=0.735  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      ...+.+|++++++++||||+++++++..++ .+++|||+++++|.+++.....+++..+..++.|++.+|++||++|++|
T Consensus        59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  137 (322)
T 2ycf_A           59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH  137 (322)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            446889999999999999999999987665 8999999999999999987788999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc---cccCCcchhHHHHHHHHHHHHhCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||+|+||++...+....++|+|||.+.............++..|+|||.+.   ...++.++|+||||+++|++++|..
T Consensus       138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  217 (322)
T 2ycf_A          138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP  217 (322)
T ss_dssp             CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999643344569999999998775554444556889999999874   4568899999999999999999999


Q ss_pred             CCCCCCc
Q 030256          167 PFSAYRP  173 (180)
Q Consensus       167 pf~~~~~  173 (180)
                      ||...+.
T Consensus       218 pf~~~~~  224 (322)
T 2ycf_A          218 PFSEHRT  224 (322)
T ss_dssp             SSCSTTC
T ss_pred             CCcccch
Confidence            9986554

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-35  Score=216.72  Aligned_cols=161  Identities=33%  Similarity=0.559  Sum_probs=137.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|++++++++||||+++++++.+.+..+++||++++ +|.+++... +.+++..+..++.|++.++++||++|+
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  121 (288)
T 1ob3_A           43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV  121 (288)
T ss_dssp             CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            346788999999999999999999999999999999999965 999988754 569999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|++++|.
T Consensus       122 ~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  198 (288)
T 1ob3_A          122 LHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT  198 (288)
T ss_dssp             CCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCHHHEEE---cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999   567789999999987654322 22334578899999998754 5899999999999999999999


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.+.
T Consensus       199 ~pf~~~~~  206 (288)
T 1ob3_A          199 PLFPGVSE  206 (288)
T ss_dssp             CSCCCSSH
T ss_pred             CCCCCCCH
Confidence            99987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.8e-35  Score=218.54  Aligned_cols=160  Identities=29%  Similarity=0.555  Sum_probs=136.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCC-----------------------------------------------
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----------------------------------------------   39 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----------------------------------------------   39 (180)
                      +...+.+.+|+.++++++||||+++++++.+.+                                               
T Consensus        45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  124 (332)
T 3qd2_B           45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV  124 (332)
T ss_dssp             TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence            345678999999999999999999999885543                                               


Q ss_pred             ----------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCc
Q 030256           40 ----------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV  106 (180)
Q Consensus        40 ----------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~  106 (180)
                                ..+++|||+++++|.+++.....   .+...+..++.|++.+|++||++|++|+||+|+||++   +.++
T Consensus       125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~  201 (332)
T 3qd2_B          125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD  201 (332)
T ss_dssp             -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred             ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCC
Confidence                      38999999999999999986543   5666789999999999999999999999999999999   5677


Q ss_pred             eEEEeecCCccccCCCC-------------cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCC
Q 030256          107 MLKIADFGLSCTLYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  169 (180)
Q Consensus       107 ~~~l~d~~~~~~~~~~~-------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~  169 (180)
                      .++|+|||++.......             ......++..|+|||.+.+..++.++|+||+|+++|++++|..|+.
T Consensus       202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence            89999999987765432             1223458899999999998899999999999999999999887763

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-35  Score=215.46  Aligned_cols=164  Identities=28%  Similarity=0.543  Sum_probs=132.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+.+|+.++++++||||+++++++. ++..+++|||+++++|.+++.... .+++..+..++.|++.++++||++
T Consensus        57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  135 (281)
T 1mp8_A           57 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK  135 (281)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            455678899999999999999999999984 456889999999999999997654 699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      |++|+||+|+||++.   .++.++|+|||++........  .....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       136 ~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~  212 (281)
T 1mp8_A          136 RFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  212 (281)
T ss_dssp             TCCCSCCSGGGEEEE---ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred             CeecccccHHHEEEC---CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHh
Confidence            999999999999994   567899999999876644322  122335668999999988889999999999999999996


Q ss_pred             -CCCCCCCCCcc
Q 030256          164 -GYPPFSAYRPC  174 (180)
Q Consensus       164 -g~~pf~~~~~~  174 (180)
                       |..||.+.+..
T Consensus       213 ~g~~pf~~~~~~  224 (281)
T 1mp8_A          213 HGVKPFQGVKNN  224 (281)
T ss_dssp             TSCCTTTTCCGG
T ss_pred             cCCCCCCcCCHH
Confidence             99999876554

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.2e-35  Score=218.12  Aligned_cols=164  Identities=30%  Similarity=0.529  Sum_probs=140.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.++......+++..+..++.|++.++++||+.|
T Consensus        65 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  144 (331)
T 4aaa_A           65 KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN  144 (331)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44566788999999999999999999999999999999999999999988776778999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++|+||+|+||++   +.++.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||+|+++|++++|
T Consensus       145 ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  221 (331)
T 4aaa_A          145 IIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG  221 (331)
T ss_dssp             CCCCCCCGGGEEE---CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEccCcChheEEE---cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhC
Confidence            9999999999999   56778999999998765432 222345578899999998765 689999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||.+.+.
T Consensus       222 ~~pf~~~~~  230 (331)
T 4aaa_A          222 EPLFPGDSD  230 (331)
T ss_dssp             SCSCCCSSH
T ss_pred             CCCCCCCCc
Confidence            999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=217.15  Aligned_cols=159  Identities=32%  Similarity=0.595  Sum_probs=137.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|++++++++||||+++++++.+  .+..+++|||+++++|.++.. ..++++..+..++.|++.+|++||++|+
T Consensus        80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i  158 (298)
T 2zv2_A           80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKI  158 (298)
T ss_dssp             -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3568899999999999999999999986  568999999999999987643 4679999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccccc---CCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~---~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..   .+.++|+||||+++|++++
T Consensus       159 vH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          159 IHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             ECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eccCCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            999999999999   567789999999987765432 223456889999999987655   3778999999999999999


Q ss_pred             CCCCCCCCC
Q 030256          164 GYPPFSAYR  172 (180)
Q Consensus       164 g~~pf~~~~  172 (180)
                      |+.||.+.+
T Consensus       236 g~~pf~~~~  244 (298)
T 2zv2_A          236 GQCPFMDER  244 (298)
T ss_dssp             SSCSSCCSS
T ss_pred             CCCCCCCcc
Confidence            999998654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.6e-35  Score=222.69  Aligned_cols=164  Identities=33%  Similarity=0.548  Sum_probs=145.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +....+.+.+|+.++++++||||+++++++.+++..+++|||+++++|.+++.....+++..+..++.+++.++++||+.
T Consensus        71 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~  150 (360)
T 3eqc_A           71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  150 (360)
T ss_dssp             CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            35566789999999999999999999999999999999999999999999999888999999999999999999999996


Q ss_pred             -CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        86 -~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                       |++|+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|++++|
T Consensus       151 ~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  226 (360)
T 3eqc_A          151 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG  226 (360)
T ss_dssp             HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHC-----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEcCCccHHHEEE---CCCCCEEEEECCCCccccccc-ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence             99999999999999   567789999999886543221 2234578899999999998999999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||...+.
T Consensus       227 ~~pf~~~~~  235 (360)
T 3eqc_A          227 RYPIPPPDA  235 (360)
T ss_dssp             SCCSSCCCH
T ss_pred             CCCCCCCCH
Confidence            999987654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-35  Score=223.52  Aligned_cols=162  Identities=31%  Similarity=0.507  Sum_probs=137.7

Q ss_pred             HHHHHHHHHHHHHHhcCC-CccccccceEEEeCC--eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ......+.+|+.+++++. ||||+++++++...+  .+++||||++ ++|..++.. ..+++..+..++.|++.+|+|||
T Consensus        49 ~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH  126 (388)
T 3oz6_A           49 STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLH  126 (388)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            445566788999999996 999999999997544  7999999996 599998874 67999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC----------------------CcccccccCccccCccccc
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----------------------NYAEKVCGSPLYMAPEVLQ  141 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~----------------------~~~~~~~~~~~~~ape~~~  141 (180)
                      +.|++||||+|+||++   +.++.++|+|||++......                      .......++..|+|||.+.
T Consensus       127 ~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (388)
T 3oz6_A          127 SGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL  203 (388)
T ss_dssp             HTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred             hCCEEeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence            9999999999999999   57788999999998765321                      1122346889999999987


Q ss_pred             c-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          142 F-QRYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       142 ~-~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      + ..++.++|+||+|+++++|++|+.||.+.+.
T Consensus       204 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          204 GSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            6 5689999999999999999999999988654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6e-35  Score=213.28  Aligned_cols=164  Identities=39%  Similarity=0.688  Sum_probs=145.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|++++++++||||+++++++.+.+..++++|++++++|.+.+.....+++..+..++.|++.++++||++|++
T Consensus        64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  143 (287)
T 2wei_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV  143 (287)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      |+||+|+||++...+....++|+|||.+.............++..|+|||.+.+ .++.++|+||||++++++++|..||
T Consensus       144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~  222 (287)
T 2wei_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF  222 (287)
T ss_dssp             CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCC
Confidence            999999999996444456799999999877655544445557888999998875 4889999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       223 ~~~~~  227 (287)
T 2wei_A          223 YGKNE  227 (287)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-35  Score=219.38  Aligned_cols=163  Identities=26%  Similarity=0.435  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+++.+|+.++++++||||+++++++..++ .+++++++.+++|.+++... ..+++..+..++.|++.++++||++|
T Consensus        59 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  137 (327)
T 3poz_A           59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  137 (327)
T ss_dssp             -CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            44567899999999999999999999998765 77889999999999998764 56999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      ++|+||+|+||++.   .++.++|+|||++.........   ....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       138 ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  214 (327)
T 3poz_A          138 LVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             CCCSCCCGGGEEEE---ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eeCCCCChheEEEC---CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence            99999999999994   5678999999998766443222   22335678999999999999999999999999999999


Q ss_pred             -CCCCCCCCCcc
Q 030256          164 -GYPPFSAYRPC  174 (180)
Q Consensus       164 -g~~pf~~~~~~  174 (180)
                       |..||.+.+..
T Consensus       215 ~g~~p~~~~~~~  226 (327)
T 3poz_A          215 FGSKPYDGIPAS  226 (327)
T ss_dssp             TSCCTTTTCCGG
T ss_pred             cCCCCccCCCHH
Confidence             99999876654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.4e-35  Score=225.80  Aligned_cols=161  Identities=27%  Similarity=0.512  Sum_probs=140.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCC-eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ..+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++...+.  ++...+..++.|++.+++|||++
T Consensus       229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~  308 (450)
T 1k9a_A          229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN  308 (450)
T ss_dssp             TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567899999999999999999999987654 79999999999999999987654  79999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      |++|+||+|+||++   +.++.++|+|||++........  ...++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       309 ~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g  383 (450)
T 1k9a_A          309 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG  383 (450)
T ss_dssp             TEECSCCCGGGEEE---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CeeCCCCCHhhEEE---CCCCCEEEeeCCCccccccccc--CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999999   5677899999999875533222  2246778999999999999999999999999999998 9


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ..||.+.+..
T Consensus       384 ~~P~~~~~~~  393 (450)
T 1k9a_A          384 RVPYPRIPLK  393 (450)
T ss_dssp             CCSSTTSCTT
T ss_pred             CCCCCCCCHH
Confidence            9999876654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.9e-36  Score=223.01  Aligned_cols=161  Identities=18%  Similarity=0.203  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....+.+|+..++.++||||+++++++..    .+..+++||++ +++|.+++...+.+++..+..++.|++.+|++||+
T Consensus        91 ~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  169 (345)
T 2v62_A           91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE  169 (345)
T ss_dssp             CCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34557788999999999999999999887    67899999999 99999999877789999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--------cccccccCccccCccccccccCCcchhHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      +|++|+||+|+||++.. +....++|+|||++.......        ......++..|+|||.+.+..++.++|+||||+
T Consensus       170 ~~ivH~Dlkp~NIll~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  248 (345)
T 2v62_A          170 NEYVHGDIKAANLLLGY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGY  248 (345)
T ss_dssp             TTEECSCCSGGGEEEES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHH
T ss_pred             CCeeCCCcCHHHEEEcc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHH
Confidence            99999999999999963 222389999999997653221        113345889999999999888999999999999


Q ss_pred             HHHHHHhCCCCCCCC
Q 030256          157 ILFELLNGYPPFSAY  171 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~  171 (180)
                      ++|++++|+.||.+.
T Consensus       249 il~ell~g~~pf~~~  263 (345)
T 2v62_A          249 CMLRWLCGKLPWEQN  263 (345)
T ss_dssp             HHHHHHHSSCTTGGG
T ss_pred             HHHHHHhCCCCcccc
Confidence            999999999999653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.4e-36  Score=226.68  Aligned_cols=165  Identities=33%  Similarity=0.581  Sum_probs=143.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++...+ .++...+..++.|++.++++||++
T Consensus       153 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~  232 (377)
T 3cbl_A          153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK  232 (377)
T ss_dssp             HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3455678899999999999999999999999899999999999999999997654 599999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |++|+||+|+||++   +.++.++|+|||++.........   ....++..|+|||.+.+..++.++|+||||+++||++
T Consensus       233 ~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  309 (377)
T 3cbl_A          233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF  309 (377)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             CcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999   56778999999998765433211   1122456799999998888999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030256          163 N-GYPPFSAYRPC  174 (180)
Q Consensus       163 ~-g~~pf~~~~~~  174 (180)
                      + |..||.+.+..
T Consensus       310 t~g~~p~~~~~~~  322 (377)
T 3cbl_A          310 SLGASPYPNLSNQ  322 (377)
T ss_dssp             TTSCCSSTTSCHH
T ss_pred             hCCCCCCCCCCHH
Confidence            8 99999876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.2e-35  Score=220.47  Aligned_cols=155  Identities=30%  Similarity=0.450  Sum_probs=139.3

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC--
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILNSH--   85 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~--   85 (180)
                      .+.+|++++++++||||+++++++...+..+++|||+++++|.+++....    ++++..+..++.|++.++++||+.  
T Consensus        73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  152 (326)
T 3uim_A           73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD  152 (326)
T ss_dssp             HHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred             HHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence            68899999999999999999999999999999999999999999997543    389999999999999999999999  


Q ss_pred             -CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 -~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                       |++|+||+|+||++   +.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+||+|+++|+++
T Consensus       153 ~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  229 (326)
T 3uim_A          153 PKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI  229 (326)
T ss_dssp             SCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHH
T ss_pred             CCeEeCCCchhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHH
Confidence             99999999999999   567789999999997654332  223344889999999998888999999999999999999


Q ss_pred             hCCCCCC
Q 030256          163 NGYPPFS  169 (180)
Q Consensus       163 ~g~~pf~  169 (180)
                      +|..||+
T Consensus       230 ~g~~pf~  236 (326)
T 3uim_A          230 TGQRAFD  236 (326)
T ss_dssp             HCCCSBC
T ss_pred             hCCCccc
Confidence            9999995

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.4e-35  Score=218.31  Aligned_cols=166  Identities=27%  Similarity=0.446  Sum_probs=144.5

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcCC-CccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG   78 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~   78 (180)
                      +|.++....+.+.+|+.++++++ ||||+++++++.+  ....+++||++++++|.+++.   .+++..+..++.|++.+
T Consensus        66 vK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~  142 (330)
T 3nsz_A           66 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKA  142 (330)
T ss_dssp             EEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHH
T ss_pred             EEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHH
Confidence            55666666778999999999996 9999999999987  668999999999999998864   48899999999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI  157 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~  157 (180)
                      +++||++|++|+||+|+||++.  .....++|+|||++.............++..|+|||.+.+ ..++.++|+||||++
T Consensus       143 l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  220 (330)
T 3nsz_A          143 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM  220 (330)
T ss_dssp             HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred             HHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHH
Confidence            9999999999999999999995  3445899999999987665555555668889999999876 568999999999999


Q ss_pred             HHHHHhCCCCCCCCC
Q 030256          158 LFELLNGYPPFSAYR  172 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~  172 (180)
                      +++|++|..||....
T Consensus       221 l~~ll~g~~p~~~~~  235 (330)
T 3nsz_A          221 LASMIFRKEPFFHGH  235 (330)
T ss_dssp             HHHHHHTCSSSSCCS
T ss_pred             HHHHHhCCCCcccCC
Confidence            999999999995543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.8e-35  Score=219.03  Aligned_cols=165  Identities=30%  Similarity=0.469  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|+.++++++||||+++++++.+++..++||||++ ++|.+++.....+++..+..++.|++.+|++||++|+
T Consensus        75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~i  153 (329)
T 3gbz_A           75 GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC  153 (329)
T ss_dssp             -----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            335567789999999999999999999999999999999996 5999999988889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecC--CCCceEEEeecCCccccCCC-CcccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~--~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++...  +....++|+|||++...... .......++..|+|||.+.+.. ++.++|+||||+++|++++
T Consensus       154 vH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  233 (329)
T 3gbz_A          154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM  233 (329)
T ss_dssp             CCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH
Confidence            999999999999532  23455999999998765432 2223345788999999987654 7999999999999999999


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||.+.++
T Consensus       234 g~~pf~~~~~  243 (329)
T 3gbz_A          234 KTPLFPGDSE  243 (329)
T ss_dssp             SSCSSCCSSH
T ss_pred             CCCCcCCCCH
Confidence            9999987654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-35  Score=221.04  Aligned_cols=164  Identities=29%  Similarity=0.523  Sum_probs=141.7

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-----------------------C
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------R   62 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~   62 (180)
                      ....+.+.+|+.+++++ +||||+++++++...+..+++|||+++++|.+++....                       .
T Consensus        89 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (344)
T 1rjb_A           89 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV  168 (344)
T ss_dssp             ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhccccccccccc
Confidence            34567789999999999 99999999999999999999999999999999997543                       2


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccc
Q 030256           63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEV  139 (180)
Q Consensus        63 ~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~  139 (180)
                      +++..+..++.|++.+|++||++|++|+||+|+||++.   .++.++|+|||++........   .....++..|+|||.
T Consensus       169 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  245 (344)
T 1rjb_A          169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  245 (344)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence            78999999999999999999999999999999999994   677899999999876543321   223446678999999


Q ss_pred             cccccCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          140 LQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       140 ~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +.+..++.++|+||||+++|++++ |..||.+.+.
T Consensus       246 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          246 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            988889999999999999999998 9999987654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.5e-35  Score=217.14  Aligned_cols=165  Identities=25%  Similarity=0.488  Sum_probs=134.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHG------RVPEQTARKFLQQ   74 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~   74 (180)
                      ....+.+.+|++++++++||||+++++++...+..      ++++||+++++|.+++....      .+++..+..++.|
T Consensus        66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q  145 (323)
T 3qup_A           66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD  145 (323)
T ss_dssp             CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence            34567789999999999999999999999876654      99999999999999986432      5899999999999


Q ss_pred             HHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhH
Q 030256           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDM  151 (180)
Q Consensus        75 i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di  151 (180)
                      ++.++++||++|++|+||+|+||++   +.++.++|+|||++.........   ....++..|+|||.+.+..++.++|+
T Consensus       146 i~~al~~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  222 (323)
T 3qup_A          146 IACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV  222 (323)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence            9999999999999999999999999   56788999999998765443221   12335667999999998889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          152 WSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       152 ~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      ||||+++|++++ |..||.+.+..
T Consensus       223 ~slG~il~ell~~g~~p~~~~~~~  246 (323)
T 3qup_A          223 WAFGVTMWEIMTRGQTPYAGIENA  246 (323)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             hhHHHHHHHHHhCCCCCccccChH
Confidence            999999999999 99999876654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.8e-35  Score=218.85  Aligned_cols=166  Identities=30%  Similarity=0.527  Sum_probs=141.8

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+|+.+++++ .||||+++++++.+.+..++||||+++++|.+++...  ..+++..+..++.|++.+|++||++
T Consensus        71 ~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~  150 (327)
T 3lm5_A           71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN  150 (327)
T ss_dssp             CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            356788999999999 5699999999999999999999999999999987543  5699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      |++|+||+|+||++......+.++|+|||++.............++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       151 givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  230 (327)
T 3lm5_A          151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT  230 (327)
T ss_dssp             TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999643346789999999998776555445566899999999999889999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.+..
T Consensus       231 ~pf~~~~~~  239 (327)
T 3lm5_A          231 SPFVGEDNQ  239 (327)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCCCch
Confidence            999876543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-35  Score=216.37  Aligned_cols=163  Identities=31%  Similarity=0.496  Sum_probs=143.6

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQTA   68 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~   68 (180)
                      ...+.+.+|+.+++++ +||||+++++++...+..+++|||+++++|.+++....                  ++++..+
T Consensus        68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (313)
T 1t46_A           68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL  147 (313)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred             HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence            4467789999999999 99999999999999999999999999999999997654                  3899999


Q ss_pred             HHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccC
Q 030256           69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY  145 (180)
Q Consensus        69 ~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~  145 (180)
                      ..++.|++.++++||++|++|+||+|+||+++   .++.++|+|||.+........   .....++..|+|||.+.+..+
T Consensus       148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  224 (313)
T 1t46_A          148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY  224 (313)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCccceEEEc---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence            99999999999999999999999999999994   677899999999876654322   223345678999999988889


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          146 DEKVDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       146 ~~~~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +.++|+||||++++++++ |..||.+.+.
T Consensus       225 ~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          225 TFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999999999 9999987654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-35  Score=221.22  Aligned_cols=164  Identities=32%  Similarity=0.545  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCC-eEEEEEeccCCCChHHHHHhcCC-----------------------
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR-----------------------   62 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-----------------------   62 (180)
                      ...+.+.+|+++++++ +||||+++++++.+.+ ..+++|||+++++|.+++.....                       
T Consensus        67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (359)
T 3vhe_A           67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP  146 (359)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred             HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence            4456789999999999 7999999999988754 58999999999999999975432                       


Q ss_pred             -------------------------------------------CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeee
Q 030256           63 -------------------------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL   99 (180)
Q Consensus        63 -------------------------------------------~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~   99 (180)
                                                                 +++..+..++.|++.+|++||++|++|+||+|+||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll  226 (359)
T 3vhe_A          147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  226 (359)
T ss_dssp             -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence                                                       8899999999999999999999999999999999999


Q ss_pred             ecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          100 SGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       100 ~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                         +.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+..
T Consensus       227 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  302 (359)
T 3vhe_A          227 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  302 (359)
T ss_dssp             ---CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ---cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence               567889999999997654332   2223456788999999998889999999999999999998 99999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.3e-35  Score=212.62  Aligned_cols=163  Identities=36%  Similarity=0.636  Sum_probs=143.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+++..++++|++++++|.+++.....+++..+..++.|++.++++||++|++
T Consensus        48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  127 (276)
T 2yex_A           48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  127 (276)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45778999999999999999999999999999999999999999999988777899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g  164 (180)
                      |+||+|+||++   +.++.++|+|||.+.......   ......++..|+|||...+..+ +.++|+||||++++++++|
T Consensus       128 H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  204 (276)
T 2yex_A          128 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (276)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             ccCCChHHEEE---ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhC
Confidence            99999999999   567789999999986553221   1233457888999999987665 7789999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ..||...+..
T Consensus       205 ~~p~~~~~~~  214 (276)
T 2yex_A          205 ELPWDQPSDS  214 (276)
T ss_dssp             SCCCSCSCTT
T ss_pred             CCCCCCCchH
Confidence            9999876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-35  Score=221.57  Aligned_cols=167  Identities=34%  Similarity=0.609  Sum_probs=137.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--------------------------
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------------   60 (180)
                      ....+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++...                          
T Consensus        69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (345)
T 3hko_A           69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE  148 (345)
T ss_dssp             -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence            345578999999999999999999999999999999999999999999987410                          


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---
Q 030256           61 --------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---  123 (180)
Q Consensus        61 --------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---  123 (180)
                                    ..+++..+..++.|++.++++||+.|++|+||+|+||++.. +....++|+|||++.......   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~  227 (345)
T 3hko_A          149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE  227 (345)
T ss_dssp             HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-
T ss_pred             ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc
Confidence                          11367889999999999999999999999999999999952 223379999999987653211   


Q ss_pred             --cccccccCccccCcccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          124 --YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       124 --~~~~~~~~~~~~ape~~~~--~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                        ......++..|+|||.+.+  ..++.++|+||||+++|++++|+.||.+.+..
T Consensus       228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  282 (345)
T 3hko_A          228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA  282 (345)
T ss_dssp             -------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH
Confidence              1234558899999999865  56889999999999999999999999876543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-35  Score=213.34  Aligned_cols=161  Identities=27%  Similarity=0.536  Sum_probs=141.8

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|++++++++||||+++++++.+.+..+++||++++++|.+++... ..+++..+..++.|++.++++||++|++
T Consensus        47 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  126 (267)
T 3t9t_A           47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI  126 (267)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            467899999999999999999999999999999999999999999999765 4589999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      |+||+|+||++   +.++.++|+|||.+........  .....++..|+|||...+..++.++|+||+|+++|++++ |.
T Consensus       127 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  203 (267)
T 3t9t_A          127 HRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK  203 (267)
T ss_dssp             CSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCCchheEEE---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCC
Confidence            99999999999   5678899999999876543211  122335677999999988889999999999999999999 89


Q ss_pred             CCCCCCCc
Q 030256          166 PPFSAYRP  173 (180)
Q Consensus       166 ~pf~~~~~  173 (180)
                      .||.+.+.
T Consensus       204 ~p~~~~~~  211 (267)
T 3t9t_A          204 IPYENRSN  211 (267)
T ss_dssp             CTTTTCCH
T ss_pred             CCCCCCCH
Confidence            99987654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-36  Score=227.69  Aligned_cols=164  Identities=27%  Similarity=0.540  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCC--eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ..+.+.+|++++++++||||+++++++...+  ..++||||+++++|.+++.....   +++..+..++.|++.+|++||
T Consensus        50 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  129 (396)
T 4eut_A           50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR  129 (396)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3566788999999999999999999988654  78999999999999999875433   999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeee-cCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc--------ccCCcchhHHHH
Q 030256           84 SHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSV  154 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~-~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Di~sl  154 (180)
                      ++|++|+||+|+||++. ..+....++|+|||.+.............++..|+|||.+.+        ..++.++|+||+
T Consensus       130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl  209 (396)
T 4eut_A          130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI  209 (396)
T ss_dssp             HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred             HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence            99999999999999973 224566799999999987765554445668999999999865        467889999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 030256          155 GAILFELLNGYPPFSAYR  172 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~  172 (180)
                      |+++|++++|+.||....
T Consensus       210 G~il~el~tg~~Pf~~~~  227 (396)
T 4eut_A          210 GVTFYHAATGSLPFRPFE  227 (396)
T ss_dssp             HHHHHHHHHSSCSEECTT
T ss_pred             HHHHHHHHHCCCCCCCCC
Confidence            999999999999997543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2e-34  Score=211.21  Aligned_cols=165  Identities=19%  Similarity=0.287  Sum_probs=142.8

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|+.+++++ +|++++++++++......++++|++ +++|.+++...+ ++++..+..++.|++.++++||++|
T Consensus        48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  126 (298)
T 1csn_A           48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS  126 (298)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345688899999999 8999999999999999999999999 999999998654 5999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecC--CCCceEEEeecCCccccCCCCc--------ccccccCccccCccccccccCCcchhHHHHHH
Q 030256           87 IIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~--~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      ++|+||+|+||++...  .....++|+|||.+........        .....++..|+|||.+.+..++.++|+||||+
T Consensus       127 ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  206 (298)
T 1csn_A          127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH  206 (298)
T ss_dssp             EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHH
Confidence            9999999999999532  1233499999999976644321        23455889999999999888999999999999


Q ss_pred             HHHHHHhCCCCCCCCCcc
Q 030256          157 ILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~~  174 (180)
                      ++|++++|+.||.+.++.
T Consensus       207 il~el~~g~~pf~~~~~~  224 (298)
T 1csn_A          207 VFMYFLRGSLPWQGLKAA  224 (298)
T ss_dssp             HHHHHHHSSCTTSSCCSC
T ss_pred             HHHHHHcCCCCcchhhcc
Confidence            999999999999886543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3e-35  Score=214.83  Aligned_cols=163  Identities=23%  Similarity=0.411  Sum_probs=137.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++..... +++..+..++.|++.+|++||+
T Consensus        52 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  131 (289)
T 4fvq_A           52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE  131 (289)
T ss_dssp             GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            345567789999999999999999999999999999999999999999999986654 9999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCC-----ceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~-----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~  158 (180)
                      +|++|+||+|+||++......     ..++|+|||.+......   ....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus       132 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il  208 (289)
T 4fvq_A          132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTL  208 (289)
T ss_dssp             TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred             CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence            999999999999999632211     12999999998655332   23346788999999887 6689999999999999


Q ss_pred             HHHHhC-CCCCCCC
Q 030256          159 FELLNG-YPPFSAY  171 (180)
Q Consensus       159 ~~~l~g-~~pf~~~  171 (180)
                      |++++| ..||...
T Consensus       209 ~el~~g~~~~~~~~  222 (289)
T 4fvq_A          209 WEICSGGDKPLSAL  222 (289)
T ss_dssp             HHHHTTTCCTTTTS
T ss_pred             HHHHcCCCCCcccc
Confidence            999995 5555543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.4e-35  Score=212.74  Aligned_cols=162  Identities=33%  Similarity=0.550  Sum_probs=134.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH---   86 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---   86 (180)
                      .+.+++|++++++++||||+++++++.+++..+++|||+++++|.+++. ..++++..+..++.|++.++++||++|   
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~  128 (271)
T 3dtc_A           50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVP  128 (271)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Confidence            4678899999999999999999999999999999999999999999886 568999999999999999999999999   


Q ss_pred             CeeecCCCCCeeeecCC-----CCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ++|+||+|+||++....     ..+.++|+|||.+......... ...++..|+|||.+.+..++.++|+||+|++++++
T Consensus       129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l  207 (271)
T 3dtc_A          129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL  207 (271)
T ss_dssp             CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred             eeecCCchHHEEEecccccccccCcceEEccCCccccccccccc-CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHH
Confidence            88999999999995311     2667999999998765443322 34588899999999988899999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.+.
T Consensus       208 ~~g~~p~~~~~~  219 (271)
T 3dtc_A          208 LTGEVPFRGIDG  219 (271)
T ss_dssp             HHCCCTTTTSCH
T ss_pred             HhCCCCCCCCCH
Confidence            999999987654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-35  Score=220.05  Aligned_cols=160  Identities=33%  Similarity=0.549  Sum_probs=140.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~   80 (180)
                      ....+.+.+|++++++++||||+++++++...      ..++++||++ +++|.+++.. .++++..+..++.|++.+|+
T Consensus        65 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~  142 (367)
T 1cm8_A           65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLR  142 (367)
T ss_dssp             HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            44566788999999999999999999998765      3469999999 8899998874 67999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF  159 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~  159 (180)
                      +||++|++|+||+|+||++   +.++.++|+|||++......  .....++..|+|||.+.+ ..++.++|+||+|++++
T Consensus       143 ~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  217 (367)
T 1cm8_A          143 YIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA  217 (367)
T ss_dssp             HHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred             HHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHH
Confidence            9999999999999999999   56788999999998765432  233457889999999876 67899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      +|++|+.||.+.+.
T Consensus       218 ell~g~~pf~~~~~  231 (367)
T 1cm8_A          218 EMITGKTLFKGSDH  231 (367)
T ss_dssp             HHHHSSCSSCCSSH
T ss_pred             HHHhCCCCCCCCCH
Confidence            99999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-35  Score=216.38  Aligned_cols=163  Identities=27%  Similarity=0.457  Sum_probs=136.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .....+.+.+|++++++++||||+++++++..  ....++||||+++++|.+++.... ++++..+..++.|++.++++|
T Consensus        51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l  130 (295)
T 3ugc_A           51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL  130 (295)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH
Confidence            34455678999999999999999999999854  456899999999999999997654 499999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~  158 (180)
                      |+.|++|+||+|+||+++   .++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|+++
T Consensus       131 H~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l  207 (295)
T 3ugc_A          131 GTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL  207 (295)
T ss_dssp             HHTTCCCSCCSGGGEEEE---ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             hcCCcccCCCCHhhEEEc---CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHH
Confidence            999999999999999994   567899999999876543321    1223356679999999988999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 030256          159 FELLNGYPPFSAY  171 (180)
Q Consensus       159 ~~~l~g~~pf~~~  171 (180)
                      |++++|..||...
T Consensus       208 ~~l~~g~~~~~~~  220 (295)
T 3ugc_A          208 YELFTYIEKSKSP  220 (295)
T ss_dssp             HHHHHTTCTTCSH
T ss_pred             HHHHhcccccCCC
Confidence            9999999998653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-34  Score=213.25  Aligned_cols=164  Identities=29%  Similarity=0.479  Sum_probs=143.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +...+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++..   ..++++..+..++.|++.++++||
T Consensus        71 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  150 (307)
T 2nru_A           71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH  150 (307)
T ss_dssp             TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            34577899999999999999999999999999999999999999999999863   345999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+ .++.++|+||||+++|+
T Consensus       151 ~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~  226 (307)
T 2nru_A          151 ENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLE  226 (307)
T ss_dssp             HTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHH
T ss_pred             cCCeecCCCCHHHEEE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHH
Confidence            9999999999999999   5677899999999876543221   223457889999998865 47899999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030256          161 LLNGYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~g~~pf~~~~~~  174 (180)
                      +++|..||...+..
T Consensus       227 l~~g~~p~~~~~~~  240 (307)
T 2nru_A          227 IITGLPAVDEHREP  240 (307)
T ss_dssp             HHHCCCSBCTTBSS
T ss_pred             HHHCCCCcccCcch
Confidence            99999999876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.9e-35  Score=225.27  Aligned_cols=162  Identities=28%  Similarity=0.468  Sum_probs=134.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEe-----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ......+.+|+.++++++||||+++++++..     .+.+++|||++ +++|.+++.....+++..+..++.||+.||+|
T Consensus        93 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~  171 (458)
T 3rp9_A           93 LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY  171 (458)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence            3445678899999999999999999999843     35799999998 67999999877889999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC----------------------------cccccccCcc
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------------------YAEKVCGSPL  133 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----------------------------~~~~~~~~~~  133 (180)
                      ||++|++||||+|+||++   +.++.++|+|||++.......                            ......++..
T Consensus       172 LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  248 (458)
T 3rp9_A          172 VHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW  248 (458)
T ss_dssp             HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCT
T ss_pred             HHhCCcCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCccccc
Confidence            999999999999999999   577889999999997654221                            1223457889


Q ss_pred             ccCcccc-ccccCCcchhHHHHHHHHHHHHh-----------CCCCCCCCC
Q 030256          134 YMAPEVL-QFQRYDEKVDMWSVGAILFELLN-----------GYPPFSAYR  172 (180)
Q Consensus       134 ~~ape~~-~~~~~~~~~Di~slg~~~~~~l~-----------g~~pf~~~~  172 (180)
                      |+|||.+ .+..++.++|+|||||++|||++           |.++|.+.+
T Consensus       249 Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~  299 (458)
T 3rp9_A          249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS  299 (458)
T ss_dssp             TCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred             ccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence            9999976 55669999999999999999998           677776654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-34  Score=216.07  Aligned_cols=160  Identities=34%  Similarity=0.591  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+.+|++++++++||||+++++++..++..++||||+. ++|.+.+.. ..++++..+..++.|++.+|++||++
T Consensus        95 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  173 (348)
T 1u5q_A           95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH  173 (348)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3445678899999999999999999999999999999999996 588777753 45799999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc---cccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |++|+||+|+||++.   .++.++|+|||++......   ....++..|+|||.+.   +..++.++|+||||+++|+++
T Consensus       174 ~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell  247 (348)
T 1u5q_A          174 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  247 (348)
T ss_dssp             TCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred             CeeeCCCCHHHEEEC---CCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999994   6778999999998765432   2345889999999884   456899999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030256          163 NGYPPFSAYRP  173 (180)
Q Consensus       163 ~g~~pf~~~~~  173 (180)
                      +|..||.+.+.
T Consensus       248 ~g~~p~~~~~~  258 (348)
T 1u5q_A          248 ERKPPLFNMNA  258 (348)
T ss_dssp             HSSCTTTTSCH
T ss_pred             hCCCCCCCCCh
Confidence            99999976543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.4e-35  Score=213.91  Aligned_cols=163  Identities=27%  Similarity=0.519  Sum_probs=141.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+++.+|++++++++||||+++++++ ..+..++++|++++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus        60 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  138 (291)
T 1xbb_A           60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF  138 (291)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3467899999999999999999999999 566789999999999999999988889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++.   .++.++|+|||++.........    ....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       139 ~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  215 (291)
T 1xbb_A          139 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS  215 (291)
T ss_dssp             ECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             EcCCCCcceEEEe---CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHh
Confidence            9999999999994   5678999999998766443221    12234577999999988888999999999999999999


Q ss_pred             -CCCCCCCCCcc
Q 030256          164 -GYPPFSAYRPC  174 (180)
Q Consensus       164 -g~~pf~~~~~~  174 (180)
                       |+.||.+.+..
T Consensus       216 ~g~~p~~~~~~~  227 (291)
T 1xbb_A          216 YGQKPYRGMKGS  227 (291)
T ss_dssp             TTCCSSTTCCHH
T ss_pred             cCCCCCCCCCHH
Confidence             99999876543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-34  Score=218.98  Aligned_cols=161  Identities=35%  Similarity=0.511  Sum_probs=131.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~   80 (180)
                      ....+.+.+|+.+++.++||||+++++++...+      ..++||||++ ++|.+.+.  ..+++..+..++.|++.||+
T Consensus        65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~  141 (371)
T 2xrw_A           65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIK  141 (371)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHH
Confidence            345667889999999999999999999987654      7899999996 58888775  56899999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +||++|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+
T Consensus       142 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  218 (371)
T 2xrw_A          142 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  218 (371)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             HHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence            9999999999999999999   5677899999999977655444445568899999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030256          161 LLNGYPPFSAYRP  173 (180)
Q Consensus       161 ~l~g~~pf~~~~~  173 (180)
                      +++|..||.+.+.
T Consensus       219 l~~g~~pf~~~~~  231 (371)
T 2xrw_A          219 MIKGGVLFPGTDH  231 (371)
T ss_dssp             HHHSSCSSCCSSH
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999987654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=216.20  Aligned_cols=164  Identities=24%  Similarity=0.471  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+..+.+|+.++++++||||+++++++.+.+..++|||++++++|.+++... ..+++..+..++.|++.+|++||++
T Consensus        87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (333)
T 1mqb_A           87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM  166 (333)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345667889999999999999999999999999999999999999999999765 5699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+||+|+||++   +.++.++|+|||.+........    .....++..|+|||.+.+..++.++|+||||+++|++
T Consensus       167 ~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  243 (333)
T 1mqb_A          167 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV  243 (333)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHH
Confidence            99999999999999   5677899999999876643321    1122346679999999988899999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030256          162 LN-GYPPFSAYRP  173 (180)
Q Consensus       162 l~-g~~pf~~~~~  173 (180)
                      ++ |..||.+.+.
T Consensus       244 lt~g~~pf~~~~~  256 (333)
T 1mqb_A          244 MTYGERPYWELSN  256 (333)
T ss_dssp             HTTSCCTTTTCCH
T ss_pred             HcCCCCCcccCCH
Confidence            99 9999976544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-34  Score=211.51  Aligned_cols=161  Identities=30%  Similarity=0.609  Sum_probs=144.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++. ..++++..+..++.|++.++++||+.|++
T Consensus        63 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  141 (303)
T 3a7i_A           63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKI  141 (303)
T ss_dssp             THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            45778999999999999999999999999999999999999999999886 46799999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||++++++++|..|
T Consensus       142 H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  218 (303)
T 3a7i_A          142 HRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP  218 (303)
T ss_dssp             CCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCChheEEE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCC
Confidence            99999999999   567789999999987665432 22344578889999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |...++
T Consensus       219 ~~~~~~  224 (303)
T 3a7i_A          219 HSELHP  224 (303)
T ss_dssp             TTTSCH
T ss_pred             CCCcCH
Confidence            987544

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.7e-35  Score=212.88  Aligned_cols=163  Identities=27%  Similarity=0.507  Sum_probs=143.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|++++++++||||+++++++.+.+..+++||++++++|.+++....  .+++..+..++.|++.++++||++|
T Consensus        52 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  131 (288)
T 3kfa_A           52 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  131 (288)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC
Confidence            45678899999999999999999999999999999999999999999998643  4999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      ++|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||.+.+..++.++|+||||++++++++ 
T Consensus       132 i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~  208 (288)
T 3kfa_A          132 FIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  208 (288)
T ss_dssp             CCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCCCCcceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence            9999999999999   56778999999998766543322  23345678999999998889999999999999999999 


Q ss_pred             CCCCCCCCCcc
Q 030256          164 GYPPFSAYRPC  174 (180)
Q Consensus       164 g~~pf~~~~~~  174 (180)
                      |..||.+.+..
T Consensus       209 g~~p~~~~~~~  219 (288)
T 3kfa_A          209 GMSPYPGIDLS  219 (288)
T ss_dssp             SCCSSTTCCGG
T ss_pred             CCCCCCCCCHH
Confidence            99999876654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-34  Score=211.64  Aligned_cols=161  Identities=32%  Similarity=0.603  Sum_probs=143.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++.. ...+++..+..++.|++.++++||+.|++
T Consensus        68 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~  147 (314)
T 3com_A           68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI  147 (314)
T ss_dssp             CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence            46688999999999999999999999999999999999999999999873 45799999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|++++|..|
T Consensus       148 H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  224 (314)
T 3com_A          148 HRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP  224 (314)
T ss_dssp             CCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CCCcCHHHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999   567789999999987654432 22334578899999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       225 ~~~~~~  230 (314)
T 3com_A          225 YADIHP  230 (314)
T ss_dssp             TTTSCH
T ss_pred             CCCCCh
Confidence            987543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.3e-35  Score=215.66  Aligned_cols=168  Identities=26%  Similarity=0.451  Sum_probs=139.7

Q ss_pred             hhhhhHHHHHHHHHHHHHHhc--CCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i   75 (180)
                      +|.+.......+.+|.+++..  ++||||+++++++..    .+..+++|||+++++|.++++ ...+++..+..++.|+
T Consensus        36 vK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i  114 (301)
T 3q4u_A           36 VKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSI  114 (301)
T ss_dssp             EEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHH
T ss_pred             EEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHH
Confidence            566666666677777777777  799999999998654    346899999999999999986 5679999999999999


Q ss_pred             HHHHHHHH--------hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-----cccccCccccCcccccc
Q 030256           76 GAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        76 ~~~l~~lh--------~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~ape~~~~  142 (180)
                      +.++++||        +.|++|+||+|+||++   +.++.++|+|||++.........     ....++..|+|||.+.+
T Consensus       115 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  191 (301)
T 3q4u_A          115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE  191 (301)
T ss_dssp             HHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence            99999999        9999999999999999   56778999999998655433221     22358899999999887


Q ss_pred             c------cCCcchhHHHHHHHHHHHHhC----------CCCCCCCCc
Q 030256          143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSAYRP  173 (180)
Q Consensus       143 ~------~~~~~~Di~slg~~~~~~l~g----------~~pf~~~~~  173 (180)
                      .      .++.++|+||+|+++|++++|          ..||....+
T Consensus       192 ~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             CCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             cCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            6      455799999999999999999          888866443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.5e-35  Score=215.12  Aligned_cols=158  Identities=28%  Similarity=0.460  Sum_probs=137.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ..+.+.+|++++++++||||+++++++...  +..+++|||+++++|.+++... ..+++..+..++.|++.++++||++
T Consensus        66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  145 (302)
T 4e5w_A           66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR  145 (302)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence            346788999999999999999999999876  6789999999999999999544 5699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+||+|+||++.   .++.++|+|||.+........    .....++..|+|||.+.+..++.++|+||+|+++|++
T Consensus       146 ~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  222 (302)
T 4e5w_A          146 QYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL  222 (302)
T ss_dssp             TEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred             CcccCCCchheEEEc---CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence            999999999999994   567899999999877654321    2234467779999999888899999999999999999


Q ss_pred             HhCCCCCC
Q 030256          162 LNGYPPFS  169 (180)
Q Consensus       162 l~g~~pf~  169 (180)
                      ++|..|+.
T Consensus       223 ~~g~~p~~  230 (302)
T 4e5w_A          223 LTYCDSDS  230 (302)
T ss_dssp             HTTTCGGG
T ss_pred             HHccCCCc
Confidence            99998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.3e-35  Score=226.83  Aligned_cols=163  Identities=26%  Similarity=0.499  Sum_probs=143.4

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...  ..+++..+..++.|++.+|+|||++|
T Consensus       259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~  338 (495)
T 1opk_A          259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  338 (495)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3567899999999999999999999999999999999999999999999864  35899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      ++|+||+|+||++   +.++.++|+|||++.........  ....++..|+|||.+.+..++.++|+||||+++|+|++ 
T Consensus       339 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~  415 (495)
T 1opk_A          339 FIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  415 (495)
T ss_dssp             EECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCCChhhEEE---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence            9999999999999   56788999999998766443221  12234567999999998889999999999999999999 


Q ss_pred             CCCCCCCCCcc
Q 030256          164 GYPPFSAYRPC  174 (180)
Q Consensus       164 g~~pf~~~~~~  174 (180)
                      |..||.+.+..
T Consensus       416 g~~p~~~~~~~  426 (495)
T 1opk_A          416 GMSPYPGIDLS  426 (495)
T ss_dssp             SCCSSTTCCGG
T ss_pred             CCCCCCCCCHH
Confidence            99999887654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-35  Score=219.02  Aligned_cols=160  Identities=33%  Similarity=0.563  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|+++++++ +||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.+|++||++|++
T Consensus       102 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  181 (355)
T 1vzo_A          102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII  181 (355)
T ss_dssp             GGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45577899999999 79999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCcccccc--ccCCcchhHHHHHHHHHHHHhC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~--~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      |+||+|+||++   +.++.++|+|||++.......  ......++..|+|||.+.+  ..++.++|+||||+++|++++|
T Consensus       182 H~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g  258 (355)
T 1vzo_A          182 YRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG  258 (355)
T ss_dssp             CCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCCHHHEEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence            99999999999   567789999999987653322  2233468999999999875  3478899999999999999999


Q ss_pred             CCCCCCCC
Q 030256          165 YPPFSAYR  172 (180)
Q Consensus       165 ~~pf~~~~  172 (180)
                      ..||...+
T Consensus       259 ~~pf~~~~  266 (355)
T 1vzo_A          259 ASPFTVDG  266 (355)
T ss_dssp             SCTTSCTT
T ss_pred             CCCCccCC
Confidence            99997544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-34  Score=210.98  Aligned_cols=164  Identities=27%  Similarity=0.512  Sum_probs=141.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +...+.+.+|++++++++||||+++++++ ..+..+++||++++++|.+++... ..+++..+..++.|++.++++||+.
T Consensus        51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  129 (287)
T 1u59_A           51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK  129 (287)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45567789999999999999999999999 455699999999999999998644 4599999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|+||+|+||++.   .++.++|+|||.+.........    ....++..|+|||.+.+..++.++|+||||+++|++
T Consensus       130 ~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  206 (287)
T 1u59_A          130 NFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA  206 (287)
T ss_dssp             TEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred             CEeeCCCchheEEEc---CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence            999999999999994   5678999999998776443221    122356789999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCcc
Q 030256          162 LN-GYPPFSAYRPC  174 (180)
Q Consensus       162 l~-g~~pf~~~~~~  174 (180)
                      ++ |+.||.+.+..
T Consensus       207 lt~g~~p~~~~~~~  220 (287)
T 1u59_A          207 LSYGQKPYKKMKGP  220 (287)
T ss_dssp             HTTSCCTTTTCCTH
T ss_pred             HcCCCCCcccCCHH
Confidence            98 99999876543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-34  Score=221.89  Aligned_cols=158  Identities=29%  Similarity=0.476  Sum_probs=133.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ......+.+|+.++++++||||+++++++...     +..++|||+++ ++|.+++.....+++..+..++.|++.||+|
T Consensus        66 ~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~  144 (432)
T 3n9x_A           66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENF  144 (432)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            34556788999999999999999999998765     57999999995 6999999877789999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-----------------------cccccccCccccCcc
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------YAEKVCGSPLYMAPE  138 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----------------------~~~~~~~~~~~~ape  138 (180)
                      ||++|++||||+|+||++   +.++.++|+|||++.......                       ......++..|+|||
T Consensus       145 LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  221 (432)
T 3n9x_A          145 IHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE  221 (432)
T ss_dssp             HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred             HHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence            999999999999999999   577889999999997664322                       123456889999999


Q ss_pred             cc-ccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256          139 VL-QFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus       139 ~~-~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      .+ .+..++.++|+||+||++|+|++|..||
T Consensus       222 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          222 LILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             HHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            85 5566899999999999999999854444

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.5e-35  Score=216.73  Aligned_cols=167  Identities=26%  Similarity=0.450  Sum_probs=143.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l   79 (180)
                      ......+.+|+.++++++||||+++++++...+..+++|||+++++|.+++....       .++...+..++.|++.++
T Consensus        74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al  153 (327)
T 2yfx_A           74 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC  153 (327)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHH
Confidence            4556678899999999999999999999999989999999999999999998653       388999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCcchhHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      ++||++|++|+||+|+||++........++|+|||.+.......   ......++..|+|||.+.+..++.++|+||||+
T Consensus       154 ~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  233 (327)
T 2yfx_A          154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV  233 (327)
T ss_dssp             HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHH
Confidence            99999999999999999999643355679999999886543221   222344678899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCc
Q 030256          157 ILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       157 ~~~~~l~-g~~pf~~~~~  173 (180)
                      ++|++++ |..||.+.+.
T Consensus       234 il~ellt~g~~p~~~~~~  251 (327)
T 2yfx_A          234 LLWEIFSLGYMPYPSKSN  251 (327)
T ss_dssp             HHHHHHTTSCCSSTTCCH
T ss_pred             HHHHHHcCCCCCCCCcCH
Confidence            9999998 9999987654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.4e-35  Score=218.23  Aligned_cols=159  Identities=22%  Similarity=0.431  Sum_probs=141.5

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY------IRL--HGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      +.+.+|++++++++||||+++++++.+.+..++||||+++++|.++      +..  ...+++..+..++.|++.++++|
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999999999988      654  45799999999999999999999


Q ss_pred             Hh-CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCc-chhHHHHHHHHH
Q 030256           83 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDE-KVDMWSVGAILF  159 (180)
Q Consensus        83 h~-~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~-~~Di~slg~~~~  159 (180)
                      |+ .|++|+||+|+||++   +.++.++|+|||.+...... ......++..|+|||...+. .++. ++|+||+|++++
T Consensus       168 H~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  243 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY  243 (348)
T ss_dssp             HHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred             hccCCEeecCCChHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence            99 999999999999999   56778999999998776443 23345588899999999877 5555 999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|..||...+.
T Consensus       244 ~l~~g~~pf~~~~~  257 (348)
T 2pml_X          244 VMFYNVVPFSLKIS  257 (348)
T ss_dssp             HHHHSSCSSCCSSC
T ss_pred             HHHhCCCCCCCCCc
Confidence            99999999987655

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.3e-35  Score=217.58  Aligned_cols=163  Identities=28%  Similarity=0.520  Sum_probs=142.3

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------GRVPEQTARKFL   72 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~   72 (180)
                      ...+.+.+|+.+++++ +||||+++++++..++..+++|||+++++|.+++...              ..+++..+..++
T Consensus        91 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (333)
T 2i1m_A           91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS  170 (333)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence            4567789999999999 8999999999999999999999999999999998643              357999999999


Q ss_pred             HHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcch
Q 030256           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  149 (180)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~  149 (180)
                      .|++.+|++||++|++|+||+|+||++.   .++.++|+|||++........   .....++..|+|||.+.+..++.++
T Consensus       171 ~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  247 (333)
T 2i1m_A          171 SQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS  247 (333)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGCEEE---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHhcCCcccCCcccceEEEC---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHH
Confidence            9999999999999999999999999994   677899999999876533221   2233456789999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          150 DMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       150 Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      |+||||+++|++++ |..||.+...
T Consensus       248 Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          248 DVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             HHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccch
Confidence            99999999999998 9999987654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-34  Score=210.05  Aligned_cols=164  Identities=25%  Similarity=0.447  Sum_probs=138.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+.+|+.++++++||||+++++++.++ ..+++||++++++|.+++.... .+++..+..++.|++.++++||++
T Consensus        54 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  132 (281)
T 3cc6_A           54 LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI  132 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34567899999999999999999999998754 4689999999999999997654 599999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      |++|+||+|+||++.   .++.++|+|||.+........  .....++..|+|||...+..++.++|+||||+++|++++
T Consensus       133 ~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt  209 (281)
T 3cc6_A          133 NCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS  209 (281)
T ss_dssp             TCCCCCCSGGGEEEE---ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CcccCCCccceEEEC---CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHh
Confidence            999999999999994   567899999999876644322  122345678999999988889999999999999999998


Q ss_pred             -CCCCCCCCCcc
Q 030256          164 -GYPPFSAYRPC  174 (180)
Q Consensus       164 -g~~pf~~~~~~  174 (180)
                       |+.||...+..
T Consensus       210 ~g~~p~~~~~~~  221 (281)
T 3cc6_A          210 FGKQPFFWLENK  221 (281)
T ss_dssp             TTCCTTTTSCGG
T ss_pred             CCCCCcccCChH
Confidence             99999765443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-34  Score=214.98  Aligned_cols=160  Identities=27%  Similarity=0.506  Sum_probs=137.6

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      +.+.+|+.++++++||||+++++++.+ +..+++++|+++++|.+++... ..+++..+..++.|++.+|++||++|++|
T Consensus        60 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  138 (325)
T 3kex_A           60 QAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH  138 (325)
T ss_dssp             CSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            456789999999999999999998864 5688999999999999998764 46899999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-CC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  165 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g~  165 (180)
                      +||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++|++++ |.
T Consensus       139 ~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  215 (325)
T 3kex_A          139 RNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA  215 (325)
T ss_dssp             SCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CccchheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCC
Confidence            9999999999   5677899999999977644322   223446678999999998889999999999999999999 99


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.+..
T Consensus       216 ~p~~~~~~~  224 (325)
T 3kex_A          216 EPYAGLRLA  224 (325)
T ss_dssp             CTTTTSCTT
T ss_pred             CCccccCHH
Confidence            999876544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=215.89  Aligned_cols=162  Identities=27%  Similarity=0.549  Sum_probs=137.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCC--ccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      .....+.+.+|+.++++++|  +||+++++++..++..+++||+ .+++|.+++.....+++..+..++.|++.+|++||
T Consensus        47 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH  125 (343)
T 3dbq_A           47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH  125 (343)
T ss_dssp             CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34455778999999999976  9999999999999999999995 48899999998889999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcccccc-----------ccCCcch
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKV  149 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~-----------~~~~~~~  149 (180)
                      ++|++|+||+|+||++.    ++.++|+|||++........   .....++..|+|||.+.+           ..++.++
T Consensus       126 ~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~  201 (343)
T 3dbq_A          126 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS  201 (343)
T ss_dssp             HTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred             hCCeecCCCCcceEEEE----CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence            99999999999999994    46799999999976643322   234568999999999864           5688899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCC
Q 030256          150 DMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       150 Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      |+||+|+++|+|++|+.||.+..
T Consensus       202 DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          202 DVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             hHHHHHHHHHHHHhCCCcchhhh
Confidence            99999999999999999997643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.3e-34  Score=211.61  Aligned_cols=165  Identities=28%  Similarity=0.509  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCC-----eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL------HGRVPEQTARKFLQQL   75 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i   75 (180)
                      ....+.+.+|+.++++++||||+++++++...+     ..++++||+++++|.+++..      ...+++..++.++.|+
T Consensus        77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi  156 (313)
T 3brb_A           77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI  156 (313)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence            344567889999999999999999999987654     35999999999999999842      3459999999999999


Q ss_pred             HHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCcchhHH
Q 030256           76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMW  152 (180)
Q Consensus        76 ~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Di~  152 (180)
                      +.+|++||++|++|+||+|+||++   +.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+|
T Consensus       157 ~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  233 (313)
T 3brb_A          157 ALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW  233 (313)
T ss_dssp             HHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred             HHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence            999999999999999999999999   567789999999987654332   11223456789999999988899999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCcc
Q 030256          153 SVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       153 slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      |||+++|++++ |..||.+.+..
T Consensus       234 slG~il~el~~~g~~p~~~~~~~  256 (313)
T 3brb_A          234 AFGVTMWEIATRGMTPYPGVQNH  256 (313)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             HHHHHHHHHHhcCCCCCccCCHH
Confidence            99999999999 99999876554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-34  Score=218.28  Aligned_cols=159  Identities=30%  Similarity=0.528  Sum_probs=136.6

Q ss_pred             HHHHHHHHhcCCCccccccceEEEe--------------------------------------CCeEEEEEeccCCCChH
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQA--------------------------------------ENCIFLVVEFCAGGNLS   54 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L~   54 (180)
                      ..+|++++++++||||+++++++..                                      ....++||||++ ++|.
T Consensus        47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~  125 (383)
T 3eb0_A           47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH  125 (383)
T ss_dssp             CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHH
T ss_pred             HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHH
Confidence            4579999999999999999999843                                      345899999996 4777


Q ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCccccccc
Q 030256           55 SYIR----LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG  130 (180)
Q Consensus        55 ~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  130 (180)
                      +.+.    ....+++..+..++.|++.+|+|||++|++|+||+|+||++.  ..++.++|+|||.+.............+
T Consensus       126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  203 (383)
T 3eb0_A          126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYIC  203 (383)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCC
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCccc
Confidence            6664    346799999999999999999999999999999999999995  3567899999999987766555556668


Q ss_pred             CccccCccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          131 SPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       131 ~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      +..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+..
T Consensus       204 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  248 (383)
T 3eb0_A          204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI  248 (383)
T ss_dssp             CSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH
Confidence            8899999988765 4899999999999999999999999876543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-34  Score=214.93  Aligned_cols=163  Identities=31%  Similarity=0.539  Sum_probs=142.7

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~   70 (180)
                      ...+.+.+|+++++++ +||||+++++++...+..++||||+++++|.+++....                .+++..+..
T Consensus        82 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (334)
T 2pvf_A           82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS  161 (334)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHH
Confidence            4456788999999999 89999999999999999999999999999999997543                388999999


Q ss_pred             HHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCc
Q 030256           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~  147 (180)
                      ++.|++.+|++||++|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++.
T Consensus       162 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  238 (334)
T 2pvf_A          162 CTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  238 (334)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence            99999999999999999999999999999   5677899999999876654322   12233567799999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          148 KVDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       148 ~~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      ++|+||||+++|++++ |..||.+.+.
T Consensus       239 ~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          239 QSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            9999999999999999 9999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-34  Score=210.20  Aligned_cols=156  Identities=31%  Similarity=0.579  Sum_probs=138.6

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEe----------------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHH
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQA----------------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL   72 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~   72 (180)
                      +.+.+|++++++++||||+++++++..                .+..+++|||+++++|.+++...  ..+++..+..++
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~  128 (284)
T 2a19_B           49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF  128 (284)
T ss_dssp             GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence            457789999999999999999998754                44689999999999999999754  579999999999


Q ss_pred             HHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHH
Q 030256           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMW  152 (180)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~  152 (180)
                      .|++.++++||++|++|+||+|+||++.   .++.++|+|||.+.............++..|+|||.+.+..++.++|+|
T Consensus       129 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  205 (284)
T 2a19_B          129 EQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY  205 (284)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHH
T ss_pred             HHHHHHHHHHHhCCeeeccCCHHHEEEc---CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhH
Confidence            9999999999999999999999999994   5678999999998877655444455688999999999988899999999


Q ss_pred             HHHHHHHHHHhCCCCCC
Q 030256          153 SVGAILFELLNGYPPFS  169 (180)
Q Consensus       153 slg~~~~~~l~g~~pf~  169 (180)
                      |||+++|++++|..||.
T Consensus       206 slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          206 ALGLILAELLHVCDTAF  222 (284)
T ss_dssp             HHHHHHHHHHSCCSSHH
T ss_pred             HHHHHHHHHHhcCCcch
Confidence            99999999999998874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.5e-35  Score=215.63  Aligned_cols=163  Identities=36%  Similarity=0.635  Sum_probs=130.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+++.+|+.++++++||||+++++++...+..+++|||+++++|.+++..        ...+++..+..++.|++.++
T Consensus        55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  134 (303)
T 2vwi_A           55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL  134 (303)
T ss_dssp             -----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999999999999999999999999874        34599999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC------cccccccCccccCcccccc-ccCCcchhHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMW  152 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~ape~~~~-~~~~~~~Di~  152 (180)
                      ++||++|++|+||+|+||++   +.++.++|+|||.+.......      ......++..|+|||.+.+ ..++.++|+|
T Consensus       135 ~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  211 (303)
T 2vwi_A          135 EYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW  211 (303)
T ss_dssp             HHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred             HHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence            99999999999999999999   567789999999886553321      1223457888999999875 4689999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCc
Q 030256          153 SVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       153 slg~~~~~~l~g~~pf~~~~~  173 (180)
                      |||+++|++++|..||.+.++
T Consensus       212 slG~il~~l~~g~~pf~~~~~  232 (303)
T 2vwi_A          212 SFGITAIELATGAAPYHKYPP  232 (303)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCG
T ss_pred             HHHHHHHHHHhCCCCCccCch
Confidence            999999999999999987554

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-34  Score=213.33  Aligned_cols=164  Identities=23%  Similarity=0.449  Sum_probs=142.0

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLGA   77 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~   77 (180)
                      .....+.+|+.++++++||||+++++++.+.+..+++||++++++|.+++...          .++++..+..++.|++.
T Consensus        70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  149 (322)
T 1p4o_A           70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD  149 (322)
T ss_dssp             HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence            44567889999999999999999999999999999999999999999998643          35789999999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  154 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~sl  154 (180)
                      ++++||++|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++.++|+|||
T Consensus       150 ~l~~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  226 (322)
T 1p4o_A          150 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  226 (322)
T ss_dssp             HHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence            9999999999999999999999   5677899999999876543221   122345678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCcc
Q 030256          155 GAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       155 g~~~~~~l~-g~~pf~~~~~~  174 (180)
                      |+++|++++ |..||.+.+..
T Consensus       227 G~il~el~~~g~~p~~~~~~~  247 (322)
T 1p4o_A          227 GVVLWEIATLAEQPYQGLSNE  247 (322)
T ss_dssp             HHHHHHHHHTSCCTTTTSCHH
T ss_pred             HHHHHHHHhcCCCccccCCHH
Confidence            999999999 89999876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-34  Score=214.15  Aligned_cols=159  Identities=36%  Similarity=0.582  Sum_probs=131.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+.+|++++++++||||+++++++.+  ..+++|||+++++|.+++....   .++...+..++.|++.++++||+
T Consensus        43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  120 (307)
T 2eva_A           43 SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS  120 (307)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHh
Confidence            446678999999999999999999998764  4789999999999999998654   37899999999999999999999


Q ss_pred             ---CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           85 ---HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ---~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                         +|++|+||+|+||++.  .....++|+|||.+.......  ....++..|+|||.+.+..++.++|+||||+++|++
T Consensus       121 ~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  196 (307)
T 2eva_A          121 MQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV  196 (307)
T ss_dssp             CSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHH
T ss_pred             CCCCCeecCCCChhHEEEe--CCCCEEEEccccccccccccc--ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHH
Confidence               8999999999999996  334458999999987654322  233478999999999988899999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|+.||....
T Consensus       197 ~~g~~p~~~~~  207 (307)
T 2eva_A          197 ITRRKPFDEIG  207 (307)
T ss_dssp             HHTCCTTTTTC
T ss_pred             HHCCCCchhhC
Confidence            99999998654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=213.90  Aligned_cols=163  Identities=26%  Similarity=0.435  Sum_probs=135.9

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|+.++++++||||+++++++..++ .+++++++.+++|.+++... ..+++..+..++.|++.+|++||++|
T Consensus        59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  137 (327)
T 3lzb_A           59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  137 (327)
T ss_dssp             CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            35677889999999999999999999998765 78889999999999998764 46999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      ++|+||+|+||++.   .++.++|+|||++.........   ....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       138 ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~  214 (327)
T 3lzb_A          138 LVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             CCCSCCCGGGEEEE---ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CcCCCCCHHHEEEc---CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence            99999999999994   5678999999999766433221   22335667999999998899999999999999999999


Q ss_pred             -CCCCCCCCCcc
Q 030256          164 -GYPPFSAYRPC  174 (180)
Q Consensus       164 -g~~pf~~~~~~  174 (180)
                       |..||.+.+..
T Consensus       215 ~g~~p~~~~~~~  226 (327)
T 3lzb_A          215 FGSKPYDGIPAS  226 (327)
T ss_dssp             TSCCTTTTCCGG
T ss_pred             CCCCCCCCCCHH
Confidence             99999886654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-34  Score=218.36  Aligned_cols=162  Identities=27%  Similarity=0.547  Sum_probs=138.2

Q ss_pred             hHHHHHHHHHHHHHHhcCC--CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +....+.+.+|+.++++++  ||||+++++++...+.++++||+ .+++|.+++.....+++..+..++.|++.+|+|||
T Consensus        94 ~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH  172 (390)
T 2zmd_A           94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH  172 (390)
T ss_dssp             CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3455678999999999996  59999999999999999999995 58899999998888999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCcccccc-----------ccCCcch
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKV  149 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~-----------~~~~~~~  149 (180)
                      +.|++|+||+|+||++.    ++.++|+|||++.......   ......++..|+|||.+.+           ..++.++
T Consensus       173 ~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~  248 (390)
T 2zmd_A          173 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS  248 (390)
T ss_dssp             TTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred             HCCeeecCCCHHHEEEE----CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence            99999999999999993    3679999999997664332   1234568999999999865           3578899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCC
Q 030256          150 DMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       150 Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      ||||||+++|+|++|+.||.+..
T Consensus       249 DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          249 DVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             hHHHHHHHHHHHHHCCCcchhhh
Confidence            99999999999999999998653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.6e-34  Score=209.76  Aligned_cols=163  Identities=31%  Similarity=0.615  Sum_probs=133.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ....+.+.+|+.++++++||||+++++++...+..+++||++++++|.+++..    ...+++..+..++.|++.++++|
T Consensus        73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  152 (310)
T 2wqm_A           73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM  152 (310)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence            55677889999999999999999999999999999999999999999998864    35689999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      |+.|++|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|++
T Consensus       153 H~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l  229 (310)
T 2wqm_A          153 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM  229 (310)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHH
Confidence            99999999999999999   567789999999987654332 22234578899999999988899999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|..||.+..
T Consensus       230 ~~g~~p~~~~~  240 (310)
T 2wqm_A          230 AALQSPFYGDK  240 (310)
T ss_dssp             HHSSCTTC---
T ss_pred             HhCCCCCcccc
Confidence            99999997643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-35  Score=220.19  Aligned_cols=158  Identities=19%  Similarity=0.300  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHhcCCCccccc---------------cceEEEe-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHH
Q 030256           11 SCLDCELNFLSSVNHPNIIR---------------LFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL   72 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~   72 (180)
                      +.+.+|++++++++||||++               +++++.. ++..+++|||+ +++|.+++...  ..+++..+..++
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~  165 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA  165 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence            46889999999999999988               5667665 67899999999 99999999875  679999999999


Q ss_pred             HHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCc--eEEEeecCCccccCCCC--------cccccccCccccCcccccc
Q 030256           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~--~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~  142 (180)
                      .|++.+|++||++|++|+||+|+||++.   .++  .++|+|||++.......        ......++..|+|||.+.+
T Consensus       166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  242 (352)
T 2jii_A          166 CRLLDALEFLHENEYVHGNVTAENIFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG  242 (352)
T ss_dssp             HHHHHHHHHHHHTTCBCSCCCGGGEEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHhCCccCCCCCHHHEEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence            9999999999999999999999999995   444  89999999997654321        1123468889999999998


Q ss_pred             ccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          143 QRYDEKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       143 ~~~~~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      ..++.++|+||||+++|++++|+.||....
T Consensus       243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            899999999999999999999999998765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-34  Score=211.18  Aligned_cols=164  Identities=29%  Similarity=0.499  Sum_probs=131.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .....+.+.+|+.++++++||||++++++. ..+..+++|||+++++|.+++... ..+++..+..++.|++.+|++||+
T Consensus        60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~  138 (289)
T 3og7_A           60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA  138 (289)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            345567799999999999999999999964 555689999999999999998644 469999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC---CcccccccCccccCccccc---cccCCcchhHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~ape~~~---~~~~~~~~Di~slg~~~  158 (180)
                      .|++|+||+|+||++.   .++.++|+|||++......   .......++..|+|||.+.   +..++.++|+||||+++
T Consensus       139 ~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il  215 (289)
T 3og7_A          139 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL  215 (289)
T ss_dssp             TTCCCSCCCGGGEEEE---TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred             CCcccccCccceEEEC---CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence            9999999999999994   6678999999998655431   2223345789999999986   55678899999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030256          159 FELLNGYPPFSAYRP  173 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~  173 (180)
                      +++++|+.||.+.+.
T Consensus       216 ~el~~g~~p~~~~~~  230 (289)
T 3og7_A          216 YELMTGQLPYSNINN  230 (289)
T ss_dssp             HHHHHSSCTTSSCCC
T ss_pred             HHHHHCCCCccccch
Confidence            999999999987543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.1e-34  Score=216.68  Aligned_cols=162  Identities=29%  Similarity=0.469  Sum_probs=131.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEe-----CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~   80 (180)
                      ....+.+.+|+.++++++||||+++++++..     ....+++||+++ ++|.+.+.... .+++..+..++.|++.+|+
T Consensus        70 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~  148 (362)
T 3pg1_A           70 SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLH  148 (362)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            3445789999999999999999999999843     347899999996 58888776443 6999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF  159 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~  159 (180)
                      +||++|++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+|+++|
T Consensus       149 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  225 (362)
T 3pg1_A          149 VLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA  225 (362)
T ss_dssp             HHHHTTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHH
Confidence            9999999999999999999   5677899999999976555544455668888999998876 66899999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030256          160 ELLNGYPPFSAYR  172 (180)
Q Consensus       160 ~~l~g~~pf~~~~  172 (180)
                      ++++|+.||.+.+
T Consensus       226 ~l~~g~~pf~~~~  238 (362)
T 3pg1_A          226 EMFNRKALFRGST  238 (362)
T ss_dssp             HHHHSSCSCCCSS
T ss_pred             HHHhCCCCCCCCC
Confidence            9999999998765

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-35  Score=219.72  Aligned_cols=164  Identities=29%  Similarity=0.512  Sum_probs=133.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEE-eCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+.+|+.++++++||||+++++++. .++..+++|||+++++|.+++.... .+++..+..++.|++.++++||++
T Consensus       132 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  211 (373)
T 3c1x_A          132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK  211 (373)
T ss_dssp             HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45677899999999999999999999865 4568899999999999999997544 588999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      |++|+||+|+||++   +.++.++|+|||++........     .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus       212 ~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e  288 (373)
T 3c1x_A          212 KFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE  288 (373)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             CEecCccchheEEE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHH
Confidence            99999999999999   5677899999999876543221     122345678999999998899999999999999999


Q ss_pred             HHh-CCCCCCCCCcc
Q 030256          161 LLN-GYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~-g~~pf~~~~~~  174 (180)
                      +++ |.+||.+.+..
T Consensus       289 llt~~~~p~~~~~~~  303 (373)
T 3c1x_A          289 LMTRGAPPYPDVNTF  303 (373)
T ss_dssp             HHTTSCCSCTTSCSS
T ss_pred             HHhCcCCCCCCCCHH
Confidence            999 78888776543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=219.78  Aligned_cols=163  Identities=29%  Similarity=0.536  Sum_probs=131.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG   78 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~   78 (180)
                      ...+.+|+.++++++||||+++++++..  ....++||||+. ++|.+++...         ..+++..+..++.|++.|
T Consensus        62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  140 (405)
T 3rgf_A           62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  140 (405)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence            4467889999999999999999999954  678999999995 5888777522         249999999999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecC-CCCceEEEeecCCccccCCC----CcccccccCccccCccccccc-cCCcchhHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW  152 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~-~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~  152 (180)
                      |+|||++|++|+||+|+||++... +..+.++|+|||++......    .......++..|+|||.+.+. .++.++|||
T Consensus       141 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  220 (405)
T 3rgf_A          141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  220 (405)
T ss_dssp             HHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred             HHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhH
Confidence            999999999999999999999532 35678999999999765432    122345678999999998874 489999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCc
Q 030256          153 SVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       153 slg~~~~~~l~g~~pf~~~~~  173 (180)
                      |+|+++|+|++|..||.+.+.
T Consensus       221 SlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          221 AIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             HHHHHHHHHHHSSCTTCCCC-
T ss_pred             HHHHHHHHHHhCCCCCCCccc
Confidence            999999999999999987654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-34  Score=215.11  Aligned_cols=164  Identities=26%  Similarity=0.415  Sum_probs=141.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEE--eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      .....+.+.+|++++++++||||+++++++.  +.+..+++|||+++++|.+++... ..+++..+..++.|++.+|++|
T Consensus        64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l  143 (327)
T 3lxl_A           64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL  143 (327)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            3455677899999999999999999999886  456799999999999999999764 4699999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~  158 (180)
                      |+.|++|+||+|+||++.   .++.++|+|||.+........    .....++..|+|||.+.+..++.++|+||||+++
T Consensus       144 H~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  220 (327)
T 3lxl_A          144 GSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL  220 (327)
T ss_dssp             HHTTEECSCCSGGGEEEE---ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred             HhCCccCCCCChhhEEEC---CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence            999999999999999994   677899999999876643321    1223466779999999888899999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030256          159 FELLNGYPPFSAYR  172 (180)
Q Consensus       159 ~~~l~g~~pf~~~~  172 (180)
                      +++++|..||....
T Consensus       221 ~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          221 YELFTYCDKSCSPS  234 (327)
T ss_dssp             HHHHTTTCGGGSHH
T ss_pred             HHHHhCCCCCcccc
Confidence            99999999986543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-34  Score=224.40  Aligned_cols=162  Identities=27%  Similarity=0.538  Sum_probs=140.3

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|+.++++++||||+++++++. .+..++||||+++++|.+++...  ..++...+..++.|++.+|+|||++|
T Consensus       226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  304 (454)
T 1qcf_A          226 SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN  304 (454)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3567899999999999999999999986 55689999999999999999754  36899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      ++|+||+|+||++   +.++.++|+|||++.........  ....++..|+|||.+.+..++.++|+||||+++||+++ 
T Consensus       305 ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~  381 (454)
T 1qcf_A          305 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY  381 (454)
T ss_dssp             CCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhC
Confidence            9999999999999   56788999999999766432211  12235677999999988889999999999999999999 


Q ss_pred             CCCCCCCCCcc
Q 030256          164 GYPPFSAYRPC  174 (180)
Q Consensus       164 g~~pf~~~~~~  174 (180)
                      |+.||.+.+..
T Consensus       382 g~~P~~~~~~~  392 (454)
T 1qcf_A          382 GRIPYPGMSNP  392 (454)
T ss_dssp             SCCSSTTCCHH
T ss_pred             CCCCCCCCCHH
Confidence            99999876543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.7e-34  Score=209.94  Aligned_cols=165  Identities=30%  Similarity=0.506  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEE-eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....+.+.+|+.++++++||||+++++++. .++..+++|||+++++|.+++... ..+++..+..++.|++.++++||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~  146 (298)
T 3f66_A           67 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS  146 (298)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            345567889999999999999999999864 566889999999999999999754 458999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      +|++|+||+|+||++   +.++.++|+|||.+........     .....++..|+|||.+.+..++.++|+||+|++++
T Consensus       147 ~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  223 (298)
T 3f66_A          147 KKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW  223 (298)
T ss_dssp             TTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             CCccCCCCchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHH
Confidence            999999999999999   5677899999999876543221     12234567899999999888999999999999999


Q ss_pred             HHHh-CCCCCCCCCcc
Q 030256          160 ELLN-GYPPFSAYRPC  174 (180)
Q Consensus       160 ~~l~-g~~pf~~~~~~  174 (180)
                      ++++ +.+||.+.+..
T Consensus       224 ~l~~~~~~~~~~~~~~  239 (298)
T 3f66_A          224 ELMTRGAPPYPDVNTF  239 (298)
T ss_dssp             HHHTTSCCSSTTSCTT
T ss_pred             HHHhCCCCCCccCCHH
Confidence            9999 67777765543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-34  Score=208.37  Aligned_cols=163  Identities=28%  Similarity=0.486  Sum_probs=138.7

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCe-EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+.+|+.++++++||||+++++++.+.+. .+++++++.+++|.+++... ..+++..+..++.|++.++++||++
T Consensus        64 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  143 (298)
T 3pls_A           64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ  143 (298)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            456778899999999999999999999986654 49999999999999999763 4689999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-----cccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      |++|+||+|+||++   +.++.++|+|||.+.......     ......++..|+|||...+..++.++|+||+|+++|+
T Consensus       144 ~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  220 (298)
T 3pls_A          144 KFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWE  220 (298)
T ss_dssp             TCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHH
Confidence            99999999999999   567789999999987553321     2223446778999999999899999999999999999


Q ss_pred             HHh-CCCCCCCCCc
Q 030256          161 LLN-GYPPFSAYRP  173 (180)
Q Consensus       161 ~l~-g~~pf~~~~~  173 (180)
                      +++ +.+||...++
T Consensus       221 l~~g~~~~~~~~~~  234 (298)
T 3pls_A          221 LLTRGAPPYRHIDP  234 (298)
T ss_dssp             HHHTSCCTTTTSCG
T ss_pred             HhhCCCCCCccCCH
Confidence            999 5555655444

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.5e-34  Score=212.97  Aligned_cols=161  Identities=30%  Similarity=0.481  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....+.+.+|++++++++||||+++++++.+.  ..++++|||+++++|.+++.. .++++..+..++.|++.++++||+
T Consensus        74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~  152 (318)
T 3lxp_A           74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHA  152 (318)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34567789999999999999999999999874  689999999999999999874 459999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      .|++|+||+|+||++   +.++.++|+|||.+........    .....++..|+|||.+.+..++.++|+||||+++++
T Consensus       153 ~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  229 (318)
T 3lxp_A          153 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE  229 (318)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred             CCccCCCCchheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHH
Confidence            999999999999999   5677899999999977654322    223346677999999998889999999999999999


Q ss_pred             HHhCCCCCCCC
Q 030256          161 LLNGYPPFSAY  171 (180)
Q Consensus       161 ~l~g~~pf~~~  171 (180)
                      +++|..||...
T Consensus       230 ll~g~~p~~~~  240 (318)
T 3lxp_A          230 LLTHCDSSQSP  240 (318)
T ss_dssp             HHTTTCGGGSH
T ss_pred             HHhCCCccccc
Confidence            99999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.9e-35  Score=222.66  Aligned_cols=160  Identities=14%  Similarity=0.175  Sum_probs=129.9

Q ss_pred             HHHHHHHHHH---HHHhcCCCccccccc-------eEEEeCC-----------------eEEEEEeccCCCChHHHHHhc
Q 030256            8 HLKSCLDCEL---NFLSSVNHPNIIRLF-------DAFQAEN-----------------CIFLVVEFCAGGNLSSYIRLH   60 (180)
Q Consensus         8 ~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~   60 (180)
                      ...+.+.+|+   +++++++||||++++       +++.+.+                 ..+++|||+ +|+|.+++...
T Consensus       115 ~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~  193 (377)
T 3byv_A          115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL  193 (377)
T ss_dssp             THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc
Confidence            3557788999   555566899999998       6666553                 289999999 67999999876


Q ss_pred             CCCCH-------HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCcc
Q 030256           61 GRVPE-------QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL  133 (180)
Q Consensus        61 ~~~~~-------~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  133 (180)
                      ..+++       ..+..++.|++.+|+|||++|++|+||+|+||++   +.++.++|+|||++.....  ......+ ..
T Consensus       194 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~  267 (377)
T 3byv_A          194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RG  267 (377)
T ss_dssp             HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TT
T ss_pred             cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cC
Confidence            55555       7888899999999999999999999999999999   4667899999999876433  2233446 88


Q ss_pred             ccCccccccc-----------cCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          134 YMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       134 ~~ape~~~~~-----------~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      |+|||.+.+.           .++.++|+||||+++|+|++|+.||.+.+..
T Consensus       268 y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~  319 (377)
T 3byv_A          268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL  319 (377)
T ss_dssp             CCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc
Confidence            9999999887           7999999999999999999999999876544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-34  Score=231.39  Aligned_cols=163  Identities=28%  Similarity=0.531  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+++.+|++++++++||||+++++++.. +..++||||+++++|.+++.....+++..+..++.|++.+|+|||++|+
T Consensus       412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i  490 (635)
T 4fl3_A          412 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF  490 (635)
T ss_dssp             GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            346789999999999999999999999865 4588999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++.   .++.++|+|||++........    .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       491 iHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt  567 (635)
T 4fl3_A          491 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS  567 (635)
T ss_dssp             CCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eCCCCChHhEEEe---CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999994   567899999999876643321    122335677999999998899999999999999999998


Q ss_pred             -CCCCCCCCCcc
Q 030256          164 -GYPPFSAYRPC  174 (180)
Q Consensus       164 -g~~pf~~~~~~  174 (180)
                       |+.||.+.+..
T Consensus       568 ~G~~Pf~~~~~~  579 (635)
T 4fl3_A          568 YGQKPYRGMKGS  579 (635)
T ss_dssp             TTCCSSTTCCHH
T ss_pred             CCCCCCCCCCHH
Confidence             99999886654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.4e-34  Score=217.37  Aligned_cols=158  Identities=31%  Similarity=0.506  Sum_probs=134.0

Q ss_pred             HHHHHHHHhcCCCccccccceEEEeCC------eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Q 030256           13 LDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus        13 ~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ..+|++++++++||||+++++++...+      ..++||||+++ ++...+.    ....+++..+..++.|++.+|+||
T Consensus        79 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L  157 (394)
T 4e7w_A           79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI  157 (394)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            347999999999999999999985433      38899999976 4433332    245799999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~  161 (180)
                      |++|++|+||+|+||+++  ..++.++|+|||++.............++..|+|||.+.+. .++.++|+||+|+++|+|
T Consensus       158 H~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el  235 (394)
T 4e7w_A          158 HSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL  235 (394)
T ss_dssp             HHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence            999999999999999995  36788999999999877555555556688999999998764 589999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.+.
T Consensus       236 l~g~~pf~~~~~  247 (394)
T 4e7w_A          236 MQGQPLFPGESG  247 (394)
T ss_dssp             HHSSCSSCCSSH
T ss_pred             HhCCCCCCCCCH
Confidence            999999988654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.6e-35  Score=212.49  Aligned_cols=161  Identities=26%  Similarity=0.506  Sum_probs=132.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ..+.+.+|++++++++||||+++++++.. .+..++++||+++++|.+++.....  +++..+..++.|++.++++||++
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  136 (278)
T 1byg_A           57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN  136 (278)
T ss_dssp             --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            45678899999999999999999998754 4578999999999999999976543  89999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      |++|+||+|+||++   +.++.++|+|||.+........  ...++..|+|||.+.+..++.++|+||||++++++++ |
T Consensus       137 ~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g  211 (278)
T 1byg_A          137 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG  211 (278)
T ss_dssp             TCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CccccCCCcceEEE---eCCCcEEEeecccccccccccc--CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCC
Confidence            99999999999999   5677899999999876543322  2346778999999988889999999999999999998 9


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ..||...+..
T Consensus       212 ~~p~~~~~~~  221 (278)
T 1byg_A          212 RVPYPRIPLK  221 (278)
T ss_dssp             CCSCTTSCGG
T ss_pred             CCCCCCCCHH
Confidence            9999876543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.4e-34  Score=213.64  Aligned_cols=160  Identities=26%  Similarity=0.479  Sum_probs=135.5

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEe--------CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~   80 (180)
                      ...+.+|+.++++++||||+++++++..        .+..++||||+++ +|.+.+... .++++..+..++.|++.+|+
T Consensus        60 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~  138 (351)
T 3mi9_A           60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY  138 (351)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            4567789999999999999999999876        4578999999965 777766543 56999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-----CcccccccCccccCcccccc-ccCCcchhHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSV  154 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~sl  154 (180)
                      +||++|++|+||+|+||++   +.++.++|+|||++......     .......++..|+|||.+.+ ..++.++|+||+
T Consensus       139 ~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  215 (351)
T 3mi9_A          139 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA  215 (351)
T ss_dssp             HHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred             HHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence            9999999999999999999   56778999999998765421     12233457888999998876 457999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCc
Q 030256          155 GAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~~  173 (180)
                      |++++++++|..||.+.++
T Consensus       216 G~il~ell~g~~pf~~~~~  234 (351)
T 3mi9_A          216 GCIMAEMWTRSPIMQGNTE  234 (351)
T ss_dssp             HHHHHHHHHSSCSCCCSSH
T ss_pred             HHHHHHHHhCCCCCCCCCh
Confidence            9999999999999987654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8e-34  Score=206.77  Aligned_cols=161  Identities=25%  Similarity=0.406  Sum_probs=137.6

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ......+.+|+..+.++ +||||+++++++.+.+..+++|||+++++|.+++...    ..+++..+..++.|++.+|++
T Consensus        51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~  130 (289)
T 1x8b_A           51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY  130 (289)
T ss_dssp             SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence            34566788899999999 9999999999999999999999999999999999765    669999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCC----------------CCceEEEeecCCccccCCCCcccccccCccccCccccccc-c
Q 030256           82 LNSHHIIHRDLKPENILLSGLD----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-R  144 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~----------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~  144 (180)
                      ||++|++|+||+|+||++....                ....++|+|||.+.......   ...++..|+|||.+.+. .
T Consensus       131 lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~  207 (289)
T 1x8b_A          131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYT  207 (289)
T ss_dssp             HHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCT
T ss_pred             HHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCC
Confidence            9999999999999999995322                44569999999987765432   23478899999998765 5


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256          145 YDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       145 ~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      ++.++|+||||++++++++|..|+..
T Consensus       208 ~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          208 HLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             THHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             CCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            66899999999999999999987654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9e-35  Score=211.41  Aligned_cols=161  Identities=25%  Similarity=0.532  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|++++++++||||+++++++.+ +..+++||++++++|.+++....  .+++..+..++.|++.++++||++|
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  129 (279)
T 1qpc_A           51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN  129 (279)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            35678899999999999999999998864 45889999999999999987543  6999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      ++|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||.+.+..++.++|+||||++++++++ 
T Consensus       130 i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~  206 (279)
T 1qpc_A          130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH  206 (279)
T ss_dssp             EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             eeccCCCHhhEEE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence            9999999999999   56778999999998776543221  22335678999999988889999999999999999999 


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |..||.+.+.
T Consensus       207 g~~p~~~~~~  216 (279)
T 1qpc_A          207 GRIPYPGMTN  216 (279)
T ss_dssp             TCCSSTTCCH
T ss_pred             CCCCCcccCH
Confidence            9999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8e-35  Score=211.60  Aligned_cols=165  Identities=36%  Similarity=0.689  Sum_probs=140.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l   79 (180)
                      .+..++.+.+|+.++++++||||+++++++.+  .+..+++|||+++++|.+++....    .+++..+..++.|++.++
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l  124 (279)
T 2w5a_A           45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  124 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence            34567789999999999999999999998754  578999999999999999987542    499999999999999999


Q ss_pred             HHHHhCC-----CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCccccccccCCcchhHHH
Q 030256           80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS  153 (180)
Q Consensus        80 ~~lh~~~-----~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Di~s  153 (180)
                      ++||+.|     ++|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||
T Consensus       125 ~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  201 (279)
T 2w5a_A          125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS  201 (279)
T ss_dssp             HHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred             HHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHH
Confidence            9999999     9999999999999   5677899999999876644322 22345788999999999888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030256          154 VGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~~  173 (180)
                      ||+++|++++|..||...+.
T Consensus       202 lG~il~~l~~g~~p~~~~~~  221 (279)
T 2w5a_A          202 LGCLLYELCALMPPFTAFSQ  221 (279)
T ss_dssp             HHHHHHHHHHSSCSSCCSSH
T ss_pred             HHHHHHHHHHCCCCCcccCH
Confidence            99999999999999987654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-34  Score=208.23  Aligned_cols=161  Identities=23%  Similarity=0.370  Sum_probs=138.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ....+.+.+|+.++++++||||+++++++.+.  +..+++|||+++++|.+++....  .+++..+..++.|++.++++|
T Consensus        48 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  127 (271)
T 3kmu_A           48 TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL  127 (271)
T ss_dssp             HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            45567799999999999999999999999876  78899999999999999998665  489999999999999999999


Q ss_pred             HhCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCc---chhHHHHHHH
Q 030256           83 NSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE---KVDMWSVGAI  157 (180)
Q Consensus        83 h~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~---~~Di~slg~~  157 (180)
                      |+.|  ++|+||+|+||++   +.++.+++.||++.......    ...++..|+|||.+.+...+.   ++|+||+|++
T Consensus       128 H~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~i  200 (271)
T 3kmu_A          128 HTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSP----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL  200 (271)
T ss_dssp             TTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTTSCT----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHH
T ss_pred             hcCCCceecCCCccceEEE---cCCcceeEEeccceeeeccc----CccCCccccChhhhccCCCCCCCchhhHHHHHHH
Confidence            9999  9999999999999   46677888887766443222    234788999999988765444   7999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030256          158 LFELLNGYPPFSAYRPC  174 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~~  174 (180)
                      +|++++|+.||.+.+..
T Consensus       201 l~el~~g~~p~~~~~~~  217 (271)
T 3kmu_A          201 LWELVTREVPFADLSNM  217 (271)
T ss_dssp             HHHHHHCSCTTTTSCHH
T ss_pred             HHHHHhCCCCccccChH
Confidence            99999999999876543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.3e-34  Score=209.80  Aligned_cols=166  Identities=19%  Similarity=0.259  Sum_probs=140.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEE-EeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...+.+.+|+.++++++|++++..+..+ ...+..+++||++ +++|.+++.. ..++++..+..++.|++.++++||++
T Consensus        46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  124 (296)
T 4hgt_A           46 TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK  124 (296)
T ss_dssp             --CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3445688899999999888777766655 6778899999999 9999999875 45699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--------ccccccCccccCccccccccCCcchhHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  157 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~  157 (180)
                      |++|+||+|+||++...+..+.++|+|||.+........        .....++..|+|||.+.+..++.++|+||+|++
T Consensus       125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i  204 (296)
T 4hgt_A          125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV  204 (296)
T ss_dssp             TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred             CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHH
Confidence            999999999999994334667799999999976644322        224568899999999999899999999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030256          158 LFELLNGYPPFSAYRPC  174 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~~  174 (180)
                      +|++++|+.||.+.++.
T Consensus       205 l~~l~~g~~pf~~~~~~  221 (296)
T 4hgt_A          205 LMYFNLGSLPWQGLKAA  221 (296)
T ss_dssp             HHHHHHSSCTTSSCCCS
T ss_pred             HHHHhcCCCCCcccchh
Confidence            99999999999876554

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.4e-34  Score=215.22  Aligned_cols=163  Identities=30%  Similarity=0.505  Sum_probs=139.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ....+.+.+|++++++++||||+++++++...     ...++++|+++ ++|.+++. ...+++..+..++.|++.+|++
T Consensus        66 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~-~~~~~~~~~~~i~~qi~~aL~~  143 (364)
T 3qyz_A           66 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK-TQHLSNDHICYFLYQILRGLKY  143 (364)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHH-HCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHH-hCCCCHHHHHHHHHHHHHHHHH
Confidence            44557788999999999999999999998654     47899999995 59999886 4679999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCcccccc-ccCCcchhHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA  156 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~  156 (180)
                      ||++|++|+||+|+||++   +.++.++|+|||.+........    .....++..|+|||.+.+ ..++.++|+||+|+
T Consensus       144 LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  220 (364)
T 3qyz_A          144 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC  220 (364)
T ss_dssp             HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHH
T ss_pred             HHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHH
Confidence            999999999999999999   5677899999999876543221    233468899999998654 45899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcc
Q 030256          157 ILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~~  174 (180)
                      ++|++++|+.||.+.+..
T Consensus       221 il~ell~g~~pf~~~~~~  238 (364)
T 3qyz_A          221 ILAEMLSNRPIFPGKHYL  238 (364)
T ss_dssp             HHHHHHHSSCSSCCSSGG
T ss_pred             HHHHHHHCCCCCCCCChH
Confidence            999999999999887644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-34  Score=214.01  Aligned_cols=158  Identities=31%  Similarity=0.544  Sum_probs=133.2

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (180)
                      .+.+|++++++++||||+++++++.+.+..++||||++ ++|.+++...+ .+++..+..++.|++.+|++||+.|++|+
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  124 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR  124 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            34579999999999999999999999999999999996 58988887654 59999999999999999999999999999


Q ss_pred             cCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        91 dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      ||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||
T Consensus       125 Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  201 (324)
T 3mtl_A          125 DLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF  201 (324)
T ss_dssp             SCCGGGEEE---CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CcCHHHEEE---CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999   567789999999987654322 2233457889999999876 56799999999999999999999999


Q ss_pred             CCCCc
Q 030256          169 SAYRP  173 (180)
Q Consensus       169 ~~~~~  173 (180)
                      .+.+.
T Consensus       202 ~~~~~  206 (324)
T 3mtl_A          202 PGSTV  206 (324)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-33  Score=207.09  Aligned_cols=156  Identities=30%  Similarity=0.463  Sum_probs=130.5

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ......|+..+.++ +|+||+++++++.+++..+++||++ +++|.+++...+ .+++..+..++.|++.+|++||+.|+
T Consensus       100 ~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  178 (311)
T 3p1a_A          100 RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL  178 (311)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            33444555555555 9999999999999999999999999 679988887554 59999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+ .++.++|+||+|+++|++++|..|
T Consensus       179 vH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~  254 (311)
T 3p1a_A          179 VHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL  254 (311)
T ss_dssp             ECCCCSGGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred             ecCCCCHHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999   5778899999999877765554455568999999998876 689999999999999999999766


Q ss_pred             CCC
Q 030256          168 FSA  170 (180)
Q Consensus       168 f~~  170 (180)
                      +..
T Consensus       255 ~~~  257 (311)
T 3p1a_A          255 PHG  257 (311)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-34  Score=212.11  Aligned_cols=163  Identities=32%  Similarity=0.553  Sum_probs=141.4

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEeCC-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR----------------VPEQTAR   69 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~   69 (180)
                      ...+.+.+|+.+++++ +||||+++++++...+ ..++++||+++++|.+++.....                +++..+.
T Consensus        72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (316)
T 2xir_A           72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  151 (316)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred             HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence            3456788999999999 7999999999987654 59999999999999999986543                8899999


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCC
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD  146 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~  146 (180)
                      .++.|++.++++||+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++
T Consensus       152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (316)
T 2xir_A          152 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  228 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence            999999999999999999999999999999   5678899999999876644322   2234467789999999988899


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          147 EKVDMWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      .++|+||||+++|++++ |..||.+.+.
T Consensus       229 ~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          229 IQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            99999999999999998 9999987654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.8e-34  Score=217.95  Aligned_cols=159  Identities=31%  Similarity=0.489  Sum_probs=134.0

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ...+|++++++++||||+++++++...      ..++++|||+++ ++.+.+.    ....+++..+..++.|++.+|+|
T Consensus        93 ~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  171 (420)
T 1j1b_A           93 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY  171 (420)
T ss_dssp             SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            345799999999999999999987432      247899999965 6666554    24579999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCcchhHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE  160 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~  160 (180)
                      ||++|++|+||+|+||++.  .+...++|+|||++.............++..|+|||.+.+. .++.++|+||+|+++||
T Consensus       172 LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e  249 (420)
T 1j1b_A          172 IHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE  249 (420)
T ss_dssp             HHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHH
Confidence            9999999999999999995  34567899999999876555444456688999999998764 68999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030256          161 LLNGYPPFSAYRP  173 (180)
Q Consensus       161 ~l~g~~pf~~~~~  173 (180)
                      |++|+.||.+.+.
T Consensus       250 ll~G~~pf~~~~~  262 (420)
T 1j1b_A          250 LLLGQPIFPGDSG  262 (420)
T ss_dssp             HHHSSCSSCCSSH
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-33  Score=206.62  Aligned_cols=164  Identities=20%  Similarity=0.267  Sum_probs=139.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEE-EeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|+.++++++|++++..+..+ ..++..+++|||+ +++|.+++.. ..++++..+..++.|++.++++||++|+
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  126 (296)
T 3uzp_A           48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF  126 (296)
T ss_dssp             CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34688999999999988876666655 5677899999999 8999999974 4569999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--------ccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      +|+||+|+||++...+.++.++|+|||.+........        .....++..|+|||.+.+..++.++|+||||+++|
T Consensus       127 vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  206 (296)
T 3uzp_A          127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM  206 (296)
T ss_dssp             ECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             eeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHH
Confidence            9999999999995333567799999999876654322        23456888999999999989999999999999999


Q ss_pred             HHHhCCCCCCCCCcc
Q 030256          160 ELLNGYPPFSAYRPC  174 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~  174 (180)
                      ++++|+.||.+.+..
T Consensus       207 ~l~~g~~pf~~~~~~  221 (296)
T 3uzp_A          207 YFNLGSLPWQGLKAA  221 (296)
T ss_dssp             HHHHSSCTTSSCCCS
T ss_pred             HHHhCCCCCCCcCch
Confidence            999999999875543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.6e-34  Score=209.59  Aligned_cols=163  Identities=33%  Similarity=0.556  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+.+|+.++++++||||+++++++...+..++++|++++++|.+++....   .+++..+..++.|++.++++||+
T Consensus        61 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  140 (295)
T 2clq_A           61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD  140 (295)
T ss_dssp             ---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh
Confidence            445678899999999999999999999999999999999999999999987652   46789999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccccc--CCcchhHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFEL  161 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~--~~~~~Di~slg~~~~~~  161 (180)
                      +|++|+||+|+||++.  ..++.++|+|||.+....... ......++..|+|||.+.+..  ++.++|+||||+++|++
T Consensus       141 ~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l  218 (295)
T 2clq_A          141 NQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM  218 (295)
T ss_dssp             TTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHH
T ss_pred             CCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999995  336789999999987664322 223445788999999987643  78999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030256          162 LNGYPPFSAYR  172 (180)
Q Consensus       162 l~g~~pf~~~~  172 (180)
                      ++|+.||...+
T Consensus       219 ~~g~~pf~~~~  229 (295)
T 2clq_A          219 ATGKPPFYELG  229 (295)
T ss_dssp             HHTSCTTGGGS
T ss_pred             HHCCCCccCCC
Confidence            99999997543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.9e-34  Score=221.83  Aligned_cols=161  Identities=24%  Similarity=0.468  Sum_probs=135.9

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|++++++++||||+++++++.+ +..++||||+++++|.+++...  ..+++..+..++.|++.+|++||++|+
T Consensus       223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  301 (452)
T 1fmk_A          223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  301 (452)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4678999999999999999999999876 6689999999999999999643  469999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.++.++|+|||++.........  ....++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       302 vHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g  378 (452)
T 1fmk_A          302 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG  378 (452)
T ss_dssp             CCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eCCCCChhhEEE---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCC
Confidence            999999999999   56788999999999765433211  22335678999999988889999999999999999999 9


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ..||.+.+..
T Consensus       379 ~~P~~~~~~~  388 (452)
T 1fmk_A          379 RVPYPGMVNR  388 (452)
T ss_dssp             CCSSTTCCHH
T ss_pred             CCCCCCCCHH
Confidence            9999876543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-33  Score=210.10  Aligned_cols=168  Identities=27%  Similarity=0.420  Sum_probs=137.6

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcC--CCccccccceEEEeC----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i   75 (180)
                      +|.+.........+|.+++..+  +||||+++++++...    +..+++|||+++++|.+++. ...+++..+..++.|+
T Consensus        65 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i  143 (337)
T 3mdy_A           65 VKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSS  143 (337)
T ss_dssp             EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHH-HCCBCHHHHHHHHHHH
T ss_pred             EEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhh-ccCCCHHHHHHHHHHH
Confidence            4555555555666677777665  999999999998877    78999999999999999996 4579999999999999


Q ss_pred             HHHHHHHHhC--------CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-----cccccCccccCcccccc
Q 030256           76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        76 ~~~l~~lh~~--------~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~ape~~~~  142 (180)
                      +.++++||+.        |++|+||+|+||++   +.++.++|+|||++.........     ....++..|+|||.+.+
T Consensus       144 ~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  220 (337)
T 3mdy_A          144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE  220 (337)
T ss_dssp             HHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence            9999999999        99999999999999   56778999999998665433221     23458899999999987


Q ss_pred             ccCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCCc
Q 030256          143 QRYDEK------VDMWSVGAILFELLNG----------YPPFSAYRP  173 (180)
Q Consensus       143 ~~~~~~------~Di~slg~~~~~~l~g----------~~pf~~~~~  173 (180)
                      ...+..      +|+||||+++|+|++|          ..||....+
T Consensus       221 ~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            665554      9999999999999999          777765433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.6e-34  Score=213.64  Aligned_cols=168  Identities=26%  Similarity=0.404  Sum_probs=142.6

Q ss_pred             hhhhhHHHHHHHHHHHHHHhc--CCCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i   75 (180)
                      +|.++....+.+.+|.++++.  ++||||+++++++...+    ..+++|||+++++|.+++.. .++++..+..++.|+
T Consensus        70 vK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i  148 (342)
T 1b6c_B           70 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALST  148 (342)
T ss_dssp             EEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred             EEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHH
Confidence            566666667778889999988  69999999999998765    89999999999999999974 579999999999999


Q ss_pred             HHHHHHHH--------hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCcccccc
Q 030256           76 GAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        76 ~~~l~~lh--------~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~  142 (180)
                      +.++++||        +.|++|+||+|+||++   +.++.++|+|||++........     .....++..|+|||.+.+
T Consensus       149 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  225 (342)
T 1b6c_B          149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  225 (342)
T ss_dssp             HHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred             HHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence            99999999        8999999999999999   5677899999999876544331     233458889999999876


Q ss_pred             c------cCCcchhHHHHHHHHHHHHhC----------CCCCCCCCc
Q 030256          143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSAYRP  173 (180)
Q Consensus       143 ~------~~~~~~Di~slg~~~~~~l~g----------~~pf~~~~~  173 (180)
                      .      .++.++|+||||+++|++++|          ..||....+
T Consensus       226 ~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             CCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             cccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            5      334689999999999999999          789876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-33  Score=206.00  Aligned_cols=160  Identities=31%  Similarity=0.538  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH--I   87 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--~   87 (180)
                      +.+.+|++++++++||||+++++++.+..  +++|||+++++|.+.+... .++++..+..++.|++.++++||+.|  +
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i  145 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI  145 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence            67889999999999999999999987665  6899999999998887644 46999999999999999999999999  9


Q ss_pred             eeecCCCCCeeeecCC--CCceEEEeecCCccccCCCCcccccccCccccCccccc--cccCCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~--~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++....  ....++|+|||++......  .....++..|+|||.+.  ...++.++|+||+|+++|++++
T Consensus       146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~  223 (287)
T 4f0f_A          146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT  223 (287)
T ss_dssp             BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence            9999999999995311  1223899999998754432  33455889999999984  4557899999999999999999


Q ss_pred             CCCCCCCCCcc
Q 030256          164 GYPPFSAYRPC  174 (180)
Q Consensus       164 g~~pf~~~~~~  174 (180)
                      |+.||...+..
T Consensus       224 g~~pf~~~~~~  234 (287)
T 4f0f_A          224 GEGPFDEYSYG  234 (287)
T ss_dssp             SSCTTTTCCCC
T ss_pred             CCCCCcccccc
Confidence            99999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-34  Score=215.11  Aligned_cols=159  Identities=37%  Similarity=0.549  Sum_probs=138.7

Q ss_pred             HHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      +.+.+|++++++++||||+++++++.+.+..+++|||+++ +|.+++.... .+++..+..++.|++.++++||++|++|
T Consensus        57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  135 (346)
T 1ua2_A           57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  135 (346)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Confidence            4678899999999999999999999999999999999965 8988887543 5899999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|+++|++++|..|
T Consensus       136 ~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~  212 (346)
T 1ua2_A          136 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  212 (346)
T ss_dssp             CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCHHHEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999999   567789999999987764332 23345678999999998654 478999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       213 ~~~~~~  218 (346)
T 1ua2_A          213 LPGDSD  218 (346)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.6e-34  Score=215.41  Aligned_cols=159  Identities=33%  Similarity=0.565  Sum_probs=126.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .....+.+|+.++++++||||+++++++...      +..+++++++ +++|.+++.. .++++..+..++.|++.+|++
T Consensus        70 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~  147 (367)
T 2fst_X           70 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKY  147 (367)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4556788999999999999999999998653      5689999999 7899998874 679999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~  160 (180)
                      ||++|++|+||+|+||++   +.++.++|+|||++......  .....++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus       148 LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  222 (367)
T 2fst_X          148 IHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE  222 (367)
T ss_dssp             HHHTTCCCCCCCGGGEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHH
T ss_pred             HHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHH
Confidence            999999999999999999   56788999999998765432  233458899999999876 678999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030256          161 LLNGYPPFSAYRP  173 (180)
Q Consensus       161 ~l~g~~pf~~~~~  173 (180)
                      |++|+.||.+.+.
T Consensus       223 ll~g~~pf~~~~~  235 (367)
T 2fst_X          223 LLTGRTLFPGTDH  235 (367)
T ss_dssp             HHHSSCSCCCSSH
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999988664

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-34  Score=227.76  Aligned_cols=163  Identities=27%  Similarity=0.514  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|++++++++||||+++++++.. +..++||||+++++|.+++... ..+++..+..++.|++.+|+|||++|
T Consensus       378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  456 (613)
T 2ozo_A          378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN  456 (613)
T ss_dssp             TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            356779999999999999999999999876 4589999999999999998654 45999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|+||+|+||++.   .++.++|+|||++.........    ....++..|+|||.+.+..++.++|+||||+++|||+
T Consensus       457 iiHrDlkp~NILl~---~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell  533 (613)
T 2ozo_A          457 FVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  533 (613)
T ss_dssp             CCCSCCSGGGEEEE---ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEcCcCCHHHEEEc---CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence            99999999999994   5678999999999766433211    1222457899999999889999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030256          163 N-GYPPFSAYRPC  174 (180)
Q Consensus       163 ~-g~~pf~~~~~~  174 (180)
                      + |+.||.+.+..
T Consensus       534 t~G~~Pf~~~~~~  546 (613)
T 2ozo_A          534 SYGQKPYKKMKGP  546 (613)
T ss_dssp             TTSCCTTTTCCSH
T ss_pred             HCCCCCCCCCCHH
Confidence            8 99999886654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.7e-34  Score=209.92  Aligned_cols=162  Identities=28%  Similarity=0.416  Sum_probs=137.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGA   77 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~   77 (180)
                      .....+.+.+|++++++++||||+++++++..    .+..++++||+++++|.+++..    ...+++..+..++.|++.
T Consensus        66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~  145 (317)
T 2buj_A           66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR  145 (317)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence            44567788999999999999999999999862    3478999999999999999875    356999999999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----------cccccCccccCcccccccc---
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----------EKVCGSPLYMAPEVLQFQR---  144 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~ape~~~~~~---  144 (180)
                      +|++||++|++|+||+|+||++   +.++.++|+|||.+.........          ....++..|+|||.+.+..   
T Consensus       146 ~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  222 (317)
T 2buj_A          146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV  222 (317)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred             HHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence            9999999999999999999999   56778999999987654321110          1233588899999986543   


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256          145 YDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       145 ~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      ++.++|+||||+++|++++|+.||..
T Consensus       223 ~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          223 IDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             ECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCChhh
Confidence            68899999999999999999999954

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.9e-34  Score=208.52  Aligned_cols=162  Identities=29%  Similarity=0.470  Sum_probs=139.1

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|++++++++||||+++++++...+ .++++|++++++|.+++... ..+++..+..++.|++.++++||++|
T Consensus        63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  141 (291)
T 1u46_A           63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR  141 (291)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            45677889999999999999999999988765 88999999999999998764 56999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++|+||+|+||++.   .++.++|+|||.+........    .....++..|+|||.+.+..++.++|+||||+++++++
T Consensus       142 i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  218 (291)
T 1u46_A          142 FIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF  218 (291)
T ss_dssp             EECSCCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             cccCCCchheEEEc---CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence            99999999999994   567899999999877644322    12234566799999998888899999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030256          163 N-GYPPFSAYRP  173 (180)
Q Consensus       163 ~-g~~pf~~~~~  173 (180)
                      + |+.||.+.+.
T Consensus       219 ~~g~~p~~~~~~  230 (291)
T 1u46_A          219 TYGQEPWIGLNG  230 (291)
T ss_dssp             TTSCCTTTTCCH
T ss_pred             hCCCCCcccCCH
Confidence            9 9999987654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-33  Score=205.91  Aligned_cols=160  Identities=28%  Similarity=0.434  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ..+.+..+...++.++||||+++++++.+.+..+++|||++ ++|.+++..    ...+++..+..++.|++.++++||+
T Consensus        49 ~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  127 (290)
T 3fme_A           49 QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS  127 (290)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            34445556666888899999999999999999999999996 488777653    4579999999999999999999999


Q ss_pred             C-CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccc----ccccCCcchhHHHHHHHHH
Q 030256           85 H-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        85 ~-~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~----~~~~~~~~~Di~slg~~~~  159 (180)
                      + |++|+||+|+||++   +..+.++|+|||.+.............++..|+|||.+    .+..++.++|+||+|++++
T Consensus       128 ~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~  204 (290)
T 3fme_A          128 KLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI  204 (290)
T ss_dssp             HSCCCCCCCSGGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHH
T ss_pred             cCCeecCCCCHHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHH
Confidence            8 99999999999999   56778999999999776655444455688999999996    4566889999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030256          160 ELLNGYPPFSAYR  172 (180)
Q Consensus       160 ~~l~g~~pf~~~~  172 (180)
                      ++++|..||....
T Consensus       205 ~l~~g~~p~~~~~  217 (290)
T 3fme_A          205 ELAILRFPYDSWG  217 (290)
T ss_dssp             HHHHTSCSSCCCS
T ss_pred             HHHHCCCCccccC
Confidence            9999999998643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-33  Score=207.76  Aligned_cols=164  Identities=29%  Similarity=0.576  Sum_probs=137.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEE--------------eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------------AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF   71 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~   71 (180)
                      +....+.+.+|++++++++||||+++++++.              +.+..+++|||++ ++|.+++. .+++++..+..+
T Consensus        48 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~  125 (320)
T 2i6l_A           48 DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLF  125 (320)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHH
Confidence            3455677889999999999999999998873              3468899999996 59999886 567999999999


Q ss_pred             HHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC----CcccccccCccccCcccccc-ccCC
Q 030256           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQF-QRYD  146 (180)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~ape~~~~-~~~~  146 (180)
                      +.|++.++++||++|++|+||+|+||++.  ..+..++|+|||.+......    .......++..|+|||.+.+ ..++
T Consensus       126 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (320)
T 2i6l_A          126 MYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT  203 (320)
T ss_dssp             HHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred             HHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence            99999999999999999999999999995  35678999999998765432    11223446788999998765 6689


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          147 EKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      .++|+||||+++|++++|+.||.+.+.
T Consensus       204 ~~~Di~slG~il~el~~g~~pf~~~~~  230 (320)
T 2i6l_A          204 KAIDMWAAGCIFAEMLTGKTLFAGAHE  230 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             chhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999999987654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-33  Score=208.20  Aligned_cols=164  Identities=26%  Similarity=0.441  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHHHhcCCCcc------ccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+.+.+|++++++++|++      ++++++++...+..+++||++ +++|.+++....  ++++..+..++.|++.+|
T Consensus        53 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l  131 (339)
T 1z57_A           53 RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV  131 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            44577889999999997664      999999999999999999999 889999998665  689999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCC----------------CceEEEeecCCccccCCCCcccccccCccccCccccccc
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDD----------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  143 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~----------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~  143 (180)
                      ++||++|++|+||+|+||++...+.                +..++|+|||.+......  .....++..|+|||.+.+.
T Consensus       132 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~  209 (339)
T 1z57_A          132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILAL  209 (339)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTS
T ss_pred             HHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCC
Confidence            9999999999999999999953111                556999999998765432  2344578999999999988


Q ss_pred             cCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          144 RYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       144 ~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      .++.++|+||||+++|++++|..||...+..
T Consensus       210 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence            9999999999999999999999999876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=208.71  Aligned_cols=162  Identities=33%  Similarity=0.620  Sum_probs=133.9

Q ss_pred             HHHHHHHHHHHHhcC-CCccccccceEEEe------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l   79 (180)
                      ..+.+.+|+.+++++ +||||+++++++..      .+..+++|||+++++|.+++...  ..+++..+..++.|++.++
T Consensus        63 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l  142 (326)
T 2x7f_A           63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL  142 (326)
T ss_dssp             TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence            456788999999999 89999999999876      56899999999999999999754  4699999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccc-----cccCCcchhHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWS  153 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~s  153 (180)
                      ++||+.|++|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.     +..++.++|+||
T Consensus       143 ~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s  219 (326)
T 2x7f_A          143 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS  219 (326)
T ss_dssp             HHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHH
T ss_pred             HHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHH
Confidence            99999999999999999999   567789999999987654322 223345788999999986     456889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030256          154 VGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~~  173 (180)
                      ||+++|++++|..||.+.++
T Consensus       220 lG~il~~l~~g~~p~~~~~~  239 (326)
T 2x7f_A          220 LGITAIEMAEGAPPLCDMHP  239 (326)
T ss_dssp             HHHHHHHHHHSSCTTTTSCH
T ss_pred             HHHHHHHHHhCCCCCCCCcH
Confidence            99999999999999977553

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-33  Score=216.61  Aligned_cols=161  Identities=35%  Similarity=0.522  Sum_probs=138.8

Q ss_pred             HHHHHHHHHHHHHhcC------CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+.+.+|+.+++.+      +|+||+++++++...+..+++||++. ++|.+++....  .+++..+..++.|++.+|
T Consensus       135 ~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL  213 (429)
T 3kvw_A          135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCL  213 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            3456677888888887      57799999999999999999999994 69999887654  499999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCce--EEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  157 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~  157 (180)
                      +|||++|++|+||+|+||++.   .++.  ++|+|||++......  .....++..|+|||.+.+..++.++||||||++
T Consensus       214 ~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  288 (429)
T 3kvw_A          214 DALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCI  288 (429)
T ss_dssp             HHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHH
T ss_pred             HHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHH
Confidence            999999999999999999995   4443  999999998665433  234457889999999999899999999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030256          158 LFELLNGYPPFSAYRPC  174 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~~  174 (180)
                      +|+|++|..||.+.++.
T Consensus       289 l~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          289 LAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             HHHHHHSSCSSCCSSHH
T ss_pred             HHHHHhCCCCCCCCCHH
Confidence            99999999999886643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.4e-34  Score=218.56  Aligned_cols=170  Identities=29%  Similarity=0.546  Sum_probs=134.3

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCC-------CHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-------PEQTARKFLQ   73 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~   73 (180)
                      +|.+..+..+.+.+|+.+++++ +||||+++++++.+++..+++||++. ++|.+++......       ++..+..++.
T Consensus        44 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~  122 (434)
T 2rio_A           44 VKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR  122 (434)
T ss_dssp             EEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHH
T ss_pred             EEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHH
Confidence            5555555566788999999987 89999999999999999999999995 6999999755432       2334578999


Q ss_pred             HHHHHHHHHHhCCCeeecCCCCCeeeecC----------CCCceEEEeecCCccccCCCCc-----ccccccCccccCcc
Q 030256           74 QLGAGLEILNSHHIIHRDLKPENILLSGL----------DDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPE  138 (180)
Q Consensus        74 ~i~~~l~~lh~~~~~h~dl~~~nil~~~~----------~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape  138 (180)
                      |++.||++||++|++|+||+|+||++...          +....++|+|||++........     .....++..|+|||
T Consensus       123 qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  202 (434)
T 2rio_A          123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE  202 (434)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHH
T ss_pred             HHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence            99999999999999999999999999632          2345799999999977654321     12346889999999


Q ss_pred             cccc-------ccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030256          139 VLQF-------QRYDEKVDMWSVGAILFELLN-GYPPFSAYR  172 (180)
Q Consensus       139 ~~~~-------~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~  172 (180)
                      .+.+       ..++.++|+||+|+++|++++ |..||.+..
T Consensus       203 ~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             HHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             HhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            9865       568899999999999999999 999997653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-34  Score=220.93  Aligned_cols=171  Identities=32%  Similarity=0.505  Sum_probs=136.0

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l   79 (180)
                      +|.+.+...+.+.+|+++++++ +||||+++++++.+.+..+++||++. ++|.+++.... ..++..+..++.|++.||
T Consensus        53 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL  131 (432)
T 3p23_A           53 VKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGL  131 (432)
T ss_dssp             EEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHH
T ss_pred             EEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHH
Confidence            4555555555677899999999 89999999999999999999999995 59999987554 355566788999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecC--CCCceEEEeecCCccccCCCC----cccccccCccccCccccc---cccCCcchh
Q 030256           80 EILNSHHIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ---FQRYDEKVD  150 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~--~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~---~~~~~~~~D  150 (180)
                      +|||++|++|+||+|+||++...  +....++|+|||++.......    ......++..|+|||.+.   ...++.++|
T Consensus       132 ~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~D  211 (432)
T 3p23_A          132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD  211 (432)
T ss_dssp             HHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHH
T ss_pred             HHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHH
Confidence            99999999999999999999532  233457899999987664331    223455899999999987   456788999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCc
Q 030256          151 MWSVGAILFELLN-GYPPFSAYRP  173 (180)
Q Consensus       151 i~slg~~~~~~l~-g~~pf~~~~~  173 (180)
                      +||+|+++|++++ |..||.....
T Consensus       212 iwSlG~il~ellt~g~~pf~~~~~  235 (432)
T 3p23_A          212 IFSAGCVFYYVISEGSHPFGKSLQ  235 (432)
T ss_dssp             HHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred             HHHHHHHHHHHHcCCCCCcchhhH
Confidence            9999999999999 9999976443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-33  Score=208.41  Aligned_cols=158  Identities=37%  Similarity=0.578  Sum_probs=136.8

Q ss_pred             HHHHHHHHHhcC---CCccccccceEEE-----eCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus        12 ~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .+.+|+.+++.+   +||||+++++++.     ..+..++++|+++ ++|.+++....  .+++..+..++.|++.+|++
T Consensus        57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~  135 (326)
T 1blx_A           57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF  135 (326)
T ss_dssp             THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence            456677777666   8999999999987     4568999999996 59999987654  49999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ||+.|++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||||+++|++
T Consensus       136 lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  212 (326)
T 1blx_A          136 LHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM  212 (326)
T ss_dssp             HHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             HHHCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence            999999999999999999   56778999999998766544444455678899999999988899999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.+.
T Consensus       213 ~~g~~pf~~~~~  224 (326)
T 1blx_A          213 FRRKPLFRGSSD  224 (326)
T ss_dssp             HHSSCSCCCSSH
T ss_pred             HcCCCCCCCCCH
Confidence            999999987653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4e-34  Score=210.07  Aligned_cols=162  Identities=31%  Similarity=0.574  Sum_probs=137.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|++++++++||||+++++++..++..++++||+++++|.+++.. ...+++..+..++.|++.++++||+.|+
T Consensus        59 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  138 (302)
T 2j7t_A           59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI  138 (302)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence            456788899999999999999999999999999999999999999998875 4569999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccc-----cccCCcchhHHHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~~~  161 (180)
                      +|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.     +..++.++|+||||+++|++
T Consensus       139 ~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l  215 (302)
T 2j7t_A          139 IHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM  215 (302)
T ss_dssp             CCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHH
T ss_pred             ccCCCCHHHEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHH
Confidence            999999999999   56778999999986432211 1112345788999999873     56688999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|..||...++
T Consensus       216 ~~g~~p~~~~~~  227 (302)
T 2j7t_A          216 AQIEPPHHELNP  227 (302)
T ss_dssp             HHSSCTTTTSCH
T ss_pred             hcCCCCCccCCH
Confidence            999999987654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.3e-33  Score=224.93  Aligned_cols=166  Identities=31%  Similarity=0.613  Sum_probs=146.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe------CCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLG   76 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~   76 (180)
                      .....+.+.+|++++++++||||+++++++..      ++..++||||++|++|.+++....   .+++..+..++.|++
T Consensus        52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl  131 (676)
T 3qa8_A           52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS  131 (676)
T ss_dssp             CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH
Confidence            44567788999999999999999999998755      667899999999999999998644   589999999999999


Q ss_pred             HHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHH
Q 030256           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        77 ~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      .++++||+.|++|+||+|+||++...+....++|+|||.+.............++..|+|||.+.+..++.++|+||+|+
T Consensus       132 ~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGv  211 (676)
T 3qa8_A          132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT  211 (676)
T ss_dssp             HHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHH
T ss_pred             HHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHH
Confidence            99999999999999999999999754445568999999998776655555567899999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCCC
Q 030256          157 ILFELLNGYPPFSAY  171 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~  171 (180)
                      ++|++++|..||...
T Consensus       212 iLyeLltG~~Pf~~~  226 (676)
T 3qa8_A          212 LAFECITGFRPFLPN  226 (676)
T ss_dssp             HHHHHHSSCSSCCSS
T ss_pred             HHHHHHHCCCCCCcc
Confidence            999999999999653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=209.87  Aligned_cols=164  Identities=28%  Similarity=0.492  Sum_probs=122.9

Q ss_pred             hHHHHHHHHHHHHHHhcCC-CccccccceEEE--------eCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQ   73 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~   73 (180)
                      .....+.+.+|+.+++++. ||||+++++++.        ....+++++||+. ++|.+++..   .+++++..+..++.
T Consensus        65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~  143 (337)
T 3ll6_A           65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFY  143 (337)
T ss_dssp             SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHH
Confidence            3445667889999999995 999999999984        3446899999995 699888764   45699999999999


Q ss_pred             HHHHHHHHHHhCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc-------------cccccCccccCcc
Q 030256           74 QLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-------------EKVCGSPLYMAPE  138 (180)
Q Consensus        74 ~i~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-------------~~~~~~~~~~ape  138 (180)
                      |++.+|++||+.|  ++|+||+|+||++   +.++.++|+|||++.........             ....++..|+|||
T Consensus       144 qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE  220 (337)
T 3ll6_A          144 QTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE  220 (337)
T ss_dssp             HHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC----------------------------
T ss_pred             HHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence            9999999999999  9999999999999   56778999999998766443211             1334788899999


Q ss_pred             cc---ccccCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          139 VL---QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       139 ~~---~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      .+   .+..++.++|+||||+++|++++|..||...+.
T Consensus       221 ~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          221 IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             ---CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             hhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            98   566688999999999999999999999976543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-34  Score=210.73  Aligned_cols=161  Identities=27%  Similarity=0.467  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....+.+.+|++++++++||||+++++++...  +..++++|++++++|.+++.... .+++..+..++.|++.+|++||
T Consensus        83 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH  162 (326)
T 2w1i_A           83 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG  162 (326)
T ss_dssp             SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            34566789999999999999999999988654  37899999999999999998664 5999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      +.|++|+||+|+||++.   .++.++|+|||.+........    .....++..|+|||.+.+..++.++|+||||++++
T Consensus       163 ~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  239 (326)
T 2w1i_A          163 TKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY  239 (326)
T ss_dssp             HTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred             hCCEeccCCCcceEEEc---CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHH
Confidence            99999999999999994   567899999999877644322    12233566799999998888999999999999999


Q ss_pred             HHHhCCCCCCC
Q 030256          160 ELLNGYPPFSA  170 (180)
Q Consensus       160 ~~l~g~~pf~~  170 (180)
                      ++++|..||..
T Consensus       240 el~tg~~~~~~  250 (326)
T 2w1i_A          240 ELFTYIEKSKS  250 (326)
T ss_dssp             HHHHTTCGGGS
T ss_pred             HHHhcCCCCCC
Confidence            99999998864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1e-33  Score=222.78  Aligned_cols=161  Identities=24%  Similarity=0.465  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|++++++++|+||+++++++.+ +..++||||+++++|.+++...  ..+++..++.++.|++.+|+|||++|+
T Consensus       306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  384 (535)
T 2h8h_A          306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  384 (535)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4678999999999999999999999876 6689999999999999999743  469999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +|+||+|+||++   +.+..++|+|||++........  .....++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus       385 vHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g  461 (535)
T 2h8h_A          385 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG  461 (535)
T ss_dssp             CCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTT
T ss_pred             eCCCCCHhhEEE---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999   5677899999999876543221  112235678999999988889999999999999999999 9


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      ..||.+.+..
T Consensus       462 ~~P~~~~~~~  471 (535)
T 2h8h_A          462 RVPYPGMVNR  471 (535)
T ss_dssp             CCSSTTCCHH
T ss_pred             CCCCCCCCHH
Confidence            9999876543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5e-33  Score=204.46  Aligned_cols=161  Identities=31%  Similarity=0.553  Sum_probs=134.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEE--eCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ..+.+.+|++++++++||||+++++++.  +.+..+++|||++++ |.+++..  ...+++..+..++.|++.++++||+
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  127 (305)
T 2wtk_C           49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS  127 (305)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999984  456899999999765 7777765  3469999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC---CcccccccCccccCcccccccc--CCcchhHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILF  159 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~ape~~~~~~--~~~~~Di~slg~~~~  159 (180)
                      +|++|+||+|+||++   +.++.++|+|||.+......   .......++..|+|||...+..  .+.++|+||||+++|
T Consensus       128 ~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  204 (305)
T 2wtk_C          128 QGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLY  204 (305)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHH
T ss_pred             CCeeecCCCcccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHH
Confidence            999999999999999   56778999999998765432   2223445788999999987644  477999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|..||.+.+.
T Consensus       205 ~l~~g~~p~~~~~~  218 (305)
T 2wtk_C          205 NITTGLYPFEGDNI  218 (305)
T ss_dssp             HHHHSSCSCCCSSH
T ss_pred             HHHhCCCCCCCchH
Confidence            99999999987553

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.5e-34  Score=211.93  Aligned_cols=156  Identities=35%  Similarity=0.734  Sum_probs=114.5

Q ss_pred             HHHhcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 030256           18 NFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (180)
Q Consensus        18 ~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~~h~d   91 (180)
                      ..++.++||||+++++++..    .+..++||||++|++|.+++....  .+++..+..++.|++.+|++||++|++|+|
T Consensus        74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~d  153 (336)
T 3fhr_A           74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD  153 (336)
T ss_dssp             HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            34667799999999999876    456899999999999999998654  599999999999999999999999999999


Q ss_pred             CCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030256           92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY  171 (180)
Q Consensus        92 l~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~  171 (180)
                      |+|+||++...+....++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|++++|..||.+.
T Consensus       154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CCHHHEEEEecCCCceEEEeccccceeccccc-cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            99999999654446679999999987654332 23345788999999998888999999999999999999999999765


Q ss_pred             Ccc
Q 030256          172 RPC  174 (180)
Q Consensus       172 ~~~  174 (180)
                      +..
T Consensus       233 ~~~  235 (336)
T 3fhr_A          233 TGQ  235 (336)
T ss_dssp             ---
T ss_pred             cch
Confidence            543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-33  Score=209.56  Aligned_cols=163  Identities=25%  Similarity=0.458  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHHhcCCCcc------ccccceEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+.+.+|+.++++++|++      ++.+.+++...+..+++||++ ++++.+.+....  ++++..+..++.|++.+|
T Consensus        58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L  136 (355)
T 2eu9_A           58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL  136 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            45677889999999997666      899999999999999999999 667777776553  699999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecC----------------CCCceEEEeecCCccccCCCCcccccccCccccCccccccc
Q 030256           80 EILNSHHIIHRDLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  143 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~----------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~  143 (180)
                      ++||++|++|+||+|+||++...                .....++|+|||.+.......  ....++..|+|||.+.+.
T Consensus       137 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~  214 (355)
T 2eu9_A          137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH--TTIVATRHYRPPEVILEL  214 (355)
T ss_dssp             HHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC--CSSCSCGGGCCHHHHTTC
T ss_pred             HHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc--cCCcCCCcccCCeeeecC
Confidence            99999999999999999999422                246679999999987654332  234588999999999988


Q ss_pred             cCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256          144 RYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       144 ~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      .++.++|+||||+++|+|++|..||...+.
T Consensus       215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          215 GWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999999999987654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.8e-33  Score=213.42  Aligned_cols=164  Identities=32%  Similarity=0.468  Sum_probs=136.6

Q ss_pred             HHHHHHHHHHHHHhcCC--------CccccccceEEE----eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVN--------HPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ   73 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~   73 (180)
                      ...+.+.+|+.++++++        |+||+++++++.    .....++|||++ ++++.+.+...  ..+++..+..++.
T Consensus        75 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~  153 (397)
T 1wak_A           75 HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ  153 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHH
Confidence            44677889999999995        788999999987    455899999999 56776666544  4699999999999


Q ss_pred             HHHHHHHHHHhC-CCeeecCCCCCeeeecCC----------------------------------------------CCc
Q 030256           74 QLGAGLEILNSH-HIIHRDLKPENILLSGLD----------------------------------------------DDV  106 (180)
Q Consensus        74 ~i~~~l~~lh~~-~~~h~dl~~~nil~~~~~----------------------------------------------~~~  106 (180)
                      |++.||++||++ |++|+||+|+||++....                                              ...
T Consensus       154 qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (397)
T 1wak_A          154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL  233 (397)
T ss_dssp             HHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGC
T ss_pred             HHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccccccc
Confidence            999999999998 999999999999995211                                              112


Q ss_pred             eEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          107 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       107 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      .++|+|||.+......  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus       234 ~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  299 (397)
T 1wak_A          234 KVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE  299 (397)
T ss_dssp             CEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             ceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence            7999999998766433  22345789999999999888999999999999999999999999876543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.9e-33  Score=212.29  Aligned_cols=162  Identities=15%  Similarity=0.181  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHHhcC--CCccccccc-------eEEEeC-----------------CeEEEEEeccCCCChHHHHHhc
Q 030256            7 KHLKSCLDCELNFLSSV--NHPNIIRLF-------DAFQAE-----------------NCIFLVVEFCAGGNLSSYIRLH   60 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~   60 (180)
                      ....+.+++|+.+++.+  +|||+++++       +++...                 ..+++||||++ ++|.+++...
T Consensus       103 ~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~  181 (371)
T 3q60_A          103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL  181 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh
Confidence            34566778885444444  799987755       444433                 34899999997 7999999764


Q ss_pred             C-CCCHHHH------HHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCcc
Q 030256           61 G-RVPEQTA------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL  133 (180)
Q Consensus        61 ~-~~~~~~~------~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  133 (180)
                      + .++....      ..++.|++.+|+|||++|++|+||+|+||++   +.++.++|+|||++........  ...++..
T Consensus       182 ~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~~~~--~~~~t~~  256 (371)
T 3q60_A          182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGTRGP--ASSVPVT  256 (371)
T ss_dssp             HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTCEEE--GGGSCGG
T ss_pred             ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCCCcc--CccCCcC
Confidence            3 3444555      6777999999999999999999999999999   5677899999999976643321  3446689


Q ss_pred             ccCcccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          134 YMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       134 ~~ape~~~~--~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      |+|||.+.+  ..++.++|+||+|+++|+|++|+.||.+..+.
T Consensus       257 y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~  299 (371)
T 3q60_A          257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG  299 (371)
T ss_dssp             GCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTT
T ss_pred             CcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcc
Confidence            999999987  67899999999999999999999999887554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5e-33  Score=208.34  Aligned_cols=161  Identities=28%  Similarity=0.495  Sum_probs=136.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ......+.+|+.++++++||||+++++++...     +..++++|++. ++|.+++.. ..+++..+..++.|++.+|++
T Consensus        50 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~  127 (353)
T 2b9h_A           50 PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKV  127 (353)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHH
Confidence            34456778999999999999999999987654     67999999995 699998874 679999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----------ccccccCccccCcccccc-ccCCcch
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------AEKVCGSPLYMAPEVLQF-QRYDEKV  149 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~ape~~~~-~~~~~~~  149 (180)
                      ||++|++|+||+|+||++   +.++.++|+|||++........           .....++..|+|||.+.+ ..++.++
T Consensus       128 LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  204 (353)
T 2b9h_A          128 LHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM  204 (353)
T ss_dssp             HHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHH
T ss_pred             HHHCCeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchh
Confidence            999999999999999999   5677899999999876543211           112357888999998754 6789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCC
Q 030256          150 DMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       150 Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      |+||||+++|++++|..||.+.+
T Consensus       205 Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          205 DVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998765

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.8e-33  Score=207.80  Aligned_cols=161  Identities=31%  Similarity=0.468  Sum_probs=135.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCC-------eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAG   78 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~   78 (180)
                      .....++++.++.++||||+++++++...+       ..+++|||+++ +|...+.    ....+++..+..++.|++.+
T Consensus        63 ~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~a  141 (360)
T 3e3p_A           63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRS  141 (360)
T ss_dssp             CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence            345667788888999999999999986543       38999999976 5554433    44568999999999999999


Q ss_pred             HHHHH--hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccccc-CCcchhHHHHH
Q 030256           79 LEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVG  155 (180)
Q Consensus        79 l~~lh--~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg  155 (180)
                      +++||  +.|++|+||+|+||++.  ..++.++|+|||++.............++..|+|||.+.+.. ++.++|+||+|
T Consensus       142 l~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG  219 (360)
T 3e3p_A          142 IGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG  219 (360)
T ss_dssp             HHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHH
Confidence            99999  99999999999999995  347789999999998776655555566889999999986554 79999999999


Q ss_pred             HHHHHHHhCCCCCCCCCc
Q 030256          156 AILFELLNGYPPFSAYRP  173 (180)
Q Consensus       156 ~~~~~~l~g~~pf~~~~~  173 (180)
                      +++|++++|+.||.+.+.
T Consensus       220 ~il~ell~g~~pf~~~~~  237 (360)
T 3e3p_A          220 CIFAEMMLGEPIFRGDNS  237 (360)
T ss_dssp             HHHHHHHHSSCSSCCSSH
T ss_pred             HHHHHHHhCCCCcCCCCh
Confidence            999999999999987654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.5e-33  Score=224.10  Aligned_cols=164  Identities=27%  Similarity=0.534  Sum_probs=139.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ...++.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.... .+++..+..++.|++.|++|||++
T Consensus       432 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  510 (656)
T 2j0j_A          432 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK  510 (656)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            445678899999999999999999999985 456899999999999999997554 699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      |++|+||+|+||++.   .++.++|+|||++.........  ....++..|+|||.+.+..++.++|+||+|+++|++++
T Consensus       511 givHrDikp~NILl~---~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  587 (656)
T 2j0j_A          511 RFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  587 (656)
T ss_dssp             TCCCSCCSGGGEEEE---ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CccccccchHhEEEe---CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence            999999999999994   5678999999998776443221  22335678999999988889999999999999999997


Q ss_pred             -CCCCCCCCCcc
Q 030256          164 -GYPPFSAYRPC  174 (180)
Q Consensus       164 -g~~pf~~~~~~  174 (180)
                       |..||.+.+..
T Consensus       588 ~g~~Pf~~~~~~  599 (656)
T 2j0j_A          588 HGVKPFQGVKNN  599 (656)
T ss_dssp             TSCCTTTTCCHH
T ss_pred             cCCCCCCCCCHH
Confidence             99999876543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.5e-33  Score=210.25  Aligned_cols=159  Identities=31%  Similarity=0.521  Sum_probs=134.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeE------EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~   80 (180)
                      +.....+.+|+.++++++||||+++++++...+..      +++||++. ++|.+.+.  ..+++..+..++.|++.+++
T Consensus        82 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~  158 (371)
T 4exu_A           82 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLK  158 (371)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHH
Confidence            34567788999999999999999999999876644      99999995 68887763  45999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF  159 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~  159 (180)
                      +||++|++|+||+|+||++   +.++.++|+|||.+......  .....++..|+|||.+.+ ..++.++|+||||++++
T Consensus       159 ~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (371)
T 4exu_A          159 YIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA  233 (371)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred             HHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHH
Confidence            9999999999999999999   56788999999998765433  223457889999999876 67899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|+.||.+.+.
T Consensus       234 el~~g~~pf~~~~~  247 (371)
T 4exu_A          234 EMLTGKTLFKGKDY  247 (371)
T ss_dssp             HHHHSSCSCCCSSH
T ss_pred             HHHhCCCCCCCCCh
Confidence            99999999987653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.1e-34  Score=211.33  Aligned_cols=165  Identities=28%  Similarity=0.405  Sum_probs=131.3

Q ss_pred             hhhhhHHHHHHHHHHHHHH--hcCCCccccccceEEEe-----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFL--SSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l--~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~   74 (180)
                      +|.++....+.+..|.+++  +.++||||+++++.+..     ...+++||||+++++|.+++.. ...++..+..++.|
T Consensus        41 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~q  119 (336)
T 3g2f_A           41 VKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHS  119 (336)
T ss_dssp             EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHH
T ss_pred             EEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHH
Confidence            4555545555555555554  45799999999986542     2367999999999999999974 45588999999999


Q ss_pred             HHHHHHHHHhC---------CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---------cccccccCccccC
Q 030256           75 LGAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMA  136 (180)
Q Consensus        75 i~~~l~~lh~~---------~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---------~~~~~~~~~~~~a  136 (180)
                      ++.+|++||+.         |++|+||+|+||++   +.++.++|+|||++.......         ......++..|+|
T Consensus       120 i~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  196 (336)
T 3g2f_A          120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA  196 (336)
T ss_dssp             HHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCC
T ss_pred             HHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeC
Confidence            99999999999         99999999999999   567789999999997654321         1123458899999


Q ss_pred             cccccc-------ccCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256          137 PEVLQF-------QRYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       137 pe~~~~-------~~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      ||.+.+       ..++.++|+||||+++|++++|..||..
T Consensus       197 PE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             HHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             chhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999876       4567889999999999999999766643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-32  Score=204.35  Aligned_cols=159  Identities=31%  Similarity=0.548  Sum_probs=117.4

Q ss_pred             HHHHHHHHH-HHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH
Q 030256           10 KSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        10 ~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ...+.+|.. +++.++||||+++++++...+..+++|||+++ +|.+++..     ...+++..+..++.|++.++.+||
T Consensus        64 ~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  142 (327)
T 3aln_A           64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK  142 (327)
T ss_dssp             HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh
Confidence            334455555 77778999999999999999999999999965 88887763     467999999999999999999999


Q ss_pred             hC-CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccc----ccccCCcchhHHHHHHHH
Q 030256           84 SH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        84 ~~-~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~----~~~~~~~~~Di~slg~~~  158 (180)
                      +. |++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+    .+..++.++|+||||+++
T Consensus       143 ~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il  219 (327)
T 3aln_A          143 ENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL  219 (327)
T ss_dssp             HHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHH
T ss_pred             ccCCEeECCCCHHHEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence            99 99999999999999   46778999999999776554444444688899999998    456689999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030256          159 FELLNGYPPFSAYR  172 (180)
Q Consensus       159 ~~~l~g~~pf~~~~  172 (180)
                      |++++|..||.+.+
T Consensus       220 ~~l~~g~~pf~~~~  233 (327)
T 3aln_A          220 YELATGRFPYPKWN  233 (327)
T ss_dssp             HHHHHSCCCSSCC-
T ss_pred             HHHHHCCCCCCCcc
Confidence            99999999998754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.3e-32  Score=212.40  Aligned_cols=163  Identities=20%  Similarity=0.260  Sum_probs=139.4

Q ss_pred             HHHHHHHHHHHhcCCC-ccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+|+++++.++| ++++.+..+....+..+++|||+ +++|.+++.. ...+++..++.++.||+.+|+|||++|+
T Consensus        46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gI  124 (483)
T 3sv0_A           46 HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF  124 (483)
T ss_dssp             SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            3457889999999976 55666666667888999999999 9999999975 4579999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--------ccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      +|+||+|+||++...+..+.++|+|||++........        .....++..|+|||.+.+..++.++||||||+++|
T Consensus       125 vHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~  204 (483)
T 3sv0_A          125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM  204 (483)
T ss_dssp             ECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             eecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHH
Confidence            9999999999995334667899999999977654322        12456889999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      +|++|+.||.+...
T Consensus       205 elltG~~Pf~~~~~  218 (483)
T 3sv0_A          205 YFLRGSLPWQGLKA  218 (483)
T ss_dssp             HHHHSSCTTSSCCC
T ss_pred             HHHhCCCCCccccc
Confidence            99999999987655

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.6e-33  Score=208.27  Aligned_cols=160  Identities=22%  Similarity=0.356  Sum_probs=134.7

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|+.++++++||||+++++++.+.+..++++||+++++|.+++.... .+++..+..++.|++.++++||++|++
T Consensus        73 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~  152 (319)
T 2y4i_B           73 LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL  152 (319)
T ss_dssp             CCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            3456789999999999999999999999999999999999999999987654 699999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC------CcccccccCccccCcccccc---------ccCCcchhHHH
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQF---------QRYDEKVDMWS  153 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~------~~~~~~~~~~~~~ape~~~~---------~~~~~~~Di~s  153 (180)
                      |+||+|+||++.    ++.++|+|||++......      .......++..|+|||.+.+         ..++.++|+||
T Consensus       153 H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~s  228 (319)
T 2y4i_B          153 HKDLKSKNVFYD----NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA  228 (319)
T ss_dssp             CCCCCSTTEEEC------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHH
T ss_pred             ccCCChhhEEEe----CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHH
Confidence            999999999993    468999999987654221      12223447788999999864         34688999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030256          154 VGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~~  173 (180)
                      ||+++|++++|..||.+.+.
T Consensus       229 lG~il~el~~g~~p~~~~~~  248 (319)
T 2y4i_B          229 LGTIWYELHAREWPFKTQPA  248 (319)
T ss_dssp             HHHHHHHHHHSSCSSSSCCH
T ss_pred             HHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999987654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.6e-32  Score=202.68  Aligned_cols=162  Identities=27%  Similarity=0.547  Sum_probs=136.2

Q ss_pred             hHHHHHHHHHHHHHHhcCC--CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +....+.+.+|++++++++  |+||+++++++...+..+++||+ .+++|.+++.....+++..+..++.|++.+|++||
T Consensus        66 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH  144 (313)
T 3cek_A           66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH  144 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3455678899999999996  59999999999999999999995 58899999998888999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcccccc-----------ccCCcch
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKV  149 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~-----------~~~~~~~  149 (180)
                      ++|++|+||+|+||++.    ++.++|+|||.+........   .....++..|+|||.+.+           ..++.++
T Consensus       145 ~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~  220 (313)
T 3cek_A          145 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS  220 (313)
T ss_dssp             HTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHH
T ss_pred             HCCceecCCCcccEEEE----CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchH
Confidence            99999999999999994    36899999999876543321   223457899999999865           4678899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCC
Q 030256          150 DMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       150 Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      |+||||+++|++++|..||....
T Consensus       221 Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          221 DVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             HHHHHHHHHHHHHhCCCchhhHH
Confidence            99999999999999999997654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.7e-33  Score=207.58  Aligned_cols=159  Identities=31%  Similarity=0.520  Sum_probs=133.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCe------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~   80 (180)
                      +...+.+.+|+.++++++||||+++++++...+.      ++++||++. ++|.+++.  .++++..+..++.|++.+|+
T Consensus        64 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~  140 (353)
T 3coi_A           64 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLK  140 (353)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHH
Confidence            3456778899999999999999999999986643      599999996 58887764  45999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF  159 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~  159 (180)
                      +||++|++|+||+|+||++   +.++.++|+|||.+......  .....++..|+|||.+.+ ..++.++|+||+|++++
T Consensus       141 ~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~  215 (353)
T 3coi_A          141 YIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA  215 (353)
T ss_dssp             HHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred             HHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHH
Confidence            9999999999999999999   56778999999998765432  223457889999999876 67899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      ++++|..||.+.+.
T Consensus       216 el~~g~~pf~~~~~  229 (353)
T 3coi_A          216 EMLTGKTLFKGKDY  229 (353)
T ss_dssp             HHHHSSCSSBSSCH
T ss_pred             HHHhCCCCCCCCCH
Confidence            99999999987653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=7.7e-34  Score=224.52  Aligned_cols=152  Identities=19%  Similarity=0.198  Sum_probs=117.0

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ++...+++.+|+++|+++ .|+||+++++++++++..||||||++|++|.+.+...+++++..   ++.||+.||+|+|+
T Consensus       281 ~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~  357 (569)
T 4azs_A          281 SQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEK  357 (569)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHH
Confidence            445667899999999999 79999999999999999999999999999999999888888754   78899999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|++||||||+|||+   +.++.+||+|||+++..... .......||+.|+|||.+.+. +..++|+||+|++.+++.+
T Consensus       358 ~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~  433 (569)
T 4azs_A          358 QGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQ  433 (569)
T ss_dssp             TTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred             CCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcc
Confidence            999999999999999   56788999999998766443 333456689999999998754 5678999999998766544


Q ss_pred             C
Q 030256          164 G  164 (180)
Q Consensus       164 g  164 (180)
                      +
T Consensus       434 ~  434 (569)
T 4azs_A          434 P  434 (569)
T ss_dssp             T
T ss_pred             c
Confidence            4

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.9e-32  Score=198.21  Aligned_cols=154  Identities=32%  Similarity=0.604  Sum_probs=127.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEe-------------CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-------------ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL   72 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~   72 (180)
                      ....+.+.+|+.++++++||||+++++++.+             .+..+++|||+++++|.+++.... .+++..+..++
T Consensus        43 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~  122 (303)
T 1zy4_A           43 EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF  122 (303)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHH
Confidence            3445778899999999999999999998754             457899999999999999998544 58889999999


Q ss_pred             HHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC---------------CcccccccCccccCc
Q 030256           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMAP  137 (180)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---------------~~~~~~~~~~~~~ap  137 (180)
                      .|++.++++||++|++|+||+|+||++   +.++.++|+|||.+......               .......++..|+||
T Consensus       123 ~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCH
T ss_pred             HHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence            999999999999999999999999999   56778999999998765422               112234578889999


Q ss_pred             cccccc-cCCcchhHHHHHHHHHHHHh
Q 030256          138 EVLQFQ-RYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus       138 e~~~~~-~~~~~~Di~slg~~~~~~l~  163 (180)
                      |.+.+. .++.++|+||+|+++|++++
T Consensus       200 E~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          200 EVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             HHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             ccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            998764 68999999999999999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.8e-32  Score=199.78  Aligned_cols=161  Identities=32%  Similarity=0.522  Sum_probs=126.3

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH-   85 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-   85 (180)
                      ...+.+..+..+++.++||||+++++++.+.+..+++|||+ ++.+..+... ...+++..+..++.|++.++++||+. 
T Consensus        66 ~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  144 (318)
T 2dyl_A           66 ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH  144 (318)
T ss_dssp             HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            33445555666788889999999999999999999999999 6666665543 46799999999999999999999995 


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccc-----cccCCcchhHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~~  160 (180)
                      |++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.     +..++.++|+||+|+++|+
T Consensus       145 ~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~  221 (318)
T 2dyl_A          145 GVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE  221 (318)
T ss_dssp             CCCCCCCCGGGEEE---CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHH
T ss_pred             CEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHH
Confidence            99999999999999   567789999999987665544444556889999999984     4567889999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030256          161 LLNGYPPFSAYR  172 (180)
Q Consensus       161 ~l~g~~pf~~~~  172 (180)
                      +++|+.||....
T Consensus       222 l~~g~~pf~~~~  233 (318)
T 2dyl_A          222 LATGQFPYKNCK  233 (318)
T ss_dssp             HHHSSCTTTTCC
T ss_pred             HHhCCCCCCCCC
Confidence            999999998643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.7e-32  Score=206.69  Aligned_cols=162  Identities=38%  Similarity=0.522  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHHhcCC-Cc-----cccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l   79 (180)
                      ...+.+.+|+.+++.++ |+     +++++.+++...+..++|||++. ++|.+++...  ..+++..+..++.|++.++
T Consensus        92 ~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al  170 (382)
T 2vx3_A           92 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL  170 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHH
Confidence            34566788999988884 55     48999999999999999999995 5999998765  3599999999999999999


Q ss_pred             HHHH--hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHH
Q 030256           80 EILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  157 (180)
Q Consensus        80 ~~lh--~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~  157 (180)
                      ++||  +.|++|+||+|+||++.. +..+.++|+|||++......  .....++..|+|||.+.+..++.++|+||||++
T Consensus       171 ~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i  247 (382)
T 2vx3_A          171 LFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCI  247 (382)
T ss_dssp             HHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred             HHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHH
Confidence            9999  579999999999999952 34667999999999776433  234457889999999999899999999999999


Q ss_pred             HHHHHhCCCCCCCCCc
Q 030256          158 LFELLNGYPPFSAYRP  173 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~  173 (180)
                      +|+|++|+.||.+.++
T Consensus       248 l~elltg~~pf~~~~~  263 (382)
T 2vx3_A          248 LVEMHTGEPLFSGANE  263 (382)
T ss_dssp             HHHHHHSSCSSCCSSH
T ss_pred             HHHHHhCCCCCCCCCH
Confidence            9999999999987654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.5e-32  Score=202.38  Aligned_cols=158  Identities=28%  Similarity=0.509  Sum_probs=138.9

Q ss_pred             HHHHHHHHHHhcCC--CccccccceEEEeCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        11 ~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      +.+.+|+.++++++  |+||+++++++...+..++++|++.+ ++|.+++.....+++..+..++.|++.+|++||+.|+
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  170 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV  170 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            45677999999995  59999999999999999999999975 8999999888899999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +|+||+|+||++.  ..++.++|+|||++....... .....++..|+|||.+.+..+ +.++|+||||+++|++++|..
T Consensus       171 vH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~  247 (320)
T 3a99_A          171 LHRDIKDENILID--LNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI  247 (320)
T ss_dssp             ECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             EeCCCCHHHEEEe--CCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence            9999999999995  366789999999987665432 223458889999999876665 678999999999999999999


Q ss_pred             CCCCC
Q 030256          167 PFSAY  171 (180)
Q Consensus       167 pf~~~  171 (180)
                      ||...
T Consensus       248 pf~~~  252 (320)
T 3a99_A          248 PFEHD  252 (320)
T ss_dssp             SCCSH
T ss_pred             CCCCh
Confidence            99753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.98  E-value=2.3e-32  Score=206.04  Aligned_cols=162  Identities=29%  Similarity=0.480  Sum_probs=136.0

Q ss_pred             HHHHHHHHHHHHHhcCC-----------CccccccceEEEeCC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK   70 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~   70 (180)
                      ...+.+.+|+.++++++           |+||+++++++...+    ..++++|++ +++|.+++...  ..+++..+..
T Consensus        57 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~  135 (373)
T 1q8y_A           57 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ  135 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHH
T ss_pred             cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHH
Confidence            34567888999999886           889999999987654    789999999 88999998764  4599999999


Q ss_pred             HHHHHHHHHHHHHhC-CCeeecCCCCCeeeecC---CCCceEEEeecCCccccCCCCcccccccCccccCccccccccCC
Q 030256           71 FLQQLGAGLEILNSH-HIIHRDLKPENILLSGL---DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD  146 (180)
Q Consensus        71 ~~~~i~~~l~~lh~~-~~~h~dl~~~nil~~~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~  146 (180)
                      ++.|++.+|++||++ |++|+||+|+||++...   +....++|+|||++......  .....++..|+|||.+.+..++
T Consensus       136 i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~  213 (373)
T 1q8y_A          136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWG  213 (373)
T ss_dssp             HHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCC
Confidence            999999999999998 99999999999999532   23447999999998766433  2234578999999999988899


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          147 EKVDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      .++|+||||+++|++++|..||...+
T Consensus       214 ~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          214 CGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             THHHHHHHHHHHHHHHHSSCCC----
T ss_pred             chHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            99999999999999999999998655

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.98  E-value=1.6e-32  Score=221.41  Aligned_cols=155  Identities=26%  Similarity=0.442  Sum_probs=132.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCe-----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ......+.+|++++++++||||+++++++...+.     .++||||++|++|.+++..  ++++..++.++.|++.+|.|
T Consensus       120 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~  197 (681)
T 2pzi_A          120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSY  197 (681)
T ss_dssp             HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHH
Confidence            4556678899999999999999999999987654     7999999999999987753  79999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ||++|++|+||+|+||++.   . ..++|+|||++......   ....++..|+|||.+.+. ++.++|+||||+++++|
T Consensus       198 lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l  269 (681)
T 2pzi_A          198 LHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL  269 (681)
T ss_dssp             HHHTTEECCCCSGGGEEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred             HHHCCCeecccChHHeEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence            9999999999999999995   3 37999999998776443   344588999999988754 48899999999999999


Q ss_pred             HhCCCCCCCC
Q 030256          162 LNGYPPFSAY  171 (180)
Q Consensus       162 l~g~~pf~~~  171 (180)
                      ++|..||.+.
T Consensus       270 ~~g~~~~~~~  279 (681)
T 2pzi_A          270 TLDLPTRNGR  279 (681)
T ss_dssp             HSCCCEETTE
T ss_pred             HhCCCCCccc
Confidence            9999998753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.98  E-value=2.7e-32  Score=201.30  Aligned_cols=159  Identities=30%  Similarity=0.500  Sum_probs=134.0

Q ss_pred             HHHHHHHHHHHhcC----CCccccccceEEEeCCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSV----NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+|+.+++++    +|+||+++++++...+..++++|+ +.+++|.+++....++++..+..++.|++.++++||+
T Consensus        78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~  157 (312)
T 2iwi_A           78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS  157 (312)
T ss_dssp             -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34566789999998    899999999999998999999999 7889999999988889999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHh
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN  163 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~  163 (180)
                      +|++|+||+|+||+++  ..++.++|+|||.+....... .....++..|+|||.+.+..+ +.++|+||||+++|++++
T Consensus       158 ~~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  234 (312)
T 2iwi_A          158 RGVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC  234 (312)
T ss_dssp             HTEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH
Confidence            9999999999999995  367789999999987665433 234457889999999876665 458999999999999999


Q ss_pred             CCCCCCCC
Q 030256          164 GYPPFSAY  171 (180)
Q Consensus       164 g~~pf~~~  171 (180)
                      |+.||...
T Consensus       235 g~~pf~~~  242 (312)
T 2iwi_A          235 GDIPFERD  242 (312)
T ss_dssp             SSCSCCSH
T ss_pred             CCCCCCCh
Confidence            99999753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=2e-30  Score=190.44  Aligned_cols=142  Identities=34%  Similarity=0.679  Sum_probs=120.8

Q ss_pred             HHHHHHHHHH-hcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFL-SSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        11 ~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ....+|+.++ +..+||||+++++++..    .+..+++|||+++++|.+++....  .+++..+..++.|++.++++||
T Consensus        55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH  134 (299)
T 3m2w_A           55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  134 (299)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567788888 55599999999999877    678999999999999999998654  5999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      +.|++|+||+|+||++.....++.++|+|||++....                     +..++.++|+||+|+++|+|++
T Consensus       135 ~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~t  193 (299)
T 3m2w_A          135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLC  193 (299)
T ss_dssp             HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHH
T ss_pred             hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHHHHHHHHHHH
Confidence            9999999999999999643336789999999875432                     2346788999999999999999


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |+.||.+.+.
T Consensus       194 g~~pf~~~~~  203 (299)
T 3m2w_A          194 GYPPFYSNHG  203 (299)
T ss_dssp             SSCSCCC---
T ss_pred             CCCCCCCCcc
Confidence            9999976543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=3e-30  Score=188.55  Aligned_cols=137  Identities=19%  Similarity=0.198  Sum_probs=118.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+.+|+.++++++||||+++++++.+++..++||||++|++|.++++. + .....+..++.|++.+|+|||++|
T Consensus        72 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~g  149 (286)
T 3uqc_A           72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAG  149 (286)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCC
Confidence            34457789999999999999999999999999999999999999999999863 3 456678999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++|+||+|+||++.   .++.++|++++.                   ++       .++.++|+||||+++|+|++|+.
T Consensus       150 ivH~Dikp~NIll~---~~g~~kl~~~~~-------------------~~-------~~~~~~Di~slG~il~elltg~~  200 (286)
T 3uqc_A          150 VALSIDHPSRVRVS---IDGDVVLAYPAT-------------------MP-------DANPQDDIRGIGASLYALLVNRW  200 (286)
T ss_dssp             CCCCCCSGGGEEEE---TTSCEEECSCCC-------------------CT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred             CccCCCCcccEEEc---CCCCEEEEeccc-------------------cC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence            99999999999994   566788774432                   22       36789999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.+..
T Consensus       201 Pf~~~~~~  208 (286)
T 3uqc_A          201 PLPEAGVR  208 (286)
T ss_dssp             CSCCCSBC
T ss_pred             CCCcCCcc
Confidence            99887653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=1.1e-32  Score=205.44  Aligned_cols=154  Identities=24%  Similarity=0.318  Sum_probs=124.3

Q ss_pred             HHHHHHHHHHhcCC--------------------------CccccccceEEEe-------------CCeEEEEEeccCCC
Q 030256           11 SCLDCELNFLSSVN--------------------------HPNIIRLFDAFQA-------------ENCIFLVVEFCAGG   51 (180)
Q Consensus        11 ~~~~~e~~~l~~l~--------------------------h~~iv~~~~~~~~-------------~~~~~lv~e~~~~~   51 (180)
                      +.+.+|+.++++++                          ||||+++++++.+             .+..++||||++++
T Consensus        68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g  147 (336)
T 2vuw_A           68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG  147 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred             HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence            67888999988886                          5555555555543             67899999999988


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeecCCCCCeeeecCC-----------------CCceEEEeec
Q 030256           52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHRDLKPENILLSGLD-----------------DDVMLKIADF  113 (180)
Q Consensus        52 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~h~dl~~~nil~~~~~-----------------~~~~~~l~d~  113 (180)
                      ++.+.+. ...+++..+..++.|++.||+||| ++|++||||||+||++....                 ....++|+||
T Consensus       148 ~ll~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DF  226 (336)
T 2vuw_A          148 IDLEQMR-TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDY  226 (336)
T ss_dssp             EETGGGT-TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCC
T ss_pred             ccHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeec
Confidence            7655554 367899999999999999999999 99999999999999996422                 1238999999


Q ss_pred             CCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHH-HHHHHhCCCCCCC
Q 030256          114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI-LFELLNGYPPFSA  170 (180)
Q Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~-~~~~l~g~~pf~~  170 (180)
                      |+++.....    ...++..|+|||.+.+.. +.++||||++.+ .+++++|..||.+
T Consensus       227 G~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          227 TLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             TTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             cccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            999766543    335889999999998766 889999998776 6778889999854

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=2.3e-29  Score=192.45  Aligned_cols=158  Identities=16%  Similarity=0.130  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHhcCCC-ccccccc---------------------eEEEe-----CCeEEEEEeccCCCChHHHHHh---
Q 030256           10 KSCLDCELNFLSSVNH-PNIIRLF---------------------DAFQA-----ENCIFLVVEFCAGGNLSSYIRL---   59 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h-~~iv~~~---------------------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---   59 (180)
                      .+.+++|+.+++.++| ++.....                     .++..     ...++++|+.+ +++|.++++.   
T Consensus       122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~  200 (413)
T 3dzo_A          122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS  200 (413)
T ss_dssp             CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence            5678899999999976 2221111                     11111     12467788876 7899988842   


Q ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCcccc
Q 030256           60 ----HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM  135 (180)
Q Consensus        60 ----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  135 (180)
                          ...+++..+..++.|++.+|+|||++|++||||||+||++   +.++.++|+|||++......  .....+ ..|+
T Consensus       201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~  274 (413)
T 3dzo_A          201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFA  274 (413)
T ss_dssp             HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTC
T ss_pred             ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-Ccee
Confidence                2237788999999999999999999999999999999999   56777999999998765433  233446 8999


Q ss_pred             Ccccc----------ccccCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030256          136 APEVL----------QFQRYDEKVDMWSVGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       136 ape~~----------~~~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~~  174 (180)
                      |||.+          .+..++.++|+||||+++|+|++|+.||.+.++.
T Consensus       275 aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~  323 (413)
T 3dzo_A          275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL  323 (413)
T ss_dssp             CHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGG
T ss_pred             CchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99998          5556888999999999999999999999886654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.7e-26  Score=181.77  Aligned_cols=148  Identities=18%  Similarity=0.187  Sum_probs=126.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .++++.+|++++++++||||+++..++...+..+++|||++|++|.+++..        +..++.|++.+++|||++|++
T Consensus       382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIi  453 (540)
T 3en9_A          382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVI  453 (540)
T ss_dssp             HHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCc
Confidence            356789999999999999999777777777778999999999999998864        668999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--------ccccccCccccCcccccc--ccCCcchhHHHHHHHH
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAIL  158 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~ape~~~~--~~~~~~~Di~slg~~~  158 (180)
                      |+||||+||++.   .  .++|+|||+++.......        .....++..|+|||.+.+  ..|+...|+|+..+-.
T Consensus       454 HrDiKp~NILl~---~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~  528 (540)
T 3en9_A          454 HNDLTTSNFIFD---K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILEL  528 (540)
T ss_dssp             CTTCCTTSEEES---S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHH
T ss_pred             cCCCCHHHEEEC---C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHH
Confidence            999999999994   3  899999999987755322        124568899999999986  5677888999998888


Q ss_pred             HHHHhCCCCCC
Q 030256          159 FELLNGYPPFS  169 (180)
Q Consensus       159 ~~~l~g~~pf~  169 (180)
                      .+-+.++.+|.
T Consensus       529 l~~v~~r~rY~  539 (540)
T 3en9_A          529 MKDVERRARYV  539 (540)
T ss_dssp             HHHHHTCSCCC
T ss_pred             HHHHHhccccC
Confidence            88888888875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.77  E-value=2.3e-19  Score=130.66  Aligned_cols=95  Identities=17%  Similarity=0.224  Sum_probs=79.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+..+.+|++++++++  | +++.+++.. +..++||||++|++|.+ +.      ......++.|++.++++||+.|++
T Consensus       147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~gii  215 (282)
T 1zar_A          147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIV  215 (282)
T ss_dssp             HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCE
Confidence            4667899999999999  5 677776654 44699999999999987 42      133557999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      |+||+|+||++   + ++.++|+|||++..
T Consensus       216 HrDlkp~NILl---~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          216 HGDLSQYNVLV---S-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CSCCSTTSEEE---E-TTEEEECCCTTCEE
T ss_pred             eCCCCHHHEEE---E-CCcEEEEECCCCeE
Confidence            99999999999   4 77899999998854

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.61  E-value=5.2e-16  Score=111.52  Aligned_cols=101  Identities=19%  Similarity=0.178  Sum_probs=77.1

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-G----NLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-   83 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-   83 (180)
                      +..+.+|++.++++.|+++.....+..  +..++||||+.+ |    +|.+....   .++..+..++.|++.++++|| 
T Consensus       114 ~~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          114 FIWTEKEFRNLERAKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHH
Confidence            457889999999998886532222222  346899999932 2    67665432   234567889999999999999 


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccC
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~  120 (180)
                      +.|++|+||+|.||++.   .  .++|+|||++....
T Consensus       189 ~~givHrDlkp~NILl~---~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          189 EAELVHADLSEYNIMYI---D--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TSCEECSSCSTTSEEES---S--SEEECCCTTCEETT
T ss_pred             HCCEEeCCCCHHHEEEc---C--cEEEEECcccccCC
Confidence            99999999999999994   3  89999999986653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.36  E-value=4.1e-13  Score=101.11  Aligned_cols=101  Identities=18%  Similarity=0.151  Sum_probs=71.5

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~d   91 (180)
                      ...+|...|.++.+.++.....+....  .++||||++|.+|.....    .  .....++.|++.++.+||++|++|||
T Consensus       159 ~A~kE~~nL~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~----~--~~~~~l~~qll~~l~~lH~~gIVHrD  230 (397)
T 4gyi_A          159 AAIKEFAFMKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS----V--PDPASLYADLIALILRLAKHGLIHGD  230 (397)
T ss_dssp             HHHHHHHHHHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC----C--SCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc----c--HHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence            345688888888655554333322222  379999999988865321    2  23456889999999999999999999


Q ss_pred             CCCCCeeeecCCC-------CceEEEeecCCccccC
Q 030256           92 LKPENILLSGLDD-------DVMLKIADFGLSCTLY  120 (180)
Q Consensus        92 l~~~nil~~~~~~-------~~~~~l~d~~~~~~~~  120 (180)
                      |+|.|||+.....       ...+.|+||+.+-...
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9999999963111       1148999999765543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=2.6e-12  Score=92.17  Aligned_cols=99  Identities=17%  Similarity=0.203  Sum_probs=79.6

Q ss_pred             HHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----
Q 030256           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS----   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~----   84 (180)
                      ...+++|+++++.+ ++..+++++++....+..+++||+++|.+|.+.+.     +......++.+++.+++.||+    
T Consensus        53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~  127 (263)
T 3tm0_A           53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDIS  127 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcc
Confidence            45688999999998 46778899999998899999999999999977531     112334677889999999998    


Q ss_pred             -------------------------------------------------------CCCeeecCCCCCeeeecCCCCceEE
Q 030256           85 -------------------------------------------------------HHIIHRDLKPENILLSGLDDDVMLK  109 (180)
Q Consensus        85 -------------------------------------------------------~~~~h~dl~~~nil~~~~~~~~~~~  109 (180)
                                                                             .+++|||++|.||++.   .+..+.
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~  204 (263)
T 3tm0_A          128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSG  204 (263)
T ss_dssp             TCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEE
T ss_pred             cCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEE
Confidence                                                                   3489999999999994   344567


Q ss_pred             EeecCCc
Q 030256          110 IADFGLS  116 (180)
Q Consensus       110 l~d~~~~  116 (180)
                      |+||+.+
T Consensus       205 lIDwe~a  211 (263)
T 3tm0_A          205 FIDLGRS  211 (263)
T ss_dssp             ECCCTTC
T ss_pred             EEEchhc
Confidence            9999976

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.09  E-value=6.5e-11  Score=84.46  Aligned_cols=96  Identities=16%  Similarity=0.170  Sum_probs=71.6

Q ss_pred             HHHHHHHHHHhcCCCcc--ccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 030256           11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH--   86 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--   86 (180)
                      ..+.+|+.+++.+.+.+  +++++.+...++..+++||+++|.++.  ..   ..+.   ..++.+++..++.||+..  
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~  129 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPA  129 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGG
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCC
Confidence            45788999999985434  567888888778899999999998884  21   1222   245667777777777643  


Q ss_pred             --------------------------------------------------------CeeecCCCCCeeeecCCCCceEEE
Q 030256           87 --------------------------------------------------------IIHRDLKPENILLSGLDDDVMLKI  110 (180)
Q Consensus        87 --------------------------------------------------------~~h~dl~~~nil~~~~~~~~~~~l  110 (180)
                                                                              ++|||++|.||++.   .+..+.+
T Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~l  206 (264)
T 1nd4_A          130 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGF  206 (264)
T ss_dssp             GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEE
T ss_pred             CCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEE
Confidence                                                                    89999999999994   3445669


Q ss_pred             eecCCcc
Q 030256          111 ADFGLSC  117 (180)
Q Consensus       111 ~d~~~~~  117 (180)
                      +||+.+.
T Consensus       207 iD~~~a~  213 (264)
T 1nd4_A          207 IDCGRLG  213 (264)
T ss_dssp             CCCTTCE
T ss_pred             Ecchhcc
Confidence            9999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.00  E-value=4e-10  Score=84.36  Aligned_cols=105  Identities=14%  Similarity=0.323  Sum_probs=80.6

Q ss_pred             HHHHHHHHHHHhcCCC--ccccccceEEEeC---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 030256           10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+|+.+++.+..  ..+++++.++.+.   +..+++||+++|.++.+.  ....++......++.+++..++.||+
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence            4578889999999964  4578888887766   458999999999887531  12347788888899999999999997


Q ss_pred             ----------------------------------------------------------CCCeeecCCCCCeeeecCCCCc
Q 030256           85 ----------------------------------------------------------HHIIHRDLKPENILLSGLDDDV  106 (180)
Q Consensus        85 ----------------------------------------------------------~~~~h~dl~~~nil~~~~~~~~  106 (180)
                                                                                .+++|||+++.||++.. +...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~-~~~~  236 (359)
T 3dxp_A          158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHP-TEPR  236 (359)
T ss_dssp             SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECS-SSSC
T ss_pred             CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeC-CCCc
Confidence                                                                      35899999999999952 1123


Q ss_pred             eEEEeecCCcc
Q 030256          107 MLKIADFGLSC  117 (180)
Q Consensus       107 ~~~l~d~~~~~  117 (180)
                      .+.++||+.+.
T Consensus       237 v~~viDwe~a~  247 (359)
T 3dxp_A          237 VLAVLDWELST  247 (359)
T ss_dssp             EEEECCCTTCE
T ss_pred             EEEEECccccc
Confidence            46899999764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=3.7e-10  Score=82.72  Aligned_cols=157  Identities=22%  Similarity=0.259  Sum_probs=98.4

Q ss_pred             HHHHHHHHHHHHhcC-CCcc--ccccceEEEeCC---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSV-NHPN--IIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ....+.+|.++++.+ .+..  +++++......+   ..++||++++|.++.....  ..++.++...++.+++..++.|
T Consensus        53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~L  130 (304)
T 3sg8_A           53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSEL  130 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHH
Confidence            456789999999888 4444  344444433332   3478999999998875332  3567777788888888888888


Q ss_pred             Hh----------------------------------------------------------CCCeeecCCCCCeeeecCCC
Q 030256           83 NS----------------------------------------------------------HHIIHRDLKPENILLSGLDD  104 (180)
Q Consensus        83 h~----------------------------------------------------------~~~~h~dl~~~nil~~~~~~  104 (180)
                      |+                                                          ..++|||++|.||++... .
T Consensus       131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~  209 (304)
T 3sg8_A          131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-K  209 (304)
T ss_dssp             HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-T
T ss_pred             HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-C
Confidence            85                                                          136999999999999621 1


Q ss_pred             CceEEEeecCCccccCCCCcccccccCccccCccccc----cc-c---------CCcchhHHHHHHHHHHHHhCCCCC
Q 030256          105 DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ----FQ-R---------YDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus       105 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~----~~-~---------~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      ...+.++||+.+..-..............-.+|+...    .. .         .....+.|+++.+++.+.+|..+|
T Consensus       210 ~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          210 NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            4567899999875432111000000000001222111    00 0         112258999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.74  E-value=4.4e-08  Score=70.30  Aligned_cols=109  Identities=14%  Similarity=0.168  Sum_probs=76.8

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~   80 (180)
                      ||.........+.+|...|+.+. +--+++++.+..+.+..+++|++++|.++.+.....    ......+..++...++
T Consensus        55 lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~  130 (272)
T 4gkh_A           55 LKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLR  130 (272)
T ss_dssp             EEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHH
T ss_pred             EEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHH
Confidence            44444455667889999999883 334788899999999999999999998887754321    1122334445555555


Q ss_pred             HHHhC----------------------------------------------------------CCeeecCCCCCeeeecC
Q 030256           81 ILNSH----------------------------------------------------------HIIHRDLKPENILLSGL  102 (180)
Q Consensus        81 ~lh~~----------------------------------------------------------~~~h~dl~~~nil~~~~  102 (180)
                      .||..                                                          .++|||+++.||++.  
T Consensus       131 ~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~--  208 (272)
T 4gkh_A          131 RLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD--  208 (272)
T ss_dssp             HHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE--
T ss_pred             HhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE--
Confidence            55531                                                          158999999999994  


Q ss_pred             CCCceEEEeecCCcc
Q 030256          103 DDDVMLKIADFGLSC  117 (180)
Q Consensus       103 ~~~~~~~l~d~~~~~  117 (180)
                       ....+.|+||+.+.
T Consensus       209 -~~~~~~viDwe~a~  222 (272)
T 4gkh_A          209 -EGKLIGCIDVGRVG  222 (272)
T ss_dssp             -TTEEEEECCCTTCE
T ss_pred             -CCeEEEEEECcccc
Confidence             45566799999764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.53  E-value=8.7e-07  Score=64.89  Aligned_cols=109  Identities=20%  Similarity=0.216  Sum_probs=71.7

Q ss_pred             HHHHHHHHHHHHHhcCCCc---cccccceEEE-eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHP---NIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      .....+.+|.++++.+.+.   .+++++.+.. ..+..+++|++++|.++....  -..++......++.++...++.||
T Consensus        51 ~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH  128 (306)
T 3tdw_A           51 QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDG--MAVLPDDAKDRLALQLAEFMNELS  128 (306)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHh
Confidence            3456789999999999642   3667777664 345678999999998887632  122344444444444444444444


Q ss_pred             hC------------------------------------------------------------CCeeecCCCCCeeeecCC
Q 030256           84 SH------------------------------------------------------------HIIHRDLKPENILLSGLD  103 (180)
Q Consensus        84 ~~------------------------------------------------------------~~~h~dl~~~nil~~~~~  103 (180)
                      +.                                                            .++|+|++|.|+++....
T Consensus       129 ~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~  208 (306)
T 3tdw_A          129 AFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS  208 (306)
T ss_dssp             HSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC
T ss_pred             cCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC
Confidence            32                                                            358999999999995211


Q ss_pred             CCce-EEEeecCCccc
Q 030256          104 DDVM-LKIADFGLSCT  118 (180)
Q Consensus       104 ~~~~-~~l~d~~~~~~  118 (180)
                      ..+. +.|+||+.+..
T Consensus       209 ~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          209 RQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             SSCCEEEECCCTTCEE
T ss_pred             CCCceEEEEehhhcCC
Confidence            2344 57999997643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.00  E-value=4.7e-06  Score=62.06  Aligned_cols=44  Identities=14%  Similarity=0.139  Sum_probs=32.1

Q ss_pred             HHHHHHHHHHhcCC-C--ccccccceEEEeC---CeEEEEEeccCCCChH
Q 030256           11 SCLDCELNFLSSVN-H--PNIIRLFDAFQAE---NCIFLVVEFCAGGNLS   54 (180)
Q Consensus        11 ~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~   54 (180)
                      ..+.+|+.+++.+. +  -.+++++.+..+.   +..+++||+++|.++.
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            45788999998884 2  3567788776654   3568999999986653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.79  E-value=8e-05  Score=54.82  Aligned_cols=30  Identities=20%  Similarity=0.357  Sum_probs=25.4

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      .+++|||+++.||++.   .+..+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~---~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLG---ENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEEC---GGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEe---CCCcEEEEehhhcc
Confidence            5799999999999993   45679999999763

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.34  E-value=0.00018  Score=52.95  Aligned_cols=34  Identities=21%  Similarity=0.273  Sum_probs=25.3

Q ss_pred             CCCeeecCCCCCeeeecCCC-CceEEEeecCCccc
Q 030256           85 HHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCT  118 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~-~~~~~l~d~~~~~~  118 (180)
                      ..++|||+.+.||++..... ...+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            46899999999999952110 25689999997643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.25  E-value=0.00041  Score=50.39  Aligned_cols=29  Identities=28%  Similarity=0.160  Sum_probs=23.0

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      .++|+|+.+.|++.    .++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil~----~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFLD----TGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEEE----CSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEEE----CCCCEEEEecccccC
Confidence            37999999999995    344579999987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.02  E-value=0.0017  Score=48.93  Aligned_cols=29  Identities=28%  Similarity=0.389  Sum_probs=23.5

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      ..++|||+.+.||++.   . ..+.++||..+.
T Consensus       227 ~~L~HGDl~~~Nil~~---~-~~~~lID~e~a~  255 (397)
T 2olc_A          227 ETLIHGDLHTGSIFAS---E-HETKVIDPEFAF  255 (397)
T ss_dssp             CEEECSCCSGGGEEEC---S-SCEEECCCTTCE
T ss_pred             CceeeCCCCcCcEEEe---C-CCeEEEeCcccc
Confidence            5689999999999994   2 248999997654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.74  E-value=0.015  Score=40.31  Aligned_cols=102  Identities=20%  Similarity=0.156  Sum_probs=59.8

Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccc
Q 030256           50 GGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK  127 (180)
Q Consensus        50 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~  127 (180)
                      ..+|.+.+... .++++++++.++.|.+..+...-. +.-...=+.|..|++.   .++.|-+.+ .       ...   
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~-------~s~---   97 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-A-------ADD---   97 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C-------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-c-------ccc---
Confidence            45788888754 579999999999999998877632 1111223344666663   344444332 1       100   


Q ss_pred             cccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256          128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus       128 ~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                       .....+.|||... ...+.+.=|||||.++|..+--..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             1233466887753 3446778899999999988875444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.56  E-value=0.0016  Score=49.02  Aligned_cols=103  Identities=19%  Similarity=0.214  Sum_probs=59.8

Q ss_pred             HHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHH--------------HHH---hc-CC----CC--H
Q 030256           11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSS--------------YIR---LH-GR----VP--E   65 (180)
Q Consensus        11 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~--------------~l~---~~-~~----~~--~   65 (180)
                      ....+|.++++.+. +.-.+++++.+.+  .  +|++|++|.+|..              .+.   .. .+    ..  .
T Consensus        98 ~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~  173 (379)
T 3feg_A           98 DSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLF  173 (379)
T ss_dssp             HHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHH
Confidence            34557989888884 3233666655543  2  8999999865531              111   00 11    11  3


Q ss_pred             HHHHHHHHHHHH-------------------HHHHH----Hh----CCCeeecCCCCCeeeecC-CCCceEEEeecCCcc
Q 030256           66 QTARKFLQQLGA-------------------GLEIL----NS----HHIIHRDLKPENILLSGL-DDDVMLKIADFGLSC  117 (180)
Q Consensus        66 ~~~~~~~~~i~~-------------------~l~~l----h~----~~~~h~dl~~~nil~~~~-~~~~~~~l~d~~~~~  117 (180)
                      .++.++..++..                   .+..|    ..    ..++|+|+.+.||++... +....+.++||..+.
T Consensus       174 ~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          174 GTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            455555554422                   12232    22    248999999999999632 113578999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.06  E-value=0.01  Score=43.48  Aligned_cols=71  Identities=13%  Similarity=0.155  Sum_probs=52.6

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcCC---CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG   78 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~   78 (180)
                      ||.........+.+|.+.|+.|.   ...+++++.+....+..+++||+++|.++..              ....++...
T Consensus        64 lK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~--------------~~~~~lG~~  129 (312)
T 3jr1_A           64 VKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ--------------SSFTIFAEK  129 (312)
T ss_dssp             EEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT--------------THHHHHHHH
T ss_pred             EEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc--------------hhHHHHHHH
Confidence            34443444667889999998883   3568899988888889999999999876521              234577888


Q ss_pred             HHHHHhCC
Q 030256           79 LEILNSHH   86 (180)
Q Consensus        79 l~~lh~~~   86 (180)
                      |+.||..+
T Consensus       130 LA~LH~~~  137 (312)
T 3jr1_A          130 IAQLHQIQ  137 (312)
T ss_dssp             HHHHHHCC
T ss_pred             HHHHHcCC
Confidence            88999853

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.36  E-value=0.014  Score=44.31  Aligned_cols=32  Identities=22%  Similarity=0.428  Sum_probs=25.5

Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccc
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~  118 (180)
                      +...++|||++|.||++.   .+. +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~---~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVT---QDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEEC---SSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEe---CCC-CEEEeCccccc
Confidence            456799999999999994   333 89999987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.03  E-value=0.025  Score=41.13  Aligned_cols=30  Identities=30%  Similarity=0.598  Sum_probs=23.8

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      .+++|+|+++.||++.   .+..+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFL---GDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence            3689999999999995   34445799998663

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.63  E-value=0.068  Score=38.91  Aligned_cols=28  Identities=25%  Similarity=0.192  Sum_probs=23.1

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      ..++|||+++.||++.    + .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~----~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR----D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES----S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc----C-CCEEEECCCCC
Confidence            3588999999999994    2 78999998653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.15  E-value=0.068  Score=39.41  Aligned_cols=30  Identities=20%  Similarity=0.386  Sum_probs=24.6

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      .+++|||+.+.|+++.   .++.+.++||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVG---NEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEEC---GGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEe---CCCeEEEEECCCCe
Confidence            3589999999999994   45678999998654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.25  E-value=0.12  Score=38.49  Aligned_cols=28  Identities=32%  Similarity=0.516  Sum_probs=22.4

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      +++|+|+.+.||++.   . ..+.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~---~-~~~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINT---N-KCLRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEEC---C--CEEECCCTTCE
T ss_pred             EEEeCCCCcccEEec---C-CcEEEEEecCCC
Confidence            589999999999984   2 348999998663

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.94  E-value=0.19  Score=38.79  Aligned_cols=36  Identities=25%  Similarity=0.330  Sum_probs=24.7

Q ss_pred             HHHHHHHhcCCCccc-cccceEEEeCCeEEEEEeccCCCCh
Q 030256           14 DCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL   53 (180)
Q Consensus        14 ~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L   53 (180)
                      .+|..+++.|...++ +++++.+  .+.  .+++|++|.+|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCccC
Confidence            578888888865444 6666665  333  49999987544

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=90.94  E-value=1.3  Score=31.48  Aligned_cols=39  Identities=10%  Similarity=0.020  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHhcCCC-cc--ccccceEEEeCCeEEEEEeccCCCCh
Q 030256           11 SCLDCELNFLSSVNH-PN--IIRLFDAFQAENCIFLVVEFCAGGNL   53 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h-~~--iv~~~~~~~~~~~~~lv~e~~~~~~L   53 (180)
                      ..+++|.+.|+.|.. ..  +++++.+  +..  +++||++++...
T Consensus        56 ~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~--~lv~e~l~~~~~   97 (288)
T 3f7w_A           56 GLFRAEALGLDWLGRSFGSPVPQVAGW--DDR--TLAMEWVDERPP   97 (288)
T ss_dssp             THHHHHHHHHHHHTCSTTCCSCCEEEE--ETT--EEEEECCCCCCC
T ss_pred             hHHHHHHHHHHHHHhhCCCCcceEEec--cCc--eEEEEeecccCC
Confidence            457889999998842 23  3444443  333  678999887654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.16  E-value=0.17  Score=38.16  Aligned_cols=31  Identities=32%  Similarity=0.396  Sum_probs=24.7

Q ss_pred             CeeecCCCCCeeeecC---CCCceEEEeecCCcc
Q 030256           87 IIHRDLKPENILLSGL---DDDVMLKIADFGLSC  117 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~---~~~~~~~l~d~~~~~  117 (180)
                      ++|+|+.+.||++...   +....+.++||..+.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6899999999999531   345669999999774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=89.12  E-value=0.11  Score=39.73  Aligned_cols=39  Identities=18%  Similarity=0.280  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHhcCCCccc-cccceEEEeCCeEEEEEeccCCCCh
Q 030256           11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL   53 (180)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L   53 (180)
                      +.+.+|..+++.+...++ +++++.+.  +.  ++++|++|.++
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~--~g--~v~e~l~G~~l  159 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFS--GG--RLEEYIPSRPL  159 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEET--TE--EEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeC--CC--EEEEEeCCccc
Confidence            345578888888843333 66666543  32  89999987443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.84  E-value=5.2  Score=27.49  Aligned_cols=82  Identities=11%  Similarity=0.147  Sum_probs=57.4

Q ss_pred             CCccccccceEEEeCCeEEEEEeccC-CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecC
Q 030256           24 NHPNIIRLFDAFQAENCIFLVVEFCA-GGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL  102 (180)
Q Consensus        24 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~  102 (180)
                      .||++++. ..-.+.+.+.+.++.-+ +-++..    -...+....++++..|+....++  ..=+|--++|+|+++   
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f---  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFF---  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEE---
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEE---
Confidence            68888877 46666777777777543 222322    34578889999999998877333  335688999999999   


Q ss_pred             CCCceEEEeecCC
Q 030256          103 DDDVMLKIADFGL  115 (180)
Q Consensus       103 ~~~~~~~l~d~~~  115 (180)
                      +.+..+++.--|+
T Consensus       113 ~~~~~p~i~~RGi  125 (215)
T 4ann_A          113 TRDGLPIAKTRGL  125 (215)
T ss_dssp             CTTSCEEESCCEE
T ss_pred             cCCCCEEEEEccC
Confidence            5777777765554

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.25  E-value=9.3  Score=26.31  Aligned_cols=82  Identities=13%  Similarity=0.094  Sum_probs=57.3

Q ss_pred             CCccccccceEEEeCCeEEEEEeccC-CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecC
Q 030256           24 NHPNIIRLFDAFQAENCIFLVVEFCA-GGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL  102 (180)
Q Consensus        24 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~  102 (180)
                      .||++  ....-.+++.+.+.++.-+ +-++...    ..++....++++..++..... |...-+|--++|+|+++   
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f---  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMF---  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEE---
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEE---
Confidence            67877  4444567788888887652 2333332    457888888888888876551 23556788999999999   


Q ss_pred             CCCceEEEeecCC
Q 030256          103 DDDVMLKIADFGL  115 (180)
Q Consensus       103 ~~~~~~~l~d~~~  115 (180)
                      +.+..+++.-.|+
T Consensus       118 ~~~~~p~i~hRGi  130 (219)
T 4ano_A          118 NRALEPFFLHVGV  130 (219)
T ss_dssp             CTTCCEEESCCEE
T ss_pred             eCCCcEEEEEcCC
Confidence            5777888876664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	180
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-54
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-51
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-48
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-47
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-45
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-43
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-43
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-41
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-40
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-39
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-39
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-38
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-35
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-15

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 5e-54
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 10/178 (5%)

Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK L K       ++  L  E+   S + HPNI+RL+  F     ++L++E+   G +  
Sbjct: 36  LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            ++   +  EQ    ++ +L   L   +S  +IHRD+KPEN+L   L     LKIADFG 
Sbjct: 96  ELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGW 152

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           S    P +    +CG+  Y+ PE+++ + +DEKVD+WS+G + +E L G PPF A   
Sbjct: 153 SVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 7e-54
 Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 5/171 (2%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +  ++   +++ +  EL  L   N P I+  + AF ++  I + +E   GG+L   ++  
Sbjct: 39  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 98

Query: 61  GRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           GR+PEQ   K    +  GL  L   H I+HRD+KP NIL   ++    +K+ DFG+S  L
Sbjct: 99  GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQL 155

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              + A    G+  YM+PE LQ   Y  + D+WS+G  L E+  G  P   
Sbjct: 156 -IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (433), Expect = 8e-54
 Identities = 64/173 (36%), Positives = 100/173 (57%), Gaps = 4/173 (2%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K      +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I
Sbjct: 39  IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
              G   E+ A + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS 
Sbjct: 99  VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
              PG+     CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF  
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  171 bits (433), Expect = 2e-53
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 2/171 (1%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
            +   ++  K  +  E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   
Sbjct: 58  FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           H ++ E  A ++++Q+  GL  ++ ++ +H DLKPENI+ +       LK+ DFGL+  L
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-TKRSNELKLIDFGLTAHL 176

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            P    +   G+  + APEV + +      DMWSVG + + LL+G  PF  
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 3e-52
 Identities = 57/173 (32%), Positives = 98/173 (56%), Gaps = 10/173 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
           +KL K  +     E   L  + HPNI+R +D++++    + CI LV E    G L +Y++
Sbjct: 45  RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 104

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
               +  +  R + +Q+  GL+ L++    IIHRDLK +NI ++       +KI D GL+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
            TL   ++A+ V G+P +MAPE+ + ++YDE VD+++ G  + E+     P+S
Sbjct: 163 -TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 213

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (425), Expect = 5e-52
 Identities = 51/176 (28%), Positives = 91/176 (51%), Gaps = 5/176 (2%)

Query: 2   LKKLNKHL---KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
            K +N      K  +  E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I 
Sbjct: 59  AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118

Query: 59  LHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
               ++ E     +++Q   GL+ ++ H I+H D+KPENI+         +KI DFGL+ 
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT 177

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            L P    +    +  + APE++  +      DMW++G + + LL+G  PF+    
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-51
 Identities = 62/182 (34%), Positives = 96/182 (52%), Gaps = 13/182 (7%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
            K ++   +  L+    E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + + 
Sbjct: 42  AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
            L   + E   +   +Q    L  L+ + IIHRDLK  NIL      D  +K+ADFG+S 
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL---FTLDGDIKLADFGVSA 158

Query: 118 TLY-PGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
                    +   G+P +MAPEV+       + YD K D+WS+G  L E+    PP    
Sbjct: 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218

Query: 172 RP 173
            P
Sbjct: 219 NP 220

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-51
 Identities = 57/178 (32%), Positives = 96/178 (53%), Gaps = 12/178 (6%)

Query: 2   LKKLNKHL------KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K           +  E + +S ++HP  ++L+  FQ +  ++  + +   G L  
Sbjct: 38  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YIR  G   E   R +  ++ + LE L+   IIHRDLKPENIL   L++D+ ++I DFG 
Sbjct: 98  YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGT 154

Query: 116 SCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           +  L P +    A    G+  Y++PE+L  +   +  D+W++G I+++L+ G PPF A
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-50
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 11/179 (6%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LH 60
           +             E+  L    H NI+     +     + +V ++C G +L  ++  + 
Sbjct: 40  VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIE 98

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            +          +Q   G++ L++  IIHRDLK  NI    L +D+ +KI DFGL+    
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKS 155

Query: 121 PGNYAEK---VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             + + +   + GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S    
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (410), Expect = 3e-50
 Identities = 56/181 (30%), Positives = 85/181 (46%), Gaps = 15/181 (8%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +KK++   K   +       E+ FL  + HPN I+    +  E+  +LV+E+C G     
Sbjct: 45  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
                  + E            GL  L+SH++IHRD+K  NIL   L +  ++K+ DFG 
Sbjct: 105 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL---LSEPGLVKLGDFGS 161

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSAYR 172
           +  + P N      G+P +MAPEV+      +YD KVD+WS+G    EL    PP     
Sbjct: 162 ASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Query: 173 P 173
            
Sbjct: 219 A 219

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-49
 Identities = 50/174 (28%), Positives = 91/174 (52%), Gaps = 5/174 (2%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            +    +  K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +   
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-E 110

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
             + E       ++    LE L+S+ +IHRD+K +NILL     D  +K+ DFG    + 
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 167

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
              +    + G+P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+    P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 7e-49
 Identities = 50/175 (28%), Positives = 88/175 (50%), Gaps = 4/175 (2%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
            K +         +  E++ L+   H NI+ L ++F++   + ++ EF +G ++   I  
Sbjct: 35  AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94

Query: 60  HG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
               + E+    ++ Q+   L+ L+SH+I H D++PENI+         +KI +FG +  
Sbjct: 95  SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQ 153

Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           L PG+    +  +P Y APEV Q        DMWS+G +++ LL+G  PF A   
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-48
 Identities = 59/172 (34%), Positives = 93/172 (54%), Gaps = 7/172 (4%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +  K        +  E+     +NH N+++ +   +  N  +L +E+C+GG L   I   
Sbjct: 38  VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 97

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
             +PE  A++F  QL AG+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+    
Sbjct: 98  IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFR 154

Query: 121 PGNYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
             N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-48
 Identities = 60/184 (32%), Positives = 98/184 (53%), Gaps = 15/184 (8%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI-- 57
              + +  K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I  
Sbjct: 39  YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98

Query: 58  --RLHGRVPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
             +    + E+   + + QL   L+         H ++HRDLKP N+ L   D    +K+
Sbjct: 99  GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 155

Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
            DFGL+  L     +A+   G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215

Query: 170 AYRP 173
           A+  
Sbjct: 216 AFSQ 219

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-47
 Identities = 62/178 (34%), Positives = 99/178 (55%), Gaps = 7/178 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL    +   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 42  LKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 100

Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 101 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF +   
Sbjct: 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  152 bits (386), Expect = 4e-47
 Identities = 68/175 (38%), Positives = 100/175 (57%), Gaps = 10/175 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
            +  + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+    
Sbjct: 46  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 105

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + E+  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L P
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDP 162

Query: 122 GNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           G    +VCG+P Y+APE+++         Y ++VDMWS G I++ LL G PPF  
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 9e-45
 Identities = 60/180 (33%), Positives = 93/180 (51%), Gaps = 11/180 (6%)

Query: 2   LKKLNKHLKSCLDCELNFL-------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K L K +    D     +        +  HP +  +F  FQ +  +F V+E+  GG+L 
Sbjct: 32  IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91

Query: 55  SYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +I+   +     A  +  ++  GL+ L+S  I++RDLK +NIL   LD D  +KIADFG
Sbjct: 92  YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFG 148

Query: 115 LSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +      G+      CG+P Y+APE+L  Q+Y+  VD WS G +L+E+L G  PF     
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 4e-44
 Identities = 55/159 (34%), Positives = 93/159 (58%), Gaps = 1/159 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL+Q+
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L+S  I H DLKPENI+L   +     +KI DFGL+  +  GN  + + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +APE++ ++    + DMWS+G I + LL+G  PF     
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  145 bits (366), Expect = 1e-43
 Identities = 67/178 (37%), Positives = 99/178 (55%), Gaps = 11/178 (6%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K +   L        E   LS V HP IIR++  FQ    IF+++++  GG L S
Sbjct: 34  MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            +R   R P   A+ +  ++   LE L+S  II+RDLKPENIL   LD +  +KI DFG 
Sbjct: 94  LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGF 150

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +  +    Y   +CG+P Y+APEV+  + Y++ +D WS G +++E+L GY PF     
Sbjct: 151 AKYVPDVTY--TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-43
 Identities = 43/174 (24%), Positives = 84/174 (48%), Gaps = 10/174 (5%)

Query: 2   LKKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL 59
           +K +           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R 
Sbjct: 35  VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94

Query: 60  HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
            GR  +      KF   +   +E L  ++ +HRDL   N+L+    +D + K++DFGL+ 
Sbjct: 95  RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSA 170
                   +       + APE L+ +++  K D+WS G +L+E+   G  P+  
Sbjct: 152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  143 bits (362), Expect = 2e-43
 Identities = 47/183 (25%), Positives = 85/183 (46%), Gaps = 11/183 (6%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGG 51
           +K L   L            E    +++NHP I+ ++D  +AE       ++V+E+  G 
Sbjct: 37  VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKI 110
            L   +   G +  + A + +      L   + + IIHRD+KP NI++S  +   VM   
Sbjct: 97  TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
               ++ +         V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+ 
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216

Query: 171 YRP 173
             P
Sbjct: 217 DSP 219

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-42
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 9/176 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +  +  LK  L  E N +  +++P I+R+    +AE+   LV+E    G L+ Y++ +  
Sbjct: 45  EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH 103

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           V ++   + + Q+  G++ L   + +HRDL   N+L   L      KI+DFGLS  L   
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALRAD 160

Query: 123 NYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRP 173
               K          + APE + + ++  K D+WS G +++E  + G  P+   + 
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-42
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 8/177 (4%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IR 58
           +K + +   S  D   E   +  ++HP +++L+     +  I LV EF   G LS Y   
Sbjct: 34  IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT 93

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
             G    +T       +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  
Sbjct: 94  QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRF 150

Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +    Y           + +PEV  F RY  K D+WS G +++E+ +        R 
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  143 bits (361), Expect = 2e-42
 Identities = 52/159 (32%), Positives = 89/159 (55%), Gaps = 5/159 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
            L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++
Sbjct: 57  MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
             GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YM
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYM 172

Query: 136 APEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           APEVLQ    YD   D +S+G +LF+LL G+ PF  ++ 
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-42
 Identities = 43/178 (24%), Positives = 85/178 (47%), Gaps = 9/178 (5%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K + +   S  +   E   + +++H  +++L+     +  IF++ E+ A G L +Y+R 
Sbjct: 33  IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 92

Query: 60  -HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
              R   Q   +  + +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  
Sbjct: 93  MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRY 149

Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSAYRP 173
           +    Y           +  PEVL + ++  K D+W+ G +++E+   G  P+  +  
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 4e-41
 Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 10/179 (5%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + +   K     +  E   +  +++P I+RL    QAE  + LV+E   GG L  ++   
Sbjct: 44  LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK 102

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              +P     + L Q+  G++ L   + +HRDL   N+L   L +    KI+DFGLS  L
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKAL 159

Query: 120 YPGNYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRP 173
              +              + APE + F+++  + D+WS G  ++E L+ G  P+   + 
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (345), Expect = 1e-40
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 11/181 (6%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +     +  +     E + +   +HPN+I L         + ++ EF   G+L S++R +
Sbjct: 62  LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
            G+         L+ + AG++ L   + +HRDL   NIL   ++ +++ K++DFGLS  L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFL 178

Query: 120 YPGNYAEKV------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYR 172
                               + APE +Q++++    D+WS G +++E+++ G  P+    
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238

Query: 173 P 173
            
Sbjct: 239 N 239

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-40
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 7/162 (4%)

Query: 16  ELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFL 72
           E+  L  V+     +IRL D F+  +   L++E      +L  +I   G + E+ AR F 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   +   ++  ++HRD+K ENIL+    +   LK+ DFG    L          G+ 
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA-LLKDTVYTDFDGTR 173

Query: 133 LYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +Y  PE +++ RY      +WS+G +L++++ G  PF     
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-40
 Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 11/179 (6%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L +   S      E N +  + H  ++RL+     +  I+++ E+   G+L  +++ 
Sbjct: 42  VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT 100

Query: 60  HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
              +            Q+  G+  +   + IHRDL+  NIL   + D +  KIADFGL+ 
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL---VSDTLSCKIADFGLAR 157

Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSAYRP 173
            +    Y  +        + APE + +  +  K D+WS G +L E++ +G  P+     
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 5e-40
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 10/176 (5%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K +    D       E   L +  HP +  L  AFQ  + +  V+E+  GG L  
Sbjct: 35  MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           ++       E+ AR +  ++ + LE L+S  +++RD+K EN++   LD D  +KI DFGL
Sbjct: 95  HLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGL 151

Query: 116 SCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                  G   +  CG+P Y+APEVL+   Y   VD W +G +++E++ G  PF  
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-39
 Identities = 61/179 (34%), Positives = 87/179 (48%), Gaps = 13/179 (7%)

Query: 2   LKKLNKHLKSCLD--------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL 53
           +KK+    +S            E+  L  ++HPNII L DAF  ++ I LV +F      
Sbjct: 28  IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE 87

Query: 54  SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
                    +     + ++     GLE L+ H I+HRDLKP N+L   LD++ +LK+ADF
Sbjct: 88  VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADF 144

Query: 114 GLSCTLYPGNYAEK-VCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           GL+ +    N A      +  Y APE+L   + Y   VDMW+VG IL ELL   P    
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-39
 Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 13/182 (7%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
           +KK+ +  K   + EL  +  ++H NI+RL   F      + E  + LV+++        
Sbjct: 50  IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108

Query: 56  ---YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
              Y R    +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ D
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD 166

Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAP-EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
           FG +  L  G        S  Y AP  +     Y   +D+WS G +L ELL G P F   
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

Query: 172 RP 173
             
Sbjct: 227 SG 228

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-39
 Identities = 51/191 (26%), Positives = 79/191 (41%), Gaps = 21/191 (10%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           M +  +K        EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R 
Sbjct: 45  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104

Query: 60  H----------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
                              +  Q    F   +  G++ L+    IHRDL   NIL+    
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---G 161

Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL- 162
           ++ + KIADFGLS                 +MA E L +  Y    D+WS G +L+E++ 
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221

Query: 163 NGYPPFSAYRP 173
            G  P+     
Sbjct: 222 LGGTPYCGMTC 232

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 5e-39
 Identities = 50/184 (27%), Positives = 77/184 (41%), Gaps = 16/184 (8%)

Query: 2   LKKLNKHLKS------CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L   + S          E+N + S++H N+IRL+        + +V E    G+L  
Sbjct: 41  VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLD 99

Query: 56  YIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +R H G     T  ++  Q+  G+  L S   IHRDL   N+L   L    ++KI DFG
Sbjct: 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL---LATRDLVKIGDFG 156

Query: 115 LSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
           L   L   +      E       + APE L+ + +    D W  G  L+E+   G  P+ 
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

Query: 170 AYRP 173
               
Sbjct: 217 GLNG 220

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 9e-39
 Identities = 42/179 (23%), Positives = 79/179 (44%), Gaps = 11/179 (6%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L     S      E   +  + H  +++L+     E  I++V E+ + G+L  +++ 
Sbjct: 46  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG 104

Query: 60  HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
                           Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+ 
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 161

Query: 118 TLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSAYRP 173
            +    Y   +       + APE   + R+  K D+WS G +L EL   G  P+     
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  132 bits (333), Expect = 1e-38
 Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 9/173 (5%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIR 58
           +K L    K  +  E+  L ++   PNII L D  +        LV E     +     +
Sbjct: 65  VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
               + +   R ++ ++   L+  +S  I+HRD+KP N+++    +   L++ D+GL+  
Sbjct: 125 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEF 179

Query: 119 LYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            +PG        S  +  PE+ + +Q YD  +DMWS+G +L  ++    PF  
Sbjct: 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-38
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 31/201 (15%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           + +K +   +  L  EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R 
Sbjct: 75  LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134

Query: 60  H-----------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN 96
                                     +  +    F  Q+  G+E L     +HRDL   N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194

Query: 97  ILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWS 153
           +L   +    ++KI DFGL+  +   +             +MAPE L    Y  K D+WS
Sbjct: 195 VL---VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251

Query: 154 VGAILFELLN-GYPPFSAYRP 173
            G +L+E+ + G  P+     
Sbjct: 252 YGILLWEIFSLGVNPYPGIPV 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 3e-38
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 8/162 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E   +   +HP+I++L      EN +++++E C  G L S++      +   +   +  Q
Sbjct: 58  EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSP 132
           L   L  L S   +HRD+   N+L   +  +  +K+ DFGLS  +    Y  A K     
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSAYRP 173
            +MAPE + F+R+    D+W  G  ++E+L +G  PF   + 
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 4e-38
 Identities = 39/162 (24%), Positives = 65/162 (40%), Gaps = 7/162 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   ++SV++P++ RL           +      G  L         +  Q    +  Q+
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
             G+  L    ++HRDL   N+L   +     +KI DFGL+  L        AE      
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRP 173
            +MA E +  + Y  + D+WS G  ++EL+  G  P+     
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (326), Expect = 4e-38
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 9/173 (5%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L +      +   E   +  + HPN+++L      E   +++ EF   GNL  Y+R 
Sbjct: 47  VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106

Query: 60  HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
             R  V          Q+ + +E L   + IHRDL   N L   + ++ ++K+ADFGLS 
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSR 163

Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
            +    Y           + APE L + ++  K D+W+ G +L+E+       
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 8e-38
 Identities = 56/164 (34%), Positives = 78/164 (47%), Gaps = 9/164 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTAR 69
            L  L +  HPN++RLFD         E  + LV E       +   ++    VP +T +
Sbjct: 60  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             + QL  GL+ L+SH ++HRDLKP+NIL+        +K+ADFGL+           V 
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVV 176

Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
            +  Y APEVL    Y   VD+WSVG I  E+    P F     
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-37
 Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 15/184 (8%)

Query: 2   LKKLNKHLK----SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSY 56
           +K LN+       S    E   +   +HPN++ L     ++E    +V+ +   G+L ++
Sbjct: 60  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 57  IRLHGRVP-EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           IR     P  +    F  Q+  G++ L S   +HRDL   N +L   D+   +K+ADFGL
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGL 176

Query: 116 SCTLYPGNYAEK-----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
           +  +Y   +              +MA E LQ Q++  K D+WS G +L+EL+  G PP+ 
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

Query: 170 AYRP 173
               
Sbjct: 237 DVNT 240

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-37
 Identities = 42/186 (22%), Positives = 76/186 (40%), Gaps = 17/186 (9%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNL 53
           ++   +        E+  L  + H N++ L +  +         +  I+LV +FC     
Sbjct: 45  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104

Query: 54  SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
                +  +      ++ +Q L  GL  ++ + I+HRD+K  N+L   +  D +LK+ADF
Sbjct: 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADF 161

Query: 114 GLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP 167
           GL+           N       +  Y  PE+L  +R Y   +D+W  G I+ E+    P 
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

Query: 168 FSAYRP 173
                 
Sbjct: 222 MQGNTE 227

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  127 bits (320), Expect = 4e-37
 Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 5/174 (2%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E              G
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG 95

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
            +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+     
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFGI 152

Query: 121 PGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           P         +  Y AP+VL   ++Y   +D+WSVG I  E++NG P F     
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-36
 Identities = 54/176 (30%), Positives = 84/176 (47%), Gaps = 6/176 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLH 60
           L    + + S    E++ L  +NHPNI++L D    EN ++LV EF              
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL 96

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
             +P    + +L QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFG 153

Query: 121 -PGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSAYRPC 174
            P         +  Y APE+L   +Y    VD+WS+G I  E++     F      
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-36
 Identities = 39/192 (20%), Positives = 70/192 (36%), Gaps = 27/192 (14%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSS 55
           +K  +   +     + E+     + H NI+    A   +N     ++LV ++   G+L  
Sbjct: 31  VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 90

Query: 56  YIRLHGRVPEQTARKFLQQLGA-------GLEILNSHHIIHRDLKPENILLSGLDDDVML 108
           Y+  +    E   +  L             +       I HRDLK +NIL   +  +   
Sbjct: 91  YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTC 147

Query: 109 KIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAI 157
            IAD GL+                  G+  YMAPEVL            ++ D++++G +
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207

Query: 158 LFELLNGYPPFS 169
            +E+        
Sbjct: 208 FWEIARRCSIGG 219

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 2e-36
 Identities = 59/178 (33%), Positives = 104/178 (58%), Gaps = 11/178 (6%)

Query: 2   LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L+K     L        E   L +VN P +++L  +F+  + +++V+E+ AGG + S
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           ++R  GR  E  AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG 
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGF 187

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
           +  +    +   +CG+P  +APE++  + Y++ VD W++G +++E+  GYPPF A +P
Sbjct: 188 AKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (313), Expect = 5e-36
 Identities = 45/204 (22%), Positives = 88/204 (43%), Gaps = 35/204 (17%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K L +   + +      E   ++  ++PNI++L         + L+ E+ A G+L+ ++
Sbjct: 48  VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 107

Query: 58  RLHGR------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93
           R                            +         +Q+ AG+  L+    +HRDL 
Sbjct: 108 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167

Query: 94  PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVD 150
             N L   + +++++KIADFGLS  +Y  +Y +          +M PE + + RY  + D
Sbjct: 168 TRNCL---VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224

Query: 151 MWSVGAILFELLN-GYPPFSAYRP 173
           +W+ G +L+E+ + G  P+     
Sbjct: 225 VWAYGVVLWEIFSYGLQPYYGMAH 248

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  123 bits (308), Expect = 2e-35
 Identities = 34/182 (18%), Positives = 64/182 (35%), Gaps = 10/182 (5%)

Query: 2   LKKLNKHLKSC-LDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRL 59
           +K      K   L  E      +     I       AE +   +V+E         +   
Sbjct: 37  IKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             +   +T      Q+ + +E ++S + IHRD+KP+N L+       ++ I DFGL+   
Sbjct: 97  SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156

Query: 120 YPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAY 171
                         + + G+  Y +           + D+ S+G +L     G  P+   
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216

Query: 172 RP 173
           + 
Sbjct: 217 KA 218

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-35
 Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 13/167 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+  L    H NII + D  +A          +V    G +L   ++    +       F
Sbjct: 56  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYF 114

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEK 127
           L Q+  GL+ ++S +++HRDLKP N+L   L+    LKI DFGL+    P +    +  +
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTE 171

Query: 128 VCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSAYRP 173
              +  Y APE++   + Y + +D+WSVG IL E+L+  P F     
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  122 bits (308), Expect = 3e-35
 Identities = 28/184 (15%), Positives = 66/184 (35%), Gaps = 12/184 (6%)

Query: 2   LKKLNKHLKS-CLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K   +   +  L  E      +     I  ++   Q      LV++             
Sbjct: 35  IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSC 117
             +   +T     +Q+ A ++ ++   +++RD+KP+N L+      +  M+ + DFG+  
Sbjct: 95  GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154

Query: 118 TLYPG--------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
                           + + G+  YM+      +    + D+ ++G +    L G  P+ 
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214

Query: 170 AYRP 173
             + 
Sbjct: 215 GLKA 218

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 4e-35
 Identities = 40/176 (22%), Positives = 75/176 (42%), Gaps = 12/176 (6%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY- 56
           +K L        +     E   +   +H NIIRL         + ++ E+   G L  + 
Sbjct: 41  IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100

Query: 57  IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
               G          L+ + AG++ L + + +HRDL   NIL+   + +++ K++DFGLS
Sbjct: 101 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS 157

Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
             L     A            + APE + ++++    D+WS G +++E++      
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-34
 Identities = 40/190 (21%), Positives = 78/190 (41%), Gaps = 21/190 (11%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K +N+      +     E + +   N  +++RL           +++E    G+L SY+
Sbjct: 55  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114

Query: 58  RLHGRV----------PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
           R                     +   ++  G+  LN++  +HRDL   N +   + +D  
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFT 171

Query: 108 LKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
           +KI DFG++  +Y  +Y     K      +M+PE L+   +    D+WS G +L+E+   
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231

Query: 165 -YPPFSAYRP 173
              P+     
Sbjct: 232 AEQPYQGLSN 241

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-34
 Identities = 52/160 (32%), Positives = 86/160 (53%), Gaps = 8/160 (5%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E   L  +   P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKVCGSP 132
           +   LE L+   II+RD+K ENIL   LD +  + + DFGLS          A   CG+ 
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 133 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSA 170
            YMAP++++     +D+ VD WS+G +++ELL G  PF+ 
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-33
 Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 25/180 (13%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------------- 58
           EL  LS + NH NI+ L  A        ++ E+C  G+L +++R                
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 59  --LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                 +  +    F  Q+  G+  L S + IHRDL   NIL   L    + KI DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLA 192

Query: 117 CTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSAYRP 173
             +   +             +MAPE +    Y  + D+WS G  L+EL +         P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-33
 Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 28/194 (14%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           +K L         S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y
Sbjct: 50  VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109

Query: 57  IRLHG----------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS 100
           ++                   ++  +       Q+  G+E L S   IHRDL   N+L  
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL-- 167

Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157
            + +D ++KIADFGL+  ++  +Y +K         +MAPE L  + Y  + D+WS G +
Sbjct: 168 -VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226

Query: 158 LFELLN-GYPPFSA 170
           L+E+   G  P+  
Sbjct: 227 LWEIFTLGGSPYPG 240

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 6e-33
 Identities = 58/184 (31%), Positives = 88/184 (47%), Gaps = 19/184 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +         +LV+ F   
Sbjct: 48  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-- 105

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
           G     +  H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKI 162

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
            DFGL+      +       +  Y APEV L + RY + VD+WSVG I+ E++ G   F 
Sbjct: 163 LDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220

Query: 170 AYRP 173
               
Sbjct: 221 GSDH 224

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-32
 Identities = 53/169 (31%), Positives = 83/169 (49%), Gaps = 5/169 (2%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L   ++ + S    E+  L  + H NI+RL D   ++  + LV EFC       +   +G
Sbjct: 37  LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
            +  +  + FL QL  GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+     
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGI 153

Query: 121 PGNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
           P         +  Y  P+VL   + Y   +DMWS G I  EL N   P 
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-31
 Identities = 56/183 (30%), Positives = 82/183 (44%), Gaps = 17/183 (9%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        ++LV+E    
Sbjct: 47  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                   +   +  +     L Q+  G++ L+S  IIHRDLKP NI    +  D  LKI
Sbjct: 107 NLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKI 160

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
            DFGL+ T            +  Y APEV+    Y E VD+WSVG I+ E++     F  
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220

Query: 171 YRP 173
              
Sbjct: 221 RDY 223

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-29
 Identities = 56/180 (31%), Positives = 92/180 (51%), Gaps = 17/180 (9%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F       E     +V    G 
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+ +   ++D  LKI 
Sbjct: 108 DLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 163

Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 164 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 9e-29
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 28/192 (14%)

Query: 2   LKKLNKH-----LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSS 55
           +K L +       ++ +      +   +H N++ L  A  +    + ++VEFC  GNLS+
Sbjct: 48  VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107

Query: 56  YIRLHGR----------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
           Y+R                    +  +    +  Q+  G+E L S   IHRDL   NIL 
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL- 166

Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156
             L +  ++KI DFGL+  +Y      +         +MAPE +  + Y  + D+WS G 
Sbjct: 167 --LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224

Query: 157 ILFELLNGYPPF 168
           +L+E+ +     
Sbjct: 225 LLWEIFSLGASP 236

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 98.6 bits (244), Expect = 1e-25
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 11/173 (6%)

Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGN---LSSYIRLHG 61
           K L+   D +     S+   +I++L D F     N + +V+ F   G           H 
Sbjct: 61  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120

Query: 62  RVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLD---DDVMLKIADFGLSC 117
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D   + + +KIAD G +C
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSA 170
                        +  Y +PEVL    +    D+WS   ++FEL+ G   F  
Sbjct: 181 WYDEHYT--NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 67.9 bits (165), Expect = 4e-15
 Identities = 20/147 (13%), Positives = 46/147 (31%), Gaps = 27/147 (18%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
            L  +    + +++          +++E               RV  +   + L  +   
Sbjct: 67  ALQKLQGLAVPKVYAWEG----NAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 138
           +       I+H DL   N+L+     +  + I DF  S  +    + E        +  +
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEEGWRE-------ILERD 164

Query: 139 VLQF-----QRYDEKVDMWSVGAILFE 160
           V        + Y  + D+ S    + +
Sbjct: 165 VRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	180
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.77
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.24
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.05
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.63
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.15
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.14

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=262.19  Aligned_cols=163  Identities=34%  Similarity=0.627  Sum_probs=148.7

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+.+.+|++++++++||||+++++++.+++.+++||||+++++|.+++...+++++..+..++.|++.||+|||++|+
T Consensus        48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~i  127 (263)
T d2j4za1          48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV  127 (263)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34667889999999999999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||||||+||++   +.++.++|+|||++....... .....||+.|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       128 vHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P  203 (263)
T d2j4za1         128 IHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP  203 (263)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             eeeeecccccee---cCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC
Confidence            999999999999   567789999999997664433 3345689999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       204 f~~~~~~  210 (263)
T d2j4za1         204 FEANTYQ  210 (263)
T ss_dssp             TCCSSHH
T ss_pred             CCCCCHH
Confidence            9887654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-45  Score=266.29  Aligned_cols=166  Identities=37%  Similarity=0.685  Sum_probs=135.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ....+.+|+.++++++||||+++++++.+++.+++||||++|++|.+++...+.+++..+..++.|++.||+|||++|++
T Consensus        50 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  129 (307)
T d1a06a_          50 KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV  129 (307)
T ss_dssp             -----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceee
Confidence            34567889999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      ||||+|+||++...+.++.++|+|||++.............||+.|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus       130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf  209 (307)
T d1a06a_         130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF  209 (307)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence            99999999999755567889999999998766555555667999999999999999999999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+.+..
T Consensus       210 ~~~~~~  215 (307)
T d1a06a_         210 YDENDA  215 (307)
T ss_dssp             CCSSHH
T ss_pred             CCCCHH
Confidence            876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=262.06  Aligned_cols=163  Identities=31%  Similarity=0.601  Sum_probs=146.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..++.+.+|++++++++||||+++++++.+++.+++||||++|++|.+++. ..++++..+..++.|++.||+|||++|+
T Consensus        59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~i  137 (293)
T d1yhwa1          59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQV  137 (293)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            345678999999999999999999999999999999999999999999776 4679999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      +||||||+||++   +.++.++|+|||++....... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.
T Consensus       138 iHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~  214 (293)
T d1yhwa1         138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP  214 (293)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCcHHHeEE---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence            999999999999   467789999999998765432 3345568999999999999999999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.++.
T Consensus       215 Pf~~~~~~  222 (293)
T d1yhwa1         215 PYLNENPL  222 (293)
T ss_dssp             TTTTSCHH
T ss_pred             CCCCCCHH
Confidence            99876643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-45  Score=261.37  Aligned_cols=163  Identities=36%  Similarity=0.636  Sum_probs=143.7

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.....+++..+..++.|++.|++|||++|++
T Consensus        46 ~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~Ii  125 (271)
T d1nvra_          46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  125 (271)
T ss_dssp             ---CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence            45678999999999999999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g  164 (180)
                      ||||||+||++   +.++.++|+|||++.......   ......||+.|+|||.+.+..+ +.++|+||+|+++|+|++|
T Consensus       126 HrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G  202 (271)
T d1nvra_         126 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  202 (271)
T ss_dssp             CSCCCGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             cCcccHHHEEE---CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence            99999999999   567789999999997654322   2234568999999999988776 5789999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      +.||...+..
T Consensus       203 ~~pf~~~~~~  212 (271)
T d1nvra_         203 ELPWDQPSDS  212 (271)
T ss_dssp             SCSCSSSSTT
T ss_pred             CCCCCCCChH
Confidence            9999876543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=260.47  Aligned_cols=163  Identities=33%  Similarity=0.640  Sum_probs=146.1

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|++++++++||||+++++++.+++.+++||||++||+|.+++...+.+++..+..++.|++.||+|||++|++
T Consensus        51 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  130 (288)
T d1uu3a_          51 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII  130 (288)
T ss_dssp             CHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEE
Confidence            34678999999999999999999999999999999999999999999999889999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      ||||||+||++   +.++.++|+|||++.......   ......||+.|+|||.+.+..++.++||||+|+++|+|++|+
T Consensus       131 HrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~  207 (288)
T d1uu3a_         131 HRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL  207 (288)
T ss_dssp             CSCCSGGGEEE---CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCcCCcccccc---CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCC
Confidence            99999999999   567789999999997764332   223456899999999999999999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.++.
T Consensus       208 ~Pf~~~~~~  216 (288)
T d1uu3a_         208 PPFRAGNEY  216 (288)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCcCHH
Confidence            999987654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-43  Score=253.89  Aligned_cols=164  Identities=32%  Similarity=0.625  Sum_probs=143.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      .+...+.+.+|++++++++||||+++++++.+    ++.+++||||+++++|.+++.+...+++..+..++.|++.||+|
T Consensus        48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y  127 (270)
T d1t4ha_          48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  127 (270)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence            34556779999999999999999999999865    34689999999999999999988899999999999999999999


Q ss_pred             HHhCC--CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        82 lh~~~--~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      ||+++  ++||||||+||++.  +.++.++|+|||++...... ......||+.|+|||.+.+ .++.++||||+|+++|
T Consensus       128 LH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvily  203 (270)
T d1t4ha_         128 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML  203 (270)
T ss_dssp             HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred             HHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHH
Confidence            99998  99999999999995  34678999999999754433 2335568999999998865 5899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030256          160 ELLNGYPPFSAYRP  173 (180)
Q Consensus       160 ~~l~g~~pf~~~~~  173 (180)
                      +|++|+.||.+.+.
T Consensus       204 el~~g~~Pf~~~~~  217 (270)
T d1t4ha_         204 EMATSEYPYSECQN  217 (270)
T ss_dssp             HHHHSSCTTTTCSS
T ss_pred             HHHHCCCCCCCccc
Confidence            99999999976543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7e-44  Score=265.17  Aligned_cols=167  Identities=32%  Similarity=0.566  Sum_probs=150.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ....+.+.+|+.++++++||||+++++++.+++.+++||||++|++|.+++. ..+++++..+..++.||+.||+|||++
T Consensus        64 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~  143 (350)
T d1koaa2          64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN  143 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            3456778999999999999999999999999999999999999999999885 345799999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      |++||||||+||++.. +.++.++|+|||++.............+|+.|+|||++.+..++.++|+||+|+++|+|++|+
T Consensus       144 ~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~  222 (350)
T d1koaa2         144 NYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL  222 (350)
T ss_dssp             TEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCeeeeechhHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCC
Confidence            9999999999999953 235679999999998877666666677999999999999999999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030256          166 PPFSAYRPC  174 (180)
Q Consensus       166 ~pf~~~~~~  174 (180)
                      .||.+.++.
T Consensus       223 ~Pf~~~~~~  231 (350)
T d1koaa2         223 SPFGGENDD  231 (350)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCCCHH
Confidence            999876654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=265.66  Aligned_cols=165  Identities=33%  Similarity=0.550  Sum_probs=147.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-   84 (180)
                      ++..++.+.+|+.++++++||||+++++++.+.+.+++||||++|++|.+++.+.+.+++..+..++.|++.||.|||+ 
T Consensus        44 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~  123 (322)
T d1s9ja_          44 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  123 (322)
T ss_dssp             CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3455678999999999999999999999999999999999999999999999988899999999999999999999997 


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      +|++||||||+||++   +.++.++|+|||++....... .....||..|+|||++.+..++.++||||+||++|||++|
T Consensus       124 ~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G  199 (322)
T d1s9ja_         124 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG  199 (322)
T ss_dssp             HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred             CCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCCc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence            599999999999999   567889999999987653322 2345689999999999999999999999999999999999


Q ss_pred             CCCCCCCCcc
Q 030256          165 YPPFSAYRPC  174 (180)
Q Consensus       165 ~~pf~~~~~~  174 (180)
                      +.||.+.+..
T Consensus       200 ~~Pf~~~~~~  209 (322)
T d1s9ja_         200 RYPIPPPDAK  209 (322)
T ss_dssp             SCCSSCCCTT
T ss_pred             CCCCCCCCHH
Confidence            9999876543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-43  Score=259.72  Aligned_cols=163  Identities=33%  Similarity=0.540  Sum_probs=150.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.+|++++||||+++++++.+.+.+++||||++||+|.+++...+.+++..+..++.|++.||+|||++|++
T Consensus        48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii  127 (337)
T d1o6la_          48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  127 (337)
T ss_dssp             CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence            35668899999999999999999999999999999999999999999999889999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCC-CCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      ||||||+||++   +.++.++|+|||+++.... ........||+.|+|||++.+..++.++|+||+||++|+|++|+.|
T Consensus       128 HRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~p  204 (337)
T d1o6la_         128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  204 (337)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccCHHHeEe---cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCC
Confidence            99999999999   5678899999999987644 3344456799999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       205 f~~~~~~  211 (337)
T d1o6la_         205 FYNQDHE  211 (337)
T ss_dssp             SCCSSHH
T ss_pred             CCCcCHH
Confidence            9987754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.7e-43  Score=262.17  Aligned_cols=166  Identities=30%  Similarity=0.559  Sum_probs=149.8

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+..+.+|++++++++||||+++++++.+++.+++||||++|++|.+.+...+ ++++..+..++.||+.||+|||++|
T Consensus        68 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~  147 (352)
T d1koba_          68 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS  147 (352)
T ss_dssp             HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            445678899999999999999999999999999999999999999988776444 6999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  166 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~  166 (180)
                      ++||||||+||++.. ...+.++|+|||++.............++..|+|||.+.+..++.++||||+||++|+|++|+.
T Consensus       148 iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~  226 (352)
T d1koba_         148 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS  226 (352)
T ss_dssp             EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred             eeecccccccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCC
Confidence            999999999999952 2457899999999988877666666778999999999999999999999999999999999999


Q ss_pred             CCCCCCcc
Q 030256          167 PFSAYRPC  174 (180)
Q Consensus       167 pf~~~~~~  174 (180)
                      ||.+.+..
T Consensus       227 Pf~~~~~~  234 (352)
T d1koba_         227 PFAGEDDL  234 (352)
T ss_dssp             SSCCSSHH
T ss_pred             CCCCCCHH
Confidence            99876644

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=253.70  Aligned_cols=166  Identities=33%  Similarity=0.619  Sum_probs=150.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+.+++||||++|++|.+++...+.+++..+..++.|++.||+|||++|++
T Consensus        56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~iv  135 (293)
T d1jksa_          56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA  135 (293)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhccee
Confidence            35778999999999999999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCC-CCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      ||||+|+||++...+ ....++++|||++.............++..|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P  215 (293)
T d1jksa_         136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  215 (293)
T ss_dssp             CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence            999999999995322 2335999999999887665555566789999999999998999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       216 f~~~~~~  222 (293)
T d1jksa_         216 FLGDTKQ  222 (293)
T ss_dssp             SCCSSHH
T ss_pred             CCCCCHH
Confidence            9876654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=257.95  Aligned_cols=164  Identities=36%  Similarity=0.592  Sum_probs=143.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++... .++++..+..++.|++.||+|||++|
T Consensus        51 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~  130 (288)
T d2jfla1          51 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK  130 (288)
T ss_dssp             GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44567889999999999999999999999999999999999999999987654 56999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccc-----cccCCcchhHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~-----~~~~~~~~Di~slg~~~~~  160 (180)
                      ++||||||+||++   +.++.++|+|||++...... .......|++.|+|||.+.     +..++.++||||+|+++|+
T Consensus       131 ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye  207 (288)
T d2jfla1         131 IIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE  207 (288)
T ss_dssp             EECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred             EEEeecChhheeE---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence            9999999999999   56778999999998665332 1223456899999999874     4457899999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030256          161 LLNGYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~g~~pf~~~~~~  174 (180)
                      |++|+.||.+.++.
T Consensus       208 mltg~~Pf~~~~~~  221 (288)
T d2jfla1         208 MAEIEPPHHELNPM  221 (288)
T ss_dssp             HHHSSCTTTTSCGG
T ss_pred             HhhCCCCCCCCCHH
Confidence            99999999887654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-42  Score=254.88  Aligned_cols=161  Identities=39%  Similarity=0.687  Sum_probs=147.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ..+.+.+|+.++++++||||+++++++.+.+.+++||||++|++|...+.....+++..+..++.|++.|++|||++|++
T Consensus        47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ii  126 (316)
T d1fota_          47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII  126 (316)
T ss_dssp             CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEE
Confidence            35678899999999999999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  168 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf  168 (180)
                      ||||||+||++   +.++.++|+|||++.......  ....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus       127 HrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~--~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf  201 (316)
T d1fota_         127 YRDLKPENILL---DKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF  201 (316)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB--CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccCchheeE---cCCCCEEEecCccceEecccc--ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCC
Confidence            99999999999   577889999999997765433  3456899999999999989999999999999999999999999


Q ss_pred             CCCCcc
Q 030256          169 SAYRPC  174 (180)
Q Consensus       169 ~~~~~~  174 (180)
                      .+.++.
T Consensus       202 ~~~~~~  207 (316)
T d1fota_         202 YDSNTM  207 (316)
T ss_dssp             CCSSHH
T ss_pred             CCcCHH
Confidence            887654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-42  Score=252.87  Aligned_cols=162  Identities=32%  Similarity=0.546  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ....+.+.+|++++++++|||||++++++.+++..++||||+++++|..++....++++..+..++.|++.||.|||++|
T Consensus        56 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~  135 (309)
T d1u5ra_          56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN  135 (309)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            44556788999999999999999999999999999999999999999887777788999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc---ccCCcchhHHHHHHHHHHHHh
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~---~~~~~~~Di~slg~~~~~~l~  163 (180)
                      ++||||||+||++   +.++.++|+|||++......   ....||+.|+|||.+.+   ..++.++||||+|+++|+|++
T Consensus       136 iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~  209 (309)
T d1u5ra_         136 MIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (309)
T ss_dssp             CBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             EeccCCCcceEEE---CCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence            9999999999999   46788999999999765432   24568999999999864   357899999999999999999


Q ss_pred             CCCCCCCCCcc
Q 030256          164 GYPPFSAYRPC  174 (180)
Q Consensus       164 g~~pf~~~~~~  174 (180)
                      |..||.+.++.
T Consensus       210 g~~Pf~~~~~~  220 (309)
T d1u5ra_         210 RKPPLFNMNAM  220 (309)
T ss_dssp             SSCTTTTSCHH
T ss_pred             CCCCCCCCCHH
Confidence            99999876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.5e-42  Score=248.11  Aligned_cols=165  Identities=41%  Similarity=0.779  Sum_probs=149.8

Q ss_pred             HHHHHHHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      +..++.+.+|+.++++++ ||||+++++++.+++..++||||++|++|.+++..++++++..+..++.||+.||+|||++
T Consensus        50 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~  129 (277)
T d1phka_          50 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL  129 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence            456677889999999996 9999999999999999999999999999999999889999999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc------ccCCcchhHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILF  159 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~------~~~~~~~Di~slg~~~~  159 (180)
                      |++||||+|+||++   +.++.++|+|||++.............++..|.|||.+.+      ..++.++|+||+|+++|
T Consensus       130 ~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvily  206 (277)
T d1phka_         130 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY  206 (277)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred             CCcccccccceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhh
Confidence            99999999999999   5788899999999988766555556678999999999863      23678999999999999


Q ss_pred             HHHhCCCCCCCCCcc
Q 030256          160 ELLNGYPPFSAYRPC  174 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~  174 (180)
                      +|++|+.||.+.++.
T Consensus       207 eml~g~~Pf~~~~~~  221 (277)
T d1phka_         207 TLLAGSPPFWHRKQM  221 (277)
T ss_dssp             HHHHSSCSSCCSSHH
T ss_pred             hhccCCCCCCCCCHH
Confidence            999999999987654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-43  Score=252.28  Aligned_cols=166  Identities=36%  Similarity=0.697  Sum_probs=135.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe--CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l   79 (180)
                      ++...+.+.+|++++++++||||+++++++.+  ++.+++||||++||+|.+++.+    ...+++..++.++.|++.||
T Consensus        43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al  122 (269)
T d2java1          43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  122 (269)
T ss_dssp             CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence            45556779999999999999999999998864  4578999999999999998853    35699999999999999999


Q ss_pred             HHHHhCC-----CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccccCCcchhHHH
Q 030256           80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS  153 (180)
Q Consensus        80 ~~lh~~~-----~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Di~s  153 (180)
                      +|||+.|     ++||||||+||++   +.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||
T Consensus       123 ~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS  199 (269)
T d2java1         123 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS  199 (269)
T ss_dssp             HHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHH
T ss_pred             HHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHh
Confidence            9999976     9999999999999   567889999999997765433 233456899999999999989999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcc
Q 030256          154 VGAILFELLNGYPPFSAYRPC  174 (180)
Q Consensus       154 lg~~~~~~l~g~~pf~~~~~~  174 (180)
                      ||+++|+|++|+.||.+.++.
T Consensus       200 lGvilyel~tg~~Pf~~~~~~  220 (269)
T d2java1         200 LGCLLYELCALMPPFTAFSQK  220 (269)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHH
T ss_pred             hCHHHHHHhhCCCCCCCCCHH
Confidence            999999999999999887654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=250.75  Aligned_cols=164  Identities=28%  Similarity=0.524  Sum_probs=143.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +..++++.+|++++++++|||||++++++.++ ..++||||+++|+|.+++....++++..+..++.||+.||+|||++|
T Consensus        49 ~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~  127 (277)
T d1xbba_          49 PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN  127 (277)
T ss_dssp             CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC
Confidence            34567899999999999999999999998654 57899999999999999998889999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++||||+|+||++   +.++.++++|||+++........    ....+++.|+|||.+.+..++.++||||+|+++||++
T Consensus       128 iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell  204 (277)
T d1xbba_         128 FVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  204 (277)
T ss_dssp             EECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             cccCCCcchhhcc---cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence            9999999999999   46788999999999766443221    2345788999999999889999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030256          163 N-GYPPFSAYRPC  174 (180)
Q Consensus       163 ~-g~~pf~~~~~~  174 (180)
                      + |+.||.+.++.
T Consensus       205 t~g~~Pf~~~~~~  217 (277)
T d1xbba_         205 SYGQKPYRGMKGS  217 (277)
T ss_dssp             TTTCCSSTTCCHH
T ss_pred             hCCCCCCCCCCHH
Confidence            8 89999886654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-42  Score=252.82  Aligned_cols=166  Identities=25%  Similarity=0.491  Sum_probs=137.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .+...+++.+|++++++++|||||++++++.+++..++||||+++|+|.+++... +.+++..+..++.|++.||+|||+
T Consensus        67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  146 (299)
T d1jpaa_          67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD  146 (299)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            3455677999999999999999999999999999999999999999999988764 469999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc------cccccCccccCccccccccCCcchhHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~  158 (180)
                      +|++||||||+||++   +.++.++|+|||+++........      ....++..|+|||.+.+..++.++||||||+++
T Consensus       147 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl  223 (299)
T d1jpaa_         147 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM  223 (299)
T ss_dssp             TTCCCSCCCGGGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred             CCCccCccccceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence            999999999999999   57788999999999766443221      123467889999999988999999999999999


Q ss_pred             HHHHh-CCCCCCCCCcc
Q 030256          159 FELLN-GYPPFSAYRPC  174 (180)
Q Consensus       159 ~~~l~-g~~pf~~~~~~  174 (180)
                      |||+| |+.||.+.++.
T Consensus       224 ~el~t~g~~Pf~~~~~~  240 (299)
T d1jpaa_         224 WEVMSYGERPYWDMTNQ  240 (299)
T ss_dssp             HHHHTTSCCTTTTCCHH
T ss_pred             HHHHhCCCCCCCCCCHH
Confidence            99998 89999876654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-42  Score=253.88  Aligned_cols=165  Identities=30%  Similarity=0.523  Sum_probs=148.9

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+..+.+|+++|++++||||+++++++.+++.+|+||||++|++|.+++...+ ++++..+..++.||+.|++|||+.|+
T Consensus        44 ~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~i  123 (321)
T d1tkia_          44 DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI  123 (321)
T ss_dssp             HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence            34568899999999999999999999999999999999999999999997655 69999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      +||||+|+||++.. +....++++|||++.............+++.|+|||...+..++.++|+||+|+++|+|++|..|
T Consensus       124 iHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~P  202 (321)
T d1tkia_         124 GHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP  202 (321)
T ss_dssp             ECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred             CcccccccceeecC-CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCC
Confidence            99999999999953 34557999999999887666555566788999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030256          168 FSAYRPC  174 (180)
Q Consensus       168 f~~~~~~  174 (180)
                      |.+.++.
T Consensus       203 f~~~~~~  209 (321)
T d1tkia_         203 FLAETNQ  209 (321)
T ss_dssp             TCCSSHH
T ss_pred             CCCCCHH
Confidence            9887654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.4e-42  Score=254.29  Aligned_cols=160  Identities=34%  Similarity=0.646  Sum_probs=147.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|+.++++++||||+++++++.+.+..++++|++.|++|..++...+.+++..+..++.||+.||.|||++|++|
T Consensus        85 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiH  164 (350)
T d1rdqe_          85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY  164 (350)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            45688999999999999999999999999999999999999999999998899999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  169 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~pf~  169 (180)
                      |||||+||++   +.++.++|+|||++.......  ....|++.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus       165 RDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~--~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  239 (350)
T d1rdqe_         165 RDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECSSCB--CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcCCHHHccc---CCCCCEEeeeceeeeeccccc--ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence            9999999999   567889999999998765432  34568999999999999999999999999999999999999998


Q ss_pred             CCCcc
Q 030256          170 AYRPC  174 (180)
Q Consensus       170 ~~~~~  174 (180)
                      +.++.
T Consensus       240 ~~~~~  244 (350)
T d1rdqe_         240 ADQPI  244 (350)
T ss_dssp             CSSHH
T ss_pred             CcCHH
Confidence            86654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=249.09  Aligned_cols=164  Identities=30%  Similarity=0.517  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      ++..+.+++|++++++++||||+++++++.+ +.+++||||+++++|.+++... .++++..+..++.|++.||+|||++
T Consensus        45 ~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~  123 (276)
T d1uwha_          45 PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK  123 (276)
T ss_dssp             TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            4556789999999999999999999998654 5689999999999999999754 5699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccc---cCCcchhHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILF  159 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~---~~~~~~Di~slg~~~~  159 (180)
                      |++||||||+||++   +.++.++|+|||++.......   ......+++.|+|||.+.+.   .++.++||||+|+++|
T Consensus       124 ~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~  200 (276)
T d1uwha_         124 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY  200 (276)
T ss_dssp             TCCCSCCCGGGEEE---ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHH
T ss_pred             CEeccccCHHHEEE---cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHH
Confidence            99999999999999   467889999999987654322   22345689999999998643   4788999999999999


Q ss_pred             HHHhCCCCCCCCCcc
Q 030256          160 ELLNGYPPFSAYRPC  174 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~  174 (180)
                      ||++|+.||.+.++.
T Consensus       201 el~tg~~Pf~~~~~~  215 (276)
T d1uwha_         201 ELMTGQLPYSNINNR  215 (276)
T ss_dssp             HHHHSSCTTTTCCCH
T ss_pred             HHHHCCCCCCCCChH
Confidence            999999999876543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-42  Score=252.92  Aligned_cols=163  Identities=35%  Similarity=0.678  Sum_probs=144.7

Q ss_pred             HHHHHHHHHHhcC-CCccccccceEEEe----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      ..+++|+.++.++ +||||+++++++.+    ++.+|+||||++||+|.+++...+  ++++..+..++.|++.||+|||
T Consensus        49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH  128 (335)
T d2ozaa1          49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  128 (335)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            4577899887655 89999999999875    467999999999999999997643  5999999999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~  163 (180)
                      ++|++||||+|+||++...+..+.++|+|||+++............|++.|+|||.+.+..++.++|+||+|+++|+|++
T Consensus       129 ~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt  208 (335)
T d2ozaa1         129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC  208 (335)
T ss_dssp             HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT
T ss_pred             HcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh
Confidence            99999999999999997545567799999999988776666666779999999999999999999999999999999999


Q ss_pred             CCCCCCCCCc
Q 030256          164 GYPPFSAYRP  173 (180)
Q Consensus       164 g~~pf~~~~~  173 (180)
                      |+.||.+.+.
T Consensus       209 g~~Pf~~~~~  218 (335)
T d2ozaa1         209 GYPPFYSNHG  218 (335)
T ss_dssp             SSCSCEETTC
T ss_pred             CCCCCCCCCH
Confidence            9999987654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=246.89  Aligned_cols=165  Identities=28%  Similarity=0.527  Sum_probs=143.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .+...+++.+|++++++++|||||++++++.++ ..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+
T Consensus        49 ~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~  127 (285)
T d1u59a_          49 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  127 (285)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            345567799999999999999999999998654 578999999999999987644 569999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +|++||||+|+||+++   .++.++|+|||+++........    ....++..|+|||.+.+..++.++||||+|+++||
T Consensus       128 ~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E  204 (285)
T d1u59a_         128 KNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE  204 (285)
T ss_dssp             TTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             CCeecCcCchhheeec---cCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHH
Confidence            9999999999999994   6778999999999876543321    22347788999999998899999999999999999


Q ss_pred             HHh-CCCCCCCCCcc
Q 030256          161 LLN-GYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~-g~~pf~~~~~~  174 (180)
                      ++| |+.||.+.+..
T Consensus       205 ~lt~G~~Pf~~~~~~  219 (285)
T d1u59a_         205 ALSYGQKPYKKMKGP  219 (285)
T ss_dssp             HHTTSCCTTTTCCTH
T ss_pred             HHhCCCCCCCCCCHH
Confidence            998 99999876654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-41  Score=247.90  Aligned_cols=163  Identities=37%  Similarity=0.616  Sum_probs=145.6

Q ss_pred             HHHHHHHHHHHh-cCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           10 KSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        10 ~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+.+.+|..++. .++||||+++++++.+++.+++||||++||+|.+++....++++..+..++.||+.||+|||++|++
T Consensus        46 ~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~ii  125 (320)
T d1xjda_          46 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV  125 (320)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            345666777665 6899999999999999999999999999999999999889999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCC-CcccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      ||||+|+||++   +..+.++|+|||.+...... .......|+..|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus       126 HrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P  202 (320)
T d1xjda_         126 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP  202 (320)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eccCcccceee---cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCC
Confidence            99999999999   57788999999999766543 333345689999999999999999999999999999999999999


Q ss_pred             CCCCCccc
Q 030256          168 FSAYRPCF  175 (180)
Q Consensus       168 f~~~~~~~  175 (180)
                      |.+.++..
T Consensus       203 F~~~~~~~  210 (320)
T d1xjda_         203 FHGQDEEE  210 (320)
T ss_dssp             SCCSSHHH
T ss_pred             CCCCCHHH
Confidence            99877653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-40  Score=249.17  Aligned_cols=156  Identities=33%  Similarity=0.587  Sum_probs=140.1

Q ss_pred             HHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 030256           15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKP   94 (180)
Q Consensus        15 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~   94 (180)
                      .|+.+++.++||||+++++++.+.+.+++||||++|++|.+++.....+++..+..++.||+.||+|||++|++||||||
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP  135 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP  135 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeecc
Confidence            34777888899999999999999999999999999999999999889999999999999999999999999999999999


Q ss_pred             CCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030256           95 ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSAYRP  173 (180)
Q Consensus        95 ~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~l~g~~pf~~~~~  173 (180)
                      +||++   +..+.++|+|||++....... .....||+.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+.
T Consensus       136 ~NILl---~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~  211 (364)
T d1omwa3         136 ANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  211 (364)
T ss_dssp             GGEEE---CSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred             ceeEE---cCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence            99999   577889999999997765443 234568999999999864 5689999999999999999999999987655


Q ss_pred             c
Q 030256          174 C  174 (180)
Q Consensus       174 ~  174 (180)
                      .
T Consensus       212 ~  212 (364)
T d1omwa3         212 K  212 (364)
T ss_dssp             S
T ss_pred             H
Confidence            4

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-41  Score=246.42  Aligned_cols=161  Identities=26%  Similarity=0.446  Sum_probs=140.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+++.+|++++++++|||||++++++.+++..+++|||+++|+|.+++...  ..+++..+..++.|++.||+|||++|
T Consensus        56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~  135 (287)
T d1opja_          56 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  135 (287)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC
Confidence            3567899999999999999999999999999999999999999999998754  46899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc--cccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++||||||+||++   +.++.++|+|||+++........  ....++..|+|||.+.+..++.++||||+|+++|||++|
T Consensus       136 iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~  212 (287)
T d1opja_         136 FIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  212 (287)
T ss_dssp             CCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             cccCccccCeEEE---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence            9999999999999   57788999999999776543322  234477889999999999999999999999999999996


Q ss_pred             CCCC-CCCC
Q 030256          165 YPPF-SAYR  172 (180)
Q Consensus       165 ~~pf-~~~~  172 (180)
                      ..|| .+.+
T Consensus       213 ~~p~~~~~~  221 (287)
T d1opja_         213 GMSPYPGID  221 (287)
T ss_dssp             SCCSSTTCC
T ss_pred             CCCCCCcch
Confidence            6655 4433

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=250.66  Aligned_cols=166  Identities=29%  Similarity=0.512  Sum_probs=143.1

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-----------------------
Q 030256            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------   61 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------   61 (180)
                      +......+.+|+.+++++ +|||||++++++.+.+..++||||+++|+|.+++....                       
T Consensus        80 ~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (325)
T d1rjba_          80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN  159 (325)
T ss_dssp             ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence            345566788999999998 89999999999999999999999999999999997542                       


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcc
Q 030256           62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE  138 (180)
Q Consensus        62 ~~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape  138 (180)
                      .+++..++.++.|++.||+|||++|++||||||+||++   +.++.++|+|||+++.......   .....+++.|+|||
T Consensus       160 ~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  236 (325)
T d1rjba_         160 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  236 (325)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence            37899999999999999999999999999999999999   4678999999999976544322   22445788999999


Q ss_pred             ccccccCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       139 ~~~~~~~~~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      .+.+..++.++||||+|+++|||++ |..||.+.+..
T Consensus       237 ~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             HHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999999999998 89999876543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.2e-41  Score=243.33  Aligned_cols=166  Identities=28%  Similarity=0.531  Sum_probs=140.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ++...+.+.+|++++++++||||+++++++...+    ..|+||||++|++|.+++...+++++..+..++.|++.|++|
T Consensus        47 ~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~  126 (277)
T d1o6ya_          47 DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF  126 (277)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence            3455677999999999999999999999987643    489999999999999999888899999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC----cccccccCccccCccccccccCCcchhHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  157 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~  157 (180)
                      ||++|++||||||+||++.   ..+..+++|||.+.......    ......|++.|+|||.+.+..++.++||||+|++
T Consensus       127 lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  203 (277)
T d1o6ya_         127 SHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV  203 (277)
T ss_dssp             HHHTTEECCCCSGGGEEEE---TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred             HHhCCccCccccCcccccC---ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHH
Confidence            9999999999999999994   67789999999876543322    2334568999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030256          158 LFELLNGYPPFSAYRPC  174 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~~  174 (180)
                      +|+|++|+.||.+.++.
T Consensus       204 lyelltG~~Pf~~~~~~  220 (277)
T d1o6ya_         204 LYEVLTGEPPFTGDSPV  220 (277)
T ss_dssp             HHHHHHSSCSCCCSSHH
T ss_pred             HHHHHhCCCCCCCcCHH
Confidence            99999999999876653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-41  Score=241.53  Aligned_cols=162  Identities=27%  Similarity=0.528  Sum_probs=133.8

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .++++.+|++++++++||||+++++++..++..++||||+++|+|.+++... ..+++..+..++.|++.|++|||++++
T Consensus        43 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~i  122 (263)
T d1sm2a_          43 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV  122 (263)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccce
Confidence            4567899999999999999999999999999999999999999999988655 458999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-C
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  164 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-g  164 (180)
                      +||||+|+||++   +.++.++|+|||+++.......  .....++..|+|||.+.+..++.++||||+|+++||+++ |
T Consensus       123 iHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~  199 (263)
T d1sm2a_         123 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG  199 (263)
T ss_dssp             CCTTCSGGGEEE---CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             eecccchhheee---cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCC
Confidence            999999999999   5778899999999876644322  223457889999999999999999999999999999999 5


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      .+||...+.
T Consensus       200 ~~~~~~~~~  208 (263)
T d1sm2a_         200 KIPYENRSN  208 (263)
T ss_dssp             CCTTCSCCH
T ss_pred             CCCCCCCCH
Confidence            666665443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-40  Score=234.76  Aligned_cols=165  Identities=25%  Similarity=0.503  Sum_probs=145.2

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ...+++.+|+.++++++||||+++++++.+++.+++||||+++|+|..++.. ...+++..+..++.|+++|++|||+.|
T Consensus        41 ~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  120 (258)
T d1k2pa_          41 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ  120 (258)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC
Confidence            3456799999999999999999999999999999999999999999998654 356899999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      ++|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++||||+|+++|||+| 
T Consensus       121 iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~  197 (258)
T d1k2pa_         121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL  197 (258)
T ss_dssp             BCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccceeEEE---cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhc
Confidence            9999999999999   5678899999999976544322  223457888999999999999999999999999999998 


Q ss_pred             CCCCCCCCCccc
Q 030256          164 GYPPFSAYRPCF  175 (180)
Q Consensus       164 g~~pf~~~~~~~  175 (180)
                      |+.||.+.+..+
T Consensus       198 g~~Pf~~~~~~~  209 (258)
T d1k2pa_         198 GKMPYERFTNSE  209 (258)
T ss_dssp             SCCTTTTSCHHH
T ss_pred             CCCCCCCCCHHH
Confidence            899998876553

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=243.48  Aligned_cols=161  Identities=35%  Similarity=0.486  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (180)
                      .+.+.+|+.++++++||||+++++++.+++.+++||||+.++++.........+++..+..++.|++.||+|||++|++|
T Consensus        44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH  123 (299)
T d1ua2a_          44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  123 (299)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence            34688999999999999999999999999999999999988777766665667999999999999999999999999999


Q ss_pred             ecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCccccccc-cCCcchhHHHHHHHHHHHHhCCCC
Q 030256           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        90 ~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      |||||+||++   +..+.++|+|||++....... ......++..|+|||.+... .++.++||||+||++|+|++|..|
T Consensus       124 rDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p  200 (299)
T d1ua2a_         124 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  200 (299)
T ss_dssp             CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCcceEEe---cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence            9999999999   577889999999997765433 23345688999999988644 579999999999999999999999


Q ss_pred             CCCCCc
Q 030256          168 FSAYRP  173 (180)
Q Consensus       168 f~~~~~  173 (180)
                      |.+.++
T Consensus       201 f~~~~~  206 (299)
T d1ua2a_         201 LPGDSD  206 (299)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-39  Score=234.77  Aligned_cols=163  Identities=23%  Similarity=0.436  Sum_probs=135.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      .+..+.++.+|++++++++|||||++++++.+.+..++++||+.++++.+.+... ..+++..+..++.|++.+++|||+
T Consensus        49 ~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~  128 (283)
T d1mqba_          49 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN  128 (283)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc
Confidence            3445667899999999999999999999999999999999999999999887655 569999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc----ccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      ++++||||||+||++   +.++.++|+|||+++.......    .....++..|+|||.+.+..++.++||||+|+++||
T Consensus       129 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~e  205 (283)
T d1mqba_         129 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE  205 (283)
T ss_dssp             TTCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred             cccccCccccceEEE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHH
Confidence            999999999999999   5778999999999976543321    123447888999999999999999999999999999


Q ss_pred             HHhCCCC-CCCC
Q 030256          161 LLNGYPP-FSAY  171 (180)
Q Consensus       161 ~l~g~~p-f~~~  171 (180)
                      |+++..| |...
T Consensus       206 l~t~~~~~~~~~  217 (283)
T d1mqba_         206 VMTYGERPYWEL  217 (283)
T ss_dssp             HHTTSCCTTTTC
T ss_pred             HHhCCCCccccC
Confidence            9996555 4443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=235.11  Aligned_cols=166  Identities=28%  Similarity=0.524  Sum_probs=134.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ....++.+.+|++++++++||||+++++++. ++..++||||+++++|.+++... .++++..++.++.|++.|++|||+
T Consensus        48 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  126 (273)
T d1mp8a_          48 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES  126 (273)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc
Confidence            3555678999999999999999999999986 45689999999999999987644 469999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++++||||+|+||++.   ..+.++|+|||++........  .....++..|+|||.+.+..++.++||||+|+++|||+
T Consensus       127 ~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~l  203 (273)
T d1mp8a_         127 KRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL  203 (273)
T ss_dssp             TTCCCSCCSGGGEEEE---ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred             cCeeccccchhheeec---CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHH
Confidence            9999999999999994   677899999999976543322  22345678899999999999999999999999999999


Q ss_pred             h-CCCCCCCCCccc
Q 030256          163 N-GYPPFSAYRPCF  175 (180)
Q Consensus       163 ~-g~~pf~~~~~~~  175 (180)
                      + |..||.+.++.+
T Consensus       204 t~g~~P~~~~~~~~  217 (273)
T d1mp8a_         204 MHGVKPFQGVKNND  217 (273)
T ss_dssp             TTSCCTTTTCCGGG
T ss_pred             hcCCCCCCCCCHHH
Confidence            8 899998877653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=235.15  Aligned_cols=160  Identities=25%  Similarity=0.508  Sum_probs=137.0

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|++++++++|||||++++++.+ +..++||||+++|+|.+++...  .++++..++.++.|++.|++|||+++
T Consensus        51 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~  129 (272)
T d1qpca_          51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN  129 (272)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35679999999999999999999998755 4578999999999999876533  35999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc--ccccccCccccCccccccccCCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++||||||+||++   +.++.++|+|||+++.......  .....++..|+|||.+.+..++.++||||+|+++|||+||
T Consensus       130 ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~  206 (272)
T d1qpca_         130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH  206 (272)
T ss_dssp             EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             cccCccchhheee---ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhC
Confidence            9999999999999   5778899999999987654332  2234578889999999988899999999999999999995


Q ss_pred             -CCCCCCCC
Q 030256          165 -YPPFSAYR  172 (180)
Q Consensus       165 -~~pf~~~~  172 (180)
                       .+||...+
T Consensus       207 ~~~~~~~~~  215 (272)
T d1qpca_         207 GRIPYPGMT  215 (272)
T ss_dssp             TCCSSTTCC
T ss_pred             CCCCCCCCC
Confidence             55555443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-40  Score=235.60  Aligned_cols=162  Identities=25%  Similarity=0.488  Sum_probs=133.6

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (180)
                      ...+.+.+|++++++++||||+++++++.+ .+.+++||||+++|+|.+++.+..  .+++..++.++.|++.|++|||+
T Consensus        42 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~  121 (262)
T d1byga_          42 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG  121 (262)
T ss_dssp             C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc
Confidence            345679999999999999999999998854 567899999999999999986543  48999999999999999999999


Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHHHh-
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  163 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~-  163 (180)
                      .+++||||+|+||++   +.++.++++|||++........  ...++..|+|||.+.+..++.++||||||+++|||++ 
T Consensus       122 ~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~~--~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~  196 (262)
T d1byga_         122 NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF  196 (262)
T ss_dssp             TTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CceeccccchHhhee---cCCCCEeecccccceecCCCCc--cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHC
Confidence            999999999999999   5778899999999876544322  3346788999999998899999999999999999998 


Q ss_pred             CCCCCCCCCcc
Q 030256          164 GYPPFSAYRPC  174 (180)
Q Consensus       164 g~~pf~~~~~~  174 (180)
                      |+.||...+..
T Consensus       197 ~~~p~~~~~~~  207 (262)
T d1byga_         197 GRVPYPRIPLK  207 (262)
T ss_dssp             SCCSCTTSCGG
T ss_pred             CCCCCCCCCHH
Confidence            78888876554

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-39  Score=236.42  Aligned_cols=166  Identities=30%  Similarity=0.488  Sum_probs=141.2

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHH
Q 030256            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA   68 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~   68 (180)
                      .++..+++.+|+++++++ +||||+++++++.+.+..++||||+++|+|.+++...                ..+++..+
T Consensus        50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  129 (309)
T d1fvra_          50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL  129 (309)
T ss_dssp             -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred             ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence            344566799999999999 7999999999999999999999999999999998643                45899999


Q ss_pred             HHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcc
Q 030256           69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK  148 (180)
Q Consensus        69 ~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~  148 (180)
                      ..++.|++.|+.|+|+.+++||||+|+||++   +....++|+|||++.............++..|+|||.+.+..++.+
T Consensus       130 ~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  206 (309)
T d1fvra_         130 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  206 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred             HHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCcc
Confidence            9999999999999999999999999999999   5778899999999876554444444557889999999999999999


Q ss_pred             hhHHHHHHHHHHHHhCC-CCCCCCCcc
Q 030256          149 VDMWSVGAILFELLNGY-PPFSAYRPC  174 (180)
Q Consensus       149 ~Di~slg~~~~~~l~g~-~pf~~~~~~  174 (180)
                      +||||||+++|||++|. .||.+.+..
T Consensus       207 sDvwSfGvil~ell~~~~~p~~~~~~~  233 (309)
T d1fvra_         207 SDVWSYGVLLWEIVSLGGTPYCGMTCA  233 (309)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             ceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999965 578776544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-39  Score=235.68  Aligned_cols=165  Identities=25%  Similarity=0.422  Sum_probs=139.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (180)
                      .+..+++.+|+.++++++|||||++++++.+++ .+++++++.+++|.+.+... ..+++..++.++.|++.||+|||++
T Consensus        52 ~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~  130 (317)
T d1xkka_          52 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR  130 (317)
T ss_dssp             -CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence            344667999999999999999999999998765 56777888899998887654 4699999999999999999999999


Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc---cccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      |++||||||+||++   +.++.++|+|||++.........   ....++..|+|||.+.+..++.++||||+|+++|||+
T Consensus       131 ~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~  207 (317)
T d1xkka_         131 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM  207 (317)
T ss_dssp             TCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CcccCcchhhccee---CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHH
Confidence            99999999999999   46778999999999776543322   2234788999999999999999999999999999999


Q ss_pred             h-CCCCCCCCCccc
Q 030256          163 N-GYPPFSAYRPCF  175 (180)
Q Consensus       163 ~-g~~pf~~~~~~~  175 (180)
                      | |..||.+.+...
T Consensus       208 t~g~~p~~~~~~~~  221 (317)
T d1xkka_         208 TFGSKPYDGIPASE  221 (317)
T ss_dssp             TTSCCTTTTSCGGG
T ss_pred             HCCCCCCCCCCHHH
Confidence            8 899998876553

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-39  Score=233.10  Aligned_cols=158  Identities=22%  Similarity=0.403  Sum_probs=131.4

Q ss_pred             HHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      .+.+.+|+.++++++|||||++++++.+ +..++||||+++|+|..++..  ...+++..++.++.|++.|+++||++|+
T Consensus        56 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~i  134 (285)
T d1fmka3          56 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  134 (285)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhe
Confidence            4679999999999999999999999855 457899999999999988753  3569999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--cccccccCccccCccccccccCCcchhHHHHHHHHHHHHhCC
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  165 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l~g~  165 (180)
                      +||||+|+||++   +.++.++|+|||+++......  ......++..|+|||.+.+..++.++||||+|+++|||++|.
T Consensus       135 vH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~  211 (285)
T d1fmka3         135 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG  211 (285)
T ss_dssp             CCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             ecccccceEEEE---CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCC
Confidence            999999999999   567889999999997654332  222355788999999999999999999999999999999965


Q ss_pred             CCC-CCC
Q 030256          166 PPF-SAY  171 (180)
Q Consensus       166 ~pf-~~~  171 (180)
                      .|| ...
T Consensus       212 ~p~~~~~  218 (285)
T d1fmka3         212 RVPYPGM  218 (285)
T ss_dssp             CCSSTTC
T ss_pred             CCCCCCC
Confidence            554 443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=230.11  Aligned_cols=157  Identities=29%  Similarity=0.511  Sum_probs=137.9

Q ss_pred             HHHHHHHHHhcCC--CccccccceEEEeCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256           12 CLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus        12 ~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      ++.+|+.++++++  ||||+++++++.+++..++|||++.+ +++.+++.....+++..+..++.|++.||+|||++|++
T Consensus        53 ~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~ii  132 (273)
T d1xwsa_          53 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL  132 (273)
T ss_dssp             EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            4668999999996  89999999999999999999999975 67888888888999999999999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccC-CcchhHHHHHHHHHHHHhCCCC
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP  167 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Di~slg~~~~~~l~g~~p  167 (180)
                      ||||||+||++.  .+.+.++|+|||++...... ......||..|+|||.+.+..+ +.++|+||+|+++|+|++|+.|
T Consensus       133 HrDiKp~NIll~--~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P  209 (273)
T d1xwsa_         133 HRDIKDENILID--LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP  209 (273)
T ss_dssp             CSCCSGGGEEEE--TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCcccceEEe--cCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence            999999999995  35578999999998765433 2334568999999999887665 5678999999999999999999


Q ss_pred             CCCC
Q 030256          168 FSAY  171 (180)
Q Consensus       168 f~~~  171 (180)
                      |.+.
T Consensus       210 f~~~  213 (273)
T d1xwsa_         210 FEHD  213 (273)
T ss_dssp             CCSH
T ss_pred             CCCc
Confidence            9764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-39  Score=231.19  Aligned_cols=163  Identities=29%  Similarity=0.461  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +..+++.+|+.++++++||||+++++++.++ ..++||||++++++.+.+... .++++..++.++.|++.||+|||++|
T Consensus        53 ~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~  131 (273)
T d1u46a_          53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR  131 (273)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence            4456789999999999999999999999654 578999999999999877654 46999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcc----cccccCccccCccccccccCCcchhHHHHHHHHHHHH
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  162 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~l  162 (180)
                      ++||||+|+||++.   .+..++|+|||+++........    ....++..|+|||.+.+..++.++|+||||+++|||+
T Consensus       132 iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml  208 (273)
T d1u46a_         132 FIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF  208 (273)
T ss_dssp             EECSCCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             EeeeeecHHHhccc---cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence            99999999999995   5678999999999876443221    2234677899999999999999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030256          163 N-GYPPFSAYRPC  174 (180)
Q Consensus       163 ~-g~~pf~~~~~~  174 (180)
                      + |..||.+.+..
T Consensus       209 t~G~~Pf~~~~~~  221 (273)
T d1u46a_         209 TYGQEPWIGLNGS  221 (273)
T ss_dssp             TTSCCTTTTCCHH
T ss_pred             hCCCCCCCCcCHH
Confidence            8 89999876654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=231.89  Aligned_cols=161  Identities=33%  Similarity=0.563  Sum_probs=138.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      ..+.+.+|++++++++||||+++++++.+++.+++||||+.+ ++..++..  ...+++..+..++.|++.||+|||++|
T Consensus        44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~  122 (298)
T d1gz8a_          44 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR  122 (298)
T ss_dssp             CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence            466788999999999999999999999999999999999965 55444432  345999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++||||||+||++   +.+..++|+|||.+....... ......++..|+|||...... .+.++|+||+|+++|+|++|
T Consensus       123 IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G  199 (298)
T d1gz8a_         123 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR  199 (298)
T ss_dssp             CCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEccccCchheee---cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence            9999999999999   567789999999997765433 334456899999999876655 57899999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||.+.++
T Consensus       200 ~~Pf~~~~~  208 (298)
T d1gz8a_         200 RALFPGDSE  208 (298)
T ss_dssp             SCSCCCSSH
T ss_pred             CCCCCCCCH
Confidence            999987653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-38  Score=230.85  Aligned_cols=165  Identities=25%  Similarity=0.501  Sum_probs=142.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC------------------------C
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------R   62 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------~   62 (180)
                      ++...++.+|++++++++||||+++++++...+..++++|++++++|.+++....                        .
T Consensus        57 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (301)
T d1lufa_          57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP  136 (301)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred             hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCC
Confidence            4456779999999999999999999999999999999999999999999986422                        3


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCC---CcccccccCccccCccc
Q 030256           63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEV  139 (180)
Q Consensus        63 ~~~~~~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~ape~  139 (180)
                      ++...++.++.|++.|++|||+.+++||||+|+||++   +.++.++|+|||++......   .......++..|+|||.
T Consensus       137 l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (301)
T d1lufa_         137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  213 (301)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence            7889999999999999999999999999999999999   56788999999998755332   22234457788999999


Q ss_pred             cccccCCcchhHHHHHHHHHHHHhCC-CCCCCCCcc
Q 030256          140 LQFQRYDEKVDMWSVGAILFELLNGY-PPFSAYRPC  174 (180)
Q Consensus       140 ~~~~~~~~~~Di~slg~~~~~~l~g~-~pf~~~~~~  174 (180)
                      +.+..++.++||||+|+++|||++|. +||.+.++.
T Consensus       214 ~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         214 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             HccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            99999999999999999999999985 678876654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-38  Score=228.55  Aligned_cols=166  Identities=30%  Similarity=0.506  Sum_probs=144.8

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHH
Q 030256            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA   68 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~   68 (180)
                      ......++.+|...+.++ +|||||++++++.+++..++||||+++|+|.+++....                .+++..+
T Consensus        58 ~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~  137 (299)
T d1fgka_          58 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL  137 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHH
T ss_pred             ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHH
Confidence            344567788899999888 89999999999999999999999999999999996442                4899999


Q ss_pred             HHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccC
Q 030256           69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY  145 (180)
Q Consensus        69 ~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~  145 (180)
                      ..++.|++.||+|||+.+++||||||+||++   +.++.++|+|||.+.......   ......++..|+|||.+.+..+
T Consensus       138 ~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y  214 (299)
T d1fgka_         138 VSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC
Confidence            9999999999999999999999999999999   577889999999987664332   2233557888999999999999


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          146 DEKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       146 ~~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      +.++||||||+++|||++ |..||.+.+..
T Consensus       215 ~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             CchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            999999999999999998 79999876654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-38  Score=229.22  Aligned_cols=160  Identities=35%  Similarity=0.529  Sum_probs=136.3

Q ss_pred             HHHHHHHHHHhcC---CCccccccceEEEe-----CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Q 030256           11 SCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus        11 ~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      ..+.+|+.+++.+   +||||+++++++..     ....++++|++.++.+...... ...+++..+..++.|++.||+|
T Consensus        52 ~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~y  131 (305)
T d1blxa_          52 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF  131 (305)
T ss_dssp             CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence            3456677777665   79999999999853     3478999999987766544433 3459999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~~  161 (180)
                      ||++|++||||||+||++   +..+.++|+|||.+.............||+.|+|||.+.+..++.++|+||+||++|+|
T Consensus       132 LH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~el  208 (305)
T d1blxa_         132 LHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM  208 (305)
T ss_dssp             HHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             HHhCCEEecCCCccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHH
Confidence            999999999999999999   57788999999998766555555567799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.++
T Consensus       209 l~g~~pf~~~~~  220 (305)
T d1blxa_         209 FRRKPLFRGSSD  220 (305)
T ss_dssp             HHSSCSCCCSSH
T ss_pred             HHCCCCCCCCCH
Confidence            999999987664

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.6e-38  Score=228.25  Aligned_cols=164  Identities=32%  Similarity=0.502  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +.....+.+|+.++++++||||+++++++.+++..+++++++.++.+..+....+.+++..+..++.|++.||++||+.|
T Consensus        41 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  120 (286)
T d1ob3a_          41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR  120 (286)
T ss_dssp             GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc
Confidence            33456788999999999999999999999999999999999987777776666778999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-ccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++||||||+||++   +.++.++++|||.+........ .....++..|.|||.+.+.. ++.++|+||+|+++++|++|
T Consensus       121 IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G  197 (286)
T d1ob3a_         121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG  197 (286)
T ss_dssp             CCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEecCCCCceeeE---cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHC
Confidence            9999999999999   5678899999999877654332 23445788899999987554 68999999999999999999


Q ss_pred             CCCCCCCCc
Q 030256          165 YPPFSAYRP  173 (180)
Q Consensus       165 ~~pf~~~~~  173 (180)
                      +.||.+.++
T Consensus       198 ~~pf~~~~~  206 (286)
T d1ob3a_         198 TPLFPGVSE  206 (286)
T ss_dssp             SCSCCCSSH
T ss_pred             CCCCCCCCH
Confidence            999987654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-37  Score=225.42  Aligned_cols=163  Identities=28%  Similarity=0.453  Sum_probs=140.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN   83 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh   83 (180)
                      +....+++.+|++++++++||||+++++++.. ++..++||||+++++|.+++.... .++...++.++.|++.|+.|+|
T Consensus        68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH  147 (311)
T d1r0pa_          68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA  147 (311)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc
Confidence            44556779999999999999999999999765 568999999999999999887443 5788899999999999999999


Q ss_pred             hCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc-----ccccccCccccCccccccccCCcchhHHHHHHHH
Q 030256           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  158 (180)
Q Consensus        84 ~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~  158 (180)
                      +.+++||||+|+||++   +++..++|+|||++........     .....++..|+|||.+....++.++||||||+++
T Consensus       148 ~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl  224 (311)
T d1r0pa_         148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL  224 (311)
T ss_dssp             HTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             ccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence            9999999999999999   5778899999999976643321     2234578889999999989999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 030256          159 FELLNGYPPFSAY  171 (180)
Q Consensus       159 ~~~l~g~~pf~~~  171 (180)
                      ||+++|..||...
T Consensus       225 ~El~t~~~p~~~~  237 (311)
T d1r0pa_         225 WELMTRGAPPYPD  237 (311)
T ss_dssp             HHHHTTSCCSCC-
T ss_pred             HHHHHCCCCCCCC
Confidence            9999977777543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-37  Score=225.41  Aligned_cols=163  Identities=31%  Similarity=0.527  Sum_probs=131.8

Q ss_pred             HHHHHHHHHHHHHhcC-CCccccccceEEEe-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHH
Q 030256            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~   69 (180)
                      ...+.+.+|...+.++ +|+||+.+.+++.. ++.++++|||+++|+|.+++...                ..+++..+.
T Consensus        58 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  137 (299)
T d1ywna1          58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  137 (299)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHH
Confidence            3455677788888777 78999999998765 45789999999999999998643                238899999


Q ss_pred             HHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC---cccccccCccccCccccccccCC
Q 030256           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  146 (180)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~  146 (180)
                      .++.|++.|++|||++|++||||||+||++   +.++.++|+|||+++......   ......++..|+|||.+.+..++
T Consensus       138 ~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~  214 (299)
T d1ywna1         138 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence            999999999999999999999999999999   577889999999997654322   22334588999999999999999


Q ss_pred             cchhHHHHHHHHHHHHhC-CCCCCCCCc
Q 030256          147 EKVDMWSVGAILFELLNG-YPPFSAYRP  173 (180)
Q Consensus       147 ~~~Di~slg~~~~~~l~g-~~pf~~~~~  173 (180)
                      .++||||+|+++|||++| ..||.+.+.
T Consensus       215 ~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         215 IQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999986 568876554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-37  Score=228.71  Aligned_cols=167  Identities=26%  Similarity=0.431  Sum_probs=144.3

Q ss_pred             hhhhhHHHHHHHHHHHHHHhcC-CCccccccceEEEe--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG   78 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~   78 (180)
                      +|.++....+.+.+|+++|+++ .||||+++++++..  ....++||||+.+++|...   ...+++..+..++.||+.|
T Consensus        65 iK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~a  141 (328)
T d3bqca1          65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKA  141 (328)
T ss_dssp             EEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHH
T ss_pred             EEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHH
Confidence            5666666677889999999999 49999999999874  4579999999999999765   3579999999999999999


Q ss_pred             HHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccccc-CCcchhHHHHHHH
Q 030256           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAI  157 (180)
Q Consensus        79 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~  157 (180)
                      |+|||++|++|+||||+||++.  ..+..++|+|||++.............++..|+|||...+.. ++.++|+||+|++
T Consensus       142 L~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~  219 (328)
T d3bqca1         142 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM  219 (328)
T ss_dssp             HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred             HHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhh
Confidence            9999999999999999999996  345679999999998776655555666889999999987654 7999999999999


Q ss_pred             HHHHHhCCCCCCCCCc
Q 030256          158 LFELLNGYPPFSAYRP  173 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~  173 (180)
                      ++++++|..||...+.
T Consensus       220 l~e~~~g~~pf~~~~~  235 (328)
T d3bqca1         220 LASMIFRKEPFFHGHD  235 (328)
T ss_dssp             HHHHHHTCSSSSCCSS
T ss_pred             hHHhccCCCCCCCCch
Confidence            9999999999977554

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-37  Score=224.88  Aligned_cols=165  Identities=30%  Similarity=0.476  Sum_probs=143.1

Q ss_pred             HHHHHHHHHHHHHHhcC-CCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHH
Q 030256            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQT   67 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~   67 (180)
                      ...+.++.+|+.+++++ +||||+++++++.+.+..+++|||+++++|.+++....                  .+++..
T Consensus        67 ~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~  146 (311)
T d1t46a_          67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED  146 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred             HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence            34566788999999999 79999999999999999999999999999999987543                  488999


Q ss_pred             HHHHHHHHHHHHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCcccccccc
Q 030256           68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR  144 (180)
Q Consensus        68 ~~~~~~~i~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~  144 (180)
                      +..++.|++.|+++||+++++||||||+||++   +..+.++++|||.++.......   .....+++.|+|||.+.+..
T Consensus       147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  223 (311)
T d1t46a_         147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV  223 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence            99999999999999999999999999999999   4678899999999977654322   22345788999999999999


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030256          145 YDEKVDMWSVGAILFELLN-GYPPFSAYRPC  174 (180)
Q Consensus       145 ~~~~~Di~slg~~~~~~l~-g~~pf~~~~~~  174 (180)
                      ++.++||||||+++|||++ |.+||.+.+..
T Consensus       224 ~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             CCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998 66667665543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-37  Score=227.46  Aligned_cols=160  Identities=32%  Similarity=0.478  Sum_probs=134.2

Q ss_pred             HHHHHHHHHhcCCCccccccceEEEe------CCeEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256           12 CLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus        12 ~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ...+|++++++++||||+++++++..      ...+++||||++++.+....   .....+++..+..++.|++.||+||
T Consensus        59 ~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL  138 (350)
T d1q5ka_          59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI  138 (350)
T ss_dssp             SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            34579999999999999999999843      23689999999765433332   3345699999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccc-ccCCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~~~~~~  161 (180)
                      |++|++||||||+||++.  .+...++|+|||++.............++..|+|||...+ ..++.++||||+|+++|||
T Consensus       139 H~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el  216 (350)
T d1q5ka_         139 HSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL  216 (350)
T ss_dssp             HTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEeh
Confidence            999999999999999994  3345799999999987766665566678999999998764 5689999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||...+.
T Consensus       217 ~~g~~pf~~~~~  228 (350)
T d1q5ka_         217 LLGQPIFPGDSG  228 (350)
T ss_dssp             HHTSCSSCCSSH
T ss_pred             hhCCCCCCCCCH
Confidence            999999987654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-37  Score=224.13  Aligned_cols=165  Identities=25%  Similarity=0.354  Sum_probs=133.1

Q ss_pred             hhhhhHHHHHHHHHH--HHHHhcCCCccccccceEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 030256            2 LKKLNKHLKSCLDCE--LNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (180)
Q Consensus         2 ~~~~~~~~~~~~~~e--~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i   75 (180)
                      +|.++.+..+...+|  +..+++++||||+++++++.+.+    .+++||||+++++|.+++++ .+++...++.++.++
T Consensus        31 vK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~i  109 (303)
T d1vjya_          31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALST  109 (303)
T ss_dssp             EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred             EEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHH
Confidence            455544444444444  44556779999999999987543    68999999999999999974 578999999999999


Q ss_pred             HHHHHHHHh--------CCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-----cccccccCccccCcccccc
Q 030256           76 GAGLEILNS--------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF  142 (180)
Q Consensus        76 ~~~l~~lh~--------~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~ape~~~~  142 (180)
                      +.+++++|+        +|++||||||+||++   +.++.++|+|||++.......     ......+++.|+|||.+.+
T Consensus       110 a~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  186 (303)
T d1vjya_         110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  186 (303)
T ss_dssp             HHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccc
Confidence            999999996        599999999999999   577899999999987664432     2234568999999999865


Q ss_pred             c------cCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030256          143 Q------RYDEKVDMWSVGAILFELLNGYPPFSA  170 (180)
Q Consensus       143 ~------~~~~~~Di~slg~~~~~~l~g~~pf~~  170 (180)
                      .      .++.++||||||+++||+++|..||..
T Consensus       187 ~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            4      357789999999999999999888754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-37  Score=225.73  Aligned_cols=164  Identities=32%  Similarity=0.533  Sum_probs=143.4

Q ss_pred             HHHHHHHHHHHHhcCCC-ccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256            9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..+.+.+|++++++++| |||+++++++.+.+..++++||+.+++|.+++...+.+++..+..++.|++.|++|+|++|+
T Consensus        71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~i  150 (322)
T d1vzoa_          71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI  150 (322)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence            34568889999999966 89999999999999999999999999999999988999999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCC--CcccccccCccccCccccccc--cCCcchhHHHHHHHHHHHHh
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN  163 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~--~~~~~~Di~slg~~~~~~l~  163 (180)
                      +|+||+|+||++   +.++.++|+|||++......  .......++..|++||...+.  .++.++||||+||++|+|++
T Consensus       151 vHrDiKp~Nill---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt  227 (322)
T d1vzoa_         151 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT  227 (322)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred             EeccCCccceee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence            999999999999   56778999999998765432  223345688999999998654  46789999999999999999


Q ss_pred             CCCCCCCCCccc
Q 030256          164 GYPPFSAYRPCF  175 (180)
Q Consensus       164 g~~pf~~~~~~~  175 (180)
                      |+.||.+.+...
T Consensus       228 G~~PF~~~~~~~  239 (322)
T d1vzoa_         228 GASPFTVDGEKN  239 (322)
T ss_dssp             SSCTTSCTTSCC
T ss_pred             CCCCCCCCCHHH
Confidence            999998776543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=225.83  Aligned_cols=162  Identities=31%  Similarity=0.537  Sum_probs=136.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~   81 (180)
                      +...+.+.+|+++|++++||||+++++++....     .++++++ +.+++|.+++. ..++++..+..++.|++.||+|
T Consensus        47 ~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~-~~~g~L~~~l~-~~~l~~~~i~~i~~qil~al~y  124 (345)
T d1pmea_          47 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH-LMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY  124 (345)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE-CCCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe-ecCCchhhhhh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            344567889999999999999999999986543     3556555 55899999987 4579999999999999999999


Q ss_pred             HHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC----cccccccCccccCcccccc-ccCCcchhHHHHHH
Q 030256           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA  156 (180)
Q Consensus        82 lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~-~~~~~~~Di~slg~  156 (180)
                      ||++|++||||||+||++   +..+.++|+|||++.......    ......++..|+|||.+.. ..++.++|+||+|+
T Consensus       125 LH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~  201 (345)
T d1pmea_         125 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC  201 (345)
T ss_dssp             HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHH
T ss_pred             HHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCc
Confidence            999999999999999999   567889999999986653321    2234558889999999854 45788999999999


Q ss_pred             HHHHHHhCCCCCCCCCc
Q 030256          157 ILFELLNGYPPFSAYRP  173 (180)
Q Consensus       157 ~~~~~l~g~~pf~~~~~  173 (180)
                      ++++|++|+.||.+.++
T Consensus       202 il~eml~g~~pf~~~~~  218 (345)
T d1pmea_         202 ILAEMLSNRPIFPGKHY  218 (345)
T ss_dssp             HHHHHHHSSCSCCCSSH
T ss_pred             eehHHhhCCCCCCCCCH
Confidence            99999999999987664

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.5e-37  Score=222.82  Aligned_cols=164  Identities=20%  Similarity=0.256  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHHhcCCCcccc-ccceEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ..++.+|++++++++|++++ .+..+..+.+..+++||++ ++++.+.+.. ...+++..+..++.|++.++++||++|+
T Consensus        46 ~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  124 (299)
T d1ckia_          46 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF  124 (299)
T ss_dssp             SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCe
Confidence            45688899999999877655 4555567888999999999 5677666654 4579999999999999999999999999


Q ss_pred             eeecCCCCCeeeecCCCCceEEEeecCCccccCCCC--------cccccccCccccCccccccccCCcchhHHHHHHHHH
Q 030256           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  159 (180)
Q Consensus        88 ~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~  159 (180)
                      +||||||+||++...+.+..++++|||++.......        ......|++.|+|||...+..++.++|+||||+++|
T Consensus       125 iHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~  204 (299)
T d1ckia_         125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM  204 (299)
T ss_dssp             ECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHH
T ss_pred             eeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHH
Confidence            999999999998644556679999999998764332        123446899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCcc
Q 030256          160 ELLNGYPPFSAYRPC  174 (180)
Q Consensus       160 ~~l~g~~pf~~~~~~  174 (180)
                      ||++|+.||......
T Consensus       205 el~tg~~P~~~~~~~  219 (299)
T d1ckia_         205 YFNLGSLPWQGLKAA  219 (299)
T ss_dssp             HHHHSSCTTCCCC--
T ss_pred             HHHhCCCcccccchH
Confidence            999999999876554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.6e-36  Score=217.14  Aligned_cols=164  Identities=19%  Similarity=0.294  Sum_probs=141.4

Q ss_pred             HHHHHHHHHHHhcCCC-ccccccceEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 030256           10 KSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (180)
Q Consensus        10 ~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (180)
                      ...+++|++.++.++| ++++.+++++..++..++|||++ +++|.+++...+ .++...+..++.|++.++++||++|+
T Consensus        44 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~gi  122 (293)
T d1csna_          44 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL  122 (293)
T ss_dssp             SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCc
Confidence            4557889999999965 89999999999999999999999 789999887654 69999999999999999999999999


Q ss_pred             eeecCCCCCeeeecC--CCCceEEEeecCCccccCCCC--------cccccccCccccCccccccccCCcchhHHHHHHH
Q 030256           88 IHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  157 (180)
Q Consensus        88 ~h~dl~~~nil~~~~--~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~  157 (180)
                      +||||||+||+++..  ...+.++|+|||+++......        ......||+.|+|||.+.+..++.++|+||||++
T Consensus       123 iHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~  202 (293)
T d1csna_         123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV  202 (293)
T ss_dssp             ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred             eeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHH
Confidence            999999999999632  235679999999997654321        2223568999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030256          158 LFELLNGYPPFSAYRPC  174 (180)
Q Consensus       158 ~~~~l~g~~pf~~~~~~  174 (180)
                      +|+|++|..||.+.+..
T Consensus       203 l~elltg~~Pf~~~~~~  219 (293)
T d1csna_         203 FMYFLRGSLPWQGLKAA  219 (293)
T ss_dssp             HHHHHHSSCTTSSCCSC
T ss_pred             HHHHHhCCCcCCCccch
Confidence            99999999999876544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-36  Score=224.06  Aligned_cols=161  Identities=33%  Similarity=0.558  Sum_probs=139.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccccccceEEEeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 030256            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL   79 (180)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l   79 (180)
                      ++...+.+.+|+++|++++||||+++++++...+      .++++|||+ +.+|....+ ..++++..+..++.|++.||
T Consensus        57 ~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL  134 (346)
T d1cm8a_          57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGL  134 (346)
T ss_dssp             SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHH
Confidence            3445667889999999999999999999997654      579999999 778877665 67899999999999999999


Q ss_pred             HHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccc-cCCcchhHHHHHHHH
Q 030256           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL  158 (180)
Q Consensus        80 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Di~slg~~~  158 (180)
                      +|||++|++|+||||+||++   +.++.++++|||.+.......  ....++..|+|||.+.+. .++.++|+||+|+++
T Consensus       135 ~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil  209 (346)
T d1cm8a_         135 RYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM  209 (346)
T ss_dssp             HHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSSC--CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred             HHHHhCCCcccccCcchhhc---ccccccccccccceeccCCcc--ccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence            99999999999999999999   578889999999997764432  345588999999998764 468999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030256          159 FELLNGYPPFSAYRP  173 (180)
Q Consensus       159 ~~~l~g~~pf~~~~~  173 (180)
                      |+|++|+.||.+.+.
T Consensus       210 ~ell~g~~pf~~~~~  224 (346)
T d1cm8a_         210 AEMITGKTLFKGSDH  224 (346)
T ss_dssp             HHHHHSSCSSCCSSH
T ss_pred             HHHHHCcCCCCCCCh
Confidence            999999999987654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=220.98  Aligned_cols=164  Identities=23%  Similarity=0.439  Sum_probs=142.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLGA   77 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~   77 (180)
                      +....+.+|++++++++||||+++++++...+..++||||+++|+|.+++...          ..++...+..++.|++.
T Consensus        65 ~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~  144 (308)
T d1p4oa_          65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD  144 (308)
T ss_dssp             HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHH
Confidence            44556889999999999999999999999999999999999999999987532          23688999999999999


Q ss_pred             HHHHHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCc---ccccccCccccCccccccccCCcchhHHHH
Q 030256           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  154 (180)
Q Consensus        78 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~sl  154 (180)
                      |+.|||+++++||||+|+||++   +.+..++|+|||++........   .....+++.|+|||.+.+..++.++|+||+
T Consensus       145 gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~  221 (308)
T d1p4oa_         145 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  221 (308)
T ss_dssp             HHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHhhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccH
Confidence            9999999999999999999999   6788899999999876543322   223457899999999999999999999999


Q ss_pred             HHHHHHHHhC-CCCCCCCCcc
Q 030256          155 GAILFELLNG-YPPFSAYRPC  174 (180)
Q Consensus       155 g~~~~~~l~g-~~pf~~~~~~  174 (180)
                      |+++|||++| ..||.+.+..
T Consensus       222 G~il~El~t~~~~p~~~~~~~  242 (308)
T d1p4oa_         222 GVVLWEIATLAEQPYQGLSNE  242 (308)
T ss_dssp             HHHHHHHHHTSCCTTTTSCHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHH
Confidence            9999999997 5888776554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-36  Score=223.55  Aligned_cols=162  Identities=33%  Similarity=0.452  Sum_probs=131.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEe------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~   80 (180)
                      +....++.+|+.++++++||||+++++++..      .+.+|++|||+.++.+ +.+  ...+++..+..++.|++.|++
T Consensus        57 ~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~  133 (355)
T d2b1pa1          57 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIK  133 (355)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHH
Confidence            4556678999999999999999999999853      3689999999966444 434  457999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHHHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  160 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~~~~~  160 (180)
                      +||++|++|+||||+||++   +.++.++++|||.+.............++..|+|||.+.+..++.++|+||+||++++
T Consensus       134 ~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e  210 (355)
T d2b1pa1         134 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  210 (355)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             HhhhcccccccCCcccccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence            9999999999999999999   5677899999999877766655566678999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030256          161 LLNGYPPFSAYRPC  174 (180)
Q Consensus       161 ~l~g~~pf~~~~~~  174 (180)
                      |++|+.||.+.++.
T Consensus       211 ll~g~~pF~~~~~~  224 (355)
T d2b1pa1         211 MVRHKILFPGRDYI  224 (355)
T ss_dssp             HHHSSCSSCCSSHH
T ss_pred             HhhCCCCCCCCCHH
Confidence            99999999876543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-36  Score=220.05  Aligned_cols=162  Identities=25%  Similarity=0.445  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEe--------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~   80 (180)
                      ....+.+|+++|++++|||++++++++..        .+..+++||++.++.+.........+++..+..++.|++.|+.
T Consensus        52 ~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~  131 (318)
T d3blha1          52 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY  131 (318)
T ss_dssp             SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHH
Confidence            45568899999999999999999998754        3468999999977666655555567999999999999999999


Q ss_pred             HHHhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-----cccccccCccccCccccccc-cCCcchhHHHH
Q 030256           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSV  154 (180)
Q Consensus        81 ~lh~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~ape~~~~~-~~~~~~Di~sl  154 (180)
                      |||++|++||||+|+||++   +.++.++++|||++.......     ......+|..|+|||.+.+. .++.++|+||+
T Consensus       132 ~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl  208 (318)
T d3blha1         132 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA  208 (318)
T ss_dssp             HHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HhccCCEEecCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence            9999999999999999999   577889999999987654322     22234588999999998765 57899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCc
Q 030256          155 GAILFELLNGYPPFSAYRP  173 (180)
Q Consensus       155 g~~~~~~l~g~~pf~~~~~  173 (180)
                      |+++|+|++|+.||.+.++
T Consensus       209 Gvil~el~~g~~pf~~~~~  227 (318)
T d3blha1         209 GCIMAEMWTRSPIMQGNTE  227 (318)
T ss_dssp             HHHHHHHHHSSCSCCCSSH
T ss_pred             CceeeeHhhCCCCCCCCCH
Confidence            9999999999999987554

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-35  Score=213.39  Aligned_cols=161  Identities=32%  Similarity=0.510  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 030256            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (180)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (180)
                      +.....+.+|+.++++++||||+++++++.+.+..+++++++.++++..++...+.+++..+..++.|++.||+|||++|
T Consensus        42 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~  121 (292)
T d1unla_          42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC
Confidence            34567889999999999999999999999999999999999999999988887888999999999999999999999999


Q ss_pred             CeeecCCCCCeeeecCCCCceEEEeecCCccccCCCC-cccccccCccccCcccccccc-CCcchhHHHHHHHHHHHHhC
Q 030256           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG  164 (180)
Q Consensus        87 ~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~l~g  164 (180)
                      ++|+||||+||++   +....++++|||.+....... ......++..|.|||.+.+.. ++.++|+||+|+++++|++|
T Consensus       122 IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g  198 (292)
T d1unla_         122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             EECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             EeeecccCccccc---ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhC
Confidence            9999999999999   567789999999997765433 233344667789999887655 68999999999999999999


Q ss_pred             CCCCCC
Q 030256          165 YPPFSA  170 (180)
Q Consensus       165 ~~pf~~  170 (180)
                      +.||..
T Consensus       199 ~~p~~~  204 (292)
T d1unla_         199 GRPLFP  204 (292)
T ss_dssp             SCCSCC
T ss_pred             CCCCCC
Confidence            998643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-35  Score=216.00  Aligned_cols=160  Identities=31%  Similarity=0.503  Sum_probs=131.4

Q ss_pred             HHHHHHHHHHHHHhcCCCccccccceEEEeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030256            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l   82 (180)
                      ...+.+.+|++++++++|||++++++++...     ...+++++++.|++|.+++. ..++++..+..++.|++.||+||
T Consensus        59 ~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~L  137 (348)
T d2gfsa1          59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYI  137 (348)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHH
Confidence            4455688999999999999999999998532     23455566677999999886 56799999999999999999999


Q ss_pred             HhCCCeeecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCcccccccc-CCcchhHHHHHHHHHHH
Q 030256           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFEL  161 (180)
Q Consensus        83 h~~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Di~slg~~~~~~  161 (180)
                      |++|++||||||+||++   +.++.++++|||.+......  .....++..|+|||...+.. ++.++|+||+|+++|+|
T Consensus       138 H~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~l  212 (348)
T d2gfsa1         138 HSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  212 (348)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHH
T ss_pred             HhCCCcccccCCccccc---cccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHH
Confidence            99999999999999999   57788999999998655332  23445788899999876654 68899999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030256          162 LNGYPPFSAYRP  173 (180)
Q Consensus       162 l~g~~pf~~~~~  173 (180)
                      ++|+.||.+.+.
T Consensus       213 l~g~~pF~~~~~  224 (348)
T d2gfsa1         213 LTGRTLFPGTDH  224 (348)
T ss_dssp             HHSSCSCCCSSH
T ss_pred             HhCCCCCCCCCH
Confidence            999999987654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=9.9e-29  Score=184.08  Aligned_cols=162  Identities=30%  Similarity=0.464  Sum_probs=124.6

Q ss_pred             HHHHHHHHHHHHhcCC-----------CccccccceEEEe--CCeEEEEEeccCCCChHHH-HH--hcCCCCHHHHHHHH
Q 030256            9 LKSCLDCELNFLSSVN-----------HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSY-IR--LHGRVPEQTARKFL   72 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~-l~--~~~~~~~~~~~~~~   72 (180)
                      ..+.+.+|++++++++           |+||+++++++..  ....+.++.+......... ..  ....+++..+..++
T Consensus        52 ~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~  131 (362)
T d1q8ya_          52 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS  131 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred             chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHH
Confidence            4567788999998885           5789999988754  3566666666544443322 22  23468999999999


Q ss_pred             HHHHHHHHHHHh-CCCeeecCCCCCeeeecCC---CCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcc
Q 030256           73 QQLGAGLEILNS-HHIIHRDLKPENILLSGLD---DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK  148 (180)
Q Consensus        73 ~~i~~~l~~lh~-~~~~h~dl~~~nil~~~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~  148 (180)
                      .|++.|+++||+ .|++||||||+||++...+   ....++++|||.+......  .....++..|+|||.+.+..++.+
T Consensus       132 ~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~  209 (362)
T d1q8ya_         132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCG  209 (362)
T ss_dssp             HHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTH
T ss_pred             HHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccccCCCcc
Confidence            999999999998 8999999999999995311   1235899999998665432  234558899999999999999999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCC
Q 030256          149 VDMWSVGAILFELLNGYPPFSAYR  172 (180)
Q Consensus       149 ~Di~slg~~~~~~l~g~~pf~~~~  172 (180)
                      +|+||+|+++++|++|+.||...+
T Consensus       210 ~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         210 ADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC----
T ss_pred             ccccchHHHHHHHHHCCCCCCCCc
Confidence            999999999999999999997654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.77  E-value=1.2e-19  Score=123.34  Aligned_cols=131  Identities=16%  Similarity=0.132  Sum_probs=92.5

Q ss_pred             HHHHHHHHHHHHhcCCCccccccceEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 030256            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (180)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (180)
                      .+....+|...+.++.|.+++..+++.  .  .+++||++++..+..       ++...+..++.|++.++++||++|++
T Consensus        57 ~~~~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~gii  125 (191)
T d1zara2          57 AIRSARNEFRALQKLQGLAVPKVYAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIV  125 (191)
T ss_dssp             HHHHHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHHccCCCcceEEEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEE
Confidence            345567789999999999998887653  2  279999998755432       44556778999999999999999999


Q ss_pred             eecCCCCCeeeecCCCCceEEEeecCCccccCCCCcccccccCccccCccccccccCCcchhHHHHHH
Q 030256           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  156 (180)
Q Consensus        89 h~dl~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slg~  156 (180)
                      |+||||+||+++    +..++|+|||.+.....+...........- -.+ +....++.++|+||+.-
T Consensus       126 HrDiKP~NILv~----~~~~~liDFG~a~~~~~~~~~~~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         126 HGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWREILERDVRN-IIT-YFSRTYRTEKDINSAID  187 (191)
T ss_dssp             CSCCSTTSEEEE----TTEEEECCCTTCEETTSTTHHHHHHHHHHH-HHH-HHHHHHCCCCCHHHHHH
T ss_pred             EccCChhheeee----CCCEEEEECCCcccCCCCCcHHHHHHHHHH-HHH-HHcCCCCCcccHHHHHH
Confidence            999999999995    245889999998666443221100000000 001 12356788999999654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.24  E-value=2.5e-06  Score=59.06  Aligned_cols=45  Identities=9%  Similarity=0.028  Sum_probs=35.5

Q ss_pred             HHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCChHHH
Q 030256           12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY   56 (180)
Q Consensus        12 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   56 (180)
                      .+.+|...++.+. +--+++++.+..+++..+++|++++|.++.+.
T Consensus        55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence            4678888888773 43468888888888999999999999887543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.05  E-value=8.1e-07  Score=61.31  Aligned_cols=47  Identities=17%  Similarity=0.103  Sum_probs=34.6

Q ss_pred             HHHHHHHHHHHHHhcCCCc--cccccceEEEeCCeEEEEEeccCCCChH
Q 030256            8 HLKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (180)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~   54 (180)
                      .....+.+|...++.+...  -+++++.+..+.+..+++|++++|.++.
T Consensus        46 ~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          46 GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            3344577888888877332  3677787778888899999999987663

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.55  E-value=8.5e-05  Score=54.43  Aligned_cols=28  Identities=29%  Similarity=0.398  Sum_probs=23.0

Q ss_pred             CCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        86 ~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      .++|||+.|.||+++    ...++++||..+.
T Consensus       224 ~LiHGDl~~gNIlv~----~~~~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFAS----EHETKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEEC----SSCEEECCCTTCE
T ss_pred             ceeccCCcCCceeEc----CCceEEechhhcc
Confidence            589999999999994    2348999998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.63  E-value=0.00069  Score=49.41  Aligned_cols=38  Identities=16%  Similarity=0.141  Sum_probs=26.2

Q ss_pred             HHHHHHHHHhcCC-CccccccceEEEeCCeEEEEEeccCCCCh
Q 030256           12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNL   53 (180)
Q Consensus        12 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   53 (180)
                      ...+|..+++.+. +.-.+++++++.+    ..|++|++|.++
T Consensus        90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            3557888888884 4334677776643    478999987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.15  E-value=0.003  Score=44.70  Aligned_cols=53  Identities=11%  Similarity=0.118  Sum_probs=31.9

Q ss_pred             ChhhhhHH--HHHHHHHHHHHHhcCCCccc--cccc-----eEEEeCCeEEEEEeccCCCCh
Q 030256            1 MLKKLNKH--LKSCLDCELNFLSSVNHPNI--IRLF-----DAFQAENCIFLVVEFCAGGNL   53 (180)
Q Consensus         1 ~~~~~~~~--~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~~L   53 (180)
                      |||..++.  ..+++..|...+..|...++  +..+     ..+...+..+.++++++|..+
T Consensus        50 VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          50 VVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             EEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             EEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            35555443  35668888888888743322  2222     224556778999999986443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.14  E-value=0.0028  Score=44.43  Aligned_cols=30  Identities=30%  Similarity=0.598  Sum_probs=24.7

Q ss_pred             CCCeeecCCCCCeeeecCCCCceEEEeecCCcc
Q 030256           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (180)
Q Consensus        85 ~~~~h~dl~~~nil~~~~~~~~~~~l~d~~~~~  117 (180)
                      .|++|+|+.++|+++.   .+....++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFL---GDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcc---cccceeEecccccc
Confidence            3689999999999994   55556899999764